Citrus Sinensis ID: 004416
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 754 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.921 | 0.817 | 0.465 | 1e-180 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.915 | 0.814 | 0.451 | 1e-175 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.916 | 0.819 | 0.454 | 1e-173 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.884 | 0.851 | 0.442 | 1e-173 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.907 | 0.821 | 0.457 | 1e-171 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.919 | 0.808 | 0.448 | 1e-169 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.936 | 0.831 | 0.437 | 1e-166 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.913 | 0.815 | 0.438 | 1e-163 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.912 | 0.806 | 0.437 | 1e-158 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.877 | 0.812 | 0.435 | 1e-154 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 633 bits (1633), Expect = e-180, Method: Compositional matrix adjust.
Identities = 340/731 (46%), Positives = 475/731 (64%), Gaps = 36/731 (4%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVA 93
+S++A+TL+ + I T+VSP FELGFF PG Y+GIWY+ I T VWVA
Sbjct: 25 YSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVA 84
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNP-VAQLLDNGNLVIRDN 151
NR++P+ G L +S+ NLV+L+QS+ +WS+N++ +V++P VA+LLDNGN V+RD+
Sbjct: 85 NRDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDS 143
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
S + + LWQSFD+PTDT+L MKLGWD +TG R+ SWKS DDPS G+F+ +L+
Sbjct: 144 KNS-APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPII 270
P++ ++N ++ +GPWNG+ F P F + +K+EV Y + S +
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVY 262
Query: 271 MILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGF 329
L ++ G +QR W E + W F+ AP C Y +CG C + + C C++GF
Sbjct: 263 SRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGF 322
Query: 330 KFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAEC 382
K ++ Q + CVR C GD F +L +KLPD S++ + +KECE +C
Sbjct: 323 KPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKC 382
Query: 383 LKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWI 442
L++C+C A+AN+ + GSGC+ W G+L D++ + G +Y+R+ A++ +K+
Sbjct: 383 LRDCNCTAFANTDIRGSGSGCVTWTGELFDIR--NYAKGGQDLYVRLAATDLEDKRNRSA 440
Query: 443 IVI---LVLPLVILPCVYIARQWSRKRKEN---ETKNLD---TNQDLLAFDVNMGITTRT 493
+I + + +++L I W RK+K + ET +D ++DLL +V I++R
Sbjct: 441 KIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVV--ISSRR 498
Query: 494 NEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVA 553
+ E + D D LPL F V AT NFS +KLG+GGFG VYKG+LL+GQE+A
Sbjct: 499 HISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552
Query: 554 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF 613
VKRLS S QG EFKNE+ LIA+LQH NLVRLL CC++ GEK+LIYEY+ N SLD LF
Sbjct: 553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
D ++ L WQ+R II+GIA+GLLYLHQ SR RIIHRDLKASNILLD++M PKISDFGM
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733
AR+FG DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LEI+SSK+N G YN
Sbjct: 673 ARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYN 732
Query: 734 TD-SFNLLGHV 743
+D NLLG V
Sbjct: 733 SDRDLNLLGCV 743
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 615 bits (1586), Expect = e-175, Method: Compositional matrix adjust.
Identities = 332/735 (45%), Positives = 469/735 (63%), Gaps = 45/735 (6%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVA 93
FS+ A + T I +T++SPSQ FELGFF+P S Y+GIWY+ IP T VWVA
Sbjct: 23 FSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVA 82
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA-QLLDNGNLVIRDN 151
NR++P+ NG L +S+ NLV+ +QS+ +WS+N++ +V++PVA +LLD GN V+RD
Sbjct: 83 NRDNPLSSSNGTLKISD-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD- 140
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTG-LERYQTSWKSADDPSPGNFTHRLDI 210
S +N +LWQSFD+PTDT+L MK+GWD ++G R SWK+ DDPS G+F+ +L
Sbjct: 141 SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRT 200
Query: 211 HVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI------VVQNKDEVYYMYES 264
P+ +YN + +GPW G F S P +P+ +N +V Y Y
Sbjct: 201 SGFPEFYIYNKESITYRSGPWLGNRFSSVPG-----MKPVDYIDNSFTENNQQVVYSYRV 255
Query: 265 YSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHC 323
+ I IL ++ G +QRL W E + W+ + +P C +Y +CG C + + C
Sbjct: 256 NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPIC 315
Query: 324 ECLEGFKFKSQQNQT------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKE 377
C++GF+ ++Q CVR C D F +L ++LPD + S+++ + LKE
Sbjct: 316 NCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKE 375
Query: 378 CEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNK 437
CE CLK C+C A+AN+ + +GGSGC++W G L D++ + G +Y+RV A + +K
Sbjct: 376 CEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIR--NYAKGGQDLYVRVAAGDLEDK 433
Query: 438 KLLWIIVI---LVLPLVILPCVYIARQWSRKRKENET-----KNLDTNQDLLAFDVNMGI 489
++ +I + + +++L I W RK+K + T +L +QD L ++
Sbjct: 434 RIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKAS 493
Query: 490 TTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNG 549
+ T++ ++K+ LPL + ++ AT NFS +KLG+GGFG VYKG LL+G
Sbjct: 494 RSYTSK--------ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDG 545
Query: 550 QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609
+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYEY+ N SLD
Sbjct: 546 KEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLD 605
Query: 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669
LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD++M PKIS
Sbjct: 606 SHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKIS 665
Query: 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729
DFGMAR+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LEI+S K+N
Sbjct: 666 DFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNK 725
Query: 730 GVYNTD-SFNLLGHV 743
G YN++ NLLG V
Sbjct: 726 GFYNSNRDLNLLGFV 740
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 608 bits (1568), Expect = e-173, Method: Compositional matrix adjust.
Identities = 332/730 (45%), Positives = 469/730 (64%), Gaps = 39/730 (5%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVA 93
FS++ +TL+ T I +T++SPSQ FELGFF+P S Y+GIWY+ IP T VWVA
Sbjct: 23 FSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVA 82
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA-QLLDNGNLVIRDN 151
NR++P+ NG L +S NLV+ +QS+ +WS+N++ +V++PVA +LLDNGN ++RD
Sbjct: 83 NRDNPLSSSNGTLKISG-NNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD- 140
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
S LWQSFD+PTDT+L MKLGWD +TG R SWK+ DDPS G F+ +L+
Sbjct: 141 ----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETS 196
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPII 270
P+ + + + +GPWNG+ F S P + +K+EV Y Y + +
Sbjct: 197 EFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLY 256
Query: 271 MILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGF 329
L +N G +QRL W E + W+ + +P C +Y CG C + +C C++GF
Sbjct: 257 SRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGF 316
Query: 330 KFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAEC 382
K ++Q + C+R C D F +L +KLPD ++ + LK C+ C
Sbjct: 317 KPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERC 376
Query: 383 LKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWI 442
L++C+C A+AN+ + +GGSGC++W +++D++ + G +Y+R+ A+E +K++
Sbjct: 377 LEDCNCTAFANADIRNGGSGCVIWTREILDMR--NYAKGGQDLYVRLAAAELEDKRIKNE 434
Query: 443 IVI---LVLPLVILPCVYIARQWSRKRKEN---ETKNLDT--NQDLLAFDVNMGITTRTN 494
+I + + +++L I W RK+K + +T N+D +QD L DV + T+
Sbjct: 435 KIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTS 494
Query: 495 EFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAV 554
+ + KS+ LPL ++ AT NFS +KLG+GGFG VYKGRLL+G+E+AV
Sbjct: 495 K--------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546
Query: 555 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614
KRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYEY+ N SLD LFD
Sbjct: 547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD++M PKISDFGMA
Sbjct: 607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666
Query: 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734
R+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LEI+S K+N G YN+
Sbjct: 667 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 726
Query: 735 D-SFNLLGHV 743
+ NLLG V
Sbjct: 727 NRDLNLLGFV 736
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 607 bits (1566), Expect = e-173, Method: Compositional matrix adjust.
Identities = 333/752 (44%), Positives = 457/752 (60%), Gaps = 85/752 (11%)
Query: 24 NIFSSLI--FYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIW 81
N+ LI + I + A D L ++DG+T+VS FE+GFFSPG S+NRY+GIW
Sbjct: 5 NVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIW 64
Query: 82 YQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNV-----SREVKN 135
Y++I TVVWVANR+SP+ D +G L VS G+L L N N IWSS+ ++N
Sbjct: 65 YKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRN 124
Query: 136 PVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKS 195
P+ Q+LD GNLV+R NSG + + Y+WQS DYP D L GMK G + TGL R+ TSW++
Sbjct: 125 PIVQILDTGNLVVR-NSGDD--QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 196 ADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQN 254
DDPS GN+T+++D + +PQ + S TGPWNG+ F P+ I++ V
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 255 KDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNS 313
++EVYY Y+ + ++ +++NP G +QR W + W + +A C Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 314 ICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSG-DRFKKLDDIKLPDLL 365
C+++++ C CL+GF K+ Q ++ CVR DC G D F K+ +KLPD
Sbjct: 302 SCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTR 361
Query: 366 DVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSI 425
+++M+L EC+ CL+NC+C AY+ + DGG GC++WFGDLID+++ + NG +
Sbjct: 362 TSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNE--NGQDL 419
Query: 426 YIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDV 485
Y+R+ +SE + R+ SR
Sbjct: 420 YVRLASSE---------------------IETLQRESSR--------------------- 437
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
+++R E +D LP +V+ AT FS +KLG+GGFGPVYKG
Sbjct: 438 ---VSSRKQE-----------EEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGT 483
Query: 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605
L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG C+++ E++LIYEY N
Sbjct: 484 LACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPN 543
Query: 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665
KSLD F+FD ++ L W RV II GIA+G+LYLH+ SRLRIIHRDLKASN+LLD MN
Sbjct: 544 KSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMN 603
Query: 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS 725
KISDFG+AR GGDE + NT R+VGTYGYMSPEY ++G FS+KSDVFSFGVL+LEI+S
Sbjct: 604 AKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSG 663
Query: 726 KKNTGVYNTD-SFNLLGH-----VSDKLYSLL 751
++N G N + NLLGH + DK Y ++
Sbjct: 664 RRNRGFRNEEHKLNLLGHAWRQFLEDKAYEII 695
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 604 bits (1557), Expect = e-171, Method: Compositional matrix adjust.
Identities = 338/739 (45%), Positives = 449/739 (60%), Gaps = 55/739 (7%)
Query: 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNS 97
++ DT+ +RDGE ++S +RF GFFS G S+ RYVGIWY QI T+VWVANR+
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 98 PIVDKNGVLTVSNRGNLVLLNQSNGT--IWSSNVSREVKNP--VAQLLDNGNLVIRDNSG 153
PI D +G++ SNRGNL + N T IWS+NVS + P VA L D GNLV+ D
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 154 SNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVL 213
S W+SFD+PTDT L M+LG+ + GL+R TSWKS DP G+ R++
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 214 PQVCVYNGSAKYTCTGPWNGVAFGSAPSNTT-FIFQPIVVQNKDEVYYMYESYSSPIIMI 272
PQ+ +Y G + G W G + P +IF V N+DEV + Y + +I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 273 LRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSV--DQTSHCECLEGF 329
VN G + R W W F++ P C +Y CGPN C +T C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 330 K-------FKSQQNQTCVRS-HSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAE 381
+ F + C + +S C D F KL +K+PD D S++ ++ LKEC+
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 382 CLKNCSCRAYANS--KVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE------ 433
CLKNCSC AYA++ + G GCL W G ++D + N +G YIRV E
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARWNR 430
Query: 434 ---QGNKKLLWIIVILV----LPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVN 486
G +++L I++ L+ L VIL CV R RK N ++ N + FD
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLLTVILFCVVRER-----RKSNRHRSSSANFAPVPFD-- 483
Query: 487 MGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRL 546
F E+ +DK+++ LPLF ++ AAT NFS Q+KLG GGFGPVYKG L
Sbjct: 484 ---------FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVL 534
Query: 547 LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606
N E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCC+E EK+L+YEY+ NK
Sbjct: 535 QNRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNK 594
Query: 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666
SLD F+F ++ L W R+ I+ GIA+G+LYLHQ SRLRIIHRDLKASNILLD M P
Sbjct: 595 SLDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIP 654
Query: 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
KISDFGMAR+FGG++++G T R+VGT+GYM+PEYA+EG FS+KSDV+SFGVLMLEI++ K
Sbjct: 655 KISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGK 714
Query: 727 KNTGVYNTDSFNLLGHVSD 745
KN+ ++ +S NL+GH+ D
Sbjct: 715 KNSA-FHEESSNLVGHIWD 732
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 594 bits (1532), Expect = e-169, Method: Compositional matrix adjust.
Identities = 328/731 (44%), Positives = 469/731 (64%), Gaps = 38/731 (5%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNR-YVGIWYQQIPD-TVVWV 92
S+ +TL+ T I +TLVSP FE+GFF ++ +R Y+G+WY+++ D T VWV
Sbjct: 29 LSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLGMWYKKVSDRTYVWV 85
Query: 93 ANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR--EVKNPVAQLLDNGNLVIRD 150
ANR++P+ + G L +S NLVLL+ SN +W +N++R E VA+LL NGN V+RD
Sbjct: 86 ANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRD 144
Query: 151 NSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDI 210
+S ++++E YLWQSFDYPTDT+L MKLG++L+TGL R+ TSW+S+DDPS GNF+++L+
Sbjct: 145 SSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLET 203
Query: 211 HVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKDEVYYMYESYSSPI 269
LP+ + + +GPWNG+ F P + + ++N +EV Y + ++
Sbjct: 204 QSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNNSF 263
Query: 270 IMILRVNPLGQVQRLIWHEMSTGWQVFFTAP-DPFCH-YGDCGPNSICSVDQTSHCECLE 327
L + G QRL W+ W F+++P DP C Y CGP + C V+ + C C++
Sbjct: 264 YSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQ 323
Query: 328 GFKFKSQQNQT-------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEA 380
GF ++ Q C+R C SGD F ++ +KLP+ +++ S+ +KEC+
Sbjct: 324 GFNPRNIQQWDQRVWAGGCIRRTQLSC-SGDGFTRMKKMKLPETTMATVDRSIGVKECKK 382
Query: 381 ECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKK-TDNHTNGVSIYIRVPASEQGNK-- 437
C+ +C+C A+AN+ + +GGSGC++W L D++ + +G +Y+R+ A++ K
Sbjct: 383 RCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAKKRN 442
Query: 438 ---KLLWIIV-ILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRT 493
K++ + V + VL L+I+ C++ +Q K N NQ+L +N + +
Sbjct: 443 ASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNL---PMNEMVLSSK 499
Query: 494 NEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVA 553
EF G+ K ++ LPL +V ATENFS +KLG+GGFG VYKGRLL+G+E+A
Sbjct: 500 REF-----SGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIA 554
Query: 554 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF 613
VKRLS S QG EF NE+ LIA+LQH NLV++LGCCIE EK+LIYEY+ N SLD +LF
Sbjct: 555 VKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLF 614
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
T++ L W R I +G+A+GLLYLHQ SR RIIHRDLK SNILLD++M PKISDFGM
Sbjct: 615 GKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGM 674
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733
AR+F DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSFGV++LEI+S KKN G YN
Sbjct: 675 ARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYN 734
Query: 734 TDSFN-LLGHV 743
D N LL +V
Sbjct: 735 LDYENDLLSYV 745
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 585 bits (1507), Expect = e-166, Method: Compositional matrix adjust.
Identities = 327/747 (43%), Positives = 469/747 (62%), Gaps = 41/747 (5%)
Query: 26 FSSLIFYWVIKFSLAADTLTPTTLIRDG---ETLVSPSQRFELGFFSPGKSQNRYVGIWY 82
S +++++ + S+AA+T+ +RDG + LVSP + FELGFFSPG S +R++GIWY
Sbjct: 11 LSLFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWY 70
Query: 83 QQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREV---KNPVA 138
I D VVWVANR +PI D++GVL +SN GNLVLL+ N T+WSSN+ N V
Sbjct: 71 GNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVV 130
Query: 139 QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADD 198
+ D GN V+ + T+ +W+SF++PTDT L M++ + +TG SW+S D
Sbjct: 131 SIHDTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETD 186
Query: 199 PSPGNFTHRLDIHVLPQVCVYNGS-AKYTCTGPWNGVAFGSAPSN---TTFIFQPIVVQN 254
PSPGN++ +D P++ ++ G+ + +G WN F P+ T +++ +
Sbjct: 187 PSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSP 246
Query: 255 KDE---VYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCG 310
DE VY+ Y +++ +V G + L W+E W F + PD C Y CG
Sbjct: 247 PDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCG 306
Query: 311 PNSICSVDQTSH-CECLEGFKFKSQQN--QTCVRSHSSDCKSG-----DRFKKLDDIKLP 362
IC + ++ C C+ G++ S N + C R C+ D F L +KLP
Sbjct: 307 KFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLP 366
Query: 363 DLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG 422
D ++ + ++ ++C CL+NCSC AY+ GG GC++W DL+DL++ + G
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS----LVGGIGCMIWNQDLVDLQQFE--AGG 419
Query: 423 VSIYIRVPASEQG-NKKLLWIIVILVLPLVILPCVYIARQWSRKRKENET-----KNLDT 476
S++IR+ SE G N+K +++ VL VIL ++ W KRK++ + KN DT
Sbjct: 420 SSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDT 479
Query: 477 NQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEG 536
+ + + T+ + + +GK S LP+FS ++ AT +F +++LG G
Sbjct: 480 SVVVADLTKSKETTSAFSGSVDIMIEGK-AVNTSELPVFSLNAIAIATNDFCKENELGRG 538
Query: 537 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596
GFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC E EK
Sbjct: 539 GFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEK 598
Query: 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656
+L+YEYM NKSLD FLFD TK+ L+ W+LR II+GIA+GLLYLH+ SRLRIIHRDLK S
Sbjct: 599 MLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVS 658
Query: 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFG 716
N+LLD MNPKISDFGMAR+FGG++ + NT R+VGTYGYMSPEYA+EG+FSVKSDV+SFG
Sbjct: 659 NVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFG 718
Query: 717 VLMLEILSSKKNTGVYNTDSFNLLGHV 743
VL+LEI+S K+NT + +++ +L+G+
Sbjct: 719 VLLLEIVSGKRNTSLRSSEHGSLIGYA 745
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 576 bits (1485), Expect = e-163, Method: Compositional matrix adjust.
Identities = 322/735 (43%), Positives = 455/735 (61%), Gaps = 46/735 (6%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNSPIV 100
+T+ + ++DG+ + S +RF GFFS G S+ RYVGIWY Q+ + T+VWVANR+ PI
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 101 DKNGVLTVSNRGNLVLLNQSNGT--IWSSNVSREVKNP--VAQLLDNGNLVIRDNSGSNS 156
D +G++ S RGNL + NGT IWS++V ++ P VA+L D GNLV+ D S
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 157 TESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQV 216
W+SF++PT+T+L MK G+ ++G++R TSW+S DP GN T+R++ PQ+
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 217 CVYNGSAKYTCTGPWNGVAFGSAPSNTT-FIFQPIVVQNKDEVYYMYESYSSPIIMILRV 275
+Y G + TG W G + P T FIF V N DEV Y + + + +
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 276 NPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTS--HCECLEGFKFK 332
N G +QR W+ W F++AP+ C Y CG N C T C CL G++ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 333 SQQN-------QTCVRSHS-SDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK 384
+ ++ C R + S C + F KL +K+P+ V+++ ++ LKECE CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 385 NCSCRAYANS--KVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE----QGN-- 436
NCSC AYA++ + DG GCL W G+++D + ++G Y+RV SE GN
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTY--LSSGQDFYLRVDKSELARWNGNGA 436
Query: 437 --KKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLA---FDVNMGITT 491
KK L +I+I ++ +V+L + ++R+ ++ L A FD+
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 492 RTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQE 551
E DKS+ LPLF +++ AT NF+ Q+KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 552 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF 611
+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCC+E EK+L+YEY+ NKSLD F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 612 LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671
+F ++ L W R+ II GI +G+LYLHQ SRLRIIHRDLKASN+LLD M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731
G+AR+FGG++++G+T R+VGTYGYMSPEYA++G FS+KSDV+SFGVL+LEI++ K+N+
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727
Query: 732 YNTDSFNLLGHVSDK 746
Y +S NL+ H+ D+
Sbjct: 728 YE-ESLNLVKHIWDR 741
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1437), Expect = e-158, Method: Compositional matrix adjust.
Identities = 321/734 (43%), Positives = 454/734 (61%), Gaps = 46/734 (6%)
Query: 37 FSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVA 93
S++ +TL+ T I +T+VSP FELGFF + Y+GIWY++I T VWVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPV-AQLLDNGNLVIRDNS 152
NR++P+ + G+L +SN NLV+L+ S+ +WS+N++ V++ V A+LLDNGN V+R S
Sbjct: 87 NRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR-GS 144
Query: 153 GSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHV 212
N ++ +LWQSFD+PTDT+L MKLG D + GL R+ TSWKS+ DPS G+F +L+
Sbjct: 145 KINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLG 204
Query: 213 LPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTF---IFQPIVVQNKDEVYYMYESYSSPI 269
LP+ + + +GPW+G+ F + I+ +N++EV Y +
Sbjct: 205 LPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVTDHNS 262
Query: 270 IMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEG 328
L +N +G+++ +W W +F+ P C YG CGP + C + + C C++G
Sbjct: 263 YSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKG 322
Query: 329 FKFKSQQNQT-------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAE 381
F+ S Q+ C R C DRF +L ++K+P +++ + LKECE +
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEK 381
Query: 382 CLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLW 441
C +C+C AYANS + +GGSGC++W G+ D++ + +G +++R+ A+E G ++ +
Sbjct: 382 CKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIR--NYAADGQDLFVRLAAAEFGERRTIR 439
Query: 442 II---------VILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTR 492
++LVL +I C + +Q + D Q+L+
Sbjct: 440 GKIIGLIIGISLMLVLSFIIY-CFWKKKQKRARATAAPIGYRDRIQELII---------- 488
Query: 493 TNEFCEADGD-GKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQE 551
TN + G + +D LPL F +V ATENFS + LG GGFG VYKGRLL+GQE
Sbjct: 489 TNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQE 548
Query: 552 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF 611
+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCI EKILIYEY+ N SLD
Sbjct: 549 IAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSH 608
Query: 612 LFDPTKK-HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670
LF+ T+ + L WQ R II+GIA+GLLYLHQ SR +IIHRDLKASN+LLD++M PKISD
Sbjct: 609 LFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISD 668
Query: 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730
FGMAR+F DE + NT+++VGTYGYMSPEYA+EG+FSVKSDVFSFGVL+LEI+S K+N G
Sbjct: 669 FGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRG 728
Query: 731 VYNT-DSFNLLGHV 743
+N+ NLLG+
Sbjct: 729 FHNSGQDNNLLGYT 742
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1408), Expect = e-154, Method: Compositional matrix adjust.
Identities = 322/740 (43%), Positives = 451/740 (60%), Gaps = 78/740 (10%)
Query: 38 SLAADTLTPTTLIRDGETLVSPSQRFELGFFS---PGKSQNRYVGIWYQQIPDTVVWVAN 94
+L + +TP ++DG+TL SP Q F+LGFFS + Q+R++G+WY + P VVWVAN
Sbjct: 22 ALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME-PFAVVWVAN 80
Query: 95 RNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREV-----KNPVAQLLDNGNLVIR 149
RN+P+ +G L +S+ G+L L + + +WSS+ S NP+ ++ +GNL+
Sbjct: 81 RNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI-- 138
Query: 150 DNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLD 209
S+ E+ LWQSFDYP +T+L GMKLG + +T +E +SWK+ DPSPG+FT LD
Sbjct: 139 ---SSDGEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLD 195
Query: 210 IHVLPQVCVY-NGSAKYTCT-GPWNGVAFGSAPS--NTTFIFQPIVVQNKDEVYYMYESY 265
LPQ+ + NG + Y+ G WNG++F AP+ +F + EV Y +
Sbjct: 196 TRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPR 255
Query: 266 SSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVD--QTSH 322
I+ L +N G++ R I + + W + TAP+ C +Y CG ++C ++ T
Sbjct: 256 HR-IVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVCGINSKNTPS 313
Query: 323 CECLEGFKFKSQQNQT-------CVRSHSSDCKSGDRFKKLDDIKLPDL----LDVSLNE 371
C CL+GFK KS + CV ++C+ D F K +KLPD D NE
Sbjct: 314 CSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAK-NE 372
Query: 372 SMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRV-- 429
M L++C+ +C NCSC AYAN+ + +GG GCL+WFGDL+D+++ + G +YIR+
Sbjct: 373 -MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF--GQDVYIRMGF 429
Query: 430 -----PASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFD 484
E + ++ I V+ +V+ C + + R R EN K ++
Sbjct: 430 AKIEFKGREVVGMVVGSVVAIAVVLVVVFAC-FRKKIMKRYRGENFRKGIE--------- 479
Query: 485 VNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKG 544
+D LP+F +++ AT++FS + LG GGFGPVYKG
Sbjct: 480 ----------------------EEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKG 517
Query: 545 RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604
+L +GQE+AVKRLS SGQG++EFKNE+ LIAKLQHRNLVRLLGCCI+ E +LIYEYM
Sbjct: 518 KLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMP 577
Query: 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664
NKSLD F+FD + L W+ R+ II+G+A+G+LYLHQ SRLRIIHRDLKA N+LLD M
Sbjct: 578 NKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDM 637
Query: 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
NPKISDFG+A+ FGGD+ + +T R+VGTYGYM PEYA++G FSVKSDVFSFGVL+LEI++
Sbjct: 638 NPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIIT 697
Query: 725 SKKNTGVYNTD-SFNLLGHV 743
K N G + D NLLGHV
Sbjct: 698 GKTNRGFRHADHDLNLLGHV 717
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 754 | ||||||
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.912 | 0.857 | 0.518 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.916 | 0.831 | 0.503 | 0.0 | |
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.885 | 0.617 | 0.505 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.917 | 0.285 | 0.479 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.895 | 0.421 | 0.509 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.933 | 0.842 | 0.505 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.924 | 0.852 | 0.504 | 0.0 | |
| 356545291 | 824 | PREDICTED: G-type lectin S-receptor-like | 0.897 | 0.821 | 0.504 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.920 | 0.844 | 0.511 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.904 | 0.839 | 0.492 | 0.0 |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/741 (51%), Positives = 503/741 (67%), Gaps = 53/741 (7%)
Query: 17 MEILPCFNIFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNR 76
ME LP F FS+L + S +AD +TP ++DG+TL+S SQ FELGFFSPG S+ R
Sbjct: 1 MESLPFFIFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKYR 60
Query: 77 YVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNP 136
YVGIWY++ P+TVVWVANRN+P+ D GVLT+ NRGNLVLL+Q IWSSN S + P
Sbjct: 61 YVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAGP 120
Query: 137 VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSA 196
VAQLLD+GNLV+RDN S +TESY WQSFD P+DT+L GMKLGW+L+TG ERY +W+S
Sbjct: 121 VAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRSI 180
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKD 256
DPSPG+FT+RLDIH LPQ+ + GS K +GPWNG+ FG P +F+PI+V+N+D
Sbjct: 181 SDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNED 240
Query: 257 EVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSIC 315
E+YY Y ++ + L +N G V+RL+ + ++GW ++ P C +YG CG N IC
Sbjct: 241 EIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGIC 300
Query: 316 SVDQTSHCECLEGFKFKSQQ---------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLD 366
+ CECL+GFK ++ ++ C + DC+SG+ F KL +KLPDLL+
Sbjct: 301 RTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLLE 360
Query: 367 VSLNESMNLKECEAECLKNCSCRAYANSKVTDG--GSGCLMWFGDLIDLKKTDNHTNGVS 424
LNESMNLKECEAEC KNCSC A+A + ++ G GSGCLMWFG+LID+++ T G
Sbjct: 361 FRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQD 420
Query: 425 IYIRVPASEQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFD 484
I+IRVPASE + +AR S+++K +T + + LL
Sbjct: 421 IHIRVPASE----------------------LEMARS-SKRKKMLKTALVASMSALLGIF 457
Query: 485 VNMGITTRTNEFCEADGDGKDKSKDS-SLPLFSFASVTAATENFSIQSKLGEGGFGPVYK 543
V+ G D+ K+ PLF ++ AT NF+ S +G GGFG VYK
Sbjct: 458 VS----------------GMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSVYK 501
Query: 544 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603
G+LL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV LLG CI + E++LIYEYM
Sbjct: 502 GKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEYM 561
Query: 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
NKSLD F+FD + LLGW+ R II GIA+GLLYLHQ S+L+I+HRDLK SN+LLD +
Sbjct: 562 PNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDSN 621
Query: 664 MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ PKISDFG+AR+ G D + T+R++GTYGYM+PEYA++G FSVKSDVFS GVL+LEI+
Sbjct: 622 LIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLEII 681
Query: 724 SSKKNTGVYNTD-SFNLLGHV 743
S KKN G + D +LLGH
Sbjct: 682 SGKKNRGFVHPDHHHHLLGHA 702
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/739 (50%), Positives = 491/739 (66%), Gaps = 48/739 (6%)
Query: 28 SLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD 87
S++F+ I S A +++ T + DG+TLVS FELGFFSPG S+NRY+GIWY++I
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 88 -TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
TVVWVANRN+P+ D +G+L + GNL +N +NGTIWSSN+SR NPVAQLLD GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTH 206
V+R + N E++LWQSFDYP D+ L GMK G TGL RY TSWKS DPS G +T+
Sbjct: 137 VVRAEN-DNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 207 RLDIHVLPQVCVYNGSAKYTCTGPWNGVAFG---SAPSNTTFIFQPIVVQNKDEVYYMYE 263
+LD + LPQ + GS +GPWNG+ F + N + F+ V N++E+YY Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFE--FVFNQEEIYYKYQ 253
Query: 264 SYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSH 322
+S ++ + ++P G +QR W + + W ++ TA C + CG + +C+++ +
Sbjct: 254 IANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPA 313
Query: 323 CECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNL 375
C+CL+ F+ KS + +Q CVR DC +G+ F K IK+PD N+++NL
Sbjct: 314 CDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINL 373
Query: 376 KECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPAS--- 432
+ECE CLKNCSC AYAN V DGGSGC++WFGDLID+++ + NG IYIR+ AS
Sbjct: 374 EECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNE--NGQDIYIRIAASVID 431
Query: 433 ----EQGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETK---NLDTNQDLLAFDV 485
+G K++ I++ + L L + + ++ RK K+ + N+ TN
Sbjct: 432 KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNP------- 484
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
E D + +++D LPLF A++T AT FSI +KLG+GGFGPVYKG
Sbjct: 485 ------------EQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGI 532
Query: 546 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605
L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+LLGCCIE E++LIYEYM N
Sbjct: 533 LQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPN 592
Query: 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665
KSLD F+FD + LL W R II+GIA+GLLYLHQ SRLRIIHRDLKASNILLD MN
Sbjct: 593 KSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMN 652
Query: 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS 725
PKISDFGMAR FGGDE NT RIVGTYGYMSPEYA++G+FSVKSDVFSFGVL+LEI+S
Sbjct: 653 PKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSG 712
Query: 726 KKNTGVYNTD-SFNLLGHV 743
+KN G + + NLLGH
Sbjct: 713 RKNRGFRHAEHKLNLLGHA 731
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1777), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/720 (50%), Positives = 473/720 (65%), Gaps = 52/720 (7%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
AD++ I D ETLVS Q FELGFFSPG S+NRY+GIWY+ P T VWVANRN+PI
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNST-ES 159
D GVLT+ N G LVLLNQS IWS N+SR +NPVAQLL+ GNLV+RD GSN T +S
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRD--GSNETSKS 413
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
Y+WQSFD P+DTML GMK+GW+L+TGL+R TSWKS+DDPS G+F++ DI+VLP + +
Sbjct: 414 YIWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLG 473
Query: 220 NGSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLG 279
GS+K +GPWNG+ F +++ + V N DEVY +YES ++ II L +N G
Sbjct: 474 VGSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSG 533
Query: 280 QVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGFKFKSQQ--- 335
+QRL+ + S+ W ++ P C +YG CG N IC + + CECL GF KSQ+
Sbjct: 534 FLQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWD 593
Query: 336 ----NQTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAY 391
+ C R DC+ + F K+ +KLPDL+D + ++L+EC+ CL NCSC AY
Sbjct: 594 MFNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAY 653
Query: 392 ANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQG---NKKLLWIIVILVL 448
A + +G GCLMW GDLID+++ + + IYIR+ SE G N+K +++ILV+
Sbjct: 654 AYTN-PNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVI 712
Query: 449 P----LVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGK 504
++ L + R W ++ MG D +
Sbjct: 713 STFSGILTLGLSFWFRFWKKR--------------------TMGT------------DQE 740
Query: 505 DKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG 564
K ++ LPLF ++ AT NFS +K+G GGFG VYKG L G VAVKRLS S QG
Sbjct: 741 SKKENLELPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQG 800
Query: 565 LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQ 624
++EFKNE +LIAKLQH+NLVRLLGCCI+ E+IL+YEYM NKSLD F+FD ++ LL W
Sbjct: 801 VQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAWD 860
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
R I+ GIA+GLLYLHQ SR +IIHRDLK SNILLD ++NPKISDFG+AR+FG +E++
Sbjct: 861 KRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEMET 920
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHV 743
TKRIVGTYGYMSPEY ++G FS+K DVFSFGVL+LEI+S +KN G + D NLLGH
Sbjct: 921 RTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLGHA 980
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 685 bits (1767), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/773 (47%), Positives = 490/773 (63%), Gaps = 81/773 (10%)
Query: 26 FSSLIF-YWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQ 84
F++L+ + +++ S+A DTLT +I DGET+ S FELGFFSP S+NRYVGIWY++
Sbjct: 4 FATLVLVFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYVGIWYKK 63
Query: 85 IPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDN 143
+ TVVWVANR P+ +G+L V++RG LV+LN +N TIWSSN SR +NP AQLLD+
Sbjct: 64 VATRTVVWVANRQIPLTASSGILKVTDRGTLVILNGTNTTIWSSNSSRPAQNPNAQLLDS 123
Query: 144 GNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGN 203
GNLV+++ + S+S E++LWQSFDYP +T+L GMK G + TGL+RY +SWK+ DDPS GN
Sbjct: 124 GNLVMKNGNDSDS-ENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTTDDPSIGN 182
Query: 204 FTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQNKDEVYYMY 262
FT+RLD PQ+ V NGS +GPWNG+ F P ++ + N E YY +
Sbjct: 183 FTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFNDKETYYTF 242
Query: 263 ESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTS 321
E +S +I L ++P G QR W + ++ W ++ +A C Y CG IC ++++
Sbjct: 243 ELVNSSVITRLVLSPEGYAQRFTWIDRTSDWILYSSAQTDDCDSYALCGVYGICEINRSP 302
Query: 322 HCECLEGFKFKSQQN-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMN 374
CEC++GF+ K Q N CVRS C+ + F K +KLPD + NESMN
Sbjct: 303 KCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPDTRNSWFNESMN 362
Query: 375 LKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQ 434
LKEC + CL NCSC AY NS + GGSGCL+WFGDLID+++ NG YIR+ SE
Sbjct: 363 LKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTE--NGQDFYIRMAKSEL 420
Query: 435 G------------------------------------NKKLLWIIV-------ILVLPLV 451
G K W+IV I++L LV
Sbjct: 421 GMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSIVGIILLSLV 480
Query: 452 ILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSS 511
+ +Y+ R+ +RK N NL + + ++N ++ +D
Sbjct: 481 L--TLYVLRKKRLRRKGN---NLYSKHNCKGAEIN------------------EREEDLE 517
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
LPLF ++ AT+NFS +KLGEGGFGPVYKG L +G+E+AVKRLS +S QGL EFKNE
Sbjct: 518 LPLFDLDTILNATDNFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNE 577
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ I+KLQHRNLV+LLGCCI EK+LIYEYM NKSLD F+FD + +L W R II+
Sbjct: 578 VTHISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIIN 637
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GLLYLHQ SRLRIIHRDLKA N+LLD MNP+ISDFGMAR F G+E + TKR+VG
Sbjct: 638 GIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVG 697
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHV 743
TYGYMSPEYA++GV+S+KSDVFSFGVL+LEI++ K+N G + D + NLLGH
Sbjct: 698 TYGYMSPEYAIDGVYSIKSDVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHA 750
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/726 (50%), Positives = 476/726 (65%), Gaps = 51/726 (7%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVANRNSPI 99
DT+ L+RDGE L S FELGFF P S RY+G+WY+++ TVVWVANR +P+
Sbjct: 813 VDTIALNQLLRDGEILTSAGGSFELGFFRPDNSSRRYLGMWYKKVSIRTVVWVANRETPL 872
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
D +GVL V+++G L +LN +N +WSSN SR +NP AQ+L++GNLV++D + N E+
Sbjct: 873 ADSSGVLKVTDQGTLAVLNGTNTILWSSNSSRSARNPTAQILESGNLVMKDGNDDNP-EN 931
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
+LWQSFDYP +T+L GMKLG + TGL+RY ++WKSADDPS G+FT+RLD PQ+ +
Sbjct: 932 FLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSADDPSKGDFTYRLDPRGYPQLILR 991
Query: 220 NGSAKYTCTGPWNGVAFGSAPS---NTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVN 276
GSA +GPWNGV F P N+ + ++ V N+ E+Y+ YE +S ++ L +N
Sbjct: 992 KGSAVTFRSGPWNGVRFSGFPELGPNSIYTYE--FVFNEKEMYFRYELVNSSVVSRLVLN 1049
Query: 277 PLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLEGFKFKSQQ 335
P G QR+ W + + GW ++ +AP C Y CG IC+++++ CEC+EGF K Q
Sbjct: 1050 PDGSKQRVNWIDRTNGWILYSSAPKDDCDSYALCGVYGICNINRSPKCECMEGFVPKFQN 1109
Query: 336 N-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSC 388
+ CVRS DC++G+ F K +KLPD + N SM L EC A CL NCSC
Sbjct: 1110 DWDMADWSNGCVRSTPLDCQNGEGFVKFSGVKLPDTRNSWFNRSMGLMECAAVCLSNCSC 1169
Query: 389 RAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN----------KK 438
AY N + DGGSGCL+WFGDLID+++ + NG IY+R+ ASE G KK
Sbjct: 1170 TAYTNLDIRDGGSGCLLWFGDLIDIREFNE--NGQEIYVRMAASELGGSKESGSNLKGKK 1227
Query: 439 LLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEFCE 498
WIIV V +VI+ + K K K + +++ +G
Sbjct: 1228 RKWIIVGSVSSVVIILVSLFLTLYLLKTKRQRKKGT------MGYNLEVG---------- 1271
Query: 499 ADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS 558
+DS L LF FA+V+ AT +FS +KLGEGGFG VYKG L GQE+AVKRLS
Sbjct: 1272 -------HKEDSKLQLFDFATVSKATNHFSFDNKLGEGGFGLVYKGILQEGQEIAVKRLS 1324
Query: 559 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
SGQGL E KNE++ IAKLQHRNLVRLLGCCI EK+LIYEYM NKSLD F+FD T+
Sbjct: 1325 KDSGQGLDELKNEVIYIAKLQHRNLVRLLGCCIHGEEKMLIYEYMSNKSLDSFIFDKTQS 1384
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L W R II+GIA+GLLYLHQ SRLRIIHRDLKA NILLD+ M PKISDFGMAR FG
Sbjct: 1385 MELDWNKRFLIINGIARGLLYLHQDSRLRIIHRDLKAGNILLDEEMAPKISDFGMARSFG 1444
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SF 737
G+E + NTKR+VGTYGYMSPEYA++G++S KSDVFSFGVL+LEI+S K+N G + D S
Sbjct: 1445 GNETEANTKRVVGTYGYMSPEYAIDGLYSTKSDVFSFGVLVLEIVSGKRNRGFSHPDHSL 1504
Query: 738 NLLGHV 743
NLLGH
Sbjct: 1505 NLLGHA 1510
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1761), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/726 (50%), Positives = 480/726 (66%), Gaps = 22/726 (3%)
Query: 36 KFSLAADTLTPTTLIRDG--ETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWV 92
+F A+TLT + IRDG TLVS FELGFFSPG S+NRYVGIWY+ IP TVVWV
Sbjct: 14 RFCNTANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWV 73
Query: 93 ANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTI-WSSNVSREVKNPVAQLLDNGNLVIRDN 151
ANRN+PI D +G L + N GNLVL++ +N T+ WSSN + ++ + +LLD+GNLV+RD
Sbjct: 74 ANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDE 133
Query: 152 SGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIH 211
NS SYLWQSFDYP+DTML GMKLGWDLR GL+R ++WKS DDPS G+FT +
Sbjct: 134 KDVNSG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQ 192
Query: 212 VLPQVCVYNGSAKYTCTGPWNGVAF-GSAPSNTTFIFQPIVVQNKDEVYYMYESYSSPII 270
P++ ++ GS KY +GPWNG+ F G A +F V N +EVYY Y + +I
Sbjct: 193 SNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVYYTYNLKNKSLI 252
Query: 271 MILRVNPLGQV--QRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECLE 327
L +N QR W+E+S W+++ P +C +Y CG C + Q+ CECLE
Sbjct: 253 TRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLE 312
Query: 328 GFKFKSQQN-------QTCVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEA 380
F KS ++ Q CVR+ DC+ GD F K +KLPD + +N++MNLKEC +
Sbjct: 313 KFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRS 372
Query: 381 ECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN-KKL 439
+CL+NCSC AY + + + SGC +WFGDLID+++ + G IYIR+ ASE L
Sbjct: 373 KCLQNCSCMAYTATDIKER-SGCAIWFGDLIDIRQFPD--GGQEIYIRMNASESSECLSL 429
Query: 440 LWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTN-EFCE 498
+ + + + L + + + + + KR E + D + ++ +T E
Sbjct: 430 IKMEMGIALSIFVACGMLLVAYYIFKRTEKLKAHYSFLLVYHVCDSHSLLSEKTGGNREE 489
Query: 499 ADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS 558
D +D LPLF F ++ AT FS+ +K+GEGGFGPVYKG L +GQE+AVK LS
Sbjct: 490 NDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDGQEIAVKTLS 549
Query: 559 NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
SGQGL EFKNE++LI KLQHRNLV+LLGCCI+ EKIL+YEYM N+SLD F+FD T+
Sbjct: 550 RSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLDSFIFDQTRG 609
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
LL W R II GIA+GLLYLHQ SRLRI+HRDLKASN+LLD+ MNPKISDFG+ARM G
Sbjct: 610 KLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMVG 669
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SF 737
GD+ +GNT R++GTYGYM+PEYA +G+FSVKSDVFSFG+LMLEI+S KK+ G Y+ D S
Sbjct: 670 GDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFYHPDRSL 729
Query: 738 NLLGHV 743
+L H
Sbjct: 730 SLTAHA 735
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/742 (50%), Positives = 486/742 (65%), Gaps = 45/742 (6%)
Query: 23 FNIFSSLIFYW-----VIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRY 77
N+F+ L+F + +++ S A D++T I+DGET++S FELGF G S+N+Y
Sbjct: 1 MNLFTELVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQY 60
Query: 78 VGIWYQQI-PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNP 136
+GIWY+++ P TVVWVANR P+ D +G L V+++G+LV+LN SNG IWSSN SR +NP
Sbjct: 61 LGIWYKKVTPRTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNP 120
Query: 137 VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSA 196
AQLLD+GNLVI+ + S+ +++LWQSFDYP DT+L GMK G + TGL+RY +SWKS
Sbjct: 121 TAQLLDSGNLVIKSGNDSDP-DNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSN 179
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQNK 255
DDPS G+FT+ LD PQ+ + +GS +GPWNG+ F P +F V N+
Sbjct: 180 DDPSKGDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNE 239
Query: 256 DEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSI 314
E+Y+ Y+ +S ++ L +NP G VQRLIW + W V+ TA C Y CG S
Sbjct: 240 KEMYFTYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYST 299
Query: 315 CSVDQTSHCECLEGF--KFKSQQNQT-----CVRSHSSDCKSGDRFKKLDDIKLPDLLDV 367
C++ ++ C C++GF KF Q + CVR S DC+ GD F K +KLPD +
Sbjct: 300 CNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNS 359
Query: 368 SLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYI 427
NESMNLKEC + C +NCSC AY NS + GGSGCL+WFGDLID+K+ NG YI
Sbjct: 360 WFNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTE--NGQDFYI 417
Query: 428 RVPASE----QGNKKLLWIIVILV-LPLVILPCVYIARQWSRKRKENETKNLDTNQDLLA 482
R+ ASE K W+IV V + +IL + + +KR + +
Sbjct: 418 RMAASELDAISKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRK------------ 465
Query: 483 FDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVY 542
G T NE E + ++ +D LPLF ++ AT NFS +KLGEGGFGPVY
Sbjct: 466 -----GTTELNNEGAETN----ERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVY 516
Query: 543 KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602
KG L +G+E+AVKRLS +S QGL EFKNE++ I+KLQHRNLV+LLGCCI EK+LIYEY
Sbjct: 517 KGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEY 576
Query: 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662
M NKSL+ F+FD + +L W R II+GIA+GLLYLHQ SRLRIIHRDLKA N+LLD
Sbjct: 577 MPNKSLNFFIFDGIQSMVLDWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDN 636
Query: 663 HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
MNP+ISDFGMAR FGG+E TKR+VGTYGYMSPEYA++GV+SVKSDVFSFGVL LEI
Sbjct: 637 EMNPRISDFGMARSFGGNETIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLXLEI 696
Query: 723 LSSKKNTGVYNTD-SFNLLGHV 743
+S K+N G + D NLLGH
Sbjct: 697 ISGKRNRGFNHPDHDLNLLGHA 718
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545291|ref|XP_003541077.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/737 (50%), Positives = 477/737 (64%), Gaps = 60/737 (8%)
Query: 38 SLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQ--NRYVGIWYQQIP-DTVVWVAN 94
++A DT+T + + D TLVS + FELGFF+PG S NRYVGIWY+ IP T+VWVAN
Sbjct: 20 AVATDTITQSEFLEDNTTLVSNNGTFELGFFTPGSSSSPNRYVGIWYKNIPIRTLVWVAN 79
Query: 95 RNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGS 154
R++PI D + L+++ +GNLVL+NQ+N IWS+N + + VAQLLD+GNLV+RD +
Sbjct: 80 RDNPIKDNSSKLSINTQGNLVLVNQNNTVIWSTNTTAKASLVVAQLLDSGNLVLRDEKDT 139
Query: 155 NSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVL- 213
N E+YLWQSFDYP+DT L GMKLGWDL+ GL + T+WK+ DDPSPG+FT R +H
Sbjct: 140 NP-ENYLWQSFDYPSDTFLPGMKLGWDLKKGLNWFLTAWKNWDDPSPGDFT-RSTLHTNN 197
Query: 214 PQVCVYNGSAKYTCTGPWNGVAFGSAPS-----NTTFIFQPIVVQNKDEVYYMYESYSSP 268
P+ ++ G+ +Y +GPW+G+ F PS NT + +V NKDE Y Y
Sbjct: 198 PEEVMWKGTTQYYRSGPWDGIGFSGIPSVSSDSNTNYT----IVSNKDEFYITYSLIDKS 253
Query: 269 IIMILRVNPLGQV-QRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSHCECL 326
+I + +N QRL W+ S W+V P FC Y CG IC + Q C+CL
Sbjct: 254 LISRVVMNQTRYARQRLAWNIDSQTWRVSSELPTDFCDQYNICGAFGICVIGQAPACKCL 313
Query: 327 EGFKFKSQQN-------QTCVRSHSSDC--KSGDRFKKLDDIKLPDLLDVSLNESMNLKE 377
+GFK KS +N Q CV + + C K D F K ++K+PD +N +M L E
Sbjct: 314 DGFKPKSPRNWTQMSWNQGCVHNQTWSCRKKGRDGFNKFSNVKVPDTRRSWVNANMTLDE 373
Query: 378 CEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE---- 433
C+ +C +NCSC AYANS + GGSGC +WF DL+D++ N G +YIR+ SE
Sbjct: 374 CKNKCWENCSCTAYANSDIKGGGSGCAIWFSDLLDIRLMPNA--GQDLYIRLAMSETAQQ 431
Query: 434 -----QGNKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVNMG 488
+KK + +I V ++ + ++I WS K K E + G
Sbjct: 432 YQEAKHSSKKKVVVIASTVSSVIAILLIFIFIYWSYKNKNKE--------------IITG 477
Query: 489 ITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLN 548
I + N K + +D LPLF AS+ AT NFS +KLGEGGFGPVYKG L
Sbjct: 478 IEGKNN---------KSQQEDFELPLFDLASIAHATNNFSNDNKLGEGGFGPVYKGILPY 528
Query: 549 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608
GQEVAVKRLS S QGLKEFKNE+ML A+LQHRNLV++LGCCI+ EK+LIYEYM NKSL
Sbjct: 529 GQEVAVKRLSETSRQGLKEFKNEVMLCAELQHRNLVKVLGCCIQDDEKLLIYEYMANKSL 588
Query: 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668
DVFLFD ++ LL W R II+GIA+GLLYLHQ SRLRIIHRDLKASN+LLD MNPKI
Sbjct: 589 DVFLFDSSQGKLLDWPKRFCIINGIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKI 648
Query: 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728
SDFG+ARM GGD+++G T R+VGTYGYM+PEYA +G+FS+KSDVFSFGVL+LEI+S KKN
Sbjct: 649 SDFGLARMCGGDQIEGKTSRVVGTYGYMAPEYAFDGIFSIKSDVFSFGVLLLEIVSGKKN 708
Query: 729 TGVYNTDSFNLLGHVSD 745
D NL+GHVSD
Sbjct: 709 RLFSPNDYNNLIGHVSD 725
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 680 bits (1754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/721 (51%), Positives = 475/721 (65%), Gaps = 27/721 (3%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIP-DTVVWVANRNSPIV 100
+TL P ++DGETL+S FELGFFS G S++RY+GIWY++IP TVVWV NR P
Sbjct: 10 ETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWVGNREVPSF 69
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
D GVL V+ +G ++L N + G IWSSN SR KNPV QLLD+GNL+++D +G+N ++
Sbjct: 70 DNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGNGNN-PDNI 128
Query: 161 LWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYN 220
+WQSFD+P +T+L MKLGW+L GL RY TSWKS DDP+ GNF+ +D+ PQ+ +
Sbjct: 129 VWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRGFPQLFMKK 188
Query: 221 GSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLG 279
G A +GPWNG+ F +P N +F V NK E+YY YE ++ ++ L V+ G
Sbjct: 189 GDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVSRLIVSEKG 248
Query: 280 QVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEGFKFKSQQNQT 338
++R W + + W +FF+ P C Y CG + C+++ C CLEGF KS + +
Sbjct: 249 ALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFVPKSPTDWS 308
Query: 339 -------CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAY 391
CVR C +GD F+KL +KLPD ++ SM+LKECE CL+NCSC AY
Sbjct: 309 ASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCLRNCSCLAY 368
Query: 392 ANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGNKKLLWIIVILVLPLV 451
ANS + GSGCL+WF LID++K G +YIR+ ASE K V +++ +
Sbjct: 369 ANSDIR--GSGCLLWFDHLIDMRKFTE--GGQDLYIRIAASELAKGKSHGKRVAIIVSCL 424
Query: 452 ILPCVYIARQ---WSRKRKENETKN-----LDTNQDLLAFDVNMGITTRTNEFCEADGDG 503
I+ A ++RKRK N L + + F + G+ T + E GD
Sbjct: 425 IIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKET--YIENYGDN 482
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ 563
K +D+ L F ++ AT NFS +KLGEGGFGPVYKG LL+GQE+AVKRLS SGQ
Sbjct: 483 GAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSETSGQ 541
Query: 564 GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGW 623
G KEFKNE++LIA+LQHRNLV+LLGCCI EK+LIYEYM NKSLD F+FD + LL W
Sbjct: 542 GGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSMLLDW 601
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
+ RII GIA+GLLYLHQ SRLRIIHRDLKASNILLD MNPKISDFG+AR FG D+
Sbjct: 602 HMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGKDQNA 661
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGH 742
NTKR+VGTYGYMSPEYA++G+FSVKSDVFSFGVL+LEI+S K+N G + D S NLLGH
Sbjct: 662 ANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLNLLGH 721
Query: 743 V 743
Sbjct: 722 A 722
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 679 bits (1751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/743 (49%), Positives = 468/743 (62%), Gaps = 61/743 (8%)
Query: 25 IFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQ 84
IF +F+ ++K S A D + T +RDGETLVS FELGFF+P S +RY+G+WY++
Sbjct: 7 IFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK 66
Query: 85 IPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNG 144
P TVVWVANR PI +K G L V+++G LVLLN +N +WSSN S V+NPVAQLLD+G
Sbjct: 67 SPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSG 126
Query: 145 NLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNF 204
NLV+RD + N +++LWQSFDYP DT+L GMKLG +L TGL + +SWK ++P+PG F
Sbjct: 127 NLVVRDGN-DNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQF 185
Query: 205 THRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS---NTTFIFQPIVVQNKDEVYYM 261
T +D+ PQ+ + + G WNG F P + + F+ V N++EVY+
Sbjct: 186 TLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFE--FVFNRNEVYFK 243
Query: 262 YESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQT 320
+E +S + L V P G VQ W + W VF TA C +Y CG N+ C + +
Sbjct: 244 FELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSS 303
Query: 321 SHCECLEGFKFKS-----QQNQT--CVRSHSSDCKSGDRFKKLDDIKLPDLLDVSLNESM 373
C+CL+GF KS QN T C+R DC D F+ +KLPD ++S
Sbjct: 304 PVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSF 363
Query: 374 NLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASE 433
+L ECE C++NCSC AYAN GSGCL WFGDLID ++ G IYIR+ AS+
Sbjct: 364 SLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAE--GGQDIYIRLAASQ 421
Query: 434 QG-----------NKKLLWIIVILVLPLVILPCVYIARQWSRKRKENETKNLDTNQDLLA 482
G + ++ VIL ++IL V+ R+RK + N +
Sbjct: 422 SGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCI----RRRKHRKNGNFEDR----- 472
Query: 483 FDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVY 542
K ++ LP+ ++ AT+NFS KLGEGGFG VY
Sbjct: 473 -----------------------KEEEMELPMLDLTTIEHATDNFSSSKKLGEGGFGAVY 509
Query: 543 KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602
KG L+ GQE+AVKRLS SGQGL EFKNE++LIAKLQHRNLV+LLGCCI + EK+LIYEY
Sbjct: 510 KGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEY 569
Query: 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662
M N+SLD F+FDPT++ L W R IIDGIA+GLLYLHQ SRLRIIHRD+KASNILLD
Sbjct: 570 MPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDN 629
Query: 663 HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+NPKISDFG+ARMFGGD+ + NTKR+VGTYGYMSPEYAL+G FSVKSDVFSFGVL+LEI
Sbjct: 630 ELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEI 689
Query: 723 LSSKKNTGVYNTD--SFNLLGHV 743
+S KKN G + D NLLGH
Sbjct: 690 VSGKKNRGFCHPDYNQKNLLGHA 712
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 754 | ||||||
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.946 | 0.84 | 0.448 | 4.3e-164 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.537 | 0.517 | 0.397 | 1.7e-163 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.931 | 0.832 | 0.441 | 4.6e-160 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.937 | 0.834 | 0.442 | 7.5e-160 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.307 | 0.284 | 0.656 | 4.6e-150 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.893 | 0.793 | 0.435 | 1.1e-144 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.286 | 0.268 | 0.671 | 1.1e-137 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.912 | 0.817 | 0.417 | 2.5e-136 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.307 | 0.272 | 0.688 | 8.7e-132 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.913 | 0.830 | 0.401 | 2.2e-130 |
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1597 (567.2 bits), Expect = 4.3e-164, P = 4.3e-164
Identities = 339/756 (44%), Positives = 469/756 (62%)
Query: 17 MEILPCF-NIFSSLIFYWVIKF---SLAADTLTPTT--LIRDGETLVSPSQRFELGFFSP 70
M LP F + ++ F+ +I F S++A+TL+ + I T+VSP FELGFF P
Sbjct: 1 MRGLPNFYHSYTFFFFFLLILFPAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKP 60
Query: 71 GKSQNRYVGIWYQQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNV 129
G Y+GIWY+ I T VWVANR++P+ G L +S+ NLV+L+QS+ +WS+N+
Sbjct: 61 GLDSRWYLGIWYKAISKRTYVWVANRDTPLSSSIGTLKISD-SNLVVLDQSDTPVWSTNL 119
Query: 130 SR-EVKNP-VAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLE 187
+ +V++P VA+LLDNGN V+RD+ S + + LWQSFD+PTDT+L MKLGWD +TG
Sbjct: 120 TGGDVRSPLVAELLDNGNFVLRDSKNS-APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFN 178
Query: 188 RYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIF 247
R+ SWKS DDPS G+F+ +L+ P++ ++N ++ +GPWNG+ F P F +
Sbjct: 179 RFIRSWKSPDDPSSGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEY 238
Query: 248 QPI-VVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-H 305
+K+EV Y + S + L ++ G +QR W E + W F+ AP C
Sbjct: 239 MVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDE 298
Query: 306 YGDCGPNSICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFXXXXX 358
Y +CG C + + C C++GFK ++ Q + CVR C GD F
Sbjct: 299 YKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKK 358
Query: 359 XXXXXXXXVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDN 418
S++ + +KECE +CL++C+C A+AN+ + GSGC+ W G+L D++ N
Sbjct: 359 MKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIR---N 415
Query: 419 HTNG-VSIYIRVPASE---QGNKKXXXXXXXXXXXXXXXXXXYIARQWSRKRKEN---ET 471
+ G +Y+R+ A++ + N+ I W RK+K + ET
Sbjct: 416 YAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIET 475
Query: 472 KNLD---TNQDLLAFDVNMGITTRTNEFCEAXXXXXXXXXXXXLPLFSFASVTAATENFS 528
+D ++DLL +V I++R + E LPL F V AT NFS
Sbjct: 476 PIVDHQLRSRDLLMNEVV--ISSRRHISRE------NNTDDLELPLMEFEEVAMATNNFS 527
Query: 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
+KLG+GGFG VYKG+LL+GQE+AVKRLS S QG EFKNE+ LIA+LQH NLVRLL
Sbjct: 528 NANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLA 587
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
CC++ GEK+LIYEY+ N SLD LFD ++ L WQ+R II+GIA+GLLYLHQ SR RI
Sbjct: 588 CCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRI 647
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV 708
IHRDLKASNILLD++M PKISDFGMAR+FG DE + NT+++VGTYGYMSPEYA++G+FS+
Sbjct: 648 IHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSM 707
Query: 709 KSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHV 743
KSDVFSFGVL+LEI+SSK+N G YN+D NLLG V
Sbjct: 708 KSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCV 743
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 1.7e-163, Sum P(2) = 1.7e-163
Identities = 170/428 (39%), Positives = 251/428 (58%)
Query: 24 NIFSSLIF--YWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIW 81
N+ LI + I + A D L ++DG+T+VS FE+GFFSPG S+NRY+GIW
Sbjct: 5 NVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIW 64
Query: 82 YQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVS-----REVKN 135
Y++I TVVWVANR+SP+ D +G L VS G+L L N N IWSS+ S ++N
Sbjct: 65 YKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRN 124
Query: 136 PVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKS 195
P+ Q+LD GNLV+R NSG + + Y+WQS DYP D L GMK G + TGL R+ TSW++
Sbjct: 125 PIVQILDTGNLVVR-NSGDD--QDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRA 181
Query: 196 ADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPS-NTTFIFQPIVVQN 254
DDPS GN+T+++D + +PQ + S TGPWNG+ F P+ I++ V
Sbjct: 182 IDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFT 241
Query: 255 KDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNS 313
++EVYY Y+ + ++ +++NP G +QR W + W + +A C Y CG
Sbjct: 242 EEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYG 301
Query: 314 ICSVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSG-DRFXXXXXXXXXXXX 365
C+++++ C CL+GF K+ Q ++ CVR DC G D F
Sbjct: 302 SCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTR 361
Query: 366 XVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSI 425
+++M+L EC+ CL+NC+C AY+ + DGG GC++WFGDLID+++ + NG +
Sbjct: 362 TSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNE--NGQDL 419
Query: 426 YIRVPASE 433
Y+R+ +SE
Sbjct: 420 YVRLASSE 427
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1559 (553.9 bits), Expect = 4.6e-160, P = 4.6e-160
Identities = 329/745 (44%), Positives = 456/745 (61%)
Query: 23 FNIFSSLIFYWVIKFSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGI 80
F IF LI + + FS++ +TL+ T I +T++SPSQ FELGFF+P S Y+GI
Sbjct: 11 FFIFLILILF--LAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGI 68
Query: 81 WYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA 138
WY+ IP T VWVANR++P+ NG L +S NLV+ +QS+ +WS+N++ +V++PVA
Sbjct: 69 WYKIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 139 -QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSAD 197
+LLDNGN ++RD S LWQSFD+PTDT+L MKLGWD +TG R SWK+ D
Sbjct: 128 AELLDNGNFLLRD-----SNNRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTD 182
Query: 198 DPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPI-VVQNKD 256
DPS G F+ +L+ P+ + + + +GPWNG+ F S P + +K+
Sbjct: 183 DPSSGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE 242
Query: 257 EVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSIC 315
EV Y Y + + L +N G +QRL W E + W+ + +P C +Y CG C
Sbjct: 243 EVTYSYRINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYC 302
Query: 316 SVDQTSHCECLEGFKFKSQQ-------NQTCVRSHSSDCKSGDRFXXXXXXXXXXXXXVS 368
+ +C C++GFK ++Q + C+R C D F
Sbjct: 303 DSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATI 362
Query: 369 LNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG-VSIYI 427
++ + LK C+ CL++C+C A+AN+ + +GGSGC++W +++D++ N+ G +Y+
Sbjct: 363 VDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMR---NYAKGGQDLYV 419
Query: 428 RVPASEQGNKKXXXXXXXXXXXXXXXX---XXYIARQWSRKRKEN---ETKNLDT--NQD 479
R+ A+E +K+ I W RK+K + +T N+D +QD
Sbjct: 420 RLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQD 479
Query: 480 LLAFDVNMGITTRTNEFCEAXXXXXXXXXXXXLPLFSFASVTAATENFSIQSKLGEGGFG 539
L DV + +R LPL ++ AT NFS +KLG+GGFG
Sbjct: 480 SLINDV---VVSR-----RGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFG 531
Query: 540 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599
VYKGRLL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LI
Sbjct: 532 IVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 591
Query: 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
YEY+ N SLD LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+L
Sbjct: 592 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 651
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
LD++M PKISDFGMAR+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+
Sbjct: 652 LDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 711
Query: 720 LEILSSKKNTGVYNTD-SFNLLGHV 743
LEI+S K+N G YN++ NLLG V
Sbjct: 712 LEIISGKRNKGFYNSNRDLNLLGFV 736
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1557 (553.2 bits), Expect = 7.5e-160, P = 7.5e-160
Identities = 329/743 (44%), Positives = 453/743 (60%)
Query: 23 FNIFSSLIFYWVIKFSLAADTLTPTT--LIRDGETLVSPSQRFELGFFSPGKSQNRYVGI 80
F +F ++F + FS+ A + T I +T++SPSQ FELGFF+P S Y+GI
Sbjct: 12 FILFIIILF---LAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGI 68
Query: 81 WYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSR-EVKNPVA 138
WY+ IP T VWVANR++P+ NG L +S+ NLV+ +QS+ +WS+N++ +V++PVA
Sbjct: 69 WYKIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVA 127
Query: 139 -QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTG-LERYQTSWKSA 196
+LLD GN V+RD S +N +LWQSFD+PTDT+L MK+GWD ++G R SWK+
Sbjct: 128 AELLDYGNFVLRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTT 186
Query: 197 DDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIF-QPIVVQNK 255
DDPS G+F+ +L P+ +YN + +GPW G F S P + +N
Sbjct: 187 DDPSSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENN 246
Query: 256 DEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC-HYGDCGPNSI 314
+V Y Y + I IL ++ G +QRL W E + W+ + +P C +Y +CG
Sbjct: 247 QQVVYSYRVNKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGY 306
Query: 315 CSVDQTSHCECLEGFKFKSQQ------NQTCVRSHSSDCKSGDRFXXXXXXXXXXXXXVS 368
C + + C C++GF+ ++Q + CVR C D F S
Sbjct: 307 CDANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETS 366
Query: 369 LNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNG-VSIYI 427
+++ + LKECE CLK C+C A+AN+ + +GGSGC++W G L D++ N+ G +Y+
Sbjct: 367 VDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIR---NYAKGGQDLYV 423
Query: 428 RVPASEQGNK--KXXXXXXXXXXXXXXXXXXYIARQ-WSRKRKENETKNLDTNQDLLAFD 484
RV A + +K K +I W RK+K + T + T D
Sbjct: 424 RVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSIT--IQTP----IVD 477
Query: 485 VNMGITTRTNEFCEAXXXXXXXXXXXX---LPLFSFASVTAATENFSIQSKLGEGGFGPV 541
+ + NE +A LPL + ++ AT NFS +KLG+GGFG V
Sbjct: 478 LVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIV 537
Query: 542 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601
YKG LL+G+E+AVKRLS S QG EF NE+ LIAKLQH NLVRLLGCC+++GEK+LIYE
Sbjct: 538 YKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYE 597
Query: 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661
Y+ N SLD LFD T+ L WQ R II+GIA+GLLYLHQ SR RIIHRDLKASN+LLD
Sbjct: 598 YLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD 657
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
++M PKISDFGMAR+FG +E + NT+R+VGTYGYMSPEYA++G+FS+KSDVFSFGVL+LE
Sbjct: 658 KNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLE 717
Query: 722 ILSSKKNTGVYNTD-SFNLLGHV 743
I+S K+N G YN++ NLLG V
Sbjct: 718 IISGKRNKGFYNSNRDLNLLGFV 740
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 802 (287.4 bits), Expect = 4.6e-150, Sum P(2) = 4.6e-150
Identities = 153/233 (65%), Positives = 189/233 (81%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
LP+F +++ AT++FS + LG GGFGPVYKG+L +GQE+AVKRLS SGQG++EFKNE
Sbjct: 485 LPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNE 544
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ LIAKLQHRNLVRLLGCCI+ E +LIYEYM NKSLD F+FD + L W+ R+ II+
Sbjct: 545 VKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIIN 604
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
G+A+G+LYLHQ SRLRIIHRDLKA N+LLD MNPKISDFG+A+ FGGD+ + +T R+VG
Sbjct: 605 GVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVG 664
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-SFNLLGHV 743
TYGYM PEYA++G FSVKSDVFSFGVL+LEI++ K N G + D NLLGHV
Sbjct: 665 TYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1414 (502.8 bits), Expect = 1.1e-144, P = 1.1e-144
Identities = 311/714 (43%), Positives = 436/714 (61%)
Query: 56 LVSPSQRFELGFFSPGKSQNRYVGIWYQQIPD-TVVWVANRNSPIVDKNGVLTVSNRGNL 114
LVSP + FELGFFSPG S +R++GIWY I D VVWVANR +PI D++GVL +SN GNL
Sbjct: 44 LVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNL 103
Query: 115 VLLNQSNGTIWSSNVSREV---KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDT 171
VLL+ N T+WSSN+ N V + D GN V+ + T+ +W+SF++PTDT
Sbjct: 104 VLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSETD----TDRPIWESFNHPTDT 159
Query: 172 MLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGS-AKYTCTGP 230
L M++ + +TG SW+S DPSPGN++ +D P++ ++ G+ + +G
Sbjct: 160 FLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQ 219
Query: 231 WNGVAFGSAPSN---TTFIFQPIVVQNKDEVYYMYESY--SSPIIMI-LRVNPLGQVQRL 284
WN F P+ T +++ + DE +Y +Y S P +++ +V G + L
Sbjct: 220 WNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEEL 279
Query: 285 IWHEMSTGWQVFFTAPDPFC-HYGDCGPNSICSVDQTSH-CECLEGFKFKSQQNQT--CV 340
W+E W F + PD C Y CG IC + ++ C C+ G++ S N + C
Sbjct: 280 RWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCR 339
Query: 341 RSHSSDCKS----GDRFXXXXXXXXXXXXXVSLNESMNLKECEAECLKNCSCRAYANSKV 396
R C+ G+ + + ++ ++C CL+NCSC AY S V
Sbjct: 340 RRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAY--SLV 397
Query: 397 TDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQG-NKKXXXXXXXXXXXXXXXXX 455
GG GC++W DL+DL++ + G S++IR+ SE G N+K
Sbjct: 398 --GGIGCMIWNQDLVDLQQFE--AGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIG 453
Query: 456 XYIARQWSRKRKENET-----KNLDTNQDLLAFDVNMGITTRTNEFCEAXXXXXXXXX-- 508
+ W KRK++ + KN DT+ ++ D+ T T+ F +
Sbjct: 454 IFALLLWRFKRKKDVSGAYCGKNTDTS--VVVADLTKSKET-TSAFSGSVDIMIEGKAVN 510
Query: 509 XXXLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF 568
LP+FS ++ AT +F +++LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EF
Sbjct: 511 TSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEF 570
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR 628
KNE++LIAKLQHRNLVRLLGCC E EK+L+YEYM NKSLD FLFD TK+ L+ W+LR
Sbjct: 571 KNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFS 630
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
II+GIA+GLLYLH+ SRLRIIHRDLK SN+LLD MNPKISDFGMAR+FGG++ + NT R
Sbjct: 631 IIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVR 690
Query: 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGH 742
+VGTYGYMSPEYA+EG+FSVKSDV+SFGVL+LEI+S K+NT + +++ +L+G+
Sbjct: 691 VVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGY 744
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 1.1e-137, Sum P(2) = 1.1e-137
Identities = 145/216 (67%), Positives = 177/216 (81%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L F ++ AT NFS+ +KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
++LI+KLQHRNLVR+LGCCIE+ EK+LIYE+MVNKSLD FLFD K+ + W R II
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GIA+GLLYLH SRLR+IHRDLK SNILLD+ MNPKISDFG+ARM+ G E Q NT+R+VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
T GYMSPEYA G+FS KSD++SFGVLMLEI+S +K
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEK 691
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1335 (475.0 bits), Expect = 2.5e-136, P = 2.5e-136
Identities = 303/726 (41%), Positives = 414/726 (57%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQI-PDTVVWVANRNSPI 99
+++ T IR+G++L+S + FELGFF+P S RYVGIWY+ I P TVVWVANR P+
Sbjct: 29 SNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPL 88
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
+D G L +++ GNLV++N N TIWS+NV E N VA L G+LV+ +S
Sbjct: 89 LDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDS---DRRK 145
Query: 160 YLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVY 219
+ W+SF+ PTDT L GM++ + G R WKS DPSPG ++ +D ++ ++
Sbjct: 146 WYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIW 205
Query: 220 NGSAKYTCTGPWNGVAFGSAPSN---TTFI--FQPIVVQNKD-EVYYMYESYSSPIIMIL 273
G + +GPWN F P T +I F+ ++D VY+ Y + S +
Sbjct: 206 EGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRF 265
Query: 274 RVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQ---TSHCECLEGF 329
+ P G ++ W++ W + P C Y CG S+C + + C C++GF
Sbjct: 266 WIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDGF 325
Query: 330 K--FKSQQNQT-----CVRSHSSDCKSG------DRFXXXXXXXXXXXXXVSLNESMNLK 376
+ + Q N C R +C D F V L+ N +
Sbjct: 326 EPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFGSVVLHN--NSE 383
Query: 377 ECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHTNGVSIYIRVPASEQGN 436
C+ C ++CSC+AYA V G GC++W DLID++ + G SI IR+ S+ G
Sbjct: 384 TCKDVCARDCSCKAYA--LVV--GIGCMIWTRDLIDMEHFER--GGNSINIRLAGSKLGG 437
Query: 437 KKXXXXXXXXXXXXXXXXXXYIARQWSRKRKENETKNLDTNQDLLAFDVNMGITTRTNEF 496
K + K K++ L +D+ D+ I R
Sbjct: 438 GKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDI---IENRDYSS 494
Query: 497 CEAXXXXXXXXXXXXLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR 556
LP+FSF SV +AT +F+ ++KLG+GGFG VYKG G+E+AVKR
Sbjct: 495 SPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKR 554
Query: 557 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPT 616
LS +S QGL+EFKNE++LIAKLQHRNLVRLLGCCIE EK+L+YEYM NKSLD FLFD +
Sbjct: 555 LSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDES 614
Query: 617 KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
K+ L W+ R +I GIA+GLLYLH+ SRL+IIHRDLKASNILLD MNPKISDFGMAR+
Sbjct: 615 KQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARI 674
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736
F + NT R+VGTYGYM+PEYA+EG+FS KSDV+SFGVL+LEI+S +KN TD
Sbjct: 675 FNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDH 734
Query: 737 FNLLGH 742
+L+G+
Sbjct: 735 GSLIGY 740
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 8.7e-132, Sum P(2) = 8.7e-132
Identities = 161/234 (68%), Positives = 192/234 (82%)
Query: 512 LPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 571
L +FSF SV AT+ FS +KLGEGGFGPVYKGRL++G+EVA+KRLS SGQGL EFKNE
Sbjct: 512 LQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNE 571
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
MLIAKLQH NLV+LLGCC+E+ EK+LIYEYM NKSLD FLFDP +K +L W+LR RI++
Sbjct: 572 AMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIME 631
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
GI QGLLYLH+YSRL++IHRD+KA NILLD+ MNPKISDFGMAR+FG E + NTKR+ G
Sbjct: 632 GIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAG 691
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS--FNLLGHV 743
T+GYMSPEY EG+FS KSDVFSFGVLMLEI+ +KN ++ NL+ HV
Sbjct: 692 TFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHV 745
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
Identities = 297/739 (40%), Positives = 413/739 (55%)
Query: 22 CFNIFSSLIFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIW 81
C I + + ++ LA D +T ++ RD ET+VS F GFFSP S RY GIW
Sbjct: 3 CLLILLLTLICFSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIW 62
Query: 82 YQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVK-NPV-A 138
+ IP TVVWVAN NSPI D +G++++S GNLV+++ WS+NV V N A
Sbjct: 63 FNNIPVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYA 122
Query: 139 QLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADD 198
+LL+ GNLV+ + N+ + LW+SF++P + L M L D +TG SWKS D
Sbjct: 123 RLLNTGNLVLLGTT--NTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFD 180
Query: 199 PSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTF---IFQ-PIVVQN 254
PSPG ++ L P++ V+ +GPWNG F P N + +F+ + N
Sbjct: 181 PSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLP-NMDYRINLFELTLSSDN 239
Query: 255 KDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNS 313
+ V Y + ++ ++ G V + W+ W+ + P C Y CG +
Sbjct: 240 RGSVSMSYAG--NTLLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFA 297
Query: 314 ICSVD--QTSHCECLEGFKFKS--QQN-----QTCVRSHSSDCKSGDRFXXXXXXXXXXX 364
C + T C C+ GFK +S + N Q CVR C+S D
Sbjct: 298 SCRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVR 357
Query: 365 XX---VSLN---ESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDN 418
V N N ++C CLKNCSC AY+ D G GCL+W G+L+D+++
Sbjct: 358 VQKMKVPHNPQRSGANEQDCPESCLKNCSCTAYS----FDRGIGCLLWSGNLMDMQEFSG 413
Query: 419 HTNGVSIYIRVPASE--QGNKKXXXXXXXXXXXXXXXXXXYIARQW--SRKRKENETKNL 474
GV YIR+ SE + + + W ++ R++N L
Sbjct: 414 --TGVVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRL 471
Query: 475 DTNQDLLAFDVNMGITTRTNEFCEAXXXXXXXXXXXXLPLFSFASVTAATENFSIQSKLG 534
N+ + A N N++ LPLF F + AT NFSI +KLG
Sbjct: 472 -LNERMEALSSNDVGAILVNQY-----------KLKELPLFEFQVLAVATNNFSITNKLG 519
Query: 535 EGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594
+GGFG VYKGRL G ++AVKRLS SGQG++EF NE+++I+KLQHRNLVRLLG CIE
Sbjct: 520 QGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGE 579
Query: 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654
E++L+YE+M LD +LFDP K+ LL W+ R IIDGI +GL+YLH+ SRL+IIHRDLK
Sbjct: 580 ERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLK 639
Query: 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFS 714
ASNILLD+++NPKISDFG+AR+F G+E + +T R+VGTYGYM+PEYA+ G+FS KSDVFS
Sbjct: 640 ASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFS 699
Query: 715 FGVLMLEILSSKKNTGVYN 733
GV++LEI+S ++N+ YN
Sbjct: 700 LGVILLEIVSGRRNSSFYN 718
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4651 | 0.9217 | 0.8176 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 754 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 9e-41 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 2e-40 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-38 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-28 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 4e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-19 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-10 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 4e-54
Identities = 78/205 (38%), Positives = 111/205 (54%), Gaps = 16/205 (7%)
Query: 528 SIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 581
++ KLGEG FG VYKG+L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LLG C E+ ++ EYM L +L + L + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPE 699
IHRDL A N L+ +++ KISDFG++R D+ + K + +M+PE
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
EG F+ KSDV+SFGVL+ EI +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 8e-54
Identities = 77/204 (37%), Positives = 112/204 (54%), Gaps = 13/204 (6%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 581
++ KLGEG FG VYKG L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LLG C E+ +++ EYM L +L + L + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIVGTYGYMSPEY 700
IHRDL A N L+ +++ KISDFG++R ++ D + ++ +M+PE
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPES 175
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
EG F+ KSDV+SFGVL+ EI +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-52
Identities = 79/205 (38%), Positives = 112/205 (54%), Gaps = 16/205 (7%)
Query: 532 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 586
KLGEG FG VYKG+L EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
LG C E+ L+ EYM L +L F +K L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIVGTYGYMSPE 699
+ +HRDL A N L+ + + KISDFG++R ++ D + T + +M+PE
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
+G+F+ KSDV+SFGVL+ EI +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 7e-51
Identities = 75/207 (36%), Positives = 109/207 (52%), Gaps = 17/207 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH 580
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N+VRLLG C + ++ EYM L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGNTKRIVGTYGYMS 697
+HRDL A N L+ +++ KISDFG++R D+ +G K + +M+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE +G F+ KSDV+SFGVL+ EI +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 6e-50
Identities = 75/194 (38%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEGGFG VY R G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
++ L+ EY SL L + K L +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 651 RDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSV 708
RDLK NILLD + K++DFG++++ D+ T IVGT YM+PE L +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 709 KSDVFSFGVLMLEI 722
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 584
+ I KLGEG FG VY R G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
RL ++ + L+ EY L L + Q I L Y
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ--------ILSALEY 112
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH I+HRDLK NILLD+ + K++DFG+AR E VGT YM+PE
Sbjct: 113 LHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPE 166
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSK 726
L + D++S GV++ E+L+ K
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-44
Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ + KLG G FG VYK + G+ VAVK L ++ + + + E+ ++ +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
VRL+ ++ L+ EY L +L ++ L +I I +GL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
IIHRDLK NILLD++ KI+DFG+A+ + VGT YM+PE L
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLG 172
Query: 704 G-VFSVKSDVFSFGVLMLEILSSK 726
G + K DV+S GV++ E+L+ K
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 9e-41
Identities = 57/115 (49%), Positives = 72/115 (62%), Gaps = 6/115 (5%)
Query: 86 PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGN 145
TVVWVANR +P+ D + L + + GNLVL + + +WSSN S + VA L D+GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 146 LVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPS 200
LV+ DNSG LWQSFD+PTDT+L G K G ++ G R TSWKS DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 54/120 (45%), Positives = 71/120 (59%), Gaps = 6/120 (5%)
Query: 49 LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTV 108
+ G+TLVS FELGFF Y I Y+ TVVWVANR++P + LT+
Sbjct: 3 PLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTL 61
Query: 109 SNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168
+ GNLV+ + S +WSSN +R N V LLD+GNLV+ D+ G ++LWQSFDYP
Sbjct: 62 QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 79/202 (39%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ G +VAVK L + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 585 RLLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+L C + E I I EYM SL FL K L QL V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMAAQIAEGMAYLE-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPEY 700
IHRDL A NIL+ +++ KI+DFG+AR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 701 ALEGVFSVKSDVFSFGVLMLEI 722
A G F++KSDV+SFG+L+ EI
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 6e-38
Identities = 56/119 (47%), Positives = 73/119 (61%), Gaps = 7/119 (5%)
Query: 49 LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTV 108
+ G+TLVS + FELGFF+ QN Y I Y+ TVVWVANR++P V + LT+
Sbjct: 3 TLSSGQTLVSGNSLFELGFFTLI-MQNDYNLILYKSSSRTVVWVANRDNP-VSDSCTLTL 60
Query: 109 SNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167
+ GNLVL + +WSSN + N V LLD+GNLVI D+ G ++LWQSFDY
Sbjct: 61 QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 532 KLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 589 CCIEQGEK-ILIY-EYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
++ + + I+ EY+ SL L +R I +GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-------VIRKYTRQ-ILEGLAYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I+HRD+K +NIL+D K++DFG A+ G E T + GT +M+PE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSK 726
+ +D++S G ++E+ + K
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 70/207 (33%), Positives = 110/207 (53%), Gaps = 20/207 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E F+++ KLG G FG V++G N VA+K L + ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-----HLL--GWQLRVRIIDGIAQGL 637
L C +I E M SL FL P + L+ Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YL + IHRDL A NIL+ + + K++DFG+AR+ D + K+I Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE A G FS KSDV+SFG+L+ E+ +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
F I K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 586 LLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
G +++ E ++ E+ SL D+ + L + + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK---STNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
IIHRD+KA+NILL K+ DFG++ +VGT +M+PE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGK 172
Query: 705 VFSVKSDVFSFGVLMLE 721
+ K+D++S G+ +E
Sbjct: 173 PYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRN 582
N+ + +G G FG VYKG L G VA+K++S + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLH 641
+V+ +G +I EY N SL + KK L + + QGL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE-Y 700
+ +IHRD+KA+NIL + K++DFG+A + +VGT +M+PE
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVI 171
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
+ G S SD++S G ++E+L+
Sbjct: 172 EMSGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 77/213 (36%), Positives = 113/213 (53%), Gaps = 25/213 (11%)
Query: 533 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
LGEG FG VYKG L N + VA+K L N + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLRVRIIDG 632
LLG C ++ +++EY+ + L FL D T K L + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIVG 691
IA G+ YL S +HRDL A N L+ + + KISDFG++R ++ D + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M PE L G F+ +SD++SFGV++ EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 531 SKLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LGEG FG V R G++VAVK L+ + Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 585 RLLGCCIEQGEKI--LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ G C + G + LI EY+ + SL +L + + + + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEY 700
R IHRDL A NIL++ KISDFG+A++ D + Y +PE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
FS SDV+SFGV + E+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 63/203 (31%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 533 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 587 LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLH 641
LG C+ ++ LI + M L ++ + ++LL W ++ IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ R++HRDL A N+L+ + KI+DFG+A++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
L +++ KSDV+S+GV + E+++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 528 SIQ--SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
SIQ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++
Sbjct: 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQ 65
Query: 586 LLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
L C E I I E M SL +L + L QL + + +A G+ YL +
Sbjct: 66 LYAVCT-LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-IDMAAQVASGMAYLEAQN 123
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YGYMSPEYA 701
IHRDL A N+L+ ++ K++DFG+AR+ D + G + +PE A
Sbjct: 124 ---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAA 176
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
L FS+KSDV+SFG+L+ EI++
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 533 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 585
LGEG FG V+ G + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQLRVRIIDGI 633
G C E I+++EYM + L+ FL D L QL ++I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL-LQIAVQI 131
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT- 692
A G++YL + +HRDL N L+ + KI DFGM+R D + R+ G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHT 184
Query: 693 ---YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+M PE + F+ +SDV+SFGV++ EI + K
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 15/196 (7%)
Query: 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
+ +G+G FG V G GQ+VAVK L + S + F E ++ L+H NLV+LLG
Sbjct: 12 ATIGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
++ ++ EYM SL +L + + Q +D + +G+ YL + +H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALD-VCEGMEYLEEK---NFVH 125
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPEYALEGVFSV 708
RDL A N+L+ + + K+SDFG+A+ + QG G + +PE E FS
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFST 178
Query: 709 KSDVFSFGVLMLEILS 724
KSDV+SFG+L+ EI S
Sbjct: 179 KSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 72/204 (35%), Positives = 111/204 (54%), Gaps = 14/204 (6%)
Query: 528 SIQSKLGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRN 582
+I+ +G G FG V +GRL L G++ VA+K L S + +F E ++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++RL G + ++I EYM N SLD FL + K V ++ GIA G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL-- 122
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK--RIVGTYGYMSPEY 700
S + +HRDL A NIL++ ++ K+SDFG++R E TK +I + +PE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEA 179
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
F+ SDV+SFG++M E++S
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592
LG G FG V+ G+ +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRD 652
Q ++ EYM N L +L +K LG + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 653 LKASNILLDQHMNPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPEYALEGVFSVKS 710
L A N L+ + K+SDFG+AR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 711 DVFSFGVLMLEILSSKK 727
DV+SFGVLM E+ S K
Sbjct: 183 DVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 24/231 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+ LG+G G VYK R G+ A+K++ + + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYL 640
+V+ G ++GE ++ EYM SL L K + V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H + IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY------NTDSFNLLGHVSD 745
+S +D++S G+ +LE G + F L+ + D
Sbjct: 172 IQGESYSYAADIWSLGLTLLECA-----LGKFPFLPPGQPSFFELMQAICD 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 70/213 (32%), Positives = 107/213 (50%), Gaps = 17/213 (7%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-R 581
++ I KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+L ++G L+ EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGD----ELQGNTKRIVGTYGYM 696
IIHRD+K NILLD+ K+ DFG+A++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 697 SPEYALEGVF---SVKSDVFSFGVLMLEILSSK 726
+PE L S SD++S G+ + E+L+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 77/207 (37%), Positives = 112/207 (54%), Gaps = 21/207 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + KLG G FG V+ G +VA+K L Q + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIID---GIAQGLLYL 640
RL + Q +I EYM N SL FL P G +L + ++ID IA+G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFI 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMS 697
R IHRDL+A+NIL+ + + KI+DFG+AR+ +E +G I T +
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----A 171
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE G F++KSDV+SFG+L+ EI++
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQH 580
E + K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSL----DVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
N+V + E ++ EYM SL + + + + QG
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI------AYVCREVLQG 128
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
L YLH +IHRD+K+ NILL + + K++DFG A + + +VGT +M
Sbjct: 129 LEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWM 183
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEIL 723
+PE + K D++S G++ +E+
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
E+ L++E+M + L +L ++ + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 652 DLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YGYMSPEYALEGVFSV 708
DL A N L+ ++ K+SDFGM R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 709 KSDVFSFGVLMLEILSSKK 727
KSDV+SFGVLM E+ S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 72/218 (33%), Positives = 114/218 (52%), Gaps = 21/218 (9%)
Query: 523 ATENFSIQSKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLI 575
++ ++ LG G FG VY+G R +G +VAVK L + S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIID 631
+K H+N+VRL+G E+ + ++ E M L FL + P + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMAR-MFGGDELQGNT 686
+A+G YL + IHRD+ A N LL P KI+DFGMAR ++ +
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ ++ +M PE L+G+F+ K+DV+SFGVL+ EI S
Sbjct: 180 RAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ I ++G+G FG VY R +G+ +K LSN S + ++ NE+ ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL--RVRIIDGIAQ---GL 637
+++ E+G+ ++ EY L + KK + +I+D Q L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI----KKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH SR +I+HRD+K NI L + K+ DFG++++ T +VGT Y+S
Sbjct: 117 KYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLS 171
Query: 698 PEYALEGV-FSVKSDVFSFGVLMLEILSSKK 727
PE + ++ KSD++S G ++ E+ + K
Sbjct: 172 PE-LCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQH 580
+ +++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 581 RNLVRLLGCCIE--QGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
N+VRL +G +++EYM + S +V + K + QL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK-QL------- 109
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+GL YLH I+HRD+K SNIL++ K++DFG+AR + T R++ T
Sbjct: 110 -LEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
Y PE L + + D++S G ++ E+ K
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 533 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 585
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKH-LLGWQLRVRIIDG---------- 632
LLG C L++EYM L+ FL P + L R
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGN 685
+A G+ YL S + +HRDL N L+ ++M KI+DFG++R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +M PE ++ +SDV+++GV++ EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 65/207 (31%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F I +K+G+G FG V+K R + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---LGWQLRVRIIDGIAQGLLY 639
++R +++G+ ++ EY N L L + L W+ ++I+ GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAH 116
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH +I+HRD+K+ N+ LD + N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSK 726
+ ++ KSDV++ GV++ E + K
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 69/200 (34%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
K+G+G FG VYKG L EVAVK + LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+++ ++ E + SL FL T K LL L A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDA------AAGMEYLESKN-- 113
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGD--ELQGNTKRIVGTYGYMSPEYALEG 704
IHRDL A N L+ ++ KISDFGM+R G + K+I + +PE G
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYG 170
Query: 705 VFSVKSDVFSFGVLMLEILS 724
++ +SDV+S+G+L+ E S
Sbjct: 171 RYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E F I KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
V+ G + + ++ EY S D + T K L ++ I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD--IMKITNKTLTEEEIAA-ILYQTLKGLEYLHS 117
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ IHRD+KA NILL++ K++DFG++ + NT ++GT +M+PE
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQ 172
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
E ++ K+D++S G+ +E+ K
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRL 586
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
G G+ + EYM SLD L + +LG +I + +GL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH-- 117
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ +IIHRD+K SNIL++ K+ DFG++ G + K VGT YM+PE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQG 173
Query: 704 GVFSVKSDVFSFGVLMLEI 722
+SVKSD++S G+ ++E+
Sbjct: 174 NDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 74/210 (35%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 533 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLV 584
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH----LLGWQLRVRIIDGIAQGLLYL 640
+LLG C+ + +I E M L +L D + LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNP-----KISDFGMAR-MFGGDELQGNTKRIVGTYG 694
Q + IHRDL A N L+ + KI DFG+AR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE L+G F+ +SDV+SFGVLM EIL+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 72/205 (35%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 533 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 588 GCCIEQGEKILIYEYMVNK-SLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
G C +GE +++ + L +L L +V A G+ YL
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES- 113
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARM--FGGDELQGNT--KRIVGTYGYMSPE 699
+HRDL A N+LL KISDFGM+R G D + T + + Y +PE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APE 168
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
G FS KSDV+S+GV + E S
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-26
Identities = 34/67 (50%), Positives = 46/67 (68%), Gaps = 1/67 (1%)
Query: 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMW 406
C GD F +L ++KLPD ++ S+ LKECE CL NCSC AYA + + GGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIW 59
Query: 407 FGDLIDL 413
G+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 69/235 (29%), Positives = 116/235 (49%), Gaps = 24/235 (10%)
Query: 527 FSIQSKLGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQH 580
+ LGEG FG V +G+L + +VAVK +L + ++EF +E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 581 RNLVRLLGCCIEQGEK------ILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIID 631
N+++L+G C E ++I +M + L FL L Q ++ +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDEL-QGNTKRI 689
IA G+ YL S IHRDL A N +L + M ++DFG+++ ++ GD QG ++
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGH 742
+++ E + V++ KSDV++FGV M EI + + GV N + ++ L H
Sbjct: 178 --PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 79/218 (36%), Positives = 117/218 (53%), Gaps = 18/218 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLH 641
RL ++ +I EYM SL FL K G L ++ID IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPE 699
R IHRDL+A+N+L+ + + KI+DFG+AR+ +E T R + + +PE
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 174
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK--NTGVYNTD 735
G F++KSDV+SFG+L+ EI++ K G+ N+D
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 73/214 (34%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 532 KLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHL----------LGWQLRVRIIDGI 633
G C E ++++EYM + L+ FL P K L L + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A G++YL + L +HRDL N L+ Q + KI DFGM+R + R +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+M PE L F+ +SD++SFGV++ EI + K
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 74/206 (35%), Positives = 114/206 (55%), Gaps = 13/206 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL K+L QL V + IA G+ Y+
Sbjct: 65 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL-VDMAAQIASGMAYVE--- 119
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPEYA 701
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E QG I T +PE A
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 175
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKK 727
L G F++KSDV+SFG+L+ E+ + +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 74/205 (36%), Positives = 110/205 (53%), Gaps = 13/205 (6%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+L E+ I + EYM SL FL D + L L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAAQVAAGMAYIE- 119
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPE 699
R+ IHRDL+++NIL+ + KI+DFG+AR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
AL G F++KSDV+SFG+L+ E+++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 75/216 (34%), Positives = 115/216 (53%), Gaps = 29/216 (13%)
Query: 532 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 584
+LGE FG VYKG L Q VA+K L +++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLRVRIID 631
LLG ++ +I+ Y + L FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGNTKR 688
IA G+ +L S ++H+DL N+L+ +N KISD G+ R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +MSPE + G FS+ SD++S+GV++ E+ S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 76/207 (36%), Positives = 116/207 (56%), Gaps = 15/207 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L E+ I + E+M SL FL + K+L QL V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVGTYGYMSPEY 700
R+ IHRDL+A+NIL+ ++ KI+DFG+AR+ +E QG I + +PE
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA 174
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKK 727
AL G F++KSDV+SFG+L+ E+++ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 63/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 528 SIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
+++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
LG C + +I E+M +L +L + ++ + L + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-LYMATQISSAMEYLEKKN-- 124
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPEYALEG 704
IHRDL A N L+ ++ K++DFG++R+ GD K + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180
Query: 705 VFSVKSDVFSFGVLMLEI 722
FS+KSDV++FGVL+ EI
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 533 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVR 585
LG G FG V+ + +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
LLG C E +I EY L FL + K L + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
L S R +HRDL A N L+ K+S +++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK 727
E FS KSDV+SFGVLM E+ + +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 71/222 (31%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 573
KLGEG FG V+ Q+ VAVK L + S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKH---LLGWQL 625
++++L N+ RLLG C +I EYM N L+ FL L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--EL 682
+ + IA G+ YL L +HRDL N L+ ++ KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
QG R +M+ E L G F+ KSDV++FGV + EIL+
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 74/206 (35%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNL 583
+ ++ +GEG FG V +G GQ+VAVK + + + Q F E ++ KL H+NL
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNL 61
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLL 638
VRLLG + G I++ E M +L FL + LL + L V A+G+
Sbjct: 62 VRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV------AEGME 114
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YL +++HRDL A NIL+ + K+SDFG+AR+ G N+K V + +P
Sbjct: 115 YLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAP 166
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILS 724
E FS KSDV+S+GVL+ E+ S
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQHRNL 583
+ K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQG 636
++LL +G+ L++E+M + L + D + K L +Q + QG
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYL-YQ--------LLQG 110
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
L + H + I+HRDLK N+L++ K++DFG+AR FG V T Y
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYR 165
Query: 697 SPEYAL-EGVFSVKSDVFSFGVLMLEILS 724
+PE L + +S D++S G + E+LS
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 76/204 (37%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 530 QSKLGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N+
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 584 VRLLGCCIEQGEKI--LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V+ GCC EQG K LI EY+ SL +L KH L + I +G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF-GGDELQGNTKRIVGTYGYMSPEY 700
IHRDL A N+LLD KI DFG+A+ G E + + + E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
E FS SDV+SFGV + E+L+
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G VA+K ++ N S + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FD-PTKKHLLGWQ 624
++VRLLG +++ E M L +L PT + +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQ 683
IA G+ YL + +HRDL A N ++ + + KI DFGM R ++ D +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K ++ +M+PE +GVF+ KSDV+SFGV++ E+ +
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 36/219 (16%)
Query: 533 LGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRNLV 584
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDP--------TKKHLLGWQL 625
LLG C ++G ++ EY + +L FL D T+K L+ +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+V A+G+ +L + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 140 QV------ARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
T +M+PE + V++ +SDV+SFGVL+ EI +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 71/215 (33%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 531 SKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQH N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 586 LLGCCIEQGEK--ILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGL 637
G C G + L+ EY+ SL +L D K L Q I +G+
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGM 121
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG---TYG 694
YL R +HRDL NIL++ KI DFG+ ++ D+ + R G +
Sbjct: 122 EYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFW 177
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKN 728
Y +PE E FSV SDV+SFGV++ E+ + S K+
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 72/208 (34%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + S EF E ++ KL H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL--HQ 642
+L G C +Q ++ EYM N L +L + K QL + + + +G+ YL Q
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQL-LEMCKDVCEGMAYLESKQ 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YGYMSPE 699
+ IHRDL A N L+D K+SDFG++R DE + VG+ + PE
Sbjct: 121 F-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPE 171
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK 727
L FS KSDV++FGVLM E+ S K
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLG 588
LG+G FG V R + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG--------IAQGLLY 639
+ EK+ L+ EY L HL R + I L Y
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--------FSHL---SKEGRFSEERARFYAAEIVLALEY 108
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH L II+RDLK NILLD + K++DFG+A+ + + NT GT Y++PE
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPE 163
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
L + D +S GVL+ E+L+
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/211 (29%), Positives = 112/211 (53%), Gaps = 30/211 (14%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQG---LKEFKNEMMLIAKLQHRNLVR 585
LG G F Y+ R + G +AVK+++ N S + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LG E L E+M S+ L + K+ ++ + + + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 644 SRLRIIHRDLKASNILLD---QHMNPKISDFGMA-----RMFGGDELQGNTKRIVGTYGY 695
+IIHRD+K +N+L+D Q + +I+DFG A + G E QG +++GT +
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQG---QLLGTIAF 174
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
M+PE + DV+S G +++E+ ++K
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 72/214 (33%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 532 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVR 585
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLF--------------DPTKKHLLGWQLRVRIID 631
LLG ++ +++EY+ L FL D T K L + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNTKRIV 690
IA G+ YL + +H+DL A NIL+ + ++ KISD G++R ++ D + K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M PE + G FS SD++SFGV++ EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
+LG G FG V+ G+ +VA+K + N+ ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
+Q ++ E+M N L +L ++ L + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 652 DLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG------YMSPEYALEGV 705
DL A N L+ K+SDFGM R DE + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFSK 177
Query: 706 FSVKSDVFSFGVLMLEILSSKK 727
+S KSDV+SFGVLM E+ + K
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 70/225 (31%), Positives = 119/225 (52%), Gaps = 21/225 (9%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
F+ ++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ GC + + L+ EY + + D+ + KK L ++ I G QGL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYLHS 133
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ R IHRD+KA NILL + K++DFG A + N+ VGT +M+PE L
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184
Query: 703 ---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVS 744
EG + K DV+S G+ +E+ +++ ++N ++ + L H++
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 71/213 (33%), Positives = 113/213 (53%), Gaps = 27/213 (12%)
Query: 526 NFSIQSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQH 580
I+ +G G FG V GRL L G+ VA+K L + + + ++F +E ++ + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLRVRIIDGIAQGL 637
N++ L G + +++ EYM N SLD FL +KH QL V ++ GIA G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQL-VGMLRGIASGM 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG--- 694
YL S + +HRDL A NIL++ ++ K+SDFG++R+ D T R G
Sbjct: 120 KYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKI 171
Query: 695 ---YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE F+ SDV+S+G++M E++S
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 53/237 (22%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFK-----NEMMLIAKL 578
++F +GEG F V + +E A+K L + Q +KE K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRL 58
Query: 579 -QHRNLVRLLGCCIEQGEKILIYEYMVN----------KSLDVFLFDPTKKHLLGWQLRV 627
H +++L ++ + EY N SLD +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE----KCTRFYAA----- 109
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL----- 682
I+ + YLH IIHRDLK NILLD+ M+ KI+DFG A++ +
Sbjct: 110 EILLALE----YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 683 -------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+ VGT Y+SPE E SD+++ G ++ ++L+ K
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 582
E S+LGEG G V K RL N + A+K ++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 583 LVRLLGCCIE--QGEKILIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIA 634
+V+ G ++ + EY SLD K+ +LG +I + +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVL 115
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+GL YLH +IIHRD+K SNILL + K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEI 722
YM+PE +S+ SDV+S G+ +LE+
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 533 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 592 EQGEKILIYEYMVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
E G + E + SL L + P K + + I +GL YLH +I
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QILEGLKYLHD---NQI 129
Query: 649 IHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-- 705
+HRD+K N+L++ + KISDFG ++ G + T+ GT YM+PE +G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 706 FSVKSDVFSFGVLMLEILSSK 726
+ +D++S G ++E+ + K
Sbjct: 188 YGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 7e-23
Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 21/206 (10%)
Query: 530 QSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
Q +G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL G + ++I EYM N +LD +L D +QL V ++ GIA G+ YL S
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQL-VGMLRGIAAGMKYL---S 124
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG------YMSP 698
+ +HRDL A NIL++ ++ K+SDFG++R+ L+ + + T G + +P
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAP 179
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILS 724
E F+ SDV+SFG++M E++S
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 9e-23
Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
N ++ +LGEG FG V+ N Q+ VAVK L + S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF-------------DPTKKHLLGWQLR 626
H ++V+ G C+E I+++EYM + L+ FL P + L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE---LTQSQM 122
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ I IA G++YL + +HRDL N L+ +++ KI DFGM+R D +
Sbjct: 123 LHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDY 175
Query: 687 KRIVG----TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
R+ G +M PE + F+ +SDV+S GV++ EI + K
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 1e-22
Identities = 73/216 (33%), Positives = 111/216 (51%), Gaps = 36/216 (16%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ----SGQGLKEFKNEMMLIAKLQ 579
+ KLGEG +G VYK R G+ VA+K RL N+ L+E L+ +L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELK 56
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFL------FDPTK-KHLLGWQLRVRIID 631
H N+V+LL I K+ L++EY + L +L P K ++ +QL
Sbjct: 57 HPNIVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIM-YQL------ 107
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+GL Y H + RI+HRDLK NIL+++ K++DFG+AR F G L+ T +V
Sbjct: 108 --LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV- 160
Query: 692 TYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y +PE L +S D++S G + E+++ K
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 74/232 (31%), Positives = 115/232 (49%), Gaps = 43/232 (18%)
Query: 530 QSKLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNE 571
+ KLGEG FG V+ ++N Q+ VAVK L + + +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTK 617
+ ++++L+ N++RLLG C+++ +I EYM N L+ FL P
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 618 KHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L + + + IA G+ YL S L +HRDL N L+ +++ KI+DFGM+R
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
Query: 676 -MFGGD--ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
++ GD +QG R V +M+ E L G F+ SDV++FGV + EIL
Sbjct: 187 NLYAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 587 LGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQYS 644
GC + E + I+ EYM S+ D K + L + + I +G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYTRQILEGVEYLH--- 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV-GTYGYMSPEYALE 703
I+HRD+K +NIL D N K+ DFG ++ G + V GT +MSPE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 704 GVFSVKSDVFSFGVLMLEILSSK 726
+ K+DV+S G ++E+L+ K
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 71/225 (31%), Positives = 119/225 (52%), Gaps = 21/225 (9%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ GC + + L+ EY + + D L + KK L ++ + G QGL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHS 133
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
++ +IHRD+KA NILL + K+ DFG A + VGT +M+PE L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVIL 184
Query: 703 ---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVS 744
EG + K DV+S G+ +E+ +++ ++N ++ + L H++
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 535 EGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLG 588
EG FG ++ G L++ +EV VK + + + + + E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 589 CCIEQGEK-ILIYEYMVNKSLDVFLFDP-----TKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
CIE GE ++Y YM +L +FL L Q V + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDE--LQGNTKRIVGTYGYMSPE 699
+ +IH+D+ A N ++D+ + KI+D ++R +F D L N R V +M+ E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV---KWMALE 189
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
+ +S SDV+SFGVL+ E+++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 80/275 (29%), Positives = 133/275 (48%), Gaps = 62/275 (22%)
Query: 526 NFSIQSKLGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
N + LGEG FG V K L G+ VAVK L N S L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----------------------FDPT 616
H ++++L G C + G +LI EY SL FL +P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 617 KKHL-------LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669
++ L WQ I++G+ YL + ++++HRDL A N+L+ + KIS
Sbjct: 121 ERALTMGDLISFAWQ--------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 670 DFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
DFG++R ++ ++ + RI +M+ E + +++ +SDV+SFGVL+ EI++
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 728 N--TGVYNTDSFNLL--GH-------VSDKLYSLL 751
N G+ FNLL G+ S+++Y+L+
Sbjct: 228 NPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLM 262
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 68/198 (34%), Positives = 112/198 (56%), Gaps = 12/198 (6%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
LG C+ + L+ + M + L ++ + K +G QL + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
R++HRDL A N+L+ + KI+DFG+AR+ GDE + N +M+ E F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 707 SVKSDVFSFGVLMLEILS 724
+ +SDV+S+GV + E+++
Sbjct: 189 THQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 69/225 (30%), Positives = 118/225 (52%), Gaps = 21/225 (9%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 582
F+ ++G G FG VY R + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ GC + + L+ EY + + D L + KK L ++ I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
++ +IHRD+KA NILL + K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 703 ---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVS 744
EG + K DV+S G+ +E+ +++ ++N ++ + L H++
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 529 IQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
++ +LGEG FG V+ N VAVK L + + K+F+ E L+ LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLF------------DPTK-KHLLGWQLRVRI 629
+V+ G C + I+++EYM + L+ FL P + K LG + I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
IA G++YL + +HRDL N L+ ++ KI DFGM+R D + R+
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRV 181
Query: 690 VG----TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
G +M PE + F+ +SDV+SFGV++ EI + K
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 22/204 (10%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 587 LGCCIEQGEKILIY-EYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
LG E + + I+ E + SL L + + ++ +L R I GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVI--RLYTR---QILLGLEYLH-- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL- 702
R +HRD+K +NIL+D + K++DFGMA+ K G+ +M+PE
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
+G + + +D++S G +LE+ + K
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-22
Identities = 84/249 (33%), Positives = 121/249 (48%), Gaps = 30/249 (12%)
Query: 525 ENFSIQSKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 575
+ + LGEG FG V K R VAVK L N + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTKKH--LL 621
+ +H+N++ LLG C ++G +I EY +L FL FD TK L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
++ V +A+G+ YL SR R IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNL 739
T +M+PE + V++ +SDV+SFG+LM EI L G+ + F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 740 L--GHVSDK 746
L GH DK
Sbjct: 249 LREGHRMDK 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 75/247 (30%), Positives = 130/247 (52%), Gaps = 32/247 (12%)
Query: 533 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 588 GCCIEQGEK------ILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLL 638
G C++ E ++I +M + L FL L Q+ V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDEL-QGNTKRIVGTYGYM 696
YL S IHRDL A N +L+++MN ++DFG++ +++ GD QG ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLLGHVS---------D 745
+ E + V++ KSDV+SFGV M EI + + GV N++ ++ L + D
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD 241
Query: 746 KLYSLLF 752
LYSL+
Sbjct: 242 GLYSLMS 248
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 17/207 (8%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + I +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V L + + ++ E+ +LD + ++ L Q+R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHS 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVGTYGYMSPEY 700
+ ++IHRDLKA NILL + K++DFG++ LQ KR +GT +M+PE
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGTPYWMAPEV 174
Query: 701 ALEGVFS-----VKSDVFSFGVLMLEI 722
F K+D++S G+ ++E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLKEFKNEMMLI 575
NF I+ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEY--------MVN--KSLDVFLFDPTKKHLLGWQL 625
+L H N+++ L IE E ++ E M+ K + + T W+
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-----WKY 111
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
V++ + H +S+ RI+HRD+K +N+ + K+ D G+ R F +
Sbjct: 112 FVQLCSALE------HMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+ VGT YMSPE E ++ KSD++S G L+ E+
Sbjct: 165 SL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 25/210 (11%)
Query: 529 IQSKLGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNL 583
I+ +G G FG V +GRL L G+ VA+K L S + + ++F +E ++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGL 637
+ L G + ++I E+M N +LD FL F QL V ++ GIA G+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI-------QL-VGMLRGIAAGM 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG---TYG 694
YL S + +HRDL A NIL++ ++ K+SDFG++R D +G
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE F+ SDV+S+G++M E++S
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 25/206 (12%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQGLLYLH 641
+ + L++E+ LD+ L KK++ L L + + QG+ Y H
Sbjct: 66 VVHSENKLYLVFEF-----LDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ R++HRDLK N+L+D+ K++DFG+AR F G ++ T +V T Y +PE
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171
Query: 702 LEG-VFSVKSDVFSFGVLMLEILSSK 726
L +S D++S G + E+++ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 16/202 (7%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYKGR GQ VA+K RL ++ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 589 CCIEQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
+++ LI+E++ + K LD P +++ ++ + I QG+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSL---PKGQYMDAELVKSYLYQ-ILQGILFCH---S 119
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
R++HRDLK N+L+D K++DFG+AR F G ++ T +V T Y +PE L
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 706 -FSVKSDVFSFGVLMLEILSSK 726
+S D++S G + E+ + K
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 8/203 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ + E L+ Y+ SL + + L + ++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEY 700
+ IHRD+KA NILL + + KI+DFG++ GGD + K VGT +M+PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 701 ALEGV-FSVKSDVFSFGVLMLEI 722
+ + K+D++SFG+ +E+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 585 RLLGCCIEQ-GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ G ++ EYM SL +L + L G L +D + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD-VCEAMEYLEAN 121
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ +HRDL A N+L+ + K+SDFG+ + Q K V + +PE E
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVK---WTAPEALRE 173
Query: 704 GVFSVKSDVFSFGVLMLEILS 724
FS KSDV+SFG+L+ EI S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 31/193 (16%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ------GLKEFKNEMMLI 575
++ I KLGEG FG VYK R + G+ VA+K++ + + L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL---RVR---- 628
KL+H N+V L+ +E+ +K K V++ P H L L V+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSK------RKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115
Query: 629 ----IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
+ + +G+ YLH+ I+HRD+KA+NIL+D KI+DFG+AR + G
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 685 NTKRIVGTYGYMS 697
GT Y +
Sbjct: 173 KGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 8e-22
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLKEFKNEM 572
++ KLGEG FG V+ E VAVK L ++ + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLL---------GW 623
++++L++ N++RLLG C+ +I EYM N L+ FL +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD-- 680
+ + IA G+ YL + L +HRDL N L+ H KI+DFGM+R ++ GD
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+QG R V +M+ E L G F+ SDV++FGV + E+ +
Sbjct: 186 RIQG---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 66/203 (32%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
KLG+G FG V +G VAVK L + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLHQY 643
G + ++ E SL D +K LG L + D IA G+ YL
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEYA 701
R IHRDL A NILL KI DFG+ R D V + + +PE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESL 172
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
FS SDV+ FGV + E+ +
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 71/227 (31%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSNQSGQGLK-EF 568
+ + KLGEG FG V+ ++ VAVK L + + + +F
Sbjct: 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHL 620
E+ ++++L+ N++RLL CI +I EYM N L+ FL +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGG 679
+ + + + IA G+ YL S L +HRDL N L+ ++ KI+DFGM+R ++ G
Sbjct: 127 ISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 680 D--ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
D +QG R V +MS E L G F+ SDV++FGV + EIL+
Sbjct: 184 DYYRIQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 67/204 (32%), Positives = 110/204 (53%), Gaps = 21/204 (10%)
Query: 533 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 587
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 588 GCCIEQ-GEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
G C+ G +++ YM + L F+ PT K L+G+ L+V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG--NTKRIVGTYGYMSPEY 700
+ +HRDL A N +LD+ K++DFG+AR E N +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
F+ KSDV+SFGVL+ E+++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 71/219 (32%), Positives = 108/219 (49%), Gaps = 34/219 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLKE-FKNEMMLIAK 577
N S LG G FG V + L +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEY-----MVN---KSLDVFLFDPTKKHLLGWQLRVR 628
L H N+V LLG C G ++I EY ++N + + FL T + LL + +V
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFL---TLEDLLSFSYQV- 150
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGN 685
A+G+ +L + IHRDL A N+LL KI DFG+AR D ++GN
Sbjct: 151 -----AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN 202
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ V +M+PE V++ +SDV+S+G+L+ EI S
Sbjct: 203 ARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)
Query: 526 NFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F + KLG+G +G VYK RL + Q A+K L + S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 583 LVR-----LLGC--CIEQGEKILIYEYMVNKSLDVFLFDPTK-KHLLGWQLRVRIIDGIA 634
++ L G CI + EY L + K + L+ Q RI +
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+GL LH+ +I+HRDLK++NILL + KI D G++++ + K +GT
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPH 166
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
YM+PE +S KSD++S G L+ E+ +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 527 FSIQSKLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH 580
+ + +G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKH 58
Query: 581 RNLVRLLGCCI-EQGEKILIY-EY--------MVNKSLDVFLFDPTKKHLLGWQLRVRII 630
N+VR I + + I EY ++ K + + I
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF----------IW 108
Query: 631 DGIAQGLLYLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ Q LL L+ ++HRDLK +NI LD + N K+ DFG+A++ G D
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSF 166
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K VGT YMSPE + KSD++S G L+ E+ +
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN-----EMMLIAKLQHRNLV 584
KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 585 RLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
LL + L++E+M V K + L K + LR GL
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR---------GLE 116
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YLH I+HRDLK +N+L+ K++DFG+AR FG + + V T Y +P
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VVTRWYRAP 171
Query: 699 EYALEGV--FSVKSDVFSFGVLMLEIL 723
E L G + V D++S G + E+L
Sbjct: 172 EL-LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-21
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 343 HSSDCKSG---DRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDG 399
+C D F KL D+KLPD ++ +++L+EC CL NCSC AYA +G
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN-ASAIT-AISLEECREACLSNCSCTAYAY---NNG 55
Query: 400 GSGCLMWFGDLIDLKKTDNHTNGVSIYIRVP 430
GCL+W G L +L+ + G ++Y+R+
Sbjct: 56 SGGCLLWNGLLNNLRSLSS--GGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 69/205 (33%), Positives = 110/205 (53%), Gaps = 17/205 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID---GIAQGLLYLH 641
+L + + +I E+M SL FL K Q ++ID IA+G+ ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPE 699
Q + IHRDL+A+NIL+ + KI+DFG+AR+ +E T R + + +PE
Sbjct: 120 QRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
G F++KSDV+SFG+L++EI++
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LKEFKNEMMLIAKLQHRN 582
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ LG ++ + EY+ S+ L L + I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG--NTKR--IVGTYGYMSP 698
+R IIHRD+K +NIL+D KISDFG+++ + L N R + G+ +M+P
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E + ++ K+D++S G L++E+L+ K
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 582
E+ S LG G G V K + G +A K + + + K+ E+ ++ + +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+V G + + + E+M SLD P +LG +I + +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
Y+ RI+HRD+K SNIL++ K+ DFG++ G+ + VGT YMSPE
Sbjct: 120 --YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPER 173
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
G ++VKSDV+S G+ ++E+ K
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 21/220 (9%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
GC +++ L+ EY + + D L + KK L ++ I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHSHN--- 141
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL---EG 704
+IHRD+KA NILL + K++DFG A VGT +M+PE L EG
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVS 744
+ K DV+S G+ +E+ +++ ++N ++ + L H++
Sbjct: 196 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHIA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 41/217 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG------LKEFKNEMMLIAKL 578
+ I ++GEG G V+K + G+ VA+K+++ + +G L+E K +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
QH +V+LL +L+ EYM V + + L + K + L+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK------ 110
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
G+ Y+H I+HRDLK +N+L+ KI+DFG+AR+F +E + + + V T
Sbjct: 111 ---GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VAT 163
Query: 693 YGYMSPEYAL------EGVFSVKSDVFSFGVLMLEIL 723
Y +PE GV D+++ G + E+L
Sbjct: 164 RWYRAPELLYGARKYDPGV-----DLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 66/194 (34%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
++ ++ E + D F KK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 652 DLKASNILLDQHMNPKISDFGMARMF-GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
DL A N L+ ++ KISDFGM+R G K+I + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 711 DVFSFGVLMLEILS 724
DV+S+G+L+ E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 584
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G ++ + +I EY S D K L I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR---IVGTYGYMSPEYA 701
IHRD+KA+NILL + + K++DFG++ +L + VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 702 LEGVFSVKSDVFSFGVLMLEIL 723
+ + K+D++S G+ +E+
Sbjct: 171 KQSGYDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 582
NF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LL + + L++E++ ++ L F+ D + + L + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ R++HRDLK N+L++ K++DFG+AR F G ++ T +V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 703 EGVF-SVKSDVFSFGVLMLEILSSK 726
+ S D++S G + E+++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA-------QG 636
V G + + + ++ EY SL ++ T+ L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT--KR--IVGT 692
L YLH+ IHRD+K +NILL + + K++DFG++ T KR +GT
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGT 164
Query: 693 YGYMSPEYALE---GVFSVKSDVFSFGVLMLE 721
+M+PE A G + K D+++ G+ +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 74/249 (29%), Positives = 120/249 (48%), Gaps = 30/249 (12%)
Query: 525 ENFSIQSKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V K + VAVK L + + + L + +EM ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLL 621
+ +H+N++ LLG C + G +I EY +L +L +D + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
++ V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR +
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNL 739
T +M+PE + V++ +SDV+SFGVLM EI L G+ + F L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 740 L--GHVSDK 746
L GH DK
Sbjct: 252 LKEGHRMDK 260
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR 581
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG--------- 632
LV L Q E+ Y+V +D+ LLG LR +
Sbjct: 61 FLVNL--WYSFQDEE---NMYLV---VDL---------LLGGDLRYHLSQKVKFSEEQVK 103
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
I L YLH IIHRD+K NILLD+ + I+DF +A D T
Sbjct: 104 FWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
GT GYM+PE +SV D +S GV E L K+
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 72/245 (29%), Positives = 121/245 (49%), Gaps = 30/245 (12%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNL 583
NF KLGEG + VYKGR G+ VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 584 VRLLGCCIEQGEKILIYEYM---VNKSLDVF----LFDPTKKHLLGWQLRVRIIDGIAQG 636
VRL + + +L++EYM + K +D DP +QL +G
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL--------LKG 112
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGY 695
+ + H+ R++HRDLK N+L+++ K++DFG+AR FG + NT V T Y
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWY 166
Query: 696 MSPEYALEG-VFSVKSDVFSFGVLMLEILSSKK-NTGVYNTDS----FNLLGHVSDKLYS 749
+P+ L +S D++S G +M E+++ + G N D F ++G ++ +
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226
Query: 750 LLFDL 754
+ L
Sbjct: 227 GISQL 231
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 533 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 587 LGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL--HQ 642
G C E G LI E++ + SL +L P K+ + + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT-YGYMSPEYA 701
Y +HRDL A N+L++ KI DFG+ + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
++ F + SDV+SFGV + E+L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQL-RVRIIDG-IAQGLLYLHQYSRL 646
+ + L+ M L +++ + G+ R I GL +LHQ
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
RI++RDLK N+LLD H N +ISD G+A G K GT GYM+PE V+
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVY 171
Query: 707 SVKSDVFSFGVLMLEILSSK 726
D F+ G + E+++ +
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 30/220 (13%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QH 580
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------FDP-------TKKHLLGWQLR 626
N++ LLG C +G L EY + +L FL DP T L QL
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
D +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R G E+
Sbjct: 128 HFAAD-VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--V 178
Query: 687 KRIVGTYG--YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K+ +G +M+ E V++ SDV+S+GVL+ EI+S
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 64/273 (23%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLKEFK-NEMMLIAKLQH 580
+ I+ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 581 RNLVRLLGCCIEQGEKI--LIYEYMVNKSLDVFLF----------DPTKKHLLGWQLRVR 628
N+V L+ +E +K L+++Y + + F K LL WQ
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMF------- 677
I G+ YLH ++HRDLK +NIL+ + KI D G+AR+F
Sbjct: 117 ----ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 678 -GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK--------- 726
D +V T Y +PE L K+ D+++ G + E+L+ +
Sbjct: 170 ADLD-------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222
Query: 727 -KNTGVYNTDS----FNLLGHVSDKLYSLLFDL 754
K + + D F +LG ++K + + +
Sbjct: 223 IKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKM 255
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 533 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 587 LGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQY 643
GC ++ EK L EYM S+ D K + L + + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR-IVGTYGYMSPEYAL 702
I+HRD+K +NIL D N K+ DFG ++ + G R + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
+ K+DV+S G ++E+L+ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 532 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRLLG 588
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 589 CCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYLHQYSR 645
+ + EK+ I+ EY +L+ L +H V + +GL YLH +
Sbjct: 67 VEVHR-EKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFG------GDELQGNTKRIVGTYGYMSPE 699
I+HRD+K +NI LD + K+ DFG A G+E+Q + GT YM+PE
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPE 173
Query: 700 YALEGVFSVK---SDVFSFGVLMLEILSSKK 727
G +D++S G ++LE+ + K+
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 71/236 (30%), Positives = 121/236 (51%), Gaps = 30/236 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH 580
F++ LG+G FG V + +L + Q+VAVK L S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 581 RNLVRLLGCCIEQGEK------ILIYEYMVNKSLDVFLF------DPTKKHLLGWQLRVR 628
N+++L+G + K ++I +M + L FL +P L Q VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDEL-QGNT 686
+ IA G+ YL S IHRDL A N +L+++M ++DFG+++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLL 740
++ +++ E + V++ SDV++FGV M EI++ + GV N++ +N L
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 10/112 (8%)
Query: 228 TGPWNGVAFGSAP-----SNTTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQ 282
+GPWNG+ F P S + F +N +EVYY Y ++ I L ++ G ++
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNF----TENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 283 RLIWHEMSTGWQVFFTAPDPFCH-YGDCGPNSICSVDQTSHCECLEGFKFKS 333
R W S W +F++AP C YG CGP C V+ + C C++GF K+
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 28/220 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-Q 579
E+ + +GEG FG V + + A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------FDPT--KKH----LLGWQLR 626
H N++ LLG C +G + EY +L FL DP K+H L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFG++R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 687 KRIVGTYG--YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K+ +G +M+ E V++ KSDV+SFGVL+ EI+S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 34/220 (15%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QH 580
T F + +GEG +G VYK R GQ VA+K + +E K E ++ K H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62
Query: 581 RNLVRLLGCCIEQGEKI------LIYEY--------MVNKSLDVFLFDPTKKHLLGWQLR 626
N+ G I++ L+ E +V K+ + +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAY--- 117
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
I+ +GL YLH+ ++IHRD+K NILL ++ K+ DFG++ + NT
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 687 KRIVGTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLE 721
+GT +M+PE + + +SDV+S G+ +E
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHR 581
NF I+ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLD-VFLFDPTKKHLLG----WQLRVRIIDGIAQG 636
N+++ L IE E ++ E L + + +K L+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H +SR R++HRD+K +N+ + K+ D G+ R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEI 722
SPE E ++ KSD++S G L+ E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGC 589
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
+E +++ EY +L ++ L I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD----EDTILHFFVQILLALHHVHTKLIL 123
Query: 650 HRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV 708
HRDLK NILLD+H M KI DFG++++ + +VGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 709 KSDVFSFGVLMLEILSSKK 727
KSD+++ G ++ E+ S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ R G ++ + +I EY+ S LD+ P ++ + LR I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
R IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 174 KQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 7e-19
Identities = 75/241 (31%), Positives = 120/241 (49%), Gaps = 30/241 (12%)
Query: 533 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRN 582
LGEG FG V + + VAVK L S+ + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLLGWQLRVRI 629
++ LLG C + G +I EY +L +L ++PT+ + L ++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLL--GHVSD 745
+M+PE + +++ +SDV+SFGVL+ EI L GV + F LL GH D
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 262
Query: 746 K 746
K
Sbjct: 263 K 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 37/217 (17%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVK------RLSNQSGQGLKE----FKNEMMLIAKLQHR 581
+G+G +G VY + G+ +AVK ++ + K+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 582 NLVRLLGCCIEQGEKIL-IY-EYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIA 634
N+V+ LG E E+ L I+ EY+ S+ L F+ QL + +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE--------QLVRFFTEQVL 118
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN--TKRIVGT 692
+GL YLH I+HRDLKA N+L+D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 693 YGYMSPE--YALEGVFSVKSDVFSFGVLMLEILSSKK 727
+M+PE ++ +S K D++S G ++LE+ + ++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 24/206 (11%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 589 CCIEQGEKILIYEYM---VNKSLDV---FLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY+ + K +D F +P +Q I+ GIA Y H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----YCHS 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ R++HRDLK N+L+D+ N K++DFG+AR F G ++ T +V T Y +PE
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEIL 175
Query: 702 LEG-VFSVKSDVFSFGVLMLEILSSK 726
L +S D++S G + E+++ K
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 63/202 (31%), Positives = 110/202 (54%), Gaps = 20/202 (9%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTK----KHLLGWQLRVRIIDGIAQGLLYLHQ 642
LG C+ + LI + M L ++ + ++LL W ++ IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
R++HRDL A N+L+ + KI+DFG+A++ G DE + + + +M+ E L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
+++ +SDV+S+GV + E+++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 532 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR----NLV 584
+LG G FG V KG ++ Q +VA+K L N++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
R++G C E +L+ E L+ FL KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYMSPEYAL 702
+HRDL A N+LL KISDFG+++ G D+ R G + + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECIN 171
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
FS +SDV+S+G+ M E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 33/215 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 579
+ + +GEG +G V K R G+ VA+K+ + + ++ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIA 634
H N+V L +G L++EY+ L++ P WQL
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------L 110
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR----IV 690
Q + Y H IIHRD+K NIL+ + K+ DFG AR L+ V
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162
Query: 691 GTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILS 724
T Y +PE + K DV++ G +M E+L
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG V+KG + + VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 587 LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--------LLGWQLRVRIIDGIAQGL 637
LG C G + L+ + SL D ++H LL W ++ IA+G+
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YL ++ R++HR+L A NILL +I+DFG+A + D+ + +M+
Sbjct: 123 YYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
E L G ++ +SDV+S+GV + E++S
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 68/197 (34%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGC 589
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
C Q + I I +V D F T+ L + +++++ A G+ YL I
Sbjct: 62 CT-QKQPIYIVMELVQGG-DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 650 HRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
HRDL A N L+ + KISDFGM+R G G K+I + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 708 VKSDVFSFGVLMLEILS 724
+SDV+SFG+L+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 76/249 (30%), Positives = 120/249 (48%), Gaps = 30/249 (12%)
Query: 533 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRN 582
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----------FDPTK--KHLLGWQLRVRI 629
++ LLG C + G ++ EY +L +L FD K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYNTDSFNLL--GHVSD 745
+M+PE + V++ +SDV+SFGVL+ EI L G+ + F LL GH D
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 256
Query: 746 KLYSLLFDL 754
K + +L
Sbjct: 257 KPANCTHEL 265
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 59/206 (28%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H +
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG G+ ++ E+ ++D + + + L Q++V I + + L YLH
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS- 128
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVGTYGYMSPEYA 701
++IIHRDLKA N+LL + K++DFG++ ++ +R +GT +M+PE
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 702 L-----EGVFSVKSDVFSFGVLMLEI 722
+ + + K+D++S G+ ++E+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 46/224 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIAK 577
+ + +++ EG +G VY+ R G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 578 LQHRNLVRL----LGCCIEQGEKILIY---EYMVN--KSL-----DVFLFDPTKKHLLGW 623
LQH N+V + +G +++ IY EY+ + KSL FL K +L
Sbjct: 61 LQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML-- 113
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
QL + G+A +LH I+HRDLK SN+LL+ KI DFG+AR + G L+
Sbjct: 114 QL----LSGVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLK 161
Query: 684 GNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T+ +V T Y +PE L +S D++S G + E+L+ K
Sbjct: 162 PYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 525 ENFSIQSKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 579 QHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQ 635
+H +V+ GC + EK L EYM S+ D K + L + R I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-TKRIVGTYG 694
G+ YLH I+HRD+K +NIL D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+MSPE + K+DV+S ++E+L+ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 36/216 (16%)
Query: 531 SKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLKEFKNEMML--IAKLQHRNL 583
+++GEG +G V+K R L G+ VA+KR+ Q+ G L + +L + +H N+
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 584 VRLLGCCI-----EQGEKILIYEYMVNKSLDVFLF---DP-----TKKHLLGWQLRVRII 630
VRL C + + L++E+ V++ L +L +P T K ++ +QL
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMM-FQL----- 119
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+GL +LH + R++HRDLK NIL+ K++DFG+AR++ Q +V
Sbjct: 120 ---LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 170
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T Y +PE L+ ++ D++S G + E+ K
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 72/229 (31%), Positives = 117/229 (51%), Gaps = 23/229 (10%)
Query: 523 ATENFSIQSKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQSGQGLK-EFKNEMMLI 575
A E ++ +LG+G FG VY KG + + E VA+K ++ + + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 576 AKLQHRNLVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL--FDPTKKHLLGWQL-----RV 627
+ ++VRLLG + QG+ L I E M L +L P ++ +
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNT 686
++ IA G+ YL+ + +HRDL A N ++ + KI DFGM R ++ D +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI--LSSKKNTGVYN 733
K ++ +MSPE +GVF+ SDV+SFGV++ EI L+ + G+ N
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 19/201 (9%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG-QGLKEFK-NEMMLIAKLQ---HRNLVRL 586
+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 587 LGCC-IEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
L C + ++ L++E+ V++ L +L K L ++ ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ RI+HRDLK NIL+ KI+DFG+AR++ + +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPEVL 178
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
L+ ++ D++S G + E+
Sbjct: 179 LQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 532 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAK----LQHRNLV 584
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
R++G C E +L+ E L+ FL KH+ + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNI-TELVHQVSMGMKYLEETN 115
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTKRIVGTYGYMSPEY 700
+HRDL A N+LL KISDFG+++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
FS KSDV+SFGVLM E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRN 582
+ I K+GEG FG +Y + + E V + + + +KE K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 583 LVRLLGCCIEQGEKILIYEY--------MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+V E G ++ EY +N+ V ++ +L W ++ I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQ------IS 111
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTY 693
GL ++H +I+HRD+K+ NI L ++ M K+ DFG+AR T VGT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTP 166
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y+SPE ++ K+D++S G ++ E+ + K
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 533 LGEGGFGPVYKGRLLNGQEVAVKRL----SNQ--SGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G +G VY G GQ +AVK++ SN + + ++ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
LG C++ + E++ S+ L F P + + + +I+DG+A YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNNC 122
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV----GTYGYMSPEY 700
++HRD+K +N++L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
E + KSD++S G + E+ + K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 56/201 (27%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S LD+ P + + L+ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 174 QQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLKEFKNEMMLIAKLQ 579
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 580 HRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQG 636
H +V+ GC + E+ L E+M S+ D K + L + + I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN-TKRIVGTYGY 695
+ YLH I+HRD+K +NIL D N K+ DFG ++ L G K + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
MSPE + K+D++S G ++E+L+ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 523 ATENFSIQSKLGEGGFGPVYKG---RLLNGQ---EVAVKRLSNQSGQGLK--EFKNEMML 574
+ E ++ +LG+G FG VY+G ++ G+ VAVK + N+S + EF NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASV 62
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLF-------DPTKKHLLGWQLRV 627
+ ++VRLLG + +++ E M + L +L + + Q +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGNT 686
++ IA G+ YL+ + +HRDL A N ++ KI DFGM R ++ D +
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K ++ M+PE +GVF+ SD++SFGV++ EI S
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 71/213 (33%), Positives = 111/213 (52%), Gaps = 30/213 (14%)
Query: 533 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QHRNLVRLL 587
+GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL-------FDP-------TKKHLLGWQLRVRIIDGI 633
G C +G L EY + +L FL DP T L QL + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL-LHFAADV 121
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R G E+ K+ +G
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRL 173
Query: 694 G--YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+ E V++ SDV+S+GVL+ EI+S
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 58/201 (28%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 582
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKS-LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S LD+ P + + LR I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLH 118
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ IHRD+KA+N+LL +H K++DFG+A +++ N VGT +M+PE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVI 173
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 174 KQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHR 581
NF I+ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLL-----GWQLRVRIIDGIAQG 636
N+++ IE E ++ E L + K+ L W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H +SR R++HRD+K +N+ + K+ D G+ R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEI 722
SPE E ++ KSD++S G L+ E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 3e-17
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVR 585
F + +G G +G VYKGR + ++A ++ + +G +E K E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 586 LLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G I++ + L+ E+ S+ L TK + L + I I +GL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LHQ+ ++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 181
Query: 700 YAL-----EGVFSVKSDVFSFGVLMLEI 722
+ + KSD++S G+ +E+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIAK 577
+ + +LG+G FG VY R G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 578 LQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR-IIDGIAQ 635
L H N+V+L E E ++EYM +L + D K + +R II I Q
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS--ESVIRSIIYQILQ 110
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN---TKRIVGT 692
GL ++H + HRDLK N+L+ KI+DFG+AR E++ T V T
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVST 161
Query: 693 YGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
Y +PE L +S D+++ G +M E+ + +
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 21/199 (10%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH---RNLVRLL 587
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL-FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
G ++ +I EY S+ + P + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI--VGTYGYMSPEYALEG 704
+IHRD+KA+NIL+ N K+ DFG+A + Q ++KR VGT +M+PE EG
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 705 V-FSVKSDVFSFGVLMLEI 722
+ K+D++S G+ + E+
Sbjct: 177 KYYDTKADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 27/217 (12%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
F I ++GEG +G VYK R G+ VA+K RL N+ E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 584 VRLLGCCI----------EQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRII 630
V L ++G L++EYM + L+ L ++ H+ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSFM 122
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ +GL Y H+ + L HRD+K SNILL+ K++DFG+AR++ +E + T +++
Sbjct: 123 KQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 691 GTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y PE L E + DV+S G ++ E+ + K
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 28/206 (13%)
Query: 533 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG G FG VYKG + E VA+K L N S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH--------LLGWQLRVRIIDGIAQGLL 638
LG C+ + L+ + M L D +++ LL W ++ IA+G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL----LDYVRENKDRIGSQDLLNWCVQ------IAKGMS 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YL + +R++HRDL A N+L+ + KI+DFG+AR+ DE + + +M+
Sbjct: 124 YLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILS 724
E L F+ +SDV+S+GV + E+++
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
++ Q LG G G VYK LL + +AVK + + + + K+ +E+ ++ K
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ G + + E+M SLDV+ P +H+LG RI + +GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIP--EHVLG-----RIAVAVVKGLTYLWS 113
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
L+I+HRD+K SN+L++ K+ DFG++ + K VGT YM+PE
Sbjct: 114 ---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERIS 166
Query: 703 EGVFSVKSDVFSFGVLMLEI 722
+ + SDV+S G+ +E+
Sbjct: 167 GEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 527 FSIQSKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIA 576
+ +Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLS 57
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIA 634
KL H +V+ +E+ +I EY + LD L T K L Q + +
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ----VCEWFI 113
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G T GT
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEI 722
YMSPE + KSD++S G ++ E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 53/231 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------------------LKEFKNEMM 573
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLD--VFLFDPTKKHLLGWQLRVR 628
++ +++H N++ L+ +E L+ + M + K +D + L + K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
I GL LH++ +HRDL +NI ++ KI+DFG+AR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 689 I------------VGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE + + D++S G + E+L+ K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 28/205 (13%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 589
LG G +G V K R + G +AVKR+ + + Q K ++ + + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV------RIIDGIAQGLLYLHQY 643
+G+ + E M + SLD F K + L + +I I + L YLH
Sbjct: 69 LFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI-VGTYGYMSPE--- 699
S+L +IHRD+K SN+L++++ K+ DFG++ G + K I G YM+PE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPERIN 176
Query: 700 --YALEGVFSVKSDVFSFGVLMLEI 722
+G + VKSDV+S G+ M+E+
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 57/202 (28%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 533 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
++ ++ EY +L + K L ++ + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV- 705
I+HRD+K NI L + K+ DFG++++ G + T +VGT YMSPE +GV
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELC-QGVK 177
Query: 706 FSVKSDVFSFGVLMLEILSSKK 727
++ KSD+++ G ++ E+L+ K+
Sbjct: 178 YNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 34/217 (15%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLK-EFKNEMMLIAKLQHRN 582
F +++GEG +G VY+ R +G+ VA+K++ + G+ E+ L+ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLD-VFLFDPTKKHLLGWQL----------RVR-II 630
+V L E +V K LD +FL + L L +V+ ++
Sbjct: 68 IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLM 114
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ +GL YLH+ IIHRDLK SN+LL KI+DFG+AR + G + T ++V
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV 170
Query: 691 GTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK 726
T Y +PE L + D+++ G ++ E+L+ K
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQ---HRNL 583
+++G G +G VYK R +G VA+K + +N+ G L + E+ L+ +L+ H N+
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNI 64
Query: 584 VRLLGCC----IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
VRL+ C ++ K+ L++E+ V++ L +L L ++ ++ +GL
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLD 122
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
+LH I+HRDLK NIL+ K++DFG+AR++ Q +V T Y +P
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAP 176
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E L+ ++ D++S G + E+ K
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 14/218 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 579
E+ ++ +GEG FG VY+G ++ VAVK N + ++E F E ++ +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I + E L +L K+ L + ++ L Y
Sbjct: 66 HPHIVKLIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
L R +HRD+ A N+L+ K+ DFG++R + +K + +M+PE
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPE 178
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVYNTD 735
F+ SDV+ FGV M EIL K GV N D
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-16
Identities = 54/214 (25%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L + S+ + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ +L++ N+V L + E ++ EY+ SL D + + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ N+LL + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+M+PE + K D++S G++ +E++ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 533 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 589
+G G FG V K G +AVKR+ S + K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 590 CIEQGEKILIYEYMVNKSLDVF---LFDPTKKHL----LGWQLRVRIIDGIAQGLLYLHQ 642
+G+ + E M + SLD F +++ K + LG +I + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK-RIVGTYGYMSPE-- 699
L+IIHRD+K SNILLD++ N K+ DFG++ G + K R G YM+PE
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERI 179
Query: 700 --YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFN 738
A +G + V+SDV+S G+ + E+ TG + +N
Sbjct: 180 DPSARDG-YDVRSDVWSLGITLYEV-----ATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H N+
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LL + ++ E+ ++D + + ++ L Q+RV + + L YLH+
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN 122
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI------VGTYGYMS 697
+IIHRDLKA NIL + K++DFG++ NT+ I +GT +M+
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMA 171
Query: 698 PEYAL-----EGVFSVKSDVFSFGVLMLEI 722
PE + + + K+DV+S G+ ++E+
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 35/214 (16%)
Query: 528 SIQSKLGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
I+ LG G FG + +G +L + +E VA+ L + S + + F E + + + H N
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLRVRIIDGIAQGLLY 639
+VRL G +++ EYM N +LD FL +KH L+ QL + ++ G+A G+ Y
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQL-MGMLPGLASGMKY 122
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS-- 697
L S + +H+ L A +L++ + KIS F + + Y MS
Sbjct: 123 L---SEMGYVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGK 169
Query: 698 -------PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE FS SDV+SFG++M E++S
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 530 QSKLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQG-----LKEFKNEMMLIAKLQHRN 582
+K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHEN 72
Query: 583 LVRLLGCCIEQGEK--------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+V L+ C + L++E+ L L + K L +++ +++ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLS-EIK-KVMKMLL 129
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG---GDELQGNTKRIVG 691
GL Y+H R +I+HRD+KA+NIL+ + K++DFG+AR F + T R+V
Sbjct: 130 NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185
Query: 692 TYGYMSPEYAL-EGVFSVKSDVFSFGVLMLE 721
T Y PE L E + D++ G +M E
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSL-DVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V G + + + + E+ SL D++ + P + + + R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ +HRD+K +NILL + + K++DFG++ K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 702 L---EGVFSVKSDVFSFGVLMLEI 722
+G ++ D+++ G+ +E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 63/213 (29%), Positives = 111/213 (52%), Gaps = 14/213 (6%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK-NE 571
L + SV + ++ K+G+G G VY + GQEVA+K++ N Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 572 MMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRII 630
++++ + +H N+V L + E ++ EY+ SL DV T+ + Q+ +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAA-VC 121
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
Q L +LH ++IHRD+K+ NILL + K++DFG ++ + +T +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT +M+PE + K D++S G++ +E++
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 517 FASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMM 573
F +V T + +G G FG V R L GQ VA+K++ + K E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
L+ L+H N++ L I E I Y V + L L L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDI----YFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI 117
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-----MFGGDELQGNTKR 688
+GL Y+H ++HRDLK SNIL++++ + KI DFG+AR M G
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG---------- 164
Query: 689 IVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L + V+ D++S G + E+L K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSL-DVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
V G + + + + EY SL D++ + P + + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
++ HRD+K +NILL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 702 L---EGVFSVKSDVFSFGVLMLEI 722
G ++ D+++ G+ +E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 10/214 (4%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L S SV + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ + ++ N+V L + E ++ EY+ SL D + + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ NILL + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+M+PE + K D++S G++ +E++ +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 586
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 587 LGCCIEQ--GEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVR-IIDGIAQGLLYLH 641
+ ++ G L++E M D+ L++ K K L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
R I HRD+K NIL+ K++DFG R G T+ I T Y +PE
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECL 170
Query: 702 L-EGVFSVKSDVFSFGVLMLEILS 724
L +G + K D+++ G + EILS
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 56/214 (26%), Positives = 104/214 (48%), Gaps = 10/214 (4%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 572
L S SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+++ + ++ N+V L + E ++ EY+ SL D + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
Q L +LH ++IHRD+K+ NILL + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+M+PE + K D++S G++ +E++ +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 49/212 (23%)
Query: 532 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
++G G G VYK G+ A+K + N ++ E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 590 CIEQGEKILIYEYMVNKSLD-------VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
GE ++ E+M SL+ FL D ++ I+ GIA YLH
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----------ILSGIA----YLH- 185
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE--- 699
R I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERIN 241
Query: 700 ----------YALEGVFSVKSDVFSFGVLMLE 721
YA D++S GV +LE
Sbjct: 242 TDLNHGAYDGYA--------GDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 533 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 588
LG+GGFG V ++ G+ A K+L+ + + K ++ M+ ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRLR 647
+ + L+ M L +++ +++ + R I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
II+RDLK N+LLD N +ISD G+A + Q TK GT G+M+PE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 708 VKSDVFSFGVLMLEILSSK 726
D F+ GV + E+++++
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 21/156 (13%)
Query: 532 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 588
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 589 CCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY ++ L + DP +QL +GL + H
Sbjct: 67 VLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQL--------LKGLAFCHS 117
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
+ ++HRDLK N+L++++ K++DFG+AR FG
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 35/206 (16%)
Query: 533 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG GGFG V ++ + A+K + ++GQ + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKL- 58
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR----------IIDGIAQGL 637
Y +K L + L LR R I +
Sbjct: 59 ------------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH II+RDLK N+LLD + K+ DFG A+ + T GT Y++
Sbjct: 107 EYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVA 160
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEIL 723
PE L + D +S G+L+ E+L
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V R +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + L + + + + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
RD+K+ +ILL K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 711 DVFSFGVLMLEIL 723
D++S G++++E++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 527 FSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNL 583
+ S +G G +G V G++VA+K+LS QS K E+ L+ + H N+
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 584 VRLLGCCIEQGEKILIYE-YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ LL + Y+V + L + K L ++ I +GL Y+H
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
IIHRDLK SNI +++ KI DFG+AR DE+ G V T Y +PE L
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYRAPEIML 188
Query: 703 EGVFSVKS-DVFSFGVLMLEILSSK 726
+ ++ D++S G +M E+L+ K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-14
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 530 QSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
++ + G G YKG+ + NG + VK +++ + E + + KLQH N+V+L+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIG 750
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
C + LI+EY+ K+L L + L W+ R +I GIA+ L +LH +
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV 708
+ +L I++D P + + + D I + Y++PE +
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITE 857
Query: 709 KSDVFSFGVLMLEILSSK 726
KSD++ FG++++E+L+ K
Sbjct: 858 KSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
SK+GEG +G V+K R GQ VA+K+ S K E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGW--QLRVRIIDGIAQGLLYLHQYSR 645
+ + L++EY D + + +K+ G L +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEY-----CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN- 120
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG- 704
IHRD+K NIL+ + K+ DFG AR+ G + V T Y +PE L G
Sbjct: 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPEL-LVGD 175
Query: 705 -VFSVKSDVFSFGVLMLEILSS 725
+ DV++ G + E+L+
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVR 585
F + +G G +G VYKGR + ++A ++ + + +E K E+ ++ K HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 586 LLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G I++ + L+ E+ S+ L TK + L I I +GL +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH + ++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPE 191
Query: 700 YAL-----EGVFSVKSDVFSFGVLMLEI 722
+ + +SD++S G+ +E+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 533 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLK-----EFKNEMMLIAKLQHRNL 583
LG+G FG V+ R + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLLYLHQ 642
V+L +G+ LI +++ L F K ++ + V+ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
L II+RDLK NILLD+ + K++DFG+++ E + GT YM+PE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
+ +D +SFGVLM E+L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
IA GL +LH II+RDLK N++LD + KI+DFGM + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
GT Y++PE + D ++FGVL+ E+L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH+ II+RDLK N+LLD + KI+DFGM + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + D ++ GVL+ E+L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 52/203 (25%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 531 SKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ E G ++ +Y + D++ ++ +L + +I+D Q L L
Sbjct: 63 QYQESFEENGNLYIVMDYC--EGGDLYKKINAQRGVLFPE--DQILDWFVQICLALKHVH 118
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSPEYALE 703
+I+HRD+K+ NI L + K+ DFG+AR+ EL + +GT Y+SPE
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPEICEN 175
Query: 704 GVFSVKSDVFSFGVLMLEILSSK 726
++ KSD+++ G ++ E+ + K
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 30/206 (14%)
Query: 536 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCI 591
G +G V+ + G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 592 EQGEK--ILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
QG+K L+ EY+ L L D + I I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHSNG 113
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFG------MARMFGGDELQGNTKRIVGTYGYMSP 698
IIHRDLK NIL+D + + K++DFG + R ++ + KRIVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILS 724
E L S D +S G ++ E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 41/213 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMML 574
+ I KLG+G +G V+K + VA+K++ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 575 IAKL-QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ +L H N+V+LL + +K L++EYM + L + ++L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMY 114
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI-- 689
+ + L Y+H S +IHRDLK SNILL+ K++DFG+AR EL+ N +
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 690 ---VGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
V T Y +PE L S ++ GV M
Sbjct: 170 TDYVATRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
E + +GEG +G V K + GQ VA+K+ S K E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
NLV L+ + L++E++ + LD P + L + + I +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF-GGDELQGNTKRIVGTYGYMSPEY 700
++ IIHRD+K NIL+ Q K+ DFG AR E+ + V T Y +PE
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPEL 171
Query: 701 ALEGVFSVKS-DVFSFGVLMLEILS 724
+ ++ D+++ G L+ E+L+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 23/204 (11%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ---GLLYLHQY 643
+ L+ M L +++ ++ G ++ R+I AQ G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER---GLEME-RVIHYSAQITCGILHLHS- 113
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ I++RD+K N+LLD N ++SD G+A + G + T+R GT GYM+PE
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR-AGTNGYMAPEILK 167
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
E +S D F+ G + E+++ +
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRN 582
++F S+LG G G V K + + ++L + + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L + + + +LG +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG---KVSI--AVLRGLAYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE- 172
Query: 701 ALEGV-FSVKSDVFSFGVLMLEI 722
L+G +SV+SD++S G+ ++E+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 43/217 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++F LG G FG V R + A+K LS LK+ NE ++ ++H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----LFDPTKKHLLGWQLRV--RIIDGIA 634
LV L G Q + L Y+V ++ LF LR R + +A
Sbjct: 61 PFLVNLYGS--FQDDSNL---YLV---MEYVPGGELFS---------HLRKSGRFPEPVA 103
Query: 635 Q--------GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ L YLH L I++RDLK N+LLD KI+DFG A+ ++G T
Sbjct: 104 RFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRT 155
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ GT Y++PE L + D ++ G+L+ E+L
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 522 AATENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKL 578
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 579 QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH-----LLGWQLRVRIIDG 632
+H N+V LL I E + ++EYM + P H L +QL
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------- 112
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+GL Y+H I+HRDLK N+L+ K++DFG+AR Q + +V T
Sbjct: 113 -LRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-T 166
Query: 693 YGYMSPEYALEGV-FSVKSDVFSFGVLMLEIL 723
Y P+ L +S D++ G + +E+L
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 51/194 (26%), Positives = 98/194 (50%), Gaps = 12/194 (6%)
Query: 532 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V + G++VAVK++ + Q + NE++++ QH N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 591 IEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649
+ E ++ E++ +L D+ T + Q+ + + + L +LH +I
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV----THTRMNEEQI-ATVCLAVLKALSFLHAQ---GVI 137
Query: 650 HRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVK 709
HRD+K+ +ILL K+SDFG + + K +VGT +M+PE + +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTE 195
Query: 710 SDVFSFGVLMLEIL 723
D++S G++++E++
Sbjct: 196 VDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 51/227 (22%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMMLIA 576
+ + +G G +G V G++VA+K++SN F + E+ L+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLR 54
Query: 577 KLQHRNLVRLLGCCI-----EQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQL 625
L+H N++ LL + + ++ E M V KS + L
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS---------PQPLT--DD 103
Query: 626 RVRIIDGIAQ---GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
++ + Q GL YLH +IHRDLK SNIL++ + + KI DFG+AR DE
Sbjct: 104 HIQYF--LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 683 QGN--TKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
+ T+ +V T Y +PE L ++ D++S G + E+L+ K
Sbjct: 159 EKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL--LGWQLRVRIIDG--IAQGLLYLHQ 642
+ L+ M L ++ H+ G++ + I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-----HMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYA 701
RI++RDLK NILLD H + +ISD G+A + G ++G VGT GYM+PE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVV 173
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSK 726
++ D ++ G L+ E+++ +
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQE--VAVKRLSNQS---GQGLKE-------FKNEMM 573
+++ LG G FG VYK R N + +A+K ++ + G+ +E +E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 574 LIAK-LQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIID 631
+I + L+H N+VR +E ++ + + L + F KK + I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ L YLH+ R I+HRDL +NI+L + I+DFG+A+ + +VG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVG 175
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
T Y PE + K+DV++FG ++ ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 44/154 (28%)
Query: 594 GEKILIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
GE + E+M SLD L KK ++LG +I + +GL YL + + +
Sbjct: 72 GEISICMEHMDGGSLDQVL----KKAGRIPENILG-----KISIAVLRGLTYLRE--KHK 120
Query: 648 IIHRDLKASNILLDQHMNPKISDFG--------MARMFGGDELQGNTKRIVGTYGYMSPE 699
I+HRD+K SNIL++ K+ DFG MA F VGT YMSPE
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------------VGTRSYMSPE 168
Query: 700 YALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVY 732
L+G ++V+SD++S G+ ++E+ G Y
Sbjct: 169 -RLQGTHYTVQSDIWSLGLSLVEMA-----IGRY 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 533 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 588 -----GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
IE ++ Y+V + L + K L + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
IIHRDLK SN+ +++ +I DFG+AR DE+ G V T Y +PE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188
Query: 703 EGV-FSVKSDVFSFGVLMLEILSSK 726
+ ++ D++S G +M E+L K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 47/226 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKL 578
+ S +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 579 QHRNLVRLLGC----CIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR----- 628
+H N++ +L E + ++ E M T + L ++ +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM-----------ETDLYKL---IKTQHLSND 106
Query: 629 ----IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
+ I +GL Y+H + ++HRDLK SN+LL+ + + KI DFG+AR+ D
Sbjct: 107 HIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHD 161
Query: 685 NTKRI---VGTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK 726
+T + V T Y +PE L K+ D++S G ++ E+LS++
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 52/153 (33%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
KLGEG + VYKGR L GQ VA+K RL ++ G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 589 CCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ L++EY+ L ++ L +QL +GL Y HQ
Sbjct: 71 IIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQL--------LRGLAYCHQ 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
R++HRDLK N+L+ + K++DFG+AR
Sbjct: 122 R---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + VYKGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYL 640
N+V L + L++EY+ +K L +L D ++ +L + + +GL Y
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL---FLFQLLRGLNYC 120
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPE 699
H R +++HRDLK N+L+++ K++DFG+AR + T V T Y P+
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPD 174
Query: 700 YALEGV-FSVKSDVFSFGVLMLEILSSK 726
L +S + D++ G + E+ + +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-12
Identities = 52/192 (27%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 549 GQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLL--GCCIEQGEKILIYEYM 603
G EVA+K L + + + F+ E L A+L H N+V LL G G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 604 VNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL-- 660
++L +V D +L ++++D +A +++ I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALA------CAHNQ-GIVHRDLKPQNIMVSQ 114
Query: 661 -DQHMNPKISDFGMARMFGG----DELQGN-TKRIVGTYGYMSPEYALEGVFSVKSDVFS 714
+ K+ DFG+ + G D T ++GT Y +PE + SD+++
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 715 FGVLMLEILSSK 726
+G++ LE L+ +
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 27/235 (11%)
Query: 497 CEADGDGKDKSKDSSL-PLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVK 555
+ D D L P A A+ +++ L G G V+ GQ V
Sbjct: 37 DDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVV 95
Query: 556 RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
Q G L E ML+ + H +++R+ + ++ + S D++ +
Sbjct: 96 LKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLT 148
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ L + I I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 149 KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
Query: 676 ------MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
F G + GT +PE ++ K+D++S G+++ E+L+
Sbjct: 206 FPVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 68/217 (31%), Positives = 101/217 (46%), Gaps = 45/217 (20%)
Query: 531 SKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
S +G G +G V G VAVK+LS QS K E+ L+ ++H N++ LL
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 588 GCCIEQGEKILIYEYMVNKSL----DVFLFDPTKKHLLGWQLR--VR-----------II 630
+ +SL DV+L HL+G L V+ +I
Sbjct: 83 DV------------FTPARSLEEFNDVYLV----THLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I +GL Y+H IIHRDLK SN+ +++ KI DFG+AR DE+ G V
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YV 178
Query: 691 GTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
T Y +PE L + ++ D++S G +M E+L+ +
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 42/111 (37%), Positives = 64/111 (57%), Gaps = 13/111 (11%)
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
T + L+ + +V A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR
Sbjct: 171 TLEDLISYSFQV------ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
Query: 676 MF--GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
D ++ R+ +M+PE + V++ +SDV+SFGVL+ EI S
Sbjct: 222 DIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRN 582
++F S+LG G G V+K +G +A K + + ++ + E+ ++ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L + + +LG +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYL 119
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE- 172
Query: 701 ALEGV-FSVKSDVFSFGVLMLEI 722
L+G +SV+SD++S G+ ++E+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 31/208 (14%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFL-------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+ L+ M L + FD + + I GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE--------ITCGLED 117
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSP 698
LH R RI++RDLK NILLD + + +ISD G+A + G+ ++G VGT GYM+P
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E ++ D + G L+ E++ K
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-12
Identities = 38/99 (38%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGNTKRI 689
+AQG+ +L + IHRD+ A N+LL KI DFG+AR D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728
V +M+PE + V++V+SDV+S+G+L+ EI S K+
Sbjct: 278 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 62/243 (25%), Positives = 114/243 (46%), Gaps = 31/243 (12%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGCC 590
K+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 591 IEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-----LHQY 643
+ ++ L+++Y + + F K + V++ G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 644 SRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSP 698
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 699 EYALEGVFSVKS-DVFSFGVLMLEILSSK----------KNTGVYNTDS----FNLLGHV 743
E L K+ D+++ G + E+L+S+ K + Y+ D FN++G
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244
Query: 744 SDK 746
+DK
Sbjct: 245 ADK 247
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 533 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G+G +G V + R Q V K L N S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 590 CIEQGEKILIYEYM-VNKSLDVF-LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647
+GE L+Y M + D++ K LL V IA L YLH+
Sbjct: 68 W--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---H 122
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
I+HRDLK N+ L + K+ D G+AR+ +T ++GT YMSPE ++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYN 180
Query: 708 VKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLL 740
KSDV++ G + E+ + K +N N L
Sbjct: 181 YKSDVWALGCCVYEMATLKH---AFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 15/202 (7%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFK---NEMMLIAKLQHRN 582
F I +++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+LL + L EY+ L L R + + + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH- 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
L IHRDLK N L+D + K++DFG+++ G +VG+ YM+PE
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
+ D +S G ++ E L
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE---LQGNTKRI 689
+A+G+ +L + IHRDL A NILL KI DFG+AR D ++GN +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
V +M+PE V++ +SDV+S+G+L+ EI S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 49/237 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGL--KEFKNEMMLIAKLQH 580
+ + I +G+GG G VY + + VA+K++ + S L K F E + A L H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLG--WQLRV----------- 627
+V + C G+ +Y M ++ T K LL WQ
Sbjct: 62 PGIVPVYSIC-SDGD--PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 628 ----RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE-- 681
I I + Y+H S+ ++HRDLK NILL I D+G A +E
Sbjct: 113 GAFLSIFHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 682 ---LQGNTK-----------RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ + + +IVGT YM+PE L S +D+++ GV++ ++L+
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 71/261 (27%), Positives = 105/261 (40%), Gaps = 73/261 (27%)
Query: 533 LGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRN 582
LG G FG V + + VAVK L + G E K M +LI H N
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILIHIGNHLN 72
Query: 583 LVRLLGCCIE-QGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQ 635
+V LLG C + G ++I E+ +L FL F P ++ + R R + ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 636 G-------------------------------------------LLYLHQYSR------- 645
+ Y Q +R
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGYMSPEYALE 703
+ IHRDL A NILL ++ KI DFG+AR D ++ + R+ +M+PE +
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFD 250
Query: 704 GVFSVKSDVFSFGVLMLEILS 724
V++ +SDV+SFGVL+ EI S
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L L++EY+ +K L ++ D +++ + I +GL Y H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH 121
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPEY 700
R +++HRDLK N+L+++ K++DFG+AR + T V T Y P+
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDV 175
Query: 701 AL-EGVFSVKSDVFSFGVLMLEILSSK 726
L +S + D++ G + E+ S +
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 34/93 (36%), Positives = 54/93 (58%)
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q LL +H +IHRD+K++NILL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
Y++PE +S K+D+FS GVL+ E+L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHR 581
+ + K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 582 N-LVRLLGCCIEQGE----KILIY---EYMVNKSLDVFL----------FDPTKKHLLGW 623
+VRLL +E E K +Y EY+ + L F+ +
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 624 QLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDEL 682
QL +G+ + H++ ++HRDLK N+L+D+ KI+D G+ R F +
Sbjct: 118 QL--------LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPV 165
Query: 683 QGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEIL 723
+ T IV T Y +PE L +S D++S G + E+
Sbjct: 166 KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+ L+ M L +++ G++ R + A+ L L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFE-EERALFYAAEILCGLEDLHRE 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
++RDLK NILLD + + +ISD G+A ++ G+ ++G VGT GYM+PE
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQR 177
Query: 706 FSVKSDVFSFGVLMLEILSSK 726
+++ D + G L+ E++ +
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 37/89 (41%), Positives = 53/89 (59%), Gaps = 11/89 (12%)
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
G+ LHQ IIHRD+K N+L+DQ + K++DFG++R G E K+ VGT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDY 159
Query: 696 MSPEYALEGVFSVK-SDVFSFGVLMLEIL 723
++PE + GV K SD +S G ++ E L
Sbjct: 160 LAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSG-QGLKEFK-NEMMLIAKLQHRNL 583
F + +GEG +G V K R +E VA+K+ + + +KE E+ ++ L+ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L +G+ L++EY+ L++ P ++ I Q + +H
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV------PPEKVRSYIYQLIKAIHWC 116
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ I+HRD+K N+L+ + K+ DFG AR + N V T Y SPE L
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLG 175
Query: 704 GVFSVKSDVFSFGVLMLEI 722
+ D++S G ++ E+
Sbjct: 176 APYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
RD+K+ +ILL K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 711 DVFSFGVLMLEIL 723
D++S G++++E++
Sbjct: 198 DIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 33/84 (39%), Positives = 54/84 (64%), Gaps = 6/84 (7%)
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H ++R +++RDLK +NILLD+H + +ISD G+A F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 701 ALEGV-FSVKSDVFSFGVLMLEIL 723
+GV + +D FS G ++ ++L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 29/204 (14%)
Query: 532 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIV-LLH 69
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
I E + L++EY V+ L ++ P L +QL +GL Y+H
Sbjct: 70 DIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL--------LRGLSYIH 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPEY 700
Q I+HRDLK N+L+ K++DFG+AR + +T V T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 701 ALEGV-FSVKSDVFSFGVLMLEIL 723
L +S D++ G + +E++
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
VR+ IA+ +L L +L II+RD+K NILLD + ++DFG+++ F +E +
Sbjct: 106 EVRVY--IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-R 162
Query: 686 TKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILS 724
GT YM+PE G D +S GVL E+L+
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 532 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590
K+GEG G V G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
+ E ++ E++ +L D + + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKS 710
RD+K+ +ILL K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 711 DVFSFGVLMLEILSSK 726
D++S G++++E++ +
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 532 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V G + +V VK L + S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV--RIIDGIAQGLLYLHQYSR 645
G C E +L+ E+ L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-- 703
IH DL N LL + KI D+G++ ++ ++ +++PE E
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 704 GVFSV-----KSDVFSFGVLMLEIL 723
G V +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 526 NFSIQSKLGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNL 583
+++ +GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP-----TKKHLLGWQLRVRIIDGIAQGLL 638
V G ++ EY L + + +L W ++ + G+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQ 114
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
++H+ R++HRD+K+ NI L Q+ K+ DFG AR+ T VGT Y+ P
Sbjct: 115 HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPP 169
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E ++ KSD++S G ++ E+ + K
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 39/94 (41%), Positives = 59/94 (62%), Gaps = 7/94 (7%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIV 690
+A+G+ +L SR + IHRDL A NILL ++ KI DFG+AR D ++ R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE + V++++SDV+SFGVL+ EI S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
+LG+G +G VYK G +A+K RL + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648
+G + EYM SLD + + RI + +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG---- 704
IHRD+K +N+L++ + K+ DFG++ G+ + K +G YM+PE G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 705 --VFSVKSDVFSFGVLMLEI 722
++V+SDV+S G+ +LE+
Sbjct: 181 NPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 532 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V G R ++ V VK L + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHLLGWQLRVRIIDGIAQGLLY 639
G CIE +L+ E+ L +L K L R+ +A GLL+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLLW 115
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSP 698
LHQ IH DL N L ++ KI D+G+A + D V +++P
Sbjct: 116 LHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAP 171
Query: 699 EYA-------LEGVFSVKSDVFSFGVLMLEI 722
E L + KS+++S GV M E+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 533 LGEGGFGPVYK---GRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
+G G FG V+ R +G+ VA+K++ N Q+ K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 588 GCCIEQGEKILIYE--YMVNKSL--DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
I Q I +E Y+V + + D+ + + L ++V + I +GL YLH
Sbjct: 66 D--ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ-ILRGLKYLHS- 121
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
I+HRD+K N+L++ + KI DFG+AR+ DE + T+ +V Y Y +PE L
Sbjct: 122 --AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI-LM 177
Query: 704 GV--FSVKSDVFSFGVLMLEILSSK 726
G ++ D++S G + E+L +
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 533 LGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLV 584
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 585 RLLGCCIEQGEKILIYEYMVNKSL-------DVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L+ G+ LI EY+ L +F+ D +L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL----------SEISLAL 113
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN--TKRIVGTYGY 695
+LHQ II+RDLK NILLD + K++DFG+ + + + T GT Y
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
M+PE + D +S G LM ++L+
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH+ II+RDLK N+LLD+ + KI+DFGM + M G +G
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE ++ D +SFGVL+ E+L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 533 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
+ L+ M L +++ G+ + R I A+ L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQ-RAIFYAAELCCGLEDLQRE 121
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
RI++RDLK NILLD + +ISD G+A ++ G+ ++G VGT GYM+PE
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177
Query: 706 FSVKSDVFSFGVLMLEIL 723
++ D + G L+ E++
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM--LIAKLQHR 581
+ ++G G G VYK R G +AVK++ + +E K +M + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHD 72
Query: 582 --NLVRLLGCCIEQGEKILIYEYMVN--KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V+ G I + + E M L + P + +LG ++ V I+ + L
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-KMTVAIV----KAL 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYM 696
YL + + +IHRD+K SNILLD N K+ DFG++ R+ + + T R G YM
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYM 181
Query: 697 SPEY----ALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732
+PE + +++DV+S G+ ++E+ TG +
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELA-----TGQF 216
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 61/216 (28%), Positives = 87/216 (40%), Gaps = 40/216 (18%)
Query: 527 FSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIA 576
F + LG G FG V YK G+ A+K L + + L K
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL------DVFLFDPTKKHLLGWQLRVRII 630
+H LV L C + + EY L DVF + R
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-----------EPRAVFY 106
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
+ GL YLH+ +I++RDLK N+LLD KI+DFG+ + M GD T
Sbjct: 107 AACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TS 159
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT +++PE E ++ D + GVL+ E+L
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 533 LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G G +G V G++VA+K+LS QS K E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 590 CIEQGEKILIYE-YMVNKSLDVFL-------FDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ Y+V + L K L +Q+ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYIH 134
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
IIHRDLK N+ +++ KI DFG+AR E+ G V T Y +PE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWYRAPEVI 186
Query: 702 LEGVFSVKS-DVFSFGVLMLEILSSK 726
L + ++ D++S G +M E+L+ K
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 32/84 (38%), Positives = 53/84 (63%), Gaps = 6/84 (7%)
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H ++R +++RDLK +NILLD+H + +ISD G+A F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 701 ALEGV-FSVKSDVFSFGVLMLEIL 723
+G + +D FS G ++ ++L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 61/243 (25%), Positives = 114/243 (46%), Gaps = 31/243 (12%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGCC 590
K+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 591 IEQGEK--ILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDG----IAQGLLYLHQY 643
+ ++ L+++Y + + F +K + QL ++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 644 SRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSP 698
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 699 EYALEGVFSVKS-DVFSFGVLMLEILSSK----------KNTGVYNTDS----FNLLGHV 743
E L K+ D+++ G + E+L+S+ K + ++ D F+++G
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244
Query: 744 SDK 746
+DK
Sbjct: 245 ADK 247
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 19/200 (9%)
Query: 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LG+G FG V RL +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
CC + +++ VN +F +++ + R R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLHDKG-- 116
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIVGTYGYMSPEYALEG 704
II+RDLK N+LLD + K++DFGM + +F G T GT Y++PE E
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQEM 171
Query: 705 VFSVKSDVFSFGVLMLEILS 724
++ D ++ GVL+ E+L
Sbjct: 172 LYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L + L++EY+ + L +L D + +++ + + +GL Y H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH 120
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ +I+HRDLK N+L+++ K++DFG+AR
Sbjct: 121 ---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 514 LFSFASVTAATENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEM 572
+ S+ T+ + I +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 573 MLIAKL-QHRNLVRLLGCCIEQ-----GEKILIYEYMVNKSLDVFLFDPTKKHLL--GWQ 624
++ L H N+V+ G + G+ L+ E S+ + K LL G +
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 625 LRVRIIDGIAQG-LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
L +I I G LL L RIIHRD+K +NILL K+ DFG++ L+
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 684 GNTKRIVGTYGYMSPEY-----ALEGVFSVKSDVFSFGVLMLEI 722
NT VGT +M+PE + + + DV+S G+ +E+
Sbjct: 185 RNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 577
NF + LG G +G V+ R ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 578 LQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQ 635
++ + L + K+ LI +Y+ L F + + V+I G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVL 116
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L +LH +L II+RD+K NILLD + + ++DFG+++ F DE++ GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEY 172
Query: 696 MSPEYAL--EGVFSVKSDVFSFGVLMLEILS 724
M+P+ +G D +S GVLM E+L+
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKE 567
F SV F++ + +G G G V + GQ VA+K+LS Q+ K
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQ------GEKILIYEYMVNKSLDVFLFDPTKKHL- 620
E++L+ + H+N++ LL Q + L+ E M V D + +
Sbjct: 62 AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS 121
Query: 621 -LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
L +Q+ G+ +LH IIHRDLK SNI++ KI DFG+AR G
Sbjct: 122 YLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170
Query: 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ T +V Y Y +PE L + D++S G +M E++
Sbjct: 171 SFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++ +G G FG V+ R ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-----FDPTKKHLLGWQLRVRIIDGIAQ 635
++RL +Q ++ EY+ L +L F + + I
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--------IVC 112
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L YLH I++RDLK NILLD+ + K++DFG A+ +L+ T + GT Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
++PE + D ++ G+L+ E+L
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 69/289 (23%), Positives = 116/289 (40%), Gaps = 48/289 (16%)
Query: 469 NETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATE--- 525
E +N DL A + ++ D D +PL A + E
Sbjct: 90 GELLVPRSNADLFASAGDGPSGAEDSDASHLDFDEAPPDAAGPVPLAQ-AKLKHDDEFLA 148
Query: 526 NFSIQSKLGEGGFGPVY--KGRLLNGQEVAVKRLSNQSGQGLKEFK-------------- 569
+F + L G FG ++ R + A +R N + QG + +
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEA-RRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 570 ----NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE---YMVNKSLDV----FLFDPT-- 616
NE++ + +L H N++++ E+IL E YM+ + D F++D
Sbjct: 208 IQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFD 259
Query: 617 -KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
K L Q R I+ + + Y+H ++IHRD+K NI L+ + DFG A
Sbjct: 260 WKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
F E + VGT SPE + +D++S G+++L++LS
Sbjct: 316 PF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 525 ENFSIQSKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAK 577
+ +G G +G V +G++VA+K++ + + L+E K ++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-FDPTKKHLLGWQLRVRIIDG---- 632
+H N++ + I DV++ D L+ L II
Sbjct: 61 FKHDNIIAIRD----------ILRPPGADFKDVYVVMD-----LMESDLH-HIIHSDQPL 104
Query: 633 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGG 679
+ +GL Y+H + +IHRDLK SN+L+++ +I DFGMAR
Sbjct: 105 TEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 680 DELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEIL 723
E + V T Y +PE L ++ D++S G + E+L
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 38/93 (40%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH I++RDLK NILLD + KI+DFGM + M G T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE L ++ D +SFGVL+ E+L
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 26/207 (12%)
Query: 528 SIQSKLGE----GGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHR 581
+ + +G+ + K + VAVK+ L + S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---LGWQLRVRIIDGIAQGLL 638
N++ + I E ++ M S + L K H L I+ + L
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDVLNALD 115
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQ----GNTKRIVGTY 693
Y+H IHR +KAS+ILL +S + M + Q K V
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 694 GYMSPEY---ALEGVFSVKSDVFSFGV 717
++SPE L+G ++ KSD++S G+
Sbjct: 173 PWLSPEVLQQNLQG-YNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-09
Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 8/84 (9%)
Query: 348 KSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK-NCSCRAYANSKVTDGGSGCLMW 406
KS D F +L + KLP + ++ +L+EC ++CL NCSCR++ + G GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 407 -FGDLIDLKKTDNHTNGVSIYIRV 429
L D + + GV +Y ++
Sbjct: 57 SESSLGDARLFPSG--GVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIVGTYG 694
L++LH++ +I+RDLK NILLD + K++DFGM + + G T GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPD 161
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y++PE E + D ++ GVLM E+++ +
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 533 LGEGGFGPV-YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL-- 80
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR---------IIDGIAQGLLYL 640
+ + +++ D +L P LG ++ ++ + +GL Y+
Sbjct: 81 ------DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H IIHRDLK N+ +++ KI DFG+AR E+ G V T Y +PE
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWYRAPEV 186
Query: 701 ALEGV-FSVKSDVFSFGVLMLEILSSK 726
L + ++ D++S G +M E+L+ K
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IA GL +LH II+RDLK N++LD + KI+DFGM + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y++PE + D ++FGVL+ E+L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 31/198 (15%)
Query: 549 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------LGCCIEQG 594
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 595 EKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651
++ EYM + L+ L +QL +GL Y+H + ++HR
Sbjct: 90 SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL--------LRGLKYIHSAN---VLHR 138
Query: 652 DLKASNILLDQH-MNPKISDFGMARMFGGD-ELQGNTKRIVGTYGYMSPEYALEGVFSVK 709
DLK +N+ ++ + KI DFG+AR+ +G + T Y SP L K
Sbjct: 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198
Query: 710 S-DVFSFGVLMLEILSSK 726
+ D+++ G + E+L+ K
Sbjct: 199 AIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKE 567
F SV A F++ + +G G G V + G VAVK+LS Q+ K
Sbjct: 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 66
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE-YMVNKSLDVFL-------FDPTKKH 619
E++L+ + H+N++ LL Q + Y+V + +D L D +
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS 126
Query: 620 LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679
L +Q + G+ +LH IIHRDLK SNI++ KI DFG+AR
Sbjct: 127 YLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175
Query: 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ + T +V Y Y +PE L + D++S G +M E++
Sbjct: 176 NFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 517 FASVTAATENFSIQSK------LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGL 565
F SV F++ + +G G G V Y L + VA+K+LS Q+
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHA 60
Query: 566 KEFKNEMMLIAKLQHRNLVRLLGC-----CIEQGEKILIYEYMVNKSLDVFLFDPTKKHL 620
K E++L+ + H+N++ LL +E+ + + Y+V + +D L + L
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV----YLVMELMDANLCQVIQMEL 116
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
++ + + G+ +LH IIHRDLK SNI++ KI DFG+AR G
Sbjct: 117 DHERMSYLLYQMLC-GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+ T +V Y Y +PE L + D++S G +M E++ K
Sbjct: 173 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 35/96 (36%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ GL +LH R II+RDLK N++LD + KI+DFGM + M G T+
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
GT Y++PE + D +++GVL+ E+L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 15/197 (7%)
Query: 533 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ EK+ VN ++F ++ L + R R +A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGG-ELFFHLQRERCFL--EPRARFYAAEVASAIGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
II+RDLK NILLD + ++DFG+ + G E + T GT Y++PE + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 707 SVKSDVFSFGVLMLEIL 723
D + G ++ E+L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 63/243 (25%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 576
++F + +G G FG V+ R + +V A+K L NQ + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILA 56
Query: 577 KLQHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-- 632
+V+L Q E+ L + EYM L + +R +
Sbjct: 57 DADSPWIVKLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEET 102
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA--------RMFGGD 680
IA+ +L L +L IHRD+K NIL+D + K++DFG+ R + +
Sbjct: 103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 681 ELQGNTKR-------------------IVGTYGYMSPEYALEGV-FSVKSDVFSFGVLML 720
+ R VGT Y++PE L G + ++ D +S GV++
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILY 221
Query: 721 EIL 723
E+L
Sbjct: 222 EML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQSGQGLKEFK---NEMMLIAKLQ 579
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI-----A 634
H V L G ++ L+ E+++ FL + R + + A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAA 138
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q +L L I++RDLK N+LLD+ K++DFG A++ + T + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
Y++PE L +D ++ G+ + EIL
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 533 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLKEFKNEMMLIAKLQHRN 582
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
LV+L G C+ E I++ EY+ LDVFL L W+L V +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 643 YSRLRIIHRDLKASNILLDQHMNP-------KISDFGMARMFGG-DELQGNTKRIVGTYG 694
+++H ++ NIL+ ++ K+SD G+ +E +RI
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERI----P 169
Query: 695 YMSPEYALEGVFSVKS--DVFSFGVLMLEILS 724
+++PE G S+ D +SFG +LEI S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ +K+ VN ++F ++ + R R IA L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGG-ELFFHLQRERSFP--EPRARFYAAEIASALGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
II+RDLK NILLD + ++DFG+ + G E T GT Y++PE + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 707 SVKSDVFSFGVLMLEILS 724
D + G ++ E+L
Sbjct: 174 DRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 517 FASVTAATENFSIQSKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLI 575
F S ++ + I +G+G +G V+K NG + AVK L +E + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 576 AKLQ-HRNLVRLLGCC----IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
L H N+V+ G ++ G+++ L+ E S+ + K+ G ++ I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPI 125
Query: 630 IDGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
I I GL +LH + IHRD+K +NILL K+ DFG++ L+ N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 686 TKRIVGTYGYMSPEY-----ALEGVFSVKSDVFSFGVLMLEI 722
T VGT +M+PE L+ + + DV+S G+ +E+
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 577
NF + LG G +G V+ R + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 578 LQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQ 635
++ + L + K+ LI +Y+ + L+ + + + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFS--EDEVRFYSGEIIL 116
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L +LH +L I++RD+K NILLD + ++DFG+++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 696 MSPEYAL-EGVFSVKSDVFSFGVLMLEILS 724
M+PE +G D +S G+L+ E+L+
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 44/225 (19%)
Query: 527 FSIQSK------LGEGGFGPVYKGR-LLNGQEVAVKRLSN------QSGQGLKEFKNEMM 573
F + +K +G G +G V + ++VA+K+++N + + L+E K
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK---- 56
Query: 574 LIAKLQHRNLVRLLGC----CIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
L+ L H N++ + E + ++YE M + +S L D ++ L
Sbjct: 57 LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQT-LSDDHCQYFLY 115
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
LR GL Y+H + ++HRDLK SN+LL+ + + KI DFG+AR E
Sbjct: 116 QLLR---------GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEK 161
Query: 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L ++ DV+S G + E+L K
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVG 691
+A+ +L + +L +HRD+K N+LLD++ + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 692 TYGYMSPEY--ALE---GVFSVKSDVFSFGVLMLEIL 723
T Y+SPE A+E G + + D +S GV M E+L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I GL +LH II+RDLK N++LD+ + KI+DFGM + +FG
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE ++ D +SFGVL+ E+L
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 526 NFSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQ 579
+ + +LG+G +G V + VA+K+++N + + K E+ L+ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 580 -HRNLVRLLGCCI---EQGEKILIYEYMVNKSL------DVFLFDPTKKHLLGWQLRVRI 629
H+N+ L I ++ +YE ++ L L D + + +Q
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQ----- 113
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTK 687
I GL Y+H + ++HRDLK N+L++ KI DFG+AR F E G
Sbjct: 114 ---ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 688 RIVGTYGYMSPEYALEGVFSVKS-DVFSFGVLMLEILSSK 726
V T Y +PE L K+ DV+S G ++ E+L K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 533 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQY 643
G C+ E I++ EY+ SLD +L + W+L V A+ L + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV------AKQLAWALHFL 116
Query: 644 SRLRIIHRDLKASNILL-----DQHMNP---KISDFGMARMFGGDELQGNTKRIVGTYGY 695
+ H ++ A N+LL + NP K+SD G++ E+ +RI +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PW 170
Query: 696 MSPEYALEG-VFSVKSDVFSFGVLMLEILS 724
+ PE S+ +D +SFG + EI S
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 52/187 (27%), Positives = 89/187 (47%), Gaps = 24/187 (12%)
Query: 550 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC-----CIEQGEKILIYEY 602
+ VA+K+LS Q+ K E++L+ + H+N++ LL +E+ + + I
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 603 MVNKSLDVFL---FDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
+++ +L + D + L +Q+ G+ +LH IIHRDLK SNI+
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLC--------GIKHLHSAG---IIHRDLKPSNIV 158
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ KI DFG+AR G + T +V Y Y +PE L + D++S G +M
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 215
Query: 720 LEILSSK 726
E++
Sbjct: 216 GEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+A+G+ +L + +HRDL A N+LL Q KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE + +++ SDV+S+G+L+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVG 691
IA+ +L +H +L +HRD+K N+LLD + + +++DFG +M +Q + VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165
Query: 692 TYGYMSPEY--ALE---GVFSVKSDVFSFGVLMLEIL 723
T Y+SPE A+E G + + D +S GV M E+L
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 45/217 (20%)
Query: 526 NFSIQSKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKL 578
+F + LG G FG V +KG G+ A+K L + +K+ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSL------------DVFLFDPTKKHLLGWQLR 626
H +V ++ ++ + E++V L DV F +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE--------- 126
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ YLH II+RDLK N+LLD + K++DFG A+ ++ T
Sbjct: 127 ------LVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRT 172
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
+ GT Y++PE D ++ GVL+ E +
Sbjct: 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 533 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLLYLHQYSRL 646
+ EK+ VN LF ++ + R R IA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHS---I 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
I++RDLK NILLD + ++DFG+ + G T GT Y++PE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 707 SVKSDVFSFGVLMLEIL 723
D + G ++ E+L
Sbjct: 174 DNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
A+ L L + +I+RDLK NILLD + + DFG+ ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
Y++PE L ++ D ++ GVL+ E+L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 15/197 (7%)
Query: 533 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 587
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-IAQGLLYLHQYSRL 646
+ + +Y+ L F ++ + R R IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
I++RDLK NILLD + ++DFG+ + E G T GT Y++PE + +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 707 SVKSDVFSFGVLMLEIL 723
D + G ++ E+L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
GT Y++PE + D ++ GVLM E+++ +
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN------QSGQGLKEFKNEMMLIAKLQ 579
+ IQ +G+G +G V G++VA+K++++ + + L+E K L+ L+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK----LLRLLR 57
Query: 580 HRNLVRLLGCCI-----EQGEKILIYEYM------VNKSLDVFLFDPTKKH--LLGWQLR 626
H ++V + + E + +++E M V K+ D D T +H +QL
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND----DLTPEHHQFFLYQL- 112
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDELQGN 685
+ L Y+H + + HRDLK NIL + KI DFG+AR F
Sbjct: 113 -------LRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 162
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKS----DVFSFGVLMLEILSSK 726
V T Y +PE L G F K D++S G + E+L+ K
Sbjct: 163 WTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-07
Identities = 64/253 (25%), Positives = 110/253 (43%), Gaps = 54/253 (21%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA-----KLQHR 581
+ + K+G G FG V+ + QE + S +GLKE + ++I +L+H+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDV-----------FLFDPTKKHLLGWQLRVRII 630
N+VR + + + + L Y++ + D +F ++H + V I
Sbjct: 73 NIVRYIDRFLNKANQKL---YILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-----VDIT 124
Query: 631 DGIAQGLLYLHQY----SRLRIIHRDLKASNILLD---QHMN--------------PKIS 669
+ L Y H + R++HRDLK NI L +H+ KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV--KSDVFSFGVLMLEILSSKK 727
DFG+++ G ++ VGT Y SPE L S KSD+++ G ++ E+ S K
Sbjct: 185 DFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK- 240
Query: 728 NTGVYNTDSFNLL 740
T + ++F+ L
Sbjct: 241 -TPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 2/156 (1%)
Query: 569 KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVR 628
++E+ +A H +V+ + +LI EY L+ + K+HL + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
++ Q +L L + +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
GT Y++PE +S K+D++S GV++ E+L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 15/99 (15%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L +LH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFC 157
Query: 691 GTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSK 726
GT Y++PE L G FSV D ++ GVLM E+++ +
Sbjct: 158 GTPNYIAPE-ILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 28/165 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E F I + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 584 VRL--------LGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGW---QLRVRIID 631
+ L L ++ + L+ EY++ + L H+ G+ ++ V+ I
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL------HIYGYFDEEMAVKYIS 111
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
+A L YLH++ IIHRDLK N+L+ + K++DFG++++
Sbjct: 112 EVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 23/214 (10%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-------SGQGLKEFKNEM 572
+ ++I S L G G V+ V K Q + G K E+
Sbjct: 87 ASVVRMQYNILSSLTPGSEGEVF---------VCTKHGDEQRKKVIVKAVTGGKTPGREI 137
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
++ + HR ++ L+ K + M D+F + + L + + I
Sbjct: 138 DILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQRR 193
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ + L YLH IIHRD+K NI LD+ N + DFG A GT
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
SPE + K+D++S G+++ E+
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I L +LH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFC 157
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
GT Y++PE + D ++ GVLM E+++ +
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 58/228 (25%), Positives = 109/228 (47%), Gaps = 51/228 (22%)
Query: 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKN-EMMLIAKLQ 579
+ +++ + + +G G FG VY+ ++ E VA+K++ ++KN E++++ L
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117
Query: 580 HRNLVRLLGC----CIEQGEKIL------------IYEYMV-----NKSLDVFLFDPTKK 618
H N++ L C ++ EK + +++YM N +L +FL
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK---- 173
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMAR-M 676
L +QL + L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ +
Sbjct: 174 -LYSYQL--------CRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEIL 723
G Q + I + Y +PE L ++ D++S G ++ E++
Sbjct: 222 LAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 14/120 (11%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH S +++RDLK N++LD+ + KI+DFG+ + G + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVSDKLYSLLF 752
Y++PE + + D + GV+M E++ + YN D +KL+ L+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD--------HEKLFELIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 579
E+F I +G G FG V +L N +V ++ N+ + LK F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGD 59
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
++ + L ++ L+ +Y V L + L + L R +A+ ++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFY----LAEMVIA 114
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSP 698
+ +L +HRD+K NIL+D + + +++DFG ++ +Q + VGT Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172
Query: 699 EY--ALE---GVFSVKSDVFSFGVLMLEIL 723
E A+E G + + D +S GV M E+L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 532 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
++G G FG V + VA VK L +N S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIIDGIAQGLLYLHQYSRL 646
G C+E +L++EY L +L L + R+ IA G+ ++H +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KH 118
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTYGYMSPEYALE-- 703
+H DL N L + K+ D+G+ + D ++ + V +++PE E
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVGEFH 177
Query: 704 -GVFSVK----SDVFSFGVLMLEILSSKK 727
G+ + + S+V++ GV + E+ +
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 46/222 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM---------- 573
E+F + +G G FG V R + ++V A+K LS K EM+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 574 ---LIAKLQHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFL--FDPTKKHLLGWQLR 626
++A +V+L Q +K L + EYM L + +D +K W
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WA-- 144
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGN 685
A+ +L L + IHRD+K N+LLD+ + K++DFG +M ++ +
Sbjct: 145 ---RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 686 TKRIVGTYGYMSPEYAL----EGVFSVKSDVFSFGVLMLEIL 723
T VGT Y+SPE +G + + D +S GV + E+L
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
IA+ +L L + I++RDLK NILLD + + DFG+++ D NT GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEI 722
Y++PE L E ++ D +S GVL+ E+
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSN-----QSGQGLKEFKNEMMLIAKL 578
E++ + +G G FG V R + Q+V A+K LS +S F E ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFA 100
Query: 579 QHRNLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIA 634
+V+L C Q +K L + EYM L + +D +K W A
Sbjct: 101 NSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TA 149
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-RMFGGDELQGNTKRIVGTY 693
+ +L L + +IHRD+K N+LLD+H + K++DFG +M ++ +T VGT
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTP 207
Query: 694 GYMSPEY----ALEGVFSVKSDVFSFGVLMLEIL 723
Y+SPE +G + + D +S GV + E+L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 35/119 (29%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH +++RDLK N++LD+ + KI+DFG+ + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVSDKLYSLL 751
Y++PE + + D + GV+M E++ + YN D +KL+ L+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD--------HEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+A G+ +L + +HRDL A N+L+ + KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE +++ SDV+SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 15/120 (12%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH +I++RDLK N++LD+ + KI+DFG+ + G K GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGT 158
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVSDKLYSLLF 752
Y++PE + + D + GV+M E++ + YN D +KL+ L+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD--------HEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 7/103 (6%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L YLH +++RD+K N++LD+ + KI+DFG+ + D K GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735
Y++PE + + D + GV+M E++ + YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 31/150 (20%), Positives = 57/150 (38%), Gaps = 13/150 (8%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RL 586
S L G VY ++ +K ++ +E + ++ + + V ++
Sbjct: 1 SSIKLLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKV 58
Query: 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
L G L+ E++ ++LD + + I + +A+ L LHQ L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEE----------KEDIAEQLAELLAKLHQLPLL 108
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARM 676
+ H DL NIL+D I D+ A
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM---------FGG----DELQ 683
L YLH Y I+HRDLK N+L+ + K++DFG++++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
K++ GT Y++PE L + D ++ G+++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 30/97 (30%), Positives = 57/97 (58%), Gaps = 7/97 (7%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+A+ +L +H ++ +HRD+K N+L+D+ + K++DFG A +++ N+K VGT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGT 166
Query: 693 YGYMSPEY------ALEGVFSVKSDVFSFGVLMLEIL 723
Y++PE +G + V+ D +S GV+ E++
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 35/127 (27%), Positives = 54/127 (42%), Gaps = 36/127 (28%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM------------ARMFGGD 680
IA+ +L + +L IHRD+K N+LLD + K+SDFG+ R+
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 681 ----------------ELQGNTKR--------IVGTYGYMSPEYALEGVFSVKSDVFSFG 716
KR VGT Y++PE L+ ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 717 VLMLEIL 723
V+M E+L
Sbjct: 227 VIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
L++++ H +L + G C+ E I++ E++ + LDV L + + W++ V +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV--AQQL 126
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNIL-----LDQHMNP--KISDFGMARMFGGDELQGNT 686
A L YL + ++H ++ A NIL L + +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 687 KRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEI 722
+RI +++PE G S +D +SFG +LEI
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLL 638
+ N ++L +LI +Y+ K D LFD KK L +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYI--KDGD--LFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
LH++ IIH D+K N+L D+ + + D+G+ ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSK 726
PE + V D ++ GVL E+L+ K
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 45/136 (33%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA-------------RMFGG 679
+A+ +L + +L IHRD+K NIL+D+ + K+SDFG++ ++ G
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 680 DELQ-GNTKR-------------------------------IVGTYGYMSPEYALEGVFS 707
+ R VGT Y++PE L+ +
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226
Query: 708 VKSDVFSFGVLMLEIL 723
+ D +S G +M E L
Sbjct: 227 QECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 45/209 (21%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 541 VYKGRLLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK- 596
+YKG N +EV ++ + +NE+ + ++ N++++ G I+ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 597 ---ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL 653
LI EY L L K+ L ++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 654 KASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS---VKS 710
+ + L+ ++ KI G+ ++ L + V Y S + L +FS +K
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKD 203
Query: 711 DVFSFGVLMLEILSSK---KN---TGVYN 733
D++S GV++ EI + K +N +Y+
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYD 232
|
Length = 283 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A+ +L L + IHRD+K N+LLD+ + K++DFG + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTP 207
Query: 694 GYMSPEY----ALEGVFSVKSDVFSFGVLMLEIL 723
Y+SPE +G + + D +S GV + E+L
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 61/269 (22%), Positives = 101/269 (37%), Gaps = 48/269 (17%)
Query: 469 NETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSK-DSSLPLFSFASVTAATENF 527
++++ D L D +M I + F +D+S D+SL L + A F
Sbjct: 41 EMNPGIESDDDCLYEDKHMDIDI-FDIF-----ADEDESDADASLALCAEARAGIEKAGF 94
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
SI G G + E V + + G E ++ + H ++++L
Sbjct: 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTA-----TEAHILRAINHPSIIQLK 149
Query: 588 G--------CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA----- 634
G C I K +Y Y+ K + I D +A
Sbjct: 150 GTFTYNKFTCLILPRYKTDLYCYLAAKR------------------NIAICDILAIERSV 191
Query: 635 -QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
+ + YLH+ RIIHRD+KA NI ++ + + DFG A F D GT
Sbjct: 192 LRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAGTI 247
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+PE + D++S G+++ E+
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 46/236 (19%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ +T+ F I S LGEG FG V + +E AVK + N + ++ K E+ + K+
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKV 182
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH---LLGWQLR--------- 626
+ + ++ + I Y N++ + + P K+ LL W ++
Sbjct: 183 RQADPA-------DRFPLMKIQRYFQNETGHMCIVMP--KYGPCLLDWIMKHGPFSHRHL 233
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----------QHMNP-----KISD 670
+II L Y H + L ++H DLK NIL++ + + P +I D
Sbjct: 234 AQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
G DE T IV T Y SPE L + +D++S G ++ E+ + K
Sbjct: 292 LGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 529 IQSKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+Q ++G G VY R G V V+ L N + + LK +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 584 VRLLGCCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+ +I +M N L + + + L+G I+ G +GL Y
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNY 116
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL-----QGNTKRIVGTY- 693
LHQ IHR++KAS+IL IS G+ + G L G ++V +
Sbjct: 117 LHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165
Query: 694 -------GYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSK 726
++SPE + + ++VKSD++S G+ E+ + +
Sbjct: 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 33/124 (26%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----------- 681
IA+ +L + +L IHRD+K N+LLD + K+SDFG+
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 682 ------LQG-NTKR---------------IVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
Q N+KR VGT Y++PE ++ ++ D +S GV+M
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 720 LEIL 723
E+L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 31/132 (23%), Positives = 53/132 (40%), Gaps = 41/132 (31%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF-----------GG-- 679
IA+ + ++ IHRD+K NIL+D+ + K++DFG+ F G
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 680 --------DELQGNTKR--------------------IVGTYGYMSPEYALEGVFSVKSD 711
+E + +VGT Y++PE L ++ D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 712 VFSFGVLMLEIL 723
+S GV++ E+L
Sbjct: 227 WWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 33/124 (26%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG-------------------- 672
IA+ +L + +L IHRD+K N+LLD + K+SDFG
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 673 ---------MARMFGGDELQGNTKRI----VGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
M + + N +++ VGT Y++PE ++ ++ D +S GV+M
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 720 LEIL 723
E+L
Sbjct: 227 YEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 30/176 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMML----- 574
++F + KLGEG FG VYK L+N + +K+ + + G ++ + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 575 -IAKLQHRNLVRLLGCCIEQGEKILIYEY---------MVNK----SLDVFLFDPTKKHL 620
A + L + ++ E L++ Y M +K +++ +L +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 621 LGWQLRVRIIDGIAQGLLY-LHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMA 674
G + +II I + +L+ L I+HRD+K NI+ + KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 34/136 (25%), Positives = 55/136 (40%), Gaps = 45/136 (33%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG-------------- 678
IA+ L + ++ IHRD+K NIL+D + K++DFG+ F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 679 -------------------GDELQGNTKR------------IVGTYGYMSPEYALEGVFS 707
GD L+ +R +VGT Y++PE L ++
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 708 VKSDVFSFGVLMLEIL 723
D +S GV++ E+L
Sbjct: 227 QLCDWWSVGVILFEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 41/162 (25%), Positives = 75/162 (46%), Gaps = 29/162 (17%)
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
++ ++ H+++V L G C+ E I++ E++ LD+F+ + W+ +V +
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV--AKQL 114
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILL-----DQHMNP--KISDFG-----MARMFGGDE 681
A L YL ++H ++ NILL D P K+SD G ++R
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------ 165
Query: 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEI 722
Q +RI +++PE + S+ +D +SFG + EI
Sbjct: 166 -QECVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 33/136 (24%), Positives = 55/136 (40%), Gaps = 45/136 (33%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG-------------- 678
IA+ + ++ IHRD+K NIL+D+ + K++DFG+ F
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 679 -------------------GDELQGNTKR------------IVGTYGYMSPEYALEGVFS 707
GD L+ +R +VGT Y++PE L ++
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 708 VKSDVFSFGVLMLEIL 723
D +S GV++ E+L
Sbjct: 227 QLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 754 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.7 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.53 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.53 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.38 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.9 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.58 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.42 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.3 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.27 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.25 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.77 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.77 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.69 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.39 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.21 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.01 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.91 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.87 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.83 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.76 | |
| PLN02236 | 344 | choline kinase | 96.72 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.57 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.55 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.35 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.14 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.94 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.75 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.57 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=380.70 Aligned_cols=236 Identities=45% Similarity=0.777 Sum_probs=206.1
Q ss_pred CCCccchhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEE
Q 004416 511 SLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590 (754)
Q Consensus 511 ~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 590 (754)
....|++.++..++++|.-.+.||+|+||.||+|.+.++..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999998999999988765443156699999999999999999999999
Q ss_pred EecC-cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 591 IEQG-EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 591 ~~~~-~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
.+.+ +.+||||||++|+|+++|+..... .++|..|++|+.++|+||+|||+...++||||||||.|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999775544 88999999999999999999999888889999999999999999999999
Q ss_pred eecCccccCCCcccCCcccc-cccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CCccchhhhHHHHH
Q 004416 670 DFGMARMFGGDELQGNTKRI-VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-TDSFNLLGHVSDKL 747 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~-~~~~~~~~~~~~~l 747 (754)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|+||+||+++..... .++.++..|++..+
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999996543311 111222 89999999999999999999999999999999999999987654 44555777776665
Q ss_pred hh
Q 004416 748 YS 749 (754)
Q Consensus 748 ~~ 749 (754)
.+
T Consensus 298 ~~ 299 (361)
T KOG1187|consen 298 EE 299 (361)
T ss_pred HC
Confidence 54
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=363.06 Aligned_cols=201 Identities=30% Similarity=0.531 Sum_probs=181.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..+|.+.+.||+|+|++||+|+++ ++.+||||.+... ..+..+.+..|+.+|++++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367888999999999999999986 4789999998765 5566777899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC------CCeEEEeecCc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH------MNPKISDFGMA 674 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~------~~~kL~DFGla 674 (754)
|||.+|+|..++ ...+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi---~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYI---RRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999 34557999999999999999999999988 9999999999999865 45899999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.+.+.. ...+.+|+|-|||||++...+|+.|+|+||+|++||||++|+.||....
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9987544 3456899999999999999999999999999999999999999998533
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=350.13 Aligned_cols=224 Identities=28% Similarity=0.405 Sum_probs=193.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|+++++||+|+||+||.++.++ ++.+|+|++++.. ....+..++|..+|.+++||.||+++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45789999999999999999998654 8899999997652 3456778999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
|+||+.||.|..+| +++..+++..+..++.+|+.||.|||+++ ||||||||+|||||++|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999988 56677899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------Cc-cchhhhHHHHHh
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DS-FNLLGHVSDKLY 748 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~-~~~~~~~~~~l~ 748 (754)
... ..+.+++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+. .. ...+...++..+
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 322 345568999999999999999999999999999999999999999988762 11 223333555555
Q ss_pred hhhhcC
Q 004416 749 SLLFDL 754 (754)
Q Consensus 749 ~~l~~l 754 (754)
|+|.+|
T Consensus 255 dll~~L 260 (357)
T KOG0598|consen 255 DLLKKL 260 (357)
T ss_pred HHHHHH
Confidence 555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.97 Aligned_cols=222 Identities=28% Similarity=0.447 Sum_probs=196.8
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999997 67999999999763 3455677899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
|++++++|..++ .+++.+++.+++.++.||+.||.|||+++ |||||||..|++++++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988 36778999999999999999999999988 999999999999999999999999999998765
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-C--------CccchhhhHHHHHhhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-T--------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~-~--------~~~~~~~~~~~~l~~~l 751 (754)
.. ...+.+|||.|+|||++....++..+||||+||++|-||.|++||+..+ . .+...+.+++..-+|||
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI 249 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLI 249 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHH
Confidence 43 3455899999999999999999999999999999999999999998864 1 33335556666666666
Q ss_pred hcC
Q 004416 752 FDL 754 (754)
Q Consensus 752 ~~l 754 (754)
.+|
T Consensus 250 ~~l 252 (592)
T KOG0575|consen 250 RKL 252 (592)
T ss_pred HHH
Confidence 654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=322.96 Aligned_cols=219 Identities=30% Similarity=0.388 Sum_probs=196.7
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++++.||.|+||.|.+++.+. |..+|+|++++.. -...+...+|..+|+.+.||.++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 688999999999999999999764 7789999998763 234556788999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|.|..++ ++.+.+++..++.++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+.+..
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999 45567899999999999999999999988 99999999999999999999999999998643
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~l 751 (754)
.+-+.+|||.|+|||++....+...+|.|||||++|||+.|.+||...++ ....++.+.+..++|||
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLL 272 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHH
Confidence 35568999999999999999999999999999999999999999987663 55567788888888888
Q ss_pred hcC
Q 004416 752 FDL 754 (754)
Q Consensus 752 ~~l 754 (754)
.+|
T Consensus 273 ~~L 275 (355)
T KOG0616|consen 273 KKL 275 (355)
T ss_pred HHH
Confidence 765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.13 Aligned_cols=199 Identities=31% Similarity=0.425 Sum_probs=178.0
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-cEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e 601 (754)
.+.+.++.||+|..|+|||++++. ++.+|+|.+... ++...+++.+|++++++.+||+||+++|.|.... +..|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 456667899999999999999864 788999998543 4556788999999999999999999999999998 5999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
||++|+|+.++. ..+.+++....+|+.++++||.|||+.. +||||||||+||||+..|++||+|||.++.+-..
T Consensus 159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999999984 3366899999999999999999999732 4999999999999999999999999999887543
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...+++||..|||||.+.+..|+.++||||||+.++|+.+|+-|+...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 445689999999999999999999999999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.56 Aligned_cols=203 Identities=28% Similarity=0.422 Sum_probs=174.9
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchh-------hHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
..+.|.+.+.||+|+||.|-+|.. ++++.||||++++.... ......+|+++|++++|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788899999999999999975 46999999999765221 1234579999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC---CCeEEEee
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDF 671 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~~kL~DF 671 (754)
..|+|||||++|.|.+++ ..++.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999998888 45566778888899999999999999999 9999999999999766 77999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF---SVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
|+|+..+... ..++++|||.|.|||++.+... ..+.|+||+||+||-++||.+||...-.
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 9999876433 4567899999999999986543 3478999999999999999999977553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=343.28 Aligned_cols=205 Identities=37% Similarity=0.603 Sum_probs=177.6
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecC-cEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~lV~e 601 (754)
....+.+.||+|+||+||+|.++....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34455567999999999999996555599999976532 22569999999999999999999999999887 7999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCccccCCC
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGD 680 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~~~~ 680 (754)
||++|+|..+++.. .+..+++..+++++.|||+||+|||++++ ||||||||+|||++.+. ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999654 46789999999999999999999999863 99999999999999997 9999999999876543
Q ss_pred cccCCcccccccCcccCccccC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYAL--EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
. .......||+.|||||++. ...|+.|+||||||++||||+||+.||+....
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2 1122268999999999999 66999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=339.08 Aligned_cols=206 Identities=28% Similarity=0.407 Sum_probs=182.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 597 (754)
...+|...+.||+|+|++|++|+.+ .++++|||++.+. .+...+-+..|-++|.+| .||.|++|+..|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4478999999999999999999854 5899999999764 233345577899999999 8999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|+||+++|+|..++. +.+.+++...+.++.+|+.||+|||++| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999994 5577999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCccc---------C--CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 678 GGDELQ---------G--NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 678 ~~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.+.... . ....++||..|.+||++..+..+..+|+|+|||+||+|+.|++||...++
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 653221 1 12458999999999999999999999999999999999999999987663
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.01 Aligned_cols=208 Identities=29% Similarity=0.445 Sum_probs=181.6
Q ss_pred cCCcceeeeeceeccEEEEeee-ecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEe-EEEecCc-EEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLG-CCIEQGE-KIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~-~~~~~~~-~~l 598 (754)
..+|+++++||+|.||.|||++ ..+|..||.|.++-. +.+..+.+..|+.+|++++|||||++++ .+.++.+ .+|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3579999999999999999997 568999999988633 4455677899999999999999999998 5556666 899
Q ss_pred EEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC-CCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 599 IYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYS-RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~-~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
||||+..|+|..++... ..++.+++..+++++.|+++||.++|+.- +..|+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999998654 45567899999999999999999999831 12399999999999999999999999999999
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... .....+|||.||+||.+.+.+|+.|+||||+||++|||..-++||...+
T Consensus 178 l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 178 LSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred hcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 876553 3445799999999999999999999999999999999999999998764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.09 Aligned_cols=209 Identities=34% Similarity=0.524 Sum_probs=182.1
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.......+.+...+.||+|.||.|+.|+++....||||.++.. ....+.|.+|+++|++++|+|||+++|+|..++..+
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 3344455667788999999999999999987789999999765 334578889999999999999999999999988999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
||||||+.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+.+
T Consensus 278 IVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc
Confidence 99999999999999965 34567888999999999999999999987 999999999999999999999999999976
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
..+.+... ....-+..|.|||.+..+.++.|+|||||||+||||+| |+.|++.-
T Consensus 354 ~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 354 GDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred CCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 65554332 23456778999999999999999999999999999999 77776653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=322.70 Aligned_cols=208 Identities=25% Similarity=0.369 Sum_probs=181.6
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
....++|+++++||+|+||.||+++-+ +|..+|+|++++.. ....+.++.|-.+|....+|.||+|+..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999865 48999999998763 34456678899999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
||||||++||++..+| .+...|++..+..++.+++-|++.||..| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999999 57788999999999999999999999998 99999999999999999999999999854
Q ss_pred cCCC----------------------ccc-----CC------------------cccccccCcccCccccCCCCCCchhh
Q 004416 677 FGGD----------------------ELQ-----GN------------------TKRIVGTYGYMSPEYALEGVFSVKSD 711 (754)
Q Consensus 677 ~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 711 (754)
+... +.. .. ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3210 000 00 01257999999999999999999999
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCC
Q 004416 712 VFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 712 VwSlGvll~elltg~~p~~~~~~ 734 (754)
.||||||+||||.|-+||....+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999987653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.34 Aligned_cols=225 Identities=24% Similarity=0.364 Sum_probs=191.8
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecC
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 594 (754)
....-++|.++++||+|.||+|+++..+. ++.+|||++++. ..+..+..+.|..++... +||.++.++..|+..+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 34456889999999999999999998764 778999999876 345677788898888887 5999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
+.++||||+.+|++..+ .....+++..+..++..|+.||.|||+++ ||+||||.+|||||.+|++||+|||++
T Consensus 443 ~l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 99999999999994333 34567899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHH
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSD 745 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~ 745 (754)
+.--.. ...+.+++|||.|||||++.+..|+..+|.|||||+|||||.|..||...++ ++.-|+.+++.
T Consensus 516 Ke~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ 593 (694)
T KOG0694|consen 516 KEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK 593 (694)
T ss_pred cccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH
Confidence 864322 2356779999999999999999999999999999999999999999997664 22336666666
Q ss_pred HHhhhhhc
Q 004416 746 KLYSLLFD 753 (754)
Q Consensus 746 ~l~~~l~~ 753 (754)
...+.|.+
T Consensus 594 ea~~il~~ 601 (694)
T KOG0694|consen 594 EAIAIMRR 601 (694)
T ss_pred HHHHHHHH
Confidence 55555544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.42 Aligned_cols=219 Identities=30% Similarity=0.456 Sum_probs=187.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. .++..+.+.+|++++++++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999754 5789999988664 44567789999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+.+ +|..+| .....++++.+..|+.+++.||.|||+.+ |+|||+||+|||++.++.+|++|||+|+-+....
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 999998 44556899999999999999999999987 9999999999999999999999999999875533
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------CCccchhhhHHHHHhhhhh
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN---------TDSFNLLGHVSDKLYSLLF 752 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~---------~~~~~~~~~~~~~l~~~l~ 752 (754)
.....+.|||.|||||.+.+++|+..+|+||+||+||||.+|++||-... .++...+..++..+.++|.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQ 232 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHH
Confidence 23345789999999999999999999999999999999999999984432 1333344455555655554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=327.07 Aligned_cols=225 Identities=27% Similarity=0.415 Sum_probs=192.5
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc----ch-hhHHHHHHHHHHHHHcc-ccceeeeEeEEEecC
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~ 594 (754)
...++|.+.+.||+|.||+|+.|++. ++..||||++... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45578999999999999999999764 5799999976553 12 33566778999999998 999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEeecC
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGM 673 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DFGl 673 (754)
..++||||+.+|+|.+++. ....+.+.++.+++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999984 3567888999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCC---------CCccchhhh
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FS-VKSDVFSFGVLMLEILSSKKNTGVYN---------TDSFNLLGH 742 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DVwSlGvll~elltg~~p~~~~~---------~~~~~~~~~ 742 (754)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+ .....++.+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC
Confidence 99873 1123455689999999999999977 85 78999999999999999999998855 244556677
Q ss_pred H-HHHHhhhhhcC
Q 004416 743 V-SDKLYSLLFDL 754 (754)
Q Consensus 743 ~-~~~l~~~l~~l 754 (754)
+ +...++++.+|
T Consensus 246 ~~S~~~~~Li~~m 258 (370)
T KOG0583|consen 246 LLSPEARSLIEKM 258 (370)
T ss_pred cCCHHHHHHHHHH
Confidence 7 77777776654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=304.29 Aligned_cols=201 Identities=26% Similarity=0.392 Sum_probs=175.5
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
+.|+.+.++|+|++|+|||+++++ |+.||||++..... ...+-..+|+++|++++|+|+|.++++|..+...+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888899999999999999875 89999999976533 334557899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|++..-|+++- .....++.+...+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||.|+.+..+.
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99887776654 34455788899999999999999999988 9999999999999999999999999999987422
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+.|..|.|||.+.+ .+|...+||||+||++.||++|.+-|+...
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S 206 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS 206 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence 12333578999999999887 789999999999999999999999998765
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=340.55 Aligned_cols=219 Identities=32% Similarity=0.511 Sum_probs=187.2
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 591 (754)
.......+.+..+.||+|+||+||+|+.. +.+.||||.++..... ..++|++|+++|++++|||||+++|+|.
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 34455567778899999999999999743 2456999999887655 7789999999999999999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCC-------C----cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPT-------K----KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl 660 (754)
+++..++|+|||..|+|.+||.... . ...++..+.+.|+.|||.||+||-++. +|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence 9999999999999999999995321 1 334888999999999999999999987 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC-CCccc
Q 004416 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN-TDSFN 738 (754)
Q Consensus 661 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~-~~~~~ 738 (754)
.++..|||+|||+++.+...++........-+.+|||||.+..++|+.++|||||||+|||++| |+.|+.... .+.++
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 9999999999999999877665554434456789999999999999999999999999999999 888975543 44444
Q ss_pred hh
Q 004416 739 LL 740 (754)
Q Consensus 739 ~~ 740 (754)
++
T Consensus 717 ~i 718 (774)
T KOG1026|consen 717 CI 718 (774)
T ss_pred HH
Confidence 33
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.90 Aligned_cols=222 Identities=29% Similarity=0.424 Sum_probs=196.3
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
....|...++||+|+.|.||.++. .+++.||||++........+-+.+|+.+|+..+|+|||+++..|..++++++|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 345677778999999999999974 4688999999977655556778999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
||++|+|.+.+ .+..+++.++..|..++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+....
T Consensus 351 ym~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999998877 4556899999999999999999999998 9999999999999999999999999999887655
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------------CCccchhhhHHHHHhh
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN------------TDSFNLLGHVSDKLYS 749 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~------------~~~~~~~~~~~~~l~~ 749 (754)
. ...+.+|||.|||||++....|.+|.||||||++++||+-|.+||-..+ ...+...++++..|+|
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 4 3445899999999999999999999999999999999999999986433 3555677889999999
Q ss_pred hhhc
Q 004416 750 LLFD 753 (754)
Q Consensus 750 ~l~~ 753 (754)
||-+
T Consensus 502 FL~~ 505 (550)
T KOG0578|consen 502 FLDR 505 (550)
T ss_pred HHHH
Confidence 9854
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.02 Aligned_cols=224 Identities=29% Similarity=0.432 Sum_probs=185.2
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC--cEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~lV~e 601 (754)
.++...+.||+|.||.||++...+ |...|||.....+....+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999998754 8899999886653333677899999999999999999999855544 6899999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeecCccccCC-
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGG- 679 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~~~- 679 (754)
|+++|+|.+++..... .+++..+.++..||++||+|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999854322 6899999999999999999999988 999999999999999 79999999999988764
Q ss_pred CcccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC------------CCCccchhhhHHHH
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVY------------NTDSFNLLGHVSDK 746 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~------------~~~~~~~~~~~~~~ 746 (754)
...........||+.|||||++..+. ...++|||||||++.||+||++||... ......++.+++..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~ 251 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE 251 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence 11222344578999999999998633 345999999999999999999999862 11223566777777
Q ss_pred Hhhhhhc
Q 004416 747 LYSLLFD 753 (754)
Q Consensus 747 l~~~l~~ 753 (754)
.+|||.+
T Consensus 252 a~~Fl~~ 258 (313)
T KOG0198|consen 252 AKDFLRK 258 (313)
T ss_pred HHHHHHH
Confidence 7777754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.33 Aligned_cols=221 Identities=28% Similarity=0.410 Sum_probs=194.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
+.|++.+.||+|+.|.|..|++. +|+.+|||++.+.. ......+.+||.+|+.+.|||++++++++.++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 56889999999999999999874 69999999997652 223456789999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|-|.+++ ..++.+.+.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|..-.++
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999998888 56778899999999999999999999988 999999999999999999999999999874433
Q ss_pred cccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC---------CCccchhhhHHHHHhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYN---------TDSFNLLGHVSDKLYSL 750 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~---------~~~~~~~~~~~~~l~~~ 750 (754)
. ..++.||.|.|.|||++.+.+| ..++||||.|||||.||||+.||+..+ .+.++.+..++..-+||
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL 242 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence 3 3456799999999999999998 478999999999999999999999765 26666777777788888
Q ss_pred hhcC
Q 004416 751 LFDL 754 (754)
Q Consensus 751 l~~l 754 (754)
|.+|
T Consensus 243 Lr~m 246 (786)
T KOG0588|consen 243 LRRM 246 (786)
T ss_pred HHHH
Confidence 7764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.22 Aligned_cols=197 Identities=31% Similarity=0.523 Sum_probs=169.9
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHH--ccccceeeeEeEEEecC----cEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCIEQG----EKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~~----~~~l 598 (754)
...++.++||+|+||.||||.+ +++.||||++... ..+.|++|-++.+. ++|+||++++++-..++ +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4556678999999999999998 4599999999754 34566777666665 58999999999977666 8999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh------cCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~------~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
|+||.+.|+|.++| +.+.++|....+++..+++||+|||+ +.+++|+|||||.+||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 67789999999999999999999996 455789999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCC-C-----chhhHHHHHHHHHHHHcCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-S-----VKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DVwSlGvll~elltg~~p~ 729 (754)
+|.++............+||.+|||||++.+... . .+.||||+|.+||||+++-+.+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 9999987766666666899999999999987542 2 3689999999999999976554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.84 Aligned_cols=205 Identities=29% Similarity=0.484 Sum_probs=170.7
Q ss_pred CCCCCccchhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHH--HHccccceeee
Q 004416 509 DSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLI--AKLQHRNLVRL 586 (754)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l--~~l~H~nIv~l 586 (754)
.+.+|.+...++ ..+.++.+.||+|.||.||+|++ .|+.||||++...++. .+.+|.++. ..|+|+||+.+
T Consensus 198 GSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 198 GSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred CCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhh
Confidence 356666655544 37788999999999999999998 5899999999876544 344455544 55799999999
Q ss_pred EeEEEecC----cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-----cCCCCceeCCCCCCC
Q 004416 587 LGCCIEQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-----YSRLRIIHRDLKASN 657 (754)
Q Consensus 587 ~~~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-----~~~~~iiH~DIkp~N 657 (754)
++....+. +++||++|.+.|||.++| ....++.+.+++++..+|.||++||. ++++.|.|||||++|
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 99876554 789999999999999999 45778999999999999999999994 688999999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCC--cccCCcccccccCcccCccccCCCCC----C--chhhHHHHHHHHHHHHc
Q 004416 658 ILLDQHMNPKISDFGMARMFGGD--ELQGNTKRIVGTYGYMSPEYALEGVF----S--VKSDVFSFGVLMLEILS 724 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~----~--~~~DVwSlGvll~ellt 724 (754)
|||++++.+.|+|+|||...... ......+..+||.+|||||++.+... . ..+||||||.++||+.-
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 99999999999999999887654 33445566799999999999876432 1 35999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.03 Aligned_cols=205 Identities=28% Similarity=0.420 Sum_probs=175.6
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 596 (754)
...+.|+.+++||+|.||.||+|+. .+|+.||+|++.-.. +.......+||.+|++|.||||++|.+...+. ...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3456789999999999999999984 569999999986543 33445568999999999999999999998877 689
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
|||+|||+. +|.-++. ...-.+++.++..++.|++.||+|+|+++ |+|||||..|||||.+|.+||+|||||+.
T Consensus 194 YlVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceee
Confidence 999999987 5655552 23446889999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+........+. .+-|.-|.|||.+.+. .|+...|+||.||||.||+.|++.|....
T Consensus 268 y~~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 268 YTPSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred ccCCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 87665444443 5679999999998874 69999999999999999999999998754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=285.10 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=174.7
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchh--hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|...++||+|.||.||+|+. .+|+.||||+++..... ......+||+.|++++|+||+.++++|-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999985 46999999998765322 23456899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
||+. +|+..+.+ +...++..++..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 78888854 4567889999999999999999999987 9999999999999999999999999999987655
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... .+-|.-|.|||.+.+ +.|+...|+||.||++.||+-|.+-|+..+
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 33222 377899999998876 468999999999999999999999887654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.38 Aligned_cols=219 Identities=24% Similarity=0.412 Sum_probs=191.4
Q ss_pred cCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..+|++.+.||+|.||+|-++.. ..|+.||||.+++. +++..-.+.+||++|..++||||+.++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 36799999999999999999974 67999999988764 455566789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||..+|.|.+++ ...+.+++.++++++.||..|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 56677999999999999999999999887 99999999999999999999999999988765
Q ss_pred CcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC------------CccchhhhHHHH
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNT------------DSFNLLGHVSDK 746 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~~------------~~~~~~~~~~~~ 746 (754)
.. ...+++|+|.|.+||++.+.+| .+..|-|||||+||-|+.|..||+..+. -+...+.+++..
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gL 282 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGL 282 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHH
Confidence 44 3456899999999999999998 5789999999999999999999987652 111244555666
Q ss_pred Hhhhh
Q 004416 747 LYSLL 751 (754)
Q Consensus 747 l~~~l 751 (754)
|+-||
T Consensus 283 IRwmL 287 (668)
T KOG0611|consen 283 IRWML 287 (668)
T ss_pred HHHHH
Confidence 66655
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.42 Aligned_cols=203 Identities=25% Similarity=0.332 Sum_probs=175.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||+||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 47899999986532 233457888999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999884 3456889999999999999999999987 999999999999999999999999999765321
Q ss_pred ccc---------------------------------CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 004416 681 ELQ---------------------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727 (754)
Q Consensus 681 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~ 727 (754)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004416 728 NTGVYN 733 (754)
Q Consensus 728 p~~~~~ 733 (754)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=287.59 Aligned_cols=203 Identities=30% Similarity=0.397 Sum_probs=180.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.-++|++.+.||+|.||.||.|+.+. +-.||+|++.+.. .+...++.+|+++-..++||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34789999999999999999999754 6689999986642 3345788999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
++||..+|.+...|... ....+++.....++.|+|.|+.|+|..+ +|||||||+|+|++..+.+||+|||.+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999998888532 4455788889999999999999999887 9999999999999999999999999997642
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....+.+||..|.|||+..+..++...|+|++|++.||++.|.+||+...
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 234556899999999999999999999999999999999999999998765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=309.77 Aligned_cols=198 Identities=25% Similarity=0.314 Sum_probs=174.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999884 3446888999999999999999999988 999999999999999999999999999876432
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223578999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.51 Aligned_cols=198 Identities=24% Similarity=0.358 Sum_probs=175.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67999999999999999999875 47899999986532 234567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999998884 3446788889999999999999999988 999999999999999999999999999876432
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 2 23579999999999999999999999999999999999999996543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.09 Aligned_cols=209 Identities=30% Similarity=0.424 Sum_probs=173.0
Q ss_pred cccCCcceeeeeceeccEEEEeeee------cCcceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEEec
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 593 (754)
...++|++.++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4557899999999999999999964 234679999987543 33456789999999999 899999999988764
Q ss_pred C-cEEEEEEcccCCCHhhHhcCCCC-------------------------------------------------------
Q 004416 594 G-EKILIYEYMVNKSLDVFLFDPTK------------------------------------------------------- 617 (754)
Q Consensus 594 ~-~~~lV~ey~~~gsL~~~l~~~~~------------------------------------------------------- 617 (754)
. ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 68899999999999988853211
Q ss_pred ----cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccC
Q 004416 618 ----KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693 (754)
Q Consensus 618 ----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~ 693 (754)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 234778888999999999999999987 9999999999999999999999999998764332222222345678
Q ss_pred cccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 694 ~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.|+|||++.+..++.++||||||++||||++ |..||....
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 8999999999999999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=312.47 Aligned_cols=210 Identities=31% Similarity=0.525 Sum_probs=180.0
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
..+.++..+.+.+.+.||+|.||+||+|++. ..||||+++.. .+...+.|++|+..+++-+|.||+-+.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3566677788889999999999999999984 47999999765 3456789999999999999999999999998877
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
. .||+.++++.+|..+++..+ ..++....+.|+.||++|+.|||.++ |||||||..||++.++++|||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 7 99999999999999997543 56888899999999999999999988 999999999999999999999999998
Q ss_pred cccCCCcccCCcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
..-..-.-........|...|||||+++. .+|+..+||||||+++|||+||..||...+.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 65433222223333567789999999864 5689999999999999999999999985443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.19 Aligned_cols=202 Identities=23% Similarity=0.343 Sum_probs=173.2
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.|++++.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999864 57899999986542 3345678999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999884 3345788888999999999999999987 9999999999999999999999999986432110
Q ss_pred c---------------------------------------------cCCcccccccCcccCccccCCCCCCchhhHHHHH
Q 004416 682 L---------------------------------------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFG 716 (754)
Q Consensus 682 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG 716 (754)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999988999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 004416 717 VLMLEILSSKKNTGVYN 733 (754)
Q Consensus 717 vll~elltg~~p~~~~~ 733 (754)
|++|||++|+.||....
T Consensus 236 ~il~elltG~~Pf~~~~ 252 (381)
T cd05626 236 VILFEMLVGQPPFLAPT 252 (381)
T ss_pred hHHHHHHhCCCCCcCCC
Confidence 99999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.88 Aligned_cols=228 Identities=26% Similarity=0.394 Sum_probs=180.2
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--------------hhHHHHHHHHHHHHHccccceee
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------QGLKEFKNEMMLIAKLQHRNLVR 585 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--------------~~~~~~~~Ei~~l~~l~H~nIv~ 585 (754)
...-++|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999854 688999999865321 12467899999999999999999
Q ss_pred eEeEEEec--CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC
Q 004416 586 LLGCCIEQ--GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (754)
Q Consensus 586 l~~~~~~~--~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~ 663 (754)
|+++..+. +..|||+||+..|.+...- .....+++.++++++.+++.||+|||.++ ||||||||.|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99987653 5889999999988764432 22223899999999999999999999998 9999999999999999
Q ss_pred CCeEEEeecCccccCCC---cccCCcccccccCcccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCC---
Q 004416 664 MNPKISDFGMARMFGGD---ELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYN--- 733 (754)
Q Consensus 664 ~~~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGvll~elltg~~p~~~~~--- 733 (754)
+++||+|||.+...... ..........|||.|+|||...++. .+.+.||||+||.||.|+.|+.||-...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999866221 1112233478999999999987733 2467899999999999999999985533
Q ss_pred ------CCccchhhh--HHHHHhhhhhcC
Q 004416 734 ------TDSFNLLGH--VSDKLYSLLFDL 754 (754)
Q Consensus 734 ------~~~~~~~~~--~~~~l~~~l~~l 754 (754)
+++..++.. +.+.++|+|.+|
T Consensus 327 l~~KIvn~pL~fP~~pe~~e~~kDli~~l 355 (576)
T KOG0585|consen 327 LFDKIVNDPLEFPENPEINEDLKDLIKRL 355 (576)
T ss_pred HHHHHhcCcccCCCcccccHHHHHHHHHH
Confidence 233333322 566667776654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.62 Aligned_cols=208 Identities=25% Similarity=0.367 Sum_probs=180.5
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
...+.|++.++||.|..++||+|+. +.+..||||++.-... ...+.+.+|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3457899999999999999999985 4578999999976533 3468899999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|.||.+|++.++++..... .+++..+..|.+++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999998654433 3889999999999999999999998 99999999999999999999999998766533
Q ss_pred Ccc--cCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DEL--QGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .....+++||+.|||||++.. ..|+.|+||||||+...||.+|..||..+.
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 221 112256899999999999654 458999999999999999999999998766
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.05 Aligned_cols=200 Identities=26% Similarity=0.374 Sum_probs=175.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC--cceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~--~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
..++|.+.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999997543 368999988643 2234567889999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 108 lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999884 3446889999999999999999999988 999999999999999999999999999875
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 432 233679999999999999889999999999999999999999997644
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.03 Aligned_cols=203 Identities=26% Similarity=0.330 Sum_probs=173.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+++|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999764 58899999986532 334567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999884 3356788899999999999999999988 999999999999999999999999999643211
Q ss_pred cc-------------c--------------------------------CCcccccccCcccCccccCCCCCCchhhHHHH
Q 004416 681 EL-------------Q--------------------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSF 715 (754)
Q Consensus 681 ~~-------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSl 715 (754)
.. . ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0 00012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 004416 716 GVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 716 Gvll~elltg~~p~~~~~ 733 (754)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN 252 (377)
T ss_pred chhhhhhhcCCCCCCCCC
Confidence 999999999999997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.02 Aligned_cols=207 Identities=24% Similarity=0.301 Sum_probs=179.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++++.||+|.-|+||++++++ +..+|+|++.+.. .+...+.+.|-+||+.++||.++.|++.++.+...++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34678889999999999999999875 5789999997653 3445677889999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
+||||+||+|...++. +..+.+++..++.++.+++-||+|||..| ||.|||||+||||.++|++-|+||.|+....
T Consensus 155 ~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999987754 45667899999999999999999999998 9999999999999999999999999875431
Q ss_pred CC--------------------------------c-c---------------------cCCcccccccCcccCccccCCC
Q 004416 679 GD--------------------------------E-L---------------------QGNTKRIVGTYGYMSPEYALEG 704 (754)
Q Consensus 679 ~~--------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 704 (754)
.. . . ......++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 0 0112336899999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 705 VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 705 ~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..+.++|.|+|||+|||||.|+.||...+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999999998866
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=301.61 Aligned_cols=201 Identities=27% Similarity=0.379 Sum_probs=173.6
Q ss_pred CcceeeeeceeccEEEEeeee-cCcceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 468899999886432 2234567889999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|...+... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..+....
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998877432 2345789999999999999999999987 9999999999999999999999999998754322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 1 223578999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=307.98 Aligned_cols=208 Identities=31% Similarity=0.482 Sum_probs=180.2
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.+.+...+.++||+|.||.|.++....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 344566788999999999999999977899999999877544 4589999999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
|||++|+|.+|+...+... +.-....+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+...
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999995443332 344566789999999999999987 999999999999999999999999999977665
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHH--cCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL--SSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ell--tg~~p~~~~~ 733 (754)
.+.......+-+.+|||||.+.-++++.++|||+||+.+||++ +...||+...
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 5544444466788999999999999999999999999999975 4788886643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.35 Aligned_cols=201 Identities=29% Similarity=0.428 Sum_probs=174.4
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHH--HHHHHHHHHHcc-ccceeeeEeEEEecC-cEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKLQ-HRNLVRLLGCCIEQG-EKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~--~~~Ei~~l~~l~-H~nIv~l~~~~~~~~-~~~ 597 (754)
.-++|.++++||.|.||.||+|+. ..+..||||+++..-.. .++ =.+|+..|++|. ||||+++.+++.+.+ .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 347899999999999999999985 45889999999765322 233 368999999998 999999999999988 999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|||||+. +|.+++.+ +++.+++..++.|+.||++||+|+|.+| ++|||+||+|||+.....+||+|||+||.+
T Consensus 87 fVfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 77777754 3778999999999999999999999998 999999999999998889999999999987
Q ss_pred CCCcccCCcccccccCcccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... .....+.|.-|.|||++. .+-|+.+.|+||+|||++|+.+-++.|+..+
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 6543 333467899999999875 5678999999999999999999999998765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.12 Aligned_cols=215 Identities=24% Similarity=0.306 Sum_probs=178.0
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 58899999987532 234456788999999999999999999999999999999999999
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCc
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 686 (754)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 9988883 3456889999999999999999999988 9999999999999999999999999997532221 122
Q ss_pred ccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhhhhc
Q 004416 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSLLFD 753 (754)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~l~~ 753 (754)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. +...++..+.+.++++|.+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 228 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAG 228 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 346799999999999999999999999999999999999999965432 1222333445555665544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=330.92 Aligned_cols=209 Identities=34% Similarity=0.573 Sum_probs=181.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC--cc----eeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~--~~----~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++.+..+.||+|.||.||+|...+ +. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 34566778999999999999998654 33 3899998765 55667899999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 596 KILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
.+|++|||++|+|..||.+.+ ....++..+.+.++.|||+|+.|||+++ +|||||.++|+||++...+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence 999999999999999996542 2456889999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNT 734 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~~ 734 (754)
|+|+.+...++........-+.+|||||.+..+.++.|+|||||||+|||++| |..||+..++
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 99997766555444333345679999999999999999999999999999999 7788877553
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=306.77 Aligned_cols=195 Identities=24% Similarity=0.316 Sum_probs=168.8
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.||+|+||.||+++.. +++.||+|+++.. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999998754 2234556788999999999999999999999999999999999999
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCc
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 686 (754)
+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 9988773 3446889999999999999999999987 99999999999999999999999999875422221 12
Q ss_pred ccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 33579999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=313.38 Aligned_cols=207 Identities=24% Similarity=0.304 Sum_probs=176.0
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
......++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++.+..+.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999875 4788999998642 2223456789999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999883 234788889999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.+..... .......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...+
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 190 MKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred eecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 87643322 1223467999999999987543 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=314.47 Aligned_cols=202 Identities=24% Similarity=0.365 Sum_probs=172.9
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.|+++++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++.+.++...++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5889999999999999999864 57889999986542 2345678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998884 3345788889999999999999999987 9999999999999999999999999986432100
Q ss_pred ---------------------------------------------ccCCcccccccCcccCccccCCCCCCchhhHHHHH
Q 004416 682 ---------------------------------------------LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFG 716 (754)
Q Consensus 682 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG 716 (754)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00011235799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 004416 717 VLMLEILSSKKNTGVYN 733 (754)
Q Consensus 717 vll~elltg~~p~~~~~ 733 (754)
|++|||++|+.||...+
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=307.39 Aligned_cols=198 Identities=24% Similarity=0.383 Sum_probs=175.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999875 47899999987542 234567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999983 3456788999999999999999999988 99999999999999999999999999986533
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 2234679999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=312.37 Aligned_cols=203 Identities=26% Similarity=0.356 Sum_probs=174.9
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999875 58899999986532 234466789999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999884 3446889999999999999999999988 999999999999999999999999998765321
Q ss_pred cccC------------------------------------CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 004416 681 ELQG------------------------------------NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724 (754)
Q Consensus 681 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt 724 (754)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 004416 725 SKKNTGVYN 733 (754)
Q Consensus 725 g~~p~~~~~ 733 (754)
|+.||...+
T Consensus 235 G~~Pf~~~~ 243 (364)
T cd05599 235 GYPPFCSDN 243 (364)
T ss_pred CCCCCCCCC
Confidence 999997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=306.77 Aligned_cols=195 Identities=25% Similarity=0.322 Sum_probs=169.2
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.||+|+||.||+++.. +++.||||++... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999998654 2334567889999999999999999999999999999999999999
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCc
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 686 (754)
+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9988873 3456889999999999999999999987 9999999999999999999999999987543221 122
Q ss_pred ccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 33579999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.83 Aligned_cols=193 Identities=24% Similarity=0.327 Sum_probs=168.1
Q ss_pred eceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++.+.+.+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4788999998643 233456778899999999999999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCccc
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 688 (754)
..++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 98884 3445889999999999999999999987 9999999999999999999999999998643222 12234
Q ss_pred ccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 679999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=301.78 Aligned_cols=220 Identities=25% Similarity=0.390 Sum_probs=189.1
Q ss_pred cCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
...|...+.||+|.||.||+|.. +.++.||+|++... .....+.+++|+.++.+++++||.++++.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35577778999999999999985 45889999998755 44567889999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+.+|++...+ .....+.+....-++.++..|+.|||.++ .+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 92 y~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999888 34455577888889999999999999988 9999999999999999999999999998876554
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----------CccchhhhHHHHHhhhh
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT----------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~----------~~~~~~~~~~~~l~~~l 751 (754)
.. ..+++|||.|||||++....|+.|+||||||++.+||.+|.+|+....+ .+..+-.+.+..+++|+
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHH
Confidence 33 3668999999999999988999999999999999999999999977553 22234445666666665
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=311.54 Aligned_cols=205 Identities=24% Similarity=0.305 Sum_probs=174.5
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
....++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 344578999999999999999999875 5789999998643 223345578899999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++|+|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 119 YMVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999883 234778888999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEG----VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 192 MDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred ccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 6443221 12335799999999998653 37889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.55 Aligned_cols=200 Identities=28% Similarity=0.350 Sum_probs=170.8
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
+|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999865 46789999987542 22344567788888877 5889999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|...+. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988873 3345788999999999999999999987 999999999999999999999999999754322
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 2 12234679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=313.48 Aligned_cols=203 Identities=23% Similarity=0.347 Sum_probs=173.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.+|++.+.||+|+||.||+++.. +++.||||++.... ....+.+++|+.++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 47899999986532 223466889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999884 3456788888999999999999999988 999999999999999999999999998543210
Q ss_pred c-----------------------------------------ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHH
Q 004416 681 E-----------------------------------------LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719 (754)
Q Consensus 681 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll 719 (754)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001135799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 004416 720 LEILSSKKNTGVYN 733 (754)
Q Consensus 720 ~elltg~~p~~~~~ 733 (754)
|||++|+.||....
T Consensus 235 yell~G~~Pf~~~~ 248 (376)
T cd05598 235 YEMLVGQPPFLADT 248 (376)
T ss_pred eehhhCCCCCCCCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.66 Aligned_cols=195 Identities=29% Similarity=0.402 Sum_probs=167.7
Q ss_pred eeeceeccEEEEeeee----cCcceeeeeeccccc----hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+.||+|+||.||+++. ..++.||||+++... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 247789999986532 22345678899999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++. ....+.+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999988883 3455778888899999999999999987 99999999999999999999999999875432221
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 2233579999999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.40 Aligned_cols=200 Identities=27% Similarity=0.346 Sum_probs=170.6
Q ss_pred CcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHcccc-ceeeeEeEEEecCcEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 600 (754)
+|++.+.||+|+||.||+|+..+ ++.||||++... .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47889999999999999998654 678999998653 233456778899999999765 5888999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988883 3345788999999999999999999987 999999999999999999999999998753221
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1 12234679999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.66 Aligned_cols=192 Identities=33% Similarity=0.497 Sum_probs=171.3
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
+....++.||.|+.|.||+|++ .++.||||+++... +.+|+-|++|+||||+.+.|+|....-++|||||+.
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 4445567999999999999998 57899999986433 357889999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
.|-|...| ..++.+.......+..+||.|+.|||.+. |||||||.-||||..+..+||+|||-++......
T Consensus 196 ~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--- 266 (904)
T KOG4721|consen 196 QGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--- 266 (904)
T ss_pred cccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---
Confidence 99999999 45667888899999999999999999987 9999999999999999999999999998775432
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....++||..|||||++...+.+.|+|||||||+|||||||..||...+
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 2334899999999999999999999999999999999999999997644
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=310.24 Aligned_cols=203 Identities=24% Similarity=0.345 Sum_probs=174.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++.+.++...++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999865 57899999986432 234567888999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999883 3456889999999999999999999988 999999999999999999999999998765321
Q ss_pred cc---------------------------------cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 004416 681 EL---------------------------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727 (754)
Q Consensus 681 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~ 727 (754)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000113579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004416 728 NTGVYN 733 (754)
Q Consensus 728 p~~~~~ 733 (754)
||....
T Consensus 235 Pf~~~~ 240 (360)
T cd05627 235 PFCSET 240 (360)
T ss_pred CCCCCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=316.02 Aligned_cols=206 Identities=19% Similarity=0.245 Sum_probs=177.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-C-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34899999999999999999743 3 577899987655555556788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
+++++|..++... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999887532 23446888999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2223344679999999999999999999999999999999999999996543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.93 Aligned_cols=198 Identities=27% Similarity=0.395 Sum_probs=168.9
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHH---HHccccceeeeEeEEEecCcEEEE
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++ .+++||||+++++++..+...++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999865 58899999986532 23345667776665 456799999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|...+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 346899999999999999999999987 99999999999999999999999999875432
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 22 12234679999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=296.50 Aligned_cols=206 Identities=32% Similarity=0.509 Sum_probs=171.3
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-----------------cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceee
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-----------------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~ 585 (754)
.++|++.++||+|+||.||+++..+ +..||+|.+.... .....++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678999999999999999997532 3369999987643 334567899999999999999999
Q ss_pred eEeEEEecCcEEEEEEcccCCCHhhHhcCCC----------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 004416 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT----------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRII 649 (754)
Q Consensus 586 l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ii 649 (754)
+++++.+.+..++||||+++++|..++.... ....+++..+.+++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999998874321 1134678889999999999999999987 99
Q ss_pred eCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc--CCC
Q 004416 650 HRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKK 727 (754)
Q Consensus 650 H~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt--g~~ 727 (754)
||||||+|||+++++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999987644332222233456789999999988899999999999999999987 455
Q ss_pred CCCCC
Q 004416 728 NTGVY 732 (754)
Q Consensus 728 p~~~~ 732 (754)
||...
T Consensus 241 p~~~~ 245 (304)
T cd05096 241 PYGEL 245 (304)
T ss_pred CCCcC
Confidence 66543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=309.49 Aligned_cols=203 Identities=25% Similarity=0.380 Sum_probs=177.1
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|.+.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999875 58899999986542 234567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999998843 356889999999999999999999987 999999999999999999999999999876543
Q ss_pred c---------------------------ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 E---------------------------LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012233579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.92 Aligned_cols=208 Identities=23% Similarity=0.289 Sum_probs=176.6
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEec
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 593 (754)
.......++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999875 4788999998643 223345678899999999999999999999999
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
...++||||+++++|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999883 234788888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++.+...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+
T Consensus 189 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 189 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred eeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 9876433221 223467999999999987543 7889999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.16 Aligned_cols=200 Identities=26% Similarity=0.373 Sum_probs=170.5
Q ss_pred CcceeeeeceeccEEEEeeee----cCcceeeeeeccccc----hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 596 (754)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999875 257889999986432 23345678899999999 599999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999998884 3445889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 5433221 22236799999999998765 4788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.98 Aligned_cols=195 Identities=28% Similarity=0.369 Sum_probs=165.6
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++.+..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47789999986532 23344556677777654 899999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99988873 3346888999999999999999999987 9999999999999999999999999998643322 22
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 334679999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.40 Aligned_cols=203 Identities=32% Similarity=0.522 Sum_probs=175.7
Q ss_pred CCcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
....|.++||.|.||.|++|+++- ...||||.++.. .+....+|..|+.||.++.||||++|.|+.......+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456788999999999999998753 346999999876 455678899999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
.|||+||+|+.||.... ..+++.+..-++++||.|+.||.+.+ +|||||.++||||+.+..+|++|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999996544 45888888999999999999999988 99999999999999999999999999998765
Q ss_pred CcccCCcccc--cccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC-CCCC
Q 004416 680 DELQGNTKRI--VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNT-GVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~-~~~~ 733 (754)
+. ...+.+. .=+.+|.|||.+..++++.++|||||||++||.++ |.+|+ +..+
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 44 2222222 22578999999999999999999999999999887 88885 4443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.95 Aligned_cols=203 Identities=24% Similarity=0.334 Sum_probs=173.3
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 4778999998653 2223456788999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999843 2346788899999999999999999987 999999999999999999999999999876543
Q ss_pred cccCCcccccccCcccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 321 1223579999999999875 467889999999999999999999996543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.20 Aligned_cols=202 Identities=25% Similarity=0.357 Sum_probs=172.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 4889999998642 2233456889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998842 2345788999999999999999999988 999999999999999999999999999766433
Q ss_pred cccCCcccccccCcccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 221 1122468999999999863 45788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=285.21 Aligned_cols=204 Identities=29% Similarity=0.426 Sum_probs=171.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchh--hHHHHHHHHHHHHHccccc-eeeeEeEEEecC------
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQG------ 594 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~------ 594 (754)
..|..+++||+|+||+||+|+.+ +|+.||+|++.....+ .-....+|+.++++++|+| |+++.+++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45777789999999999999864 5889999998765332 3345689999999999999 999999998877
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCc-ccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++|+||++. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999955 888888544322 35666888999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
|+.+.-+.. .....++|.-|.|||++.+. .|+...||||+||++.||+++++-|....+
T Consensus 167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 997653221 13335788999999999887 689999999999999999999999887654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.50 Aligned_cols=195 Identities=24% Similarity=0.308 Sum_probs=168.0
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.||+|+||.||+++.. +++.||+|+++.. .......+.+|++++..++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 5889999998753 2234466788999999999999999999999999999999999999
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 9988873 34568899999999999999999997 56 99999999999999999999999999875432221 2
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 233579999999999999999999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=300.60 Aligned_cols=195 Identities=28% Similarity=0.388 Sum_probs=167.6
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+|+.+ +++.||||++... .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998653 223456677888888877 699999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 99988873 3346889999999999999999999987 9999999999999999999999999987643221 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 233579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=300.08 Aligned_cols=200 Identities=26% Similarity=0.367 Sum_probs=170.5
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 600 (754)
+|+..+.||+|+||.||+++.. +++.||+|++.... ....+.+..|+.++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3678899999999999999865 58899999987532 233456778899998885 567888999999889999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999998883 3346889999999999999999999987 999999999999999999999999999764322
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 21 2233579999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.30 Aligned_cols=195 Identities=26% Similarity=0.366 Sum_probs=167.6
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
++||+|+||.||+|+.. +++.||||+++.. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 4789999998653 223445677888888876 799999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 99988873 3446788999999999999999999988 99999999999999999999999999976432221 2
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 233578999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=300.91 Aligned_cols=203 Identities=25% Similarity=0.342 Sum_probs=172.1
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.++||+|+||.||+++.+. ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998754 678999998643 2223455888999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999843 2345788889999999999999999987 999999999999999999999999999765432
Q ss_pred cccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 21 1122357999999999886 3467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=311.76 Aligned_cols=212 Identities=26% Similarity=0.359 Sum_probs=178.0
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeecCc-ceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEE-Ee---
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC-IE--- 592 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~-~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~-~~--- 592 (754)
.+.....+++|.+.|.+|||+.||.|+...+ .+||+|++-..++...+.+++||++|++|+ |+|||.+++.. ..
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3455667789999999999999999997665 999999998878888999999999999997 99999999932 21
Q ss_pred ---cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 593 ---QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 593 ---~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
.-+.+|.||||++|.|-+++......+ |++.++++|+.|+++|+++||... ++|||||||-|||||..+++.|||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence 237789999999999998885443333 999999999999999999999875 789999999999999999999999
Q ss_pred eecCccccCCCcccC-C------cccccccCcccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 670 DFGMARMFGGDELQG-N------TKRIVGTYGYMSPEYA---LEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 670 DFGla~~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|||.|.-.-...... . .-...-|+-|+|||++ .+.+++.|+|||||||+||.|+....||+..
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999986532211100 0 0012468999999986 4778999999999999999999999999886
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=313.03 Aligned_cols=211 Identities=23% Similarity=0.313 Sum_probs=178.6
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC--
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-- 594 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-- 594 (754)
.....++|.+.+.||+|+||.||+++.. +++.||||++... .......+++|+.++..++|+||+++...+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445579999999999999999999854 6899999998654 3445567889999999999999999988775433
Q ss_pred ------cEEEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeE
Q 004416 595 ------EKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (754)
Q Consensus 595 ------~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~k 667 (754)
..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 367999999999999988543 23456889999999999999999999987 99999999999999999999
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999987654333333344689999999999999999999999999999999999999997543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=292.49 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=173.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.+.||+|+||.||+++.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999875 47889999986542 2335678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987766542 2345888999999999999999999987 9999999999999999999999999998764332
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 11 222357899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=296.10 Aligned_cols=200 Identities=27% Similarity=0.368 Sum_probs=175.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|++.+.||+|+||.||+++.. ++..||+|++... .....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999875 4788999988654 33345679999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999884 3345788999999999999999999853 49999999999999999999999999998653322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23357899999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=300.32 Aligned_cols=193 Identities=25% Similarity=0.376 Sum_probs=166.7
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 4788999998753 223445678899988877 899999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99988773 3456889999999999999999999987 9999999999999999999999999997542221 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2346799999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=298.75 Aligned_cols=194 Identities=26% Similarity=0.379 Sum_probs=167.6
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 47889999997542 23456688999999888 699999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99988773 3446899999999999999999999987 9999999999999999999999999997532211 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 23467999999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=300.35 Aligned_cols=193 Identities=23% Similarity=0.360 Sum_probs=167.4
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999865 5789999998753 223445688999999998 799999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 99988773 3456899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2346799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=296.44 Aligned_cols=195 Identities=28% Similarity=0.381 Sum_probs=166.2
Q ss_pred eeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7889999987542 23345566788888764 899999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99998883 3345788899999999999999999987 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 234678999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=297.59 Aligned_cols=195 Identities=27% Similarity=0.355 Sum_probs=166.2
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+|+.. +++.||+|+++... ....+.+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999875 47899999986532 22345567788888765 899999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 99988873 3345788999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 234679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.87 Aligned_cols=195 Identities=29% Similarity=0.407 Sum_probs=168.6
Q ss_pred eceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
||+|+||+||+++.. +++.||+|++.... ....+.+..|+.++++++|+||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 57899999986532 22345678899999999999999999999999999999999999999
Q ss_pred hhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcc
Q 004416 609 DVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687 (754)
Q Consensus 609 ~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 687 (754)
...+... .....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 8877543 23456889999999999999999999987 99999999999999999999999999987644322 223
Q ss_pred cccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 688 ~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 357899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=304.38 Aligned_cols=209 Identities=32% Similarity=0.466 Sum_probs=173.6
Q ss_pred cccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEEec
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 593 (754)
...++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+.+++.+ +|+||+++++++.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44568999999999999999998732 23579999997542 33456788999999999 899999999999999
Q ss_pred CcEEEEEEcccCCCHhhHhcCCC---------------------------------------------------------
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPT--------------------------------------------------------- 616 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~--------------------------------------------------------- 616 (754)
...++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999998874311
Q ss_pred ----------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCc
Q 004416 617 ----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (754)
Q Consensus 617 ----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 686 (754)
....+++..+.+++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 1134778889999999999999999987 999999999999999999999999999876433221122
Q ss_pred ccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 22345678999999998999999999999999999997 999986644
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=276.34 Aligned_cols=200 Identities=28% Similarity=0.424 Sum_probs=175.0
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..+.|++.+.||+|.|+.||+..+ ..|+.+|+|++... .....+.+++|+.+-+.++||||+++.....+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 457899999999999999999965 45899999987543 344678899999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFGla~~ 676 (754)
+|+|.+++|-.-+ ..+...++..+-..++||+++|.|+|.++ |||||+||+|+|+.. ..-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999986544 23456788899999999999999999988 999999999999953 34599999999999
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
++... ..-.++|||+|||||++...+++..+|||+-||+||-|+.|.+||-.
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 87433 33347899999999999999999999999999999999999999866
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=290.58 Aligned_cols=222 Identities=24% Similarity=0.382 Sum_probs=191.5
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchh--hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.-|.+.+.||+|.|++|-++++ ..|..||||++.+..-+ ....+.+|+..|+.++|||||+++++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 5578889999999999999985 47999999999776433 34567889999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCeEEEeecCccccCCC
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~kL~DFGla~~~~~~ 680 (754)
.-.+|+|.+|+.. ....+.+..+.+++.||+.|+.|+|..+ +|||||||+||.+- +-|-+||+|||.+..+.+.
T Consensus 98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999853 3445889999999999999999999987 99999999999764 5688999999999887665
Q ss_pred cccCCcccccccCcccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCC---------ccchhhhHHHHHhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFS-VKSDVFSFGVLMLEILSSKKNTGVYNTD---------SFNLLGHVSDKLYSL 750 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGvll~elltg~~p~~~~~~~---------~~~~~~~~~~~l~~~ 750 (754)
. ...+.+|...|.|||++.+..|+ ++.||||||||||.|++|++||...++. ....+.|++..-+|+
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdL 249 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDL 249 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHH
Confidence 4 34558999999999999999886 6799999999999999999999887742 334667788888888
Q ss_pred hhcC
Q 004416 751 LFDL 754 (754)
Q Consensus 751 l~~l 754 (754)
|.+|
T Consensus 250 I~sM 253 (864)
T KOG4717|consen 250 IQSM 253 (864)
T ss_pred HHHH
Confidence 8754
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=298.41 Aligned_cols=195 Identities=26% Similarity=0.329 Sum_probs=164.6
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHH-HHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||+||+|+.. +++.||||++.... ....+++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986532 222344455544 56779999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99988883 3456888999999999999999999988 9999999999999999999999999987542221 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.19 Aligned_cols=201 Identities=27% Similarity=0.369 Sum_probs=169.1
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999875 588999999865432 223467889999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|++ ++|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666532 2345788889999999999999999988 9999999999999999999999999997643322
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1223568899999998865 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.38 Aligned_cols=201 Identities=26% Similarity=0.386 Sum_probs=169.9
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999865 57899999986542 22345678999999999999999999999988899999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++ +|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 88877732 2345788899999999999999999987 99999999999999999999999999976533221
Q ss_pred cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+++.|+|||++.+ ..++.++||||+|+++|||++|++||...+
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223467899999998865 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=301.20 Aligned_cols=203 Identities=26% Similarity=0.432 Sum_probs=181.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc-EEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE-KILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-~~lV~ 600 (754)
++|..++++|+|+||.++.++++ +++.+++|++.-. .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 67889999999999999999875 4778999987643 33344567899999999999999999999999998 99999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
+|++||++.+.+.... ...++++.+.+++.||+.|+.|||++. |+|||||+.||+++.+..|||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986543 566889999999999999999999776 999999999999999999999999999998765
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ....+..|||.||.||.+.+.+|..|+|||||||++|||++-+++|...+
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~ 210 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN 210 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc
Confidence 5 23445799999999999999999999999999999999999999998765
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=277.97 Aligned_cols=202 Identities=28% Similarity=0.409 Sum_probs=169.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchh-hH-HHHHHHHHHHHHccccceeeeEeEEEec--CcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-GL-KEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~-~~-~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 598 (754)
-+.|+.++.|++|.||.||+|+.+ +++.||+|+++-..+. +. -.-.+||.+|.+++|||||.+-.+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 367999999999999999999865 5788999998754321 11 1247899999999999999998887644 47899
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||++. +|...+... ...+...+...++.|+++|++|||.+. |+||||||+|+|+...|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 788877433 356778888999999999999999987 9999999999999999999999999999987
Q ss_pred CCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+.. .....+-|.-|.|||.+.+. .|+...|+||+|||+.||+++++.|....
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 6532 22336779999999998875 58999999999999999999999987754
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=297.70 Aligned_cols=195 Identities=25% Similarity=0.325 Sum_probs=164.1
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHH-HHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 57899999986532 222344555554 67889999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99988773 3456788888999999999999999987 9999999999999999999999999987532222 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 334678999999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=297.95 Aligned_cols=195 Identities=26% Similarity=0.336 Sum_probs=163.1
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHH-HHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEM-MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999875 46789999986532 12223344444 456778999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+.+..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 99998884 3445778888889999999999999988 9999999999999999999999999997543222 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 334679999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=300.10 Aligned_cols=195 Identities=30% Similarity=0.371 Sum_probs=168.8
Q ss_pred eeeceeccEEEEeeee----cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 531 SKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~----~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5899999999999864 357899999987542 2234567789999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999988883 3456889999999999999999999987 9999999999999999999999999998654322 1
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 2233678999999999998889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=288.18 Aligned_cols=205 Identities=28% Similarity=0.398 Sum_probs=181.2
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
...+.|+.-++||+||||.||-++.+ +|+.+|.|++.+. ..++.....+|-.+|.+++.+.||.+-.+|+..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34456888899999999999999865 5899999998654 2345566788999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|+..|.+|+|..+|+.. ....++++.++.++.+|+.||++||.+. ||.||+||+|||+|++|+++|+|+|+|..+
T Consensus 262 lVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999988654 3467899999999999999999999987 999999999999999999999999999988
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
...... ...+||.+|||||++.+..|+...|.|||||+||||+.|+.||..+.
T Consensus 338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 665422 22489999999999999999999999999999999999999997765
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=288.64 Aligned_cols=201 Identities=28% Similarity=0.387 Sum_probs=173.4
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
+|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999864 58899999986532 2223457889999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999877532 2345889999999999999999999987 9999999999999999999999999998754322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1 123478999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.18 Aligned_cols=198 Identities=27% Similarity=0.381 Sum_probs=162.7
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----cEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~l 598 (754)
-.|...+++|.|+||.||+|.... +++||||+.-.... .--+|+.+|+++.|||||+++.+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 356777999999999999998654 68999998754432 1146899999999999999999987543 2358
Q ss_pred EEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEeecCccc
Q 004416 599 IYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARM 676 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DFGla~~ 676 (754)
|||||+. +|...+.+. ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999977 677766432 33556777778889999999999999977 9999999999999987 8899999999999
Q ss_pred cCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+...+.. ....-|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|...+
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 8665532 223457899999998875 58999999999999999999999998844
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.11 Aligned_cols=207 Identities=30% Similarity=0.418 Sum_probs=172.6
Q ss_pred ccCCcceeeeeceeccEEEEeeee------cCcceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecC
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 594 (754)
..++|++.++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345799999999999999999963 235689999986542 33456788999999999 8999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCC----------------------------------------------------------
Q 004416 595 EKILIYEYMVNKSLDVFLFDPT---------------------------------------------------------- 616 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~---------------------------------------------------------- 616 (754)
..++||||+++|+|..++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999988884321
Q ss_pred --------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 617 --------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 617 --------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 1124778889999999999999999987 99999999999999999999999999987644332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
........++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~ 320 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence 211222345678999999999999999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=288.51 Aligned_cols=192 Identities=21% Similarity=0.351 Sum_probs=165.7
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhh---HHHHHHHHHHHHHccccceeeeEeEEEe----cCcEEEEEEcc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYM 603 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ey~ 603 (754)
..||+|+++.||+|+. +++.||||+++...... .+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 68899999987643322 5778899999999999999999999877 34788999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++|+|..++. ....+++....+++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999984 3346888999999999999999999842 28899999999999999999999999998654322
Q ss_pred CCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 12467899999999876 678999999999999999999999997654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=298.45 Aligned_cols=195 Identities=25% Similarity=0.324 Sum_probs=164.9
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHH-HHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+++.. +++.||+|++.... .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 58899999986542 223345555554 46778999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988773 4456889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 234679999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=281.39 Aligned_cols=219 Identities=26% Similarity=0.436 Sum_probs=190.7
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+-|.++++||+|+||.|||+.++. |+.+|||++... ...+++..|+.+|.+.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 458889999999999999998764 899999998764 35788999999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
..|+..+++. .+++.+++.++..++...++||+|||... -||||||+.|||++.+|.+||+|||.|-.+...-
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 9999999884 35678999999999999999999999976 8999999999999999999999999998764433
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------------CCccchhhhHHHHHhhhh
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN------------TDSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~------------~~~~~~~~~~~~~l~~~l 751 (754)
...+++.|||.|||||++..-.|..++||||||+...||.-|++|+..-. ++.+.-++.-+..|-|++
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 33455899999999999999999999999999999999999999986533 344445555566666665
Q ss_pred h
Q 004416 752 F 752 (754)
Q Consensus 752 ~ 752 (754)
+
T Consensus 264 ~ 264 (502)
T KOG0574|consen 264 R 264 (502)
T ss_pred H
Confidence 4
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=294.32 Aligned_cols=195 Identities=27% Similarity=0.352 Sum_probs=167.6
Q ss_pred eeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+++... ++.||||+++... ....+.+..|++++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999998754 7789999987542 23455677899999888 799999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99988873 3346889999999999999999999987 9999999999999999999999999987532221 12
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 233578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=298.98 Aligned_cols=194 Identities=21% Similarity=0.284 Sum_probs=166.8
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
....+|++.+.||+|+||.||+++.. .++.||+|+... +.+.+|++++++++||||+++++++......++|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 34468999999999999999999864 578999997532 34678999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
|++. ++|..++. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 163 e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9995 67777763 3345788999999999999999999987 999999999999999999999999999754322
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.|+
T Consensus 236 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 236 N-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred c-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 1 11223467999999999999999999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=301.83 Aligned_cols=209 Identities=33% Similarity=0.456 Sum_probs=175.9
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCc----ce-eeeeeccc---cchhhHHHHHHHHHHHHHccccceeeeEeE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNG----QE-VAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~----~~-vAVK~l~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 589 (754)
..++..-++..+.++||+|+||.||+|+++.+ .. ||||..+. .......+|.+|+++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34555566777779999999999999986532 23 89999875 235667899999999999999999999999
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
+......++|||++.+|+|+++|.... ..++..++.+++.+.|.||+|||+++ +|||||.++|+|++.+..+||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999999994332 25889999999999999999999988 9999999999999999999999
Q ss_pred eecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|||+++.-. ........-.-+.+|+|||.+....|+.++|||||||++||+++ |..|+....
T Consensus 305 DFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 305 DFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred ccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 999987532 11111111235679999999999999999999999999999999 788876543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=315.19 Aligned_cols=206 Identities=26% Similarity=0.343 Sum_probs=174.1
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.++||+|+||.||+|+.. +++.||||++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999865 48899999986532 233567899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCC--------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 601 EYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
||+++++|..++.... ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999998875321 1234566778899999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcc----------------cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDEL----------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9987621110 001123579999999999999999999999999999999999999996543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=300.41 Aligned_cols=209 Identities=29% Similarity=0.417 Sum_probs=174.2
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC------cceeeeeeccccc-hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEe
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE 592 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~ 592 (754)
....++|++.++||+|+||.||+|+... +..||||+++... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 4456789999999999999999997531 3469999997543 334567899999999996 9999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCC--------------------------------------------------------
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPT-------------------------------------------------------- 616 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~-------------------------------------------------------- 616 (754)
....++||||+++|+|.+++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999998875321
Q ss_pred -------------------------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEE
Q 004416 617 -------------------------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (754)
Q Consensus 617 -------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NIL 659 (754)
....+++..+.+++.||++||+|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 0124678888999999999999999987 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 660 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
+++++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999987644332222233456788999999999999999999999999999997 88998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=295.28 Aligned_cols=202 Identities=28% Similarity=0.418 Sum_probs=180.1
Q ss_pred cccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchh---hHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~---~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~ 596 (754)
...+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+......
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345779999999999999999998765 899999999766432 3468899999999998 99999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC----CCeEEEeec
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISDFG 672 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~----~~~kL~DFG 672 (754)
++|||++.+|.|.+.+... . +++.++..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999998888543 3 899999999999999999999988 9999999999999643 479999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||....
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 9998766 224556899999999999999999999999999999999999999997765
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=298.73 Aligned_cols=202 Identities=24% Similarity=0.365 Sum_probs=174.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|.+.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999865 58899999987542 234567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999988432 246889999999999999999999988 999999999999999999999999999876543
Q ss_pred cccCCcccccccCcccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYAL------EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 322 222357899999999986 456788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=293.65 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=167.6
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----cEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKI 597 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 597 (754)
+|++.++||+|+||.||+|+.. +++.||||++... ......++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999864 5889999998643 2233457889999999999999999999876432 479
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+. ++|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 57887773 3445889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCcc-cCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDEL-QGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 33221 112233578999999999865 678999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=288.29 Aligned_cols=201 Identities=27% Similarity=0.444 Sum_probs=166.0
Q ss_pred CCcceeeeeceeccEEEEeeeec--Ccceeeeeeccccc--hhhHHHHHHHHHHHHHc---cccceeeeEeEEEe-----
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIE----- 592 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~--~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~----- 592 (754)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999863 46789999886432 22234566788777766 69999999998863
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
....++||||++ ++|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999996 5888877432 2345788999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|++||....
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 998764332 2234578999999999988899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=299.70 Aligned_cols=198 Identities=27% Similarity=0.389 Sum_probs=171.1
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHcc-c-----cceeeeEeEEEecCcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~~~~~~~~~~~ 597 (754)
.+|.+.+.||+|.||.|.++.. .+++.||||++++... -..+...|+.+|..++ | -|+|+++++|...++.+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3899999999999999999975 4589999999977543 4556688999999997 5 37999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC--CCeEEEeecCcc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMAR 675 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~--~~~kL~DFGla~ 675 (754)
||+|.+. .+|.+++... +...++...++.|+.||+.||.+||+.+ |||+|||||||||.+. ..+||+|||.|.
T Consensus 265 iVfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999985 4888888543 3455889999999999999999999987 9999999999999754 469999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....... ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|...+
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 7543332 3466789999999999999999999999999999999998888766
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=292.04 Aligned_cols=201 Identities=28% Similarity=0.379 Sum_probs=174.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..++|++.++||+|+||.||+++.. ++..+|+|++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999875 4778999987654 3334567899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++. ....+++..+..++.|++.||.|||+.+ +|+|+||||+|||+++++.+||+|||++..+...
T Consensus 83 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999884 3345788889999999999999999753 3999999999999999999999999999765332
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 22357899999999999888999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=296.26 Aligned_cols=198 Identities=28% Similarity=0.412 Sum_probs=166.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 356778899999999999999865 58899999986543 3345678999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.... ...+..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999875432 3456777889999999999999987 9999999999999999999999999998764322
Q ss_pred ccCCcccccccCcccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||....
T Consensus 223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1233578999999998743 234568999999999999999999997433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=280.05 Aligned_cols=206 Identities=28% Similarity=0.432 Sum_probs=174.2
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccc--cchhhHHHHHHHHHHHHHccccceeeeEeEEEe-----
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----- 592 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----- 592 (754)
......|...+.||+|++|.|..+..+ +|+.||||++.. ......++..+|+++|+.++|+||+.+...+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344466776799999999999999864 589999999873 345566788999999999999999999998765
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
-...|+|+|+| ..+|...+ ..+..++...+..++.||++||.|+|+.+ |+||||||.|+|++.+..+||+|||
T Consensus 98 f~DvYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 34789999999 55888888 34445889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+|+..............+.|..|.|||++. ...|+...||||.|||+.||++|++-|...+
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d 232 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD 232 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc
Confidence 999886542223334467899999999875 4679999999999999999999999998865
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=276.00 Aligned_cols=203 Identities=26% Similarity=0.339 Sum_probs=178.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.-++|..+++||+|.||+|.+++-+ .++.+|+|++++.- ......-..|-.+|+..+||.+..+-..|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999865 58899999998753 2333445678899999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||..+|.|..+| .+.+.+++...+.+-.+|+.||.|||+++ ||.||||.+|+|+|++|++||+|||+++.-
T Consensus 246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc-
Confidence 99999999987777 56778899999999999999999999987 999999999999999999999999999752
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
-......++++|||.|+|||++....|....|.|.+||++|||++|+.||-..+
T Consensus 319 -I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 319 -IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred -ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 222345667999999999999999999999999999999999999999986655
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=286.47 Aligned_cols=207 Identities=31% Similarity=0.515 Sum_probs=176.1
Q ss_pred cCCcceeeeeceeccEEEEeeeec------CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467899999999999999999742 24568999987766666778999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCC----------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeE
Q 004416 598 LIYEYMVNKSLDVFLFDPT----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~k 667 (754)
+||||+++++|..++.... ....+++..+..++.|++.||+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999885321 2235899999999999999999999987 99999999999999999999
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999987644332222222345778999999998889999999999999999998 899986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=286.03 Aligned_cols=207 Identities=31% Similarity=0.516 Sum_probs=176.0
Q ss_pred cCCcceeeeeceeccEEEEeeeecC------cceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
.++|.+.+.||+|+||.||+|+..+ ++.||||+++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568889999999999999997643 468999998765443 457899999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCC-----------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC
Q 004416 597 ILIYEYMVNKSLDVFLFDP-----------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~-----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~ 665 (754)
++||||+++++|..++... .....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 9999999999999998532 12345788899999999999999999987 999999999999999999
Q ss_pred eEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 666 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999986543332222223456788999999999999999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=299.65 Aligned_cols=204 Identities=29% Similarity=0.439 Sum_probs=177.3
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecC------cEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------EKI 597 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------~~~ 597 (754)
.|...+.||+|+||.||+|+++ .|+.||||.++... ....+...+|+++|++++|+|||++++.-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4556689999999999999964 59999999997643 344567789999999999999999998865443 568
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC--CCC--eEEEeecC
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMN--PKISDFGM 673 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~--~~~--~kL~DFGl 673 (754)
+||||+.+|+|...+..+++...+++.+.+.++.+++.||.|||+++ |+||||||.||++-. +++ -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999999999999999999999999999999887 999999999999843 333 69999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~~~ 735 (754)
|+.+..+. ....++||+.|++||.... +.|+..+|.|||||++||..||..||.....+
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99987655 4556899999999999985 78899999999999999999999999765543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=281.66 Aligned_cols=203 Identities=27% Similarity=0.414 Sum_probs=171.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec----Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+..+.+++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357899999999999999999753 35689999987653 3345678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|..++... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999988432 346889999999999999999999987 9999999999999999999999999876543
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 22211 1112345678999999999999999999999999999875 99998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=284.07 Aligned_cols=208 Identities=29% Similarity=0.468 Sum_probs=173.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++|++.+.||+|+||.||+|+.. .+..||||++.... .....++.+|+.++++++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998643 24679999986432 2345678899999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCC-------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 596 KILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
.++||||+++++|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998853221 234577888999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999986644332222222345778999999998899999999999999999999 688886543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=284.33 Aligned_cols=205 Identities=33% Similarity=0.501 Sum_probs=173.2
Q ss_pred CCcceeeeeceeccEEEEeeee-----cCcceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
++|++.+.||+|+||.||+|+. ..+..||+|.+... ......++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5688889999999999999974 24578999998753 33445678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCC--------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC
Q 004416 599 IYEYMVNKSLDVFLFDPT--------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~ 664 (754)
||||+++++|..++.... ....+++.....++.|++.||+|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884221 1235788889999999999999999987 99999999999999999
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999987644332222333456778999999988889999999999999999999 88888543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=283.91 Aligned_cols=206 Identities=34% Similarity=0.551 Sum_probs=174.2
Q ss_pred CCcceeeeeceeccEEEEeeeecC------cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
++|++.+.||+|+||.||+|.... ...||+|.+.... ....+++.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 578889999999999999997543 2579999986543 334567899999999999999999999999889999
Q ss_pred EEEEcccCCCHhhHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC
Q 004416 598 LIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~ 664 (754)
++|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998853211 145788899999999999999999987 99999999999999999
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999987644332222333456889999999988899999999999999999998 999986533
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=278.64 Aligned_cols=205 Identities=31% Similarity=0.465 Sum_probs=175.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456799999999999999999998778889999986543 3456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++.... ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999885432 346789999999999999999999987 99999999999999999999999999987753321
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
. .......+..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1 1111233457999999998899999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=288.07 Aligned_cols=203 Identities=31% Similarity=0.504 Sum_probs=170.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccc----eeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~----~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.+|++.+.||+|+||.||+|++. +++ .||||+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999854 333 38999986543 34567889999999999999999999998764 5779
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
|+||+++|+|.+++... ...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988532 345788889999999999999999987 9999999999999999999999999998775
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
............++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 4332222222344678999999999999999999999999999998 999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=286.10 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=169.1
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|.+.++||+|+||.||+|+.+ +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67999999999999999999865 47789999986543 22334678899999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++ +|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 77776633 2345788889999999999999999987 99999999999999999999999999976533221
Q ss_pred cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223467899999998865 468899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=280.11 Aligned_cols=193 Identities=27% Similarity=0.393 Sum_probs=165.3
Q ss_pred eceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
||+|+||.||+++.+ +++.||+|++.... ....+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 48899999986432 12234556799999999999999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCccc
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 688 (754)
..++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++..+..... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 8877432 2344788889999999999999999987 99999999999999999999999999987643221 123
Q ss_pred ccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 46899999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=298.19 Aligned_cols=200 Identities=22% Similarity=0.389 Sum_probs=163.3
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec-------
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------- 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------- 593 (754)
...++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+|+.+|++++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34578999999999999999999864 57899999885432 2335799999999999999999886532
Q ss_pred -CcEEEEEEcccCCCHhhHhcC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEe
Q 004416 594 -GEKILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISD 670 (754)
Q Consensus 594 -~~~~lV~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~D 670 (754)
...++||||+++ ++..++.. ......+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 146789999986 56555432 234556889999999999999999999988 99999999999999665 699999
Q ss_pred ecCccccCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
||+|+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus 215 FGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 215 FGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred cccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998764322 12235789999999988764 6899999999999999999999999754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=277.71 Aligned_cols=204 Identities=33% Similarity=0.496 Sum_probs=176.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+......+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 447899999999999999999998788899999986533 3457889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999988543 2345788889999999999999999987 99999999999999999999999999987654322
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.. .....++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 159 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred ec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 11 122345678999999988889999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=291.22 Aligned_cols=199 Identities=23% Similarity=0.318 Sum_probs=171.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeec---CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
...+|.+.+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++.+......++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999643 3568999988643 2346899999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||++. ++|..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99996 5777777 34456899999999999999999999987 99999999999999999999999999987655
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 433333344679999999999999999999999999999999999999986544
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=282.41 Aligned_cols=203 Identities=25% Similarity=0.417 Sum_probs=177.3
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
....+|++.+.||+|++|.||+|+.. +++.||+|.+........+.+.+|+.+++++.|+||+++++.+..+...++||
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 34478999999999999999999854 58899999987665555678899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ...+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 97 EYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cccCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 9999999999883 234788899999999999999999988 999999999999999999999999998865433
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1222468899999999998889999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=280.78 Aligned_cols=201 Identities=27% Similarity=0.373 Sum_probs=172.7
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.|+..+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++.+.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999864 58899999986542 2234557889999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998887532 2345899999999999999999999987 9999999999999999999999999997653322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1223578999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=282.12 Aligned_cols=206 Identities=32% Similarity=0.514 Sum_probs=176.3
Q ss_pred CCcceeeeeceeccEEEEeeeec------CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 56888999999999999999742 345699999877666666789999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC
Q 004416 599 IYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~ 665 (754)
||||+++++|.+++.... ....+++..++.++.||+.|++|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985321 2235789999999999999999999988 999999999999999999
Q ss_pred eEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 666 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999987644332222233456788999999999999999999999999999999 999985543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.63 Aligned_cols=202 Identities=31% Similarity=0.461 Sum_probs=173.2
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
++|++.+.||+|+||.||+++.+++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4688899999999999999998888899999886432 334678899999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|..++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988532 235788999999999999999999987 9999999999999999999999999998654332211
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 112345668999999988889999999999999999999 899986544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.17 Aligned_cols=201 Identities=29% Similarity=0.394 Sum_probs=172.2
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++++++|++|+++++.+..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999865 58899999886532 2233567789999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999887432 2345888999999999999999999987 9999999999999999999999999997654322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 1 123478999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=284.27 Aligned_cols=210 Identities=30% Similarity=0.469 Sum_probs=173.9
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC--------cceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 590 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~--------~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 590 (754)
....++|.+.+.||+|+||.||+++... ...+|+|.++.. ......++.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3345789999999999999999997521 246999998754 234456788999999999 799999999999
Q ss_pred EecCcEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCC
Q 004416 591 IEQGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (754)
Q Consensus 591 ~~~~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~N 657 (754)
...+..++||||+++++|..++.... ....+++..+++++.|++.||+|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 99999999999999999999985432 1235888999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||+++++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999999999986643222111222234568999999998889999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=275.81 Aligned_cols=201 Identities=31% Similarity=0.454 Sum_probs=172.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-----hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
++|.+.+.||+|++|.||++... ++++||+|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 58899999876432 1234578899999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
|+||+++++|.+.+. ....+++..+.+++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999998874 3345788889999999999999999987 9999999999999999999999999998764
Q ss_pred CCcccCC-cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 679 GDELQGN-TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 679 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 3221111 1234678899999999998899999999999999999999999855
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=312.57 Aligned_cols=230 Identities=26% Similarity=0.312 Sum_probs=192.7
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEe
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 592 (754)
...+....++|.++++||+|+||.|..++++. ++.||+|++++. ......-|..|-.+|..-..+=|+.+.-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 44566677899999999999999999999865 788999999763 23344668899999998888999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
..++|+|||||+||+|-.++. +...+++..++.++..|+-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999998883 3336899999999999999999999998 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccC----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----------CCc
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYAL----E-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN-----------TDS 736 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DVwSlGvll~elltg~~p~~~~~-----------~~~ 736 (754)
.+-.+..+... .....+|||.|++||++. + +.|++..|.||+||++|||+.|..||-... .+.
T Consensus 221 sClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 221 SCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 99888765432 233468999999999985 2 568999999999999999999999995432 234
Q ss_pred cchh--hhHHHHHhhhhhc
Q 004416 737 FNLL--GHVSDKLYSLLFD 753 (754)
Q Consensus 737 ~~~~--~~~~~~l~~~l~~ 753 (754)
+.++ ..+++..+|+|.+
T Consensus 300 l~FP~~~~VSeeakdLI~~ 318 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEA 318 (1317)
T ss_pred cCCCcccccCHHHHHHHHH
Confidence 4444 3466666666654
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=276.90 Aligned_cols=202 Identities=33% Similarity=0.502 Sum_probs=172.4
Q ss_pred CCcceeeeeceeccEEEEeeeecC----cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
++|++.+.||+|+||.||+|++.. ...||||+++... .....++.+|+.++++++||||+++++.+.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578899999999999999998642 3579999987543 33456789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|..++... ...+++..+.+++.|++.|++|||+.+ |+|+||||+|||+++++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999988432 236789999999999999999999987 99999999999999999999999999998752
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGV 731 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~ 731 (754)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 221112222345678999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=279.20 Aligned_cols=202 Identities=40% Similarity=0.595 Sum_probs=167.9
Q ss_pred ceeeeeceeccEEEEeeeec-----Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 528 SIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 528 ~i~~~LG~G~fg~Vy~~~~~-----~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999876 2568999999654 33457889999999999999999999999998888999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++|+|.+++... ....+++..+..|+.||++||+|||+.+ ++|+||+++||++++++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999543 2356889999999999999999999987 9999999999999999999999999998773322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.............|+|||.+....++.++||||||+++|||++ |+.|+....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222223456778999999998889999999999999999999 678886643
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=288.52 Aligned_cols=208 Identities=31% Similarity=0.454 Sum_probs=172.3
Q ss_pred cccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEEec
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 593 (754)
.+.++|++.+.||+|+||.||+|+.. .++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34568999999999999999999642 24689999987542 23456678899999999 899999999988754
Q ss_pred -CcEEEEEEcccCCCHhhHhcCCCC-------------------------------------------------------
Q 004416 594 -GEKILIYEYMVNKSLDVFLFDPTK------------------------------------------------------- 617 (754)
Q Consensus 594 -~~~~lV~ey~~~gsL~~~l~~~~~------------------------------------------------------- 617 (754)
...++++||+++++|..++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 568899999999999988743211
Q ss_pred ---cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCc
Q 004416 618 ---KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694 (754)
Q Consensus 618 ---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (754)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 136788999999999999999999987 99999999999999999999999999987644332222233456778
Q ss_pred ccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 695 y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
|+|||++.+..++.++|||||||+||||++ |+.||...
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=279.59 Aligned_cols=198 Identities=30% Similarity=0.411 Sum_probs=174.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 57899999986532 234567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999884 3356889999999999999999999987 999999999999999999999999999876443
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||...+
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233568899999999988888999999999999999999999986544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.50 Aligned_cols=206 Identities=33% Similarity=0.531 Sum_probs=180.3
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.+..+|++.++||.|+||.||+|+..+++.+|+|.+.........++.+|+.+++.++||||+++++++......++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567999999999999999999988889999999987666566789999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++.... ...+++..+.+++.||+.|++|||+.+ ++|+||||+||++++++.+||+|||.+..+....
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999986532 345789999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.... ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||....
T Consensus 159 ~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 159 YLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred cccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 2211 2345778999999988899999999999999999998 899986644
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=291.55 Aligned_cols=200 Identities=26% Similarity=0.381 Sum_probs=168.1
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----cEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKI 597 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 597 (754)
+|++.++||+|+||.||+++.. +++.||||++... .....+++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 6889999998653 2234567889999999999999999999988766 789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|+||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46766663 3456889999999999999999999987 999999999999999999999999999865
Q ss_pred CCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 154 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 154 EPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 4332211 2224678999999998774 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=262.89 Aligned_cols=198 Identities=29% Similarity=0.414 Sum_probs=171.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-----h---hhHHHHHHHHHHHHHc-cccceeeeEeEEEec
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----G---QGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ 593 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-----~---~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~ 593 (754)
..+|.-.+.||+|..++|.++.++ +++++|+|++.... + ...++-.+|+.+|+++ -||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777789999999999998765 58899999885431 1 1234567899999998 699999999999999
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
...++|+|.|+.|.|.++| ...-.++++..++|+.|+.+|++|||.++ ||||||||+|||++++.++||+|||.
T Consensus 96 sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999 45567899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCC------CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE------GVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
|..+.+.+ .....+|||+|+|||.+.- ..|+...|+||.||++|.|+.|-+||=
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 99987655 3455899999999998753 346778999999999999999999983
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=278.06 Aligned_cols=208 Identities=28% Similarity=0.456 Sum_probs=175.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC------cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34689999999999999999997642 3679999986543 3345678899999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCC-------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 596 KILIYEYMVNKSLDVFLFDPTK-------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
.++||||+++++|..++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 9999999999999998854321 234678899999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 99999987654432222233456789999999988889999999999999999998 899986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=279.02 Aligned_cols=208 Identities=29% Similarity=0.458 Sum_probs=172.1
Q ss_pred cccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
...++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999653 24579999886443 233456788999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCC-------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeE
Q 004416 595 EKILIYEYMVNKSLDVFLFDPT-------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~k 667 (754)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999985321 1234567788899999999999999987 99999999999999999999
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
|+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999986644332222222345678999999998899999999999999999999 78888543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=288.40 Aligned_cols=199 Identities=28% Similarity=0.331 Sum_probs=167.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 594 (754)
..++|++.+.||+|+||.||+++.. .++.||||++... ......++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 4889999998643 2334567889999999999999999999886543
Q ss_pred -cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++||||++++ |...+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 479999999764 544442 23678888899999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 97653322 1223578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=279.40 Aligned_cols=206 Identities=32% Similarity=0.506 Sum_probs=174.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec------CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
..+|++.++||+|+||.||+++.. ++..+|+|.+........+.+.+|++++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999632 35679999988766666788999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCC------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC
Q 004416 598 LIYEYMVNKSLDVFLFDPTK------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~ 665 (754)
++|||+++++|..++..... ...+++..+..++.||+.|++|||+.+ ++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999998853221 135788999999999999999999987 999999999999999999
Q ss_pred eEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 666 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |++||...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 99999999986543332222222345788999999999999999999999999999998 89998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=276.38 Aligned_cols=204 Identities=28% Similarity=0.470 Sum_probs=169.4
Q ss_pred cceeeeeceeccEEEEeeeecC----cceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc-----
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE----- 595 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~----- 595 (754)
|.+.+.||+|+||.||+|.... +..||||+++.. .....+.+.+|++.+++++||||+++++.+.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998754 23345678999999999999999999998876554
Q ss_pred -EEEEEEcccCCCHhhHhcCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 596 -KILIYEYMVNKSLDVFLFDPT---KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 596 -~~lV~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
.++|+||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998875432 2346889999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 99987654332222222345678999999988889999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=275.12 Aligned_cols=204 Identities=31% Similarity=0.498 Sum_probs=172.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..++|++.++||+|+||.||+|+..+...||+|+++... ...+++.+|+.++++++||||+++++.+. ....++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 346799999999999999999988777789999987533 23467899999999999999999998874 4568999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.++.+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999988532 2345788999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1 1122346678999999988899999999999999999999 788886543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=273.37 Aligned_cols=202 Identities=29% Similarity=0.441 Sum_probs=170.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-----chhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 596 (754)
.+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999864 4889999987532 123356788999999999999999999988764 467
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++. ....+++....+++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999884 2345788888999999999999999987 99999999999999999999999999986
Q ss_pred cCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+...... .......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 6432211 1223356889999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=278.05 Aligned_cols=204 Identities=28% Similarity=0.465 Sum_probs=175.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
..+.|++.++||+|+||.||+|+... ++.||+|.+........+.+.+|+.++++++||||+++++.+..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 34779999999999999999998754 78999999987766677889999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++.. ....+++..+..++.|++++++|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 90 FCPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred cCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999887643 2345889999999999999999999987 9999999999999999999999999987643322
Q ss_pred ccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.......+++.|+|||++. ...++.++||||||+++|||++|+.||...+
T Consensus 165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 165 --QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred --cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 1223356888999999885 3456789999999999999999999986543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=271.81 Aligned_cols=202 Identities=30% Similarity=0.446 Sum_probs=176.1
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|.+.+.||+|++|.||+++.. +++.|++|.+... .....+++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999865 5789999988643 334567789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++... ....+++..+.+++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988543 2356888999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .....|++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223568899999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=291.90 Aligned_cols=193 Identities=27% Similarity=0.359 Sum_probs=161.5
Q ss_pred eceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc---cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
||+|+||.||+|+.. +++.||||++.... ......+..|..++.+. +||||++++..+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 48899999986432 12233445667777665 699999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988873 3456889999999999999999999988 9999999999999999999999999997543222 12
Q ss_pred cccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 2346799999999998765 47899999999999999999999986644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=261.30 Aligned_cols=213 Identities=25% Similarity=0.288 Sum_probs=178.3
Q ss_pred hhccccCCcceeeeeceeccEEEEeee-ecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC---
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--- 594 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--- 594 (754)
.+....++|++.+.||+|||+.||.++ ..++..+|+|++.-...+..+..++|++.-++++|||+++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 345567899999999999999999998 4568899999998777777888999999999999999999998765433
Q ss_pred --cEEEEEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 595 --EKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 595 --~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
+.||+++|...|+|.+.+.... ++..+++.+.++|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence 5899999999999988875543 4458999999999999999999999976 47999999999999999999999999
Q ss_pred cCccccCCCccc-------CCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 672 GMARMFGGDELQ-------GNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 672 Gla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|.+....-.... .......-|..|.|||.+. +...+.++|||||||+||+|+.|..||+..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 999765321100 0111234688999999875 455789999999999999999999999653
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=278.39 Aligned_cols=202 Identities=25% Similarity=0.429 Sum_probs=177.4
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
..++|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 346799999999999999999975 4688999999876555556788999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++. ...+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||++..+....
T Consensus 97 ~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 97 YLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred ecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999883 335789999999999999999999987 9999999999999999999999999988764432
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred cc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 223468889999999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=278.81 Aligned_cols=203 Identities=26% Similarity=0.409 Sum_probs=177.6
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
...++|++.+.||+|++|.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3447899999999999999999986 468999999987655555677889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. +..+++..+..++.|++.+|.|||+.+ ++|+||||+|||++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999883 345788899999999999999999987 999999999999999999999999999876443
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 169 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred ccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 223468889999999998889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=277.08 Aligned_cols=208 Identities=33% Similarity=0.499 Sum_probs=172.8
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC------cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++|.+.+.||+|++|.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45779999999999999999998753 5678999886543 3344678999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC---CeEE
Q 004416 596 KILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKI 668 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~~kL 668 (754)
.++||||+++++|..++.... ....+++..+.+++.||+.||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999885332 1235889999999999999999999987 99999999999998764 5999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999987643332222222334568999999999999999999999999999997 999987543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=291.06 Aligned_cols=209 Identities=28% Similarity=0.429 Sum_probs=173.2
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEe
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE 592 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~ 592 (754)
....++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+.+|+.+|.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344567888899999999999999853 24679999997542 333457889999999997 9999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCC--------------------------------------------------------
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPT-------------------------------------------------------- 616 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~-------------------------------------------------------- 616 (754)
.+..++||||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999885321
Q ss_pred ---------------------------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCC
Q 004416 617 ---------------------------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (754)
Q Consensus 617 ---------------------------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~N 657 (754)
....+++..+.+++.||+.||+|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 1124677788899999999999999877 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
||+++++.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999986543222112222456789999999998889999999999999999998 88898654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=272.97 Aligned_cols=197 Identities=29% Similarity=0.443 Sum_probs=165.5
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999864 6889999987654 234456789999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCccc
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 688 (754)
.+++.. ....+++..+..++.|+++||+|||+.+ ++|+||||+|||++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998842 2345789999999999999999999987 99999999999999999999999999986543221111111
Q ss_pred ccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~ 200 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL 200 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 123457999999998899999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.76 Aligned_cols=193 Identities=23% Similarity=0.328 Sum_probs=163.5
Q ss_pred cccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
....+|++.+.||+|+||.||+|+... ++.||+|+.... ....|+.++++++||||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 344679999999999999999998754 678999975432 2256899999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+. ++|..++.. ....+++..+.+++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 577776632 3456889999999999999999999987 999999999999999999999999999753221
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
. ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 222357899999999999999999999999999999999866554
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=279.17 Aligned_cols=205 Identities=30% Similarity=0.478 Sum_probs=171.3
Q ss_pred CcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
+|++.+.||+|+||.||+|+.. ....+|+|.+.... ....+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 23568999886543 3345678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCC---------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCC
Q 004416 599 IYEYMVNKSLDVFLFDPT---------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~N 657 (754)
|+||+.+++|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998874321 1235788999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999987643332222222456778999999988889999999999999999999 999986543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=287.48 Aligned_cols=204 Identities=27% Similarity=0.419 Sum_probs=180.6
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
......|.+.++||+|.|++|..+++. .+.+||||.+.+.. ....+.+.+|+++|+.+.|||||+++.+.+....+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 344578999999999999999999864 58899999987653 333455889999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+.+|.+.+++ .+...+.+..+..++.|+.+|++|||+++ |||||||++||||+.+.++||+|||++..+
T Consensus 132 lV~eya~~ge~~~yl---~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 132 LVMEYASGGELFDYL---VKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEeccCchhHHHH---HhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 999999999999999 45555667888999999999999999988 999999999999999999999999999988
Q ss_pred CCCcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ...+.+|++.|.|||++.+.++ .+++|+||+|++||-|++|..||+..+
T Consensus 206 ~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 206 DYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 6433 4456899999999999998887 589999999999999999999998755
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=272.90 Aligned_cols=202 Identities=33% Similarity=0.492 Sum_probs=173.1
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
++|++.+.||+|+||.||+|+..++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5688899999999999999988777789999886543 334678999999999999999999999998889999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|.+++... ...+++..+.+++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999988432 235789999999999999999999987 9999999999999999999999999998764432211
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 112345678999999988889999999999999999999 999986544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=280.27 Aligned_cols=211 Identities=30% Similarity=0.472 Sum_probs=176.7
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecC------cceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 591 (754)
+....++|++.+.||+|+||.||++.... ...+|+|++... ......++.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34455789999999999999999997542 367999998754 334456788999999999 8999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCC-------------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCE
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NI 658 (754)
.+...+++|||+++++|..++... .....+++..+.+++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999988432 22456889999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 659 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999999987654332222222345678999999988899999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=274.89 Aligned_cols=202 Identities=30% Similarity=0.519 Sum_probs=166.3
Q ss_pred ceeeeeceeccEEEEeeeecCcc---eeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec------CcE
Q 004416 528 SIQSKLGEGGFGPVYKGRLLNGQ---EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------GEK 596 (754)
Q Consensus 528 ~i~~~LG~G~fg~Vy~~~~~~~~---~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~~~ 596 (754)
.+.++||+|+||.||+|+..+.. .||+|.++.. .....+.+.+|+.++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 46689999999999999875432 5899988653 344567889999999999999999999987542 246
Q ss_pred EEEEEcccCCCHhhHhcCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 597 ILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
++++||+++++|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999998877322 22345789999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 987654332112222346778999999999999999999999999999999 78888653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.73 Aligned_cols=202 Identities=28% Similarity=0.455 Sum_probs=173.4
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+-|++.+.||+|+||.||+|+... +..+++|.+........+.+.+|+++++.++||||+++++.+..+...++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 346788999999999999998754 7788999987666666778899999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|..++.. ....+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 99999887743 2346889999999999999999999987 9999999999999999999999999997653322
Q ss_pred CCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.......+++.|+|||++. +..++.++|||||||++|||++|++||...+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 1223357899999999874 4457789999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=281.85 Aligned_cols=209 Identities=31% Similarity=0.483 Sum_probs=173.4
Q ss_pred cccCCcceeeeeceeccEEEEeeeec--------Ccceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 591 (754)
...++|.+.+.||+|+||.||+++.. ....+|+|+++.. .......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34478899999999999999999642 2456999998754 234456788999999999 6999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCE
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NI 658 (754)
.....++||||+++++|..++.... ....+++..+.+++.||+.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 9999999999999999999985422 1245888999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 659 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999987654322222222234567999999998899999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=270.04 Aligned_cols=203 Identities=26% Similarity=0.446 Sum_probs=177.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|++++++++||||+++++.+......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 468999999999999999999864 4778999998776555678899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++.. ....+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999998743 2246889999999999999999999987 99999999999999999999999999987643221
Q ss_pred cCCcccccccCcccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG---VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12235688899999998776 78899999999999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=275.72 Aligned_cols=203 Identities=31% Similarity=0.466 Sum_probs=169.5
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccc----eeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~----~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.++|++.++||+|+||.||+|++. +++ .||+|+++.. .....+++.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467889999999999999999753 344 4899998654 33445678899999999999999999999875 4578
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+++||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999988843 2345889999999999999999999987 999999999999999999999999999877
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 54332211222345678999999998899999999999999999998 88998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=274.34 Aligned_cols=193 Identities=28% Similarity=0.426 Sum_probs=169.3
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.++||+|+||.||+|+. .+++.||+|++... .....+++.+|++++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 45789999988654 333456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999987543 3567888899999999999999988 9999999999999999999999999998654322
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.....||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2235789999999999998999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=272.30 Aligned_cols=198 Identities=33% Similarity=0.527 Sum_probs=173.1
Q ss_pred cceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhH--HHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~--~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
|++.+.||+|+||+||+++... ++.||+|++........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999998764 66899999977644332 23456999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|..++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--N 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--T
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence 9999999984 4567899999999999999999999987 999999999999999999999999999864211 1
Q ss_pred CCcccccccCcccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.......+++.|+|||++. +..++.++||||+|+++++|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2233467899999999998 888999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=275.30 Aligned_cols=200 Identities=26% Similarity=0.452 Sum_probs=173.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||.||+|+.. +++.||+|.++.........+++|+.+++.++||||+++++.+..++..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357889999999999999999864 5889999998766555556788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++. ....+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999873 3446889999999999999999999987 9999999999999999999999999997664322
Q ss_pred cCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.......|++.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 1223357899999999874 45578899999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=277.72 Aligned_cols=199 Identities=28% Similarity=0.441 Sum_probs=163.9
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHc---cccceeeeEeEEEec-----C
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQ-----G 594 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~-----~ 594 (754)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999875 58899999886532 12233456777777766 699999999987642 3
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++ +|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999975 787777432 2345889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+.+.... ......+|+.|+|||++.+..++.++||||+||++|||++|++||...
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 8764322 122356889999999999889999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=272.39 Aligned_cols=202 Identities=28% Similarity=0.454 Sum_probs=173.0
Q ss_pred CcceeeeeceeccEEEEeeeecCcceeeeeeccccc------hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
+|++.+.||+|+||.||+|...+++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988788999999886432 22345688999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
+||+++++|..++. ....+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999884 2345788889999999999999999987 99999999999999999999999999986532
Q ss_pred Cc----ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DE----LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. .........++..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 11 1112223568899999999998889999999999999999999999996533
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=290.79 Aligned_cols=194 Identities=24% Similarity=0.305 Sum_probs=166.7
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
...|.+.+.||+|+||.||++++.. ++.||||.... ..+.+|+.+|++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998754 78899996422 3457899999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+. ++|..++.. ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 677777632 2346899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
........||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223467999999999999999999999999999999999988764
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=279.18 Aligned_cols=207 Identities=30% Similarity=0.441 Sum_probs=173.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecC
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 594 (754)
..++|.+.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467999999999999999999631 24579999987543 33456789999999999 7999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|..++.... ...+++.++..++.|++.||+|||+++ |+|+||||+|||+++++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999885322 234789999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 87644322111222345778999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.06 Aligned_cols=200 Identities=26% Similarity=0.431 Sum_probs=172.6
Q ss_pred cCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+++|+.++++++||||+++++.+..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 36799999999999999999986 45789999998765545556788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+.....
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999998884 3346788999999999999999999987 99999999999999999999999999987643221
Q ss_pred cCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
......+++.|+|||.+. ...++.++||||+|+++|||++|+.||..
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 122356889999999874 34578899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=305.96 Aligned_cols=209 Identities=24% Similarity=0.374 Sum_probs=171.8
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC-cceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec--Cc
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GE 595 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~ 595 (754)
....++|.+.+.||+|+||.||+++... ++.||+|++... .......+..|+.++++++||||+++++++... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3455789999999999999999998754 678999988643 333456789999999999999999999988654 46
Q ss_pred EEEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCC----CCceeCCCCCCCEEEcCC-------
Q 004416 596 KILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSR----LRIIHRDLKASNILLDQH------- 663 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~iiH~DIkp~NILl~~~------- 663 (754)
.+|||||+++++|..+|... .....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999988542 223568999999999999999999998541 349999999999999642
Q ss_pred ----------CCeEEEeecCccccCCCcccCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 664 ----------MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 664 ----------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998764332 1233579999999999864 4588999999999999999999999965
Q ss_pred C
Q 004416 732 Y 732 (754)
Q Consensus 732 ~ 732 (754)
.
T Consensus 246 ~ 246 (1021)
T PTZ00266 246 A 246 (1021)
T ss_pred C
Confidence 3
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.67 Aligned_cols=204 Identities=35% Similarity=0.525 Sum_probs=175.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..++|.+.++||+|+||.||++...+++.||||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457899999999999999999998778899999987543 3456789999999999999999999999988999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++... ....+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999988542 2345889999999999999999999987 99999999999999999999999999987654221
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
. .......+..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1112334568999999998889999999999999999999 99998553
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=272.39 Aligned_cols=205 Identities=34% Similarity=0.510 Sum_probs=174.4
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
...++|++.++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence 3457899999999999999999998888999999987543 3356789999999999999999999886 4567899999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999987543 2346788999999999999999999887 9999999999999999999999999998765332
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
... .....++..|+|||++....++.++||||||+++|||++ |+.||...+
T Consensus 157 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 157 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred ccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 211 122345678999999988889999999999999999999 999996543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=277.86 Aligned_cols=205 Identities=34% Similarity=0.511 Sum_probs=172.0
Q ss_pred CCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.+|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45778899999999999999753 247899999975533 23467889999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCC-------------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC
Q 004416 598 LIYEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~ 664 (754)
+++||+++++|..++... .....+++..+.+++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999887421 11235788889999999999999999987 99999999999999999
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999987644332222233456789999999988889999999999999999998 88888654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=274.91 Aligned_cols=208 Identities=28% Similarity=0.427 Sum_probs=175.9
Q ss_pred cccCCcceeeeeceeccEEEEeeeecC-----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEe-cC
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QG 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~ 594 (754)
...++|.+.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345789999999999999999998765 678999988654 33446778999999999999999999998776 46
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCc-----ccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKK-----HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
..++++||+++++|..++...... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999988543222 56889999999999999999999987 9999999999999999999999
Q ss_pred eecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 9999987654332222222345678999999998889999999999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=276.77 Aligned_cols=204 Identities=26% Similarity=0.429 Sum_probs=176.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
+.++|++.+.||.|++|.||+++.. +++.+|+|.+........+.+.+|++++++++||||+++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3467999999999999999999875 578999999877666667789999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++.. ....+++..+.+++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 83 FCDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred ccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998743 2346889999999999999999999988 9999999999999999999999999987654322
Q ss_pred ccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......+++.|+|||++. ...++.++||||||+++|||++|+.||...+
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 1 222356899999999875 3456789999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.17 Aligned_cols=201 Identities=31% Similarity=0.504 Sum_probs=171.6
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch---------hhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~---------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 578999998864322 123568899999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++|+||+++++|..++. ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999883 3345788889999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcccC----CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDELQG----NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 775322111 112346889999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=277.83 Aligned_cols=198 Identities=27% Similarity=0.369 Sum_probs=171.9
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+++.+|++++.+++||||+++++.+..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36899999999999999999865 4778999988654 333456788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++. ....+++..+..++.|+++||.|||+.. +++|+||||+|||+++++.+||+|||++..+....
T Consensus 81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999984 3355788999999999999999999842 39999999999999999999999999987653221
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2335788999999999888899999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.19 Aligned_cols=197 Identities=26% Similarity=0.427 Sum_probs=159.6
Q ss_pred eeeceeccEEEEeeeec---CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe--cCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ey~~~ 605 (754)
++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++.+.. +...++|+||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 58999999999999864 45789999986542 23456789999999999999999998864 3467899999965
Q ss_pred CCHhhHhcCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE----cCCCCeEEEeecCcc
Q 004416 606 KSLDVFLFDP------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMAR 675 (754)
Q Consensus 606 gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~~kL~DFGla~ 675 (754)
+|..++... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +..+.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 676665321 12235888999999999999999999988 9999999999999 456789999999998
Q ss_pred ccCCCccc-CCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543211 122346789999999998764 58899999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.17 Aligned_cols=203 Identities=31% Similarity=0.467 Sum_probs=168.5
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cc--eeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~--~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 599 (754)
++|++.+.||+|+||.||+|+..+ +. .+++|.++.. .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 32 4788888743 334456789999999999 799999999999999999999
Q ss_pred EEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999885321 1235788999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999986432111 1111233557999999988889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.39 Aligned_cols=203 Identities=26% Similarity=0.429 Sum_probs=174.7
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.++||+|+||.||+|+.. +++.||||+++.. .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 5889999987542 2344567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||+++++|..++.... ....+++..+..++.|+++||+|||+++ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988874322 3445788999999999999999999987 99999999999999999999999999987644
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 321 112356888999999998888999999999999999999999998544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=272.31 Aligned_cols=204 Identities=33% Similarity=0.511 Sum_probs=172.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3467899999999999999999887888899999875433 3467899999999999999999999874 5568999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999988542 2345789999999999999999999987 99999999999999999999999999987644322
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 1 1112345668999999988889999999999999999999 888986543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.72 Aligned_cols=203 Identities=30% Similarity=0.483 Sum_probs=173.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..+|.+.+.||+|++|.||+|... .++.||+|++... ....+++.+|++++++++||||+++++++..+...++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 356888999999999999999865 4788999998654 33456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++... ....+++..++.++.|++++|+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999988432 2345788999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 160 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 160 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred ec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 11 112334668999999999999999999999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=270.06 Aligned_cols=203 Identities=28% Similarity=0.443 Sum_probs=176.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|++|.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999876 6889999988642 2334568899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999888543 23455789999999999999999999987 99999999999999999999999999986543
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 321 122346888999999999888999999999999999999999998554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.80 Aligned_cols=202 Identities=30% Similarity=0.421 Sum_probs=169.1
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccc----eeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~----~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
++|++.+.||+|+||.||+|+.. +++ .+++|.+.... .....++..|+..++++.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888899999999999999864 343 47888875443 234567888999999999999999999875 456789
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
++||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 2346889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
............++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 4332222333567789999999998899999999999999999998 99998654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=269.94 Aligned_cols=202 Identities=25% Similarity=0.385 Sum_probs=174.5
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+|++.+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999865 5889999988543 3345577889999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|..++... ....+++..+.+++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998877432 3345788999999999999999999987 99999999999999999999999999987643221
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 1223568899999999998889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=285.79 Aligned_cols=199 Identities=27% Similarity=0.326 Sum_probs=167.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec------
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 593 (754)
..++|++.+.||+|+||.||+++.. .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999864 4788999998653 233456778999999999999999999987543
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5655552 23678888999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 98754322 1223578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=277.07 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=171.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|+||.||+++.. .++.||+|.+... .....+.+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999875 5889999988654 334456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++........+++..+..++.|+++||.|||+.. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999988854333446899999999999999999999742 39999999999999999999999999997653322
Q ss_pred cCCcccccccCcccCccccCCCC------CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 22346788999999885543 478999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.08 Aligned_cols=199 Identities=28% Similarity=0.335 Sum_probs=167.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 594 (754)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3478999999999999999999864 5789999998653 2334567788999999999999999999886432
Q ss_pred -cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++||||+++ ++...+. ..+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 56999999976 4555442 23778888999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98654322 1223578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=288.25 Aligned_cols=214 Identities=29% Similarity=0.457 Sum_probs=181.7
Q ss_pred eeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHhh
Q 004416 532 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~ 610 (754)
+||+|.+|+||-|+..+ ...+|||.+........+.+.+||.+-++++|.|||+++|.+.+++..-|.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999765 45799999988877778889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCcccc--cHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeecCccccCCCcccCCcc
Q 004416 611 FLFDPTKKHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTK 687 (754)
Q Consensus 611 ~l~~~~~~~~l--~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~ 687 (754)
+|.. +-+++ .+..+-.+..||++||.|||++. |||||||-+||||+. .|.+||+|||-++++.+- ..-++
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 9843 33444 77888899999999999999987 999999999999975 688999999999988553 34567
Q ss_pred cccccCcccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCC------------CccchhhhHHHHHhhhhh
Q 004416 688 RIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYNT------------DSFNLLGHVSDKLYSLLF 752 (754)
Q Consensus 688 ~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGvll~elltg~~p~~~~~~------------~~~~~~~~~~~~l~~~l~ 752 (754)
++.||..|||||++..++ |...+|||||||.+.||.||++||-.... -...++..++..-+.+|.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence 789999999999998654 88899999999999999999999844322 111255556666666654
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=277.09 Aligned_cols=208 Identities=31% Similarity=0.489 Sum_probs=174.7
Q ss_pred cccCCcceeeeeceeccEEEEeeeec--------Ccceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 591 (754)
...++|.+.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44578899999999999999999641 2447999998654 234567789999999999 8999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCE
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NI 658 (754)
.....++||||+++++|..++.... ....+++..+..++.||++||+|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999985432 1235788889999999999999999987 99999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 659 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
|+++++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999987754332222333456778999999998889999999999999999998 77887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.12 Aligned_cols=202 Identities=33% Similarity=0.491 Sum_probs=171.4
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
.+|++.+.||+|+||.||+++.+++..+|+|++.... .....+.+|++++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999988777789999986432 234568889999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|.+++... ...+++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999988432 236789999999999999999999988 9999999999999999999999999998664322111
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 111233457999999998999999999999999999999 788986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=293.19 Aligned_cols=202 Identities=25% Similarity=0.337 Sum_probs=165.0
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcccc------ceeeeEeEEE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR------NLVRLLGCCI 591 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~------nIv~l~~~~~ 591 (754)
.+....++|++.++||+|+||+||+|+.. .++.||||+++... ...+.+..|+.++++++|. +++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455688999999999999999999864 47889999986432 2344567788888887654 5888888887
Q ss_pred ec-CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCC-----
Q 004416 592 EQ-GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHM----- 664 (754)
Q Consensus 592 ~~-~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~----- 664 (754)
.. ...++|||++ +++|..++. ....+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 64 4688999988 667777763 335688999999999999999999974 6 99999999999998765
Q ss_pred -----------CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 665 -----------NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 665 -----------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864321 1234689999999999999999999999999999999999999997644
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=270.68 Aligned_cols=195 Identities=33% Similarity=0.455 Sum_probs=163.7
Q ss_pred eeceeccEEEEeeee---cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 532 KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~---~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+||+|+||.||+|.+ .+++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 347889999986543 334578899999999999999999999875 55778999999999
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC-C
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-N 685 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~ 685 (754)
+|..++. ....+++..+.+++.|++.||+|||+++ |+||||||.||++++++.+||+|||+++.+....... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999883 3345889999999999999999999987 9999999999999999999999999998765433211 1
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 203 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 112234678999999988889999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=269.52 Aligned_cols=200 Identities=38% Similarity=0.562 Sum_probs=173.2
Q ss_pred eeeceeccEEEEeeeecC----cceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||++.... +..||+|.++..... ..+.+.+|++.+.+++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999998765433 367889999999999999999999999999999999999999
Q ss_pred CCHhhHhcCCCC------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 606 KSLDVFLFDPTK------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 606 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
++|..++..... ...+++..+..++.|+++||+|||+++ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999854321 367899999999999999999999987 99999999999999999999999999988765
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
...........+++.|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 432222334567889999999988889999999999999999999 589987653
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.58 Aligned_cols=206 Identities=29% Similarity=0.482 Sum_probs=172.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++|++.+.||+|+||.||+++.. ++..||+|++.... ....+++.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467899999999999999999753 36789999987543 3445678999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCC-------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCC
Q 004416 596 KILIYEYMVNKSLDVFLFDPT-------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~ 656 (754)
.++|+||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999885321 1234778889999999999999999987 999999999
Q ss_pred CEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004416 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGV 731 (754)
Q Consensus 657 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~ 731 (754)
||++++++.++|+|||+++.+..............+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999986644332222222345678999999988899999999999999999998 8788754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.85 Aligned_cols=203 Identities=29% Similarity=0.479 Sum_probs=171.3
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEec------
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ------ 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~------ 593 (754)
.+.+.|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999865 47889999986543 3446788999999998 799999999998753
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
...++||||+++++|..++... ....+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999988532 3346889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
++...... .......|++.|+|||++. +..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 98754322 1223367899999999986 34578899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=272.36 Aligned_cols=201 Identities=32% Similarity=0.465 Sum_probs=170.4
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788999999999999999875 58899999886432 22346788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
++ ++|..++........+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777754444467889999999999999999999987 99999999999999999999999999976543321
Q ss_pred cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......+++.|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 11223568899999988654 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=275.67 Aligned_cols=206 Identities=31% Similarity=0.481 Sum_probs=170.0
Q ss_pred cCCcceeeeeceeccEEEEeeeecC---------------cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLL 587 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~---------------~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~ 587 (754)
..+|++.+.||+|+||.||+++..+ ...||+|+++.. .....+.+.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4679999999999999999987532 234899998754 334456789999999999999999999
Q ss_pred eEEEecCcEEEEEEcccCCCHhhHhcCCC---------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCE
Q 004416 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPT---------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (754)
Q Consensus 588 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NI 658 (754)
+++......++||||+++++|..++.... ....+++..+.+++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999884321 1123678889999999999999999987 99999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 004416 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVY 732 (754)
Q Consensus 659 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt--g~~p~~~~ 732 (754)
++++++.+||+|||++..+.............++..|+|||++.+..++.++||||||+++|||++ +..||...
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999986543322222222345678999999998899999999999999999998 55566543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=268.74 Aligned_cols=196 Identities=31% Similarity=0.422 Sum_probs=167.1
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHh
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 609 (754)
++||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37999999999999988888999999876533 33457889999999999999999999999999999999999999999
Q ss_pred hHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccc
Q 004416 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (754)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 689 (754)
.++.. ....+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.+||+|||++.......... ....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 98743 2345789999999999999999999987 9999999999999999999999999997654332211 1112
Q ss_pred cccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 690 ~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 34668999999988889999999999999999999 99998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=263.66 Aligned_cols=197 Identities=26% Similarity=0.370 Sum_probs=170.3
Q ss_pred eeeceeccEEEEeee-ecCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
+.||+|+++.|-.+. +.++.++|||++.+.......++.+|++++...+ |+||+.++++|++++..|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999886 5689999999999887778889999999999995 99999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC---eEEEeecCccccCCC-----
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARMFGGD----- 680 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---~kL~DFGla~~~~~~----- 680 (754)
...+ .+...+++.++.+++.+|+.||.+||.++ |.|||+||+|||..+... +||+||.++.-+...
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 8888 45566899999999999999999999998 999999999999976554 899999998654322
Q ss_pred cccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.......+.+|+..|||||+.. ...|+.+.|.|||||+||-||+|-+||-...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 1122333468999999999863 2457889999999999999999999996644
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=274.83 Aligned_cols=206 Identities=32% Similarity=0.472 Sum_probs=173.4
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-----------------cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceee
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 585 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-----------------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~ 585 (754)
.++|++.+.||+|+||.||+++..+ +..||+|++.... ....+++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999987542 2458999987553 345678899999999999999999
Q ss_pred eEeEEEecCcEEEEEEcccCCCHhhHhcCCC--------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCC
Q 004416 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPT--------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (754)
Q Consensus 586 l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~N 657 (754)
+++++..+...++|+||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999885432 1236889999999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 004416 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVY 732 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt--g~~p~~~~ 732 (754)
|++++++.++|+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ +..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999987644332222233456788999999988889999999999999999998 66677543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=269.27 Aligned_cols=206 Identities=29% Similarity=0.419 Sum_probs=171.9
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34455656679999999999999865 46789999987766666778999999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~~~ 679 (754)
||+++++|..++.........++..+..++.||++||+|||+.+ |+||||||+||+++. ++.++|+|||++..+..
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999998854322112277888899999999999999987 999999999999986 67899999999976643
Q ss_pred CcccCCcccccccCcccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... ......+++.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 221 122246789999999986644 788999999999999999999998653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.04 Aligned_cols=203 Identities=27% Similarity=0.435 Sum_probs=175.0
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|++|.||+++. .+++.+|||.+... .....+++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 46889999987643 2334567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||+++++|..++... .....+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999887532 23456889999999999999999999987 99999999999999999999999999887643
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... ......++..|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 321 122356889999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=269.20 Aligned_cols=202 Identities=30% Similarity=0.457 Sum_probs=170.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-----hhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 596 (754)
.+|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 58899999875431 23346788999999999999999999988753 567
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++++||+++++|..++. ....+++.....++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999998884 3345788889999999999999999887 99999999999999999999999999986
Q ss_pred cCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+..... ........++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 643211 11222356889999999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.46 Aligned_cols=199 Identities=26% Similarity=0.361 Sum_probs=161.3
Q ss_pred eeeceeccEEEEeeeecC---cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~---~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.||+|+||.||+|+..+ ...+|+|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888876443 334567889999999999999999999999999999999999999
Q ss_pred CHhhHhcCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 607 SLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 607 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+|.+++..... ....++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999854322 233567788899999999999999987 9999999999999999999999999987643332211
Q ss_pred CcccccccCcccCccccCC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
......+++.|+|||++.. ..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 2222456778999998643 356789999999999999999 77888654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.48 Aligned_cols=200 Identities=27% Similarity=0.350 Sum_probs=164.0
Q ss_pred eeeceeccEEEEeeeecC---cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~---~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.||+|+||.||+|+..+ +..+|+|+++... ......+.+|+.++++++||||+++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997543 4579999886543 233457889999999999999999999999999999999999999
Q ss_pred CHhhHhcCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 607 SLDVFLFDPT--KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 607 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+|.+++.... .....++..+.+++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999885432 2234567778899999999999999987 9999999999999999999999999997654333222
Q ss_pred CcccccccCcccCccccCCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEG-------VFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
......+++.|+|||++.+. .++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 22335678899999988642 35789999999999999996 999996544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.51 Aligned_cols=204 Identities=30% Similarity=0.495 Sum_probs=170.7
Q ss_pred CCcceeeeeceeccEEEEeeeecC-c---ceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~---~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..|++.+.||+|+||.||+|+... + ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999998653 3 35999998754 344567899999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988432 345788999999999999999999987 99999999999999999999999999986643
Q ss_pred CcccCCccc-cc--ccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 680 DELQGNTKR-IV--GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
......... .. .+..|+|||.+....++.++||||||+++|||++ |..||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 221111111 11 2457999999999999999999999999999987 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.44 Aligned_cols=200 Identities=26% Similarity=0.409 Sum_probs=175.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999865 58899999986543 34456788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998842 26889999999999999999999987 99999999999999999999999999988754321
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 2233568889999999998889999999999999999999999996543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=267.68 Aligned_cols=201 Identities=29% Similarity=0.445 Sum_probs=176.5
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||.||+|+..+ ++.+|+|.+..... .+++.+|++++++++||||+++++.+..+...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999998765 78999999865432 67899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++.. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999998842 2456889999999999999999999987 99999999999999999999999999987654321
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......++..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 2223457889999999998899999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=278.21 Aligned_cols=202 Identities=33% Similarity=0.484 Sum_probs=168.5
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cc--eeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~--~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 599 (754)
++|++.+.||+|+||.||+|+.++ +. .+|+|.++.. .....+++.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578899999999999999998643 43 4688877643 334556788999999999 899999999999999999999
Q ss_pred EEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
|||+++++|..++.... ....+++..+..++.||++|++|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999885321 1235788999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
||+|||+++...... ......++..|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 999999986432111 1111234668999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=286.64 Aligned_cols=193 Identities=35% Similarity=0.523 Sum_probs=169.0
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
+.|.-++.||.|+||.||.++. .+.+.||||++.-. +...++.+..|+..|.+++|||++.+-|+|......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 4577788999999999999985 45788999998643 3345678899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
|||-| +-.+++. ..++++.+.++..|..+.++||+|||+.+ .||||||+.|||+++.|.|||+|||.|....+
T Consensus 106 EYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99954 6666662 34567888999999999999999999988 99999999999999999999999999987543
Q ss_pred cccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
.+.++|||.|||||++. .+.|+-|+||||||+...||.-.++|.
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 34589999999999875 678999999999999999999999984
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=268.54 Aligned_cols=202 Identities=32% Similarity=0.502 Sum_probs=170.7
Q ss_pred cCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
.++|.+.+.||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|+|++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 36789999999999999999988777789999886543 23467889999999999999999998874 55688999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999988543 2345788999999999999999999987 999999999999999999999999999876433221
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122345678999999988889999999999999999999 88898654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=287.29 Aligned_cols=223 Identities=24% Similarity=0.399 Sum_probs=189.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCc-ceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~-~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
+.+.|.|+..||-|+||+||++..++. -.-|.|++...+....+.|.-||+||....||+||++++.|...+.++++.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 346788999999999999999987653 4457888887788888999999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
||.||-++.++. .-.+.+.+.++..+..|++.||.|||++. |||||||+.|||++-+|.++|+|||.+.......
T Consensus 110 FC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred ecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH
Confidence 999999998874 34567899999999999999999999987 9999999999999999999999999987643322
Q ss_pred ccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC------------CCccchhhhHH
Q 004416 682 LQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN------------TDSFNLLGHVS 744 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~------------~~~~~~~~~~~ 744 (754)
.....+.|||.|||||++. ..+|+.++||||||+.|.||..+.+|....+ ++..-.+.+-+
T Consensus 185 --qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 185 --QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred --hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 2344589999999999864 5789999999999999999999999975533 23333445556
Q ss_pred HHHhhhhh
Q 004416 745 DKLYSLLF 752 (754)
Q Consensus 745 ~~l~~~l~ 752 (754)
-.|.|+|.
T Consensus 263 ~~F~DfLk 270 (1187)
T KOG0579|consen 263 RSFSDFLK 270 (1187)
T ss_pred hHHHHHHH
Confidence 66777764
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=272.36 Aligned_cols=201 Identities=34% Similarity=0.456 Sum_probs=167.4
Q ss_pred CCc-ceeeeeceeccEEEEeeee-----cCcceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEec--Cc
Q 004416 525 ENF-SIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GE 595 (754)
Q Consensus 525 ~~y-~i~~~LG~G~fg~Vy~~~~-----~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~ 595 (754)
++| ++.+.||+|+||+||++.. .+++.||+|.++... ....+.+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988642 357789999987543 23456788999999999999999999988764 35
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|..++. ...+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 789999999999999883 235899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.+...... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 76543211 1112234566799999998888999999999999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=267.99 Aligned_cols=196 Identities=31% Similarity=0.460 Sum_probs=162.9
Q ss_pred eeceeccEEEEeeeec---Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCC
Q 004416 532 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 607 (754)
.||+|+||.||+|.+. ++..||+|++.... ....+++.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 35579999987653 334567899999999999999999999875 557899999999999
Q ss_pred HhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC-Cc
Q 004416 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-NT 686 (754)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~ 686 (754)
|.+++.. ....+++..+.+++.|+++||+|||+++ ++||||||+|||++.++.+||+|||+++.+....... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998843 2446889999999999999999999987 9999999999999999999999999998654332111 11
Q ss_pred ccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
....+++.|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 11233578999999988889999999999999999996 999986543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=268.99 Aligned_cols=192 Identities=24% Similarity=0.377 Sum_probs=161.1
Q ss_pred eeeceeccEEEEeeeecC-------------cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 531 SKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-------------~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
+.||+|+||.||+|+... ...||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2258999887665555668889999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC-------eEEEe
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-------PKISD 670 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-------~kL~D 670 (754)
+||||+++++|+.++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988742 2345888999999999999999999987 999999999999987664 89999
Q ss_pred ecCccccCCCcccCCcccccccCcccCccccC-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCC
Q 004416 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEIL-SSKKNTGVYN 733 (754)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGvll~ell-tg~~p~~~~~ 733 (754)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9998765321 2245788999999886 466899999999999999998 5888876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=267.32 Aligned_cols=202 Identities=27% Similarity=0.400 Sum_probs=172.2
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEec-CcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~e 601 (754)
+|++.+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999865 47889999986532 33456788999999999999999999887644 46789999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++... ....+++.++..++.|++.++++||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888542 2345789999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.......+++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 12233568899999999999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=271.62 Aligned_cols=213 Identities=25% Similarity=0.371 Sum_probs=175.8
Q ss_pred cchhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEe
Q 004416 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (754)
Q Consensus 515 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 592 (754)
+.+..+....++|++.+.||+|+||.||+++.. +++.+|+|++.... ....++.+|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445566778899999999999999999999864 47889999876432 2235678899999999 69999999998753
Q ss_pred -----cCcEEEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 593 -----QGEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 593 -----~~~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
+...++||||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 34689999999999999877432 23456788899999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
||+|||+++.+..... ......|++.|+|||++.. ..++.++||||+|+++|||++|+.||....
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999987643321 1223468999999998753 457889999999999999999999986543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=267.60 Aligned_cols=199 Identities=31% Similarity=0.452 Sum_probs=172.5
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-----hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+.++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999875 68899999886533 23457789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
+||+++++|..++. ....+++..+..++.||++|++|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999884 2345788999999999999999999987 99999999999999999999999999987643
Q ss_pred CcccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 33 123356889999999987766 8899999999999999999999986543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=275.45 Aligned_cols=197 Identities=26% Similarity=0.427 Sum_probs=159.2
Q ss_pred eeeceeccEEEEeeeecC---cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe--cCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~---~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ey~~~ 605 (754)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998643 4689999886542 23457889999999999999999998854 4577899999976
Q ss_pred CCHhhHhcCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE----cCCCCeEEEeecCcc
Q 004416 606 KSLDVFLFDP------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMAR 675 (754)
Q Consensus 606 gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~~kL~DFGla~ 675 (754)
+|..++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555554211 12335788899999999999999999987 9999999999999 566789999999998
Q ss_pred ccCCCccc-CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+...... .......+|+.|+|||++.+ ..++.++||||||+++|||+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76543221 12233578999999999876 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=267.72 Aligned_cols=199 Identities=31% Similarity=0.494 Sum_probs=173.3
Q ss_pred cCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
.++|++.+.||+|++|.||+|... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 467889999999999999999874 78999999976543 5678899999999999999999999999899999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999884322 235889999999999999999999987 99999999999999999999999999987633221
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
....+..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1234567999999988889999999999999999997 999986553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=270.45 Aligned_cols=204 Identities=30% Similarity=0.485 Sum_probs=171.3
Q ss_pred CCcceeeeeceeccEEEEeeeecC----cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.+|++.+.||+|+||.||+|+... ...+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578899999999999999997642 3369999886542 33456889999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|..++... ...+++.++..++.|++.|++|||+.+ ++||||||+|||+++++.++|+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998432 245788999999999999999999987 99999999999999999999999999987654
Q ss_pred CcccC-CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 680 DELQG-NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 32111 1111233568999999998899999999999999999887 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.10 Aligned_cols=199 Identities=30% Similarity=0.385 Sum_probs=175.3
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
+|++.+.||.|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4889999999999999999875 48899999986542 2456788999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999998832 356889999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 1223567889999999988889999999999999999999999998655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=282.00 Aligned_cols=197 Identities=28% Similarity=0.392 Sum_probs=166.9
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEec------
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 593 (754)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3478999999999999999999864 57899999986532 23345678899999999999999999887543
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
...++++|++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 778887762 345889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9875432 223578999999999876 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=272.68 Aligned_cols=206 Identities=32% Similarity=0.482 Sum_probs=171.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-----------------Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceee
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 585 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-----------------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~ 585 (754)
.++|++.++||+|+||.||+++.. +...||+|++... .....+++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999998532 2346899998754 3344578899999999999999999
Q ss_pred eEeEEEecCcEEEEEEcccCCCHhhHhcCCCC--------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCC
Q 004416 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTK--------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (754)
Q Consensus 586 l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~N 657 (754)
+++++..++..++||||+++++|..++..... ...+++..+.+++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998854221 134678889999999999999999987 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 004416 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS--SKKNTGVY 732 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt--g~~p~~~~ 732 (754)
||+++++.++|+|||+++.+.............+++.|+|||....+.++.++||||||+++|||++ |..||...
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999987644332222222344678999999888889999999999999999998 66777544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=267.31 Aligned_cols=202 Identities=31% Similarity=0.453 Sum_probs=170.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-----chhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 596 (754)
.+|++.+.||+|+||.||+|+.. +++.||+|++... .......+++|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999864 5889999987432 223456789999999999999999999998764 457
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++|+||+++++|..++. ....+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999998883 2344788889999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...... ........++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 643211 11122356889999999999888999999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=276.61 Aligned_cols=197 Identities=27% Similarity=0.415 Sum_probs=171.1
Q ss_pred cceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
|.....||+|+||.||+++.. +++.||+|++........+.+.+|+.+++.++||||+++++.+..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334458999999999999864 5889999998665545567788999999999999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+..... .
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 99998772 345789999999999999999999987 99999999999999999999999999976543321 1
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22356889999999999888999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=266.82 Aligned_cols=205 Identities=31% Similarity=0.465 Sum_probs=173.9
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
...++|.+.++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+||+++.+.+.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3457899999999999999999987777889999886542 345678899999999999999999999877 77899999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+..+....
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999988543 2345788889999999999999999987 9999999999999999999999999998764332
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.. ......++..|+|||++....++.++|+||||+++|||++ |+.||...+
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 21 1122345678999999988889999999999999999999 899987543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=280.75 Aligned_cols=207 Identities=30% Similarity=0.448 Sum_probs=169.8
Q ss_pred ccCCcceeeeeceeccEEEEeeee------cCcceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEEec-
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ- 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~- 593 (754)
..++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 447899999999999999999963 346789999987543 33456788999999999 789999999988654
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCC--------------------------------------------------------
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTK-------------------------------------------------------- 617 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~-------------------------------------------------------- 617 (754)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999988743210
Q ss_pred --------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccc
Q 004416 618 --------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (754)
Q Consensus 618 --------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 689 (754)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124678888999999999999999987 999999999999999999999999999875433221222223
Q ss_pred cccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 690 ~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 45678999999998899999999999999999997 88898653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=269.13 Aligned_cols=202 Identities=27% Similarity=0.469 Sum_probs=172.2
Q ss_pred CcceeeeeceeccEEEEeeee-cCcceeeeeeccccc------hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
+|+..+.||+|++|.||+++. .+++.||+|++.... ....+.+++|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 458899999886432 1235678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCcccc
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~ 677 (754)
|+||+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999884 3346788999999999999999999987 99999999999998776 5999999999877
Q ss_pred CCCccc--CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQ--GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
...... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 543211 11223568899999999988889999999999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=273.41 Aligned_cols=200 Identities=27% Similarity=0.390 Sum_probs=168.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 67999999999999999999865 47889999986442 23345678899999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
++ ++|..++.. ....+++..+..++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588777743 2345788899999999999999999987 99999999999999999999999999976533221
Q ss_pred cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......+++.|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11224568899999987654 5788999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=279.03 Aligned_cols=195 Identities=29% Similarity=0.464 Sum_probs=170.0
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 607 (754)
++||.|.||+||-|+++ +|+.||||++.+. ..+...++.+|+.||.+++||.||.+--.|+..+..++|||-+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 78999999999999875 5999999998764 34456789999999999999999999999999999999999996544
Q ss_pred HhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC---CCeEEEeecCccccCCCcccC
Q 004416 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~~kL~DFGla~~~~~~~~~~ 684 (754)
|+-+| . ..+..+++.....++.||+.||.|||.++ |+|+||||+|||+.+. ..+||+|||.|+.+++...
T Consensus 650 LEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 650 LEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred HHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 44444 3 34556888888889999999999999988 9999999999999653 5699999999999987653
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+..+|||.|+|||++....|...-|+||.|||+|--++|.-||....
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 345799999999999999999999999999999999999999996654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=269.68 Aligned_cols=201 Identities=28% Similarity=0.395 Sum_probs=171.9
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999875 48899999886442 2234567899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|++++.|..++. ....+++..+..++.|++.+|+|||+.+ ++|+||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 3345889999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223457889999999876 557889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=275.86 Aligned_cols=199 Identities=25% Similarity=0.388 Sum_probs=172.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+.|.....||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 44555578999999999999864 57899999987665556677899999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++..+.....
T Consensus 102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~- 173 (292)
T cd06658 102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP- 173 (292)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence 9999998873 234788999999999999999999987 99999999999999999999999999976543321
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 122356889999999998888999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=266.41 Aligned_cols=206 Identities=27% Similarity=0.440 Sum_probs=177.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999854 57889999986542 33567889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999854333356889999999999999999999987 99999999999999999999999999987654332
Q ss_pred cC--CcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QG--NTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......|+..|+|||++... .++.++|+||||++++||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 21 22335688999999998877 78899999999999999999999986543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=265.92 Aligned_cols=201 Identities=30% Similarity=0.403 Sum_probs=177.5
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|++|.||+++... ++.||||++..... ...+.+.+|+..+.+++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998764 88999999876543 4567899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
+++++|..++.. ...+++..+..++.|++++++|||+ .+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999843 3568899999999999999999999 87 9999999999999999999999999998765433
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 221 23567889999999998889999999999999999999999997664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=268.06 Aligned_cols=199 Identities=26% Similarity=0.436 Sum_probs=173.3
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..|+..+.||.|+||.||+|... +++.||+|++.... ....+.+.+|+.+++++.||||+++++.+.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777889999999999999865 47899999886543 34567889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999883 245788889999999999999999987 99999999999999999999999999987644332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122246788999999998888999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=269.58 Aligned_cols=201 Identities=30% Similarity=0.494 Sum_probs=169.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-----CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~ 597 (754)
++|++.+.||+|+||.||+++.+ ++..||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57889999999999999999742 4778999999876666678899999999999999999999987543 4688
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|+||+++++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999988432 345789999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccC-CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 678 GGDELQG-NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 678 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
....... ......++..|+|||++.+..++.++||||||+++|||++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 4332111 1111233456999999998899999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=277.00 Aligned_cols=209 Identities=30% Similarity=0.472 Sum_probs=173.2
Q ss_pred cccCCcceeeeeceeccEEEEeeeecC--------cceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~--------~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 591 (754)
....+|++.+.||+|+||.||+++... ...||+|.++.. .....+++.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 344678999999999999999996421 236899988754 234567889999999999 8999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCE
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NI 658 (754)
+....++++||+++++|..++.... ....+++..+..++.|+++||+|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 9999999999999999999885421 2345788899999999999999999987 99999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 659 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|+++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..||...+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999987654322222222344568999999999999999999999999999998 888886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=272.01 Aligned_cols=199 Identities=27% Similarity=0.454 Sum_probs=172.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45777889999999999999864 47889999886443 34456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++. ...+++..+..++.|+++|+.|||+++ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998873 345788999999999999999999987 99999999999999999999999999987643321
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......++..|+|||++.+..++.++||||||+++|||++|+.|+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 122246788999999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=268.91 Aligned_cols=203 Identities=32% Similarity=0.441 Sum_probs=172.1
Q ss_pred CCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
++|++.+.||+|+||.||+|+.+ +.+.||+|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67889999999999999999854 2457999988665433 4578999999999999999999999999889999
Q ss_pred EEEEcccCCCHhhHhcCCCCc------ccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 598 LIYEYMVNKSLDVFLFDPTKK------HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543321 25899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGV 731 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~ 731 (754)
|+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 998754332211 2223456778999999988888999999999999999999 7778854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=268.12 Aligned_cols=204 Identities=31% Similarity=0.491 Sum_probs=171.6
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cc----eeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~----~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
..+|++.+.||+|+||.||+|..++ +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3678899999999999999998643 32 58999886553 3345778999999999999999999999876 7899
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|+||+++++|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999988532 334889999999999999999999987 999999999999999999999999999877
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 54332222222234568999999988889999999999999999999 999987644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.20 Aligned_cols=206 Identities=27% Similarity=0.372 Sum_probs=176.1
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccc--cchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~--~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~ 596 (754)
+......|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.+++ |.+|+++++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3455677999999999999999999987888899997643 35667888999999999995 99999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
|+||||= ..+|..+|.... ..+..-.+..+..||++|+.++|.++ |||.||||.|+|+-+. .+||+|||+|..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcc
Confidence 9999976 558999884322 22222267789999999999999998 9999999999999764 899999999999
Q ss_pred cCCCcccCCcccccccCcccCccccCCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV-----------FSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+..+.+.......+||+.||+||.+.... .++++||||||||||+|+.|++||+..
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 98888777777889999999999886422 567899999999999999999999764
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=270.83 Aligned_cols=202 Identities=22% Similarity=0.325 Sum_probs=171.1
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+++... ++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999998754 7889999886543 233567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999983 3346888999999999999999999987 999999999999999999999999998642111
Q ss_pred c-------------ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 E-------------LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. .........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0 000111245788999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=291.43 Aligned_cols=200 Identities=32% Similarity=0.452 Sum_probs=175.0
Q ss_pred ceeeeeceeccEEEEeeee-cCcc----eeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 528 SIQSKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 528 ~i~~~LG~G~fg~Vy~~~~-~~~~----~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
+..++||.|+||+||+|.+ ..++ +||||++... ..+...++.+|+.+|.++.|||++|++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999975 3343 6899988654 4556788999999999999999999999998766 889999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
||+.|.|.++++. .+..+..+..+.|..|||+||.|||++. ++||||.++||||++..++||+|||+|+.+..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999854 4556788899999999999999999887 9999999999999999999999999999998877
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.........-.+.|||-|.+....|+.++|||||||.+||++| |.+|+..-.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 6666655666789999999999999999999999999999998 888876644
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=268.40 Aligned_cols=203 Identities=28% Similarity=0.364 Sum_probs=168.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++|+||+++.+++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999764 588999999865432 23346788999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+. +++..++.. ....+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 566665532 2234677888899999999999999987 999999999999999999999999999765332
Q ss_pred cccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 21 12224578899999998764 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=264.31 Aligned_cols=198 Identities=31% Similarity=0.447 Sum_probs=168.1
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHh
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 609 (754)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877899999988765333 5568899999999999999999999999999999999999999999
Q ss_pred hHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccc
Q 004416 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (754)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 689 (754)
.++... ...+++..+..++.+++++++|||+++ ++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988432 235778889999999999999999987 999999999999999999999999999866432222111222
Q ss_pred cccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 690 ~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
..+..|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 34567999999988899999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=267.16 Aligned_cols=203 Identities=27% Similarity=0.387 Sum_probs=170.2
Q ss_pred cCCcceeeeeceeccEEEEeeeecC----cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4668899999999999999998643 2468999887654 4456789999999999999999999998764 56789
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998432 335789999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
........ ...+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 159 DESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred cccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 44322111 2344568999999988889999999999999999996 999986543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=308.28 Aligned_cols=208 Identities=29% Similarity=0.433 Sum_probs=178.4
Q ss_pred ccccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
...+-+++-...||.|.||.||.+.. .+|.-.|+|.++... ........+|+.++..++|||+|+++|+-.+++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 33445667778999999999999975 458889999876543 344567889999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
|.||||++|+|.+.+ ...+..++.....+..|++.|++|||++| ||||||||.||+|+.+|-+|++|||.|+.+
T Consensus 1311 IFMEyC~~GsLa~ll---~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLL---EHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHH---HhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 999999999999998 34455677777889999999999999998 999999999999999999999999999998
Q ss_pred CCCc--ccCCcccccccCcccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 678 GGDE--LQGNTKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 678 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.+.. .....+...||+.|||||++.+.. ...++|||||||++.||+||++||...+.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 7653 233445678999999999998754 45689999999999999999999977553
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=266.95 Aligned_cols=200 Identities=28% Similarity=0.412 Sum_probs=169.5
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch----------hhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG----------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
+|.+.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|+.++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999754 588999998753211 12356788999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|..++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998843 256888899999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
+...............++..|+|||.+.... ++.++|+||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 8654322222233356889999999987654 78899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=262.69 Aligned_cols=202 Identities=25% Similarity=0.415 Sum_probs=175.3
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|+..+.||+|+||.||.++.. +++.+++|++... .....+++.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999753 5888999987643 344567789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++.... ...+++..+..++.|+++++.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885332 346789999999999999999999987 99999999999999999999999999987644332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 2233568999999999988889999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=268.95 Aligned_cols=191 Identities=26% Similarity=0.373 Sum_probs=159.1
Q ss_pred eeceeccEEEEeeeecC-------------------------cceeeeeeccccchhhHHHHHHHHHHHHHccccceeee
Q 004416 532 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 586 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~~-------------------------~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 586 (754)
.||+|+||.||+|.+.. ...||+|++.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13489999876555555678899999999999999999
Q ss_pred EeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC--
Q 004416 587 LGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-- 664 (754)
Q Consensus 587 ~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-- 664 (754)
++++.+....++||||+++++|+.++.. ....+++..+.+++.||++||+|||+++ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988843 2345788899999999999999999987 99999999999997643
Q ss_pred -----CeEEEeecCccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHH-HcCCCCCCCCC
Q 004416 665 -----NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEI-LSSKKNTGVYN 733 (754)
Q Consensus 665 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~el-ltg~~p~~~~~ 733 (754)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3799999998654221 12356788999998865 5688999999999999998 47999987644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=271.89 Aligned_cols=196 Identities=26% Similarity=0.424 Sum_probs=165.1
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 58899999986532 22235678899999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++ +|..++.. ....+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 67666532 2345889999999999999999999987 99999999999999999999999999986643221
Q ss_pred cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
......+++.|+|||++.+. .++.++||||||+++|||++|+.|+
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 11224578899999988764 4789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=272.35 Aligned_cols=205 Identities=26% Similarity=0.412 Sum_probs=169.4
Q ss_pred CcceeeeeceeccEEEEeeeecC---cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKI 597 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~---~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~ 597 (754)
+|++.++||+|++|.||+|+... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998643 7899999987632 33446778899999999999999999999988 7899
Q ss_pred EEEEcccCCCHhhHhcC-CCC-cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC----CCCeEEEee
Q 004416 598 LIYEYMVNKSLDVFLFD-PTK-KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ----HMNPKISDF 671 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~-~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~----~~~~kL~DF 671 (754)
+||||+++ ++...+.. ... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 55554432 222 236889999999999999999999987 999999999999999 899999999
Q ss_pred cCccccCCCcc-cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 672 GMARMFGGDEL-QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 672 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
|+++.+..... ........+++.|+|||++.+. .++.++||||||++++||++|++||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987644322 1122335678999999987764 578999999999999999999999976654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=268.15 Aligned_cols=199 Identities=37% Similarity=0.542 Sum_probs=166.8
Q ss_pred eeeceeccEEEEeeeecC-------cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+.||+|+||.||+|+..+ ++.+|||.+.... .....++.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999997643 2579999886543 23466789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-----CeEEEeecC
Q 004416 603 MVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-----NPKISDFGM 673 (754)
Q Consensus 603 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-----~~kL~DFGl 673 (754)
+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++++. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999885422 2234788999999999999999999887 99999999999999887 899999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 987644332222222355788999999999999999999999999999998 99998654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=265.18 Aligned_cols=192 Identities=27% Similarity=0.407 Sum_probs=168.1
Q ss_pred eceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
||.|++|.||+++... ++.||+|++.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999998754 8899999986532 23456789999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCccc
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 688 (754)
.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 998843 345788999999999999999999987 9999999999999999999999999998764432 1223
Q ss_pred ccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..+++.|+|||.+.+..++.++|+||+|+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 467889999999988889999999999999999999999997665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=264.95 Aligned_cols=197 Identities=30% Similarity=0.410 Sum_probs=168.4
Q ss_pred eeeceeccEEEEeeeecC--c--ceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~--~--~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 2 3689999987655 567789999999999999999999999888 889999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc-C
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ-G 684 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 684 (754)
++|..++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998854332 46889999999999999999999987 999999999999999999999999999877542211 1
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1122456789999999998899999999999999999999 99998543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=264.73 Aligned_cols=196 Identities=32% Similarity=0.514 Sum_probs=167.2
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEE-ecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI-EQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~-~~~~~~lV~ey~ 603 (754)
++|++.+.||+|+||.||++.. .+..||+|.++... ..+.+.+|+.++++++|+|++++++++. ++...++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788999999999999999976 47889999886433 3467899999999999999999999765 445789999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|.+++... ....+++..+.+++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999988532 2335788999999999999999999987 9999999999999999999999999997653322
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
....++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12344568999999998889999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=271.32 Aligned_cols=205 Identities=25% Similarity=0.316 Sum_probs=174.9
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccch---hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|++|.||+++..+ ++.||+|.+..... ...+.+.+|++++++++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468899999999999999998754 88999999876432 24567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988432 3356888999999999999999999987 999999999999999999999999998765321
Q ss_pred ccc---------------------------CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQ---------------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .......||..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123468899999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=263.85 Aligned_cols=201 Identities=30% Similarity=0.489 Sum_probs=174.5
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|.+.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999864 588999999876543 3677899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++. ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999884 3345788899999999999999999988 99999999999999999999999999987754332
Q ss_pred cCC--cccccccCcccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGN--TKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... .....+++.|+|||++.+.. ++.++||||||++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 211 12356788999999988766 889999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=264.60 Aligned_cols=196 Identities=36% Similarity=0.489 Sum_probs=163.9
Q ss_pred eeeceeccEEEEeeeecC----cceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999876543 34567899999999999999999999875 5578999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC-
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG- 684 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~- 684 (754)
++|.+++.. ...+++..+..++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999843 336889999999999999999999987 9999999999999999999999999998764433211
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 1111234567999999998899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=269.31 Aligned_cols=201 Identities=26% Similarity=0.427 Sum_probs=175.6
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 478999999999999999999754 5788999998655545567789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++. ...+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999883 334778889999999999999999987 99999999999999999999999999876644332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223468889999999988889999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=267.59 Aligned_cols=200 Identities=29% Similarity=0.430 Sum_probs=164.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHH-HHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMML-IAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.+.||+|+||.||+++.. +++.||+|+++... .....++..|+.+ ++..+||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999875 58999999986542 2233455556665 566689999999999999999999999
Q ss_pred cccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 602 YMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 602 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|++ ++|..++... .....+++..+..++.||+.||+|||++ + ++||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5777766432 2345689999999999999999999986 5 99999999999999999999999999987643
Q ss_pred CcccCCcccccccCcccCccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALE----GVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 22 1122467889999998865 4468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-30 Score=267.77 Aligned_cols=194 Identities=29% Similarity=0.426 Sum_probs=166.1
Q ss_pred eceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
||+|+||+||++... +++.||+|++.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 58899999886432 22345667899999999999999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCccc
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 688 (754)
..++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 98885432 246889999999999999999999987 9999999999999999999999999998654322 1223
Q ss_pred ccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 467889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=261.08 Aligned_cols=202 Identities=29% Similarity=0.443 Sum_probs=176.8
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIY 600 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 600 (754)
+|.+.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 588999999866542 4567899999999999999999999999988 8899999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++.. ...+++..+..++.|++++|+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999998843 237889999999999999999999987 999999999999999999999999999877554
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..........++..|+|||.+.+...+.++||||||+++++|++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 42111233578889999999988889999999999999999999999997754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=264.97 Aligned_cols=204 Identities=31% Similarity=0.505 Sum_probs=170.9
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-c---ceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~---~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..+|+..+.||+|+||.||+|+... + ..+|+|++... .....+.+.+|++++++++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999998653 3 36999998654 33445678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|..++.. ....+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998843 2345788999999999999999999987 9999999999999999999999999998664
Q ss_pred CCcccCC-cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 679 GDELQGN-TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
....... ......++.|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 3221111 111223457999999988889999999999999999997 99998543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=269.38 Aligned_cols=200 Identities=27% Similarity=0.367 Sum_probs=170.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999875 478999998865422 234678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..+.. ....+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999887763 2334789999999999999999999987 9999999999999999999999999998764433
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 1 1223467889999998875 44788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.45 Aligned_cols=208 Identities=29% Similarity=0.471 Sum_probs=179.3
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.++....++.+.++||-|.||.||.|.++. .-.||||.++.. ....++|..|+.+|+.++|||+|+|+|+|.....+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344455667788999999999999999865 668999999764 456789999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
||+|||.+|+|.++|....+ ..++....+.++.||+.|++||..++ +|||||.++|+|+.++..+|++|||+++.+
T Consensus 340 IiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999965433 34556677889999999999999887 999999999999999999999999999999
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
..+.+.... ....+..|.|||.+.-..++.|+|||+|||+||||.| |-.|+..-
T Consensus 416 tgDTYTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 416 TGDTYTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred cCCceeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 876643322 2345678999999999999999999999999999998 66677653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=273.88 Aligned_cols=210 Identities=29% Similarity=0.439 Sum_probs=178.9
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeecC---cc--eeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEE
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 590 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~---~~--~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~ 590 (754)
........+.....++||.|-||.||+|.+.+ |+ .||||..+.. .+...+.|..|+.+|++++||||++++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 33444555666677899999999999997533 22 5999999874 455678899999999999999999999998
Q ss_pred EecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEe
Q 004416 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (754)
Q Consensus 591 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~D 670 (754)
.+ ...+||||.++-|.|..+|. .++..++......++.||..||+|||+.. +|||||..+|||+....-+||+|
T Consensus 461 ~e-~P~WivmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 461 VE-QPMWIVMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred ec-cceeEEEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence 75 47899999999999999994 45566888888999999999999999987 99999999999999999999999
Q ss_pred ecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||+++.+..+.+.... ...-+..|||||.+.=+.++.++|||.|||++||+++ |.+||....
T Consensus 535 FGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred cchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 9999999876655443 3456788999999999999999999999999999987 889986543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=261.65 Aligned_cols=202 Identities=31% Similarity=0.504 Sum_probs=172.4
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
.+|++.+.||+|+||.||++...++..+|+|++.... ....++.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 5688899999999999999988778899999886543 234678999999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|.+++.. ....+++..+..++.|++.+++|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999988843 2335788999999999999999999987 9999999999999999999999999998664332211
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 112335678999999998889999999999999999998 899986543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=267.03 Aligned_cols=191 Identities=26% Similarity=0.417 Sum_probs=160.9
Q ss_pred eeeceeccEEEEeeeecC--------cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~--------~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+.||+|+||.||+|.... ..+||+|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 235899988765555567889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC--------eEEEeecCc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--------PKISDFGMA 674 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--------~kL~DFGla 674 (754)
+++++|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998532 235788999999999999999999987 999999999999987765 699999998
Q ss_pred cccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK-KNTGVY 732 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~-~p~~~~ 732 (754)
...... ....+++.|+|||++.+ ..++.++||||||+++|||++|. .|+...
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 765322 22467889999999876 45789999999999999999995 555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=263.94 Aligned_cols=196 Identities=30% Similarity=0.483 Sum_probs=159.7
Q ss_pred eeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEe-cCcEEEEEEccc
Q 004416 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKILIYEYMV 604 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~lV~ey~~ 604 (754)
+.||+|+||.||+|...+ ...||+|++... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997532 357999998543 33456788899999999999999999998764 456889999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc-
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ- 683 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 683 (754)
+++|..++... ...+++..+..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998432 234567778899999999999999987 999999999999999999999999999865432211
Q ss_pred -CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 004416 684 -GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS-KKNTGV 731 (754)
Q Consensus 684 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg-~~p~~~ 731 (754)
.......+++.|+|||.+.+..++.++||||||+++|||++| .+||..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 111223567789999999888999999999999999999995 555643
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=267.85 Aligned_cols=200 Identities=29% Similarity=0.390 Sum_probs=169.2
Q ss_pred CcceeeeeceeccEEEEeeee----cCcceeeeeeccccc----hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 596 (754)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 367899999986532 22346778999999999 599999999999988899
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++|+||+++++|.+++. ....+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999884 3345788889999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+...... ......|+..|+|||.+... .++.++||||||+++|+|++|+.||...
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 6443222 12235688999999998753 4678999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=267.51 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=168.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|++|.||+|+.+ +++.||||.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999865 578999999865422 2234567899999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++ +|..++... ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888877432 236788999999999999999999987 99999999999999999999999999876432211
Q ss_pred cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1112346789999998865 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=273.20 Aligned_cols=199 Identities=20% Similarity=0.278 Sum_probs=164.7
Q ss_pred eeeeecee--ccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 529 IQSKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 529 i~~~LG~G--~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
++++||+| +|++||+++.. +++.||+|++.... ....+.+++|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999864 58899999986542 234467788999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc-
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL- 682 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~- 682 (754)
++++|.+++.... ...+++..+.+++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999884322 234788999999999999999999987 99999999999999999999999987654321110
Q ss_pred ----cCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 683 ----QGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 683 ----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 011122356778999999876 4588999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=265.35 Aligned_cols=196 Identities=33% Similarity=0.483 Sum_probs=162.6
Q ss_pred eeeceeccEEEEeeeecC-cc--eeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-~~--~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|+||.||+|+..+ +. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998754 33 5788988753 334556789999999999 899999999999999999999999999
Q ss_pred CCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 606 KSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 606 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885321 1234788999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
++...... ........+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 98632211 11111234567999999988889999999999999999997 99998543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=270.82 Aligned_cols=203 Identities=33% Similarity=0.536 Sum_probs=168.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccc----eeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~----~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.++|++.+.||+|+||.||+|+.. ++. .||+|.+.... .....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 367888899999999999999754 343 47899886543 33345788999999999999999999998654 567
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998843 2335788899999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54332222223445778999999998999999999999999999997 88998653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=261.71 Aligned_cols=201 Identities=24% Similarity=0.388 Sum_probs=173.1
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|+||.||+++.. +++.||+|++... .....+++.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 5789999988643 233456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++... ....+++..+.+++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998887432 2235788899999999999999999987 99999999999999999999999999987644321
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......|++.|+|||++.+..++.++|+||||++++||++|+.||...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 122346788999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=286.33 Aligned_cols=200 Identities=23% Similarity=0.359 Sum_probs=158.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC--cceeeee------------------eccccchhhHHHHHHHHHHHHHccccc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSNQSGQGLKEFKNEMMLIAKLQHRN 582 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~--~~~vAVK------------------~l~~~~~~~~~~~~~Ei~~l~~l~H~n 582 (754)
..++|++.++||+|+||+||+++.+. +...++| .+. ........+++|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34789999999999999999986532 2222222 111 12223456889999999999999
Q ss_pred eeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE
Q 004416 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPT--KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (754)
Q Consensus 583 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl 660 (754)
|+++++++...+..++|+|++.. +|..++.... .........+..++.||+.||+|||+++ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999864 5555553221 1222345667789999999999999987 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004416 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728 (754)
Q Consensus 661 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p 728 (754)
+.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999877543321 22236799999999999999999999999999999999998854
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=267.91 Aligned_cols=200 Identities=31% Similarity=0.499 Sum_probs=168.8
Q ss_pred CCcceeeeeceeccEEEEeeee-----cCcceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~ 596 (754)
..|++.+.||+|+||.||+++. .++..||+|.++... ....+.+.+|+.++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578899999999999999974 247789999987543 34456799999999999999999999998875 568
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999988432 235789999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6543211 1122345677899999998888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-30 Score=273.54 Aligned_cols=209 Identities=22% Similarity=0.326 Sum_probs=176.8
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
....-|..++.||-|+||.|.+++- ++...+|+|.+.+.+ .......+.|-.||++-..+=||+|+-.|++++.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3445688899999999999999964 446789999987653 334556788999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++|++-.+|. +.+.+.+..++.++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-+
T Consensus 706 FVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999988873 5567888999999999999999999988 999999999999999999999999998643
Q ss_pred CC---------Ccc-------------------------------cCCcccccccCcccCccccCCCCCCchhhHHHHHH
Q 004416 678 GG---------DEL-------------------------------QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGV 717 (754)
Q Consensus 678 ~~---------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGv 717 (754)
.- ... .......+||+.|+|||++....++...|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 10 000 00011257999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCc
Q 004416 718 LMLEILSSKKNTGVYNTDS 736 (754)
Q Consensus 718 ll~elltg~~p~~~~~~~~ 736 (754)
|||||+.|+.||-...+.+
T Consensus 860 il~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHHhhCCCCccCCCCCc
Confidence 9999999999997766443
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=266.47 Aligned_cols=210 Identities=27% Similarity=0.460 Sum_probs=173.6
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEe-
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE- 592 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~- 592 (754)
++.+...+.+.|++.+.||+|+||.||+|+.. +++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34455556789999999999999999999874 57889999885543 3346788999999998 69999999999863
Q ss_pred -----cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeE
Q 004416 593 -----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (754)
Q Consensus 593 -----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~k 667 (754)
....+++|||+++++|..++... ....+++..+..++.||+.|+.|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 35789999999999999888432 2345778888999999999999999987 99999999999999999999
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|+|||++....... .......|++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999988653322 1223357899999999876 345788999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=265.24 Aligned_cols=212 Identities=27% Similarity=0.379 Sum_probs=175.6
Q ss_pred cchhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEe
Q 004416 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (754)
Q Consensus 515 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 592 (754)
+...++..+.++|.+.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 444566667899999999999999999999864 57899999986532 2345678899999999 89999999999875
Q ss_pred cC-----cEEEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 593 QG-----EKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 593 ~~-----~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
.+ ..++|+||+++++|..++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 589999999999999887432 23456889999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-----VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
||+|||+++.+...... .....|+..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999999876432221 1224688899999987643 3678999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=265.81 Aligned_cols=201 Identities=27% Similarity=0.389 Sum_probs=172.9
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.+.||+|++|.||+|+.. +++.||||+++.. .....+.+.+|++++++++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999875 4789999998654 23345778999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887776552 3345789999999999999999999987 9999999999999999999999999998765443
Q ss_pred ccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. ......++..|+|||++.+. .++.++||||||+++|||++|++||...
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 22235678899999999888 7899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=265.17 Aligned_cols=192 Identities=28% Similarity=0.391 Sum_probs=158.0
Q ss_pred eeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHH---ccccceeeeEeEEEecCcEEEEEEccc
Q 004416 532 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAK---LQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~---l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
.||+|+||.||+++.. +++.+|+|.+.... ......+.+|..++.. .+||||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 57899999886432 1122334445444433 479999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|..++. ....+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999998884 3346899999999999999999999988 9999999999999999999999999997654322
Q ss_pred CcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....|++.|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 122468999999998864 568899999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=268.87 Aligned_cols=200 Identities=30% Similarity=0.424 Sum_probs=173.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|+||+||+++.. +++.||+|++.... ....+++.+|+++++.++||||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 57888999999999999999864 58889999876542 34457889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++. ....+++..+..++.+++.+|.|||+.. +++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999998873 3346889999999999999999999742 39999999999999999999999999987543221
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 223578999999999988889999999999999999999999997544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=263.35 Aligned_cols=199 Identities=27% Similarity=0.451 Sum_probs=172.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+-|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34677889999999999999764 57899999876432 33456788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|..++. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999998883 345789999999999999999999987 99999999999999999999999999977643321
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 122346788999999998888999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=260.64 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=172.7
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|++|.||++... +++.+|||++... .....+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999764 5788999988654 234467889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~~~~~ 681 (754)
+++++|.+++... ....+++..+..++.|++++++|||+++ ++|+||+|+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999988532 2345788999999999999999999987 99999999999998654 57999999998765432
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 1 222568889999999998889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=266.72 Aligned_cols=201 Identities=29% Similarity=0.445 Sum_probs=168.9
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788999999999999999865 58899999886542 22345788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+. ++|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5788777433 2356889999999999999999999987 99999999999999999999999999986643221
Q ss_pred cCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+++.|+|||++.+.. ++.++||||||+++|||+||+.||...+
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 112235688999999887644 6889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=264.60 Aligned_cols=208 Identities=27% Similarity=0.355 Sum_probs=173.5
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCc
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~ 595 (754)
.....+|..+.+||+|+||+|.++.-+. .+.+|||++++.- .+..+--+.|-++|+.. +-|.++.+..+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3445678889999999999999997654 5679999998652 22233345666677666 46788999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
+|+||||+.+|+|-..+. .-..+.+..+..++.+||-||-+||+++ ||.||||.+|||+|.+|++||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999977773 3344667778899999999999999998 9999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~~ 736 (754)
.---+ ...+++++|||.|+|||++.-++|+..+|.||+||+||||+.|++||+..++++
T Consensus 499 Eni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 499 ENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred ccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 53211 234667999999999999999999999999999999999999999999877543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=264.73 Aligned_cols=200 Identities=28% Similarity=0.415 Sum_probs=171.6
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999864 58899999987543 33456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+ +++|..++... ...+++..+..++.||+++|+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999887432 256889999999999999999999987 99999999999999999999999999987654321
Q ss_pred cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.......++..|+|||.+.+. .++.++||||+|++++||++|++||...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 122335788999999988654 4688999999999999999998887543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=311.90 Aligned_cols=191 Identities=27% Similarity=0.491 Sum_probs=162.5
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
..+...+.||+|+||.||+|+. .++..||||++...... ..+|++.+++++||||+++++++.+....++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4566778999999999999986 46889999998654321 135688999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++|+|.+++. .++|..+.+++.||++|++|||.....+|+||||||+||+++.++..++. |+.+......
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999983 27899999999999999999997655679999999999999999888875 6665443211
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 1236789999999999999999999999999999999999998543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=263.60 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=170.8
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+|++.++||+|++|.||+|+.. +++.||||+++.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999875 588999999875432 23456778999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++ +|..++........+++..+.+++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777754444456899999999999999999999987 99999999999999999999999999976543221
Q ss_pred CCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11224578899999988664 56889999999999999999999987544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=260.98 Aligned_cols=201 Identities=37% Similarity=0.563 Sum_probs=171.0
Q ss_pred cceeeeeceeccEEEEeeeecC-----cceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~-----~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
+++.+.||+|+||.||+++..+ +..||+|++...... ..+.+.+|+.++.+++|+||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998754 378999999765433 5678999999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998843221 12789999999999999999999987 999999999999999999999999999877544
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
...... ...+++.|+|||.+.+..++.++||||||++++||++ |+.||...
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222211 2347789999999988889999999999999999998 78888653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=263.33 Aligned_cols=205 Identities=29% Similarity=0.435 Sum_probs=172.5
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecC-----
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG----- 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~----- 594 (754)
.+.++|++.+.||+|++|.||+|+.. +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999875 477899999865443 346789999999999 7999999999997654
Q ss_pred -cEEEEEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999998875422 2456889999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
++........ ......+++.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9976543221 2223568899999998753 34678899999999999999999999643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=261.86 Aligned_cols=189 Identities=29% Similarity=0.484 Sum_probs=160.0
Q ss_pred eeeceeccEEEEeeeecCcc-----------eeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 531 SKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~-----------~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999875432 4788877654433 6788999999999999999999999988 788999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-------CeEEEeec
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-------NPKISDFG 672 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-------~~kL~DFG 672 (754)
|||+++++|..++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998532 226788999999999999999999987 99999999999999887 79999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9986543 1224567789999998876 78999999999999999999 56777554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=278.56 Aligned_cols=195 Identities=30% Similarity=0.460 Sum_probs=166.1
Q ss_pred eeeeeceeccEEEEeeeec-Ccceeeeeeccc----cchhhHHHHHHHHHHHHHccccceeeeEeEEEecCc--EEEEEE
Q 004416 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE--KILIYE 601 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~----~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~--~~lV~e 601 (754)
...+||+|+|-+||||... +|-+||=-.++. +.+...++|..|+.+|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3469999999999999753 466775433321 245567899999999999999999999999987665 779999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeecCccccCCC
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGD 680 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~~~~ 680 (754)
.|..|+|..|+. +.+.++...+..|++||++||.|||++. ++|||||||.+||+|+. -|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999983 4556788899999999999999999986 68999999999999975 588999999999987543
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. .....|||.|||||+.. ..|+..+||||||++++||+|+..||...
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC 246 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC 246 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh
Confidence 3 23379999999999876 88999999999999999999999998653
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=260.54 Aligned_cols=206 Identities=28% Similarity=0.450 Sum_probs=172.7
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe--cCcEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKILIY 600 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 600 (754)
+|++.+.||.|+||.||++... +++.||+|++... .....+++.+|+.++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999754 5788999988643 33445678899999999999999999998764 34678999
Q ss_pred EcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC--CCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 601 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
||+++++|..++... .....+++..+..++.||+.||+|||..+ ..+++|+||||+||++++++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999888532 23456889999999999999999999332 234999999999999999999999999999877
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
...... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||...+
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 543321 223568999999999998889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=264.30 Aligned_cols=198 Identities=24% Similarity=0.377 Sum_probs=171.5
Q ss_pred CcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
.|...+.||+|++|.||++... +++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445579999999999999864 578899999866555556678899999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998843 45788999999999999999999987 99999999999999999999999999876543221
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 122356889999999998888999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=265.71 Aligned_cols=202 Identities=26% Similarity=0.348 Sum_probs=166.3
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCc-----
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGE----- 595 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~----- 595 (754)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 58899999876542 223457788999999995 6999999999887665
Q ss_pred EEEEEEcccCCCHhhHhcCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeec
Q 004416 596 KILIYEYMVNKSLDVFLFDPTK--KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFG 672 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFG 672 (754)
.++||||+++ +|..++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777643322 346799999999999999999999987 999999999999998 8899999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9986543221 1122356788999998865 45789999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=263.08 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=171.7
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 600 (754)
++|+..+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999874 57889999987543 23457789999999999999999999988654 3689999
Q ss_pred EcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||+++++|.+++... .....+++.....++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23455788899999999999999999987 99999999999999999999999999876533
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 22 12245788999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=255.88 Aligned_cols=199 Identities=32% Similarity=0.516 Sum_probs=176.4
Q ss_pred CcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
.|.+.+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999875 588999999977655566789999999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|.+++... ...+++..+..++.|+++++.+||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999988432 246889999999999999999999977 99999999999999999999999999987654332
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23457889999999998888999999999999999999999998765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=261.82 Aligned_cols=193 Identities=26% Similarity=0.347 Sum_probs=160.9
Q ss_pred cCCcceeeee--ceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKL--GEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~L--G~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|.+.+.+ |+|+||.||+++.+ ++..+|+|.+........ |+.....+ +||||+++++.+...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3566666666 99999999999864 578899998865422211 22222222 799999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCccccC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFG 678 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~~ 678 (754)
|||+++++|..++. ....+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999884 2337899999999999999999999987 99999999999999998 99999999997654
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ...++..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 162 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 162 TPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 322 2467899999999999899999999999999999999999997544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=262.40 Aligned_cols=197 Identities=23% Similarity=0.375 Sum_probs=157.7
Q ss_pred eeceeccEEEEeeeecCcc---eeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCC
Q 004416 532 KLGEGGFGPVYKGRLLNGQ---EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~~~~---~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 607 (754)
+||+|+||.||+++..++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999754433 45677665432 3445788999999999999999999999999999999999999999
Q ss_pred HhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCc
Q 004416 608 LDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (754)
Q Consensus 608 L~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 686 (754)
|..++.... ......+..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999885432 2234566778899999999999999987 999999999999999999999999998643222211222
Q ss_pred ccccccCcccCccccCC-------CCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 004416 687 KRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILSS-KKNTGV 731 (754)
Q Consensus 687 ~~~~gt~~y~aPE~~~~-------~~~~~~~DVwSlGvll~elltg-~~p~~~ 731 (754)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 33567889999998753 2357789999999999999974 667754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=263.25 Aligned_cols=191 Identities=29% Similarity=0.399 Sum_probs=158.1
Q ss_pred eeceeccEEEEeeeec-Ccceeeeeeccccch---hhHHHHHHHHH---HHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 532 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMM---LIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~~~~Ei~---~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
.||+|+||.||+++.. +++.||+|.+..... .....+..|.. .+....||+|+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 478999998865321 11222344443 3444579999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|..++. ....+++..+..++.|+++|++|||+.+ |+||||||+||++++++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998873 3456899999999999999999999987 9999999999999999999999999997654322
Q ss_pred CcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2234789999999998754 6889999999999999999999999755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-31 Score=273.43 Aligned_cols=222 Identities=23% Similarity=0.328 Sum_probs=190.1
Q ss_pred cCCcceeeeeceeccEEEEeeeecCcc-eeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~-~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
-.+++++..||-||||.|=+++..... .+|+|++++. +....+.+..|-.+|...+.|.||+++-.|.+....|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 356677789999999999999875433 4899988765 344556678899999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||-|-+|.+-..| +.+..++...+..++..+++|++|||.++ ||.|||||+|.|++.+|-+||.|||.|+.++.
T Consensus 499 mEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999888 45566888888899999999999999988 99999999999999999999999999999865
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----------CccchhhhHHHHHh
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT-----------DSFNLLGHVSDKLY 748 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~-----------~~~~~~~~~~~~l~ 748 (754)
.. .+-+++|||.|.|||++.+..++..+|.||||+++|||++|++||...++ +...++.++...-.
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~ 649 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTAT 649 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHH
Confidence 44 45669999999999999999999999999999999999999999988764 44455555666556
Q ss_pred hhhhcC
Q 004416 749 SLLFDL 754 (754)
Q Consensus 749 ~~l~~l 754 (754)
+|+++|
T Consensus 650 ~Lik~L 655 (732)
T KOG0614|consen 650 DLIKKL 655 (732)
T ss_pred HHHHHH
Confidence 665554
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=262.70 Aligned_cols=199 Identities=30% Similarity=0.418 Sum_probs=173.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|++|.||++... +++.||+|++.... ....+++.+|++++++++||||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999876 58899999987653 34556789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
+++++|..++.... ..+++....+++.|++++++|||+ .+ ++|+||||+||++++++.++|+|||.+..+....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999884322 567888999999999999999998 76 9999999999999999999999999987654322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 1156888999999999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=265.56 Aligned_cols=200 Identities=29% Similarity=0.399 Sum_probs=169.1
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchh-----hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
+|++.+.||+|++|.||+|... +++.||||++...... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999864 5889999998754322 345677899999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+ +++|..++.... ..+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999884322 36889999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ......+++.|+|||.+.+ ..++.++||||||+++|||++|.+||....
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 321 1122356788999998865 457899999999999999999988776433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=263.88 Aligned_cols=205 Identities=27% Similarity=0.415 Sum_probs=178.0
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
....+.|++.+.||+|++|.||+|... +++.||+|++..... ..+.+.+|++++++++|+|++++++.+......++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 345677888999999999999999876 588999999876544 567788999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
+||+++++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 99999999999984322 37899999999999999999999987 99999999999999999999999999876543
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 169 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 169 EKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred chh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1223457889999999998889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=262.11 Aligned_cols=199 Identities=26% Similarity=0.471 Sum_probs=171.6
Q ss_pred CcceeeeeceeccEEEEeeee-cCcceeeeeecccc-chhhHHHHHHHHHHHHHcc---ccceeeeEeEEEecCcEEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.|++.+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999986 45889999998654 3345567889999999997 999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ...+++..+..++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999998873 236889999999999999999999987 999999999999999999999999999877543
Q ss_pred cccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 1223568899999998865 456889999999999999999999996543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=277.50 Aligned_cols=224 Identities=29% Similarity=0.408 Sum_probs=185.7
Q ss_pred cCCcceeeeeceeccEEEEeeeecC--cc--eeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~--~~--~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.++..+.++||+|.||+|++|.+.. |+ .||||.+...... ....|.+|+.+|.+|+|||++||+|+..+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3556677899999999999998753 43 5899999876544 67899999999999999999999999876 77889
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
|+|.++.|+|.+.|+. ..+..+-......++.|||.||.||..++ +|||||..+|+||-....+||+||||.+-++
T Consensus 188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 9999999999999976 45566778888999999999999999987 9999999999999999999999999999887
Q ss_pred CCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC----------CccchhhhHHHH
Q 004416 679 GDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNT----------DSFNLLGHVSDK 746 (754)
Q Consensus 679 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~~----------~~~~~~~~~~~~ 746 (754)
..+. ........-...|.|||.+....++.++|||+|||.||||+| |..||..... +...-++...+.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csed 343 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSED 343 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHH
Confidence 6442 222222344678999999999999999999999999999999 6678866442 222344566777
Q ss_pred Hhhhhh
Q 004416 747 LYSLLF 752 (754)
Q Consensus 747 l~~~l~ 752 (754)
|++++.
T Consensus 344 IY~imk 349 (1039)
T KOG0199|consen 344 IYQIMK 349 (1039)
T ss_pred HHHHHH
Confidence 777654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=264.52 Aligned_cols=198 Identities=32% Similarity=0.485 Sum_probs=167.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..+.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+++.+|++++++++||||+++.+++......++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3466899999999999999999865 58899999886432 2344678899999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
|+||++ +++..++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 466555532 2345889999999999999999999987 9999999999999999999999999987653
Q ss_pred CCcccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. ....+++.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 22 2246788999999874 456888999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=261.24 Aligned_cols=204 Identities=29% Similarity=0.474 Sum_probs=167.0
Q ss_pred cceeeeeceeccEEEEeeeec----Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC------
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 594 (754)
|.+.++||+|+||.||+|... .++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3678999988654 3345677899999999999999999999886532
Q ss_pred cEEEEEEcccCCCHhhHhcCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 595 EKILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
..++++||+++++|..++... .....+++....+++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998876432 12235788899999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|+++.+.............+++.|++||.+....++.++||||||+++|||++ |++||...+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 99987644332222222455678999999998889999999999999999999 888886543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=253.06 Aligned_cols=205 Identities=26% Similarity=0.385 Sum_probs=168.5
Q ss_pred CCcceeeeeceeccEEEEeeeec---C--cceeeeeeccccchh--hHHHHHHHHHHHHHccccceeeeEeEEEe-cCcE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL---N--GQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~---~--~~~vAVK~l~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~ 596 (754)
..|++...||+|.+|.||+|.-+ + .+++|||+++..... ......+|+.++++++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 56888899999999999999532 2 347999999765321 22456789999999999999999999887 7788
Q ss_pred EEEEEcccCCCHhhHhc--CCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC----CCeEEEe
Q 004416 597 ILIYEYMVNKSLDVFLF--DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISD 670 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~----~~~kL~D 670 (754)
++++||.+. +|-.+++ ...+.+.++......|+.||+.|+.|||++= |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 5555553 2234467888999999999999999999875 9999999999999766 8999999
Q ss_pred ecCccccCCCcccC-CcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 671 FGMARMFGGDELQG-NTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 671 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
||+|+.+...-..- ....++-|.-|.|||.+.+.. ||.+.||||.|||+.||+|-++-|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999986643221 334467799999999988754 7899999999999999999999987765
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=262.51 Aligned_cols=204 Identities=20% Similarity=0.265 Sum_probs=153.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCc----ceeeeeeccccchhhH-----------HHHHHHHHHHHHccccceeeeE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLL 587 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~----~~vAVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~nIv~l~ 587 (754)
..++|.+.++||+|+||.||+|+..++ ..+|+|+......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 447899999999999999999986543 4566665432221110 0112233345566899999999
Q ss_pred eEEEecC----cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC
Q 004416 588 GCCIEQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (754)
Q Consensus 588 ~~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~ 663 (754)
+.+.... ..++++|++.. ++...+. .....++..+..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 8766543 34677777643 4555442 2223467778899999999999999987 9999999999999999
Q ss_pred CCeEEEeecCccccCCCcc-----cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 664 MNPKISDFGMARMFGGDEL-----QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 664 ~~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.++|+|||+|+.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999987643211 111223479999999999999999999999999999999999999998763
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=264.64 Aligned_cols=193 Identities=25% Similarity=0.386 Sum_probs=169.0
Q ss_pred eeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHh
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 609 (754)
.+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999874 58899999986555555677899999999999999999999999999999999999999999
Q ss_pred hHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccc
Q 004416 610 VFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689 (754)
Q Consensus 610 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 689 (754)
.++. ...+++.....++.|++.+++|||+.+ ++|+||+|+||++++++.++|+|||++..+..... .....
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 8773 235788899999999999999999987 99999999999999999999999999876643321 12235
Q ss_pred cccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 690 ~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.+++.|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6889999999998888999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=255.31 Aligned_cols=199 Identities=33% Similarity=0.470 Sum_probs=174.6
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|++|.||+++.. +++.||+|.+..... ...+.+.+|++++++++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578999999876543 4567899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++++|.+++. ....+++..+..++.|++.++.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999883 3356889999999999999999999987 99999999999999999999999999987754332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. .....++..|+|||.+.+..++.++||||+|+++++|++|+.||...
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 1 22356888999999998888899999999999999999999998643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=263.19 Aligned_cols=203 Identities=30% Similarity=0.425 Sum_probs=175.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 599 (754)
++|.+.+.||+|++|.||+++.. +++.||+|++... .....+.+.+|++++.+++ ||||+++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999865 6889999998653 2233467889999999998 99999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|..++. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999884 3346899999999999999999999987 99999999999999999999999999987654
Q ss_pred Cccc------------------CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQ------------------GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... .......++..|+|||++....++.++||||||+++++|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3321 22233567899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=262.09 Aligned_cols=199 Identities=29% Similarity=0.445 Sum_probs=166.8
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
|++.+.||.|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++.++...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 68899999986542 223456888999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
+ ++|..++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888874322 235889999999999999999999987 99999999999999999999999999976543221
Q ss_pred CCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223568899999987654 5788999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=262.73 Aligned_cols=203 Identities=31% Similarity=0.445 Sum_probs=171.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-----Ccceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEe--cCcE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-----~~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~ 596 (754)
+.|++.+.||+|+||.||++++. .++.||||+++..... ..+.+.+|++++++++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999853 3678999998765443 56789999999999999999999999877 5578
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|..++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998432 235889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 753221 11111234456799999998889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=268.65 Aligned_cols=201 Identities=27% Similarity=0.413 Sum_probs=167.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----cE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~ 596 (754)
.++|++.++||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999864 5889999998643 2334566788999999999999999998876543 57
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++|+||+++ +|...+ ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 776666 3346889999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
....... .......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6432211 12223568899999998754 56889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=257.30 Aligned_cols=196 Identities=33% Similarity=0.505 Sum_probs=166.8
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
++|++.+.||+|+||.||++.. .++.||+|+++... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999975 67889999986532 346788999999999999999999998654 5799999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|..++... ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999988543 2345788899999999999999999987 9999999999999999999999999997643211
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 11234568999999988899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=260.41 Aligned_cols=195 Identities=27% Similarity=0.376 Sum_probs=167.7
Q ss_pred eceeccEEEEeeeecC-cceeeeeeccccch---hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
||+|+||.||+++... ++.+|+|++..... ...+.+.+|++++++++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998764 88999999865433 4566789999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc------
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL------ 682 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~------ 682 (754)
..++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 998843 236889999999999999999999987 99999999999999999999999999876533211
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
........++..|+|||.+.....+.++||||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112223567889999999988889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=269.23 Aligned_cols=198 Identities=28% Similarity=0.352 Sum_probs=167.6
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec------C
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------G 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~ 594 (754)
.++|++.+.||+|+||.||+++.. +++.||||++... .....+++.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 478999999999999999999864 5889999998643 233456678899999999999999999988643 3
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+.+ +|...+.. .++...+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 57999999965 77766621 2788888999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+....... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 87644321 222467889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=258.88 Aligned_cols=202 Identities=26% Similarity=0.437 Sum_probs=169.9
Q ss_pred CcceeeeeceeccEEEEeeeecC--cceeeeeecccc----------chhhHHHHHHHHHHHHH-ccccceeeeEeEEEe
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCIE 592 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~--~~~vAVK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~ 592 (754)
.|++.+.||+|+||.||+|+... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998765 678999987532 22234567788888875 799999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
++..++||||+++++|.+++... .....+++..+..++.|++.+|.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998877432 23456888999999999999999999632 3999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9998764433 223356889999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=262.07 Aligned_cols=200 Identities=28% Similarity=0.396 Sum_probs=168.3
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV 599 (754)
++|++.+.||+|++|.||+|+.. +++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999875 478899999865422 2234567899999999999999999998877 889999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
+||+++ +|..++.. ....+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 88777743 2236889999999999999999999987 99999999999999999999999999987654
Q ss_pred CcccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... ......+++.|+|||.+.+.. ++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 122245788999999887644 688999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=264.11 Aligned_cols=210 Identities=31% Similarity=0.426 Sum_probs=174.9
Q ss_pred hccccCCcceeeeeceeccEEEEeee-ecCcceeeeeecccc-------chhhHHHHHHHHHHHHHccccceeeeEeEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~-------~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 591 (754)
-....++|-++++||+|||+.||++- +...+.||||+-... ...-.+...+|..+-+.+.||.||++++++.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 33445779999999999999999996 445788999975322 1122345678999999999999999999987
Q ss_pred ec-CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeE
Q 004416 592 EQ-GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPK 667 (754)
Q Consensus 592 ~~-~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~k 667 (754)
-+ +.++-|+||+++.+|+.+| ...+.+++.+++.|+.||+.||.||.+.. ++|||-||||.|||+.+ -|.+|
T Consensus 538 lDtdsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eccccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeE
Confidence 54 5788999999999999999 45677999999999999999999999874 78999999999999964 47799
Q ss_pred EEeecCccccCCCcccC-----CcccccccCcccCccccCCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQG-----NTKRIVGTYGYMSPEYALEG----VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+|||+++.+..+.... .+....||..|++||.+.-+ +++.|+||||.|||+|+.+.|++||+..-
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 99999999997765432 24447899999999987643 47889999999999999999999998743
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=259.32 Aligned_cols=196 Identities=27% Similarity=0.373 Sum_probs=162.0
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEec--CcEEEEEE
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ--GEKILIYE 601 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~e 601 (754)
|++.++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567899999999999999864 58899999987542 222233457888999885 99999999999987 88999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++ ++...+.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++.+....
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 67666632 2346889999999999999999999987 999999999999999 999999999998764332
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. .....+++.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 1 122457889999997654 55788999999999999999999999654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=256.55 Aligned_cols=191 Identities=26% Similarity=0.340 Sum_probs=160.7
Q ss_pred eeeceeccEEEEeeeec-Ccceeeeeeccccch---hhHHHHHHHHHHH-HHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLI-AKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+|++|.||+|+.. +++.||||++..... .....+..|..++ ...+|+|++++++.+..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 578999999865432 2223344555444 445899999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|..++. ....+++..+.+++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999883 3345788999999999999999999987 99999999999999999999999999876432
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....+++.|+|||.+.+..++.++||||||+++|||++|..||...+
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 223467889999999988888999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=230.39 Aligned_cols=110 Identities=52% Similarity=0.793 Sum_probs=83.2
Q ss_pred CCeeEEeccCCCCCcCC--CceEEEeccCcEEEecCCCCeEEEe-cccCCc-cCceEEEecCCCEEEecCCCCCCccccc
Q 004416 86 PDTVVWVANRNSPIVDK--NGVLTVSNRGNLVLLNQSNGTIWSS-NVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYL 161 (754)
Q Consensus 86 ~~~~vW~an~~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~wst-~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~ 161 (754)
++||||+|||+.|+.+. .++|.|+.||||+|++..++++|++ ++.+.+ ..+.|.|+|+|||||++. .+.+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-----~~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-----SGNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-----TSEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-----cceEE
Confidence 46999999999999553 5899999999999999999999999 666554 678899999999999996 56899
Q ss_pred ccccCCCccccccccccccccccCCcceEEeecCCCCCC
Q 004416 162 WQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPS 200 (754)
Q Consensus 162 WqSFd~PtDtlLpg~kl~~~~~tg~~~~l~Sw~s~~dps 200 (754)
||||||||||+||+|+|+.+..++....++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888888899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=257.97 Aligned_cols=201 Identities=28% Similarity=0.417 Sum_probs=165.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999865 58899999886542 2334678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeecCccccCCC
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGD 680 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~~~~ 680 (754)
|+++ +|..++... ....+++..+..++.||+.||+|||+++ ++|+||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 676665322 2233577888899999999999999987 999999999999985 557999999999765432
Q ss_pred cccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||...
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 1122457889999998866 45789999999999999999999999653
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=261.72 Aligned_cols=201 Identities=29% Similarity=0.421 Sum_probs=166.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 598 (754)
.++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999865 588999999864322 2233567899999999999999999998765 46899
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++ +|..++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++..+.
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 777776432 356889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|++||...
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 43211 112345788999998865 45789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=257.03 Aligned_cols=200 Identities=30% Similarity=0.443 Sum_probs=168.6
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEEEEEE
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKILIYE 601 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~lV~e 601 (754)
|++.+.||+|++|.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 577899999999999999875 47899999997653 33446788999999999999999999999888 79999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 787777432 246889999999999999999999987 9999999999999999999999999998775443
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1222456788999998765 457899999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=259.53 Aligned_cols=199 Identities=29% Similarity=0.388 Sum_probs=168.2
Q ss_pred CcceeeeeceeccEEEEeeee----cCcceeeeeeccccc----hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 596 (754)
+|++.+.||+|++|.||+++. .+++.||||.++... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999974 246789999886432 22345688999999999 599999999999989999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|..++. ....+++..+..++.|++++|+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999998874 3345788899999999999999999987 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
+...... ......|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 6443211 122346889999999987655 78899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=253.98 Aligned_cols=202 Identities=27% Similarity=0.441 Sum_probs=172.2
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788999999999999999875 47889999986532 23456788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC-eEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-~kL~DFGla~~~~~~~ 681 (754)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988532 2335789999999999999999999987 999999999999998864 6999999998765432
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......|++.|+|||++.+..++.++||||||++++||++|+.||...+
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1 1122468899999999988889999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=251.78 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=176.9
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|++|.||++... +++.||+|++..... ...+++.+|++++++++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999875 588999999876532 4567789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
+++++|..++.... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885431 2467899999999999999999999987 9999999999999999999999999998765443
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......|++.|+|||.+.+..++.++||||+|+++++|++|+.||...+
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 1 2233568899999999988889999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=265.97 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=167.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec-----Cc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 595 (754)
..+|.+.+.||+|+||.||+++.. +++.||||++... ......++.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 367999999999999999999864 5889999988653 233345678899999999999999999987644 24
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++|+||+. ++|..++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 57877773 3356889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 764432 11223467889999998765 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.34 Aligned_cols=201 Identities=30% Similarity=0.443 Sum_probs=174.2
Q ss_pred CcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|++.+.||+|++|.||+++.. +++.+|+|.+... ......++.+|+.++++++|+||+++++.+.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788999999999999999754 5789999998653 233456778899999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
+++++|..++... .....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999887442 22356888999999999999999999987 9999999999999999999999999998765431
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....+++.|+|||.+.+..++.++|+||||++++||++|+.||...+
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222467889999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=246.38 Aligned_cols=203 Identities=24% Similarity=0.383 Sum_probs=176.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 597 (754)
.-.+|.++++||+|++++|..++++ +.+.+|+|++++. ....++-.+.|-.+..+. +||.+|.+..+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478999999999999999999875 4788999998764 333455667787777776 7999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|.||+++|+|-.+. .+.+.++++.++.+..+|.-||.|||+++ ||.||||.+|+|+|..|++||+|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999985444 56677899999999999999999999999 999999999999999999999999999853
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
-.+ ...+.+++|||.|+|||++.+..|....|.|+|||+++||+.|+.||....
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 222 224567999999999999999999999999999999999999999996643
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=259.81 Aligned_cols=203 Identities=27% Similarity=0.410 Sum_probs=165.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecC-------
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------- 594 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------- 594 (754)
++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 67999999999999999999865 58899999886432 222345678999999999999999999987654
Q ss_pred -cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++||||+.+ +|...+.. ....+++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 34999999975 67666632 2235789999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCccc--CCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9876433211 112234578899999988664 46889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=284.06 Aligned_cols=197 Identities=32% Similarity=0.491 Sum_probs=157.9
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEec-------
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------- 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------- 593 (754)
-..+|+.++.||+||||.|||++.+ ||+.||||++... +......+.+|+..+++|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467888999999999999999865 7999999999765 334456688999999999999999998543210
Q ss_pred --------------------------------------------------------------------------------
Q 004416 594 -------------------------------------------------------------------------------- 593 (754)
Q Consensus 594 -------------------------------------------------------------------------------- 593 (754)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHH
Q 004416 594 --------------------------------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641 (754)
Q Consensus 594 --------------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH 641 (754)
..+||-||||+...+..++.+..... .....++++.+|+.||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 11367788888888877774322211 46778899999999999999
Q ss_pred hcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC----C------------CcccCCcccccccCcccCccccCCCC
Q 004416 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG----G------------DELQGNTKRIVGTYGYMSPEYALEGV 705 (754)
Q Consensus 642 ~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~~ 705 (754)
+++ ||||||||.||+++++..|||+|||+|.... . ..........+||.-|+|||++.+..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998732 0 00111223468999999999987654
Q ss_pred ---CCchhhHHHHHHHHHHHHc
Q 004416 706 ---FSVKSDVFSFGVLMLEILS 724 (754)
Q Consensus 706 ---~~~~~DVwSlGvll~ellt 724 (754)
|+.|+|+|||||+|+||+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc
Confidence 9999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=265.01 Aligned_cols=201 Identities=29% Similarity=0.436 Sum_probs=167.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHc-cccceeeeEeEEEec--CcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ--GEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~--~~~~ 597 (754)
.++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 478999999999999999999865 5789999988542 233445677899999999 999999999988654 3679
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 488887732 26788888999999999999999987 999999999999999999999999999876
Q ss_pred CCCccc---CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 678 GGDELQ---GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 443221 12233568999999998765 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=258.44 Aligned_cols=201 Identities=26% Similarity=0.410 Sum_probs=165.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc-hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 599 (754)
..++|++.+.||+|++|.||+|+..+ ++.||||+++... .....++..|+.++.+.. ||||+++++++.++...++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678999999999999999999765 8899999986542 233455667887777775 99999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++ ++..++.. ....+++..+..++.||++||+|||+.. +|+||||+|+||++++++.+||+|||++..+..
T Consensus 93 ~e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999854 66665532 2236888999999999999999999742 399999999999999999999999999987643
Q ss_pred CcccCCcccccccCcccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.... ....+++.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2211 2235788999999987554 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=262.43 Aligned_cols=202 Identities=29% Similarity=0.396 Sum_probs=168.4
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec-
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ- 593 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~- 593 (754)
.++...+++|.+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 34555678999999999999999999975 46889999998653 223346678899999999999999999987643
Q ss_pred -----CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 594 -----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 594 -----~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
...+++++++ +++|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888876 778887763 235889999999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+|||+++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999764322 223467889999998866 56788999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=258.93 Aligned_cols=202 Identities=29% Similarity=0.411 Sum_probs=165.3
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|...+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999865 47899999986542 334567889999999996 9999999999999999999999
Q ss_pred cccCCCHhhHhcC--CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 602 YMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 602 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|+.. ++..+... ......+++..+..++.|+++||+|||+.. +++||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 54443211 122356889999999999999999999752 399999999999999999999999999986643
Q ss_pred CcccCCcccccccCcccCccccCCC---CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEG---VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
... .....|++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 221 1224678899999998776 6889999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=254.40 Aligned_cols=198 Identities=30% Similarity=0.460 Sum_probs=165.4
Q ss_pred cceeeeeceeccEEEEeeeecC-cceeeeeeccccch--hhHHHHHHHHHHHHHc---cccceeeeEeEEEecCc-----
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQGE----- 595 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~~~----- 595 (754)
|++.+.||+|+||.||+|+... ++.||+|+++.... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5778999999999999999764 88999999864322 2234566788877766 59999999999988776
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.+++|||+.+ +|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 787777432 2235889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.+..... .....++..|+|||++.+..++.++||||||+++|||++|++||...
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~ 209 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT 209 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC
Confidence 7644321 12245788999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=258.38 Aligned_cols=196 Identities=33% Similarity=0.502 Sum_probs=166.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..|...+.||+|+||.||+++.. ++..||+|++... .....+.+.+|+.++++++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45888899999999999999864 5789999998643 2234457889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++ ++.+.+.. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 66665532 2345889999999999999999999987 999999999999999999999999998754322
Q ss_pred cccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
....+++.|+|||++. .+.++.++||||||+++|||++|+.||...
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 2346888999999874 456889999999999999999999998553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=258.34 Aligned_cols=203 Identities=29% Similarity=0.441 Sum_probs=167.2
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecC----
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG---- 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 594 (754)
...++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999875 47899999986542 223356788999999999999999999987654
Q ss_pred ------cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 595 ------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 595 ------~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 56555532 2346889999999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
+|||++..+...... ......++..|+|||.+.+ ..++.++||||||++++||++|++||..
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999876443211 1122346778999998765 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=245.94 Aligned_cols=197 Identities=25% Similarity=0.308 Sum_probs=165.0
Q ss_pred ccCCccee-eeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEe----cCc
Q 004416 523 ATENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE----QGE 595 (754)
Q Consensus 523 ~~~~y~i~-~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~----~~~ 595 (754)
.+++|++. ++||-|-.|+|..+.++ +++.+|+|++... ....+|+++--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45677765 68999999999999765 5889999998643 2336788776665 69999999998764 346
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeec
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFG 672 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFG 672 (754)
+.+|||.|++|.|...+.+ .....+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999888743 34556899999999999999999999987 999999999999964 5569999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.|+.-.. .....+.+-||.|.|||++...+|+...|+||+||++|-|++|-+||-.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 9987433 3344557889999999999999999999999999999999999999844
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-28 Score=261.85 Aligned_cols=197 Identities=27% Similarity=0.393 Sum_probs=166.9
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 594 (754)
..++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999754 5889999998543 2233456889999999999999999999887543
Q ss_pred -cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999999 678887763 345889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+....... ....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98653321 23467889999998876 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=256.32 Aligned_cols=199 Identities=31% Similarity=0.467 Sum_probs=169.1
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
|++.+.||+|++|.||+++.. +++.+++|++..... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999864 588899999865432 24567889999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++ ++..++.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 77777633 2256889999999999999999999987 9999999999999999999999999998775543
Q ss_pred CCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112224578889999998876 78999999999999999999999986533
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=264.15 Aligned_cols=202 Identities=23% Similarity=0.365 Sum_probs=168.3
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEe----cCcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~ 596 (754)
.++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999864 58899999987542 2345677889999999999999999988753 3467
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++|+||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888773 3445899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc--CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQ--GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 6433211 11123578899999998765 45789999999999999999999999553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=258.85 Aligned_cols=199 Identities=30% Similarity=0.428 Sum_probs=167.5
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe-cCcE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEK 596 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~ 596 (754)
...+++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446788999999999999999999854 6889999987542 22345678899999999999999999999876 4578
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++|+||+ +++|..++. ...+++.....++.|+++||+|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 558887773 345678888899999999999999987 99999999999999999999999999975
Q ss_pred cCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 122467889999998765 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-29 Score=232.46 Aligned_cols=210 Identities=28% Similarity=0.387 Sum_probs=171.6
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 596 (754)
.+...+.......||+|++|.|-+-++. +|+..|+|++... ..+..++..+|+.+..+. ..|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4445566666789999999999998864 5889999998765 344556777888877665 689999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 597 ILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
++.||.|. .+|+.+-... .+...+++...-+|+..+.+||.|||++- .+||||+||.|||++.+|++|++|||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 4777664332 45667888889999999999999999954 69999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALE----GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DVwSlGvll~elltg~~p~~~~~~~ 735 (754)
.+...-. .....|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++....+
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 7644321 112467789999998754 36889999999999999999999999876544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=249.63 Aligned_cols=193 Identities=30% Similarity=0.398 Sum_probs=167.7
Q ss_pred eceeccEEEEeeeec-Ccceeeeeeccccch---hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 533 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
||+|+||.||++... +++.+|+|++..... ...+.+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999865432 2456789999999999999999999999999999999999999999
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCccc
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 688 (754)
.+++. ....+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLS---KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 99884 2335889999999999999999999977 9999999999999999999999999998764432 12233
Q ss_pred ccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 689 IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 689 ~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..++..|+|||...+...+.++|+||||+++|||++|+.||...+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 567889999999988889999999999999999999999996554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=255.31 Aligned_cols=194 Identities=33% Similarity=0.486 Sum_probs=163.7
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
|...++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666788999999999999864 57899999986432 23446788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+.+ ++..++.. ....+++..+..++.||+.++.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 964 66665532 2345889999999999999999999987 99999999999999999999999999864322
Q ss_pred cCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22357888999999974 456888999999999999999999998553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=258.68 Aligned_cols=203 Identities=30% Similarity=0.451 Sum_probs=164.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecC------
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 594 (754)
.++|++.++||+|++|.||+|+.. +++.+|||++..... .....+.+|++++++++||||+++++.+.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 578999998864322 22345678999999999999999998875443
Q ss_pred --cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 595 --EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 595 --~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
..++|+||+.. ++...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 56555532 2346899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccC---------CcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 673 MARMFGGDELQG---------NTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 673 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~ 230 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence 998764322111 11224568889999987654 5789999999999999999999998643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=258.48 Aligned_cols=201 Identities=29% Similarity=0.398 Sum_probs=164.6
Q ss_pred CcceeeeeceeccEEEEeeeec-C--cceeeeeecccc--chhhHHHHHHHHHHHHHc-cccceeeeEeEEEec----Cc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-N--GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQ----GE 595 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~--~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~----~~ 595 (754)
+|.+.+.||+|+||.||+++.. . +..||+|++... .....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999864 3 678999988643 222356778899999999 599999999876433 35
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++++||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 788899886 57888773 3456889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc--CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQ--GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+...... .......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 76533221 11233578999999998765 568899999999999999999999987543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=260.01 Aligned_cols=202 Identities=27% Similarity=0.367 Sum_probs=165.8
Q ss_pred CCcce-eeeeceeccEEEEeeeec-Ccceeeeeeccccchhh--------------HHHHHHHHHHHHHccccceeeeEe
Q 004416 525 ENFSI-QSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLLG 588 (754)
Q Consensus 525 ~~y~i-~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~nIv~l~~ 588 (754)
++|.. .+.||+|+||.||+|+.. +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56654 477999999999999865 58899999886432211 124778999999999999999999
Q ss_pred EEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 589 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
++..+...++||||+. ++|..++. ....+++.....++.|+++||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 58888773 3445889999999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcc------------cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 669 SDFGMARMFGGDEL------------QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+|||+++....... ........+++.|+|||++.+. .++.++||||||+++|||++|+.||...+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999987652110 0111123467889999998764 46899999999999999999999987543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=253.82 Aligned_cols=198 Identities=29% Similarity=0.408 Sum_probs=165.7
Q ss_pred cceeeeeceeccEEEEeeeecC-cceeeeeeccccch-hhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEEcc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
|++.+.||+|++|.||+|+..+ ++.||||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678899999999999998754 78899999865422 22234567999999999 999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
+++|...+.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 778887774322 346789999999999999999999987 99999999999999999999999999987643221
Q ss_pred CCcccccccCcccCccccC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....++..|+|||++. ...++.++|+||||++++||++|++||...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 12246788999999875 455789999999999999999999998544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-29 Score=240.91 Aligned_cols=201 Identities=25% Similarity=0.408 Sum_probs=164.7
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeecccc-chhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++.+.+..||.|..|.|++.+.+. |..+|||.+... +....+++...+.++.+-+ .|.||+.+|+|..+...++-||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 344566789999999999999764 789999998765 4445677777777776664 8999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
.|.. .++.++. ...+++++.-+-++...+..||.||.+++ .|||||+||+|||+|+.|++||+|||++-++-...
T Consensus 172 lMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 9854 3444442 23455788888889999999999999865 69999999999999999999999999997764433
Q ss_pred ccCCcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......|-+.|||||-+.. ..|+.++||||||+.|+||.||+.||+..+
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 2233678999999998864 458889999999999999999999998743
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=260.67 Aligned_cols=201 Identities=30% Similarity=0.423 Sum_probs=171.2
Q ss_pred CcceeeeeceeccEEEEeeeecC-cceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----cEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKI 597 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~ 597 (754)
+|++.+.||+|++|.||+|+... ++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57889999999999999998754 8899999987543 344567899999999999999999999988765 789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++ +|..++. ....+++..+..++.||+.||+|||+.+ |+|+||||+|||+++++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7877773 3347889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcc-cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDEL-QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ........+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 54321 0112334678899999999887 78999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=259.82 Aligned_cols=196 Identities=30% Similarity=0.435 Sum_probs=164.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC------
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------ 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------ 594 (754)
..+|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468999999999999999999864 5889999998643 2223456789999999999999999999987543
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 666554 235788899999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765322 123467889999999876 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=261.38 Aligned_cols=197 Identities=24% Similarity=0.338 Sum_probs=168.4
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccch--------hhHHHHHHHHHHHHHcc---ccceeeeEeEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQ---HRNLVRLLGCCI 591 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~ 591 (754)
..+|..++.+|+|+||.|+.+.++. ..+|+||.+.+..- ...-.+-.||.||..++ |+||++++.+|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3468999999999999999998865 66899998865421 11122457999999997 999999999999
Q ss_pred ecCcEEEEEEccc-CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEe
Q 004416 592 EQGEKILIYEYMV-NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (754)
Q Consensus 592 ~~~~~~lV~ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~D 670 (754)
+++.+||+||-.. +-+|.+++ +.+..+++.++.-|+.|++-|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999999885 44666666 56677999999999999999999999999 99999999999999999999999
Q ss_pred ecCccccCCCcccCCcccccccCcccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCC
Q 004416 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS-VKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGvll~elltg~~p~~ 730 (754)
||.|....... ...++||..|.|||++.+.+|- ..-|||++|++||.++....||-
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998765433 4458999999999999999884 56899999999999999888863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=264.88 Aligned_cols=210 Identities=26% Similarity=0.452 Sum_probs=180.6
Q ss_pred cchhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEe
Q 004416 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (754)
Q Consensus 515 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 592 (754)
..++.+...++.|++.++||+|.+|.||+++.+ +++..|||++.... ...++++.|.++++.. .|||+++++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 445666778899999999999999999999864 58889999886543 3446778899999988 69999999999874
Q ss_pred -----cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeE
Q 004416 593 -----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (754)
Q Consensus 593 -----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~k 667 (754)
+++++||||||.+|+.-+++.... ...+.|..+..|+..+++|+.+||... ++|||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 468999999999999999886555 777999999999999999999999876 99999999999999999999
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
|.|||.+..+... .....+..|||.|||||++.. ..|+.++|+||||++..||--|.+|+-.
T Consensus 164 LvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 164 LVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred Eeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 9999999877543 344556899999999999864 3477899999999999999999999744
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=260.93 Aligned_cols=201 Identities=25% Similarity=0.358 Sum_probs=165.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec---------
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--------- 593 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--------- 593 (754)
..+|.+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999864 5889999998766656667889999999999999999998776543
Q ss_pred -----CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeE
Q 004416 594 -----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPK 667 (754)
Q Consensus 594 -----~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~k 667 (754)
...++|+||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. +..+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 48877762 335788999999999999999999987 999999999999974 56789
Q ss_pred EEeecCccccCCCccc-CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 668 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999876432211 11122357889999998654 56788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=246.65 Aligned_cols=202 Identities=21% Similarity=0.185 Sum_probs=163.0
Q ss_pred eccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHhhHhcC
Q 004416 536 GGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614 (754)
Q Consensus 536 G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~ 614 (754)
|.+|.||+++.. +++.||+|++.... .+.+|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999864 57899999986543 233455555666799999999999999999999999999999888742
Q ss_pred CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCc
Q 004416 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694 (754)
Q Consensus 615 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (754)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+..+.... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 335889999999999999999999987 9999999999999999999999999887654321 22345778
Q ss_pred ccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----CccchhhhHHHHHhhhhhc
Q 004416 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT-----DSFNLLGHVSDKLYSLLFD 753 (754)
Q Consensus 695 y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~-----~~~~~~~~~~~~l~~~l~~ 753 (754)
|+|||.+.+..++.++||||+|+++|||++|+.|+..... .....+.++...++++|.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 211 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHH
Confidence 9999999888899999999999999999999988654331 1122344555556666554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=256.01 Aligned_cols=199 Identities=23% Similarity=0.235 Sum_probs=163.2
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCC
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.+.+|.|+++.|++++. +++.||||++... .....+.+.+|++++++++|+||+++++++.+....+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 444556666666666655 6889999998654 3445678999999999999999999999999999999999999999
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc----
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---- 682 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~---- 682 (754)
+|..++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999885332 235788888999999999999999987 99999999999999999999999999876533211
Q ss_pred -cCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 -QGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 -~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
........++..|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 111223457788999999876 35788999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=261.34 Aligned_cols=216 Identities=25% Similarity=0.329 Sum_probs=176.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.++.|.+...+|.|+|+.|-++.+. +++..+||++.+... +..+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678888899999999999999764 588999999976522 234577666655 7999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE-cCCCCeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL-DQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl-~~~~~~kL~DFGla~~~~~ 679 (754)
|.+.++-+...+. ..+... .++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++...+
T Consensus 396 e~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999887766662 222233 677789999999999999988 9999999999999 5899999999999987655
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-----ccchh---hhHHHHHhhhh
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-----SFNLL---GHVSDKLYSLL 751 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~-----~~~~~---~~~~~~l~~~l 751 (754)
. ..+.+-|..|.|||++....++.++|+||||++||+||+|+.||.....+ ....+ ..+++..+|+|
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLL 543 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHH
Confidence 4 22346788999999999999999999999999999999999999887654 11122 55677777776
Q ss_pred hcC
Q 004416 752 FDL 754 (754)
Q Consensus 752 ~~l 754 (754)
..|
T Consensus 544 ~~L 546 (612)
T KOG0603|consen 544 QQL 546 (612)
T ss_pred HHh
Confidence 554
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=256.68 Aligned_cols=198 Identities=24% Similarity=0.299 Sum_probs=161.9
Q ss_pred eeecee--ccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G--~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.||+| +||+||+++.. +++.||||++... .....+.+++|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 99999999864 6899999998643 233457889999999999999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc--
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ-- 683 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-- 683 (754)
+++..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998875432 234788889999999999999999987 999999999999999999999999865443221110
Q ss_pred ---CCcccccccCcccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 684 ---GNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 684 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 011112356679999998764 4788999999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=249.21 Aligned_cols=200 Identities=30% Similarity=0.410 Sum_probs=165.8
Q ss_pred CcceeeeeceeccEEEEeeeecC-cceeeeeecccc-----chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
+|.+.+.||+|+||.||+++... +..+++|.++.. ......++.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998643 445666655431 122334567899999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 600 YEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
+||+++++|..++... .....+++..+..++.|+++|+.|||+.+ ++|+||||+||++++ +.++|+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887432 23456899999999999999999999987 999999999999976 569999999998764
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4322 12235678899999999888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=223.11 Aligned_cols=200 Identities=26% Similarity=0.392 Sum_probs=164.6
Q ss_pred CcceeeeeceeccEEEEeeeecC-cceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+|.-.++||+|.+|+||+|+.++ ++.||+|+..-. ++..-....+|+-++++++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566899999999999998654 778999987644 233345678999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+.. +|..+.. .-++.++.+.+..++.|+++||.++|+++ +.|||+||+|.||+.+|++||+|||+|+-++-+..
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 6666552 34456888899999999999999999987 99999999999999999999999999998765432
Q ss_pred cCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcC-CCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSS-KKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg-~~p~~~~~ 733 (754)
.. ...+-|..|.+|.++.+.+ |+...|+||-||++.|+... ++.|+..+
T Consensus 157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 11 1235688999999988765 78899999999999999874 44465543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=263.70 Aligned_cols=204 Identities=22% Similarity=0.308 Sum_probs=153.8
Q ss_pred ccCCcceeeeeceeccEEEEeeee-----------------cCcceeeeeeccccchhhHH--------------HHHHH
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLK--------------EFKNE 571 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-----------------~~~~~vAVK~l~~~~~~~~~--------------~~~~E 571 (754)
..++|++.++||+|+||.||+|.. ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999953 23467999998654322222 23457
Q ss_pred HHHHHHccccce-----eeeEeEEEe--------cCcEEEEEEcccCCCHhhHhcCCC---------------------C
Q 004416 572 MMLIAKLQHRNL-----VRLLGCCIE--------QGEKILIYEYMVNKSLDVFLFDPT---------------------K 617 (754)
Q Consensus 572 i~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~ey~~~gsL~~~l~~~~---------------------~ 617 (754)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 677777653 356899999999999999885321 1
Q ss_pred cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccC
Q 004416 618 KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697 (754)
Q Consensus 618 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 697 (754)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123456778899999999999999987 999999999999999999999999999765432211 1112345789999
Q ss_pred ccccCCCCC----------------------CchhhHHHHHHHHHHHHcCCC-CCC
Q 004416 698 PEYALEGVF----------------------SVKSDVFSFGVLMLEILSSKK-NTG 730 (754)
Q Consensus 698 PE~~~~~~~----------------------~~~~DVwSlGvll~elltg~~-p~~ 730 (754)
||.+..... ..+.||||+||+++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 124699999999999999875 654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=275.24 Aligned_cols=145 Identities=29% Similarity=0.448 Sum_probs=130.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|.+.++||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.++||||+++++.+......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67999999999999999999875 58899999986532 233567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
||+.+++|..++.. ...+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998842 345788889999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-30 Score=247.99 Aligned_cols=203 Identities=28% Similarity=0.402 Sum_probs=164.9
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++.+-+..||.|+||+|+|-.++ .|+..|||++.... ....+++..|.+...+- +.||||+++|.+...+..++-||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 44555678999999999999875 48999999997653 35667888888866655 68999999999999999999999
Q ss_pred cccCCCHhhHhcC--CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 602 YMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 602 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
.|. .+++.+-.. ...+..++++-.-.|..-.++||.||.... +|||||+||+|||++..|.+||+|||++-.+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 994 466654321 234556788888888888999999998754 699999999999999999999999999977644
Q ss_pred CcccCCcccccccCcccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ...-.|-..|||||-+... .|+.++||||||+.|||+.||+-|+...+
T Consensus 221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~ 273 (361)
T KOG1006|consen 221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD 273 (361)
T ss_pred HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH
Confidence 322 2224678899999988643 48899999999999999999999987654
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=214.37 Aligned_cols=108 Identities=40% Similarity=0.883 Sum_probs=103.8
Q ss_pred eccCCCCCcccccCCCC-cccceeeEEeecCCceEEEEeecCCCeeEEEEEccCCcEEEEEeeecCCceEEEEecCCCCC
Q 004416 226 TCTGPWNGVAFGSAPSN-TTFIFQPIVVQNKDEVYYMYESYSSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPDPFC 304 (754)
Q Consensus 226 w~sg~w~g~~~~~~~~~-~~~~~~~~~v~n~~e~~~~~~~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 304 (754)
||+|||||..|.|+|++ ...++.+.|+.+.+|++++|...+.+.++|++||++|++++|.|++.+++|.++|.+|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999998 56788899999999999999999999999999999999999999999999999999999999
Q ss_pred c-cCCcCCCCcccCCCCCcccccCCCccCC
Q 004416 305 H-YGDCGPNSICSVDQTSHCECLEGFKFKS 333 (754)
Q Consensus 305 ~-~g~CG~~g~C~~~~~~~C~C~~Gf~~~~ 333 (754)
| |+.||+||+|+.++.|.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9 9999999999988889999999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=253.27 Aligned_cols=197 Identities=34% Similarity=0.506 Sum_probs=165.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
...|...+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|++++++++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777889999999999999865 4788999988642 223456788999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
+||+. +++...+.. ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 577666532 2345788999999999999999999987 99999999999999999999999999876543
Q ss_pred CcccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. ....+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 2 2246788999999874 356788999999999999999999998553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=276.35 Aligned_cols=209 Identities=33% Similarity=0.477 Sum_probs=174.9
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeec----C----cceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEe
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL----N----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLG 588 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~----~----~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 588 (754)
..+...++..+.+.||+|.||.|++|... . ...||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34555566677789999999999999642 1 3569999998653 34667899999999999 6999999999
Q ss_pred EEEecCcEEEEEEcccCCCHhhHhcCCC------C-----c--ccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCC
Q 004416 589 CCIEQGEKILIYEYMVNKSLDVFLFDPT------K-----K--HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKA 655 (754)
Q Consensus 589 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp 655 (754)
+|.+++..++|+||+..|+|..+|...+ . . ..++..+.+.++.|||.|++||++.. +|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999996443 0 0 24888999999999999999999987 99999999
Q ss_pred CCEEEcCCCCeEEEeecCccccCCCcccCCccccc--ccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004416 656 SNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV--GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGV 731 (754)
Q Consensus 656 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~ 731 (754)
+|||+.++..+||+|||+|+............ .. -+..|||||.+....|+.++|||||||+||||+| |..|++.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999765544332111 12 3456999999999999999999999999999999 7788875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=258.00 Aligned_cols=197 Identities=29% Similarity=0.417 Sum_probs=167.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE---- 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~---- 595 (754)
..++|++.+.||+|++|.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999875 4789999998643 22334667889999999999999999988766554
Q ss_pred --EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 596 --KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 596 --~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
.++|+||+ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 568888773 245889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 223467889999998865 36788999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=249.59 Aligned_cols=199 Identities=32% Similarity=0.447 Sum_probs=169.0
Q ss_pred cceeeeeceeccEEEEeeeecC-cceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
|++.+.||+|++|.||+|+... ++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998754 8899999987653 333467788999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
+ ++|..++.... ..+++..+.+++.|+++||+|||+.+ |+|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988884321 46889999999999999999999987 99999999999999999999999999987644321
Q ss_pred CCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......++..|+|||.+.+. .++.++||||||++++||++|++||...+
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 11223457789999998766 78999999999999999999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=230.98 Aligned_cols=199 Identities=33% Similarity=0.467 Sum_probs=172.0
Q ss_pred cceeeeeceeccEEEEeeeecC-cceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
|.+.+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999865 789999999766544 57789999999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+++|..++..... .+++.....++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+..+..... .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999998843221 1788899999999999999999987 99999999999999999999999999987654321 1
Q ss_pred CcccccccCcccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYA-LEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=236.55 Aligned_cols=215 Identities=27% Similarity=0.376 Sum_probs=183.0
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeE
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 589 (754)
..++.....+++....+-+|.||.||.|.+. +.+.|-||.++.. +......+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456666778888889999999999999543 3567889988765 44456788999999999999999999999
Q ss_pred EEec-CcEEEEEEcccCCCHhhHhc-----CCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC
Q 004416 590 CIEQ-GEKILIYEYMVNKSLDVFLF-----DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (754)
Q Consensus 590 ~~~~-~~~~lV~ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~ 663 (754)
+.+. +..+++|.++.-|+|..||. +......++-.+...++.|++.|++|||.++ +||.||.++|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9876 46788899999999999997 5555667778888999999999999999988 9999999999999999
Q ss_pred CCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 004416 664 MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYNT 734 (754)
Q Consensus 664 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~~ 734 (754)
.++||+|=.+++.+-+.++.........+..||+||.+....|+..+|||||||+||||+| |+.|+..-++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 9999999999998877666554444455779999999999999999999999999999998 8888866543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=206.31 Aligned_cols=115 Identities=46% Similarity=0.757 Sum_probs=102.9
Q ss_pred cccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCCCCeEEEe
Q 004416 48 TLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSS 127 (754)
Q Consensus 48 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst 127 (754)
++|.+|++|+|+++.|++|||.+..+...|.+|||++...++||.|||+.| ....+.|.|+.||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 578899999999999999999987655599999998776789999999998 5678899999999999999999999999
Q ss_pred cccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCC
Q 004416 128 NVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168 (754)
Q Consensus 128 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 168 (754)
++.+......|+|+|||||||++.+ +.+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9886345677899999999999973 57899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-28 Score=234.17 Aligned_cols=196 Identities=27% Similarity=0.394 Sum_probs=161.7
Q ss_pred eeeeceeccEEEEeeee-cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----cEEEEEE
Q 004416 530 QSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-----EKILIYE 601 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~e 601 (754)
.+.||.|+||.||.++. ++|+.||.|++..-- -..-+++-+|+++|.-++|.|++..++..+-.. +.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46899999999999986 469999999986542 223467889999999999999998887755332 5678888
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
.|.. +|..++ .....++...+.-+..||++||.|||+.+ |.||||||.|+|++.+..+||+|||+|+.-+.++
T Consensus 138 LmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8854 666666 34456777788889999999999999987 9999999999999999999999999999876655
Q ss_pred ccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....+. .+-|..|.|||++++. .|+...||||.||++.||+.++-.|...+
T Consensus 211 ~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 211 RLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred hhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 554544 3558899999999875 58999999999999999999998887644
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=229.35 Aligned_cols=203 Identities=27% Similarity=0.466 Sum_probs=162.3
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe--------c
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--------Q 593 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--------~ 593 (754)
..|.-..+||+|.||.||+|+.++ ++.||+|+.--. .+.--....+|+.+|..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 456667899999999999998754 778899865321 21122344789999999999999999888753 2
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
...++|+++++. +|.-+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 357999999976 66666632 3345788899999999999999999876 99999999999999999999999999
Q ss_pred ccccCCCc--ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDE--LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+.+.-.. ........+-|..|.+||.+.+ ..++++.|||.-||++.||+||.+-+....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt 233 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT 233 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence 98764322 2233334566899999998876 568999999999999999999999876643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=236.76 Aligned_cols=207 Identities=24% Similarity=0.295 Sum_probs=171.3
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccc--cc----eeeeEe
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RN----LVRLLG 588 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~n----Iv~l~~ 588 (754)
.+......+.+|.+..++|+|.||.|-++.... +..||||+++.-. ...++.+-|++++.++.+ |+ ++.+.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 344445557899999999999999999997543 6889999997643 334556789999999943 32 778888
Q ss_pred EEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-------
Q 004416 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD------- 661 (754)
Q Consensus 589 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~------- 661 (754)
++...++.+||+|.+ +.|+.+++... +..+++...++.++.|+++++++||+.. ++|.||||+|||+.
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 899999999999988 55888888432 3456788999999999999999999987 99999999999983
Q ss_pred -------------CCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004416 662 -------------QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728 (754)
Q Consensus 662 -------------~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p 728 (754)
++..++|+|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||+|+.||...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 13458999999998643322 447889999999999999999999999999999999999999
Q ss_pred CCCCC
Q 004416 729 TGVYN 733 (754)
Q Consensus 729 ~~~~~ 733 (754)
|...+
T Consensus 309 FqtHe 313 (415)
T KOG0671|consen 309 FQTHE 313 (415)
T ss_pred cccCC
Confidence 87655
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=257.83 Aligned_cols=200 Identities=23% Similarity=0.298 Sum_probs=140.8
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-----cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeE------EE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------CI 591 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~------~~ 591 (754)
..++|++.++||+|+||.||+|++.+ +..||||++...... +....| .+.+..+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 588999987643221 111111 1122222222222211 24
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCCC-----------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCC
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPTK-----------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIk 654 (754)
.+.+.++|+||+++++|.+++..... ........+..++.||++||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56689999999999999888743211 011123345679999999999999987 9999999
Q ss_pred CCCEEEcC-CCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCC----------------------CCCchhh
Q 004416 655 ASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG----------------------VFSVKSD 711 (754)
Q Consensus 655 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 711 (754)
|+|||+++ ++.+||+|||+|+.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57899999999987643322 123346889999999965422 2334669
Q ss_pred HHHHHHHHHHHHcCCCCCC
Q 004416 712 VFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 712 VwSlGvll~elltg~~p~~ 730 (754)
||||||+||||+++..++.
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999766543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=227.50 Aligned_cols=186 Identities=33% Similarity=0.451 Sum_probs=164.3
Q ss_pred ccEEEEeeeecC-cceeeeeeccccchhh-HHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHhhHhcC
Q 004416 537 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD 614 (754)
Q Consensus 537 ~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~ 614 (754)
+||.||+|+..+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998764 8899999997665444 68899999999999999999999999999999999999999999998843
Q ss_pred CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCc
Q 004416 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694 (754)
Q Consensus 615 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (754)
. ..+++..+..++.++++++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 22788999999999999999999987 9999999999999999999999999998765432 2233567889
Q ss_pred ccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 695 y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
|+|||.+.+..++.++||||||+++++|++|+.||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=252.27 Aligned_cols=200 Identities=29% Similarity=0.419 Sum_probs=162.3
Q ss_pred cceeeeeceeccEE-EEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEccc
Q 004416 527 FSIQSKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 527 y~i~~~LG~G~fg~-Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
|.-.+.+|.|.-|+ ||+|.. ++++||||++-.. ......+|+..|+.- +||||||+++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34446789999986 899988 6889999998543 334567899999888 6999999999988889999999999
Q ss_pred CCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---C--CCeEEEeecCccccC
Q 004416 605 NKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---H--MNPKISDFGMARMFG 678 (754)
Q Consensus 605 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~--~~~kL~DFGla~~~~ 678 (754)
..+|++++... ...........+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++++.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 55899988542 11111111445678999999999999977 999999999999976 2 468999999999997
Q ss_pred CCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCC
Q 004416 679 GDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS-KKNTGVYNT 734 (754)
Q Consensus 679 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg-~~p~~~~~~ 734 (754)
..... .......||-+|+|||++....-+..+||+|+||++|+.++| ..||+..-.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH
Confidence 65432 234557899999999999998888899999999999999997 889987543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=217.05 Aligned_cols=197 Identities=22% Similarity=0.398 Sum_probs=164.0
Q ss_pred ccCCcceeeeeceeccEEEEeee-ecCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecC--cEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG--EKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~--~~~l 598 (754)
..++|++.+++|+|.++.||.|. ..+++.++||+++.-. .+.+++|+.+|..+. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 34789999999999999999997 4568899999997643 356789999999997 999999999877653 5679
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEeecCcccc
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMF 677 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DFGla~~~ 677 (754)
|+||+.+.+...+. ..++..+++.++.+++.||.|+|+.| |+|||+||.|++||.. -.++|+|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876644 34667788899999999999999999 9999999999999965 56999999999887
Q ss_pred CCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.+... .+..+.+..|.-||.+.. +.|+..-|+|||||+|..|+..+.||=...+
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 65442 222456677899998875 4578899999999999999999999844443
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=194.50 Aligned_cols=113 Identities=48% Similarity=0.777 Sum_probs=99.4
Q ss_pred cccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCCCCeEEEe
Q 004416 48 TLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSS 127 (754)
Q Consensus 48 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst 127 (754)
+.|..|++|+|+++.|++|||.+..+ ..+.+|||+..+.++||+|||+.|+.+ .+.|.|+.||+|+|+|.+|.++|+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56888999999999999999998654 689999998766789999999999654 4899999999999999999999999
Q ss_pred cccCCccCceEEEecCCCEEEecCCCCCCcccccccccCC
Q 004416 128 NVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (754)
Q Consensus 128 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 167 (754)
++........++|+|+|||||++.+ +.+|||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSD-----GNFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEeCCCCC
Confidence 9874445677899999999999874 4699999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=234.54 Aligned_cols=225 Identities=22% Similarity=0.263 Sum_probs=184.0
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccc------cceeeeEe
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH------RNLVRLLG 588 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H------~nIv~l~~ 588 (754)
.+...+....+|.+....|+|-|++|.+|+.. .+++||||++..... ..+.=..|+++|++|+. -|+++|+-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 33344556678999999999999999999864 478999999976532 23444789999999963 47999999
Q ss_pred EEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeE
Q 004416 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPK 667 (754)
Q Consensus 589 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~k 667 (754)
.|....++|||+|-+ .-+|...|......-.|....+..++.|+.-||..|...+ |+|.||||+||||.+.- .+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999999988 4578888877777777889999999999999999999887 99999999999998764 589
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CCccchhhhHHHH
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN-TDSFNLLGHVSDK 746 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~-~~~~~~~~~~~~~ 746 (754)
|||||.|.....++... ..-+..|.|||++.+-+|+...|+||.||.||||-||+-.|+... +....+...++++
T Consensus 578 LCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 578 LCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 99999998876655322 123457999999999999999999999999999999999997765 4455565665555
Q ss_pred Hhh
Q 004416 747 LYS 749 (754)
Q Consensus 747 l~~ 749 (754)
+.+
T Consensus 654 ~p~ 656 (752)
T KOG0670|consen 654 FPN 656 (752)
T ss_pred CcH
Confidence 543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=214.60 Aligned_cols=197 Identities=21% Similarity=0.362 Sum_probs=157.8
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEe-EEEecCcEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLG-CCIEQGEKILIY 600 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~-~~~~~~~~~lV~ 600 (754)
.+.|.|.+.||+|.||.+-+++++. ...+++|-++.. ....++|.+|..---.+ .|.||+.-++ .|+..+.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4789999999999999999999876 567899987653 23457888887655555 5889987664 466677888999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc--CCCCeEEEeecCccccC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGMARMFG 678 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~~~kL~DFGla~~~~ 678 (754)
||++.|+|..-+ ....+.+....+++.|++.|+.|+|+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998776 3355778888999999999999999988 99999999999994 34579999999998764
Q ss_pred CCcccCCcccccccCcccCccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEG-----VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ....-+..|.|||..... ...+.+|||+||+++|.++||+.||....
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 432 112345678999976532 24677999999999999999999998554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=9e-23 Score=203.46 Aligned_cols=183 Identities=40% Similarity=0.638 Sum_probs=158.0
Q ss_pred eceeccEEEEeeeecC-cceeeeeeccccchh-hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHhh
Q 004416 533 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~ 610 (754)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|+..+++++|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 889999998765432 35678999999999999999999999999899999999999999999
Q ss_pred HhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeecCccccCCCcccCCcccc
Q 004416 611 FLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRI 689 (754)
Q Consensus 611 ~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 689 (754)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 884321 45788999999999999999999987 999999999999999 89999999999987644321 12224
Q ss_pred cccCcccCccccCCC-CCCchhhHHHHHHHHHHH
Q 004416 690 VGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEI 722 (754)
Q Consensus 690 ~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~el 722 (754)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 577899999998877 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-24 Score=213.12 Aligned_cols=197 Identities=28% Similarity=0.339 Sum_probs=160.8
Q ss_pred cCCcceeeeeceeccEEEEeee-ecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec------C
Q 004416 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------G 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~ 594 (754)
..+|.-++.+|.|.- .|-.+- .-.++.||+|++... .....++..+|..++..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357777888999988 555543 235789999987543 234456778999999999999999999998643 3
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
+.|+|||+|.. +|...+. ..++-+.+..|..|+..|++|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 67999999954 6766663 33566778899999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.-+... .....+.|..|.|||++.+..+...+||||+||++.||++|+--|...+
T Consensus 166 r~e~~~~---~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 166 RTEDTDF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred cccCccc---ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 8754431 2223577889999999999889999999999999999999998887533
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=215.54 Aligned_cols=132 Identities=26% Similarity=0.335 Sum_probs=107.1
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-----cc---ceeeeEeEEEec-
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HR---NLVRLLGCCIEQ- 593 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~---nIv~l~~~~~~~- 593 (754)
..+|.+.++||-|.|++||++... +.+.||+|+.+.. ..-.+....||++|++++ |+ .||+|++.|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 378999999999999999999754 4678999998653 334466789999999984 33 599999999754
Q ss_pred ---CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE
Q 004416 594 ---GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (754)
Q Consensus 594 ---~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl 660 (754)
.+.++|+|++.. +|..+|.. ...+.++...+.+|+.||+.||.|||.++ +|||.||||+|||+
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 488999999955 45444432 23345778889999999999999999977 69999999999998
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.1e-23 Score=218.78 Aligned_cols=168 Identities=18% Similarity=0.205 Sum_probs=131.1
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec--Ccceeeeeecccc-----chhhHHHHHHHHHHHHHccccceeeeEeEEEec
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~~vAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 593 (754)
....++|.+.+.||+|+||+||+|++. +++.||||++... .....+.+.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 445578999999999999999999864 4677899986532 12235678999999999999999853322 2
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCC-CCCCEEEcCCCCeEEEeec
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL-KASNILLDQHMNPKISDFG 672 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DI-kp~NILl~~~~~~kL~DFG 672 (754)
+..++||||+++++|.... ... ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5689999999999986321 111 1467889999999999988 999999 9999999999999999999
Q ss_pred CccccCCCcccCC------cccccccCcccCccccCCC
Q 004416 673 MARMFGGDELQGN------TKRIVGTYGYMSPEYALEG 704 (754)
Q Consensus 673 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 704 (754)
+|+.+........ .....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9998755331111 1346788999999988653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-24 Score=233.54 Aligned_cols=199 Identities=26% Similarity=0.447 Sum_probs=174.4
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
...++|..+..+|.|.+|.|||++.. .++..|||+++-.......-+++|+-+++..+||||+.++|.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 35578999999999999999999864 58889999998877777888899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+.+|+|++.- ..-.++++.++....++..++++|||+++ -+|||||-.|||+++.+.+|++|||.+..+...
T Consensus 92 EycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 999999998865 34567888899999999999999999998 799999999999999999999999999877543
Q ss_pred cccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKN 728 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p 728 (754)
. ...+.+.||+.|||||+.. .+.|..++|||++|+...|+---++|
T Consensus 166 i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 166 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 3 3345589999999999753 46688999999999999998555554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=209.91 Aligned_cols=207 Identities=25% Similarity=0.416 Sum_probs=168.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeec----CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 597 (754)
..+.|..+++||+|.|++||++... ..+.||+|.+...+ ...++.+|+++|.++ -+.||+++.+++..++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4467889999999999999999753 35789999886543 335688999999999 5999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEeecCccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARM 676 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DFGla~~ 676 (754)
+|+||++.....++.. .++..++..++..+..||.++|.+| ||||||||.|+|.+.. +.-.|.|||+|..
T Consensus 112 ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHH
Confidence 9999999998888773 2557888899999999999999998 9999999999999864 5678999999983
Q ss_pred cCCCc-------------cc-----------------------------CCcccccccCcccCccccCCC-CCCchhhHH
Q 004416 677 FGGDE-------------LQ-----------------------------GNTKRIVGTYGYMSPEYALEG-VFSVKSDVF 713 (754)
Q Consensus 677 ~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVw 713 (754)
..... .. .......||++|.|||++..- .-++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 00 000124699999999998764 468899999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCccchh
Q 004416 714 SFGVLMLEILSSKKNTGVYNTDSFNLL 740 (754)
Q Consensus 714 SlGvll~elltg~~p~~~~~~~~~~~~ 740 (754)
|-||+++-+++++.||-...++-..+.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ 289 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALA 289 (418)
T ss_pred eccceeehhhccccccccCccccchHH
Confidence 999999999999999876655544433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-22 Score=191.38 Aligned_cols=204 Identities=21% Similarity=0.298 Sum_probs=170.1
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccc-cceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~ 600 (754)
...+|.++++||.|+||.+|.|.. .+|.+||||+-+.... ..++..|..+...++| ..|..+..+..++....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 447899999999999999999974 5799999998755432 2456788999999976 67888888888999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC---CCeEEEeecCcccc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARMF 677 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~~kL~DFGla~~~ 677 (754)
|.+ +.+|++++. -..+.++..+.+-++.|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+|+.+
T Consensus 91 dLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 778988763 23455788899999999999999999988 9999999999999643 45899999999988
Q ss_pred CCCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 678 GGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 678 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
...... .......||.+|.+-....+..-+.+.|+-|+|.+|....-|..||....+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 653321 233447899999998888888889999999999999999999999987653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=196.38 Aligned_cols=205 Identities=22% Similarity=0.322 Sum_probs=174.2
Q ss_pred cccCCcceeeeeceeccEEEEeee-ecCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 599 (754)
...-+|++.++||+|.||.++.|+ +-+++.||||.-...+ ...++..|....+.|. .++|...+-+..++.+-.||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 445689999999999999999997 4579999999764432 3457788998888884 68999999888899999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-----CCeEEEeecCc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-----MNPKISDFGMA 674 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-----~~~kL~DFGla 674 (754)
+|.+ +.+|+++.. -..+.++......++.|++.-++|+|++. +|.|||||+|+||... ..+.++|||+|
T Consensus 103 idLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9988 779988763 24556889999999999999999999988 9999999999999643 34899999999
Q ss_pred cccCCCcccC-----CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 675 RMFGGDELQG-----NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 675 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
+.+..+.+.. ..+...||.+||+-.-..+..-+.+.|+-|||-++++.|-|..||.....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 9987654322 34457899999999999999999999999999999999999999987653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.8e-21 Score=206.63 Aligned_cols=203 Identities=25% Similarity=0.302 Sum_probs=166.2
Q ss_pred CcceeeeeceeccEEEEeeeecCc--ceeeeeeccccchhhHHHHHHHHHHHHHccc----cceeeeEeEE-EecCcEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNLVRLLGCC-IEQGEKIL 598 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~~--~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~~~~-~~~~~~~l 598 (754)
+|.+.++||+|+||.||++..... ..+|+|............++.|+.++..+.+ +++.+++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999986543 4788888765433333377889999999973 5888888888 46778899
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-----CCeEEEeecC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-----MNPKISDFGM 673 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-----~~~kL~DFGl 673 (754)
||+.+ +.+|.++..... .+.++.....+|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 778988764333 567899999999999999999999998 9999999999999765 4599999999
Q ss_pred cc--ccCCCcc----cC-C-cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 AR--MFGGDEL----QG-N-TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++ .+..... .. . ...++||.+|.+++...+...+.+.|+||++.++.|++.|..||....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 99 4322211 11 1 223679999999999999999999999999999999999999996654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=192.39 Aligned_cols=202 Identities=35% Similarity=0.501 Sum_probs=170.2
Q ss_pred cceeeeeceeccEEEEeeeecCcceeeeeeccccchh---hHHHHHHHHHHHHHcccc-ceeeeEeEEEecCcEEEEEEc
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ey 602 (754)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++...+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999875 78899988765332 367899999999999988 799999999777778999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~~~~~ 681 (754)
+.++++..++........+.......++.|++.++.|+|..+ ++||||||+||+++... .++++|||.++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966632211136788899999999999999999988 99999999999999998 79999999998665443
Q ss_pred ccC----CcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQG----NTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ......||..|+|||.+.+ .......|+||+|++++++++|..|+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 2355789999999999987 578889999999999999999999966554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-20 Score=186.15 Aligned_cols=171 Identities=15% Similarity=0.162 Sum_probs=133.4
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhH---HH------HHHHHHHHHHccccceeeeEeEEEe
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL---KE------FKNEMMLIAKLQHRNLVRLLGCCIE 592 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~---~~------~~~Ei~~l~~l~H~nIv~l~~~~~~ 592 (754)
...++|++.++||.|+||.||.... ++..+|||.+........ .. +.+|+..+.+++|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999765 577899999975432222 22 6899999999999999998887654
Q ss_pred c--------CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC
Q 004416 593 Q--------GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (754)
Q Consensus 593 ~--------~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~ 664 (754)
. ...++||||+++.+|.++.. ++. ....+++.++..+|..+ ++||||||.||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999977631 222 24568999999999988 99999999999999988
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHH
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~el 722 (754)
++|+|||..+....+... ..++....+..++|+|+||+.+...
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence 999999988755322110 1134455667799999999988765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.6e-20 Score=182.09 Aligned_cols=139 Identities=17% Similarity=0.141 Sum_probs=107.9
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchh--h-------H-----------------HHHHHHHHHHHHccccce
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------L-----------------KEFKNEMMLIAKLQHRNL 583 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~H~nI 583 (754)
.+.||+|+||.||+|...+|+.||||+++..... . . .....|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999878999999998654211 1 1 122459999999988876
Q ss_pred eeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHH-HhcCCCCceeCCCCCCCEEEcC
Q 004416 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL-HQYSRLRIIHRDLKASNILLDQ 662 (754)
Q Consensus 584 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiH~DIkp~NILl~~ 662 (754)
....... ....++||||++++++..... ....++......++.|++.+|.++ |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 4433222 223489999999877654431 234678889999999999999999 6777 999999999999984
Q ss_pred CCCeEEEeecCcccc
Q 004416 663 HMNPKISDFGMARMF 677 (754)
Q Consensus 663 ~~~~kL~DFGla~~~ 677 (754)
+.++|+|||+|...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=226.63 Aligned_cols=149 Identities=18% Similarity=0.195 Sum_probs=112.4
Q ss_pred Hccc-cceeeeEeEE-------EecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 004416 577 KLQH-RNLVRLLGCC-------IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (754)
Q Consensus 577 ~l~H-~nIv~l~~~~-------~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 648 (754)
.++| +||+++++++ .+....+.++||+ .++|..++.. ....+++.++..++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5777777776 2334567888987 5599999853 2355899999999999999999999988 9
Q ss_pred eeCCCCCCCEEEcCCC-------------------CeEEEeecCccccCCCcc--------------cCCcccccccCcc
Q 004416 649 IHRDLKASNILLDQHM-------------------NPKISDFGMARMFGGDEL--------------QGNTKRIVGTYGY 695 (754)
Q Consensus 649 iH~DIkp~NILl~~~~-------------------~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 695 (754)
+||||||+||||+..+ .+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455666666653211000 0000113578899
Q ss_pred cCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 696 ~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
||||++.+..++.++|||||||+||||++|.+|+..
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999999988753
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=176.76 Aligned_cols=141 Identities=19% Similarity=0.211 Sum_probs=111.1
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchh--------------------------hHHHHHHHHHHHHHccccce
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------------------------GLKEFKNEMMLIAKLQHRNL 583 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~nI 583 (754)
.+.||+|++|.||+|+..+|+.||||++...... ....++.|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754211 01234679999999999987
Q ss_pred eeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCEEEcC
Q 004416 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQ 662 (754)
Q Consensus 584 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NILl~~ 662 (754)
.....+... ..++||||++++++..... ....++.....+++.|++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544433322 3489999999885543321 22356778889999999999999999 77 99999999999999
Q ss_pred CCCeEEEeecCccccCC
Q 004416 663 HMNPKISDFGMARMFGG 679 (754)
Q Consensus 663 ~~~~kL~DFGla~~~~~ 679 (754)
++.++|+|||+++.+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=168.89 Aligned_cols=187 Identities=16% Similarity=0.135 Sum_probs=139.0
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeeccccchh----hHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEEcc
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~----~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+...|++|+||+||.+.- ++.+++.+.+.....- ....+.+|+++|++++ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457999999999997765 6778887777554321 1235889999999995 5789999876 4569999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCC-CCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL-KASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DI-kp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
.+.+|...+. . ....++.|++++|+++|+++ |+|||| ||+|||+++++.++|+|||+|....+...
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998865431 1 11357789999999999998 999999 79999999999999999999986543221
Q ss_pred c----C--C-----cccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 Q----G--N-----TKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~----~--~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. . . ......++.|++|+...- .+--.+.+.++.|..+|+++|++.+.-...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 0 001235778888875322 222257899999999999999998854433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-18 Score=200.98 Aligned_cols=224 Identities=21% Similarity=0.235 Sum_probs=174.3
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcc---ccceeeeEeEEEecCcE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~ 596 (754)
.+...+.|.|.+.||+|+||+||+|...+++.||+|+-+....- +|.--.+++.||+ -+.|..+..++.-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34456789999999999999999999888999999987655432 2222233444454 23455555555667788
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-------CCCeEEE
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-------HMNPKIS 669 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-------~~~~kL~ 669 (754)
+||+||.+.|+|.+++. ..+.+++.....++.|+++.+++||..+ |||+||||+|.||.. ...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999884 6677899999999999999999999988 999999999999942 3458999
Q ss_pred eecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC--CCCC----CC-ccchhhh
Q 004416 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT--GVYN----TD-SFNLLGH 742 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~--~~~~----~~-~~~~~~~ 742 (754)
|||-+..+..-.........++|-.+-.+|+..+++++.++|.|.|+-+++-||.|+.-- .... .. .+..-.+
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~~~~ 923 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYWKRD 923 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchhhhhHH
Confidence 999998764322223445578899999999999999999999999999999999998542 1111 11 3345578
Q ss_pred HHHHHhhhhh
Q 004416 743 VSDKLYSLLF 752 (754)
Q Consensus 743 ~~~~l~~~l~ 752 (754)
+|..|.+.|+
T Consensus 924 ~W~~~F~~lL 933 (974)
T KOG1166|consen 924 MWNKFFDLLL 933 (974)
T ss_pred HHHHHHHHHh
Confidence 9999988775
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.3e-18 Score=166.22 Aligned_cols=107 Identities=21% Similarity=0.161 Sum_probs=93.0
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
|+|.+++.. .+..+++..++.++.||++||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 578888842 2456899999999999999999999865 999999999999999 99998754322
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
..||+.|||||++.+..++.++|||||||++|||++|+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 26889999999999999999999999999999999999998654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=164.77 Aligned_cols=135 Identities=22% Similarity=0.259 Sum_probs=104.6
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHc-----cccceeeeEeEEEecC---c-EEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-----QHRNLVRLLGCCIEQG---E-KILIY 600 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~~~~~~~~---~-~~lV~ 600 (754)
.+.||+|+|+.||. +++....+||++........+.+.+|+.+++++ .||||+++++++..+. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36899999999996 444333479988665444567899999999999 5799999999998764 3 33789
Q ss_pred Ec--ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHH-HHHHhcCCCCceeCCCCCCCEEEcC----CCCeEEEeecC
Q 004416 601 EY--MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL-LYLHQYSRLRIIHRDLKASNILLDQ----HMNPKISDFGM 673 (754)
Q Consensus 601 ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~iiH~DIkp~NILl~~----~~~~kL~DFGl 673 (754)
|| .++++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 558999999943 224444 35677888777 9999988 999999999999974 34799999444
Q ss_pred cc
Q 004416 674 AR 675 (754)
Q Consensus 674 a~ 675 (754)
+.
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.5e-19 Score=191.78 Aligned_cols=186 Identities=28% Similarity=0.360 Sum_probs=154.5
Q ss_pred eeceeccEEEEeee----ecCcceeeeeeccccchh--hHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEEccc
Q 004416 532 KLGEGGFGPVYKGR----LLNGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~----~~~~~~vAVK~l~~~~~~--~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
.+|+|.||.|+.++ .+.+..+|+|++++.... .....+.|..++...+ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999875 234677899988654221 1124566888888887 9999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+|.|...+ .......+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99987766 33444566666777888999999999988 99999999999999999999999999987533221
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.+||..|||||++. .....+|.||||++.+||+||..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999987 667789999999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-18 Score=197.30 Aligned_cols=199 Identities=23% Similarity=0.300 Sum_probs=156.5
Q ss_pred eeeeeceeccEEEEeeeec-Ccceeeeeecc----c-cch-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS----N-QSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~----~-~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
..+.+|.|++|.|+..... ..+..+.|.+. . ... +....+..|+.+-..++|||++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3468999999977777532 33334444332 1 111 112225667777788899999888777777666666699
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++ +|..++ .....+...++..++.|+..|+.|+|+.+ |.|||+|++|+++..++.+||+|||.+..+.-+.
T Consensus 402 ~~~~-Dlf~~~---~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLV---MSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHH---hcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 988887 33346788889999999999999999998 9999999999999999999999999998765433
Q ss_pred cc--CCcccccccCcccCccccCCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 682 LQ--GNTKRIVGTYGYMSPEYALEGVFSVK-SDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 682 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.. ......+|+..|+|||.+.+..|.++ .||||.|+++..|++|+.||.....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 22 44556889999999999999999765 8999999999999999999977663
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.5e-17 Score=167.63 Aligned_cols=199 Identities=20% Similarity=0.299 Sum_probs=131.6
Q ss_pred CcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHcc----------ccceeeeEeEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ----------HRNLVRLLGCCI 591 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~----------H~nIv~l~~~~~ 591 (754)
.+...+.||.|+++.||.+++.. ++++|||++... .....+++++|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45667899999999999998754 899999987533 2335677777776555532 212222122111
Q ss_pred ---------ecC--------cEEEEEEcccCCCHhhHhc---CC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 004416 592 ---------EQG--------EKILIYEYMVNKSLDVFLF---DP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650 (754)
Q Consensus 592 ---------~~~--------~~~lV~ey~~~gsL~~~l~---~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH 650 (754)
... ..+++|+-+ .++|..++. .. .....+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 235677777 557776642 11 12234555666778899999999999998 999
Q ss_pred CCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCC--------CCCCchhhHHHHHHHHHHH
Q 004416 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE--------GVFSVKSDVFSFGVLMLEI 722 (754)
Q Consensus 651 ~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DVwSlGvll~el 722 (754)
+||||+|++++++|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988765432211 234578999997643 2468899999999999999
Q ss_pred HcCCCCCCCCC
Q 004416 723 LSSKKNTGVYN 733 (754)
Q Consensus 723 ltg~~p~~~~~ 733 (754)
.+++.||+...
T Consensus 244 WC~~lPf~~~~ 254 (288)
T PF14531_consen 244 WCGRLPFGLSS 254 (288)
T ss_dssp HHSS-STCCCG
T ss_pred HHccCCCCCCC
Confidence 99999998654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=164.43 Aligned_cols=150 Identities=17% Similarity=0.141 Sum_probs=114.4
Q ss_pred hccccCCcceeeeeceeccEEEEeee--ecCcceeeeeeccccchh------------------------hHHHHHHHHH
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLKEFKNEMM 573 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~--~~~~~~vAVK~l~~~~~~------------------------~~~~~~~Ei~ 573 (754)
+.....-|.+.+.||+|++|.||+|. ..+|+.||||++...... ....+++|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444458899999999999999998 567999999988643210 1123578999
Q ss_pred HHHHccccc--eeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeC
Q 004416 574 LIAKLQHRN--LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651 (754)
Q Consensus 574 ~l~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~ 651 (754)
.+.++.+.. +.++++. ...++||||+++.++..... ....+.......++.||+.++++||+.+ .++||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 999997643 3444432 24589999999988765441 2233555667889999999999999875 49999
Q ss_pred CCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 652 DLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 652 DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||||+||+++ ++.++|+|||.+.....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999999 88999999999976543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.5e-18 Score=164.96 Aligned_cols=197 Identities=22% Similarity=0.365 Sum_probs=154.2
Q ss_pred ceeeeeceeccEEEEeeeecCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 528 ~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
.+..+|.+...|..|+|++. |..+++|++.... ....+.|..|.-.|+-+.||||+++++.|.......++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457889999999999994 5667778876542 23346788899899999999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
|+|...|+... .-..+..++.+++.+||+|++|||+..+ -|----|..+.+++|++.+++|. .+-++. .-.
T Consensus 272 gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-mad~kf------sfq 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MADTKF------SFQ 342 (448)
T ss_pred hHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-ccccee------eee
Confidence 99999996543 3456778899999999999999999863 24445688999999999888763 111111 111
Q ss_pred cccccccCcccCccccCCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFS---VKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~---~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.....-.|.||+||.++..+-+ ..+|+|||+++||||.|+..||....+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 1123446899999999876643 469999999999999999999987653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=7e-18 Score=191.98 Aligned_cols=198 Identities=20% Similarity=0.236 Sum_probs=151.2
Q ss_pred CcceeeeeceeccEEEEeeeecCcceeeeeeccccc-hhhHHHHHHHHHHH--HHccccceeeeEeEEEecCcEEEEEEc
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-GQGLKEFKNEMMLI--AKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l--~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++...+.||.+.|=+|.+++++.|. |+||++-+.. ....+.|+++++-+ ..++|||.+++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677789999999999999998887 8999987664 33455555554444 445899999987776666677888888
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
..+ +|.+.+ .-+..+...+...|+.|++.||.-+|..+ |+|+|||.+||||+.-.-+.|+||..-+...-++.
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 865 555555 45667888888999999999999999988 99999999999999999999999998765432211
Q ss_pred -cCCc----ccccccCcccCccccCCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004416 683 -QGNT----KRIVGTYGYMSPEYALEG----------V-FSVKSDVFSFGVLMLEILS-SKKNTGV 731 (754)
Q Consensus 683 -~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~DVwSlGvll~ellt-g~~p~~~ 731 (754)
.... .+...-..|+|||-+... . .+++.||||+||++.||++ |+++|+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 1111 112223479999976431 2 5788999999999999998 5777854
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=158.43 Aligned_cols=134 Identities=19% Similarity=0.285 Sum_probs=112.7
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccch--------hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
+.||+|++|.||+|+. .+..|+||+...... .....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 677899997653321 1124578899999999999988777777777888999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
+++++|.+.+... .. .+..++.+++.+|.++|+.+ ++|+|++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887321 11 67889999999999999988 99999999999999 78899999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=156.25 Aligned_cols=143 Identities=19% Similarity=0.169 Sum_probs=111.4
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccch----------------------hhHHHHHHHHHHHHHc
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----------------------QGLKEFKNEMMLIAKL 578 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~----------------------~~~~~~~~Ei~~l~~l 578 (754)
......|.+.+.||+|+||.||++..++++.||||++..... .....+..|+.++.++
T Consensus 11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 333344778899999999999999988899999998654220 0112367889999999
Q ss_pred cccc--eeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCC
Q 004416 579 QHRN--LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (754)
Q Consensus 579 ~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~ 656 (754)
.|++ +.+.++ ....++||||+++++|..... ......++.+++.++.++|+.+ |+|+||||+
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 8874 444443 345689999999999876541 0234578899999999999987 999999999
Q ss_pred CEEEcCCCCeEEEeecCccccCC
Q 004416 657 NILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 657 NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||++++++.++|+|||++.....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=155.95 Aligned_cols=131 Identities=21% Similarity=0.319 Sum_probs=106.6
Q ss_pred eeceeccEEEEeeeecCcceeeeeeccccch--------hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
.||+|+||.||+|.. ++..|++|+...... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998643211 12356788999999999987665555566677789999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
++++|...+... . . .++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc---H-H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998876321 1 0 78899999999999988 99999999999999 789999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.2e-16 Score=176.56 Aligned_cols=138 Identities=19% Similarity=0.286 Sum_probs=111.8
Q ss_pred cCCcceeeeeceeccEEEEeeeecCcceeeeeec-ccc-c------hhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL-SNQ-S------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l-~~~-~------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
...|...+.||+|+||.||+|.+.+. .+++|+. .+. . ....+++.+|++++.+++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999987544 3444432 211 1 1123568899999999999999888878777778
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988772 34678999999999999988 9999999999999 67799999999997
Q ss_pred cc
Q 004416 676 MF 677 (754)
Q Consensus 676 ~~ 677 (754)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-16 Score=127.32 Aligned_cols=66 Identities=56% Similarity=1.191 Sum_probs=58.5
Q ss_pred CCCCCceeEecccCCCCccccccccccCHHHHHHHHhcCCCeEeeeccccCCCCccceecccccccc
Q 004416 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDL 413 (754)
Q Consensus 347 C~~~~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~g~l~~~ 413 (754)
|+.+|+|+++++|++|++....++.+.++++|++.||+||||+||+|.++. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 556799999999999999877766789999999999999999999997655 668999999999885
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.9e-15 Score=144.77 Aligned_cols=138 Identities=20% Similarity=0.231 Sum_probs=99.2
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchh--hHHH----------------------HHHHHHHHHHccccc--e
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKE----------------------FKNEMMLIAKLQHRN--L 583 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~n--I 583 (754)
.+.||+|+||.||+|+..+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999987653211 1111 135666677765543 4
Q ss_pred eeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCEEEcC
Q 004416 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQ 662 (754)
Q Consensus 584 v~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NILl~~ 662 (754)
.+.++. ...++||||++++.+......... . ...+..++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 346899999998543211100000 1 15567899999999999998 76 99999999999999
Q ss_pred CCCeEEEeecCccccCC
Q 004416 663 HMNPKISDFGMARMFGG 679 (754)
Q Consensus 663 ~~~~kL~DFGla~~~~~ 679 (754)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=136.66 Aligned_cols=135 Identities=22% Similarity=0.236 Sum_probs=113.7
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccc--cceeeeEeEEEecCcEEEEEEcccCC
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQGEKILIYEYMVNK 606 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~~lV~ey~~~g 606 (754)
+.+.||+|.++.||+++..+ ..+++|....... ...+.+|+.+++.++| .++++++.+...++..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998744 7899999865433 4678899999999987 48999998888778899999999887
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
.+..+ +......++.++++++++||......++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66432 4556677889999999999986545699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.1e-15 Score=167.86 Aligned_cols=167 Identities=25% Similarity=0.354 Sum_probs=120.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
...+|..++.|..|++|.||.++++. .+.+|+|+- ++.-. +++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li----lRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI----LRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccchh----hhc---cccccCCccee-----------------
Confidence 34679999999999999999999864 678888542 22110 011 22222334333
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC-
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD- 680 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~- 680 (754)
|+-...+ ..-+.++. +++.+++|||+.+ |+|||+||+|.||+.-|++|++|||+.+..-..
T Consensus 136 ----gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 2222223 11122222 2378999999988 999999999999999999999999998754211
Q ss_pred ------------cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 681 ------------ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 681 ------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...-..+..+|||.|+|||++....|...+|.|++|+|+||.+-|..||...
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 0011233469999999999999999999999999999999999999998765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.2e-14 Score=143.52 Aligned_cols=134 Identities=22% Similarity=0.264 Sum_probs=103.4
Q ss_pred eeec-eeccEEEEeeeecCcceeeeeeccccc-------------hhhHHHHHHHHHHHHHccccce--eeeEeEEEecC
Q 004416 531 SKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLLGCCIEQG 594 (754)
Q Consensus 531 ~~LG-~G~fg~Vy~~~~~~~~~vAVK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~~~~~~~~ 594 (754)
..|| .||.|+||++... +..++||++.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999998774 6788998774311 1223567889999999998875 67777654432
Q ss_pred ----cEEEEEEcccC-CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 595 ----EKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 595 ----~~~lV~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
..++|+|++++ .+|..++.. ..++.. .+.+|++++.+||+.+ |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688887732 234433 3568999999999998 9999999999999999999999
Q ss_pred eecCccc
Q 004416 670 DFGMARM 676 (754)
Q Consensus 670 DFGla~~ 676 (754)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.3e-15 Score=161.38 Aligned_cols=192 Identities=24% Similarity=0.269 Sum_probs=136.0
Q ss_pred cceeeeeceeccEEEEeeeecCc----ceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeE------eEEEe---
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLL------GCCIE--- 592 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~~----~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~------~~~~~--- 592 (754)
..+.+..+..+++.+...+...+ ..++.+..+..+-.......+++-.+.... |+..+..- .....
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 34455667777777766653322 334444443333112222233444444443 44332211 01111
Q ss_pred --cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEe
Q 004416 593 --QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (754)
Q Consensus 593 --~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~D 670 (754)
....++.|+++.-.+|.+++.........++..+..++.|++.+++| ++ .+|+|+||.||+...+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 23578999999999999999766666667788899999999999999 55 99999999999999999999999
Q ss_pred ecCccccCCCc----ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 004416 671 FGMARMFGGDE----LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724 (754)
Q Consensus 671 FGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt 724 (754)
||+........ .........||..||+||++.+..|+.|+||||||++|+||++
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99998775544 1122334689999999999999999999999999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.6e-14 Score=148.58 Aligned_cols=145 Identities=23% Similarity=0.348 Sum_probs=104.6
Q ss_pred cccceeeeEeEEEe---------------------------cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHH
Q 004416 579 QHRNLVRLLGCCIE---------------------------QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631 (754)
Q Consensus 579 ~H~nIv~l~~~~~~---------------------------~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 631 (754)
+|||||++.++|.+ ....|+||.-.+ .+|..++.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 49999999987653 224578877663 477777733 2344556677899
Q ss_pred HHHHHHHHHHhcCCCCceeCCCCCCCEEEc--CCC--CeEEEeecCccccCCC--c--ccCCcccccccCcccCccccCC
Q 004416 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHM--NPKISDFGMARMFGGD--E--LQGNTKRIVGTYGYMSPEYALE 703 (754)
Q Consensus 632 qia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~--~~kL~DFGla~~~~~~--~--~~~~~~~~~gt~~y~aPE~~~~ 703 (754)
|+++|+.|||.++ |.|||+|.+|||+. +|. .+.|+|||.+---+.. . +....-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999983 333 3789999976432211 1 1111112346667899998764
Q ss_pred CC------CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 704 GV------FSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 704 ~~------~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.+ .-.|+|.|+.|-+.||++....||-.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 33 23589999999999999999999855
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7e-14 Score=153.03 Aligned_cols=155 Identities=29% Similarity=0.463 Sum_probs=126.6
Q ss_pred HHHccccceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCC
Q 004416 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (754)
Q Consensus 575 l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIk 654 (754)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++.+|+.||+|||... --.|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999954 3445788888889999999999999854 23999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCC-------CCchhhHHHHHHHHHHHHcCCC
Q 004416 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-------FSVKSDVFSFGVLMLEILSSKK 727 (754)
Q Consensus 655 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DVwSlGvll~elltg~~ 727 (754)
+.|.++|....+||+|||+.................-..-|.|||.+.... .+.+.||||+|++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987764311111111122345789999987642 4667999999999999999999
Q ss_pred CCCCCC
Q 004416 728 NTGVYN 733 (754)
Q Consensus 728 p~~~~~ 733 (754)
||....
T Consensus 157 ~~~~~~ 162 (484)
T KOG1023|consen 157 PFDLRN 162 (484)
T ss_pred cccccc
Confidence 998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-14 Score=166.14 Aligned_cols=208 Identities=23% Similarity=0.316 Sum_probs=165.9
Q ss_pred CCcceeeeeceeccEEEEeeeecC--cceeeeeeccccc--hhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~--~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 599 (754)
..|.+.+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-+.+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 557777889999999999886533 3456777665442 333445556777777886 99999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHH-hcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCcccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH-QYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~ 677 (754)
.+|..++++...+... .....+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999887666311 1113455666789999999999999 766 99999999999999999 9999999999988
Q ss_pred CC-CcccCCcccccc-cCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004416 678 GG-DELQGNTKRIVG-TYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736 (754)
Q Consensus 678 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~~~~~ 736 (754)
.. ..........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+.......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 76 444445555788 99999999988754 4678999999999999999999998876433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.2e-12 Score=145.55 Aligned_cols=141 Identities=21% Similarity=0.241 Sum_probs=99.8
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhhH----------------------------------------HHHHH
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL----------------------------------------KEFKN 570 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~----------------------------------------~~~~~ 570 (754)
+.||.|++|.||+|++++|+.||||+.+....... -.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865321100 02445
Q ss_pred HHHHHHHcc----ccceeeeEeEE-EecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHH-HHHHHHhcC
Q 004416 571 EMMLIAKLQ----HRNLVRLLGCC-IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ-GLLYLHQYS 644 (754)
Q Consensus 571 Ei~~l~~l~----H~nIv~l~~~~-~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~yLH~~~ 644 (754)
|+..+.+++ |.+-+.+-..+ ......+|||||+++.+|.+....... .. .+.+++.++++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666653 32223322222 234567999999999999876532111 11 23456666666 467888877
Q ss_pred CCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 645 ~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
++|+|++|.||++++++.++++|||++..+.+
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999988754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.6e-13 Score=110.13 Aligned_cols=71 Identities=24% Similarity=0.394 Sum_probs=60.7
Q ss_pred CCCCCceeEecccCCCCccccccccccCHHHHHHHHhc---CCCeEeeeccccCCCCccceeccccc-cccccCCCCCCC
Q 004416 347 CKSGDRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK---NCSCRAYANSKVTDGGSGCLMWFGDL-IDLKKTDNHTNG 422 (754)
Q Consensus 347 C~~~~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~C~~w~g~l-~~~~~~~~~~~~ 422 (754)
|...++|.++.++++|++.. .+++||++.|++ ||||+||+|.+. +.||++|+++| ++++...+ .+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~--~g 73 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFS--HG 73 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccC--CC
Confidence 45567899999999998754 689999999999 999999999653 35899999999 99988765 57
Q ss_pred eeEEEe
Q 004416 423 VSIYIR 428 (754)
Q Consensus 423 ~~~ylr 428 (754)
.++|+|
T Consensus 74 ~~Ly~r 79 (80)
T cd00129 74 FDLYEN 79 (80)
T ss_pred ceeEeE
Confidence 899987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.8e-12 Score=108.01 Aligned_cols=80 Identities=41% Similarity=0.885 Sum_probs=64.4
Q ss_pred CCCCCCC---CceeEecccCCCCccccccccccCHHHHHHHHhcCCCeEeeeccccCCCCccceeccccccccccCCCCC
Q 004416 344 SSDCKSG---DRFKKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGDLIDLKKTDNHT 420 (754)
Q Consensus 344 ~l~C~~~---~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~g~l~~~~~~~~~~ 420 (754)
+++|... +.|.++.++++|+..... .+.++++|++.|++||+|+||+|.. ++++|.+|.+.+.+.+....
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~-- 74 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSS-- 74 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecC--
Confidence 3567544 689999999999875533 7789999999999999999999964 35689999999988765433
Q ss_pred CCeeEEEecc
Q 004416 421 NGVSIYIRVP 430 (754)
Q Consensus 421 ~~~~~ylrl~ 430 (754)
.+..+|+|+|
T Consensus 75 ~~~~~yiKv~ 84 (84)
T cd01098 75 GGGTLYLRLA 84 (84)
T ss_pred CCcEEEEEeC
Confidence 3578999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-11 Score=117.81 Aligned_cols=131 Identities=23% Similarity=0.163 Sum_probs=97.6
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccccee-eeEeEEEecCcEEEEEEcccCCCH
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
.+.|+.|.++.||+++.. ++.|++|+...... ....+.+|+.+++.+.+.+++ +++.. .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 367899999999999864 77899998755432 223467899999999766654 44443 33446899999999876
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--CCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
.... .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 011245678999999999876 22369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.6e-11 Score=135.30 Aligned_cols=145 Identities=19% Similarity=0.235 Sum_probs=94.9
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhh----------------------------------HH---
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQG----------------------------------LK--- 566 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~----------------------------------~~--- 566 (754)
..|.. +.||.|++|+||+|++++ |++||||+..+..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999987 9999999986542100 11
Q ss_pred ---HHHHHHHHHHHcc----ccceeeeEeEEEe-cCcEEEEEEcccCCCHhhHhcCCCCc---ccccHHHHHHHHHHHHH
Q 004416 567 ---EFKNEMMLIAKLQ----HRNLVRLLGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKK---HLLGWQLRVRIIDGIAQ 635 (754)
Q Consensus 567 ---~~~~Ei~~l~~l~----H~nIv~l~~~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia~ 635 (754)
.+.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++++.+.+.-.....+ ..+.......++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 1344554444443 3333443333333 45778999999999997642111111 123233333333333
Q ss_pred HHHHHHhcCCCCceeCCCCCCCEEEcCCC----CeEEEeecCccccCCC
Q 004416 636 GLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFGMARMFGGD 680 (754)
Q Consensus 636 ~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~~kL~DFGla~~~~~~ 680 (754)
+..+ ++|+|+||.||+++.++ .++++|||++..+.+.
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3455 99999999999999988 9999999999887543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-10 Score=112.09 Aligned_cols=136 Identities=15% Similarity=0.105 Sum_probs=98.6
Q ss_pred eeeceeccEEEEeeeecC-------cceeeeeeccccc----------------------hhhHHHH----HHHHHHHHH
Q 004416 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS----------------------GQGLKEF----KNEMMLIAK 577 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-------~~~vAVK~l~~~~----------------------~~~~~~~----~~Ei~~l~~ 577 (754)
..||.|.-+.||.|...+ +..+|||+.+... ....+.+ ++|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997543 4789999764210 0112233 389999999
Q ss_pred ccc--cceeeeEeEEEecCcEEEEEEcccCCCHhh-HhcCCCCcccccHHHHHHHHHHHHHHHHHH-HhcCCCCceeCCC
Q 004416 578 LQH--RNLVRLLGCCIEQGEKILIYEYMVNKSLDV-FLFDPTKKHLLGWQLRVRIIDGIAQGLLYL-HQYSRLRIIHRDL 653 (754)
Q Consensus 578 l~H--~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~iiH~DI 653 (754)
+.. -++.+.+++ ...+|||||+.+..+.. .+ +...++......+..+++.+|..| |..+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 964 456666654 56789999997654321 22 112344455667889999999998 7776 999999
Q ss_pred CCCCEEEcCCCCeEEEeecCccccC
Q 004416 654 KASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 654 kp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
++.|||+++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.9e-10 Score=124.84 Aligned_cols=165 Identities=18% Similarity=0.243 Sum_probs=125.0
Q ss_pred cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHH
Q 004416 547 LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLR 626 (754)
Q Consensus 547 ~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~ 626 (754)
.++.+|.|...+.......+..++-++.|+.++||||++++......+..|||+|-+. .|..++.. +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3678888888876655444567788899999999999999999999999999999873 44444521 234555
Q ss_pred HHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCC
Q 004416 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706 (754)
Q Consensus 627 ~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 706 (754)
.-.+.||+.||.|||+.+ +++|++|.-..|+|++.|+.||++|.++........ ..+...---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 667899999999999866 699999999999999999999999998865433221 111112223466676554333
Q ss_pred CchhhHHHHHHHHHHHHcC
Q 004416 707 SVKSDVFSFGVLMLEILSS 725 (754)
Q Consensus 707 ~~~~DVwSlGvll~elltg 725 (754)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 356999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=110.61 Aligned_cols=142 Identities=18% Similarity=0.258 Sum_probs=108.2
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccch-hhHHHHHHHHHHHHHcccc--ceeeeEeEEEecC---cEEEEEEccc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHR--NLVRLLGCCIEQG---EKILIYEYMV 604 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~---~~~lV~ey~~ 604 (754)
+.|+.|..+.||+++..+|+.+++|+...... ....++..|+++++.+++. ++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999886668999998765322 1345788999999999764 4567777765532 5689999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS---------------------------------------- 644 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------- 644 (754)
+.++...+. ...++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988766442 134566777778888888888888421
Q ss_pred -------------CCCceeCCCCCCCEEEcC--CCCeEEEeecCccc
Q 004416 645 -------------RLRIIHRDLKASNILLDQ--HMNPKISDFGMARM 676 (754)
Q Consensus 645 -------------~~~iiH~DIkp~NILl~~--~~~~kL~DFGla~~ 676 (754)
...++|+|+.|.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-10 Score=125.70 Aligned_cols=201 Identities=27% Similarity=0.336 Sum_probs=155.6
Q ss_pred CCcceeeeece--eccEEEEeeee---cCcceeeeeecccc--chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcE
Q 004416 525 ENFSIQSKLGE--GGFGPVYKGRL---LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~--G~fg~Vy~~~~---~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 596 (754)
..|.+.+.+|. |.+|.||.++. .++..+|+|+-+.. .+.....=.+|+...+++ .|+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667789999 99999999976 35778999974322 222222335666666667 599999988888889999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHH----HHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEee
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ----GLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDF 671 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DF 671 (754)
++-+|.+. .+|..+.+ .....++......+..+..+ |+.++|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 67766653 23344667777788888888 999999987 9999999999999999 88999999
Q ss_pred cCccccCCCcccCCc---ccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 672 GMARMFGGDELQGNT---KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 672 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|+...+......... ....|...|++||.. ...++...|+|++|.++.+-.++-...-..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 999998775532221 223577889999965 567788999999999999998887765444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.2e-09 Score=100.51 Aligned_cols=131 Identities=21% Similarity=0.312 Sum_probs=101.0
Q ss_pred eeeceeccEEEEeeeecCcceeeeeec-ccc--ch-----hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRL-SNQ--SG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l-~~~--~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
..+++|+-+.+|.+.+. |.++++|.= ++. .+ -..++-.+|+.++.+++--.|...+-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36789999999999664 344666632 221 11 1234567899999999877776666667788888999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
+++..|.+.+... ...++..+-..+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888322 2456777888899999988 99999999999998875 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.7e-09 Score=98.76 Aligned_cols=143 Identities=23% Similarity=0.293 Sum_probs=105.4
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeee-cccc--ch-----hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQ--SG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~-l~~~--~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
....|-+|+-+.|+++.. .|+...||. +.+. .+ -..++.++|+.++.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999987 466666663 3322 11 12456789999999998767665555666777778999
Q ss_pred EcccC-CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC---eEEEeecCccc
Q 004416 601 EYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARM 676 (754)
Q Consensus 601 ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---~kL~DFGla~~ 676 (754)
||+++ .++.+++....... ...+....++.+|-+.+.-||..+ |||+||..+||++.+++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 46677764332222 222333678889999999999988 999999999999976654 58999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.9e-09 Score=109.35 Aligned_cols=152 Identities=24% Similarity=0.282 Sum_probs=114.4
Q ss_pred HHHHccccceeeeEeEEEec-----CcEEEEEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004416 574 LIAKLQHRNLVRLLGCCIEQ-----GEKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647 (754)
Q Consensus 574 ~l~~l~H~nIv~l~~~~~~~-----~~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 647 (754)
-|-.+.|.|||++..++.+. .+..++.|||..|++..+|.... ....+......++..||..||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 44566799999999887543 46789999999999999996543 3345777788899999999999999974 78
Q ss_pred ceeCCCCCCCEEEcCCCCeEEEeecCccccCCC---cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc
Q 004416 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGD---ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724 (754)
Q Consensus 648 iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt 724 (754)
|+|+++..+.|++..++-+|+.- +.-...... ........-.+-++|.|||.=.....+..+|||+||+...||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999988888632 211111110 00111222346789999998777777889999999999999977
Q ss_pred CCC
Q 004416 725 SKK 727 (754)
Q Consensus 725 g~~ 727 (754)
+.-
T Consensus 278 lEi 280 (458)
T KOG1266|consen 278 LEI 280 (458)
T ss_pred hee
Confidence 654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=3e-08 Score=96.93 Aligned_cols=126 Identities=25% Similarity=0.260 Sum_probs=81.7
Q ss_pred EEEeeeecCcceeeeeeccccc--------------------------hhhHHHHHHHHHHHHHcccc--ceeeeEeEEE
Q 004416 540 PVYKGRLLNGQEVAVKRLSNQS--------------------------GQGLKEFKNEMMLIAKLQHR--NLVRLLGCCI 591 (754)
Q Consensus 540 ~Vy~~~~~~~~~vAVK~l~~~~--------------------------~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~ 591 (754)
.||.|...++..+|||+.+... .......++|.+.|.++..- ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4889988888999999764310 00123467899999999766 45666644
Q ss_pred ecCcEEEEEEccc--CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHH-HHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 592 EQGEKILIYEYMV--NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 592 ~~~~~~lV~ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y-LH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
....|||||++ +..+..+... .++......++.++++.+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 5444433211 11123345677778885555 56766 9999999999999988 9999
Q ss_pred EeecCccccC
Q 004416 669 SDFGMARMFG 678 (754)
Q Consensus 669 ~DFGla~~~~ 678 (754)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.7e-09 Score=117.40 Aligned_cols=197 Identities=21% Similarity=0.221 Sum_probs=149.2
Q ss_pred cccCCcceeeeeceeccEEEEeeee--cCcceeeeeeccccchhhHHH--HHHHHHHHHHc-cccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKE--FKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~~vAVK~l~~~~~~~~~~--~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 596 (754)
....+|..+..||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.+++++...+.+....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999864 357789999886653322222 13466666665 588999988888888888
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEeecCcc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMAR 675 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DFGla~ 675 (754)
++=-||++++++...+ .-...+++...+++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999987766 33345677788899999999999999877 9999999999999886 788999999987
Q ss_pred ccCCCcccCCcccccccCccc--CccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYM--SPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
.+.-.. .....+.+++ +++......+-.++|++|||.-+.|.+++..--
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 532111 1122333444 555555677889999999999999999887643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=9.4e-08 Score=99.10 Aligned_cols=132 Identities=17% Similarity=0.152 Sum_probs=95.5
Q ss_pred EEEeeeecCcceeeeeeccccchh-hH----------HHHHHHHHHHHHccccce--eeeEeEEEe-----cCcEEEEEE
Q 004416 540 PVYKGRLLNGQEVAVKRLSNQSGQ-GL----------KEFKNEMMLIAKLQHRNL--VRLLGCCIE-----QGEKILIYE 601 (754)
Q Consensus 540 ~Vy~~~~~~~~~vAVK~l~~~~~~-~~----------~~~~~Ei~~l~~l~H~nI--v~l~~~~~~-----~~~~~lV~e 601 (754)
.|.+... +|+.+.||+....... .. ..+.+|...+.++...+| ++.+++... ....+||+|
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 3556655 5678899976433211 11 147899999999865444 445556543 235789999
Q ss_pred cccCC-CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-------CCCeEEEeecC
Q 004416 602 YMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-------HMNPKISDFGM 673 (754)
Q Consensus 602 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-------~~~~kL~DFGl 673 (754)
++++. +|.+++.... ....+......++.+++..+.-||..+ |+|+|++++|||++. +..+.|+||+.
T Consensus 116 ~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 116 DLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99986 7888873211 233455677789999999999999998 999999999999985 46799999998
Q ss_pred ccc
Q 004416 674 ARM 676 (754)
Q Consensus 674 a~~ 676 (754)
++.
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.3e-09 Score=122.34 Aligned_cols=207 Identities=20% Similarity=0.232 Sum_probs=146.2
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
....+.+.+.+-+-.|.++.++.++-.. +...++|...... ....+....+-.++-.-+||-+++...-+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 3455778888889999999999886432 3334444332211 11122222333333333456666655555566788
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
+|+++|..+++|...++.. ...+.+..+..+..+.++.++||... +.|+|++|.|+|...+++.+++||+....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 9999999999998887433 23455555667777899999999876 89999999999999999999999984433
Q ss_pred cCCC-------------------------ccc----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 004416 677 FGGD-------------------------ELQ----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727 (754)
Q Consensus 677 ~~~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~ 727 (754)
...- ... .......||+.|.+||.+.+......+|.|+.|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2110 000 01122578999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004416 728 NTGVYN 733 (754)
Q Consensus 728 p~~~~~ 733 (754)
||....
T Consensus 1034 p~na~t 1039 (1205)
T KOG0606|consen 1034 PFNAET 1039 (1205)
T ss_pred CCCCcc
Confidence 997654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.7e-07 Score=94.05 Aligned_cols=137 Identities=21% Similarity=0.203 Sum_probs=98.1
Q ss_pred CcceeeeeceeccEEEEeeeecCcceeeeeeccccc----------------------hhhHHHHHHHHHHHHHcccc--
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------------GQGLKEFKNEMMLIAKLQHR-- 581 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~----------------------~~~~~~~~~Ei~~l~~l~H~-- 581 (754)
-..+..+||-|.-+.||.|....|.++|||.=+... .-.....++|.++|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 355678999999999999999899999999522110 01123467899999999755
Q ss_pred ceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc
Q 004416 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (754)
Q Consensus 582 nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~ 661 (754)
.+.+.+++ +...+||||+++-.|...- ++......++..|++-+..+-..| |||+|+.+-||+++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 67776644 5678999999986654322 112223334444555555444556 99999999999999
Q ss_pred CCCCeEEEeecCcccc
Q 004416 662 QHMNPKISDFGMARMF 677 (754)
Q Consensus 662 ~~~~~kL~DFGla~~~ 677 (754)
++|.+.++||-.+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999877654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.3e-07 Score=96.75 Aligned_cols=169 Identities=20% Similarity=0.293 Sum_probs=126.0
Q ss_pred cEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe----cCcEEEEEEcccC-CCHhhH
Q 004416 538 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYMVN-KSLDVF 611 (754)
Q Consensus 538 fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ey~~~-gsL~~~ 611 (754)
-.+.||+.. .||..|++|+++....+.......-+++++++.|+|+|++..++.. +...++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788874 4799999999954433332223456788999999999999998873 3467899999985 456554
Q ss_pred hcCC------------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 612 LFDP------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 612 l~~~------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
-+.. ......++...+.++.|+..||.++|+.| +..+-|.|++||++.+.+++|..-|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4322 23345778999999999999999999998 88899999999999999999988777655433
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p 728 (754)
+.. |-+.+ -.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 1257999999999999999665
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-07 Score=83.89 Aligned_cols=87 Identities=24% Similarity=0.319 Sum_probs=63.0
Q ss_pred eEEEeccCcEEEecCC-CCeEEEecccCCc-cCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccccccccc
Q 004416 105 VLTVSNRGNLVLLNQS-NGTIWSSNVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (754)
Q Consensus 105 ~l~~~~~g~l~l~~~~-~~~~wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 182 (754)
.+.++.||+||+++.. +.++|++++.... .++.+.|+++|||||++.+ +.++|+|
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S------------------ 79 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-----GRVVWSS------------------ 79 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-----CCEEEEe------------------
Confidence 4556789999999865 5899999986543 3367789999999999873 4678886
Q ss_pred ccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeecc
Q 004416 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCT 228 (754)
Q Consensus 183 ~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~s 228 (754)
......|.+.+.++.+|...++-.++ .+.|.+
T Consensus 80 -------------~t~~~~~~~~~~L~ddGnlvl~~~~~-~~~W~S 111 (114)
T smart00108 80 -------------NTTGANGNYVLVLLDDGNLVIYDSDG-NFLWQS 111 (114)
T ss_pred -------------cccCCCCceEEEEeCCCCEEEECCCC-CEEeCC
Confidence 11123566889999999976543333 466764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.2e-06 Score=87.70 Aligned_cols=107 Identities=22% Similarity=0.203 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHHHccccc--eeeeEeEEEecC----cEEEEEEcccCC-CHhhHhcCCCCcccccHHHHHHHHHHHHHHH
Q 004416 565 LKEFKNEMMLIAKLQHRN--LVRLLGCCIEQG----EKILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637 (754)
Q Consensus 565 ~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~----~~~lV~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L 637 (754)
.....+|...+.++...+ ..+.+++..... ..++|+|++++. +|.+++.... ..+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 345788999888886543 456666665532 458999999874 7888874311 155666788999999999
Q ss_pred HHHHhcCCCCceeCCCCCCCEEEcCCC---CeEEEeecCcccc
Q 004416 638 LYLHQYSRLRIIHRDLKASNILLDQHM---NPKISDFGMARMF 677 (754)
Q Consensus 638 ~yLH~~~~~~iiH~DIkp~NILl~~~~---~~kL~DFGla~~~ 677 (754)
.-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.5e-07 Score=80.79 Aligned_cols=87 Identities=23% Similarity=0.229 Sum_probs=62.7
Q ss_pred EEEec-cCcEEEecCC-CCeEEEecccCC-ccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccccccccc
Q 004416 106 LTVSN-RGNLVLLNQS-NGTIWSSNVSRE-VKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (754)
Q Consensus 106 l~~~~-~g~l~l~~~~-~~~~wst~~~~~-~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 182 (754)
+.++. ||+||+++.. +.++|++++... .....+.|+++|||||++.+ +.++|+|=
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~S~----------------- 81 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-----GTVVWSSN----------------- 81 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-----CcEEEEec-----------------
Confidence 45666 9999999765 589999998753 34566789999999999874 46789861
Q ss_pred ccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccC
Q 004416 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTG 229 (754)
Q Consensus 183 ~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg 229 (754)
...+.+.+.+.++.+|...++-.+ ..+.|.+.
T Consensus 82 --------------~~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 82 --------------TTRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred --------------ccCCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 111356788999999987654333 35677654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.3e-07 Score=99.23 Aligned_cols=142 Identities=15% Similarity=0.190 Sum_probs=93.3
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchh------------------------------hHH----------HHHH
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ------------------------------GLK----------EFKN 570 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~------------------------------~~~----------~~~~ 570 (754)
+.|+.++-|+||+|++++|+.||||+....-.. ..+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 689999999999999999999999987542110 011 1344
Q ss_pred HHHHHHHcc----ccceeeeEeEEE-ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHH-HHHHHhcC
Q 004416 571 EMMLIAKLQ----HRNLVRLLGCCI-EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG-LLYLHQYS 644 (754)
Q Consensus 571 Ei~~l~~l~----H~nIv~l~~~~~-~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~-L~yLH~~~ 644 (754)
|+..+.+++ +..-+++-..+. -.+...|+|||++|-.+.+...... ...+. ..++..++++ +..+=..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhcC
Confidence 555555553 222223323333 3568899999999998887742221 22332 2333333333 22222234
Q ss_pred CCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 645 ~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
++|.|..|.||+++.++++.+.|||+...+.+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999887653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=7.3e-06 Score=80.75 Aligned_cols=139 Identities=16% Similarity=0.166 Sum_probs=102.1
Q ss_pred eceeccEEEEeeeecCcceeeeeecccc------chhhHHHHHHHHHHHHHccccc--eeeeEeEEEec----CcEEEEE
Q 004416 533 LGEGGFGPVYKGRLLNGQEVAVKRLSNQ------SGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIEQ----GEKILIY 600 (754)
Q Consensus 533 LG~G~fg~Vy~~~~~~~~~vAVK~l~~~------~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~----~~~~lV~ 600 (754)
-|+||-+-|++..+ +|+.+-+|+-... .+.....|.+|...|.++...+ +.+........ -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46688888998776 3457888876521 1446678999999999996533 44544222221 1467999
Q ss_pred Eccc-CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC--eEEEeecCccc
Q 004416 601 EYMV-NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--PKISDFGMARM 676 (754)
Q Consensus 601 ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--~kL~DFGla~~ 676 (754)
|-++ -.+|.+++... .....+......++.++++++.-||+.+ +.|+|+.++|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9775 35787777322 2234567777899999999999999998 999999999999986667 99999987754
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.9e-06 Score=74.59 Aligned_cols=99 Identities=24% Similarity=0.381 Sum_probs=65.8
Q ss_pred EEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEec-cCCCCCcCCCceEEEeccCcEEEecCCCCeEEEecccCCc
Q 004416 55 TLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVA-NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREV 133 (754)
Q Consensus 55 ~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~a-n~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~ 133 (754)
.+.+.+|.+.|-|...|+ |-|.-. ..+++|.+ +...+-. ..+.+.|+.||||||+|..+.++|+|.. ..
T Consensus 13 p~~~~s~~~~L~l~~dGn-----Lvl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~p 82 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN-----LVLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--YP 82 (114)
T ss_dssp EEEECETTEEEEEETTSE-----EEEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--SS
T ss_pred ccccccccccceECCCCe-----EEEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--CC
Confidence 455545778888887665 444321 35779999 5454421 5799999999999999999999999932 33
Q ss_pred cCceEEEec--CCCEEEecCCCCCCcccccccccCCCc
Q 004416 134 KNPVAQLLD--NGNLVIRDNSGSNSTESYLWQSFDYPT 169 (754)
Q Consensus 134 ~~~~a~l~d--~GNlvl~~~~~~~~~~~~~WqSFd~Pt 169 (754)
..++...++ +||++ +.. ...+.|.|=+.|+
T Consensus 83 tdt~L~~q~l~~~~~~-~~~-----~~~~sw~s~~dps 114 (114)
T PF01453_consen 83 TDTLLPGQKLGDGNVT-GKN-----DSLTSWSSNTDPS 114 (114)
T ss_dssp S-EEEEEET--TSEEE-EES-----TSSEEEESS----
T ss_pred ccEEEeccCcccCCCc-ccc-----ceEEeECCCCCCC
Confidence 456667787 89998 654 2467888866663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.4e-06 Score=81.04 Aligned_cols=138 Identities=18% Similarity=0.192 Sum_probs=93.3
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhh-------------------H-----HHHHHHHHHHHHcc--cccee
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------L-----KEFKNEMMLIAKLQ--HRNLV 584 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~-------------------~-----~~~~~Ei~~l~~l~--H~nIv 584 (754)
..|..|..+.||+|...++..+|||+++...... . .-..+|..-|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3567788889999988789999999985432110 0 11245667777764 33445
Q ss_pred eeEeEEEecCcEEEEEEcccCCCH-hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC
Q 004416 585 RLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (754)
Q Consensus 585 ~l~~~~~~~~~~~lV~ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~ 663 (754)
+-+++ ....|||||+..... .-.|. .-.+...+...+..++++.+.-|-... ++||+||+.-|||+. +
T Consensus 134 ~Pi~~----~~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAF----RNNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceee----cCCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence 55544 245799999965421 12221 122233356677788888888777633 499999999999999 7
Q ss_pred CCeEEEeecCccccCC
Q 004416 664 MNPKISDFGMARMFGG 679 (754)
Q Consensus 664 ~~~kL~DFGla~~~~~ 679 (754)
+.+.|+|||.|.....
T Consensus 203 ~~p~iID~~QaV~~~h 218 (268)
T COG1718 203 GEPYIIDVSQAVTIDH 218 (268)
T ss_pred CeEEEEECccccccCC
Confidence 8999999999987643
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.27 E-value=2e-06 Score=71.29 Aligned_cols=72 Identities=36% Similarity=0.806 Sum_probs=53.9
Q ss_pred CceeEecccCCCCccccccccccCHHHHHHHHhc-CCCeEeeeccccCCCCccceecc-ccccccccCCCCCCCeeEEEe
Q 004416 351 DRFKKLDDIKLPDLLDVSLNESMNLKECEAECLK-NCSCRAYANSKVTDGGSGCLMWF-GDLIDLKKTDNHTNGVSIYIR 428 (754)
Q Consensus 351 ~~f~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~C~~w~-g~l~~~~~~~~~~~~~~~ylr 428 (754)
+.|.+++++.+++..... ....++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+....++ .+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~--~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPS--GGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceeccc--CCceeEEe
Confidence 569999999999664432 456799999999999 99999999964 456799999 77776653333 34455544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.8e-06 Score=86.28 Aligned_cols=192 Identities=14% Similarity=0.150 Sum_probs=123.1
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEE------e-cCcEEEEE
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI------E-QGEKILIY 600 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~------~-~~~~~lV~ 600 (754)
..+.||+|+-+.+|-.-.. ...+.|+..........+ .+..|... .||-+-.-+.+=+ + +...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3468999999999965321 123456665443322222 22333333 4554332111110 1 11245667
Q ss_pred EcccCCCHhhHhcC----CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 601 EYMVNKSLDVFLFD----PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 601 ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
..+++.---..++. ...-....|.-.++.+..++.+.+.||..| .+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 76655421111221 122345789999999999999999999998 88999999999999999999998544332
Q ss_pred cCCCcccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSS-KKNTGV 731 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg-~~p~~~ 731 (754)
... .......+|...|.+||... +-.-+...|.|.||+++++++.| +.||..
T Consensus 167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 211 11223357889999999654 23345679999999999999987 889865
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.5e-05 Score=80.93 Aligned_cols=138 Identities=17% Similarity=0.198 Sum_probs=85.3
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEeEEEecCcEEEEEEcccCCC-
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIEQGEKILIYEYMVNKS- 607 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~ey~~~gs- 607 (754)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-+ +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 25567888876533 2345688999999987544 4667777777777889999999863
Q ss_pred HhhHh---------------------cCCC-CcccccHHHHHHHHHH----------HHH-HHHHHHh-cCCCCceeCCC
Q 004416 608 LDVFL---------------------FDPT-KKHLLGWQLRVRIIDG----------IAQ-GLLYLHQ-YSRLRIIHRDL 653 (754)
Q Consensus 608 L~~~l---------------------~~~~-~~~~l~~~~~~~i~~q----------ia~-~L~yLH~-~~~~~iiH~DI 653 (754)
+...+ +... ....+.. ...++..+ +.+ ...+|.. .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~-~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS-YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH-HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100 0000100 00001000 111 1222221 12235789999
Q ss_pred CCCCEEEcCCCCeEEEeecCcc
Q 004416 654 KASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 654 kp~NILl~~~~~~kL~DFGla~ 675 (754)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.3e-05 Score=77.56 Aligned_cols=138 Identities=15% Similarity=0.193 Sum_probs=93.8
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHH---------HHHHHHHHHHccccc---eeeeEeEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---------FKNEMMLIAKLQHRN---LVRLLGCC 590 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~---------~~~Ei~~l~~l~H~n---Iv~l~~~~ 590 (754)
...+|.+.+++-......|.+-.. +++.+.+|..........+. ..+++..+.+++..+ ...++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 446788888888888888887776 57889999887654332222 234555555554322 23323332
Q ss_pred Ee-----cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC
Q 004416 591 IE-----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (754)
Q Consensus 591 ~~-----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~ 665 (754)
.. ....+++|||++|..|.++.. +++ .+...+++++.-||..| +.|+|+.|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 22 234568999999988765431 222 24456778899999998 9999999999999966 4
Q ss_pred eEEEeecCccc
Q 004416 666 PKISDFGMARM 676 (754)
Q Consensus 666 ~kL~DFGla~~ 676 (754)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.8e-07 Score=99.85 Aligned_cols=194 Identities=17% Similarity=0.119 Sum_probs=138.8
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc-eeeeEeEEEecCcE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCIEQGEK 596 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~~~~~~~~~~ 596 (754)
..+...+..+...+.+++++.++++|.+-...+...++.+... ....-++++|.+.+||| .++.++.+..++..
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 3444555666667889999999999987544444445554332 33456889999999999 78888888778888
Q ss_pred EEEEEcccCC-CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 597 ILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 597 ~lV~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
+++++++..+ +..... ....-.+..-+...+...-.+++++||+.. =+|+| ||+..+ +..+..||+.+.
T Consensus 310 ~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred chhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCc
Confidence 9999999877 211111 011112223333445556678899999853 48988 787766 578999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
.+.+.. ..+...+|+.++|||+.....+..+.|+|++++-..+|--|-+|-
T Consensus 380 ~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 380 QLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 775543 344578999999999999999999999999998777777666653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.08 E-value=3e-05 Score=78.85 Aligned_cols=144 Identities=21% Similarity=0.198 Sum_probs=85.6
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEeEEEe---cCcEEEEEEccc
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIE---QGEKILIYEYMV 604 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~---~~~~~lV~ey~~ 604 (754)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+.... +.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999999866 68999987554 45567788999999886443 5566664432 234689999999
Q ss_pred CCCHhh----------------Hh---cCC-CCcccccHHH---------HHHH------------HHHHHH-HHHHHHh
Q 004416 605 NKSLDV----------------FL---FDP-TKKHLLGWQL---------RVRI------------IDGIAQ-GLLYLHQ 642 (754)
Q Consensus 605 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qia~-~L~yLH~ 642 (754)
+..+.. .+ +.. .......... .... ...+.+ .++.++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987776 11 111 0000001000 0000 111222 3333332
Q ss_pred ----cCCCCceeCCCCCCCEEEc-CCCCeEEEeecCccc
Q 004416 643 ----YSRLRIIHRDLKASNILLD-QHMNPKISDFGMARM 676 (754)
Q Consensus 643 ----~~~~~iiH~DIkp~NILl~-~~~~~kL~DFGla~~ 676 (754)
.....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1345699999999999999 556667999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.9e-05 Score=78.30 Aligned_cols=140 Identities=14% Similarity=0.103 Sum_probs=85.3
Q ss_pred eeceecc-EEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEEcccCCCHh
Q 004416 532 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLD 609 (754)
Q Consensus 532 ~LG~G~f-g~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~ 609 (754)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 788998764 4678888875443 345678999998884 444667787776666789999999998776
Q ss_pred hHh-------------------cCCCC-cccccH--HHHHHH-HH-------------------HHHHHHHHHHh----c
Q 004416 610 VFL-------------------FDPTK-KHLLGW--QLRVRI-ID-------------------GIAQGLLYLHQ----Y 643 (754)
Q Consensus 610 ~~l-------------------~~~~~-~~~l~~--~~~~~i-~~-------------------qia~~L~yLH~----~ 643 (754)
... +.... ...... ...... .. .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11000 000000 000000 00 01111222211 1
Q ss_pred CCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 644 ~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 22458999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3e-05 Score=86.91 Aligned_cols=141 Identities=19% Similarity=0.244 Sum_probs=89.5
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhh-------------------------------HH------HHHHHHH
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-------------------------------LK------EFKNEMM 573 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~-------------------------------~~------~~~~Ei~ 573 (754)
+.|+.-+.|.||+|++++|+.||||+-+..-... .+ .|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999865431110 01 1344554
Q ss_pred HHHHc----cccce---eeeEeEEE-ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHH-HHhcC
Q 004416 574 LIAKL----QHRNL---VRLLGCCI-EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY-LHQYS 644 (754)
Q Consensus 574 ~l~~l----~H~nI---v~l~~~~~-~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y-LH~~~ 644 (754)
-..++ +|-++ |++-.++. -...+.|+||||+|..+.+...- .+..++... ++..+.++... +=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~---i~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHD---ILNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 44443 35551 11222222 24578999999999887665321 222344443 33333333221 11223
Q ss_pred CCCceeCCCCCCCEEEcC----CCCeEEEeecCccccCC
Q 004416 645 RLRIIHRDLKASNILLDQ----HMNPKISDFGMARMFGG 679 (754)
Q Consensus 645 ~~~iiH~DIkp~NILl~~----~~~~kL~DFGla~~~~~ 679 (754)
++|+|-.|.||++++ ++.+.+.|||+...+..
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67799999999987644
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.8e-05 Score=74.76 Aligned_cols=105 Identities=21% Similarity=0.204 Sum_probs=82.2
Q ss_pred HHHHHHHHHccc-cceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004416 569 KNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLR 647 (754)
Q Consensus 569 ~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 647 (754)
..|.-+|..+++ +++++++|+| ..++|.||...+++...-.....-...+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999998 34678999987655321000011224679999999999999999999855445
Q ss_pred ceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 648 IIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 648 iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+..+|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0001 Score=69.80 Aligned_cols=129 Identities=22% Similarity=0.332 Sum_probs=87.9
Q ss_pred cceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceee-eEeEEEecCcEEEEEEcccC
Q 004416 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~-l~~~~~~~~~~~lV~ey~~~ 605 (754)
....+.|++|.+|.||++.+. +.++|+|+-...+ ....++.|+++|..++-.++.+ ++.+ ++-.+.|||+.+
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcC
Confidence 345578999999999999884 5689999865443 4577899999999998777654 4433 233455999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCC--CCEEEcCCCCeEEEeecCccc
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKA--SNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp--~NILl~~~~~~kL~DFGla~~ 676 (754)
..|...-... +. +-+..+++.---|...+ |-|..|.- +||++.+ ..+.|+||..|+.
T Consensus 97 ~~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 8876644111 11 22233445544455555 88888863 4555544 4999999999974
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00029 Score=85.39 Aligned_cols=78 Identities=19% Similarity=0.382 Sum_probs=57.1
Q ss_pred eeeeceeccEEEEeeeecCc---ceeeeeeccccc-hhhHHHHHHHHHHHHHcc-ccce--eeeEeEEEec---CcEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLLGCCIEQ---GEKILI 599 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~---~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~nI--v~l~~~~~~~---~~~~lV 599 (754)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 47889999999999876543 467788764432 123356789999999995 6654 7788877654 467899
Q ss_pred EEcccCCC
Q 004416 600 YEYMVNKS 607 (754)
Q Consensus 600 ~ey~~~gs 607 (754)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=5.5e-06 Score=92.88 Aligned_cols=96 Identities=25% Similarity=0.457 Sum_probs=75.0
Q ss_pred HHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC-------CcccccccCcccCccccCC
Q 004416 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-------NTKRIVGTYGYMSPEYALE 703 (754)
Q Consensus 631 ~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 703 (754)
.+++.|+.|+|..- .+||++|.|++|.++..+..||+.|+.+....+..... ...-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999854 69999999999999999999999999987655421110 1111223467999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCC
Q 004416 704 GVFSVKSDVFSFGVLMLEILSSKKN 728 (754)
Q Consensus 704 ~~~~~~~DVwSlGvll~elltg~~p 728 (754)
...+.++|+||+|+++|-+..|.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcc
Confidence 8889999999999999999955444
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00041 Score=67.97 Aligned_cols=125 Identities=23% Similarity=0.380 Sum_probs=90.3
Q ss_pred CCcceeeeeceecc-EEEEeeeecCcceeeeeeccc---cc-----------h-------hhHHHHHHHHHHHHHccc--
Q 004416 525 ENFSIQSKLGEGGF-GPVYKGRLLNGQEVAVKRLSN---QS-----------G-------QGLKEFKNEMMLIAKLQH-- 580 (754)
Q Consensus 525 ~~y~i~~~LG~G~f-g~Vy~~~~~~~~~vAVK~l~~---~~-----------~-------~~~~~~~~Ei~~l~~l~H-- 580 (754)
.+++.++.||.|.- |.||++++ +|+.+|+|++.. .. . .....|..|.+...++++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999998 678999999321 00 0 112357889998888853
Q ss_pred -cce--eeeEeEEEecC------------------cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHH
Q 004416 581 -RNL--VRLLGCCIEQG------------------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639 (754)
Q Consensus 581 -~nI--v~l~~~~~~~~------------------~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y 639 (754)
.++ |+.+|+..-.. ...||.||++... .+. .+-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 455 89999874321 2357777775532 112 2234567778888
Q ss_pred HHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 640 LH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999985 4589999865
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00022 Score=73.08 Aligned_cols=73 Identities=14% Similarity=0.209 Sum_probs=46.5
Q ss_pred eeeceeccEE-EEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccc---ceeeeEeEEEec---CcEEEEEEcc
Q 004416 531 SKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCIEQ---GEKILIYEYM 603 (754)
Q Consensus 531 ~~LG~G~fg~-Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~~~---~~~~lV~ey~ 603 (754)
+.|+.|+... ||+. +..+++|..+.. .....+.+|++.+..+... .+.+.++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 4677777764 8875 235777875442 2345788999999888532 344444433221 2347899999
Q ss_pred cCCCHh
Q 004416 604 VNKSLD 609 (754)
Q Consensus 604 ~~gsL~ 609 (754)
++.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00033 Score=69.23 Aligned_cols=131 Identities=18% Similarity=0.253 Sum_probs=91.2
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccc----------------hhhHHHHHHHHHHHHHcc------ccceeeeEe
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLLG 588 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~nIv~l~~ 588 (754)
..||+|+.=.||. +++.....||+..... ....++..+|+.....+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4799999999986 4556667888876544 223466777887777776 778999999
Q ss_pred EEEecCcEEEEEEcccC--C----CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC
Q 004416 589 CCIEQGEKILIYEYMVN--K----SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (754)
Q Consensus 589 ~~~~~~~~~lV~ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~ 662 (754)
..+.+...-+|+|.+.+ | +|.+++ ....++. ... ..+-+-..||-+.+ |+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 99999889999998753 2 455555 3333444 223 33334455666655 999999999999964
Q ss_pred CC----CeEEEe-ecCc
Q 004416 663 HM----NPKISD-FGMA 674 (754)
Q Consensus 663 ~~----~~kL~D-FGla 674 (754)
.. .+.|+| ||-.
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 32 577888 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00067 Score=71.96 Aligned_cols=78 Identities=13% Similarity=0.106 Sum_probs=57.3
Q ss_pred ceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccc---cceeeeEeEEEe---cCcEEEEEE
Q 004416 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCIE---QGEKILIYE 601 (754)
Q Consensus 528 ~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~~~~~~---~~~~~lV~e 601 (754)
.-.+.||.|..+.||+....++ .+++|..+.. .....+.+|++.|+.+.. ..+.++++.+.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3457899999999999876555 4666764331 123578899999999853 367888887754 356899999
Q ss_pred cccCCCH
Q 004416 602 YMVNKSL 608 (754)
Q Consensus 602 y~~~gsL 608 (754)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00047 Score=70.50 Aligned_cols=73 Identities=19% Similarity=0.251 Sum_probs=48.7
Q ss_pred eeeceeccEEEEeeeecC--cceeeeeeccccchhhHHHHHHHHHHHHHcccccee-eeEeEEEecCcEEEEEEcccCCC
Q 004416 531 SKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMVNKS 607 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~--~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~~gs 607 (754)
+.|..|-...+|+....+ ++.|++|+........ -...+|+.++..+...+++ ++++.. + ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence 577888888999987654 5788899775432221 2235789899988654443 444332 2 247999999876
Q ss_pred H
Q 004416 608 L 608 (754)
Q Consensus 608 L 608 (754)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0018 Score=70.91 Aligned_cols=74 Identities=14% Similarity=0.186 Sum_probs=54.0
Q ss_pred eeeceeccEEEEeeeecCc-ceeeeeecccc-----c--hhhHHHHHHHHHHHHHcc-c--cceeeeEeEEEecCcEEEE
Q 004416 531 SKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~-~~vAVK~l~~~-----~--~~~~~~~~~Ei~~l~~l~-H--~nIv~l~~~~~~~~~~~lV 599 (754)
+.||.|.+..||++...+| +.|+||.-... . +...+++..|.+.|..+. + ..+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998776 58999974321 1 224567778888888863 2 356677766 44567899
Q ss_pred EEcccCC
Q 004416 600 YEYMVNK 606 (754)
Q Consensus 600 ~ey~~~g 606 (754)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00083 Score=69.73 Aligned_cols=139 Identities=14% Similarity=0.071 Sum_probs=79.1
Q ss_pred eeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccce-eeeEeEEEecCcEEEEEEcccCCCHhh
Q 004416 532 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYMVNKSLDV 610 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~~~gsL~~ 610 (754)
.+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++... ...+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 345577778888863 567888887654322211134789999999865444 3344432 2368999999876532
Q ss_pred H-----------------hcCCC-CcccccHH-HHHHHHHH---------HHHHHHHHHhc-----CCCCceeCCCCCCC
Q 004416 611 F-----------------LFDPT-KKHLLGWQ-LRVRIIDG---------IAQGLLYLHQY-----SRLRIIHRDLKASN 657 (754)
Q Consensus 611 ~-----------------l~~~~-~~~~l~~~-~~~~i~~q---------ia~~L~yLH~~-----~~~~iiH~DIkp~N 657 (754)
. ++... ....++.. ....+..+ +.+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 11111211 11111111 11222222211 12358999999999
Q ss_pred EEEcCCCCeEEEeecCccc
Q 004416 658 ILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~ 676 (754)
|++++++ +.|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0021 Score=68.20 Aligned_cols=143 Identities=17% Similarity=0.147 Sum_probs=86.4
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEeE------EEecCcEEEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CIEQGEKILIYE 601 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~------~~~~~~~~lV~e 601 (754)
.+.|..|....+|+.... +..+++|+... ...++...|+.++..+++.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457777888899998764 44788898764 22355677888888886443 4444431 123456689999
Q ss_pred cccCCCHhh----H----------hcCC----CC----cccccHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 004416 602 YMVNKSLDV----F----------LFDP----TK----KHLLGWQLRV----------RIIDGIAQGLLYLHQ----YSR 645 (754)
Q Consensus 602 y~~~gsL~~----~----------l~~~----~~----~~~l~~~~~~----------~i~~qia~~L~yLH~----~~~ 645 (754)
|++|..+.. . ++.. .. .....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 0 0100 00 0111111110 011223344455543 122
Q ss_pred CCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 646 LRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 646 ~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987778999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00084 Score=69.46 Aligned_cols=148 Identities=14% Similarity=0.158 Sum_probs=100.1
Q ss_pred cchhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc----------c-------hh-----hHHHHHHHH
Q 004416 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----------S-------GQ-----GLKEFKNEM 572 (754)
Q Consensus 515 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~----------~-------~~-----~~~~~~~Ei 572 (754)
..+.++.....-+.+.++||-|.-+.||.+...+|++.++|.=.-. . .. ..-...+|.
T Consensus 82 LAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEf 161 (465)
T KOG2268|consen 82 LALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEF 161 (465)
T ss_pred HHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHH
Confidence 3444444444557788999999999999999888999988842110 0 00 011346788
Q ss_pred HHHHHcccc--ceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 004416 573 MLIAKLQHR--NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650 (754)
Q Consensus 573 ~~l~~l~H~--nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH 650 (754)
..|+.+... .+.+.++ ....++|||++.+-.|...-+ ..+. ..+...+..-+--|..+| +||
T Consensus 162 afmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~---~~ly~~lm~~Iv~la~~G---lIH 225 (465)
T KOG2268|consen 162 AFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDP---PTLYDDLMGLIVRLANHG---LIH 225 (465)
T ss_pred HHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee------cCCh---HHHHHHHHHHHHHHHHcC---cee
Confidence 888888532 3445443 456789999998877654321 1112 223344444555666667 999
Q ss_pred CCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 651 RDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 651 ~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
+|..-=||++++++.++++||-......
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred cccchheeEEecCCCEEEeechHhhccC
Confidence 9999999999999999999998765443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.008 Score=64.53 Aligned_cols=142 Identities=18% Similarity=0.189 Sum_probs=78.1
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEe------EEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLG------CCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~------~~~~~~~~~lV~ey 602 (754)
+.|..|....+|+....++ .+++|++.... .+.+..|+.++..+...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5677777789999876554 68889875212 234445666666664322 333332 11234567899999
Q ss_pred ccCCCHhh-----------Hh---cCCC------C--cccccH-HHHHH------------HH-HHHHHHHHHHHhc---
Q 004416 603 MVNKSLDV-----------FL---FDPT------K--KHLLGW-QLRVR------------II-DGIAQGLLYLHQY--- 643 (754)
Q Consensus 603 ~~~gsL~~-----------~l---~~~~------~--~~~l~~-~~~~~------------i~-~qia~~L~yLH~~--- 643 (754)
+++..+.. .+ +... . ...+.+ ..... .+ ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 98875421 11 1100 0 001111 11111 11 1111222333211
Q ss_pred -CCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 644 -SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 644 -~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
-+..+||+|+.|.|||++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999765568999998853
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0085 Score=63.27 Aligned_cols=143 Identities=18% Similarity=0.174 Sum_probs=98.4
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeeccccc----------------------hhhHH----HHHHHHHHHHHccccc
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------------GQGLK----EFKNEMMLIAKLQHRN 582 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~----------------------~~~~~----~~~~Ei~~l~~l~H~n 582 (754)
+...|..|.-+.||.+.-.+|..+|||+++..- ....+ -...|+.-|++++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 446788999999999998899999999875310 00011 1356888888887655
Q ss_pred eeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC
Q 004416 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (754)
Q Consensus 583 Iv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~ 662 (754)
|.-.--... ....|||+|+....... ...+.-.++...+..+-.|+++-+.-|-..+ ++||.||.--|+|+.+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 432111111 23479999996433211 1123345666778888888888888888776 5999999999999865
Q ss_pred CCCeEEEeecCccccCC
Q 004416 663 HMNPKISDFGMARMFGG 679 (754)
Q Consensus 663 ~~~~kL~DFGla~~~~~ 679 (754)
|.+.|+|.+.+.....
T Consensus 301 -G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEHDH 316 (520)
T ss_pred -CEEEEEEccccccCCC
Confidence 5899999998876544
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.011 Score=62.92 Aligned_cols=141 Identities=27% Similarity=0.333 Sum_probs=83.6
Q ss_pred eeeceeccEEEEeeeecC-------cceeeeeeccccchhhHHHHHHHHHHHHHcccccee-eeEeEEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-------~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey 602 (754)
+.|..|-...+|+....+ ++.+++|+...... ......+|.+++..+...++. ++++.+. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 466667777899887654 47888998755432 223457888888888644443 4555443 2 358999
Q ss_pred ccCCCHhhH-----------------hcCCCCcc------ccc--HHHHHH--------------------------HHH
Q 004416 603 MVNKSLDVF-----------------LFDPTKKH------LLG--WQLRVR--------------------------IID 631 (754)
Q Consensus 603 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 631 (754)
++|..+... ++...... ... +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766321 11111100 000 111101 111
Q ss_pred HHHHHHHHHHh------cCCCCceeCCCCCCCEEEcCC----CCeEEEeecCccc
Q 004416 632 GIAQGLLYLHQ------YSRLRIIHRDLKASNILLDQH----MNPKISDFGMARM 676 (754)
Q Consensus 632 qia~~L~yLH~------~~~~~iiH~DIkp~NILl~~~----~~~kL~DFGla~~ 676 (754)
.+...+..|.. .....++|+|+.|.|||++++ +.++++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134568999999999999985 7899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.011 Score=61.85 Aligned_cols=31 Identities=26% Similarity=0.516 Sum_probs=25.9
Q ss_pred CCceeCCCCCCCEEEcCCCC-eEEEeecCccc
Q 004416 646 LRIIHRDLKASNILLDQHMN-PKISDFGMARM 676 (754)
Q Consensus 646 ~~iiH~DIkp~NILl~~~~~-~kL~DFGla~~ 676 (754)
..++|+|+.|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.012 Score=63.79 Aligned_cols=142 Identities=18% Similarity=0.255 Sum_probs=83.4
Q ss_pred eeeceeccEEEEeeeecC-----cceeeeeeccccchhhHHHHHHHHHHHHHcccccee-eeEeEEEecCcEEEEEEccc
Q 004416 531 SKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~-----~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~ 604 (754)
+.|-.|-.-.+|+....+ ++.|++|+..........+ .+|..+++.+...++. ++++.+. .+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeC
Confidence 455557777888886432 3578899876554333333 7799999998765554 4555543 22 5899998
Q ss_pred CCCHhhH-----------------hcCCC--C-cccccHHHHHHHHHH-----------------HHHHHHHHH----h-
Q 004416 605 NKSLDVF-----------------LFDPT--K-KHLLGWQLRVRIIDG-----------------IAQGLLYLH----Q- 642 (754)
Q Consensus 605 ~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~q-----------------ia~~L~yLH----~- 642 (754)
+.++... +|... . .....+....++..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7766421 11111 0 111112222233211 111222222 1
Q ss_pred cCCCCceeCCCCCCCEEEcC-CCCeEEEeecCcccc
Q 004416 643 YSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMF 677 (754)
Q Consensus 643 ~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~ 677 (754)
.....++|+|+++.|||+++ ++.+.++||..|..-
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 22345899999999999986 467999999988753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.023 Score=60.67 Aligned_cols=143 Identities=19% Similarity=0.222 Sum_probs=82.4
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEeE------EEecCcEEEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CIEQGEKILIYE 601 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~------~~~~~~~~lV~e 601 (754)
.+.++.|....+|+....++ .+++|+..... ..+....|++++..+...+ +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876444 57788764421 1234556777777775332 3444432 112456789999
Q ss_pred cccCCCHhh-----------H---hcCCCC------c---ccccHHHHH------------HHHHHHHHHHHHHHh----
Q 004416 602 YMVNKSLDV-----------F---LFDPTK------K---HLLGWQLRV------------RIIDGIAQGLLYLHQ---- 642 (754)
Q Consensus 602 y~~~gsL~~-----------~---l~~~~~------~---~~l~~~~~~------------~i~~qia~~L~yLH~---- 642 (754)
|++|..+.. . ++.... . ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998855321 0 111000 0 011111100 011223344555542
Q ss_pred cCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 643 ~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.....++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223469999999999999998767899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.012 Score=61.74 Aligned_cols=75 Identities=16% Similarity=0.207 Sum_probs=49.5
Q ss_pred ceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcc---ccceeeeEeEEEecCcEEEEEEccc
Q 004416 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 528 ~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|++-|+.|. --.+.+.+++...++..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 345789989999999987 467889999865 233467888999999884 3357788888877778899999998
Q ss_pred CC
Q 004416 605 NK 606 (754)
Q Consensus 605 ~g 606 (754)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0037 Score=51.06 Aligned_cols=52 Identities=12% Similarity=0.315 Sum_probs=36.6
Q ss_pred eEecccCCCCccccccccccCHHHHHHHHhcCCCeEeeeccccCCCCccceecccc
Q 004416 354 KKLDDIKLPDLLDVSLNESMNLKECEAECLKNCSCRAYANSKVTDGGSGCLMWFGD 409 (754)
Q Consensus 354 ~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~g~ 409 (754)
..+.++.+++...... ...+.++|++.|+.||+|.||.|.. +...|.++.+.
T Consensus 7 ~~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 7 RQGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred cccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 3445666665443222 3568999999999999999999963 23469887754
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.089 Score=56.61 Aligned_cols=72 Identities=14% Similarity=0.161 Sum_probs=47.9
Q ss_pred eeceeccEEEEeeeecCc-ceeeeeecccc-------chhhHHHHHHHHHHHHHcc--cc-ceeeeEeEEEecCcEEEEE
Q 004416 532 KLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ--HR-NLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 532 ~LG~G~fg~Vy~~~~~~~-~~vAVK~l~~~-------~~~~~~~~~~Ei~~l~~l~--H~-nIv~l~~~~~~~~~~~lV~ 600 (754)
.||-|....||++...++ +.|+||.-... -+-..++...|.+.|+... -| .+.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999987654 58999964321 1233455667778886653 24 34455543 455667999
Q ss_pred EcccC
Q 004416 601 EYMVN 605 (754)
Q Consensus 601 ey~~~ 605 (754)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.051 Score=57.61 Aligned_cols=146 Identities=17% Similarity=0.247 Sum_probs=79.9
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeecc-ccchhhHHHHHHHHHHHHHccc--cceeeeEeEEEecC--cEEEEEEccc
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQG--EKILIYEYMV 604 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~-~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~--~~~lV~ey~~ 604 (754)
.+.+..|---.+|..... ++++++.+-. ..........++|..+|+.+.- .-+.+.++.|.++. ..+.||+|.+
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 344433333334444332 6777777221 1122334455778888888743 34455667776665 6699999998
Q ss_pred CCCHhhHhcCCCC-----------------------------------cccccHHHHHHH--------HHHHHHHHHHHH
Q 004416 605 NKSLDVFLFDPTK-----------------------------------KHLLGWQLRVRI--------IDGIAQGLLYLH 641 (754)
Q Consensus 605 ~gsL~~~l~~~~~-----------------------------------~~~l~~~~~~~i--------~~qia~~L~yLH 641 (754)
+..+...+..... .+...+....+. .-.......+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 8533221110000 000001111100 001122233444
Q ss_pred hc-----CCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 642 QY-----SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 642 ~~-----~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
.+ ++..++|+|+.+.||+++++..+-|+||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 32 235689999999999999998899999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.022 Score=68.36 Aligned_cols=157 Identities=20% Similarity=0.187 Sum_probs=109.4
Q ss_pred HHHHHHHHHHHHHccccceeeeEeEEEecCcEE----EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHH
Q 004416 565 LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640 (754)
Q Consensus 565 ~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~----lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL 640 (754)
+.....|.+.+.++.|+|+++++++..+....- +..|++..-++...+ .....++....+.+..++..|++|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHH
Confidence 344566788888999999999999987654333 334556666665555 3445577788888999999999999
Q ss_pred HhcCCCCceeCCCCCC---CEEEcCCCCeEEE--eecCccccCCCcccCCcccccccCcccCccccCCCCCCc--hhhHH
Q 004416 641 HQYSRLRIIHRDLKAS---NILLDQHMNPKIS--DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSV--KSDVF 713 (754)
Q Consensus 641 H~~~~~~iiH~DIkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DVw 713 (754)
|+.. ..|.-+... +-..+.++.+.+. ||+..+.+....... ...-+..+.|||......... ..|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHH
Confidence 9875 555444444 4445566667776 998887765433211 123345677888776665554 47999
Q ss_pred HHHHHHHHHHcCCCCCC
Q 004416 714 SFGVLMLEILSSKKNTG 730 (754)
Q Consensus 714 SlGvll~elltg~~p~~ 730 (754)
.+|.++..+..|..+-.
T Consensus 377 ~lgll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISE 393 (1351)
T ss_pred HHHHHHhhhhhcCcccc
Confidence 99999999999887643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.0014 Score=79.57 Aligned_cols=160 Identities=11% Similarity=-0.067 Sum_probs=111.8
Q ss_pred HHHHHHHHHHccccceeeeEeEEE--ecCcEEEEEEcccCCCHhhHhcCCCC-cccccHHHHHHHHHHHHHHHHHHHhcC
Q 004416 568 FKNEMMLIAKLQHRNLVRLLGCCI--EQGEKILIYEYMVNKSLDVFLFDPTK-KHLLGWQLRVRIIDGIAQGLLYLHQYS 644 (754)
Q Consensus 568 ~~~Ei~~l~~l~H~nIv~l~~~~~--~~~~~~lV~ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~ 644 (754)
...|...+++..|+++.....-.. +..+.+.+++|+..|.+...+..... ...+....+.....+......-.|.+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 444555666678998876554332 33467889999999999888754433 333433333333333345555555432
Q ss_pred --CCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHH
Q 004416 645 --RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722 (754)
Q Consensus 645 --~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~el 722 (754)
..--+|+++|+-|.+|..+.++|+.++|+.+...+.. .......+++.|++|++...-.++.++|+|..|+.+|+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2346999999999999999999999999998332222 122235678889999998888899899999999999998
Q ss_pred HcCCCCC
Q 004416 723 LSSKKNT 729 (754)
Q Consensus 723 ltg~~p~ 729 (754)
--|.++|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8877765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.056 Score=58.28 Aligned_cols=142 Identities=17% Similarity=0.248 Sum_probs=81.2
Q ss_pred eeeceeccEEEEeeeecC----cceeeeeeccccchhhHHHHHHHHHHHHHcccccee-eeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~~~ 605 (754)
+.|..|=.-.+|+....+ +..|++|+........+.+ .+|..+++.+...++- ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR-~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDR-ERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEech-HHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455557777788886533 2378889876543333333 6799999999766664 4555542 22 58999977
Q ss_pred CCHhhH-----------------hcCCC---CcccccHHHHHHHHHHH----------------------HHHHHHHHh-
Q 004416 606 KSLDVF-----------------LFDPT---KKHLLGWQLRVRIIDGI----------------------AQGLLYLHQ- 642 (754)
Q Consensus 606 gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~qi----------------------a~~L~yLH~- 642 (754)
..+..- +|... .....-+..+.++..++ .+-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665221 11111 01111122222222211 111222211
Q ss_pred ----cCCCCceeCCCCCCCEEEcC-CCCeEEEeecCcccc
Q 004416 643 ----YSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMF 677 (754)
Q Consensus 643 ----~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~ 677 (754)
..+.-++|.|+.+.|||+++ ++.++++||..|..-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11234799999999999975 578999999988654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.11 Score=56.81 Aligned_cols=73 Identities=10% Similarity=0.036 Sum_probs=50.3
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeecccc-----c--hhhHHHHHHHHHHHHHcc---ccceeeeEeEEEecCcEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~~~~~lV 599 (754)
.+.||-|....||+.... ++.++||+-... . +....+-..|++.|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 478999999999998763 557899976421 1 113344455677776653 246778887765 556889
Q ss_pred EEcccC
Q 004416 600 YEYMVN 605 (754)
Q Consensus 600 ~ey~~~ 605 (754)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.018 Score=57.69 Aligned_cols=30 Identities=33% Similarity=0.499 Sum_probs=21.4
Q ss_pred CceeCCCCCCCEEE-cCCCCeEEEeecCccc
Q 004416 647 RIIHRDLKASNILL-DQHMNPKISDFGMARM 676 (754)
Q Consensus 647 ~iiH~DIkp~NILl-~~~~~~kL~DFGla~~ 676 (754)
-++|.|+.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47999999999999 8889999999998854
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 754 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-19 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-114
Identities = 95/248 (38%), Positives = 133/248 (53%), Gaps = 16/248 (6%)
Query: 506 KSKDSSLPLFSFASVTAATENFS------IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSN 559
+ D+ FSF + T NF +K+GEGGFG VYKG + N VAVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 560 ----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
+ + ++F E+ ++AK QH NLV LLG + + L+Y YM N SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 616 TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
L W +R +I G A G+ +LH+ IHRD+K++NILLD+ KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD 735
T RIVGT YM+PE L G + KSD++SFGV++LEI++ + +
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239
Query: 736 SFNLLGHV 743
LL
Sbjct: 240 PQLLLDIK 247
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-109
Identities = 96/234 (41%), Positives = 142/234 (60%), Gaps = 6/234 (2%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMM 573
FS + A++NFS ++ LG GGFG VYKGRL +G VAVKRL + QG + +F+ E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-LGWQLRVRIIDG 632
+I+ HRNL+RL G C+ E++L+Y YM N S+ L + + L W R RI G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
A+GL YLH + +IIHRD+KA+NILLD+ + DFG+A++ + T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT---GVYNTDSFNLLGHV 743
G+++PEY G S K+DVF +GV++LE+++ ++ + N D LL V
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-100
Identities = 86/215 (40%), Positives = 134/215 (62%), Gaps = 4/215 (1%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
+ AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-LGWQLRVRIIDGI 633
++ +H +LV L+G C E+ E ILIY+YM N +L L+ + + W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
A+GL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728
GY+ PEY ++G + KSDV+SFGV++ E+L ++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 6e-81
Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 22/244 (9%)
Query: 503 GKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 562
G SS ++ + + G FG V+K +L + VAVK Q
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK 60
Query: 563 QGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILIYEYMVNKSLDVFLFDPTKK 618
Q + + E+ + ++H N+++ +G + LI + SL FL K
Sbjct: 61 QS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KA 115
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQ-------YSRLRIIHRDLKASNILLDQHMNPKISDF 671
+++ W I + +A+GL YLH+ + I HRD+K+ N+LL ++ I+DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-----FSVKSDVFSFGVLMLEILSSK 726
G+A F + G+T VGT YM+PE + ++ D+++ G+++ E+ S
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 727 KNTG 730
Sbjct: 236 TAAD 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 3e-69
Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 32/243 (13%)
Query: 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 575 IAKLQHRNLVRLLGCCIE-----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
+ ++H N+ R + + E +L+ EY N SL +L H W R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 630 IDGIAQGLLYLHQ------YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG---- 679
+ +GL YLH + + I HRDL + N+L+ ISDFG++ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 680 --DELQGNTKRIVGTYGYMSPEYALEGVFSV--------KSDVFSFGVLMLEILSSKKNT 729
E VGT YM+PE LEG ++ + D+++ G++ EI +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 730 GVY 732
Sbjct: 236 FPG 238
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-61
Identities = 63/204 (30%), Positives = 112/204 (54%), Gaps = 6/204 (2%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
+ +I+ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V +G + ++ EY+ SL L + L + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
I+HR+LK+ N+L+D+ K+ DFG++R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
+ + KSDV+SFGV++ E+ + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-59
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++ +G G FG V K + ++VA+K++ ++S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+ L+ EY SL L + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 645 RLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 704 GVFSVKSDVFSFGVLMLEILSSKK 727
+S K DVFS+G+++ E+++ +K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-58
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ LG+G FG K G+ + +K L + + F E+ ++ L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
++ +G + I EY+ +L + + W RV IA G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR------------IVG 691
+ IIHRDL + N L+ ++ N ++DFG+AR+ ++ Q R +VG
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+M+PE + K DVFSFG+++ EI+
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-58
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLKEFKNEMMLIAKLQH 580
+++ +G GGFG VY+ G EVAVK Q ++ + E L A L+H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++ L G C+++ L+ E+ L+ L + + V IA+G+ YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNP--------KISDFGMARMFGGDELQGNTKRIVGT 692
H + + IIHRDLK+SNIL+ Q + KI+DFG+AR + G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GA 177
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y +M+PE +FS SDV+S+GVL+ E+L+ +
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-57
Identities = 60/218 (27%), Positives = 114/218 (52%), Gaps = 25/218 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LKEFKNEMMLIA 576
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
L H N+V+L G ++ E++ L L D K H + W +++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ Y+ I+HRDL++ NI L + K++DFG+++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 692 TYGYMSPE--YALEGVFSVKSDVFSFGVLMLEILSSKK 727
+ +M+PE A E ++ K+D +SF +++ IL+ +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 5e-57
Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
++ +G I + ++ SL L K + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA 138
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE--- 699
IIHRDLK++NI L + KI DFG+A +++ G+ +M+PE
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSK 726
+S +SDV++FG+++ E+++ +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 6e-57
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
+ + +KL E G ++KGR G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 583 LVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ +LG C I +M SL L + T ++ V+ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFL 127
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H L I L + ++++D+ M +IS + F + + +++PE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 701 ALEG----VFSVKSDVFSFGVLMLEILSSK 726
AL+ +D++SF VL+ E+++ +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
E I +G+G FG VY GR +G EVA++ + + + LK FK E+M + +H N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V +G C+ +I ++L + D L +I I +G+ YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA 148
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI---VGTYGYMSPE 699
I+H+DLK+ N+ D + I+DFG+ + G + ++ G +++PE
Sbjct: 149 ---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 700 ---------YALEGVFSVKSDVFSFGVLMLEILSSK 726
+ FS SDVF+ G + E+ + +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHR 581
+ ++ +G+G +G V++G G+ VAVK S++ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 582 NLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
N++ + + LI Y SL +L + L +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 638 LYLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIV 690
+LH + I HRDLK+ NIL+ ++ I+D G+A M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 691 GTYGYMSPE------YALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733
GT YM+PE + D+++FG+++ E+ + G+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRN 582
+ + ++G+G +G V+ G+ G++VAVK + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 583 LVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
++ + I+ LI +Y N SL +L K L + +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 639 YLH-----QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVG 691
+LH + I HRDLK+ NIL+ ++ I+D G+A F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 692 TYGYMSPEYALEGVFSV-------KSDVFSFGVLMLEILS 724
T YM PE L+ + +D++SFG+++ E+
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-48
Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 25/233 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
H N+V+ G C G + LI EY+ SL +L K + ++ I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RIV 690
YL R IHRDL NIL++ KI DFG+ ++ D+ ++ +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-- 182
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHV 743
+ +PE E FSV SDV+SFGV++ E+ + + + + ++G+
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-48
Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 25/233 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
H N+V+ G C G + LI EY+ SL +L K + ++ I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RIV 690
YL R IHRDL NIL++ KI DFG+ ++ D+ ++ +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-- 213
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHV 743
+ +PE E FSV SDV+SFGV++ E+ + + + + ++G+
Sbjct: 214 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-48
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
LGEG FG V G+ VAVK L ++ Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 579 QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
H ++++ GCC + G L+ EY+ SL +L +H +G + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RI 689
+ YLH IHRDL A N+LLD KI DFG+A+ ++ +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE E F SDV+SFGV + E+L+
Sbjct: 203 -----WYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-48
Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRL 586
+Q +G+G FG V++G+ G+EVAVK S++ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 587 LGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+ + L+ +Y + SL +L ++ + + +++ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 643 -----YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTYGY 695
+ I HRDLK+ NIL+ ++ I+D G+A D + VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 696 MSPEYALEGVFSV-------KSDVFSFGVLMLEILS 724
M+PE L+ ++ ++D+++ G++ EI
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-48
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 585 RLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + I EYM SL +L + L G L ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLDVCEAMEYL--- 133
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG------YMS 697
+HRDL A N+L+ + K+SDFG+ + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA-------SSTQDTGKLPVKWTA 182
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE E FS KSDV+SFG+L+ EI S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-48
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
E+ + ++G G FG V+ GRL + VAVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+VRL+G C ++ ++ E + FL T+ L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEY 700
IHRDL A N L+ + KISDFGM+R G +++ + +PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
G +S +SDV+SFG+L+ E S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-47
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 34/225 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ ++ +LGEG FG V+ N VAVK L + + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQL 625
QH ++V+ G C + I+++EYM + L+ FL K LG
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--EL 682
+ I IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 683 QGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
G+T R +M PE + F+ +SDV+SFGV++ EI +
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
LGEG FG V R G++VAVK L G + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 579 QHRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
H N+V+ G C E G LI E++ + SL +L P K+ + + +++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RI 689
+ YL + +HRDL A N+L++ KI DFG+ + D+ ++ +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE ++ F + SDV+SFGV + E+L+
Sbjct: 195 -----WYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-47
Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 33/224 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKEFKNEMMLIAKL 578
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQLR 626
QH+++VR G C E ++++EYM + L+ FL + LG
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQ 683
+ + +A G++YL + L +HRDL N L+ Q + KI DFGM+R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 684 GNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
G T R +M PE L F+ +SDV+SFGV++ EI +
Sbjct: 218 GRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-47
Identities = 73/202 (36%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL ++ I I EYM N SL FL P+ L +L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKL-LDMAAQIAEGMAFI---E 126
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--MSPEYAL 702
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E T R + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
G F++KSDV+SFG+L+ EI++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 76/226 (33%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQ 624
LQH N+V LLG + +I+ Y + L FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--E 681
V ++ IA G+ YL S ++H+DL N+L+ +N KISD G+ R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 682 LQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
L GN+ R +M+PE + G FS+ SD++S+GV++ E+ S
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + L + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYL--- 127
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYA 701
+ IHRDL A N L+ ++ K++DFG++R+ GD K + + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
FS+KSDV++FGVL+ EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-47
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + ++ EYM SL +L + L G L ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-LKFSLDVCEAMEYL--- 305
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+HRDL A N+L+ + K+SDFG+ + Q K V + +PE E
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360
Query: 704 GVFSVKSDVFSFGVLMLEILS 724
FS KSDV+SFG+L+ EI S
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-47
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 579
+ S+LG+G FG V R G VAVK+L + ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 580 HRNLVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V+ G G + L+ EY+ + L FL + L + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTK---RIV 690
YL R +HRDL A NIL++ + KI+DFG+A++ D+ ++ +
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE + +FS +SDV+SFGV++ E+ +
Sbjct: 196 ----WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-47
Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+EQ L+ E+M + L +L + L + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETL-LGMCLDVCEGMAYL---E 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 702
+IHRDL A N L+ ++ K+SDFGM R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
+S KSDV+SFGVLM E+ S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-46
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L ++ I I E+M SL FL +L + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFI---E 301
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--MSPEYAL 702
+ IHRDL+A+NIL+ + KI+DFG+AR+ +E T R + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
G F++KSDV+SFG+L++EI++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C +Q +I EYM N L +L + + QL + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQL-LEMCKDVCEAMEYL---E 137
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 702
+ +HRDL A N L++ K+SDFG++R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
FS KSD+++FGVLM EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 6e-46
Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E ++ +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G C ++ ++ EY+ N L +L + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 702
+ IHRDL A N L+D+ + K+SDFGM R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 703 EGVFSVKSDVFSFGVLMLEILS 724
+S KSDV++FG+LM E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 9e-46
Identities = 72/250 (28%), Positives = 109/250 (43%), Gaps = 40/250 (16%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+G G FG VY G LL+ AVK L + +F E +++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 583 LVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGL 637
++ LLG C+ L + YM + L F+ +PT K L+G+ L +A+G+
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGM 141
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG--- 694
YL + + +HRDL A N +LD+ K++DFG+AR D + G
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKL 194
Query: 695 ---YMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVYNTDSFNLL--GHV---- 743
+M+ E F+ KSDV+SFGVL+ E+++ V D L G
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254
Query: 744 ---SDKLYSL 750
D LY +
Sbjct: 255 EYCPDPLYEV 264
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 38/219 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIA 634
+ ++ RLLG C+ ++ I + M L ++ + ++LL W + IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+G+ YL R++HRDL A N+L+ + KI+DFG+A++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 695 Y---------MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
M+ E L +++ +SDV+S+GV + E+++
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-45
Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + L + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-LYMATQISSAMEYL--- 334
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--MSPEYA 701
+ IHR+L A N L+ ++ K++DFG++R+ GD T + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 391
Query: 702 LEGVFSVKSDVFSFGVLMLEILS 724
FS+KSDV++FGVL+ EI +
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIAT 414
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 70/224 (31%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKL-Q 579
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHLLGWQL 625
H N++ LLG C +G L EY + +L FL + T L QL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFG++R G +
Sbjct: 145 -LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKK 198
Query: 686 TK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
T R +M+ E V++ SDV+S+GVL+ EI+S
Sbjct: 199 TMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ LGEG FG V +G L VAVK + N S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 579 QHRNLVRLLGCCIEQG-----EKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRI 629
H N++RLLG CIE + ++I +M L +L + KH+ L ++
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-LKF 152
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGNT 686
+ IA G+ YL S +HRDL A N +L M ++DFG+++ ++ GD
Sbjct: 153 MVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA 209
Query: 687 K---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
K + +++ E + V++ KSDV++FGV M EI +
Sbjct: 210 KMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-45
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
I+ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N++RL G +++ EYM N SLD FL QL V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQL-VGMLRGVGAGMRY 166
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY---- 695
L S L +HRDL A N+L+D ++ K+SDFG++R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 696 --------MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+PE FS SDV+SFGV+M E+L+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-45
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
+G+G FG VY G ++ + A+K L Q ++ F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 580 HRNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++ L+G + + YM + L F+ P +++ L + +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDL-ISFGLQVARGME 138
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY--GYM 696
YL + + +HRDL A N +LD+ K++DFG+AR E + +
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ E F+ KSDV+SFGVL+ E+L+
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G + VA+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------FDPTKKHLLGWQLRVRI 629
++VRLLG + ++I E M L +L +P ++ +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM-IQM 143
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGNT 686
IA G+ YL + + +HRDL A N ++ + KI DFGM R ++ D G
Sbjct: 144 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 200
Query: 687 K---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
R +MSPE +GVF+ SDV+SFGV++ EI +
Sbjct: 201 LLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G + ++I EYM N +LD FL + QL V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQL-VGMLRGIAAGMK 161
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG---- 694
YL + + +HRDL A NIL++ ++ K+SDFG++R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 695 --YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE F+ SDV+SFG++M E+++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKL 578
LG G FG V+KG + E V +K + ++SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIA 634
H ++VRLLG C ++ + +Y+ SL + + LL W + IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRIVG 691
+G+ YL ++HR+L A N+LL +++DFG+A + D+ K +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI- 181
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+ E G ++ +SDV+S+GV + E+++
Sbjct: 182 --KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 2e-44
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 582
+G G FG VY G LL+ AVK L + +F E +++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 583 LVRLLGCCIEQGEKIL-IYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGL 637
++ LLG C+ L + YM + L F+ +PT K L+G+ L +A+G+
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL------QVAKGM 205
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG--- 694
+L + + +HRDL A N +LD+ K++DFG+AR E + T
Sbjct: 206 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLP 259
Query: 695 --YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+ E F+ KSDV+SFGVL+ E+++
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 43/234 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL---------------------FDPT 616
+ N+V+LLG C L++EYM L+ FL
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 617 KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR- 675
L ++ I +A G+ YL S + +HRDL N L+ ++M KI+DFG++R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 676 MFGGD--ELQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
++ D + GN R +M PE ++ +SDV+++GV++ EI S
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 26/219 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 579 QHRNLVRLLGCCIEQGEKI------LIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVR 628
H ++ +L+G + K +I +M + L FL +L L VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL-VR 141
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD--ELQGN 685
+ IA G+ YL S IHRDL A N +L + M ++DFG++R ++ GD
Sbjct: 142 FMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+K V +++ E + +++V SDV++FGV M EI++
Sbjct: 199 SKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-44
Identities = 71/200 (35%), Positives = 110/200 (55%), Gaps = 7/200 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL T K+L QL V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYV---E 297
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 705 VFSVKSDVFSFGVLMLEILS 724
F++KSDV+SFG+L+ E+ +
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGI 633
H+N+VR +G ++ + ++ E M L FL P++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMAR-MFGGD--ELQGNTK 687
A G YL IHRD+ A N LL KI DFGMAR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 688 ---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +M PE +EG+F+ K+D +SFGVL+ EI S
Sbjct: 207 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 585 RLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
RL+G C Q E +++ E L FL ++ + + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNV-AELLHQVSMGMKYL--- 126
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL----QGNTKRIVGTYGYMSPE 699
+HRDL A N+LL KISDFG+++ G D+ + K + + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183
Query: 700 YALEGVFSVKSDVFSFGVLMLEILS 724
FS +SDV+S+GV M E LS
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 9e-44
Identities = 71/200 (35%), Positives = 110/200 (55%), Gaps = 7/200 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L E+ I + EYM SL FL T K+L QL V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQL-VDMAAQIASGMAYV---E 380
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
R+ +HRDL+A+NIL+ +++ K++DFG+AR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 705 VFSVKSDVFSFGVLMLEILS 724
F++KSDV+SFG+L+ E+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 9e-44
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGI 633
H+N+VR +G ++ + ++ E M L FL P++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMAR-MFGGD--ELQGNTK 687
A G YL IHRD+ A N LL KI DFGMAR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 688 ---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +M PE +EG+F+ K+D +SFGVL+ EI S
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 68/242 (28%), Positives = 112/242 (46%), Gaps = 59/242 (24%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+N + LGEG FG V K + VAVK L N S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------------------- 612
+ H ++++L G C + G +LI EY SL FL
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 613 --FDPTKKHLL--GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668
T L+ WQ I+QG+ YL + ++++HRDL A NIL+ + KI
Sbjct: 143 DERALTMGDLISFAWQ--------ISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKI 191
Query: 669 SDFGMAR-MFGGDELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
SDFG++R ++ D ++ + +M+ E + +++ +SDV+SFGVL+ EI
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 723 LS 724
++
Sbjct: 246 VT 247
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-43
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
N SI +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N++RL G + +++ EYM N SLD FL QL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQL-VGMLRGIASGMKY 162
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY---- 695
L S + +HRDL A NIL++ ++ K+SDFG+ R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 696 --------MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
SPE F+ SDV+S+G+++ E++S
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ ++ RLLG C+ ++ I + M L ++ + K +G Q + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY--- 695
YL R++HRDL A N+L+ + KI+DFG+A++ G +E Y
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179
Query: 696 ------MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
M+ E L +++ +SDV+S+GV + E+++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 65/230 (28%), Positives = 110/230 (47%), Gaps = 40/230 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHL 620
+ +H+N++ LLG C + G +I EY +L +L ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGG 679
L V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR +
Sbjct: 155 TFKDL-VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 680 DELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
D + T + +M+PE + V++ +SDV+SFGVLM EI +
Sbjct: 211 DYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I I E L FL K L L + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR-KYSLDLASL-ILYAYQLSTALAY 131
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMS 697
L R +HRD+ A N+L+ + K+ DFG++R K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE F+ SDV+ FGV M EIL
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAK 577
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L HRNL+RL G + K+ + E SL L + H L L R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH-QGHFLLGTL-SRYAVQVAEGM 134
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT---YG 694
YL R IHRDL A N+LL KI DFG+ R ++ + +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE FS SD + FGV + E+ +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 51/267 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--------------FDPTKKHL 620
+ +H+N++ LLG C + G +I EY +L +L ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGG 679
L V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFG+AR +
Sbjct: 201 TFKDL-VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 680 DELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN--TGVY 732
D + T + +M+PE + V++ +SDV+SFGVLM EI + + G+
Sbjct: 257 DYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 733 NTDSFNLL--GHV-------SDKLYSL 750
+ F LL GH +++LY +
Sbjct: 311 VEELFKLLKEGHRMDKPANCTNELYMM 337
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 577
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 578 L-QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFL-------------FDPTKKHLLG 622
+ H N+V LLG C + G + +I E+ +L +L + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDE 681
+ + +A+G+ +L + + IHRDL A NILL + KI DFG+AR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 682 LQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +M+PE + V++++SDV+SFGVL+ EI S
Sbjct: 204 YVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E+ + LGEG FG VY+G N + VAVK + + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQ 635
H ++V+L+G E+ I I E L +L L+ + L I +
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICK 124
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTK---RIV 690
+ YL + +HRD+ NIL+ K+ DFG++R ++ T+ +
Sbjct: 125 AMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-- 179
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+MSPE F+ SDV+ F V M EILS
Sbjct: 180 ----WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 578
+ +++ K LG G FG V KG + VAVK L E E ++ +L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 579 QHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+ +VR++G C + E L+ E L+ +L +H+ + + ++ ++ G+
Sbjct: 76 DNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGM 130
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTKRIVGTY 693
YL +HRDL A N+LL KISDFG+++ DE Q + K V
Sbjct: 131 KYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV--- 184
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +PE FS KSDV+SFGVLM E S
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 38/222 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 576
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
KL H++LV G C+ E IL+ E++ SLD +L + W+L + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAA 125
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNP--------KISDFGMARMFGGDELQGNTKR 688
+ +L +IH ++ A NILL + + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 689 IVGTYGY-----MSPEYALEG-VFSVKSDVFSFGVLMLEILS 724
+ PE ++ +D +SFG + EI S
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 28/224 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
L H N+V LLG C G ++I EY L FL + + D
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 633 -----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD 680
+A+G+ +L + IHRDL A NILL KI DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +M+PE V++ +SDV+S+G+ + E+ S
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 36/226 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
N LG G FG V + + VAVK L S + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------------FDPTKKHLLGWQ 624
L QH N+V LLG C G ++I EY L FL F
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGDE-- 681
L + +AQG+ +L + IHRD+ A N+LL KI DFG+AR +
Sbjct: 166 L-LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 682 LQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
++GN + + +M+PE + V++V+SDV+S+G+L+ EI S
Sbjct: 222 VKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-42
Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 38/229 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL---------FDPTKKHLLGWQL 625
+ +H+N++ LLG C + G +I EY +L +L + H QL
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 626 R----VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-MFGGD 680
V +A+G+ YL + + IHRDL A N+L+ + KI+DFG+AR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 681 --ELQGNTK---RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ N + + +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 246 YYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 6e-41
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 529 IQSKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL+G C + + + E L FL ++ + + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVGK-REEIPVSNV-AELLHQVSMGMKYL---E 453
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE----LQGNTKRIVGTYGYMSPEY 700
+HR+L A N+LL KISDFG+++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 701 ALEGVFSVKSDVFSFGVLMLEILS 724
FS +SDV+S+GV M E LS
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 63/234 (26%), Positives = 95/234 (40%), Gaps = 43/234 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 577
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL------FDPTKKHLLGWQLRVRII 630
L H N+V LLG C G LI+EY L +L F + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 631 DG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR- 675
D +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 676 MFGGDELQGNTK-----RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ + +M+PE EG++++KSDV+S+G+L+ EI S
Sbjct: 222 IMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-40
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 579
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E I I E L FL +K L + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE--LQGNTKRIVGTYGYMS 697
L R +HRD+ A N+L+ + K+ DFG++R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILS 724
PE F+ SDV+ FGV M EIL
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+F +G GGFG V+K + ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 584 VRLLGCCIEQGEKI----------------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRV 627
V GC + E+ +L+ ++ + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
+ + I +G+ Y+H ++I+RDLK SNI L KI DFG+ D G
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
R GT YMSPE + + D+++ G+++ E+L
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+F LG GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 583 LVRLLGCCIE---------QGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRII 630
+VR +E K+ +Y + ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR-- 688
IA+ + +LH ++HRDLK SNI K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 689 --------IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
VGT YMSPE +S K D+FS G+++ E+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 9/205 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+ E G ++ +Y L + + K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+I+HRD+K+ NI L + ++ DFG+AR+ +GT Y+SPE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSK 726
++ KSD+++ G ++ E+ + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 589 CCIEQGEK----ILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLYLHQY 643
+ +L+ E M + +L +L K+ ++ ++ I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 644 SRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
IIHRDLK NI + + KI D G+A + K ++GT +M+PE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203
Query: 703 EGVFSVKSDVFSFGVLMLEILSSK 726
E DV++FG+ MLE+ +S+
Sbjct: 204 EKY-DESVDVYAFGMCMLEMATSE 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 25/227 (11%)
Query: 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMM 573
F S++ +SI ++G GG V++ Q A+K L Q L ++NE+
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78
Query: 574 LIAKLQHRNL--VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID 631
+ KLQ + +RL I ++ E N L+ +L KK + R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWK 134
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ + + +HQ+ I+H DLK +N L+ K+ DFG+A D VG
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 692 TYGYMSPEYALEGV------------FSVKSDVFSFGVLMLEILSSK 726
T YM PE A++ + S KSDV+S G ++ + K
Sbjct: 191 TVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 64/266 (24%), Positives = 102/266 (38%), Gaps = 19/266 (7%)
Query: 466 RKENETKNLDTNQDLLAFDVNMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATE 525
+ + +D + L F + R F G+ + + S +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSF---RGEASETLQSPGYDPSRPESFF--QQ 57
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKL-QHR 581
+F S+LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
VRL E G L E SL L Q+ + D L +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRD-TLLALAHLH 174
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
++H D+K +NI L K+ DFG+ G + G YM+PE
Sbjct: 175 S---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE-L 227
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKK 727
L+G + +DVFS G+ +LE+ + +
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNME 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 27/257 (10%)
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
+ ++ G D +S SV +SI ++G GG V++
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG--RIYSILKQIGSGGSSKVFQVL 76
Query: 546 LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLGCCIEQGEKILIYE 601
Q A+K L Q L ++NE+ + KLQ + +RL I ++ E
Sbjct: 77 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661
N L+ +L KK + R + + + +HQ+ I+H DLK +N L+
Sbjct: 137 C-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 189
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV------------FSVK 709
K+ DFG+A D VG YM PE A++ + S K
Sbjct: 190 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSRENGKSKSKISPK 247
Query: 710 SDVFSFGVLMLEILSSK 726
SDV+S G ++ + K
Sbjct: 248 SDVWSLGCILYYMTYGK 264
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 582
+SI ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 583 L--VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+RL I ++ E N L+ +L KK + R + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE- 699
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 700 ----------YALEGVFSVKSDVFSFGVLMLEILSSK 726
+ S KSDV+S G ++ + K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+F + LG+G FG V K R L+ + A+K++ + + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVF---------LFD--PTKKHLLGWQLRVRIID 631
+VR +E+ + + KS L+D ++ R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF------------GG 679
I + L Y+H IIHRDLK NI +D+ N KI DFG+A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 680 DELQGNTKRIVGTYGYMSPE-YALEGVFSVKSDVFSFGVLMLEIL 723
N +GT Y++ E G ++ K D++S G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
E++ + +G G +G K R +G+ + K + + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 582 NLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKHLLGWQLRV-RIIDGIAQGLL 638
N+VR I++ L + EY L + TK+ + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 639 YLHQ--YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H+ ++HRDLK +N+ LD N K+ DFG+AR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILS 724
SPE ++ KSD++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCA 211
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQH 580
NF I+ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLLY 639
N+++ IE E ++ E L + K+ L+ + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
+H R++HRD+K +N+ + K+ D G+ R F ++ +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSK 726
E ++ KSD++S G L+ E+ + +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 592 EQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650
E I I+ E + SL L Q I +GL YLH +I+H
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 651 RDLKASNILLDQHM-NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV--FS 707
RD+K N+L++ + KISDFG ++ G + T+ GT YM+PE +G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 708 VKSDVFSFGVLMLEILSSK 726
+D++S G ++E+ + K
Sbjct: 204 KAADIWSLGCTIIEMATGK 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 25/223 (11%)
Query: 520 VTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
V +++ KLGEGGF V L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 579 QHRNLVRLLGCCIEQGEK----ILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGI 633
H N++RL+ C+ + L+ + +L + K + L + ++ GI
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR-----MFGGDELQGNTKR 688
+GL +H HRDLK +NILL P + D G + G +
Sbjct: 144 CRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 689 I--VGTYGYMSPE------YALEGVFSVKSDVFSFGVLMLEIL 723
T Y +PE + V ++DV+S G ++ ++
Sbjct: 201 AAQRCTISYRAPELFSVQSHC---VIDERTDVWSLGCVLYAMM 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 15/229 (6%)
Query: 498 EADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKR 556
E + D + + + + ++F S+LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 557 LS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--F 613
+ + E+ ++ + +V G GE + E+M SLD L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125
Query: 614 DPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
+ +LG ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG+
Sbjct: 126 GRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+ + N+ VGT YMSPE +SV+SD++S G+ ++E+
Sbjct: 179 SGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLI 575
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA- 634
+ V G +G+ + E M + SLD F K G + I+ IA
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDK---GQTIPEDILGKIAV 116
Query: 635 ---QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ L +LH S+L +IHRD+K SN+L++ K+ DFG++ D++ + G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AG 171
Query: 692 TYGYMSPE----YALEGVFSVKSDVFSFGVLMLEI 722
YM+PE + +SVKSD++S G+ M+E+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 42/203 (20%), Positives = 82/203 (40%), Gaps = 24/203 (11%)
Query: 529 IQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 585
++ + GG G +Y +NG+ V +K L + + E +A++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 586 LL--GCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ ++ + Y EY+ +SL L + + I L YL
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYL 198
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H + +++ DLK NI+L + K+ D G + GT G+ +PE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEI 248
Query: 701 ALEGVFSVKSDVFSFGVLMLEIL 723
G +V +D+++ G + +
Sbjct: 249 VRTGP-TVATDIYTVGRTLAALT 270
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 24/217 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 582
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 583 LVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+V+L E+ E+ SL L +P+ + L + ++ + G+ +
Sbjct: 69 IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 640 LHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L + I+HR++K NI+ D K++DFG AR DE + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY 181
Query: 696 MSPE--------YALEGVFSVKSDVFSFGVLMLEILS 724
+ P+ + + D++S GV +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V L + E ++ EY+ SL D + + + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
++IHRD+K+ NILL + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 703 EGVFSVKSDVFSFGVLMLE 721
+ K D++S G++ +E
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGL 637
+++V G E + + ++ E +SL + K+ L + R + I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 154
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH+ R+IHRDLK N+ L++ + KI DFG+A D + + GT Y++
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSK 726
PE + S + DV+S G +M +L K
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGL 637
+++V G E + + ++ E +SL + K+ L + R + I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 128
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
YLH R R+IHRDLK N+ L++ + KI DFG+A D + + GT Y++
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 183
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSK 726
PE + S + DV+S G +M +L K
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 24/217 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 582
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 583 LVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
+V+L E+ E+ SL L +P+ + L + ++ + G+ +
Sbjct: 69 IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 640 LHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L + I+HR++K NI+ D K++DFG AR DE + GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY 181
Query: 696 MSPE--------YALEGVFSVKSDVFSFGVLMLEILS 724
+ P+ + + D++S GV +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
I KLG GG VY + +VA+K + + LK F+ E+ ++L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
++ E L+ EY+ +L ++ L + + I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH--- 128
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+RI+HRD+K NIL+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGE 187
Query: 705 VFSVKSDVFSFGVLMLEIL 723
+D++S G+++ E+L
Sbjct: 188 ATDECTDIYSIGIVLYEML 206
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 18/215 (8%)
Query: 518 ASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 576
+ Q ++G G FG V++ + G + AVK++ + + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 577 KLQHRNLVRLLGCCIEQGEKILIY-EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
L +V L G E G + I+ E + SL + + L + + +
Sbjct: 106 GLSSPRIVPLYGAVRE-GPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALE 161
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTKR---IVG 691
GL YLH RI+H D+KA N+LL + + DFG A D L + I G
Sbjct: 162 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T +M+PE + K D++S +ML +L+
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 55/204 (26%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + I +LG+G FG VYK + G A K + +S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LLG G+ ++ E+ ++D + + L Q++V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE--- 699
RIIHRDLKA N+L+ + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 700 --YALEGVFSVKSDVFSFGVLMLE 721
+ + K+D++S G+ ++E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLIAKLQHR 581
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA----QGL 637
+V+ G +G+ + E M + S D F +L + I+ I + L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
+L L+IIHRD+K SNILLD+ N K+ DFG++ + G YM+
Sbjct: 139 NHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMA 193
Query: 698 PE----YALEGVFSVKSDVFSFGVLMLEI 722
PE A + V+SDV+S G+ + E+
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
K+GEG G V R +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V + + E ++ E++ +L D + L + + + + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+IHRD+K+ +ILL K+SDFG D + + +VGT +M+PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 703 EGVFSVKSDVFSFGVLMLE 721
+++ + D++S G++++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 48/210 (22%), Positives = 87/210 (41%), Gaps = 21/210 (10%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLV 584
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
R C + + + E +L ++ K + ++ GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIEL-CAATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 644 SRLRIIHRDLKASNILL-----DQHMNPKISDFGMARMFGGDEL-QGNTKRIVGTYGYMS 697
L I+HRDLK NIL+ + ISDFG+ + + GT G+++
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 698 PEY---ALEGVFSVKSDVFSFGVLMLEILS 724
PE + + D+FS G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+V+ G + + ++ EY S+ D + K L ++ I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD--IIRLRNKTLTEDEIAT-ILQSTLKGLEYLH 142
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+R IHRD+KA NILL+ + K++DFG+A + NT ++GT +M+PE
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 702 LEGVFSVKSDVFSFGVLMLE 721
E ++ +D++S G+ +E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (319), Expect = 2e-30
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 583
+ ++ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 584 VRLLGCCIEQGEKI-------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQG 636
V + +K+ L EY L +L L ++ I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 637 LLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
L YLH+ RIIHRDLK NI+L Q + KI D G A+ EL VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
Y++PE + ++V D +SFG L E ++
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 48/229 (20%), Positives = 86/229 (37%), Gaps = 36/229 (15%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKL-Q 579
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL--FDPTKKHLLGWQLRVRIIDGIAQGL 637
H ++VR E ++ EY SL + + +L+ ++ + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ-VGRGL 128
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP-------------------KISDFGMARMFG 678
Y+H + ++H D+K SNI + + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
+ + G +++ E E K+D+F+ + ++ ++
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 56/201 (27%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
+ + G ++ + +I EY+ S D + L I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+ IHRD+KA+N+LL +H K++DFG+A +++ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 702 LEGVFSVKSDVFSFGVLMLEI 722
+ + K+D++S G+ +E+
Sbjct: 192 KQSAYDSKADIWSLGITAIEL 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRN 582
+++ +Q +G G V ++VA+KR++ + Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIIDGIA----QGL 637
+V + + E L+ + + S+ D+ K L I I +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM-ARMFGGDELQGNTKR--IVGTYG 694
YLH + IHRD+KA NILL + + +I+DFG+ A + G ++ N R VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 695 YMSPEYALEGV-FSVKSDVFSFGVLMLEI 722
+M+PE + + K+D++SFG+ +E+
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 52/233 (22%), Positives = 99/233 (42%), Gaps = 22/233 (9%)
Query: 501 GDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL-S 558
G K + A + ++G G G V+K R G +AVK++
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 559 NQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF---LFD 614
+ + + K ++ +++ +V+ G I + + E M + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG 119
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674
P + +LG ++ I + L YL + +IHRD+K SNILLD+ K+ DFG++
Sbjct: 120 PIPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 675 RMFGGDELQGNTKRIVGTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLEI 722
D+ + G YM+PE + + +++DV+S G+ ++E+
Sbjct: 173 GRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 580
E+F + + LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTK---KHLLGWQLRVRIIDGIAQG 636
+++ L E + L+ E N + K K + R + I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITG 124
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
+LYLH + I+HRDL SN+LL ++MN KI+DFG+A + T + GT Y+
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEIL 723
SPE A ++SDV+S G + +L
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLL 206
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 21/225 (9%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
++ +G GG G VY+ + + VA+K +S + E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+ G+ + + L L ++ L V I+ I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL-QGNTKRIVGTYGYMSPEYALE 703
HRD+K NIL+ + DFG+A ++L Q VGT YM+PE E
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERFSE 209
Query: 704 GVFSVKSDVFSFGVLMLEILSSKKNTGV--YNTDSFNL-LGHVSD 745
+ ++D+++ ++ E L TG Y D ++ H++
Sbjct: 210 SHATYRADIYALTCVLYECL-----TGSPPYQGDQLSVMGAHINQ 249
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLV 584
+ LG GG V+ R L + ++VAVK L + F+ E A L H +V
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 585 RLLGCCIEQGEKILIY----EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ + + EY+ +L + + + + + +I Q L +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-NTKRIVGTYGYMSPE 699
H + IIHRD+K +NI++ K+ DFG+AR T ++GT Y+SPE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 700 YALEGVFSVKSDVFSFGVLMLEIL 723
A +SDV+S G ++ E+L
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVL 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 22/246 (8%), Positives = 53/246 (21%), Gaps = 43/246 (17%)
Query: 513 PLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEF 568
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 569 KNEMMLIAKLQHRNLVRLLGCC--------------------------IEQGEKILIYEY 602
A+L + +L+
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 603 MV---NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
F + G + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL--EGVFSVKSDVFSFGV 717
+ + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 718 LMLEIL 723
+ +
Sbjct: 282 SIYRVW 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 579
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N ++ GC + + L+ EY + + D L + KK L ++ + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM-ARMFGGDELQGNTKR--IVGTYGYM 696
LH +IHRD+KA NILL + K+ DFG + M VGT +M
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGTPYWM 217
Query: 697 SPE---YALEGVFSVKSDVFSFGVLMLEI 722
+PE EG + K DV+S G+ +E+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLKE 567
++ I L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 568 FKNEMMLIAKLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSL-----DVFLFDPTKKHLL 621
FKNE+ +I +++ + G I +++ +IYEYM N S+ F+ D +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
Q+ II + Y+H + I HRD+K SNIL+D++ K+SDFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVK-------SDVFSFGVLMLEIL 723
++G GTY +M PE FS + D++S G+ + +
Sbjct: 207 IKG----SRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 50/232 (21%), Positives = 90/232 (38%), Gaps = 33/232 (14%)
Query: 519 SVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK 577
+V ++ L EGGF VY+ + + +G+E A+KRL + + + E+ + K
Sbjct: 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKK 81
Query: 578 LQ-HRNLVRLLGCCIEQGEK-------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI 629
L H N+V+ E+ L+ + L FL + L ++I
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+ + ++H + IIHRDLK N+LL K+ DFG A + +
Sbjct: 142 FYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 690 ----------VGTYGYMSPEYALEGVFSV--------KSDVFSFGVLMLEIL 723
T Y +PE + + K D+++ G ++ +
Sbjct: 201 RALVEEEITRNTTPMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLC 247
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 56/227 (24%), Positives = 85/227 (37%), Gaps = 36/227 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLVR 585
+ LG G G V G+ VAVKR+ E+ +L H N++R
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 586 LLGCCIEQGEKI-LIYEYMVNKSLDVFL----FDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
C + + E N +L + L + ++ IA G+ +L
Sbjct: 74 YY-CSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 641 HQYSRLRIIHRDLKASNILLD-------------QHMNPKISDFGMARMFGGDE--LQGN 685
H L+IIHRDLK NIL+ +++ ISDFG+ + + + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 686 TKRIVGTYGYMSPEYALEGVFSV-------KSDVFSFGVLMLEILSS 725
GT G+ +PE E D+FS G + ILS
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 45/218 (20%), Positives = 83/218 (38%), Gaps = 18/218 (8%)
Query: 518 ASVTAATENFSIQSKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEM 572
+S + + + +G+G V R G+ V V+R L S + + + E+
Sbjct: 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSL-DVFLFDPTKKHLLGWQLRVRIID 631
+ H N+V I E ++ +M S D L + I+
Sbjct: 78 HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQ 135
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT----- 686
G+ + L Y+H + +HR +KAS+IL+ +S +
Sbjct: 136 GVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 687 KRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEI 722
K V ++SPE + + + KSD++S G+ E+
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 34/222 (15%), Positives = 67/222 (30%), Gaps = 22/222 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK 577
++ + LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD--VFLFDPTKKHLLGWQLRVRIIDGIAQ 635
++ + Q +L+ E +L + L+ T + ++ L + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNP-----------KISDFGMARMFGGDELQG 684
+ +H IIH D+K N +L + D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T G+ E ++ + D F + +L
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 579
E+F I LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G ++ LI EY ++ L K Q I +A L
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
Y H R+IHRD+K N+LL KI+DFG + + GT Y+ P
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPP 176
Query: 699 EYALEGVFSVKSDVFSFGVLMLEIL 723
E + K D++S GVL E L
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 57/265 (21%), Positives = 88/265 (33%), Gaps = 66/265 (24%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
+F +G GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID----------- 631
+VR +E + E D P V+I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 632 ----GIAQGLLY----------LHQYSRLR-----------------------------I 648
+ LY L + R +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK----------RIVGTYGYMSP 698
+HRDLK SNI K+ DFG+ DE + VGT YMSP
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 699 EYALEGVFSVKSDVFSFGVLMLEIL 723
E +S K D+FS G+++ E+L
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 36/219 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRI 629
+L+H+N+VRL + L++E+ S + L K L +QL
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-FQL---- 110
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
+GL + H ++HRDLK N+L++++ K+++FG+AR F G ++ + +
Sbjct: 111 ----LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV 162
Query: 690 VGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSKK 727
V T Y P+ ++S D++S G + E+ ++ +
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-28
Identities = 31/230 (13%), Positives = 66/230 (28%), Gaps = 43/230 (18%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQH-------- 580
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 581 --------RNLVRLLGCC-----------IEQGEKILIYEYMVNKSLDVF--LFDPTKKH 619
+LV+ + + +Y M + L + H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 620 -LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L R+++ + + L LH ++H L+ +I+LDQ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 679 GDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEIL 723
G R + + + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 576
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRII 630
+L H N+V L+ + L++E+M V L D K L +QL
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-YQL----- 128
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+G+ + HQ+ RI+HRDLK N+L++ K++DFG+AR F G ++ T +V
Sbjct: 129 ---LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 691 GTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y +P+ + +S D++S G + E+++ K
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQ 563
S + E ++I LG+G FG V K + + QE AVK + ++ +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 564 GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLL 621
E+ L+ KL H N+++L + ++ E L FD +K
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFS 119
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFG 678
RII + G+ Y+H+ I+HRDLK NILL ++ + KI DFG++ F
Sbjct: 120 EHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ K +GT Y++PE L G + K DV+S GV++ +LS
Sbjct: 176 QNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
+E + KLG G +G V R + E A+K + ++ S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLL 638
N+++L ++ L+ E L FD + II + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 639 YLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
YLH+ I+HRDLK N+LL ++ KI DFG++ +F + K +GT Y
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILS 724
++PE L + K DV+S GV++ +L+
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLA 232
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 22/230 (9%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL 565
S SL +++ F + +G G +G VYKGR + GQ A+K + + +G
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEE 64
Query: 566 KEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI------LIYEYMVNKSL-DVFLFDPTK 617
+E K E+ ++ K HRN+ G I++ L+ E+ S+ D L TK
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTK 122
Query: 618 KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677
+ L + I I +GL +LHQ ++IHRD+K N+LL ++ K+ DFG++
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 678 GGDELQGNTKRIVGTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLEI 722
+ NT +GT +M+PE + + KSD++S G+ +E+
Sbjct: 180 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 19/227 (8%)
Query: 502 DGKDKSKDSSLPLFSFASVTAATENFS----IQSKLGEGGFGPVYKGR-LLNGQEVAVKR 556
+ DK + + V + I +LG G FG V++ G+ K
Sbjct: 24 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83
Query: 557 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD-- 614
++ KNE+ ++ +L H L+ L ++ E +LI E++ LFD
Sbjct: 84 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE----LFDRI 139
Query: 615 PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFG 672
+ + + + + +GL ++H+ I+H D+K NI+ + KI DFG
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFG 196
Query: 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+A DE K T + +PE +D+++ GVL
Sbjct: 197 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 22/234 (9%)
Query: 501 GDGKDKSKDSSLP-LFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS 558
G G + P +F S ++ + Q LG+G FG V + + GQE AVK +S
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 559 N---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD- 614
+ + E+ L+ +L H N+++L ++G L+ E L FD
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE 116
Query: 615 -PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISD 670
++K RII + G+ Y+H+ +I+HRDLK N+LL + N +I D
Sbjct: 117 IISRKRFSEVDAA-RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIID 172
Query: 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
FG++ F + K +GT Y++PE L G + K DV+S GV++ +LS
Sbjct: 173 FGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 522 AATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLI 575
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+L+H N+VRL + + L++E+M + K +D T + L ++
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ QGL + H+ +I+HRDLK N+L+++ K+ DFG+AR F G + + +V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
Y +P+ + +S D++S G ++ E+++ K
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 576
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRII 630
+L+H N+V+L + +L++E++ + + L T K L QL
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQL----- 109
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
G+ Y H R++HRDLK N+L+++ KI+DFG+AR F G ++ T IV
Sbjct: 110 ---LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 691 GTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y +P+ + +S D++S G + E+++
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 44/228 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKE-FKN----EMMLIA 576
+ +K+G+G FG V+K R GQ+VA+K + N+ KE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----KEGFPITALREIKILQ 71
Query: 577 KLQHRNLVRLLGCCIEQGEKI--------LIYEYMVN------KSLDVFLFDPTKKHLLG 622
L+H N+V L+ C + L++++ + ++ V K ++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM- 130
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG---G 679
L GL Y+H+ +I+HRD+KA+N+L+ + K++DFG+AR F
Sbjct: 131 QML--------LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 680 DELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
+ T R+V T Y PE L E + D++ G +M E+ +
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLIAKL 578
E + KLGEG + VYKG+ L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
+H N+V L + L++EY+ + K L +QL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQL------- 109
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+GL Y H+ +++HRDLK N+L+++ K++DFG+AR + +V T
Sbjct: 110 -LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163
Query: 693 YGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
Y P+ L +S + D++ G + E+ + +
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 36/192 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN--------EMM 573
+ + LGEG F VYK R Q VA+K +L ++S E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKILIYEYM------VNKSLDVFLFDPTKKHLLGWQLRV 627
L+ +L H N++ LL + L++++M + K + L K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LMT-- 121
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFG+A+ F G + T
Sbjct: 122 ------LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171
Query: 688 RIVGTYGYMSPE 699
++V T Y +PE
Sbjct: 172 QVV-TRWYRAPE 182
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
+ + +KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLD--VFLFDPTKKHLLGWQLRVRII 630
+LQHRN++ L LI+EY + K +D + K L +QL
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-YQL----- 141
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-----KISDFGMARMFGGDELQGN 685
G+ + H R +HRDLK N+LL KI DFG+AR F G ++
Sbjct: 142 ---INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 686 TKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T I+ T Y PE L +S D++S + E+L
Sbjct: 195 THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 33/237 (13%), Positives = 72/237 (30%), Gaps = 54/237 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ--------- 579
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 580 ----------------HRNLVRLLGCC--IEQGEKILIYEYMVNKSLDVF--LFDPTKKH 619
+ ++R+ + + +Y M + L + H
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 620 -LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678
L R+++ + + L LH Y ++H L+ +I+LDQ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 679 GDELQGNTKRIVGTYGYMSPEYAL-----------EGVFSVKSDVFSFGVLMLEILS 724
G + G+ PE + + D ++ G+++ I
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 21/233 (9%)
Query: 498 EADGDGKDKSKDSSLPLFSFASVTAATENFS------IQSKLGEGGFGPVYKGR-LLNGQ 550
+ F VTA + LG G FG V+K G
Sbjct: 56 SKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115
Query: 551 EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDV 610
++A K + + + +E KNE+ ++ +L H NL++L + + +L+ EY+
Sbjct: 116 KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE--- 172
Query: 611 FLFD--PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-- 666
LFD + + L + + I +G+ ++HQ + I+H DLK NIL
Sbjct: 173 -LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQI 228
Query: 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
KI DFG+AR + E K GT +++PE S +D++S GV+
Sbjct: 229 KIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 20/206 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 579
++F I LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGL 637
H N++R+ ++I L+ E+ L + K Q ++ +A L
Sbjct: 73 HPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADAL 127
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEIL 723
PE K D++ GVL E L
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
E ++I LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLL 638
N+++L + ++ E L FD +K RII + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 639 YLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
Y+H+ I+HRDLK NILL ++ + KI DFG++ F + K +GT Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 696 MSPEYALEGVFSVKSDVFSFGVLM 719
++PE L G + K DV+S GV++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ +++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYL 640
++RL + + L+ E LF+ K+ RI+ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 641 HQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
H+ L + HRDLK N L K+ DFG+A F ++ + VGT Y+S
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 698 PEYALEGVFSVKSDVFSFGVLM 719
P+ LEG++ + D +S GV+M
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 23/210 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 577
+ + + +G+G F V + GQ+ AVK + ++ G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGW---QLRVRIIDG 632
L+H ++V LL G +++E+M L + + +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQ 138
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRI 689
I + L Y H IIHRD+K +LL + K+ FG+A G
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGR 193
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
VGT +M+PE + DV+ GV++
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 49/223 (21%), Positives = 89/223 (39%), Gaps = 15/223 (6%)
Query: 502 DGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ 560
+ P +++ I +LG G FG V++ G A K +
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193
Query: 561 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKK 618
+ + E+ ++ L+H LV L + E ++IYE+M LF+ +
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEH 249
Query: 619 HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARM 676
+ + V + + +GL ++H+ +H DLK NI+ + K+ DFG+
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ + K GT + +PE A +D++S GVL
Sbjct: 307 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLIAK 577
E + +GEG +G V K R G+ VA+K S+ K K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVF--LFDPTK-KHLLGWQLRVRIID 631
L+H NLV LL C ++ L++E++ + L++F D + L +Q+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQI------ 133
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
G+ + H + IIHRD+K NIL+ Q K+ DFG AR + +
Sbjct: 134 --INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA- 186
Query: 692 TYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y +PE + + + DV++ G L+ E+ +
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 49/228 (21%)
Query: 529 IQSKLGEGGFGPVYKGR---LLNGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHR 581
K+G G +G VYK + + ++ A+K++ S E+ L+ +L+H
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78
Query: 582 NLVRLLGCCIEQGEKI--LIYEYM--------------VNKSLDVFLFDPTKKHLLGWQL 625
N++ L + ++ L+++Y V L K LL +Q+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQI 137
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG--G 679
G+ YLH ++HRDLK +NIL+ KI+D G AR+F
Sbjct: 138 --------LDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 680 DELQGNTKRIVGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
L +V T+ Y +PE L ++ D+++ G + E+L+S+
Sbjct: 187 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + I +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++ H N++ L + + +LI E + LFD +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFD-------------FLAQKESLS 113
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH +I H DLK NI+L P K+ DFG+A
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 171 DGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHR 581
+ F + KLG G FG V+ +G E +K ++ ++S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD-----PTKKHLLGWQLRVRIIDGIAQG 636
N++++ + ++ E L + + L ++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 637 LLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
L Y H ++H+DLK NIL H KI DFG+A +F DE GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTA 190
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLM 719
YM+PE + + K D++S GV+M
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLKEFK 569
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 570 NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRV 627
NE+ L+ L H N+++L ++ L+ E+ L F+ +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 628 RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQG 684
I+ I G+ YLH+ I+HRD+K NILL + +N KI DFG++ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +GT Y++PE L+ ++ K DV+S GV+M +L
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + I +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++ H N++ L + + +LI E + LFD +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFD-------------FLAQKESLS 113
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH +I H DLK NI+L P K+ DFG+A
Sbjct: 114 EEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 171 DGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+++ + +LG G F V K R G+E A K RLS+ +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
+++H N++ L + + +LI E + L FD + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FD-------------FLAEKESLT 106
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH RI H DLK NI+L P K+ DFG+A
Sbjct: 107 EDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 575
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYM---VNKSLDVF--LFDPTK-KHLLGWQLRVRI 629
+L+H NLV LL + L++EY V LD + K + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQT---- 111
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRI 689
Q + + H++ IHRD+K NIL+ +H K+ DFG AR+ +
Sbjct: 112 ----LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV 163
Query: 690 VGTYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y SPE + + + DV++ G + E+LS
Sbjct: 164 A-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLKEFKNEMMLIA 576
+S S LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIA 634
+++H N++++L E L+ E + LD LF + L L I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGS-GLD--LFAFIDRHPRLDEPLASYIFRQLV 140
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
+ YL IIHRD+K NI++ + K+ DFG A +L GT
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIE 194
Query: 695 YMSPEYALEGVFSVKS------DVFSFGVLM 719
Y +PE V +++S GV +
Sbjct: 195 YCAPE-----VLMGNPYRGPELEMWSLGVTL 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 50/274 (18%), Positives = 86/274 (31%), Gaps = 60/274 (21%)
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RL 557
S F S+ + + ++ +G+G +G V A+K ++
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 558 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------------CIEQGEKILIYEYMVN 605
+ + ++ K E+ L+ KL H N+ RL G + + +
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGH---LLDKLNV 121
Query: 606 KSLDVFLFDPTKKHLLGWQLRV----------------------------RIIDGIAQGL 637
D I+ I L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 638 LYLHQYSRLRIIHRDLKASNILL--DQHMNPKISDFGMARMFGGDELQGNT--KRIVGTY 693
YLH I HRD+K N L ++ K+ DFG+++ F GT
Sbjct: 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 694 GYMSPEYALEGV---FSVKSDVFSFGVLMLEILS 724
+++PE L + K D +S GVL+ +L
Sbjct: 239 YFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 32/203 (15%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 587
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 588 G-CCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLR---VRIIDGIAQGLLYLH 641
E+ +K+ ++ EY V + + D +K Q ++IDG+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I+H+D+K N+LL KIS G+A + G+ + PE
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE-- 181
Query: 702 LEGVFS-------VKSDVFSFGV 717
+ + K D++S GV
Sbjct: 182 ---IANGLDTFSGFKVDIWSAGV 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 48/221 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 576
+ + +LG G F V K R G + A K R + +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---- 632
++QH N++ L + + ILI E + L FD + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL----FD-------------FLAEKESLT 112
Query: 633 ----------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFG 678
I G+ YLH L+I H DLK NI+L P KI DFG+A
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K I GT +++PE +++D++S GV+
Sbjct: 170 FGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 38/226 (16%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLI 575
AT + +++G G +G VYK R +G VA+K R+ N G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 576 AKLQ---HRNLVRLLGCCIEQGEKI-----LIYEYM-------VNKSLDVFLFDPTKKHL 620
+L+ H N+VRL+ C L++E++ ++K+ L T K L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
+ Q +GL +LH I+HRDLK NIL+ K++DFG+AR++
Sbjct: 126 M-RQF--------LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T +V T Y +PE L+ ++ D++S G + E+ K
Sbjct: 174 --MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 48/226 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRN 582
++ +G G FG V++ +L+ EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 583 LVRLLGCCIEQGEKI------LIYEYM---VNKSLDVFL-----FDPTKKHLLGWQLRVR 628
+V L G+K L+ EY+ V ++ + L +QL
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL--- 150
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGNTK 687
+ L Y+H + I HRD+K N+LLD K+ DFG A++ + N
Sbjct: 151 -----LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 688 RIVGTYGYMSPE-------YALEGVFSVKSDVFSFGVLMLEILSSK 726
I Y Y +PE Y + D++S G +M E++ +
Sbjct: 201 YICSRY-YRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 45/214 (21%), Positives = 80/214 (37%), Gaps = 42/214 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + I LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
++ L E ++I+E++ + F+ RI
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDI----FE-------------RINTSAFELNEREIV 105
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGN 685
+ + L +LH I H D++ NI+ + KI +FG AR +
Sbjct: 106 SYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-- 160
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ + Y +PE V S +D++S G L+
Sbjct: 161 -RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 36/222 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIA 576
+ + +++GEG +G V+K R G+ VA+KR+ + + G ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 577 KLQHRNLVRLL----GCCIEQGEKI-LIYEYM-------VNKSLDVFLFDPTKKHLLGWQ 624
+H N+VRL ++ K+ L++E++ ++K + + T K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
L +GL +LH + R++HRDLK NIL+ K++DFG+AR++
Sbjct: 129 L--------LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MA 175
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T +V T Y +PE L+ ++ D++S G + E+ K
Sbjct: 176 LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 582
N+ + +G+G F V R +L G+EVA+K + + L++ E+ ++ L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 583 LVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKH---------LLGWQLRVRIIDG 632
+V+L IE + + LI EY + FD H Q I+
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQ----IVSA 126
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ Y H + RI+HRDLKA N+LLD MN KI+DFG + F G
Sbjct: 127 VQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGA 176
Query: 693 YGYMSPEYALEGVFS------VKSDVFSFGVLM 719
Y +PE +F + DV+S GV++
Sbjct: 177 PPYAAPE-----LFQGKKYDGPEVDVWSLGVIL 204
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 64/228 (28%), Positives = 99/228 (43%), Gaps = 51/228 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 581
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 582 NLVRLLGCCIEQGEKI------LIYEYM---VNKSLDVF------LFDPTKKHLLGWQLR 626
N+VRL GEK L+ +Y+ V + + L K + +QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQL- 165
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGN 685
+ L Y+H I HRD+K N+LLD K+ DFG A+ E N
Sbjct: 166 -------FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--N 213
Query: 686 TKRIVGTYGYMSPE-------YALEGVFSVKSDVFSFGVLMLEILSSK 726
I Y Y +PE Y + DV+S G ++ E+L +
Sbjct: 214 VSYICSRY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 42/214 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
+V L L+ + + L FD RI++
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FD-------------RILERGVYTEKDASL 110
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGN 685
+ + YLH+ I+HRDLK N+L +++ I+DFG+++M +
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--- 164
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
GT GY++PE + +S D +S GV+
Sbjct: 165 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 44/220 (20%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+ L+++ + L F+ I+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FE-------------DIVAREFYSEADA 107
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQ 683
I + + Y H I+HR+LK N+LL K++DFG+A E
Sbjct: 108 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 163
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT GY+SPE + +S D+++ GV +L IL
Sbjct: 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV-ILYIL 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 43/205 (20%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 591 IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQGLL 638
+G L EY LFD + Q ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPD--IGMPEPDAQRFFHQ----LMAGVV---- 119
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YLH + I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++P
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 699 EYALEGVFS------VKSDVFSFGV 717
E + DV+S G+
Sbjct: 177 E-----LLKRREFHAEPVDVWSCGI 196
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+ L+++ + L F+ I+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FE-------------DIVAREFYSEADA 130
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQ 683
I + + Y H I+HR+LK N+LL K++DFG+A E
Sbjct: 131 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
GT GY+SPE + +S D+++ GV++
Sbjct: 187 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 41/248 (16%)
Query: 501 GDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN 559
G G S +++ + + F ++ G+G FG V G+ G VA+K++
Sbjct: 1 GPGSMMSLNAAAA--ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58
Query: 560 QSGQGLKEFKN----EMMLIAKLQHRNLVRLLGCCIEQGEK-------ILIYEYM----- 603
F+N M +A L H N+V+L GE+ ++ EY+
Sbjct: 59 D-----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH 113
Query: 604 -VNKSLDVFLFDPTKKH--LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660
++ P + +QL + + LH S + + HRD+K N+L+
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQL--------IRSIGCLHLPS-VNVCHRDIKPHNVLV 164
Query: 661 DQHMNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVL 718
++ K+ DFG A+ E N I Y Y +PE ++ D++S G +
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEP--NVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 719 MLEILSSK 726
E++ +
Sbjct: 222 FAEMMLGE 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 32/232 (13%)
Query: 507 SKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--------RL 557
++D++LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 558 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD- 614
S + Q L+E E+ ++ K+ H N+++L L+++ M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 615 -PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673
K L + R +I+ + + + LH+ L I+HRDLK NILLD MN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPE------YALEGVFSVKSDVFSFGVLM 719
+ E + + GT Y++PE + + D++S GV+M
Sbjct: 171 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 47/225 (20%), Positives = 89/225 (39%), Gaps = 53/225 (23%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE---FKNEMML 574
+ + + LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-- 632
+ KL H ++++ + + ++ E M L FD +++
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FD-------------KVVGNKR 110
Query: 633 ------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677
+ + YLH IIHRDLK N+LL ++ KI+DFG +++
Sbjct: 111 LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 678 GGDELQGNTKRIVGTYGYMSPE---YALEGVFSVKSDVFSFGVLM 719
G L + + GT Y++PE ++ D +S GV++
Sbjct: 168 GETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 43/205 (20%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 591 IEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQGLL 638
+G L EY LFD + Q ++ G+
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPD--IGMPEPDAQRFFHQ----LMAGVV---- 119
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YLH + I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++P
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 699 EYALEGVFS------VKSDVFSFGV 717
E + DV+S G+
Sbjct: 177 E-----LLKRREFHAEPVDVWSCGI 196
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 55/231 (23%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLKE 567
++++ ++G+G +G V + A+K LS
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 568 FKNEMML------IA---KLQHRNLVRLLGCCIEQGEKILIY---EYMVNKSLDVFLFD- 614
+ + IA KL H N+V+L+ ++ + +Y E + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEV 128
Query: 615 PTKKHLLGWQLRV---RIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671
PT K L Q R +I GI YLH +IIHRD+K SN+L+ + + KI+DF
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 672 GMARMF-GGDELQGNTKRIVGTYGYMSPEYALEGVFSV----KSDVFSFGV 717
G++ F G D L VGT +M+PE +L + DV++ GV
Sbjct: 182 GVSNEFKGSDAL---LSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 51/244 (20%), Positives = 97/244 (39%), Gaps = 53/244 (21%)
Query: 506 KSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK-------RL 557
+S L +A+ + + + +G G V + G E AVK RL
Sbjct: 75 QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL 134
Query: 558 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDP 615
S + + ++E + E ++ ++ H +++ L+ L+++ M L FD
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FD- 189
Query: 616 TKKHLLGWQLRVRIIDG--------------IAQGLLYLHQYSRLRIIHRDLKASNILLD 661
+ + + + + +LH I+HRDLK NILLD
Sbjct: 190 ------------YLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 662 QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE------YALEGVFSVKSDVFSF 715
+M ++SDFG + E + + GT GY++PE + + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 716 GVLM 719
GV++
Sbjct: 292 GVIL 295
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 42/216 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 580
TE + + +LG+G F V + +L GQE A + S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG-------- 632
N+VRL E+G LI++ + L F+ I+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FE-------------DIVAREYYSEADA 112
Query: 633 ------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQ 683
I + +L+ HQ + ++HR+LK N+LL + K++DFG+A G+ Q
Sbjct: 113 SHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--Q 167
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
GT GY+SPE + + D+++ GV++
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLKEFKNEMML 574
+ + + LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDG 632
+ KL H ++++ + + ++ E M LFD K L +
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCK-LYFYQ 247
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRI 689
+ + YLH+ IIHRDLK N+LL ++ KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 690 VGTYGYMSPE---YALEGVFSVKSDVFSFGVLM 719
GT Y++PE ++ D +S GV++
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----LFDPTKKHLLGWQLRVRIIDG---- 632
V+L Q ++ L Y L L ++ ++ D
Sbjct: 90 PFFVKLYFTF--QDDEKL---YFG---LSYAKNGELLK----YIR----KIGSFDETCTR 133
Query: 633 -----IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK 687
I L YLH IIHRDLK NILL++ M+ +I+DFG A++ + Q
Sbjct: 134 FYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
VGT Y+SPE E SD+++ G ++ ++++
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 56/240 (23%), Positives = 87/240 (36%), Gaps = 47/240 (19%)
Query: 504 KDKSKDSSLPLFSFASVTAATENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVK--RLSN 559
D F S+ + + SK LG G F V + GQE A K +
Sbjct: 7 HSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR 66
Query: 560 QSGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK 618
+ E +E+ ++ + ++ L E ILI EY + F
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FS---- 118
Query: 619 HLLGWQLRVRIIDG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL-- 660
+ I +G+ YLHQ I+H DLK NILL
Sbjct: 119 ---------LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSS 166
Query: 661 -DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ KI DFGM+R G + I+GT Y++PE + +D+++ G++
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 34/211 (16%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKL 578
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 579 QHR--NLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIA 634
++RLL E+ + LI E D LFD T++ L +L +
Sbjct: 104 SSGFSGVIRLLDW-FERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVL 159
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
+ + + H ++HRD+K NIL+D K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 694 GYMSPEYALEGVFS------VKSDVFSFGVL 718
Y PE + V+S G+L
Sbjct: 213 VYSPPE-----WIRYHRYHGRSAAVWSLGIL 238
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 52/219 (23%), Positives = 83/219 (37%), Gaps = 48/219 (21%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLS----------NQSGQGLKEFKNEMML 574
+ + LG+GGFG V+ G L + +VA+K + + S E +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 575 IAKLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHL-------LGWQLR 626
A H ++RLL E E L+ E + + D+F + K L Q
Sbjct: 92 GAGGGHPGVIRLLDW-FETQEGFMLVLERPLP-AQDLFDYITEKGPLGEGPSRCFFGQ-- 147
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-KISDFGMARMFGGDELQGN 685
++ I + H ++HRD+K NIL+D K+ DFG + +
Sbjct: 148 --VVAAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--- 195
Query: 686 TKRIVGTYGYMSPEYALEGVFS------VKSDVFSFGVL 718
GT Y PE S + + V+S G+L
Sbjct: 196 -TDFDGTRVYSPPE-----WISRHQYHALPATVWSLGIL 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 54/227 (23%), Positives = 82/227 (36%), Gaps = 52/227 (22%)
Query: 524 TENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H 580
+ + +Q LGEG V L+ QE AVK + Q G E+ ++ + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID--------- 631
RN++ L+ E+ L++E M S+ I
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSI----LS-------------HIHKRRHFNELEA 113
Query: 632 -----GIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF-----G 678
+A L +LH I HRDLK NIL +Q KI DF +
Sbjct: 114 SVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSV------KSDVFSFGVLM 719
G+ YM+PE +E + D++S GV++
Sbjct: 171 SPISTPELLTPCGSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 43/214 (20%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
++ F ++S+LG G VY+ + + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG---------- 632
+++L E L+ E + L FD RI++
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-------------RIVEKGYYSERDAAD 152
Query: 633 ----IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGN 685
I + + YLH+ I+HRDLK N+L KI+DFG++++ L
Sbjct: 153 AVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--- 206
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
K + GT GY +PE + + D++S G++
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646
I ++ EY+ L FD K + R+ I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH---RH 130
Query: 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF 706
++HRDLK N+LLD HMN KI+DFG++ M E + G+ Y +PE V
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE-----VI 182
Query: 707 S------VKSDVFSFGVLM 719
S + D++S GV++
Sbjct: 183 SGRLYAGPEVDIWSCGVIL 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFD--PTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ L + ++ E M L D +K + ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 641 HQYSRLRIIHRDLKASNILL-DQHMNP---KISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H ++HRDLK SNIL D+ NP +I DFG A+ + G T ++
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFV 187
Query: 697 SPEYALEGVFSVKSDVFSFGVLM 719
+PE + D++S GVL+
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 48/209 (22%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 588
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 589 CCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLG-----------WQLRVRIIDGIAQG 636
I I ++ EY+ L FD K+ G Q I+ G+
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKN--GRLDEKESRRLFQQ----ILSGVD-- 130
Query: 637 LLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
Y H R ++HRDLK N+LLD HMN KI+DFG++ M E + G+ Y
Sbjct: 131 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYA 182
Query: 697 SPEYALEGVFS------VKSDVFSFGVLM 719
+PE V S + D++S GV++
Sbjct: 183 APE-----VISGRLYAGPEVDIWSSGVIL 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 2e-20
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 576
+FS+ +G GGFG VY R + ++ A+K L L E + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQL----RVRI-I 630
+V + +K+ I + M L HL + +R
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--------HYHLSQHGVFSEADMRFYA 298
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I GL ++H +++RDLK +NILLD+H + +ISD G+A F + V
Sbjct: 299 AEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 351
Query: 691 GTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEIL 723
GT+GYM+PE +GV S D FS G ++ ++L
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLL 385
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-20
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLL 638
R +V L E + L+ M + +++ + + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
+LHQ II+RDLK N+LLD N +ISD G+A + TK GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358
Query: 699 EYALEGVFSVKSDVFSFGVLMLEIL 723
E L + D F+ GV + E++
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 65/217 (29%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLLG 588
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 589 CCIEQGEKILIYEYMVNKSLDVF---------LFDPTKKHLLG-----------WQLRVR 628
Y+ + + D+ LFD + Q
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQ---- 116
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
II I Y H R +I+HRDLK N+LLD ++N KI+DFG++ + K
Sbjct: 117 IICAIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKT 166
Query: 689 IVGTYGYMSPEYALEGVFS------VKSDVFSFGVLM 719
G+ Y +PE V + + DV+S G+++
Sbjct: 167 SCGSPNYAAPE-----VINGKLYAGPEVDVWSCGIVL 198
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 47/228 (20%), Positives = 83/228 (36%), Gaps = 67/228 (29%)
Query: 524 TENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H 580
T+++ + + LG G G V + GQ+ A+K L + + + E+ +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRVRII 630
++V +L +YE M + + LF RI
Sbjct: 82 PHIVCILD----------VYENMHHGKRCLLIIMECMEGGELFS-------------RIQ 118
Query: 631 DG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDF 671
+ I + +LH I HRD+K N+L ++ K++DF
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDF 175
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
G A+ + LQ T Y++PE + D++S GV+M
Sbjct: 176 GFAKETTQNALQT----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 44/207 (21%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 589
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIID--------------GIAQ 635
+Q L+ E + L F+ RI +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FE-------------RIKKKKHFSETEASYIMRKLVS 117
Query: 636 GLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ ++H + ++HRDLK N+L + ++ KI DFG AR+ D K T
Sbjct: 118 AVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLM 719
Y +PE + + D++S GV++
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 43/245 (17%), Positives = 94/245 (38%), Gaps = 53/245 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 581
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRV-------------- 627
N+++L+ G++ + + + + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 628 -----RIIDG-------------------IAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663
+++ + + + ++H L I HRD+K N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 664 MNP-KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLE 721
N K+ DFG A+ + + I + Y +PE L ++ D++S G + E
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 722 ILSSK 726
++ K
Sbjct: 235 LILGK 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRI-IDGIAQGLL 638
R +V L E + + L+ M L ++ + + R I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAAEICCGLE 300
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
LH R RI++RDLK NILLD H + +ISD G+A + K VGT GYM+P
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAP 354
Query: 699 EYALEGVFSVKSDVFSFGVLMLEIL 723
E ++ D ++ G L+ E++
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMI 379
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 45/201 (22%), Positives = 89/201 (44%), Gaps = 41/201 (20%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + I+ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 574 LIAKLQHRNLVRLLGCCI----EQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +L H ++V++L I E+ +++ ++ E + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
+ + G+ Y+H S I+HRDLK +N L++Q + K+ DFG+AR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 683 QGNTKRIVGTYGYMSPEYALE 703
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTFPH 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 46/213 (21%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR 581
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 582 NLVRLLGCCIEQGEK--ILIYEYMVNKSLDVF---LFDPTKKHLLGWQLRVRIIDGIAQG 636
N++ L + + L++E++ N L D + + +++ +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-YEI--------LKA 142
Query: 637 LLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
L Y H S I+HRD+K N+++D +H ++ D+G+A Q R+ Y +
Sbjct: 143 LDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196
Query: 696 MSPEYALEGVFSVKS-DVFSFGVLMLEILSSKK 727
PE ++ S D++S G ++ ++ K+
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 53/216 (24%), Positives = 80/216 (37%), Gaps = 68/216 (31%)
Query: 533 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 590
+G G FG R L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 591 IEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLG-----------WQLRVRI 629
E ++ + + L++ G Q +
Sbjct: 82 ---------KEVILTPT-HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQ----L 125
Query: 630 IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARMFGGDELQGNTK 687
+ G++ Y H ++I HRDLK N LLD KI DFG ++ K
Sbjct: 126 LSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 175
Query: 688 RIVGTYGYMSPEYALEGVFS------VKSDVFSFGV 717
VGT Y++PE V +DV+S GV
Sbjct: 176 STVGTPAYIAPE-----VLLRQEYDGKIADVWSCGV 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 37/95 (38%), Positives = 58/95 (61%), Gaps = 9/95 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL---QGNTKRI 689
+A+G+ +L + + IHRDL A NILL + KI DFG+AR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ +M+PE + V++++SDV+SFGVL+ EI S
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 34/160 (21%), Positives = 57/160 (35%), Gaps = 19/160 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 576
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 577 KLQHRNLVRLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
H N+V LLG C + G + +I E+ +L +L R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
G + + I DLK + + S F +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 44/219 (20%), Positives = 76/219 (34%), Gaps = 65/219 (29%)
Query: 532 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 589
LG G G V + ++ A+K L + + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD- 122
Query: 590 CIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRVRIIDG------- 632
+YE + + LF RI D
Sbjct: 123 ---------VYENLYAGRKCLLIVMECLDGGELFS-------------RIQDRGDQAFTE 160
Query: 633 ---------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGD 680
I + + YLH + I HRD+K N+L + K++DFG A+
Sbjct: 161 REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719
+ T Y++PE + D++S GV+M
Sbjct: 218 N---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 38/226 (16%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE--FKN---------EM 572
+++Q + G +G V G G VA+KR+ N G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 573 MLIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLL 621
L+ H N++ L + E L+ E M V + + ++ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ I GL LH+ ++HRDL NILL + + I DF +AR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
N V Y +PE ++ F+ D++S G +M E+ + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 23/200 (11%), Positives = 57/200 (28%), Gaps = 43/200 (21%)
Query: 529 IQSKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNL 583
+ G ++ L ++VA+ + Q L+E + + ++++ +
Sbjct: 35 LLIFHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
R+L + +++ E++ SL +R + +A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH-- 146
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
R + S + +S G + M
Sbjct: 147 -RAGVALSIDHPSRVR--------VSIDGDVV--------------LAYPATMPDA---- 179
Query: 704 GVFSVKSDVFSFGVLMLEIL 723
+ + D+ G + +L
Sbjct: 180 ---NPQDDIRGIGASLYALL 196
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQ 624
L+ + H+N++ LL +E+ + + ++ E M + + + + L +LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 625 -LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
L G+ +LH IIHRDLK SNI++ KI DFG+AR G +
Sbjct: 136 MLC---------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L + D++S G +M E++
Sbjct: 184 TPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
+ + + +G G +G V +G++VA+K+LS QS K E++L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 581 RNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQLRVRIID 631
N++ LL + L+ +M + K + + + ++L+ +Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ------- 134
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVG 691
+ +GL Y+H ++HRDLK N+ +++ KI DFG+AR E+ G V
Sbjct: 135 -MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGY----VV 185
Query: 692 TYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
T Y +PE L ++ D++S G +M E+L+ K
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-17
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM---VNKSLDVFLFDPTKKHLLGWQ 624
L+ + H+N++ LL +E+ + + L+ E M + + + + L +LL +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL-YQ 172
Query: 625 LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684
+ G+ +LH IIHRDLK SNI++ KI DFG+AR G +
Sbjct: 173 --------MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 219
Query: 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L + D++S G +M E++ K
Sbjct: 220 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 54/225 (24%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKN---EMMLIAKLQH 580
++F I +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLG----WQL---------RV 627
LV L Q E+ + +MV +D LLG + L V
Sbjct: 75 PFLVNLWYSF--QDEEDM---FMV---VD---------LLLGGDLRYHLQQNVHFKEETV 117
Query: 628 RI-IDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
++ I + L YL RIIHRD+K NILLD+H + I+DF +A M +
Sbjct: 118 KLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---I 171
Query: 687 KRIVGTYGYMSPEYALEGVFSVKS--------DVFSFGVLMLEIL 723
+ GT YM+PE +FS + D +S GV E+L
Sbjct: 172 TTMAGTKPYMAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 51/229 (22%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
++ S +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 574 LIAKLQHRNLVRLLGC----CIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ + +H N++ + IEQ + + ++ + M + K+ L + + L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH--LSNDHICYFL- 134
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+Q LR GL Y+H S ++HRDLK SN+LL+ + KI DFG+AR+ D
Sbjct: 135 YQILR---------GLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DP 180
Query: 682 LQGNTKRI---VGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
+T + V T Y +PE L ++ D++S G ++ E+LS++
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 43/203 (21%), Positives = 81/203 (39%), Gaps = 43/203 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+N+ I+ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +L+ ++RL I ++ E + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ L G ++H IIHRDLK +N LL+Q + K+ DFG+AR ++
Sbjct: 136 YNLLL---------GENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 682 LQGNTKRIVGTYGYMSPEYALEG 704
+ L+
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKK 206
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 60/257 (23%), Positives = 99/257 (38%), Gaps = 43/257 (16%)
Query: 486 NMGITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGR 545
N + +E +D + + TA + F LG G FG V +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 546 L-LNGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601
+G A+K L Q LK+ NE ++ + LV+L + L
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF--KDNSNL--- 116
Query: 602 YMVNKSLDVF----LFDPTKKHLLGWQLR-VRIIDG---------IAQGLLYLHQYSRLR 647
YMV ++ +F LR + I YLH
Sbjct: 117 YMV---MEYVAGGEMF---------SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--- 161
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS 707
+I+RDLK N+L+DQ +++DFG A+ ++G T + GT ++PE L ++
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 708 VKSDVFSFGVLMLEILS 724
D ++ GVL+ E+ +
Sbjct: 217 KAVDWWALGVLIYEMAA 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 35/218 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
E+F I +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMV--------NKSLDVFLFDPTKKHLLGWQLRVRI-I 630
+ + L + + L+ +Y V +K D + R +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-----------MARFYL 181
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ + +HQ L +HRD+K NIL+D + + +++DFG D + V
Sbjct: 182 AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 237
Query: 691 GTYGYMSPE-----YALEGVFSVKSDVFSFGVLMLEIL 723
GT Y+SPE +G + + D +S GV M E+L
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 581 RNLVRLL-----GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLGWQLRVR 628
N++ LL ++ L+ +M + K L + + L+ +Q
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLV-YQ---- 136
Query: 629 IIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR 688
+ +GL Y+H IIHRDLK N+ +++ KI DFG+AR E+ G
Sbjct: 137 ----MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTGY--- 185
Query: 689 IVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
V T Y +PE L ++ D++S G +M E+++ K
Sbjct: 186 -VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 583 LVRLL-------------GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLG 622
+V++ + + + ++ EYM V + L + + +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP--LLEEHARLFM- 126
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGD 680
+Q LR GL Y+H + ++HRDLK +N+ ++ + + KI DFG+AR+
Sbjct: 127 YQLLR---------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174
Query: 681 ELQGN--TKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
++ +V T Y SP L ++ D+++ G + E+L+ K
Sbjct: 175 YSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.5 bits (187), Expect = 4e-15
Identities = 34/199 (17%), Positives = 57/199 (28%), Gaps = 46/199 (23%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLKEFKNEMML 574
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 575 IAKLQ---------HRNLVRLLGCCIEQGE--KILIYEYMVNKSLDVFLFDPTK------ 617
+L + L QG +L+ + S D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 618 ------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659
L I+ + L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 660 LDQHMNPKISDFGMARMFG 678
L + K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 60/237 (25%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ +F ++S LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 574 LIAKLQHRNLVRLLGCCIEQGEKI-----LIYEYM------VNKSLDVFLFDPTKKHLLG 622
++ +H N++ + + +I E M V + L D ++ +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM--LSDDHIQYFI- 118
Query: 623 WQ-LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+Q LR + LH + +IHRDLK SN+L++ + + K+ DFG+AR+ DE
Sbjct: 119 YQTLR---------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DE 164
Query: 682 LQGNTKRIVGTYGYMSPEY-------ALEGVFSVKS-----DVFSFGVLMLEILSSK 726
+ G M E+ A E + + DV+S G ++ E+ +
Sbjct: 165 SAADNSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 58/248 (23%), Positives = 102/248 (41%), Gaps = 37/248 (14%)
Query: 497 CEADGDGKDKSKDSSLPLFSFASVTAAT-----ENFSIQSKLGEGGFGPVYKGRLLNGQE 551
+ K+K+ D+ L + E++ + +G G FG V R + ++
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 552 V-AVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607
V A+K LS + F E ++A +V+L Q ++ L YMV
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--QDDRYL---YMV--- 147
Query: 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQ--------GLLYLHQYSRLRIIHRDLKASNIL 659
++ + P L+ + + A+ L +H + IHRD+K N+L
Sbjct: 148 ME---YMP-GGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNML 200
Query: 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE----YALEGVFSVKSDVFSF 715
LD+ + K++DFG + + VGT Y+SPE +G + + D +S
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 716 GVLMLEIL 723
GV + E+L
Sbjct: 260 GVFLYEML 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 38/221 (17%)
Query: 529 IQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFK-------NEMMLIAK 577
+ KLG G F V+ + ++N VA+K + E K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 578 LQHRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
+ ++++LL +G +++E L L KK+ + + + I
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHR-GIPLIYVKQI 136
Query: 634 AQ----GLLYLHQYSRLRIIHRDLKASNILLDQHMNP------KISDFGMARMFGGDELQ 683
++ GL Y+H R IIH D+K N+L++ +P KI+D G A + +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY- 192
Query: 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+ T Y SPE L + +D++S L+ E+++
Sbjct: 193 ---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 49/226 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
E + S +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 574 LIAKLQHRNLVRLL-----GCCIEQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLL 621
L+ ++H N++ LL +E+ + L+ M + K L D + L+
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLI 138
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+Q I +GL Y+H IIHRDLK SN+ +++ KI DFG+AR DE
Sbjct: 139 -YQ--------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-ADE 185
Query: 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSK 726
+ G V T Y +PE L ++ D++S G +M E+L+ +
Sbjct: 186 MTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 45/219 (20%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
++F I LG G FG V+ R + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVF-----LFDPTKKHLLGWQLR-VRIIDG-- 632
++R+ G Q + + +M+ +D + LF LR +
Sbjct: 66 PFIIRMWGTF--QDAQQI---FMI---MD-YIEGGELF---------SLLRKSQRFPNPV 107
Query: 633 -------IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685
+ L YLH II+RDLK NILLD++ + KI+DFG A+ +
Sbjct: 108 AKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDV 159
Query: 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
T + GT Y++PE ++ D +SFG+L+ E+L+
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 580
++F I +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMV--------NKSLDVFLFDPTKKHLLGWQLRVRI-I 630
R + +L + + L+ EY V +K + + R +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-----------MARFYL 168
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
I + +H+ L +HRD+K NILLD+ + +++DFG D + V
Sbjct: 169 AEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAV 224
Query: 691 GTYGYMSPE-------YALEGVFSVKSDVFSFGVLMLEIL 723
GT Y+SPE G + + D ++ GV E+
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 49/196 (25%), Positives = 91/196 (46%), Gaps = 42/196 (21%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 573
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 574 LIAKLQ-HRNLVRLLGCCI-EQGEKI-LIYEYM------VNKSLDVFLFDPTKKHLLGWQ 624
++ +L H N+V LL + + L+++YM V ++ L K++++ +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI--LEPVHKQYVV-YQ 117
Query: 625 -LRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683
++ + YLH S ++HRD+K SNILL+ + K++DFG++R F
Sbjct: 118 LIK---------VIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 684 GNTKRIVGTYGYMSPE 699
N + + +
Sbjct: 166 TNNIPLSINENTENFD 181
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-13
Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 19/126 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ LT + G++L + + Y T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNL------VLYD--HSTSVWASNTGIL-GK 50
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
K + + GN V+ + ++W+S+ R N V L ++GN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 162 WQSFDY 167
W + Y
Sbjct: 103 WSTGTY 108
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 41/203 (20%), Positives = 81/203 (39%), Gaps = 40/203 (19%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLKEFKNEMML----- 574
+ + +G+GGFG +Y + + + VK + +G E K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 575 IAKLQHRNLVRLLG-----CCIEQGEKILIYEYMV----NKSL-DVFLFDP---TKKHLL 621
I K ++ LG + Y +M+ L ++ + ++K +L
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMFGG 679
QL +RI+D + Y+H++ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 156 --QLSLRILDILE----YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 680 DEL-----QGNTKRIVGTYGYMS 697
+ + + GT + S
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 64/258 (24%), Positives = 100/258 (38%), Gaps = 47/258 (18%)
Query: 488 GITTRTNEFCEADGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL 547
GI+ + + L ++ A +F +G+G FG V R
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 548 NGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLLGCCIEQGEKILIYEY 602
+ AVK L ++ KE K+ M L+ ++H LV L + +K+ Y
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL----Y 115
Query: 603 MVNKSLDVF-----LFDPTKKHLLGWQL---------RVRI-IDGIAQGLLYLHQYSRLR 647
V LD + LF + L R R IA L YLH L
Sbjct: 116 FV---LD-YINGGELF---------YHLQRERCFLEPRARFYAAEIASALGYLHS---LN 159
Query: 648 IIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIVGTYGYMSPEYALEGV 705
I++RDLK NILLD + ++DFG+ + + T GT Y++PE +
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYLAPEVLHKQP 215
Query: 706 FSVKSDVFSFGVLMLEIL 723
+ D + G ++ E+L
Sbjct: 216 YDRTVDWWCLGAVLYEML 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 53/214 (24%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 580
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 581 RNLVRLLGCCIEQGEKI-LIYEYMVNKSL-------DVFLFDPTKKHLLGWQLRVRI-ID 631
L L + +++ + EY L VF D R R
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----------RARFYGA 255
Query: 632 GIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRI 689
I L YLH S +++RDLK N++LD+ + KI+DFG+ + + G K
Sbjct: 256 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTF 309
Query: 690 VGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + + D + GV+M E++
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
+ I S +G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 582 -----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLR-VRII-DGI 633
+V L + + L++E L L+D + + G L R +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVG 691
LL+L L IIH DLK NILL KI DFG + G + + I
Sbjct: 167 CTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI---YQYIQS 221
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
+ Y SPE L + + D++S G +++E
Sbjct: 222 RF-YRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-12
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 579
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
L +L C + +++ + EY VN + + F
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEY-VNGGDLMYHIQQVGRFKEP-----------HAVFY 447
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
IA GL +L II+RDLK N++LD + KI+DFGM + ++ G TK
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTK 500
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + D ++FGVL+ E+L
Sbjct: 501 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 37/216 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 579
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
L +L C + +++ + EY VN + + F
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEY-VNGGDLMYHIQQVGRFKEP-----------HAVFY 126
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
IA GL +L II+RDLK N++LD + KI+DFGM + ++ G TK
Sbjct: 127 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTK 179
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + D ++FGVL+ E+L
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-12
Identities = 25/123 (20%), Positives = 43/123 (34%), Gaps = 19/123 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
++L+ + G +L + L + Y VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS--GKPVWASNTGGLGSG 52
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
L N GNLV+ +QSN IW + + + + V L + N+VI +
Sbjct: 53 CRLTLH--NNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 162 WQS 164
W +
Sbjct: 103 WAT 105
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I L YLH +++RD+K N++LD+ + KI+DFG+ + + G K
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFC 166
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE + + D + GV+M E++
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L +LHQ II+RDLK NI+L+ + K++DFG+ + + G T
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFC 182
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT YM+PE + + D +S G LM ++L
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
+A L +LH L II+RDLK NILLD+ + K++DFG+++ + +
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYSFC 187
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT YM+PE + +D +SFGVLM E+L
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 38/186 (20%), Positives = 67/186 (36%), Gaps = 63/186 (33%)
Query: 521 TAATENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 578
A +++ + S+ LG G G V + ++ A+K L + + + E+ L +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRA 67
Query: 579 -QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVF----------LFDPTKKHLLGWQLRV 627
Q ++VR++ +YE + + LF
Sbjct: 68 SQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFS------------- 104
Query: 628 RIIDG----------------IAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKI 668
RI D I + + YLH + I HRD+K N+L + K+
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKL 161
Query: 669 SDFGMA 674
+DFG A
Sbjct: 162 TDFGFA 167
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
+ + +G+G FG V K Q VA+K + N+ Q +E + ++ L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQD 154
Query: 582 -----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK-HLLGWQLR-VRII-DGI 633
N++ +L + + +E L + L++ KK G+ L VR I
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVG 691
Q L LH + RIIH DLK NILL Q K+ DFG + + + +
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYIQ 261
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEI 722
+ Y +PE L + + D++S G ++ E+
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 171
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
GT Y++PE + D ++ GVLM E+++
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTKRIV 690
I+ L YLH+ II+RDLK N+LLD + K++D+GM + + GD T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFC 214
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
GT Y++PE + D ++ GVLM E+++
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 33/204 (16%), Positives = 75/204 (36%), Gaps = 40/204 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLKEFK------ 569
+ ++S G +Y+ Q+ ++K L + G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 570 -----NEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHL 620
N+ + + +G + Q + Y ++V +SL D + KH+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHV 155
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMF- 677
L + +++ + L +LH+ +H ++ A NI +D ++ + +G A +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 678 -GGDEL---QGNTKRIVGTYGYMS 697
G + +G+ G ++S
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFIS 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
I L +LH+ L II+RD+K NILLD + + ++DFG+++ F DE + GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 693 YGYMSPEYALEG----VFSVKSDVFSFGVLMLEIL 723
YM+P+ G +V D +S GVLM E+L
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELL 256
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 37/216 (17%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQ 579
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 580 HRNLVRLLGCCIEQGEKI-LIYEYMVN--------KSLDVFLFDPTKKHLLGWQLRVRII 630
H L + C + E + + EY +N +S F R
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEY-LNGGDLMYHIQSCHKFDLS-----------RATFY 123
Query: 631 DG-IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR--MFGGDELQGNTK 687
I GL +LH I++RDLK NILLD+ + KI+DFGM + M G T
Sbjct: 124 AAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTN 176
Query: 688 RIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE L ++ D +SFGVL+ E+L
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA--RMFGGDELQGNTKRIV 690
I L++LH II+RDLK N+LLD + K++DFGM + G T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFC 185
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEIL 723
GT Y++PE E ++ D ++ GVL+ E+L
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 41/192 (21%), Positives = 72/192 (37%), Gaps = 36/192 (18%)
Query: 526 NFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQGL 637
++ ++ E + SL+ LFD + + QL R+
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQLISRME------- 119
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPK-----ISDFGMARMFGGDELQGNT------ 686
Y+H + +I+RD+K N L+ + N I DF +A+ + + +
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKHIPYRE 173
Query: 687 -KRIVGTYGYMS 697
K + GT YMS
Sbjct: 174 HKSLTGTARYMS 185
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-11
Identities = 29/124 (23%), Positives = 49/124 (39%), Gaps = 18/124 (14%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
+D L + G +L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYD--NNRAVWASGTNGK-- 48
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
VL + N GNLV+ + + IW+SN +R+ N L + N+VI DNS +
Sbjct: 49 ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 161 LWQS 164
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 17/72 (23%), Positives = 35/72 (48%), Gaps = 1/72 (1%)
Query: 96 NSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSN 155
+ + + + N NLVL + +N +W+S + + V ++ ++GNLVI S +
Sbjct: 13 GGSLAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAI 71
Query: 156 STESYLWQSFDY 167
+ Q+ +Y
Sbjct: 72 WASNTNRQNGNY 83
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 42/199 (21%), Positives = 74/199 (37%), Gaps = 35/199 (17%)
Query: 526 NFSIQSKLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLKEFKNEMML-----IA 576
+ + K+G GGFG +Y ++ A VK ++G E K + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 577 KLQHRNLVRLLG-----CCIEQGEKILIYEYMV----NKSLDVFLFDPTKKHLLG--WQL 625
K R + LG K Y +MV L + QL
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQ-KISGQNGTFKKSTVLQL 156
Query: 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI--SDFGMARMFGGDEL- 682
+R++D + Y+H+ +H D+KA+N+LL ++ +D+G++ + +
Sbjct: 157 GIRMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 683 ----QGNTKRIVGTYGYMS 697
+ K GT + S
Sbjct: 210 KQYQENPRKGHNGTIEFTS 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 43/194 (22%), Positives = 81/194 (41%), Gaps = 38/194 (19%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 581
++ + ++GEG FG +++G LLN Q+VA+K +S Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIA 634
+ + E +L+ + + SL+ L D + Q+ R+
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQ---- 120
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK-----ISDFGMARMFGGDELQGN---- 685
+H+ S +++RD+K N L+ + + + DFGM + + D +
Sbjct: 121 ----SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPY 172
Query: 686 --TKRIVGTYGYMS 697
K + GT YMS
Sbjct: 173 REKKNLSGTARYMS 186
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-11
Identities = 22/123 (17%), Positives = 40/123 (32%), Gaps = 20/123 (16%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + +L + + L + + YQ +W +N +
Sbjct: 3 NVLLSGQTLHADHSLQA--GAYTLTIQNKCNL------VKYQN--GRQIWASNTDRR--G 50
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
LT+ + GNLV+ + +N +W S + L +G VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 162 WQS 164
W
Sbjct: 103 WSL 105
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 44/192 (22%), Positives = 76/192 (39%), Gaps = 36/192 (18%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RN 582
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRIIDGIAQ 635
+ + C E +++ E + SL+ LF+ + L Q+ RI
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSLKTVLLLADQMISRIE----- 119
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPK---ISDFGMARMFGGDELQGNT------ 686
Y+H + IHRD+K N L+ I DFG+A+ + + + +
Sbjct: 120 ---YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRE 171
Query: 687 -KRIVGTYGYMS 697
K + GT Y S
Sbjct: 172 NKNLTGTARYAS 183
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 581
F + K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGG 62
Query: 582 NLV-RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLR--VRIIDGIAQGLL 638
+ + +E +L+ + + SL+ LF+ + L L+ + + D + +
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKL---SLKTVLMLADQMINRVE 117
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPK---ISDFGMARMFGGDELQG------NTKRI 689
++H S +HRD+K N L+ I DFG+A+ + D K +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNL 173
Query: 690 VGTYGYMS 697
GT Y S
Sbjct: 174 TGTARYAS 181
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-10
Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 19/129 (14%)
Query: 37 FSLAADTLTPTTLIRDGE-TLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANR 95
FS D P L ++ + + + + Y + +W N
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNL------VLYDN--NNPIWATNT 56
Query: 96 NSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSN 155
+ G LV++ N T+W S V+ + + V L + N+VI ++
Sbjct: 57 GGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--- 111
Query: 156 STESYLWQS 164
LW +
Sbjct: 112 -----LWAT 115
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 5e-10
Identities = 28/123 (22%), Positives = 45/123 (36%), Gaps = 20/123 (16%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + GE L + R+ + Y D +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNL------VLYDV--DKPIWATNTGGL--D 49
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
+ L++ + GNLV+ + N IW+SN E N V L + N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 162 WQS 164
W +
Sbjct: 102 WAT 104
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 9e-09
Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 23/126 (18%)
Query: 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSP 98
L + L + L + F+L Y G W N+
Sbjct: 1 LGTNYLLSGQTLDTEGHLKN--GDFDLVMQDDCNLV-LYNGNWQS------------NTA 45
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
++ LT+++ G LV+ N T+W S N A + +G LV+ S
Sbjct: 46 NNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 159 SYLWQS 164
+++
Sbjct: 100 --VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 17/125 (13%), Positives = 44/125 (35%), Gaps = 18/125 (14%)
Query: 40 AADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPI 99
+ L + ++ D L + + + L + + +VW + +
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSGR- 55
Query: 100 VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTES 159
++ + + + G L + + T++ SN + + V L NG V+ +
Sbjct: 56 -GQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA------- 107
Query: 160 YLWQS 164
+W +
Sbjct: 108 -VWST 111
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 37 FSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRN 96
+ L ++ L + +L + Y W +N +
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCNL------VLY---GGKYGWQSNTH 50
Query: 97 SPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVI 148
++ L ++++G L++ + TIWSS S + V L D+G VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-07
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 7/71 (9%)
Query: 94 NRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSG 153
+ + KN L + NLVL W SN ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVL--YGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 154 SNSTESYLWQS 164
+W S
Sbjct: 74 KT-----IWSS 79
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 50/228 (21%)
Query: 527 FSIQSKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 581
+ I LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 582 ------NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRV--RIIDG 632
V + G + +E L F+ K++ + L +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP-------------------KISDFGM 673
+ L +LH ++ H DLK NIL +++DFG
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
A F + IV T Y PE LE ++ DV+S G ++ E
Sbjct: 189 A-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 5e-08
Identities = 86/582 (14%), Positives = 165/582 (28%), Gaps = 152/582 (26%)
Query: 245 FIFQPIVVQNKDEVYYMYESYSSPIIM------ILRV-NPLGQVQRLIW---HEMSTGWQ 294
+F+ V N D + + I+ I+ + + RL W + Q
Sbjct: 23 SVFEDAFVDNFD-CKDV-QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQ 80
Query: 295 VFFTAPDPFCHYGDCGPNSICSVDQTSHCECLEGFKFKSQQNQTCVRSHSSD----CKSG 350
F V + ++ + K + +Q R +
Sbjct: 81 KFVE-----------------EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 351 DRFKKLDDIKLPDLLDVSLNES-MNLKE-----------CEAECLKNCSCRAYANSKVTD 398
F K ++ L ++ + L+ + C +Y KV
Sbjct: 124 QVFAKY-NVSRLQPYL-KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY---KVQC 178
Query: 399 GGSGCLMW--FG-------DLIDLKK-----TDNHTNGVSIYIRVPAS-EQGNKKLLWII 443
+ W L L+K N T+ + +L ++
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238
Query: 444 VILVLP--LVILPCVYIARQWSRKRKENETKNLDTNQDLLAFDVN--MGITTRTNEFCEA 499
L++L V A+ W+ AF+++ + +TTR
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWN------------------AFNLSCKILLTTR------- 273
Query: 500 DGDGKDKSKDSSLPLFSFASVTAATENFSIQSKLGEGGFGPVY-KGRLLNGQEVAVKRLS 558
K + F S T I P K LL + + L
Sbjct: 274 -----FKQ------VTDFLSAATTTH---ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 559 NQSGQGL--------KEFKNEMMLIAKLQHRN---LVRLLGCCIEQGEKILIYEYMVNKS 607
+ + ++ + +H N L ++ + E +
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF--DR 377
Query: 608 LDVFLFD---PTKKHLLG--W-QLRVRIIDGIAQGLLYLHQYS---------RLRI--IH 650
L VF PT LL W + + + LH+YS + I I+
Sbjct: 378 LSVFPPSAHIPTI--LLSLIWFDVIKSDVMVVVNK---LHKYSLVEKQPKESTISIPSIY 432
Query: 651 RDLKASNILLDQHMNPKISD-FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSV 708
+LK + + ++ I D + + + F D+L + Y Y + L+ +
Sbjct: 433 LELKV-KLENEYALHRSIVDHYNIPKTFDSDDL---IPPYLDQYFYSHIGHHLKNIEHPE 488
Query: 709 KSDVFSFGVLMLEILSSK-KNTGVYNTDSFNLLGHVSD-KLY 748
+ +F L L K ++ S ++L + K Y
Sbjct: 489 RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 44/227 (19%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 581
F + K+G+G FG V + + N + AVK + N E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 582 ----NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKH-LLGWQLRV--RIIDGIA 634
N+V+ G + LI+E L L++ ++ G+ + I
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR------ 688
+ L YL ++ + H DLK NILLD K G TK
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 689 --------------IVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
I+ T Y +PE L + V SD++SFG ++ E
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 54/230 (23%)
Query: 527 FSIQSKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 581
+ I LGEG FG V + G+ VAVK + N E + ++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTT 71
Query: 582 ------NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQ-LRVRIIDGIA 634
V++L G +++E L + +D K++ G+ R+ I +A
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKEN--GFLPFRLDHIRKMA 124
Query: 635 QGLL----YLHQYSRLRIIHRDLKASNILLDQHMNP-------------------KISDF 671
+ +LH ++ H DLK NIL Q K+ DF
Sbjct: 125 YQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLE 721
G A + + +V T Y +PE L +S DV+S G +++E
Sbjct: 182 GSA-TYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 53/276 (19%), Positives = 90/276 (32%), Gaps = 94/276 (34%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + KLG G F V+ + + VA+K + + + +E I L+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDE---IRLLKS-- 89
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVF------------LFDPTKKHLLGWQLR---- 626
+ + MV + LD F +F+ HLL W ++
Sbjct: 90 --------VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQ 141
Query: 627 ------VR-IIDGIAQGLLYLHQYSRLRIIHRDLKASNILL------------------- 660
V+ II + QGL YLH ++ RIIH D+K NILL
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 661 ------------------------------DQHMNPKISDFGMARMFGGDELQGNTKRIV 690
+ + KI+D G A + +
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DI 254
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T Y S E + ++ +D++S + E+ +
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 2e-06
Identities = 17/78 (21%), Positives = 27/78 (34%), Gaps = 8/78 (10%)
Query: 87 DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
D V + N+ + G + +L N +W+S SR V L + NL
Sbjct: 166 DRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNL 225
Query: 147 VIRDNSGSNSTESYLWQS 164
I + LW +
Sbjct: 226 AIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 5e-04
Identities = 24/146 (16%), Positives = 43/146 (29%), Gaps = 11/146 (7%)
Query: 87 DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNL 146
D VW +N + + + G LV+L N WSS + N V L + +
Sbjct: 44 DVRVWASNTAGATGCR---AVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTH 206
I LW S +++ L + S +
Sbjct: 101 TIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152
Query: 207 RLDIHVLPQVCVYNGSAKYTCTGPWN 232
RL + + +++ + T
Sbjct: 153 RLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.4 bits (111), Expect = 7e-06
Identities = 30/162 (18%), Positives = 52/162 (32%), Gaps = 22/162 (13%)
Query: 38 SLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNS 97
+ L + G+ L+SP+QRF+L G + VWVAN
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNL------VIQD--NGATVWVANEQQ 62
Query: 98 PIV------DKNGVLTVSNRGNLVLLNQSNGTIWSS-----NVSREVKNPVAQLLDNGNL 146
P +K L + L + S +W + + + L D+GN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 147 VIRDNSGSNSTESYLWQSFDYPTDTML---QGMKLGWDLRTG 185
V+ D+ + + +L + G G
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAG 164
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 12/62 (19%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 99 IVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158
+ ++ + NLVL N + SN + +L + G L I + +
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVW 74
Query: 159 SY 160
Y
Sbjct: 75 VY 76
|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A Length = 99 | Back alignment and structure |
|---|
Score = 39.0 bits (90), Expect = 5e-04
Identities = 14/50 (28%), Positives = 21/50 (42%), Gaps = 5/50 (10%)
Query: 304 CHYGDCGPNSICSV--DQTSHCECLEGFKFKSQQNQTCVRSHSSDCKSGD 351
C C NS C D+ C+CL +K Q+ CV + + C +
Sbjct: 7 CVKKQCPQNSGCFRHLDEREECKCLLNYK---QEGDKCVENPNPTCNENN 53
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 754 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.86 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.86 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.83 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.82 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.81 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.75 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.7 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.68 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.61 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.6 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.59 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.41 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.33 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.23 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.21 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.47 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.1 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.87 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.85 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.37 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.77 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 92.94 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 91.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.95 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 86.32 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=400.90 Aligned_cols=225 Identities=27% Similarity=0.374 Sum_probs=196.3
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++++++..|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999864 5889999999753 234567899999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++|+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999983 4557999999999999999999999988 99999999999999999999999999998865
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhh
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSL 750 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~ 750 (754)
........+.+||+.|||||++.+..|+.++||||+||+||||++|+.||...+. ....++..+++.++|+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDL 264 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHH
Confidence 5544455668999999999999999999999999999999999999999976542 2334555667777777
Q ss_pred hhcC
Q 004416 751 LFDL 754 (754)
Q Consensus 751 l~~l 754 (754)
|.+|
T Consensus 265 i~~l 268 (311)
T 4aw0_A 265 VEKL 268 (311)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=398.25 Aligned_cols=221 Identities=24% Similarity=0.347 Sum_probs=190.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.+.|++.++||+|+||+||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 367999999999999999999875 5899999999766555567789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++|+|.+++. +..+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999883 345899999999999999999999988 99999999999999999999999999998754332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------------CccchhhhHHHHHhhh
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT------------DSFNLLGHVSDKLYSL 750 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~------------~~~~~~~~~~~~l~~~ 750 (754)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+. ........+++.++|+
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 23457999999999999999999999999999999999999999976431 1122334456666666
Q ss_pred hhc
Q 004416 751 LFD 753 (754)
Q Consensus 751 l~~ 753 (754)
|.+
T Consensus 304 i~~ 306 (346)
T 4fih_A 304 LDR 306 (346)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=396.63 Aligned_cols=208 Identities=31% Similarity=0.510 Sum_probs=182.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeec------CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
..++|.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++++|.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3467999999999999999999864 3678999999877777788999999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCC----------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 597 ILIYEYMVNKSLDVFLFDP----------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
+|||||+++|+|.++|... .....+++.++++|+.||++||+|||+++ ||||||||+||||++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999542 23456899999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||...+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999987755443333344679999999999999999999999999999999999 899997644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=396.04 Aligned_cols=208 Identities=32% Similarity=0.511 Sum_probs=175.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeec------CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
..++|.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++++|.+....
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467889999999999999999864 3678999999877777788999999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCC------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC
Q 004416 597 ILIYEYMVNKSLDVFLFDPT------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~ 664 (754)
+|||||+++|+|.+++.... ....+++.++++|+.||++||+|||+++ ||||||||+||||++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 99999999999999986532 2346899999999999999999999987 99999999999999999
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 999999999998755443334445689999999999999999999999999999999999 899997643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=396.84 Aligned_cols=203 Identities=25% Similarity=0.395 Sum_probs=174.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|+++++||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999864 5899999998654 34456789999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++|+|.+++... +...+++..++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998432 3445789999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 12234689999999999999999999999999999999999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=400.03 Aligned_cols=201 Identities=24% Similarity=0.364 Sum_probs=181.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.+.|++.++||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999875 5899999999766555567789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
|++|+|.+++. ...+++..+..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999883 345899999999999999999999998 99999999999999999999999999998754332
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 2345789999999999999999999999999999999999999997643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=386.49 Aligned_cols=206 Identities=33% Similarity=0.520 Sum_probs=179.8
Q ss_pred CCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46778899999999999999863 46789999997543 344678999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC
Q 004416 598 LIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~ 664 (754)
||||||++|+|.++|.... ....+++..+.+|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999995432 1346899999999999999999999987 99999999999999999
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.+||+|||+|+.+.............||+.|||||++.++.++.++|||||||+||||+| |+.||...+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999998755444344445689999999999999999999999999999999999 899997644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=383.43 Aligned_cols=206 Identities=28% Similarity=0.473 Sum_probs=172.3
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
++...+++++.++||+|+||+||+|++.+ .||||+++.. .....++|.+|+.+|++++|||||++++++. ++..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEE
Confidence 34556789999999999999999998753 5999998643 3455678999999999999999999999875 45789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
|||||+++|+|.++|.. .+..+++.++.+|+.||++||+|||+++ ||||||||+||||++++.+||+|||+|+..
T Consensus 108 iVmEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999854 2346899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
............+||+.|||||++.+ .+++.++|||||||+||||+||+.||...+
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 54433334455789999999999864 468999999999999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=376.83 Aligned_cols=219 Identities=27% Similarity=0.442 Sum_probs=173.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 5899999998654 2334567999999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+ +|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 578888873 3456999999999999999999999988 999999999999999999999999999876443
Q ss_pred cccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSL 750 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~ 750 (754)
. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+. ....++.++++.++++
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 242 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL 242 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 2 2334789999999999998886 5799999999999999999999976542 2223444566666666
Q ss_pred hhc
Q 004416 751 LFD 753 (754)
Q Consensus 751 l~~ 753 (754)
|.+
T Consensus 243 i~~ 245 (275)
T 3hyh_A 243 IKR 245 (275)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=376.01 Aligned_cols=197 Identities=30% Similarity=0.461 Sum_probs=170.0
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe----cCcEEEE
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILI 599 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV 599 (754)
|++.++||+|+||+||+|++. +++.||||++... .....++|.+|+++|++++|||||++++++.. +...+||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999875 4789999998654 34456789999999999999999999999875 2457999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCeEEEeecCccccC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFG 678 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~kL~DFGla~~~~ 678 (754)
|||+++|+|.+++. +...+++..+..++.||++||+|||+++ .+||||||||+||||+ +++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999994 4557899999999999999999999875 3599999999999998 47899999999998643
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. .....+||+.|||||++.+ .++.++|||||||+||||+||+.||...
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 32 2345789999999998865 6999999999999999999999999653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=386.93 Aligned_cols=219 Identities=24% Similarity=0.282 Sum_probs=182.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.+.|++.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+|++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 357889999999999999999875 589999999975432 24699999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCccccCCCc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGGDE 681 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~~~~~ 681 (754)
+++|+|.+++. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999994 4456899999999999999999999987 99999999999999987 69999999999876543
Q ss_pred ccC---CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc------------cchhhhHHHH
Q 004416 682 LQG---NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS------------FNLLGHVSDK 746 (754)
Q Consensus 682 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~~------------~~~~~~~~~~ 746 (754)
... .....+||+.|||||++.+..++.++|||||||+||||+||+.||...+... ..+..++++.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 211 2234689999999999999999999999999999999999999997654321 1233445566
Q ss_pred Hhhhhhc
Q 004416 747 LYSLLFD 753 (754)
Q Consensus 747 l~~~l~~ 753 (754)
++++|.+
T Consensus 286 ~~~li~~ 292 (336)
T 4g3f_A 286 TAQAIQE 292 (336)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6666543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=388.36 Aligned_cols=221 Identities=28% Similarity=0.344 Sum_probs=181.2
Q ss_pred CCcceeeeeceeccEEEEeeeec----Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
++|++.+.||+|+||+||+|+.. .++.||||+++... .....++.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 36789999986542 2234467899999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999983 4557899999999999999999999988 9999999999999999999999999998754
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhh
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYS 749 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~ 749 (754)
... ......+||+.|||||++.+..++.++|||||||+||||+||+.||...+. ....++..+++.+++
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 255 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 255 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 332 223347899999999999999999999999999999999999999976542 222344556666677
Q ss_pred hhhc
Q 004416 750 LLFD 753 (754)
Q Consensus 750 ~l~~ 753 (754)
+|.+
T Consensus 256 li~~ 259 (304)
T 3ubd_A 256 LLRM 259 (304)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=382.24 Aligned_cols=215 Identities=29% Similarity=0.430 Sum_probs=184.6
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeeecC------cceeeeeeccccc-hhhHHHHHHHHHHHHHccc-cceeeeE
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQH-RNLVRLL 587 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H-~nIv~l~ 587 (754)
.....+...++|++.++||+|+||+||+|++.. ++.||||+++... ....++|.+|+++|.++.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334566778999999999999999999997542 3679999997653 3446789999999999965 8999999
Q ss_pred eEEEec-CcEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCC
Q 004416 588 GCCIEQ-GEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL 653 (754)
Q Consensus 588 ~~~~~~-~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DI 653 (754)
++|.+. ...++|||||++|+|.++|+... ....+++..+..++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 56899999999999999995432 2356899999999999999999999987 999999
Q ss_pred CCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 654 KASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 654 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
||+|||+++++.+||+|||+|+.+............+||+.|||||++.+..++.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765443334445689999999999999999999999999999999998 89999765
Q ss_pred C
Q 004416 733 N 733 (754)
Q Consensus 733 ~ 733 (754)
.
T Consensus 292 ~ 292 (353)
T 4ase_A 292 K 292 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=362.98 Aligned_cols=233 Identities=20% Similarity=0.208 Sum_probs=180.0
Q ss_pred hccccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCC----CceEEEeccCc
Q 004416 38 SLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDK----NGVLTVSNRGN 113 (754)
Q Consensus 38 ~~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~----~~~l~~~~~g~ 113 (754)
+++.|+|++||+|++|++|+|++|+|+||||.++ ++|+ |+ ..+ +||+|||++|+.++ +++|+|+.||+
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 5678999999999999999999999999999543 6777 77 444 99999999999875 88999999999
Q ss_pred EEE--ecCCCCeEEEecccCC-----ccCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccccccccccCC
Q 004416 114 LVL--LNQSNGTIWSSNVSRE-----VKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRTGL 186 (754)
Q Consensus 114 l~l--~~~~~~~~wst~~~~~-----~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~~tg~ 186 (754)
||| .|++|.+||+|+++.. ..+..|+|+|+|||||++ +.+|||| |||||+|||||||.++++|.
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~-------~~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD-------SLALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE-------EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC-------CceeeCc--ccccccccccccccccccCc
Confidence 999 7888999999998652 345789999999999997 2589999 99999999999999999986
Q ss_pred cceEEeecCCCCCCCcceEEeeecCCCCeEEEec-CCceeeccCCCCCcccccCCCCcccceeeEEeecCCceEEEEeec
Q 004416 187 ERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYN-GSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKDEVYYMYESY 265 (754)
Q Consensus 187 ~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~-~~~~yw~sg~w~g~~~~~~~~~~~~~~~~~~v~n~~e~~~~~~~~ 265 (754)
. | ++.+||++|.|+++++++|. +++|+ ++.+||++|+|++..... ..... -.+.+.++.+ ..+-++..
T Consensus 154 ~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l--~l~~d-GnLvl~d~~~-~~vWsS~t 222 (276)
T 3m7h_A 154 E--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRA--VFQGD-GNLVVYGAGN-AVLWHSHT 222 (276)
T ss_dssp E--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEE--EECTT-SCEEEECTTS-CEEEECSC
T ss_pred c--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEE--EEcCC-CeEEEEeCCC-cEEEEecC
Confidence 5 4 67899999999999999995 44565 468999999997532100 00000 0112223322 22222222
Q ss_pred CCCeeEEEEEccCCcEEEEEeeecCCceEEEEecCC
Q 004416 266 SSPIIMILRVNPLGQVQRLIWHEMSTGWQVFFTAPD 301 (754)
Q Consensus 266 ~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~ 301 (754)
......|++|+.||++++|.| ...|+.++..|.
T Consensus 223 ~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 223 GGHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp TTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred CCCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 223358999999999999998 245766665554
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=363.24 Aligned_cols=201 Identities=27% Similarity=0.428 Sum_probs=162.7
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCc-------
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE------- 595 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------- 595 (754)
++|++.+.||+|+||+||+|+.+ +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999865 58899999986543 3445778999999999999999999999876543
Q ss_pred -----EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEe
Q 004416 596 -----KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (754)
Q Consensus 596 -----~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~D 670 (754)
.++||||+++|+|.+++.........++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999965544445667778899999999999999988 99999999999999999999999
Q ss_pred ecCccccCCCcccC----------CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 671 FGMARMFGGDELQG----------NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 671 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 99999875532211 1233579999999999999999999999999999999997 6643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.23 Aligned_cols=202 Identities=26% Similarity=0.380 Sum_probs=165.9
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC----cEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 600 (754)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||++++++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4688999999999999999998 5889999999754322 223455677777899999999999998764 579999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-----CCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
||+++|+|.+++. ...+++..+.+++.|+++||+|||++ ..++||||||||+||||++++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999994 34689999999999999999999986 23359999999999999999999999999998
Q ss_pred ccCCCcc--cCCcccccccCcccCccccCCC------CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDEL--QGNTKRIVGTYGYMSPEYALEG------VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
....... .......+||+.|||||++.+. .++.++|||||||+||||+||++|++..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 7754332 2223346899999999998765 3677999999999999999998877543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=381.95 Aligned_cols=220 Identities=29% Similarity=0.380 Sum_probs=182.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHH---HHHHHHHccccceeeeEeEEEecCcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKN---EMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~---Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
-++|++.++||+|+||+||+|+.+ +|+.||||++.+.. ......+.+ ++.+++.++|||||++++++++.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999875 58899999986532 122233333 45666677899999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
|+||||+++|+|..+|. ....+++..+..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999983 4567899999999999999999999988 99999999999999999999999999998
Q ss_pred cCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------------ccchhhhH
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD------------SFNLLGHV 743 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~~~------------~~~~~~~~ 743 (754)
+.... ....+||+.|||||++.+ ..|+.++|||||||+||||++|++||...+.. ...++.++
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~ 417 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccC
Confidence 75433 344799999999999974 57999999999999999999999999764422 12234455
Q ss_pred HHHHhhhhhc
Q 004416 744 SDKLYSLLFD 753 (754)
Q Consensus 744 ~~~l~~~l~~ 753 (754)
++.++++|.+
T Consensus 418 S~~a~dLI~~ 427 (689)
T 3v5w_A 418 SPELRSLLEG 427 (689)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 6666666654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.75 Aligned_cols=201 Identities=24% Similarity=0.368 Sum_probs=171.3
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec----CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecC
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 594 (754)
+....++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+++ +||||+++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3445678999999999999999999753 46789999886543 345678999999998 6999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEeecC
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGM 673 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DFGl 673 (754)
..++||||+++++|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999882 3789999999999999999999998 9999999999999877 7999999999
Q ss_pred ccccCCCccc--------------------------CCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCC
Q 004416 674 ARMFGGDELQ--------------------------GNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSK 726 (754)
Q Consensus 674 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~ 726 (754)
|+........ ......+||+.|||||++.+.. ++.++||||+||++|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9876432211 1122357999999999998764 899999999999999999999
Q ss_pred CCCCC
Q 004416 727 KNTGV 731 (754)
Q Consensus 727 ~p~~~ 731 (754)
.||..
T Consensus 245 ~Pf~~ 249 (361)
T 4f9c_A 245 YPFYK 249 (361)
T ss_dssp SSSSC
T ss_pred CCCCC
Confidence 99854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=360.85 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=173.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEe------cC
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE------QG 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~------~~ 594 (754)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999864 58999999996542 3345678899999999999999999998764 35
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..||||||++ |+|..++. ....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67888883 4567999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCc--ccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDE--LQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||...+
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 8774432 12233457999999999998875 46899999999999999999999997643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=374.80 Aligned_cols=222 Identities=25% Similarity=0.376 Sum_probs=191.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
++|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+....+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999875 58999999997766666778999999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC--CCeEEEeecCccccCCCc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARMFGGDE 681 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~--~~~kL~DFGla~~~~~~~ 681 (754)
++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999988843 3456899999999999999999999988 9999999999999854 899999999999876543
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------------ccchhhhHHHHHh
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-------------SFNLLGHVSDKLY 748 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~-------------~~~~~~~~~~~l~ 748 (754)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. .......+++.++
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 234468999999999999999999999999999999999999999765421 1112234566777
Q ss_pred hhhhcC
Q 004416 749 SLLFDL 754 (754)
Q Consensus 749 ~~l~~l 754 (754)
|||.+|
T Consensus 389 dli~~~ 394 (573)
T 3uto_A 389 DFIRKL 394 (573)
T ss_dssp HHHHTT
T ss_pred HHHHHH
Confidence 777654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=318.35 Aligned_cols=217 Identities=13% Similarity=0.155 Sum_probs=169.4
Q ss_pred ccccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEec
Q 004416 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLN 118 (754)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 118 (754)
++.|+|++||+|.+|++| ++|.|+|||+.+++ +.+ |. .+|+||+|||+.| ..+.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~--~~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FD--SDVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EE--SSSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EE--CCEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 567999999999999999 59999999998765 334 43 3799999999988 57899999999999999
Q ss_pred CCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccc-cccccccccc-ccCC-----cceEE
Q 004416 119 QSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTM-LQGMKLGWDL-RTGL-----ERYQT 191 (754)
Q Consensus 119 ~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtl-Lpg~kl~~~~-~tg~-----~~~l~ 191 (754)
++|.+||+|++......+.|+|+|+|||||++. ++||||||||||+ ||+| |.|. .+|+ .+.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~--------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC--------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 999999999987655567899999999999952 6999999999877 5665 5554 5555 56776
Q ss_pred eecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCCCCCcccccCCCCcccceeeEEeecCCceEEEEeecCCCeeE
Q 004416 192 SWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGVAFGSAPSNTTFIFQPIVVQNKDEVYYMYESYSSPIIM 271 (754)
Q Consensus 192 Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~w~g~~~~~~~~~~~~~~~~~~v~n~~e~~~~~~~~~~~~~~ 271 (754)
+.+||++|.|+++++++| +++++++..+||++++|++. +.+.+++......+.+..++++++..|..... ..+
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~~ 215 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GRY 215 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SCC
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CCE
Confidence 478999999999999999 67788888999999999753 44444442122222333344455555544333 468
Q ss_pred EEEEccCCcEEEEE
Q 004416 272 ILRVNPLGQVQRLI 285 (754)
Q Consensus 272 rl~l~~~G~l~~~~ 285 (754)
|++|++||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999983
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=325.54 Aligned_cols=202 Identities=25% Similarity=0.414 Sum_probs=181.2
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 457899999999999999999985 4688999999876655567788999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 98 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999883 335889999999999999999999988 9999999999999999999999999998775443
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2334689999999999999999999999999999999999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.53 Aligned_cols=217 Identities=40% Similarity=0.676 Sum_probs=190.1
Q ss_pred ccchhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec
Q 004416 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (754)
Q Consensus 514 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 593 (754)
.+++.++....++|++.+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34556677788999999999999999999999888999999998877666778899999999999999999999999999
Q ss_pred CcEEEEEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
+..++||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999885432 2335899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 9987654332223334578999999999998999999999999999999999999986544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.37 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=178.6
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|++.+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999875 5889999998654 233466788999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999998883 3456889999999999999999999988 99999999999999999999999999986433
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 22 12344689999999999999999999999999999999999999997644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.09 Aligned_cols=203 Identities=29% Similarity=0.432 Sum_probs=179.9
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
...++|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++......++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999999987 46899999998654 34456778999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999883 3456889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFS-VKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .....+||+.|+|||++.+..+. .++||||||+++|||++|+.||...+
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 432 23446899999999999888875 78999999999999999999997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.32 Aligned_cols=212 Identities=24% Similarity=0.329 Sum_probs=182.7
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEE
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 591 (754)
.+..+....++|++.++||+|+||+||+|+.+. ++.||||++++.. ....+.+.+|+.++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345566777899999999999999999999764 7889999986532 122334889999999999999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
+....++||||+++|+|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999953 2356899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+|+.+...... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 999876543322 123368999999999987 5678999999999999999999999997654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.20 Aligned_cols=203 Identities=27% Similarity=0.389 Sum_probs=174.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 597 (754)
..++|++.++||+|+||.||+|+.+ +++.||||+++.. .....+.+.+|..++..+ +||||+++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999875 4889999998754 233456788999999998 7999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999883 3456899999999999999999999988 999999999999999999999999999864
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 3322 22344689999999999998899999999999999999999999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=336.16 Aligned_cols=202 Identities=24% Similarity=0.373 Sum_probs=176.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 597 (754)
..++|++.++||+|+||.||+|+.+ +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+....+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3478999999999999999999875 47889999987542 22335678899999887 8999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999998884 3456899999999999999999999988 999999999999999999999999999863
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 3222 2334578999999999999999999999999999999999999999643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.22 Aligned_cols=204 Identities=27% Similarity=0.389 Sum_probs=178.3
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~ 596 (754)
...++|.+.+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999875 58899999997542 33456778899999987 999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999883 3456889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 43222 12344789999999999999999999999999999999999999997654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.92 Aligned_cols=198 Identities=29% Similarity=0.423 Sum_probs=177.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999875 58899999986542 234567889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999984 3456889999999999999999999987 999999999999999999999999999875432
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 234689999999999999999999999999999999999999997644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.53 Aligned_cols=210 Identities=30% Similarity=0.481 Sum_probs=181.6
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec--------Ccceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 590 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~--------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 590 (754)
....++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+++.+|+.+++++ +||||+++++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345678999999999999999999752 3557999999765 334567899999999999 899999999999
Q ss_pred EecCcEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCC
Q 004416 591 IEQGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (754)
Q Consensus 591 ~~~~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~N 657 (754)
.+.+..++||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999985432 1245789999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999997765443333444567889999999999999999999999999999999 999997644
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.93 Aligned_cols=202 Identities=28% Similarity=0.380 Sum_probs=179.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchh------hHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..+.|.+.+.||+|+||.||+++.. +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4478999999999999999999875 5889999998754321 35788999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC----CeEEEee
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDF 671 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~~kL~DF 671 (754)
.++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999983 3456899999999999999999999988 99999999999998877 7999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998875432 2234679999999999999999999999999999999999999997644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.73 Aligned_cols=202 Identities=27% Similarity=0.340 Sum_probs=177.9
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 598 (754)
.++|++.+.||+|+||.||+|+.+. ++.||||+++.. .....+.+.+|..++..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4789999999999999999998764 789999998754 223456788999999888 89999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999884 3356889999999999999999999988 9999999999999999999999999998643
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 222 12344689999999999999999999999999999999999999997654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.26 Aligned_cols=213 Identities=31% Similarity=0.517 Sum_probs=174.2
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
........++|++.+.||+|+||.||+|+. +++.||||++.... ....+++.+|++++++++||||+++++++.+..
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334455668899999999999999999987 57889999986543 344578899999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|.+++........+++..+..++.||++||+|||+++ .+|+||||||+|||+++++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999999965444455899999999999999999999875 34999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 187 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 187 RLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 86543321 2234679999999999999999999999999999999999999997654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.14 Aligned_cols=205 Identities=28% Similarity=0.397 Sum_probs=176.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 378999999999999999999875 68899999986543 2334678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999883 4456899999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 3333445689999999999987776 7789999999999999999999976554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.30 Aligned_cols=212 Identities=23% Similarity=0.328 Sum_probs=182.3
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEE
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 591 (754)
.+.+.....++|++.++||+|+||.||+++.+ +++.||||++++.. ....+.+.+|+.++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34556667789999999999999999999875 58899999986532 223345789999999999999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
+....++||||+++|+|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999842 1246889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYAL-------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+++.+...... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 999877543321 122368999999999987 4578999999999999999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=318.26 Aligned_cols=207 Identities=28% Similarity=0.470 Sum_probs=181.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
..++|.+.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.++...++|||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 4578999999999999999999875 588999999877677777889999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+....
T Consensus 88 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 88 YIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999853 2356889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccC------------CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 682 LQG------------NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 682 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
... ......||+.|+|||++.+..++.++||||||+++|||++|..|+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 211 11146799999999999999999999999999999999999999876553
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.58 Aligned_cols=204 Identities=28% Similarity=0.454 Sum_probs=174.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4578999999999999999999864 5889999988543 33445788999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 v~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EEeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999983 3456899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 43321 2333679999999999999999999999999999999999999997654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.64 Aligned_cols=202 Identities=26% Similarity=0.400 Sum_probs=177.8
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3478999999999999999999865 47889999986532 3345778899999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+.+++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999884 3456899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .....+||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 432 2344689999999999874 458999999999999999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.16 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=176.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 598 (754)
.++|++.+.||+|+||.||+++.+ +++.||||+++.. .....+.+.+|+.++.++ +||||+++++++......++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 367999999999999999999875 4889999998754 233456788999999998 89999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999884 3456899999999999999999999988 9999999999999999999999999998643
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 222 123446899999999999999999999999999999999999999965
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=321.32 Aligned_cols=197 Identities=27% Similarity=0.418 Sum_probs=177.9
Q ss_pred cceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
|...+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 777889999999999999876 6899999999776666678899999999999999999999999999999999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 99999883 345899999999999999999999987 99999999999999999999999999987654332 2
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 23468999999999999999999999999999999999999999654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=327.07 Aligned_cols=219 Identities=42% Similarity=0.716 Sum_probs=189.7
Q ss_pred CCCccchhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccch-hhHHHHHHHHHHHHHccccceeeeEeE
Q 004416 511 SLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (754)
Q Consensus 511 ~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 589 (754)
....+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4566888999999999999999999999999999988899999999876432 223468999999999999999999999
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
+......++||||+++++|..++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||+++++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999986543 3445899999999999999999999982223999999999999999999999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999876543322 2233569999999999988899999999999999999999999995
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.40 Aligned_cols=203 Identities=29% Similarity=0.390 Sum_probs=168.4
Q ss_pred ccCCcceeeeeceeccEEEEeeee----cCcceeeeeeccccc----hhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
..++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++++++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 447899999999999999999986 468899999987542 233456789999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999883 3456888999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 86533221 2234679999999999999999999999999999999999999997654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.25 Aligned_cols=209 Identities=23% Similarity=0.289 Sum_probs=180.3
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEe
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 592 (754)
...+....++|++.++||+|+||.||+|+.+ +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455667789999999999999999999876 47899999986532 1223457899999999999999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
....++||||+++|+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 999999999999999999883 335889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGV----FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++.+...... .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+
T Consensus 214 ~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 214 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp TCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 99876544321 223468999999999997665 7889999999999999999999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.85 Aligned_cols=199 Identities=25% Similarity=0.323 Sum_probs=178.1
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999875 58899999986542 23457788999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999884 3346889999999999999999999988 99999999999999999999999999987643
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 2 234689999999999999999999999999999999999999997654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.88 Aligned_cols=201 Identities=23% Similarity=0.322 Sum_probs=178.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||.||+++.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999875 47899999986543 3456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC--CCCeEEEeecCccccCCC
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGD 680 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~--~~~~kL~DFGla~~~~~~ 680 (754)
+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999988 999999999999987 789999999999887543
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 3 2234679999999999999889999999999999999999999997654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=321.06 Aligned_cols=221 Identities=25% Similarity=0.387 Sum_probs=185.0
Q ss_pred cCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47899999999999999999986 468899999986432 22345789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+ +|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 678877773 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred CcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCC---------ccchhhhHHHHHhh
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNTD---------SFNLLGHVSDKLYS 749 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~~~---------~~~~~~~~~~~l~~ 749 (754)
.. .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ....+..+++.+.+
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHH
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 33 2234679999999999988776 78999999999999999999999765421 12234445666666
Q ss_pred hhhcC
Q 004416 750 LLFDL 754 (754)
Q Consensus 750 ~l~~l 754 (754)
+|.+|
T Consensus 238 li~~~ 242 (336)
T 3h4j_B 238 LIRRM 242 (336)
T ss_dssp HHHTT
T ss_pred HHHHH
Confidence 66554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.35 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=177.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999875 5889999998654 334557789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC---CeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~~kL~DFGla~~ 676 (754)
|||+++++|.+.+. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999988883 3456899999999999999999999988 99999999999998654 599999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 65432 2234689999999999999999999999999999999999999996543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.83 Aligned_cols=203 Identities=25% Similarity=0.310 Sum_probs=168.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHH-HHHccccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMML-IAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
..++|++.+.||+|+||.||+++.+. ++.||||+++... ....+.+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 44789999999999999999998754 7889999987543 2234456667766 46789999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999883 3456888999999999999999999988 999999999999999999999999999864
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 3322 12344789999999999999999999999999999999999999997644
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.24 Aligned_cols=209 Identities=17% Similarity=0.168 Sum_probs=178.3
Q ss_pred hhhccccCCcceeeeeceeccEEEEeee------ecCcceeeeeeccccchhhHHHHHHHHHHHHHcc---ccceeeeEe
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLG 588 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~------~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~~ 588 (754)
.+.....++|.+.++||+|+||.||+|+ ...++.||||+++... ..++.+|+.++++++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445567889999999999999999994 3458899999987543 456778888888886 999999999
Q ss_pred EEEecCcEEEEEEcccCCCHhhHhcCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC----
Q 004416 589 CCIEQGEKILIYEYMVNKSLDVFLFDP--TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---- 662 (754)
Q Consensus 589 ~~~~~~~~~lV~ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---- 662 (754)
++...+..++||||+++|+|.+++... .....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 999999999999999999999998532 13456899999999999999999999987 999999999999998
Q ss_pred -------CCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 663 -------HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 663 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999997654322222334467999999999999999999999999999999999999998543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=326.08 Aligned_cols=216 Identities=29% Similarity=0.439 Sum_probs=183.0
Q ss_pred cchhhhccccCCcceeeeeceeccEEEEeeee------cCcceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeee
Q 004416 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRL 586 (754)
Q Consensus 515 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l 586 (754)
+.........++|++.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34556677789999999999999999999963 346789999997643 34457799999999999 79999999
Q ss_pred EeEEEecC-cEEEEEEcccCCCHhhHhcCCCC------------------------------------------------
Q 004416 587 LGCCIEQG-EKILIYEYMVNKSLDVFLFDPTK------------------------------------------------ 617 (754)
Q Consensus 587 ~~~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~------------------------------------------------ 617 (754)
++++.+.+ ..++||||+++++|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999865432
Q ss_pred ---------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 618 ---------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 618 ---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
...+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999988 99999999999999999999999999987654433
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 233334678999999999999999999999999999999999 999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.84 Aligned_cols=201 Identities=27% Similarity=0.382 Sum_probs=177.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch------hhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
.+.|.+.+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999875 588999999865432 1367899999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC----CeEEEeec
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFG 672 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~~kL~DFG 672 (754)
++||||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999983 3456899999999999999999999988 99999999999999887 79999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 998875432 2234679999999999999999999999999999999999999996543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=322.90 Aligned_cols=202 Identities=24% Similarity=0.328 Sum_probs=178.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.+|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999875 5889999999776555667889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC--CCCeEEEeecCccccCCC
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGD 680 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~--~~~~kL~DFGla~~~~~~ 680 (754)
+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999988 999999999999974 477999999999887543
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 3 2233579999999999999999999999999999999999999997644
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.20 Aligned_cols=204 Identities=26% Similarity=0.391 Sum_probs=177.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecC--cEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~l 598 (754)
..++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 45789999999999999999998754 8899999987543 344677889999999999999999999998765 7799
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE----cCCCCeEEEeecCc
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMA 674 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~~kL~DFGla 674 (754)
||||+++++|..++........+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999966544455899999999999999999999988 9999999999999 77888999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccC--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYAL--------EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+.+..... .....||+.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 87754432 23357999999999886 577899999999999999999999999643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=323.94 Aligned_cols=204 Identities=25% Similarity=0.371 Sum_probs=176.3
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-----hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999865 58899999985432 124678999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC---eEEEeecC
Q 004416 598 LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGM 673 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---~kL~DFGl 673 (754)
+||||+++++|...+... .....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998777432 22345889999999999999999999988 999999999999987655 99999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
++.+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 988755332 123357999999999999999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=337.03 Aligned_cols=205 Identities=28% Similarity=0.390 Sum_probs=180.8
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45578999999999999999999875 5899999998653 2234567889999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++|+|..++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+
T Consensus 261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999988543 2345889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 5433 2233589999999999999999999999999999999999999997754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.85 Aligned_cols=218 Identities=41% Similarity=0.623 Sum_probs=188.5
Q ss_pred CCCccchhhhccccCCccee------eeeceeccEEEEeeeecCcceeeeeecccc----chhhHHHHHHHHHHHHHccc
Q 004416 511 SLPLFSFASVTAATENFSIQ------SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH 580 (754)
Q Consensus 511 ~~~~~~~~~~~~~~~~y~i~------~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~----~~~~~~~~~~Ei~~l~~l~H 580 (754)
..+.|++.++...+++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45667888888888888766 8999999999999987 6789999998643 23346789999999999999
Q ss_pred cceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE
Q 004416 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (754)
Q Consensus 581 ~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl 660 (754)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||+|||+.+ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999865555567899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 661 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 9999999999999987654332222334679999999998765 58899999999999999999999997654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=335.36 Aligned_cols=207 Identities=28% Similarity=0.404 Sum_probs=182.0
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
...++|.+.+.||+|+||.||+++.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++......+
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34578999999999999999999875 58999999986542 234567889999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 598 LIYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
+||||+++++|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999886542 2456899999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 339 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 339 LKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 754332 2233589999999999999999999999999999999999999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.35 Aligned_cols=203 Identities=27% Similarity=0.411 Sum_probs=173.7
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCc-------
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE------- 595 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------- 595 (754)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 67999999999999999999976 68899999986543 3456789999999999999999999999876542
Q ss_pred --------------------------------------------------EEEEEEcccCCCHhhHhcCCCCcccccHHH
Q 004416 596 --------------------------------------------------KILIYEYMVNKSLDVFLFDPTKKHLLGWQL 625 (754)
Q Consensus 596 --------------------------------------------------~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~ 625 (754)
.++||||+++++|.+++..........+..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 799999999999999997665556667778
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc----------CCcccccccCcc
Q 004416 626 RVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ----------GNTKRIVGTYGY 695 (754)
Q Consensus 626 ~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~y 695 (754)
+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 8999999999999999988 999999999999999999999999999987654211 122335799999
Q ss_pred cCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 696 ~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999987753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.72 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=176.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999864 68899999986543 33456789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc---CCCCeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~~kL~DFGla~~ 676 (754)
|||+++++|.+.+. ....+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999988884 3456899999999999999999999988 99999999999998 467899999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... ......||+.|+|||++.+..++.++||||||+++|||++|++||...+
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 654332 2233689999999999999999999999999999999999999996543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=311.95 Aligned_cols=205 Identities=28% Similarity=0.393 Sum_probs=174.5
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
+...++|++.++||+|+||.||+|+..+++.||||++.... ....+.+.+|++++++++||||+++++++......++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 44558899999999999999999998889999999986542 2235678899999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++ +|...+.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 97 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999985 67666643 3345889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 171 IPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 2233578999999999876 568999999999999999999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.73 Aligned_cols=213 Identities=28% Similarity=0.463 Sum_probs=163.9
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCcc----eeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~----~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 591 (754)
.......++|++.+.||+|+||.||+|+..... .||||+++.. .....+++.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344566789999999999999999999875432 7999998754 3445678999999999999999999999998
Q ss_pred ecCcE------EEEEEcccCCCHhhHhcCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC
Q 004416 592 EQGEK------ILIYEYMVNKSLDVFLFDPT---KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ 662 (754)
Q Consensus 592 ~~~~~------~lV~ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~ 662 (754)
..... ++||||+++++|..++.... ....+++..+..++.||++||+|||+++ |+||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence 77655 99999999999999884321 2225889999999999999999999988 999999999999999
Q ss_pred CCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 663 HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 663 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
++.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999999987755443333333567889999999999999999999999999999999 999997644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=321.39 Aligned_cols=211 Identities=29% Similarity=0.454 Sum_probs=182.6
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec--------Ccceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGC 589 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~--------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 589 (754)
.....++|.+.++||+|+||.||+|+.. .+..||||+++.. .....+++.+|+++++++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3556689999999999999999999752 2357999998765 344567889999999999 99999999999
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCC
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~ 656 (754)
+...+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 9999999999999999999999854321 245899999999999999999999987 999999999
Q ss_pred CEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 657 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|||+++++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999987765443333444677899999999999999999999999999999999 999997643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=335.32 Aligned_cols=203 Identities=24% Similarity=0.310 Sum_probs=168.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4478999999999999999999864 5889999998753 23345667889999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
||||+++++|..++. ....+++..+..++.||++||+|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999998883 34568999999999999999999998 76 999999999999999999999999999864
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 3322 12334689999999999999999999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.18 Aligned_cols=205 Identities=32% Similarity=0.498 Sum_probs=179.7
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
...++|++.+.||+|+||.||+|+..+++.||||++.... ...+++.+|++++++++||||+++++++.+....++|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3457899999999999999999998888899999997543 234678999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 86 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred eCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999853 3345889999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 161 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp HH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 22 2223467788999999998999999999999999999999 999997644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=318.54 Aligned_cols=202 Identities=25% Similarity=0.369 Sum_probs=162.3
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
....++|++.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999999999999876 47889999987543 346788999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFGla~~ 676 (754)
|||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999884 3456889999999999999999999988 999999999999975 88999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 201 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 201 VEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred cCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 64432 2234679999999999999999999999999999999999999996544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=319.19 Aligned_cols=206 Identities=26% Similarity=0.385 Sum_probs=170.1
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc--
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE-- 595 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~-- 595 (754)
...++|++.+.||+|+||.||+++. .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 3457899999999999999999986 46889999998764 23345678999999999999999999999876653
Q ss_pred --EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 596 --KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 596 --~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
.++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cccEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 399999999999999984 3446889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++.+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 987654322 122334578999999999999999999999999999999999999997654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.18 Aligned_cols=212 Identities=30% Similarity=0.448 Sum_probs=182.5
Q ss_pred hhccccCCcceeeeeceeccEEEEeeee------cCcceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 591 (754)
......++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 3455668899999999999999999975 23578999999754 3445678899999999999999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCCC---------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCcee
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPTK---------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIH 650 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH 650 (754)
+.+..++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 99999999999999999999854322 234889999999999999999999988 999
Q ss_pred CCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 004416 651 RDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNT 729 (754)
Q Consensus 651 ~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~ 729 (754)
|||||+|||+++++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987755443333334567889999999998899999999999999999999 99999
Q ss_pred CCCC
Q 004416 730 GVYN 733 (754)
Q Consensus 730 ~~~~ 733 (754)
....
T Consensus 254 ~~~~ 257 (314)
T 2ivs_A 254 PGIP 257 (314)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 7654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.84 Aligned_cols=214 Identities=29% Similarity=0.453 Sum_probs=183.2
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeE
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 589 (754)
........++|++.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4455667789999999999999999999874 3478999999765 33446789999999999999999999999
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCCC---------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPTK---------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 648 (754)
+.+.+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 9999999999999999999999854321 256899999999999999999999988 9
Q ss_pred eeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 004416 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKK 727 (754)
Q Consensus 649 iH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~ 727 (754)
+||||||+|||+++++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987754433333344578899999999998899999999999999999999 999
Q ss_pred CCCCCC
Q 004416 728 NTGVYN 733 (754)
Q Consensus 728 p~~~~~ 733 (754)
||....
T Consensus 276 p~~~~~ 281 (343)
T 1luf_A 276 PYYGMA 281 (343)
T ss_dssp TTTTSC
T ss_pred cCCCCC
Confidence 997643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.74 Aligned_cols=203 Identities=28% Similarity=0.440 Sum_probs=174.4
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC----cEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EKI 597 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~ 597 (754)
...++|++.++||+|+||.||+|+.. ++.||||++..... ....+.+|+.++++++||||+++++++.... ..+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 34578999999999999999999874 78999999965433 3445577999999999999999999998755 369
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc----------CCCCceeCCCCCCCEEEcCCCCeE
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY----------SRLRIIHRDLKASNILLDQHMNPK 667 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~----------~~~~iiH~DIkp~NILl~~~~~~k 667 (754)
+||||+++++|.+++. ...+++..+..++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999983 34589999999999999999999987 6 99999999999999999999
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-----VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+|||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999887655443344446899999999998863 45668999999999999999999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=320.83 Aligned_cols=208 Identities=19% Similarity=0.273 Sum_probs=179.0
Q ss_pred cccCCcceeeeecee--ccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G--~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
...++|++.++||+| +||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345789999999999 99999999876 58899999987543 34457788999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||.+..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999988543 2245889999999999999999999988 99999999999999999999999999876
Q ss_pred cCCCc-----ccCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDE-----LQGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 53211 1112233578999999999987 578999999999999999999999997644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.74 Aligned_cols=206 Identities=31% Similarity=0.446 Sum_probs=179.9
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
....++|++.+.||+|+||.||+|+..++..||||+++... ...+++.+|+.++.+++||||+++++++.+....++||
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 34567899999999999999999998888899999997543 23467899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999998843 2345889999999999999999999988 999999999999999999999999999876554
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 158 QYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp CEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred hhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 3222 223456778999999998889999999999999999999 999997644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=308.86 Aligned_cols=209 Identities=31% Similarity=0.468 Sum_probs=179.4
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.......++|++.+.||+|+||.||+++..++..||||+++.... ..+++.+|++++++++||||+++++++.+....+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 344556789999999999999999999988888999999975432 3467899999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 96 IITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEECCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EEEeccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999999853 2345899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 171 LDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp CCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 543322 1223456788999999998899999999999999999998 999997644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.33 Aligned_cols=197 Identities=25% Similarity=0.394 Sum_probs=169.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999875 58899999986542 3345778899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|++++.+..+. .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99875444443 23456899999999999999999999988 9999999999999999999999999998765332
Q ss_pred ccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~ 729 (754)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 2 223357899999999998766 799999999999999999998885
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.71 Aligned_cols=207 Identities=30% Similarity=0.476 Sum_probs=175.5
Q ss_pred cccCCcceeeeeceeccEEEEeeeec----Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
...++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.++...
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34578999999999999999999874 3446999999764 344567899999999999999999999999998999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 126 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999843 2346889999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCcccC-CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQG-NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 75432211 1222456788999999998999999999999999999999 999996543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=319.43 Aligned_cols=197 Identities=29% Similarity=0.381 Sum_probs=169.2
Q ss_pred eeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccCCC
Q 004416 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKS 607 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gs 607 (754)
..+.||+|+||.||+|+.. +++.||+|+++.......+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3578999999999999864 588999999987666667889999999999999999999999999999999999999999
Q ss_pred HhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE--cCCCCeEEEeecCccccCCCcccCC
Q 004416 608 LDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL--DQHMNPKISDFGMARMFGGDELQGN 685 (754)
Q Consensus 608 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~ 685 (754)
|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 9887743 3345889999999999999999999988 9999999999999 5678899999999998754332
Q ss_pred cccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 686 TKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 686 ~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223579999999999999999999999999999999999999997654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.72 Aligned_cols=211 Identities=30% Similarity=0.450 Sum_probs=178.2
Q ss_pred hccccCCcceeeeeceeccEEEEeeee------cCcceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 591 (754)
.....++|.+.+.||+|+||.||+|+. .++..||||++... .....+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345668999999999999999999985 23568999999754 233457789999999999 8999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCCC--------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeC
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPTK--------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHR 651 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~ 651 (754)
..+..++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999999864322 134789999999999999999999988 9999
Q ss_pred CCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 004416 652 DLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTG 730 (754)
Q Consensus 652 DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~ 730 (754)
||||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987654432222334567889999999998999999999999999999998 999997
Q ss_pred CCC
Q 004416 731 VYN 733 (754)
Q Consensus 731 ~~~ 733 (754)
...
T Consensus 277 ~~~ 279 (344)
T 1rjb_A 277 GIP 279 (344)
T ss_dssp TCC
T ss_pred cCC
Confidence 654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.45 Aligned_cols=200 Identities=24% Similarity=0.357 Sum_probs=168.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--------------------------hhHHHHHHHHHHHH
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------------------QGLKEFKNEMMLIA 576 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 576 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+++.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999864 588999999865421 12356889999999
Q ss_pred HccccceeeeEeEEEe--cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCC
Q 004416 577 KLQHRNLVRLLGCCIE--QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLK 654 (754)
Q Consensus 577 ~l~H~nIv~l~~~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIk 654 (754)
+++||||+++++++.+ ....++||||+++++|..++ ....+++..+..++.||++||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999987754 3456899999999999999999999988 9999999
Q ss_pred CCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 655 ASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 655 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987754332 123357999999999987765 37889999999999999999999965
Q ss_pred C
Q 004416 732 Y 732 (754)
Q Consensus 732 ~ 732 (754)
.
T Consensus 243 ~ 243 (298)
T 2zv2_A 243 E 243 (298)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=318.11 Aligned_cols=204 Identities=27% Similarity=0.359 Sum_probs=169.9
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHccc--cceeeeEeEEEecCcE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCIEQGEK 596 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~nIv~l~~~~~~~~~~ 596 (754)
....++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++..+...
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3456789999999999999999999888999999998644 34456788999999999976 9999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||| +.+++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++.
T Consensus 85 ~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99999 56789999884 3456889999999999999999999988 99999999999997 56899999999988
Q ss_pred cCCCcccCCcccccccCcccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALE-----------GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 765443333345689999999999864 67899999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=328.35 Aligned_cols=202 Identities=27% Similarity=0.461 Sum_probs=178.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3478999999999999999999875 68999999986542 2345678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999984 3456899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 433 2234689999999999988776 689999999999999999999997654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.49 Aligned_cols=202 Identities=28% Similarity=0.380 Sum_probs=178.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch------hhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++|++.+.||+|+||.||+++.. +++.||||++..... ...+++.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999875 588999999865432 136789999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC----CeEEEee
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDF 671 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~~kL~DF 671 (754)
.++||||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999984 3456899999999999999999999988 99999999999999888 7999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 9998765432 2233579999999999999999999999999999999999999997643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.31 Aligned_cols=208 Identities=33% Similarity=0.484 Sum_probs=177.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeec------Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++|++.+.||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4578999999999999999999843 3568999999654 34455678999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC---CeEE
Q 004416 596 KILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKI 668 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~~kL 668 (754)
.++||||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999985322 2245889999999999999999999988 99999999999999555 5999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999986643332233334678999999999999999999999999999999998 999997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.38 Aligned_cols=197 Identities=27% Similarity=0.312 Sum_probs=164.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|++.++||+|+||+||+|+.. +++.||||++... ......++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999876 6899999987653 223344555666666665 899999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+ +++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6688877743 2346899999999999999999999987 99999999999999999999999999987654
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 33 2233579999999998876 78999999999999999999977654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.74 Aligned_cols=205 Identities=28% Similarity=0.397 Sum_probs=178.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367999999999999999999875 58899999986543 3445788999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999998883 3456889999999999999999999988 9999999999999999999999999998764433
Q ss_pred ccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 2223344678999999999987775 6789999999999999999999976553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.97 Aligned_cols=211 Identities=30% Similarity=0.478 Sum_probs=180.2
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec--------Ccceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGC 589 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~--------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 589 (754)
.....++|++.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++++ +||||++++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3445689999999999999999999753 4668999999754 334567889999999999 89999999999
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCC
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~ 656 (754)
+.+.+..++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 9999999999999999999999864322 234889999999999999999999988 999999999
Q ss_pred CEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 657 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999988765443233334567889999999988899999999999999999999 999997643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=344.06 Aligned_cols=223 Identities=25% Similarity=0.308 Sum_probs=187.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~ 597 (754)
..++|++.++||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999875 4778999998753 233456778899999887 7999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999884 3356899999999999999999999988 999999999999999999999999999864
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHh
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLY 748 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~ 748 (754)
.... ......+||+.|+|||++.+..++.++||||||++||||++|+.||...+. ....++..+++.+.
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 570 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHH
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence 3322 123457899999999999999999999999999999999999999976542 22234444555566
Q ss_pred hhhhc
Q 004416 749 SLLFD 753 (754)
Q Consensus 749 ~~l~~ 753 (754)
++|.+
T Consensus 571 ~li~~ 575 (674)
T 3pfq_A 571 AICKG 575 (674)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 65544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=304.17 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=177.3
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||.||+|+... +..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4679999999999999999998754 678999999776556678899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE---cCCCCeEEEeecCccccCC
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~~kL~DFGla~~~~~ 679 (754)
+++++|.+++. ....+++..+..++.|+++||+|||+++ |+||||||+|||+ +.++.+||+|||++..+..
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999988873 3455889999999999999999999988 9999999999999 7889999999999987654
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......||+.|+|||++.+. ++.++||||||+++|||++|+.||....
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 33 22335799999999988654 8999999999999999999999997644
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.89 Aligned_cols=209 Identities=28% Similarity=0.417 Sum_probs=179.5
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.....++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+++.+|+.+|++++||||+++++++...+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3455678999999999999999999976 68899999987543 334467889999999999999999999999989999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 189 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999842 2345889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.............+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 54332222222345778999999998899999999999999999999 999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=306.42 Aligned_cols=200 Identities=25% Similarity=0.388 Sum_probs=170.4
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|+||.||+|+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999998779999999986543 22346788999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++ +|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 88887743 2345889999999999999999999988 99999999999999999999999999987653321
Q ss_pred cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12235789999999998764 5899999999999999999999999654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.55 Aligned_cols=202 Identities=34% Similarity=0.551 Sum_probs=166.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccc----hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+|+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 4578999999999999999999874 8899999986542 2335778999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC--------CCCeEEEe
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--------HMNPKISD 670 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~--------~~~~kL~D 670 (754)
||||+++++|..++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||+++ ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999883 446889999999999999999999987556999999999999986 67899999
Q ss_pred ecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
||+++.+.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998764432 123578999999999999999999999999999999999999997643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.13 Aligned_cols=211 Identities=29% Similarity=0.401 Sum_probs=181.5
Q ss_pred hccccCCcceeeeeceeccEEEEeeee------cCcceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 591 (754)
.....++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 345568899999999999999999974 346789999997553 34457899999999999 9999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCCC---------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCC
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPTK---------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~ 656 (754)
..+..++||||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence 99999999999999999999854321 225889999999999999999999988 999999999
Q ss_pred CEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 657 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|||+++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999988765443222333567889999999999999999999999999999999 999997654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=320.64 Aligned_cols=203 Identities=27% Similarity=0.348 Sum_probs=169.9
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHcc--ccceeeeEeEEEecCcEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~~~~ 597 (754)
...++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ ||||+++++++...+..+
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 344679999999999999999999878899999998654 3445678999999999996 599999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||| +.+++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++.+
T Consensus 133 lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 9999 568899998843 346788899999999999999999987 99999999999996 578999999999887
Q ss_pred CCCcccCCcccccccCcccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALE-----------GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 55443333344689999999999865 46889999999999999999999999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.54 Aligned_cols=204 Identities=21% Similarity=0.260 Sum_probs=177.4
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 457899999999999999999986 4688999999865432 34678999999999 9999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC-----eEEEeecCcc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-----PKISDFGMAR 675 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-----~kL~DFGla~ 675 (754)
||+ +++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 999 99999988532 456899999999999999999999988 999999999999998887 9999999999
Q ss_pred ccCCCcccC-----CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 676 MFGGDELQG-----NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 676 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 765433211 12346899999999999999999999999999999999999999987653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=313.00 Aligned_cols=216 Identities=28% Similarity=0.438 Sum_probs=183.1
Q ss_pred cchhhhccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeE
Q 004416 515 FSFASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLL 587 (754)
Q Consensus 515 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~ 587 (754)
+...+.....++|++.+.||+|+||.||+|+.. .++.||||++.... .....++.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344456677789999999999999999999764 36789999987543 34456789999999999999999999
Q ss_pred eEEEecCcEEEEEEcccCCCHhhHhcCCC-------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE
Q 004416 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPT-------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (754)
Q Consensus 588 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl 660 (754)
+++.+....++||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999884321 1245688999999999999999999988 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 661 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 9999999999999987654333223333567889999999998999999999999999999999 889987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.55 Aligned_cols=212 Identities=27% Similarity=0.339 Sum_probs=183.8
Q ss_pred CCCccchhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-----cccee
Q 004416 511 SLPLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLV 584 (754)
Q Consensus 511 ~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv 584 (754)
....+++.......++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++++++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3455677777788899999999999999999999874 5789999998643 344567788999999997 99999
Q ss_pred eeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC--
Q 004416 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-- 662 (754)
Q Consensus 585 ~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-- 662 (754)
++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 9999999999999999999 89999988532 2235889999999999999999999988 999999999999975
Q ss_pred -----------------------CCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHH
Q 004416 663 -----------------------HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLM 719 (754)
Q Consensus 663 -----------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll 719 (754)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 788999999999865332 2336789999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 004416 720 LEILSSKKNTGVYN 733 (754)
Q Consensus 720 ~elltg~~p~~~~~ 733 (754)
|||++|+.||...+
T Consensus 250 ~ell~g~~pf~~~~ 263 (360)
T 3llt_A 250 AELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHSSCSCCCSS
T ss_pred HHHHHCCCCCCCCc
Confidence 99999999997644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=311.73 Aligned_cols=198 Identities=25% Similarity=0.340 Sum_probs=153.3
Q ss_pred CCccee---eeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQ---SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~---~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 599 (754)
++|++. +.||+|+||.||+++.. +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 345543 78999999999999875 5889999998653 3456788999999997 99999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC---CeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~~kL~DFGla~~ 676 (754)
|||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 85 MELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp ECCCCSCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEccCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999884 3456899999999999999999999988 99999999999998765 799999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 159 KPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 654332 2233578999999999999999999999999999999999999997644
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=318.04 Aligned_cols=203 Identities=28% Similarity=0.381 Sum_probs=173.6
Q ss_pred cCCcceeeeeceeccEEEEeeee----cCcceeeeeeccccc----hhhHHHHHHHHHHHHHc-cccceeeeEeEEEecC
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQG 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~ 594 (754)
.++|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999986 368899999986532 23345677899999999 6999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999984 3346889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.+...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 876443322 2234679999999999986 347899999999999999999999997644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=313.92 Aligned_cols=212 Identities=24% Similarity=0.297 Sum_probs=174.4
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-----chhhHHHHHHHHHHHHHccccceeeeEeEEEe
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 592 (754)
++....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34456688999999999999999999864 5788999998643 23456789999999999999999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCC-------------------------------------CCcccccHHHHHHHHHHHHH
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDP-------------------------------------TKKHLLGWQLRVRIIDGIAQ 635 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~-------------------------------------~~~~~l~~~~~~~i~~qia~ 635 (754)
....++||||+++++|.+++... .....+++..+..++.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988411 01223467788899999999
Q ss_pred HHHHHHhcCCCCceeCCCCCCCEEEcCCC--CeEEEeecCccccCCCcc--cCCcccccccCcccCccccCC--CCCCch
Q 004416 636 GLLYLHQYSRLRIIHRDLKASNILLDQHM--NPKISDFGMARMFGGDEL--QGNTKRIVGTYGYMSPEYALE--GVFSVK 709 (754)
Q Consensus 636 ~L~yLH~~~~~~iiH~DIkp~NILl~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 709 (754)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999988 99999999999998776 899999999987643221 112334679999999999875 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 710 SDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 710 ~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+||||||+++|||++|+.||....
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999996643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.78 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=177.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999865 4889999998654 334457789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC---eEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---~kL~DFGla~~ 676 (754)
|||+++++|...+. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999988773 3456889999999999999999999988 999999999999987655 99999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 654332 233679999999999999999999999999999999999999996543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=324.27 Aligned_cols=199 Identities=28% Similarity=0.335 Sum_probs=166.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec------
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 593 (754)
..++|++.++||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999864 5889999998654 344567789999999999999999999998654
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
...++||||++++ |...+. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3579999999875 544442 23788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765432 2334689999999999999999999999999999999999999997643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=309.61 Aligned_cols=215 Identities=29% Similarity=0.433 Sum_probs=182.1
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeee------cCcceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeE
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLL 587 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~ 587 (754)
.........++|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445566778999999999999999999974 346889999987643 33456789999999999 799999999
Q ss_pred eEEEecC-cEEEEEEcccCCCHhhHhcCCCC-------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCC
Q 004416 588 GCCIEQG-EKILIYEYMVNKSLDVFLFDPTK-------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDL 653 (754)
Q Consensus 588 ~~~~~~~-~~~lV~ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DI 653 (754)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987755 58999999999999999864332 223889999999999999999999988 999999
Q ss_pred CCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 654 KASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 654 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987654433223334567899999999999999999999999999999998 99999765
Q ss_pred C
Q 004416 733 N 733 (754)
Q Consensus 733 ~ 733 (754)
.
T Consensus 255 ~ 255 (316)
T 2xir_A 255 K 255 (316)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.44 Aligned_cols=202 Identities=24% Similarity=0.369 Sum_probs=175.2
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccch--------hhHHHHHHHHHHHHHccccceeeeEeEEEec
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 593 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346899999999999999999985 4588999999865421 1334577899999999999999999999999
Q ss_pred CcEEEEEEcccCC-CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 594 GEKILIYEYMVNK-SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 594 ~~~~lV~ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
+..++||||+..| +|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9988884 3446899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++.+.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 998765433 2234679999999999988877 789999999999999999999996533
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.01 Aligned_cols=205 Identities=32% Similarity=0.500 Sum_probs=165.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeec----Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
..++|.+.+.||+|+||.||+|++. ++..||||+++.. .....+++.+|+.++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4468999999999999999999864 4678999999764 3445678999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999853 2346889999999999999999999987 999999999999999999999999999877
Q ss_pred CCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 678 GGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 678 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~ 254 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 543221 11222345778999999999999999999999999999998 99998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.93 Aligned_cols=203 Identities=29% Similarity=0.483 Sum_probs=157.3
Q ss_pred cCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36799999999999999999986 468899999986542 22357789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|..++.. ....+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999998853 2356889999999999999999999988 99999999999999999999999999987653
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 321 1223578999999999999899999999999999999999999997644
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.70 Aligned_cols=203 Identities=25% Similarity=0.346 Sum_probs=178.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|.+.+.||+|+||.||+++..+ ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34689999999999999999998754 788999988654 23456778999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998873 3456889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 2233578999999999999899999999999999999999999997653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.44 Aligned_cols=201 Identities=30% Similarity=0.408 Sum_probs=173.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999865 46789999986532 2235678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999998883 3345889999999999999999999987 9999999999999999999999999986543
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 322 233578999999999999999999999999999999999999997654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.71 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=164.2
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.+...++|++.+.||+|+||.||+|+.. ..||||+++.. .....+.+.+|+.++++++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 3556689999999999999999999864 35999998654 344567899999999999999999999964 566789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999998843 3456889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.............||+.|+|||++. +..++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 5433233334467999999999986 6678899999999999999999999997643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.41 Aligned_cols=204 Identities=31% Similarity=0.503 Sum_probs=168.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccce----eeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQE----VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~----vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.++|++.+.||+|+||.||+|++. +++. ||+|.+... .....+++.+|+.++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 467999999999999999999864 3443 588877543 334567899999999999999999999999865 478
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+|+||+++++|..++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999998853 2346889999999999999999999987 999999999999999999999999999987
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence 65544333444567889999999999999999999999999999999 999997644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.56 Aligned_cols=204 Identities=31% Similarity=0.493 Sum_probs=172.6
Q ss_pred ccCCcceeeeeceeccEEEEeeee-----cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec--Cc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~ 595 (754)
..++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457899999999999999999974 25789999999877777778899999999999999999999998654 45
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999998432 335889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.+...... .......+|+.|+|||++.+..++.++||||||+++|||++|..|+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 77543221 122234577889999999999999999999999999999999998864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.54 Aligned_cols=206 Identities=27% Similarity=0.376 Sum_probs=164.8
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
....++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++||||+++++++ ..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence 4456789999999999999999998643 456999998754 334567789999999999999999999997 4567
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 8999999999999999843 2345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.+...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~ 222 (281)
T 1mp8_A 165 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence 77543322 1223457789999999998899999999999999999997 999997644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=300.54 Aligned_cols=200 Identities=27% Similarity=0.391 Sum_probs=174.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch------hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
++|++.+.||+|+||.||+++.. +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999876 588999998865421 23678999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC----CeEEEeecC
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFGM 673 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~~kL~DFGl 673 (754)
+||||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999883 3456899999999999999999999987 99999999999998877 799999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 98765432 1233578999999999999999999999999999999999999997644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=302.01 Aligned_cols=199 Identities=30% Similarity=0.418 Sum_probs=167.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHH--ccccceeeeEeEEEec----CcE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCIEQ----GEK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~----~~~ 596 (754)
..++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999987 6889999998654 33555667777777 7999999999997653 357
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHH--------hcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
++||||+++++|.+++ ....+++..+.+++.||++||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHH----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHH----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 8999999999999999 3346899999999999999999999 665 999999999999999999999
Q ss_pred EeecCccccCCCccc--CCcccccccCcccCccccCCC------CCCchhhHHHHHHHHHHHHcC----------CCCCC
Q 004416 669 SDFGMARMFGGDELQ--GNTKRIVGTYGYMSPEYALEG------VFSVKSDVFSFGVLMLEILSS----------KKNTG 730 (754)
Q Consensus 669 ~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DVwSlGvll~elltg----------~~p~~ 730 (754)
+|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999876443221 122335799999999999876 455799999999999999999 78875
Q ss_pred CC
Q 004416 731 VY 732 (754)
Q Consensus 731 ~~ 732 (754)
..
T Consensus 235 ~~ 236 (301)
T 3q4u_A 235 DV 236 (301)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.98 Aligned_cols=201 Identities=26% Similarity=0.329 Sum_probs=165.9
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
..++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999875 588999999865432 33668899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC--eEEEeecCccccCC
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--PKISDFGMARMFGG 679 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--~kL~DFGla~~~~~ 679 (754)
|+++++|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999883 3446899999999999999999999988 999999999999987765 99999999975432
Q ss_pred CcccCCcccccccCcccCccccCCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVK-SDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence 22 2233579999999999988888766 899999999999999999997644
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=306.37 Aligned_cols=213 Identities=29% Similarity=0.458 Sum_probs=169.1
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeec----Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI 591 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~ 591 (754)
..+....++|.+.+.||+|+||.||+|+.. .++.||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 445566789999999999999999999754 3457999998754 3345677899999999999999999999998
Q ss_pred ecC-----cEEEEEEcccCCCHhhHhcCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC
Q 004416 592 EQG-----EKILIYEYMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (754)
Q Consensus 592 ~~~-----~~~lV~ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~ 663 (754)
+.. ..++||||+++++|..++... .....+++..++.++.||++||.|||+++ |+||||||+|||++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 755 349999999999999988432 23456899999999999999999999987 9999999999999999
Q ss_pred CCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 664 MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 664 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+.+||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999999999987755433233334567889999999999999999999999999999999 888987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=308.48 Aligned_cols=203 Identities=25% Similarity=0.346 Sum_probs=178.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|.+.+.||+|+||.||+++..+ ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 44689999999999999999998754 778999998654 23456778999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998873 3456889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 3321 2233679999999999999999999999999999999999999997654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.77 Aligned_cols=199 Identities=21% Similarity=0.321 Sum_probs=171.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..++|++.+.||+|+||.||+++.+ +++.||||++..... ...+|++++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3467999999999999999999875 588999999965432 235688888888 7999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC----CCeEEEeecCccc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH----MNPKISDFGMARM 676 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~----~~~kL~DFGla~~ 676 (754)
||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999998884 3456899999999999999999999988 9999999999998543 3499999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 654332 2234688999999999988889999999999999999999999997643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=301.15 Aligned_cols=206 Identities=30% Similarity=0.461 Sum_probs=176.4
Q ss_pred cccCCcceee-eeceeccEEEEeeeec---Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~-~LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
...++|.+.+ .||+|+||.||+|+.. ++..||||+++.. .....+++.+|++++++++||||+++++++ +.+..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 3456787776 9999999999999753 4778999999764 344567899999999999999999999998 56779
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999999843 3455889999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+..... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 754332 122223457889999999988889999999999999999999 999997644
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=321.45 Aligned_cols=203 Identities=30% Similarity=0.471 Sum_probs=175.2
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC-cEE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG-EKI 597 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~-~~~ 597 (754)
......++|++.+.||+|+||.||+|+.. ++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 34556688999999999999999999874 7799999997643 4578899999999999999999999988765 789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 999999999999998532 2234788999999999999999999988 999999999999999999999999999864
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.... ....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 391 (450)
T 1k9a_A 340 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391 (450)
T ss_dssp C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred cccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3221 22367889999999999999999999999999999999 999997654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=307.97 Aligned_cols=204 Identities=26% Similarity=0.349 Sum_probs=170.5
Q ss_pred cCCccee-eeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEE
Q 004416 524 TENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 524 ~~~y~i~-~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3678885 78999999999999854 6889999999776656678899999999995 7999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC---eEEEeecCcccc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGMARMF 677 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---~kL~DFGla~~~ 677 (754)
||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999884 3356889999999999999999999987 999999999999998776 999999999876
Q ss_pred CCCcc-----cCCcccccccCcccCccccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDEL-----QGNTKRIVGTYGYMSPEYALE-----GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 43211 111223569999999999875 557899999999999999999999997654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=329.80 Aligned_cols=209 Identities=29% Similarity=0.472 Sum_probs=181.8
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
..+...++|++.++||+|+||.||+|++.. +..||||+++... ...++|.+|+.+|++++||||+++++++.+....+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345566789999999999999999998765 7899999997643 34678999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 293 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999998542 2345889999999999999999999988 999999999999999999999999999887
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
....... .....+|+.|+|||++....++.++||||||++||||++ |+.||...+
T Consensus 369 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 369 TGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp TTCCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cCCceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 5443222 223456789999999998999999999999999999999 999997644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.22 Aligned_cols=209 Identities=30% Similarity=0.455 Sum_probs=180.4
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.......++|.+.+.||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++||||+++++++. ....+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34566778999999999999999999999888899999997643 35678999999999999999999999975 66789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++|+|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 259 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999998532 2235788899999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
....... .....+|+.|+|||++....++.++||||||++||||++ |+.||....
T Consensus 335 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 335 EDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp CCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 5432221 222456789999999998999999999999999999999 999997543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.81 Aligned_cols=204 Identities=21% Similarity=0.295 Sum_probs=177.0
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 599 (754)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++|
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3457899999999999999999985 468899999986443 234678899999999 799999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC-----eEEEeecCc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-----PKISDFGMA 674 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-----~kL~DFGla 674 (754)
|||+ +++|.+++... ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 85 ~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 9999 99999998532 345899999999999999999999987 999999999999987776 999999999
Q ss_pred cccCCCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 887554321 12344679999999999999999999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=314.57 Aligned_cols=203 Identities=28% Similarity=0.445 Sum_probs=163.8
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecC--cE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQG--EK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~--~~ 596 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3478999999999999999999864 5889999998543 3445667889999999997 999999999998654 68
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||++ ++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 58888873 346889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcc-------------------cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDEL-------------------QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 643110 111233589999999999886 678999999999999999999999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.32 Aligned_cols=204 Identities=26% Similarity=0.389 Sum_probs=176.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecC--cEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--EKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~~~l 598 (754)
..++|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 45789999999999999999998754 8899999987543 334677889999999999999999999998765 7799
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE----cCCCCeEEEeecCc
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKISDFGMA 674 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~~kL~DFGla 674 (754)
||||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999965444445899999999999999999999988 9999999999999 77788999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE--------GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+.+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 87754332 233579999999998865 56778999999999999999999999643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=319.15 Aligned_cols=201 Identities=23% Similarity=0.346 Sum_probs=163.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--------hhhHHHHHHHHHHHHHccccceeeeEeEEEec
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~ 593 (754)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999865 47899999986532 112235789999999999999999999974 5
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC---CeEEEe
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM---NPKISD 670 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~---~~kL~D 670 (754)
...++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 66899999999999988873 4456899999999999999999999988 99999999999997544 599999
Q ss_pred ecCccccCCCcccCCcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
||+++.+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 99998765432 2234689999999999863 567889999999999999999999997644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=318.75 Aligned_cols=200 Identities=26% Similarity=0.402 Sum_probs=167.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec-----C
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----G 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~ 594 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.+|++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3478999999999999999999865 4788999998653 334557889999999999999999999998766 5
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||++ ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999997 58988884 3456899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccc--------------------CCcccccccCcccCcccc-CCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 675 RMFGGDELQ--------------------GNTKRIVGTYGYMSPEYA-LEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 675 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
+........ ......+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 987543211 122446899999999986 5566999999999999999999865554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=313.36 Aligned_cols=197 Identities=22% Similarity=0.286 Sum_probs=162.1
Q ss_pred CCccee-eeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHH-ccccceeeeEeEEEe----cCcEE
Q 004416 525 ENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCIE----QGEKI 597 (754)
Q Consensus 525 ~~y~i~-~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~~~~~~----~~~~~ 597 (754)
++|.+. +.||+|+||+||+++.. +++.||||++... ..+.+|+.++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567776 78999999999999875 5889999998642 356788888755 489999999999876 55789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeecCc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMA 674 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFGla 674 (754)
+||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998542 2345899999999999999999999987 999999999999998 788999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 8764322 2234688999999999999999999999999999999999999997654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.86 Aligned_cols=204 Identities=29% Similarity=0.428 Sum_probs=160.6
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 367999999999999999999865 58899999986543 2334678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 602 YMVNKSLDVFLFDP---TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 602 y~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
|++ ++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888877432 12245889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 2233578999999999876 468999999999999999999999997644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=304.83 Aligned_cols=200 Identities=29% Similarity=0.450 Sum_probs=167.1
Q ss_pred cCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
.++|++.+.||+|+||.||+++.. ++.||||++... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 367999999999999999999874 788999998643 34578899999999999999999999875 4579999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC-eEEEeecCccccCCCcc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-PKISDFGMARMFGGDEL 682 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-~kL~DFGla~~~~~~~~ 682 (754)
++++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 99999999976554456788999999999999999999943334999999999999998887 7999999997654321
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 23468999999999999999999999999999999999999997543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.93 Aligned_cols=210 Identities=29% Similarity=0.467 Sum_probs=182.4
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
.......++|++.+.||+|+||.||+|+... ++.||||++... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 3445667899999999999999999998764 788999998654 33567889999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999998542 3345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 161 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 161 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp SCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 6544322 2223467889999999998999999999999999999999 999997644
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=322.71 Aligned_cols=195 Identities=25% Similarity=0.392 Sum_probs=154.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec-----C
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----G 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~ 594 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.+|++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999865 5889999998653 334567889999999999999999999998543 4
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+. ++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 131 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 6899999985 68888873 3456899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccc-------------------------CCcccccccCcccCcccc-CCCCCCchhhHHHHHHHHHHHHc
Q 004416 675 RMFGGDELQ-------------------------GNTKRIVGTYGYMSPEYA-LEGVFSVKSDVFSFGVLMLEILS 724 (754)
Q Consensus 675 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DVwSlGvll~ellt 724 (754)
+.+...... ......+||+.|+|||++ ....++.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 876532211 122335789999999976 45679999999999999999999
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=301.81 Aligned_cols=201 Identities=29% Similarity=0.371 Sum_probs=170.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999875 48899999886543 2335678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|..++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988873 3455889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 2 1233578999999999876 668999999999999999999999997654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.15 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=176.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 368999999999999999999875 47789999986532 22356789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999998884 3345889999999999999999999987 99999999999999999999999999976543
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 22 233578999999999999999999999999999999999999997644
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.51 Aligned_cols=212 Identities=30% Similarity=0.445 Sum_probs=179.8
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeecC-c-----ceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLN-G-----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 590 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~-~-----~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 590 (754)
......++|.+.+.||+|+||.||+|+... + ..||+|++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 355667899999999999999999998643 2 479999987653 34567789999999999 899999999999
Q ss_pred EecCcEEEEEEcccCCCHhhHhcCCC-----------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEE
Q 004416 591 IEQGEKILIYEYMVNKSLDVFLFDPT-----------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (754)
Q Consensus 591 ~~~~~~~lV~ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NIL 659 (754)
.+.+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999884321 1345789999999999999999999987 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 660 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+++++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999987644332222333567889999999998999999999999999999999 999987644
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.54 Aligned_cols=198 Identities=26% Similarity=0.417 Sum_probs=172.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-c-------ceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~-------~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
..++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 45789999999999999999998653 2 469999997776677788999999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC--------e
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--------P 666 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--------~ 666 (754)
..++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999853 2334889999999999999999999988 999999999999998887 9
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCC-CCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKK-NTGV 731 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~-p~~~ 731 (754)
||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|.. |+..
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 99999999765322 23568899999999987 678999999999999999999654 4443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=304.02 Aligned_cols=200 Identities=24% Similarity=0.364 Sum_probs=173.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|.+.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 468999999999999999999875 5889999999765544556789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE---cCCCCeEEEeecCccccCC
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~~kL~DFGla~~~~~ 679 (754)
+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999988873 3446889999999999999999999988 9999999999999 7889999999999976433
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2233578999999999999999999999999999999999999996543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.62 Aligned_cols=204 Identities=29% Similarity=0.446 Sum_probs=171.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccce----eeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQE----VAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~----vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.++|++.+.||+|+||.||+|++. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 468999999999999999999864 3444 7777764432 233456788999999999999999999875 56789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999988532 346888999999999999999999988 999999999999999999999999999987
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 65544434445678889999999998999999999999999999999 999997644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=304.20 Aligned_cols=203 Identities=23% Similarity=0.288 Sum_probs=166.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 378999999999999999999865 58899999987542 23357789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999884 3346889999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 3321 2223578999999999999999999999999999999999999997643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.83 Aligned_cols=202 Identities=27% Similarity=0.446 Sum_probs=179.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4467999999999999999999864 58899999986543 345678999999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+...
T Consensus 100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999883 346889999999999999999999988 999999999999999999999999999876543
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 32 2234578999999999999999999999999999999999999997643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=311.05 Aligned_cols=205 Identities=19% Similarity=0.262 Sum_probs=168.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC------cceeeeeeccccchhhH-----------HHHHHHHHHHHHccccceee
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVR 585 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~nIv~ 585 (754)
..++|++.+.||+|+||.||+|++.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 47899999865532111 12334555666778999999
Q ss_pred eEeEEEec----CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc
Q 004416 586 LLGCCIEQ----GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD 661 (754)
Q Consensus 586 l~~~~~~~----~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~ 661 (754)
+++++... ...++||||+ +++|..++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998875 3589999999 9999998843 2356899999999999999999999987 99999999999999
Q ss_pred --CCCCeEEEeecCccccCCCcccC-----CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 662 --QHMNPKISDFGMARMFGGDELQG-----NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 662 --~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 88999999999998775432211 1233569999999999999999999999999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.23 Aligned_cols=203 Identities=29% Similarity=0.447 Sum_probs=169.9
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc-----hhhHHHHHHHHHHHHHcc---ccceeeeEeEEEec
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCIEQ 593 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~-----~~~~~~~~~Ei~~l~~l~---H~nIv~l~~~~~~~ 593 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999986 458899999986432 112345677888877775 99999999999876
Q ss_pred C-----cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEE
Q 004416 594 G-----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKI 668 (754)
Q Consensus 594 ~-----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL 668 (754)
. ..++||||+. ++|..++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4799999997 5998888543 2234899999999999999999999988 999999999999999999999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+|||+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998764332 2234688999999999999999999999999999999999999996543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=302.10 Aligned_cols=203 Identities=30% Similarity=0.482 Sum_probs=172.7
Q ss_pred ccCCcceeeeeceeccEEEEeeee-----cCcceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEec--C
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--G 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~ 594 (754)
..+.|++.+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 346799999999999999999983 35889999998754 334567889999999999999999999999876 6
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 68999999999999999843 2345889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 675 RMFGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 675 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
+.+..... ........||+.|+|||++.+..++.++||||||+++|||++|+.|+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 88754432 122333568889999999999999999999999999999999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.57 Aligned_cols=201 Identities=28% Similarity=0.381 Sum_probs=176.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 4478999999999999999999875 5889999998765 3445678899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
||+++++|.+++. ....+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 111 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 111 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999984 334688999999999999999999986 6 99999999999999999999999999976532
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2233578999999999999999999999999999999999999997543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=320.53 Aligned_cols=209 Identities=31% Similarity=0.487 Sum_probs=174.0
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
.......++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ ...+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34456678899999999999999999998877889999997643 345789999999999999999999999865 6789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 255 iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 999999999999998421 2345889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
...... ......+|+.|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 331 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 331 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 543321 1223457789999999998999999999999999999999 999997543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=296.56 Aligned_cols=205 Identities=32% Similarity=0.483 Sum_probs=178.8
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
...++|++.+.||+|+||.||+++..+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 34578999999999999999999988888999999976532 34678999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 84 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999998843 2345789999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 159 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp HH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 21 1223467889999999998899999999999999999999 899987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=303.99 Aligned_cols=213 Identities=26% Similarity=0.377 Sum_probs=179.1
Q ss_pred ccchhhhccccCCccee-eeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHc-cccceeeeEe
Q 004416 514 LFSFASVTAATENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLG 588 (754)
Q Consensus 514 ~~~~~~~~~~~~~y~i~-~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~nIv~l~~ 588 (754)
...+.......+.|.+. +.||+|+||.||+|+.. +++.||||++.... .....++.+|+.++.++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34455556667788887 89999999999999875 58899999987542 33467889999999999 5699999999
Q ss_pred EEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCC
Q 004416 589 CCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMN 665 (754)
Q Consensus 589 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~ 665 (754)
++.+....++||||+++++|..++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 999999999999999999999988432 3456899999999999999999999988 999999999999998 789
Q ss_pred eEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 666 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+||+|||+++.+.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998765432 2233679999999999999999999999999999999999999996643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.05 Aligned_cols=207 Identities=34% Similarity=0.503 Sum_probs=177.9
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.....++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 445568899999999999999999998888899999986543 34578899999999999999999999875 5568999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++++|.+++... ....+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999998431 2235889999999999999999999988 99999999999999999999999999988754
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
..... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 162 NEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp SCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 43222 223467889999999988889999999999999999999 899987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=319.43 Aligned_cols=202 Identities=16% Similarity=0.239 Sum_probs=164.5
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHH---HHHHHccccceeeeE-------
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEM---MLIAKLQHRNLVRLL------- 587 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~nIv~l~------- 587 (754)
...++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+ .++++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999986 45899999998743 344567889999 555566899999998
Q ss_pred eEEEecC-----------------cEEEEEEcccCCCHhhHhcCC----CCcccccHHHHHHHHHHHHHHHHHHHhcCCC
Q 004416 588 GCCIEQG-----------------EKILIYEYMVNKSLDVFLFDP----TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646 (754)
Q Consensus 588 ~~~~~~~-----------------~~~lV~ey~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~ 646 (754)
+++...+ ..++||||+ +|+|.+++... .....+++..+..++.||++||+|||+++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 6655443 278999999 67999988432 11234556888899999999999999988
Q ss_pred CceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCC-----------CCCchhhHHHH
Q 004416 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-----------VFSVKSDVFSF 715 (754)
Q Consensus 647 ~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DVwSl 715 (754)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 99999999999999999999999999986433 2233567 999999999887 89999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 004416 716 GVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 716 Gvll~elltg~~p~~~~~ 733 (754)
|+++|||++|+.||....
T Consensus 300 G~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHCCCCCcccc
Confidence 999999999999997654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=296.29 Aligned_cols=202 Identities=27% Similarity=0.447 Sum_probs=169.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4578999999999999999999875 68899999986542 2345688999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999884 3345889999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 4321 223578999999999988765 589999999999999999999997643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.75 Aligned_cols=203 Identities=28% Similarity=0.393 Sum_probs=164.8
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
...++|++.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999854 688999999865432 234567899999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-----CCCCeEEEeecC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-----QHMNPKISDFGM 673 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-----~~~~~kL~DFGl 673 (754)
||||+++ +|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 8888873 3345889999999999999999999988 99999999999994 455599999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++.+..... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 987654321 22335789999999999874 48999999999999999999999997543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=298.40 Aligned_cols=202 Identities=30% Similarity=0.576 Sum_probs=170.3
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchh-------hHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++...... ..+++.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 4578999999999999999999874 6889999998653221 1267899999999999999999999875443
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC-----eEEE
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN-----PKIS 669 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~-----~kL~ 669 (754)
++||||+++++|..++.. ....+++..+..++.|++.||+|||+++ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999887753 3446899999999999999999999875 34999999999999988776 9999
Q ss_pred eecCccccCCCcccCCcccccccCcccCcccc--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYA--LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
|||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||.....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 9999985433 22336799999999998 455678999999999999999999999976553
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.61 Aligned_cols=201 Identities=31% Similarity=0.453 Sum_probs=172.4
Q ss_pred CCc-ceeeeeceeccEEEEeeeec-----Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEec--Cc
Q 004416 525 ENF-SIQSKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GE 595 (754)
Q Consensus 525 ~~y-~i~~~LG~G~fg~Vy~~~~~-----~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~ 595 (754)
++| ++.+.||+|+||.||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 455 99999999999999887542 57889999997653 34567799999999999999999999999884 57
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHh----hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 899999999999999983 334889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.+..... ........+|+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 8754322 11233356788999999999989999999999999999999999998653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=323.95 Aligned_cols=202 Identities=30% Similarity=0.438 Sum_probs=177.1
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
...++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999875 68899999986432 345678999999999999999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE---cCCCCeEEEeecCc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMA 674 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~~kL~DFGla 674 (754)
+||||+.+++|.+.+. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 103 lv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EEECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999988884 3456899999999999999999999988 9999999999999 56789999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.+.... ......||+.|+|||++.+ .++.++||||||+++|||++|++||...+
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 8765433 2234579999999999876 68999999999999999999999997654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.97 Aligned_cols=202 Identities=30% Similarity=0.434 Sum_probs=173.6
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch-------------hhHHHHHHHHHHHHHccccceeeeE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLL 587 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~l~ 587 (754)
...++|.+.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35578999999999999999999875 478999999865321 2356789999999999999999999
Q ss_pred eEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC---
Q 004416 588 GCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM--- 664 (754)
Q Consensus 588 ~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~--- 664 (754)
+++.+....++||||+++++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999988873 3456899999999999999999999988 99999999999998776
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+||+|||+++.+.... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||...+
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 69999999998775433 223357999999999886 568999999999999999999999997654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=307.07 Aligned_cols=205 Identities=31% Similarity=0.500 Sum_probs=166.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Cccee----eeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEV----AVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~v----AVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
..++|++.++||+|+||.||+|++. +++.+ |+|.+... .....+++.+|+.++++++||||+++++++... ..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SE
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cc
Confidence 3478999999999999999999864 45544 66766433 344567899999999999999999999998765 48
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++|+||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred eEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 899999999999998853 2345889999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 755443333334567889999999999999999999999999999999 999997644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=309.85 Aligned_cols=198 Identities=27% Similarity=0.398 Sum_probs=166.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 594 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3578999999999999999999864 5889999998543 3344577899999999999999999999987653
Q ss_pred -cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 789998883 245889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9875432 233578999999999877 678999999999999999999999997643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=321.33 Aligned_cols=201 Identities=30% Similarity=0.446 Sum_probs=173.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3478999999999999999999875 5889999998643 233467889999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc---CCCCeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~~kL~DFGla~~ 676 (754)
|||+++++|...+. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999988773 3456899999999999999999999988 99999999999995 456799999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 2233579999999999875 58999999999999999999999996643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.66 Aligned_cols=198 Identities=33% Similarity=0.494 Sum_probs=171.5
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++......++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 345699999999999999999986 468899999986432 3345678999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+. |+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 132 v~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EEECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EEecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 999997 567666632 2356889999999999999999999988 9999999999999999999999999998754
Q ss_pred CCcccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. ....||+.|+|||++. +..++.++||||||+++|||++|+.||...
T Consensus 206 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 206 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp SB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 32 2357999999999884 567899999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.48 Aligned_cols=201 Identities=26% Similarity=0.407 Sum_probs=164.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchhh-HHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.+.||+|+||.||+|+.. +++.||||++....... ...+.+|+.++++++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 58899999986543221 12456799999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LDK-DLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 974 78777743 2346889999999999999999999988 99999999999999999999999999986543221
Q ss_pred cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2223578999999999876 568999999999999999999999997644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.92 Aligned_cols=200 Identities=23% Similarity=0.310 Sum_probs=171.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3468999999999999999999875 6899999998754 233456788999999999 99999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC--------------
Q 004416 599 IYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-------------- 663 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-------------- 663 (754)
||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999984321 1255889999999999999999999988 9999999999999844
Q ss_pred -----CCeEEEeecCccccCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 664 -----MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 664 -----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|.+++..
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999998765432 24589999999999876 566899999999999999999987644
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=294.40 Aligned_cols=200 Identities=29% Similarity=0.436 Sum_probs=171.0
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec----CcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ----GEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----~~~ 596 (754)
...|.+.+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 356889999999999999999864 4778999998654 344567889999999999999999999998763 458
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCeEEEeecCcc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMAR 675 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~kL~DFGla~ 675 (754)
++||||+++++|.+++. ....+++..+..++.||++||+|||+.+ .+|+||||||+|||++ +++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999983 3356889999999999999999999864 3499999999999998 78999999999997
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
...... .....||+.|+|||++. ..++.++||||||+++|||++|+.||...
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 654322 23357899999999876 45899999999999999999999999763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.13 Aligned_cols=204 Identities=26% Similarity=0.426 Sum_probs=171.1
Q ss_pred cCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEec-------
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------- 593 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------- 593 (754)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999987 468899999886542 22345678999999999999999999999873
Q ss_pred -CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 594 -GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 594 -~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999986 56555533 2345889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcc--cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDEL--QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987753221 122334678999999999876 457999999999999999999999997643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.33 Aligned_cols=201 Identities=22% Similarity=0.360 Sum_probs=172.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec--CcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ--GEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~--~~~~l 598 (754)
..++|++.+.||+|+||.||+|+.. ++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3468999999999999999999984 888999998754 334557899999999999999999999999877 68899
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++... ....+++..+..++.||++||+|||+++ ..|+||||||+|||+++++.++|.|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999542 2335899999999999999999999864 349999999999999999999999999876432
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSV---KSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ....||+.|+|||++.+..++. ++||||||+++|||++|+.||....
T Consensus 165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2 2257899999999998766544 7999999999999999999997643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.04 Aligned_cols=194 Identities=21% Similarity=0.363 Sum_probs=170.1
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEe--cCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE--QGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~--~~~~~l 598 (754)
..++|++.+.||+|+||.||+|+. .+++.||||+++... .+.+.+|+.++++++ ||||+++++++.+ ....++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 347899999999999999999986 468899999986433 467889999999997 9999999999987 567899
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCcccc
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~ 677 (754)
||||+++++|..++. .+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 111 v~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999998872 3788899999999999999999988 99999999999999776 8999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 54332 233578999999999887 6789999999999999999999999954
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.25 Aligned_cols=199 Identities=27% Similarity=0.326 Sum_probs=163.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 594 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3478999999999999999999864 5889999998653 3344567889999999999999999999987654
Q ss_pred -cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++||||+++ +|...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 68999999975 6776663 24788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98764332 1233578999999999999999999999999999999999999997643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=297.05 Aligned_cols=205 Identities=29% Similarity=0.392 Sum_probs=171.5
Q ss_pred cccCCcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
...++|.+.+.||+|+||.||+|+..+ +..||||++... .....+.+.+|+.++++++||||+++++++. .+..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-SSSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCC
Confidence 455789999999999999999997543 346999998765 3445678999999999999999999999875 4567
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 899999999999999843 2345889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~ 219 (281)
T 3cc6_A 163 IEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC
Confidence 6543321 1223467889999999998899999999999999999998 999996543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=298.79 Aligned_cols=203 Identities=30% Similarity=0.435 Sum_probs=172.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
++|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44555569999999999999864 57899999997766666788999999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeecCccccCCCcc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFGla~~~~~~~~ 682 (754)
++++|.+++........+++..+..++.||++||+|||+.+ |+|+||||+|||++. ++.+||+|||+++.+.....
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999865444445678889999999999999999987 999999999999987 89999999999987654321
Q ss_pred cCCcccccccCcccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 223357899999999987644 789999999999999999999999654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.05 Aligned_cols=201 Identities=27% Similarity=0.405 Sum_probs=170.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..++|++.+.||+|+||.||+|+.. ++..||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999875 57899999987542 33456789999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC---CCeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~~kL~DFGla~~ 676 (754)
|||+++++|.+.+. ....+++..+..++.||++||+|||+++ |+||||||+|||++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999988773 3456889999999999999999999988 9999999999999764 4599999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||....
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 75433 223367999999999886 568999999999999999999999997644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.57 Aligned_cols=203 Identities=25% Similarity=0.402 Sum_probs=171.3
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999864 58899999986543 3356789999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE---cCCCCeEEEeecCcccc
Q 004416 602 YMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677 (754)
Q Consensus 602 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~~kL~DFGla~~~ 677 (754)
|+++++|.+.+... .....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999998887432 23356889999999999999999999988 9999999999999 45678999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 5432 223357899999999875 568999999999999999999999997644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.96 Aligned_cols=203 Identities=20% Similarity=0.255 Sum_probs=166.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec----Ccceeeeeeccccchh-----------hHHHHHHHHHHHHHccccceeeeE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLL 587 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~ 587 (754)
..++|++.+.||+|+||.||+|+.. .+..||||++...... ..+.+.+|+..+..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3478999999999999999999875 5678999998654321 112366788899999999999999
Q ss_pred eEEEe----cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC
Q 004416 588 GCCIE----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH 663 (754)
Q Consensus 588 ~~~~~----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~ 663 (754)
+++.. ....++||||+ +++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISG---QNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCB---GGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 99988 67889999999 999999984 3337899999999999999999999987 9999999999999988
Q ss_pred C--CeEEEeecCccccCCCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 664 M--NPKISDFGMARMFGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 664 ~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7 9999999999877543211 1123457999999999999999999999999999999999999999653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=312.97 Aligned_cols=201 Identities=23% Similarity=0.368 Sum_probs=167.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCc------E
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE------K 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~------~ 596 (754)
...+|++.++||+|+||.||+|+...+..||+|++..... ...+|++++++++||||+++++++..... .
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3467999999999999999999987777799998854332 12469999999999999999999976543 7
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCeEEEeecCcc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMAR 675 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~kL~DFGla~ 675 (754)
++||||++++.+............+++..+..++.||++||+|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 899999988655544322233556889999999999999999999988 99999999999999 78999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7644332 2235789999999998765 58999999999999999999999997654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.67 Aligned_cols=202 Identities=29% Similarity=0.410 Sum_probs=171.0
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4789999999999999999998754 8899999886543 333566889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988763 3345889999999999999999999988 999999999999999999999999999876543
Q ss_pred cccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 22335789999999998875 68999999999999999999999997654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.49 Aligned_cols=203 Identities=26% Similarity=0.378 Sum_probs=167.0
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEE----------
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCI---------- 591 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~---------- 591 (754)
..++|++.+.||+|+||.||+|+... ++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 35789999999999999999998764 8899999998776677788999999999999999999999873
Q ss_pred ----ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCe
Q 004416 592 ----EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNP 666 (754)
Q Consensus 592 ----~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~ 666 (754)
+....++||||++ ++|.+++. ...+++..+..++.||++||+|||+++ |+||||||+|||++ +++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 58998883 346889999999999999999999988 99999999999997 56789
Q ss_pred EEEeecCccccCCCcc-cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 667 KISDFGMARMFGGDEL-QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 667 kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
||+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999987654321 122233567999999998765 678999999999999999999999997654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=298.41 Aligned_cols=205 Identities=27% Similarity=0.379 Sum_probs=159.9
Q ss_pred ccccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc-h-hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-G-QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~-~-~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
+...++|++.+.||+|+||.||+++. .+++.||||++.... . ...+.+.++...++.++||||+++++++.+.+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 34568899999999999999999986 468899999987542 2 22334455555678889999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 598 LIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
+||||+++ +|..++... .....+++..+..++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999975 777666321 2345689999999999999999999997 7 9999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCcccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYA----LEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.+..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 159 YLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 7654332 2234789999999996 5667899999999999999999999999753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.72 Aligned_cols=206 Identities=32% Similarity=0.475 Sum_probs=169.6
Q ss_pred cccCCcceeeeeceeccEEEEeeeecC-----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~-----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
...++|.+.+.||+|+||.||+|+... +..||||+++.. .......+.+|+.++++++||||+++++++.+...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 345789999999999999999998643 235999998754 33445678999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999843 2346889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
.+...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 77543211 11222456788999999999999999999999999999999 99999653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=304.67 Aligned_cols=209 Identities=33% Similarity=0.485 Sum_probs=173.2
Q ss_pred cccCCcceeeeeceeccEEEEeeeec------Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
...++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34578999999999999999999842 4668999999654 3445667899999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeE
Q 004416 595 EKILIYEYMVNKSLDVFLFDPT----KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPK 667 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~k 667 (754)
..++||||+++++|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999985432 2245889999999999999999999988 999999999999984 44699
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
|+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 999999987644433333334578899999999998999999999999999999998 999997643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.01 Aligned_cols=200 Identities=19% Similarity=0.224 Sum_probs=171.5
Q ss_pred cCCcceeeeeceeccEEEEeeeecC---------cceeeeeeccccchhhHHHHHHHHHHHHHccccceee---------
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR--------- 585 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~---------~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~--------- 585 (754)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999998753 789999998654 35789999999999999987
Q ss_pred ------eEeEEEe-cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCE
Q 004416 586 ------LLGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNI 658 (754)
Q Consensus 586 ------l~~~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NI 658 (754)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999998532 2356899999999999999999999988 99999999999
Q ss_pred EEcCCC--CeEEEeecCccccCCCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 659 LLDQHM--NPKISDFGMARMFGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 659 Ll~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999877543211 112335799999999999999999999999999999999999999987
Q ss_pred CC
Q 004416 732 YN 733 (754)
Q Consensus 732 ~~ 733 (754)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 64
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=293.00 Aligned_cols=202 Identities=26% Similarity=0.357 Sum_probs=175.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---------hhhHHHHHHHHHHHHHcc-ccceeeeEeEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCI 591 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~ 591 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4478999999999999999999875 58899999986432 123466889999999996 999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
.....++||||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999984 3456889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYAL------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|++..+.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9998765433 223357899999999875 4568899999999999999999999996543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.45 Aligned_cols=202 Identities=29% Similarity=0.456 Sum_probs=172.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+++.+|+.++++++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999875 48899999986543 34678899999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998842 3456889999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2233578999999999999999999999999999999999999997643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.74 Aligned_cols=205 Identities=26% Similarity=0.446 Sum_probs=172.5
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
...++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34578999999999999999999875 48899999997766667788999999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|..++.. ....+++..+..++.||++||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp ECCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EeCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999988743 2345889999999999999999999988 999999999999999999999999998643221
Q ss_pred cccCCcccccccCcccCcccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYA-----LEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
. .......||+.|+|||++ .+..++.++||||||+++|||++|+.||...+
T Consensus 171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 171 L--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp H--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred c--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 1 112235789999999988 46778999999999999999999999997644
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.16 Aligned_cols=200 Identities=24% Similarity=0.361 Sum_probs=168.1
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--------hhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 467999999999999999999865 47899999986532 12234588999999999999999999998655
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC---eEEEee
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDF 671 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---~kL~DF 671 (754)
..++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4899999999999998883 3456889999999999999999999988 999999999999987665 999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|+++.+.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9998765432 122357899999999873 5678899999999999999999999997654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.15 Aligned_cols=198 Identities=12% Similarity=0.146 Sum_probs=153.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHc--cccceeeeE-------eEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL--QHRNLVRLL-------GCC 590 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l--~H~nIv~l~-------~~~ 590 (754)
..+|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 356999999999999999999865 68899999997643 23456778887666666 599988755 444
Q ss_pred EecC-----------------cEEEEEEcccCCCHhhHhcCCCCcccccHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 004416 591 IEQG-----------------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLR------VRIIDGIAQGLLYLHQYSRLR 647 (754)
Q Consensus 591 ~~~~-----------------~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~yLH~~~~~~ 647 (754)
...+ ..++||||++ ++|.+++... ...+.+..+ ..++.||++||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 4332 3799999999 8999998532 223344444 677799999999999988
Q ss_pred ceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcC
Q 004416 648 IIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSS 725 (754)
Q Consensus 648 iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg 725 (754)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998764322 13467799999999987 6799999999999999999999
Q ss_pred CCCCCCC
Q 004416 726 KKNTGVY 732 (754)
Q Consensus 726 ~~p~~~~ 732 (754)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999776
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.81 Aligned_cols=208 Identities=30% Similarity=0.428 Sum_probs=173.6
Q ss_pred hhccccCCcceee-eeceeccEEEEeeee---cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEe
Q 004416 519 SVTAATENFSIQS-KLGEGGFGPVYKGRL---LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (754)
Q Consensus 519 ~~~~~~~~y~i~~-~LG~G~fg~Vy~~~~---~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 592 (754)
++....++|.+.+ .||+|+||.||+|.. ..++.||||+++... ....+++.+|+.++++++||||+++++++ +
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3344557899988 999999999999954 246889999987543 33467899999999999999999999998 6
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
.+..++||||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence 7788999999999999999843 345889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 673 MARMFGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+++.+...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99877543321 11222456789999999988889999999999999999999 999997644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.79 Aligned_cols=211 Identities=27% Similarity=0.358 Sum_probs=173.0
Q ss_pred ccchhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHcc--ccceeeeEeE
Q 004416 514 LFSFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGC 589 (754)
Q Consensus 514 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~ 589 (754)
.+.+.++....++|++.+.||+|+||.||+++..+++.||||++... .....+.+.+|+.++.+++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 45566777788899999999999999999999888999999998643 3445678899999999997 4999999999
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
+......++||| +.+++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++ +.+||+
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEEC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEe
Confidence 999999999999 56889999884 3346889999999999999999999987 999999999999975 789999
Q ss_pred eecCccccCCCcccCCcccccccCcccCccccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-----------GVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|||+++.+.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 9999987755433333334679999999999875 46888999999999999999999999654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.67 Aligned_cols=197 Identities=27% Similarity=0.417 Sum_probs=161.0
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHH--ccccceeeeEeEEEec----C
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCIEQ----G 594 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~----~ 594 (754)
....++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344578999999999999999999875 8899999986432 2334455555554 4899999999999887 6
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC-----CCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS-----RLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
..++||||+++++|.+++. ...+++..+..++.|++.||+|||++. +.+|+||||||+|||++.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 8899999999999999983 346889999999999999999999870 1139999999999999999999999
Q ss_pred eecCccccCCCcccC--CcccccccCcccCccccCCCCCCch------hhHHHHHHHHHHHHcC
Q 004416 670 DFGMARMFGGDELQG--NTKRIVGTYGYMSPEYALEGVFSVK------SDVFSFGVLMLEILSS 725 (754)
Q Consensus 670 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DVwSlGvll~elltg 725 (754)
|||+++.+....... ......||+.|+|||++.+.....+ +||||||+++|||++|
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 999998765433211 1224579999999999987766654 9999999999999999
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.13 Aligned_cols=206 Identities=30% Similarity=0.468 Sum_probs=170.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEe-cCcE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~ 596 (754)
...+|++.+.||+|+||.||+|+..+ ...||+|.+... .....+.+.+|+.++++++||||+++++++.+ +...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568999999999999999998643 235899988754 33456789999999999999999999998654 4578
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999853 3345788999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc--CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQ--GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 7543321 12233567889999999999999999999999999999999 556665543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.89 Aligned_cols=202 Identities=26% Similarity=0.418 Sum_probs=176.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhh-----------------HHHHHHHHHHHHHccccceee
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG-----------------LKEFKNEMMLIAKLQHRNLVR 585 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~-----------------~~~~~~Ei~~l~~l~H~nIv~ 585 (754)
..++|++.+.||+|+||.||+|+. +++.||||++....... .+.+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999999998 89999999986542211 278899999999999999999
Q ss_pred eEeEEEecCcEEEEEEcccCCCHhhH------hcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCE
Q 004416 586 LLGCCIEQGEKILIYEYMVNKSLDVF------LFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNI 658 (754)
Q Consensus 586 l~~~~~~~~~~~lV~ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NI 658 (754)
+++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||+|||+ .+ |+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 99999999999999999999999988 422 225678999999999999999999998 77 99999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 659 LLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSV-KSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 659 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999876443 22335789999999999887 6666 9999999999999999999997654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.02 Aligned_cols=204 Identities=23% Similarity=0.378 Sum_probs=176.5
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--------hhhHHHHHHHHHHHHHc-cccceeeeEeEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 590 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--------~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 590 (754)
....++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344578999999999999999999875 68999999886532 11245688999999999 799999999999
Q ss_pred EecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEe
Q 004416 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISD 670 (754)
Q Consensus 591 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~D 670 (754)
......++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||+++++.+||+|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999884 3456889999999999999999999988 99999999999999999999999
Q ss_pred ecCccccCCCcccCCcccccccCcccCccccCC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 671 FGMARMFGGDELQGNTKRIVGTYGYMSPEYALE------GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 671 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 244 fG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 244 FGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 99998775433 2234689999999998853 358889999999999999999999996543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.65 Aligned_cols=211 Identities=24% Similarity=0.312 Sum_probs=175.7
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe----
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE---- 592 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---- 592 (754)
..+....++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 33445667899999999999999999986 4688999999877666677889999999999999999999999873
Q ss_pred cCcEEEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
....++||||+++++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEec
Confidence 34788999999999999888532 23456899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCccc-------CCcccccccCcccCccccCCCC---CCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 672 GMARMFGGDELQ-------GNTKRIVGTYGYMSPEYALEGV---FSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 672 Gla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
|++......... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 998765321110 0112245799999999987654 68899999999999999999999854
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.34 Aligned_cols=204 Identities=26% Similarity=0.376 Sum_probs=173.2
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEec-----C
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----G 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~ 594 (754)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34578999999999999999999864 57889999987543 33457789999999999999999999998755 3
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++ +|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~~-~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCSE-EHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccCc-CHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 68999999974 8888773 345889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCccc-CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 876543221 12234689999999998654 558999999999999999999999997654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=324.01 Aligned_cols=206 Identities=29% Similarity=0.453 Sum_probs=170.8
Q ss_pred cccCCcceee-eeceeccEEEEeeeec---Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~-~LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
...+++.+.+ .||+|+||.||+|.+. ++..||||+++... ....+++.+|+++|++++||||+++++++.. +..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3445666666 8999999999999764 46679999997653 3456889999999999999999999999865 679
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 411 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 999999999999999843 3456899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+...... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 544 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence 7543211 11222345789999999999999999999999999999998 999997654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=297.65 Aligned_cols=208 Identities=28% Similarity=0.447 Sum_probs=173.6
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe--cCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~l 598 (754)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 478999999999999999999875 5889999998654 33456779999999999999999999998865 467899
Q ss_pred EEEcccCCCHhhHhcCCC-CcccccHHHHHHHHHHHHHHHHHHHhcC--CCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 599 IYEYMVNKSLDVFLFDPT-KKHLLGWQLRVRIIDGIAQGLLYLHQYS--RLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999885321 2334889999999999999999999875 1249999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 7644321 1223578999999999999999999999999999999999999997654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=298.13 Aligned_cols=205 Identities=25% Similarity=0.317 Sum_probs=170.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc----hhhHHHHHHHHHHHHHccccceeeeEeEEE--ecCcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCI--EQGEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~--~~~~~ 596 (754)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 378999999999999999999874 57899999986542 234678999999999999999999999984 44578
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||++++ |..++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 65555332 3456889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGV--FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 75433333334467899999999987644 3789999999999999999999997644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=294.62 Aligned_cols=199 Identities=28% Similarity=0.411 Sum_probs=169.2
Q ss_pred CcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE-EEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK-ILI 599 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~-~lV 599 (754)
.|.+.++||+|+||.||+|++.+ +..||+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999997532 236999998754 334567889999999999999999999999876655 999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+.+++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999854 3456789999999999999999999988 99999999999999999999999999987654
Q ss_pred Ccc--cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 680 DEL--QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 680 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
... ........+|+.|+|||.+.+..++.++||||||+++|||++|+.|+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 331 12233457889999999999999999999999999999999965553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=323.37 Aligned_cols=209 Identities=31% Similarity=0.487 Sum_probs=179.4
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
...+...++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++||||+++++++.+ ...+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34556678899999999999999999999888889999997643 345789999999999999999999999865 6789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++++|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+
T Consensus 338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999999999999998421 2245889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
...... ......++..|+|||++....++.++||||||++||||++ |+.||....
T Consensus 414 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 414 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp CCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred CCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 543221 1222456789999999998999999999999999999999 899997543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.11 Aligned_cols=204 Identities=28% Similarity=0.421 Sum_probs=177.3
Q ss_pred ccCCcceeeeeceeccEEEEeeee-----cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe--cCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~ 595 (754)
..++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 347899999999999999999983 3578999999987777777889999999999999999999999874 456
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 8999999999999999843 2345899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 676 MFGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 676 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.+..... ........+|+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 7754322 1122335688889999999998999999999999999999999999854
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=305.24 Aligned_cols=204 Identities=23% Similarity=0.288 Sum_probs=171.6
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc--------ccceeeeEeEEE-
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLLGCCI- 591 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~~~~~- 591 (754)
...++|++.++||+|+||.||+|+.. +++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34588999999999999999999864 5889999999653 344577899999999996 788999999987
Q ss_pred ---ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCC---
Q 004416 592 ---EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHM--- 664 (754)
Q Consensus 592 ---~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~--- 664 (754)
.....++||||+.+ ++...+... ....+++..+..++.||++||+|||++ + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence 45578999999954 554444322 234588999999999999999999998 7 99999999999999775
Q ss_pred ----------------------------------------------CeEEEeecCccccCCCcccCCcccccccCcccCc
Q 004416 665 ----------------------------------------------NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698 (754)
Q Consensus 665 ----------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 698 (754)
.+||+|||+++..... .....||+.|+||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP 262 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence 7999999999876432 2235789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 004416 699 EYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS 736 (754)
Q Consensus 699 E~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~~ 736 (754)
|++.+..++.++|||||||++|||++|+.||.......
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 99999999999999999999999999999998766443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=302.18 Aligned_cols=213 Identities=24% Similarity=0.313 Sum_probs=163.4
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEe---
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE--- 592 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~--- 592 (754)
..+.....+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 344556678999999999999999999864 58899999987766666778999999999996 9999999999853
Q ss_pred -----cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeE
Q 004416 593 -----QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPK 667 (754)
Q Consensus 593 -----~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~k 667 (754)
....++||||+. |+|.+++........+++..+..++.||+.||+|||+.+ .+|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEE
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEE
Confidence 234799999996 688887754334556899999999999999999999864 3499999999999999999999
Q ss_pred EEeecCccccCCCcccC----------CcccccccCcccCcccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQG----------NTKRIVGTYGYMSPEYA---LEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|+|||+++.+....... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 99999998765432111 11135689999999998 5677899999999999999999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.14 Aligned_cols=203 Identities=30% Similarity=0.418 Sum_probs=167.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchh-----hHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999875 4889999998653221 124678999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++ +|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 78777743 3345788889999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... ......||+.|+|||++.+. .++.++||||||+++|||++|.+||...+
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 654321 22335789999999998764 58899999999999999999999986643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.24 Aligned_cols=204 Identities=29% Similarity=0.474 Sum_probs=162.2
Q ss_pred CCcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEe-cCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-QGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-~~~~~l 598 (754)
..|.+.+.||+|+||.||+|+..+ ...||||.++.. .....+++.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457888999999999999998642 246899998654 33456789999999999999999999998765 457899
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999853 3345788999999999999999999988 9999999999999999999999999998764
Q ss_pred CCcccC--CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 679 GDELQG--NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 432211 1223467889999999999999999999999999999999 677776544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=293.93 Aligned_cols=203 Identities=22% Similarity=0.316 Sum_probs=168.7
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEE-EecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-IEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 600 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++++++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 447899999999999999999986 4688999998654422 24578899999999988877766665 5667789999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE---cCCCCeEEEeecCcccc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~~kL~DFGla~~~ 677 (754)
||+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999998842 2345899999999999999999999988 9999999999999 78899999999999887
Q ss_pred CCCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 554321 12234689999999999999999999999999999999999999998755
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-33 Score=297.20 Aligned_cols=214 Identities=27% Similarity=0.444 Sum_probs=173.2
Q ss_pred CccchhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEE
Q 004416 513 PLFSFASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 590 (754)
Q Consensus 513 ~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 590 (754)
+.+.+..+....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34556667778899999999999999999999874 68899999986543 3346789999999999 899999999999
Q ss_pred Ee------cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC
Q 004416 591 IE------QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM 664 (754)
Q Consensus 591 ~~------~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~ 664 (754)
.. ....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 87 45789999999999999988532 2356889999999999999999999988 99999999999999999
Q ss_pred CeEEEeecCccccCCCcccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 665 NPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 665 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+||+|||++..+..... ......||+.|+|||++. +..++.++||||||+++|||++|+.||...+
T Consensus 167 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999987643221 223357899999999987 5678899999999999999999999996543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=295.35 Aligned_cols=206 Identities=26% Similarity=0.428 Sum_probs=165.8
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++... .....+++.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999986 46889999998653 34456778999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 599 IYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
||||+++++|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999988432 23456889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 44321 2223578999999999999999999999999999999999999996543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.33 Aligned_cols=203 Identities=22% Similarity=0.316 Sum_probs=172.5
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEE-EecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-IEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~-~~~~~~~lV~ 600 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++++++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 457899999999999999999986 5689999999865432 24688999999999998876666655 5567789999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE---cCCCCeEEEeecCcccc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~~kL~DFGla~~~ 677 (754)
||+ +++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+ ++++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 8999998842 2346899999999999999999999988 9999999999999 48889999999999887
Q ss_pred CCCcccC-----CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQG-----NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 5543211 1234679999999999999999999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.40 Aligned_cols=209 Identities=27% Similarity=0.362 Sum_probs=169.9
Q ss_pred chhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccch-----------hhHHHHHHHHHHHHHcccccee
Q 004416 516 SFASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-----------QGLKEFKNEMMLIAKLQHRNLV 584 (754)
Q Consensus 516 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H~nIv 584 (754)
...++....++|++.+.||+|+||.||+|+..+++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 34566777899999999999999999999988899999998854321 2247889999999999999999
Q ss_pred eeEeEEEecC-----cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEE
Q 004416 585 RLLGCCIEQG-----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNIL 659 (754)
Q Consensus 585 ~l~~~~~~~~-----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NIL 659 (754)
++++++.... ..++||||++ ++|...+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999986533 5799999998 577776642 3446899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 660 LDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 660 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999998654332 2233578999999999877 678999999999999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=301.53 Aligned_cols=203 Identities=25% Similarity=0.383 Sum_probs=171.1
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEec-----Cc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 595 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999875 5889999998654 334456788999999999999999999987654 67
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+. ++|..++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 58888873 346889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccC--------CcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQG--------NTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 775432111 1223578999999998764 778999999999999999999999997643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.98 Aligned_cols=203 Identities=33% Similarity=0.479 Sum_probs=170.3
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccce--eeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~--vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 599 (754)
++|++.+.||+|+||.||+|+.. ++.. +|||+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999865 3554 599988653 333456789999999999 999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 600 YEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
|||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999985432 2346899999999999999999999988 9999999999999999999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999753221 12223467889999999988889999999999999999998 999996643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=300.16 Aligned_cols=196 Identities=31% Similarity=0.513 Sum_probs=159.2
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHH--HHHHHHccccceeeeEeEEEec-----Cc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~E--i~~l~~l~H~nIv~l~~~~~~~-----~~ 595 (754)
..++|++.+.||+|+||.||+|+. +++.||||++..... +.+..| +..+..++||||+++++.+... ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 347899999999999999999987 688999999865432 333444 4444558999999999866532 25
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc---------CCCCceeCCCCCCCEEEcCCCCe
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY---------SRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~---------~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
.++||||+++++|.+++. ....++..+.+++.||++||+|||+. + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 689999999999999983 33458888999999999999999988 6 9999999999999999999
Q ss_pred EEEeecCccccCCCcc------cCCcccccccCcccCccccCC-------CCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 667 KISDFGMARMFGGDEL------QGNTKRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 667 kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
||+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 9999999987754321 112223579999999999887 35667899999999999999997765
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=303.98 Aligned_cols=199 Identities=30% Similarity=0.405 Sum_probs=156.2
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec-----
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ----- 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~----- 593 (754)
...++|++.+.||+|+||.||+|+. .+++.||||++... .....+++.+|+.++++++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3458899999999999999999985 45889999998653 334567788999999999999999999998654
Q ss_pred -CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 594 -GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 594 -~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
...++|+|++ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 678888773 356899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 178 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 178 LARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99875432 233578999999999887 678999999999999999999999997654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=309.58 Aligned_cols=199 Identities=26% Similarity=0.383 Sum_probs=163.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC------cE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------EK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------~~ 596 (754)
..+|++.+.||+|+||.||+|++. +++.||||++..... ...+|+++|++++||||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 357999999999999999999875 588999999865422 2347999999999999999999986532 36
Q ss_pred EEEEEcccCCCHhhHhcC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-CCeEEEeecCc
Q 004416 597 ILIYEYMVNKSLDVFLFD-PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMA 674 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-~~~kL~DFGla 674 (754)
++||||+++ ++...+.. ......+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 45444421 123456889999999999999999999987 9999999999999965 56899999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 87644331 2235789999999998765 78999999999999999999999997644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-33 Score=302.72 Aligned_cols=197 Identities=26% Similarity=0.410 Sum_probs=167.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE---
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK--- 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~--- 596 (754)
..++|.+.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999864 5889999998754 333457889999999999999999999999876654
Q ss_pred ---EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 597 ---ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 597 ---~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
++||||+. ++|...+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 57777662 23889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 233578999999999887 678999999999999999999999997643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.58 Aligned_cols=200 Identities=31% Similarity=0.498 Sum_probs=165.9
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec-CcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ 600 (754)
...++|++.+.||+|+||.||+++. .++.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3457899999999999999999987 47899999987543 457789999999999999999999997654 4789999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++... ....+++..+..++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999988421 2233788999999999999999999988 999999999999999999999999999865432
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
. ....+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2 22467889999999998999999999999999999998 999997654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.52 Aligned_cols=204 Identities=31% Similarity=0.507 Sum_probs=175.3
Q ss_pred ccCCcceeeeeceeccEEEEeeee-----cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC--c
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG--E 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-----~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~--~ 595 (754)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346799999999999999999973 358899999998776667788999999999999999999999986544 6
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 89999999999999998432 345889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
........ .......++..|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 87543321 112224577889999999988899999999999999999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=306.25 Aligned_cols=216 Identities=16% Similarity=0.186 Sum_probs=175.4
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccc--------hhhHHHHHHHHHHHHHcc---------ccceee
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVR 585 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~nIv~ 585 (754)
..++|++.+.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 347899999999999999999987 68999999987542 233478899999999996 777777
Q ss_pred eEeEEE------------------------------ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHH
Q 004416 586 LLGCCI------------------------------EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635 (754)
Q Consensus 586 l~~~~~------------------------------~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~ 635 (754)
+.+.+. .....++||||+++|++...+. +..+++..+..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 777643 1678999999999997655552 245789999999999999
Q ss_pred HHHHHH-hcCCCCceeCCCCCCCEEEcCCC--------------------CeEEEeecCccccCCCcccCCcccccccCc
Q 004416 636 GLLYLH-QYSRLRIIHRDLKASNILLDQHM--------------------NPKISDFGMARMFGGDELQGNTKRIVGTYG 694 (754)
Q Consensus 636 ~L~yLH-~~~~~~iiH~DIkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 694 (754)
||+||| +++ |+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 888 99999999999999887 8999999999876432 3589999
Q ss_pred ccCccccCCCCCCchhhHHHHHHH-HHHHHcCCCCCCCC-----------------CCCccchhhhHHHHHhhhhhcC
Q 004416 695 YMSPEYALEGVFSVKSDVFSFGVL-MLEILSSKKNTGVY-----------------NTDSFNLLGHVSDKLYSLLFDL 754 (754)
Q Consensus 695 y~aPE~~~~~~~~~~~DVwSlGvl-l~elltg~~p~~~~-----------------~~~~~~~~~~~~~~l~~~l~~l 754 (754)
|+|||++.+.. +.++||||++++ .+++++|..||... ..........+++.+.++|.+|
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 99999998776 889999998776 88899999998531 1122234556778888887664
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.89 Aligned_cols=207 Identities=22% Similarity=0.300 Sum_probs=159.5
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCc---
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE--- 595 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~--- 595 (754)
.....++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+..+..++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 3445589999999999999999999875 58899999885542 223455778888999999999999999976544
Q ss_pred ----EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHH--hcCCCCceeCCCCCCCEEEcC-CCCeEE
Q 004416 596 ----KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH--QYSRLRIIHRDLKASNILLDQ-HMNPKI 668 (754)
Q Consensus 596 ----~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~iiH~DIkp~NILl~~-~~~~kL 668 (754)
.++||||++++.+............+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 7899999987533332222234566888999999999999999999 776 999999999999997 899999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+|||+++.+..... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+
T Consensus 174 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 174 CDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp CCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999987754332 22357899999999987654 8999999999999999999999997644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=324.29 Aligned_cols=196 Identities=31% Similarity=0.434 Sum_probs=164.9
Q ss_pred eeeceeccEEEEeeeec---Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+.+|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 58999999999999643 46789999997643 334678999999999999999999999985 5568999999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc-C
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ-G 684 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 684 (754)
++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999984 3456889999999999999999999988 999999999999999999999999999887543321 1
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
......+|+.|+|||++.+..++.++||||||++||||++ |+.||....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~ 577 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2223456789999999999999999999999999999998 999997644
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=303.96 Aligned_cols=202 Identities=22% Similarity=0.335 Sum_probs=166.1
Q ss_pred ccccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec------
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------ 593 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------ 593 (754)
....++|++.+.||+|+||.||+|+. .+++.||||++..... ...+|+.+|++++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 4689999999865432 224799999999999999999998543
Q ss_pred --------------------------------CcEEEEEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHH
Q 004416 594 --------------------------------GEKILIYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYL 640 (754)
Q Consensus 594 --------------------------------~~~~lV~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yL 640 (754)
...++||||+++ +|...+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 237899999984 776666421 2345689999999999999999999
Q ss_pred HhcCCCCceeCCCCCCCEEEc-CCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCC-CCchhhHHHHHHH
Q 004416 641 HQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVL 718 (754)
Q Consensus 641 H~~~~~~iiH~DIkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvl 718 (754)
|+.+ |+||||||+|||++ +++.+||+|||+|+.+..... .....+|+.|+|||++.+.. ++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9987 99999999999998 688999999999987654332 22357899999999987754 8999999999999
Q ss_pred HHHHHcCCCCCCCCC
Q 004416 719 MLEILSSKKNTGVYN 733 (754)
Q Consensus 719 l~elltg~~p~~~~~ 733 (754)
+|||++|+.||....
T Consensus 232 l~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 232 FGELILGKPLFSGET 246 (383)
T ss_dssp HHHHHHSSCSSCCSS
T ss_pred HHHHHhCCCCCCCCC
Confidence 999999999997644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=304.28 Aligned_cols=201 Identities=24% Similarity=0.306 Sum_probs=173.0
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHc------cccceeeeEeEEEecC
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL------QHRNLVRLLGCCIEQG 594 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~~~~~~~~ 594 (754)
....+|++.++||+|+||.||+|+.. +++.||||++... ....+++.+|+.+++.+ .|+||+++++++....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 34578999999999999999999865 4889999999654 33456778899999988 4669999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC--eEEEeec
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN--PKISDFG 672 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~--~kL~DFG 672 (754)
..++||||+. ++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999996 5888777432 2234889999999999999999999998 999999999999999887 9999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...+
T Consensus 248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99765332 223578999999999999999999999999999999999999997654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=290.98 Aligned_cols=197 Identities=28% Similarity=0.474 Sum_probs=171.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe---------
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--------- 592 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--------- 592 (754)
...+|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467999999999999999999875 68999999987543 346789999999999999999998864
Q ss_pred -------cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC
Q 004416 593 -------QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (754)
Q Consensus 593 -------~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~ 665 (754)
....++||||+++++|.+++... ....+++..+..++.||++||.|||+++ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999998532 2346889999999999999999999987 999999999999999999
Q ss_pred eEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 666 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
+||+|||+++.+..... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999988754332 223578999999999999999999999999999999999998864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.42 Aligned_cols=209 Identities=25% Similarity=0.405 Sum_probs=159.3
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 45588999999999999999999864 58899999986543 33456788999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcC-----CCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 600 YEYMVNKSLDVFLFD-----PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
|||+++++|.+++.. ......+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998842 123456899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcc---cCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDEL---QGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 87643221 112233578999999999875 568999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-32 Score=291.36 Aligned_cols=201 Identities=25% Similarity=0.345 Sum_probs=174.3
Q ss_pred cccCCcceeeeeceeccEEEEeeee--cCcceeeeeeccccchhhHHHHHHHHHHHHHccccc------eeeeEeEEEec
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCIEQ 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~~~~~ 593 (754)
...++|++.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.++++++|++ ++++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 4457999999999999999999975 35789999998654 344577899999999998775 99999999999
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-----------
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ----------- 662 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~----------- 662 (754)
+..++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred CcEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence 9999999999 88998888432 2235789999999999999999999988 999999999999987
Q ss_pred --------CCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 663 --------HMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 663 --------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999865332 233578999999999999999999999999999999999999997654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=289.25 Aligned_cols=201 Identities=31% Similarity=0.448 Sum_probs=173.6
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3478999999999999999999875 58899999986542 34567889999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC---CCeEEEeecCccc
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH---MNPKISDFGMARM 676 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~---~~~kL~DFGla~~ 676 (754)
+||+++++|.+.+. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999988773 3346889999999999999999999988 9999999999999764 4699999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...+
T Consensus 174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 65432 1223468999999998865 48999999999999999999999997643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.1e-33 Score=292.82 Aligned_cols=205 Identities=29% Similarity=0.398 Sum_probs=164.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeec--Cc--ceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL--NG--QEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~--~~--~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
..++|++.+.||+|+||.||+|++. ++ ..||||+++.. .....+++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-C
Confidence 4578999999999999999999853 22 36899998754 234567899999999999999999999998765 4
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++|+||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+|+||||+|||++.++.+||+|||+++
T Consensus 95 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 8899999999999998843 2345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 676 MFGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.+...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 87543321 12233567889999999988889999999999999999999 999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=292.86 Aligned_cols=204 Identities=27% Similarity=0.445 Sum_probs=171.1
Q ss_pred cccCCcceeeeeceeccEEEEeeee--cCcceeeeeeccccch--hhHHHHHHHHHHHHHc---cccceeeeEeEEE---
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKL---QHRNLVRLLGCCI--- 591 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~--~~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~--- 591 (754)
...++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999987 3578999999865422 1223566788777776 7999999999987
Q ss_pred --ecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 592 --EQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 592 --~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
.....++||||++ ++|..++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 6998887432 2334889999999999999999999988 9999999999999999999999
Q ss_pred eecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 999998764322 2233678999999999999999999999999999999999999997543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.6e-32 Score=293.38 Aligned_cols=201 Identities=26% Similarity=0.394 Sum_probs=170.5
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHH--ccccceeeeEeEEEecC----
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCIEQG---- 594 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~~~~~~~~---- 594 (754)
....++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34457899999999999999999987 5889999998643 34567889999988 78999999999998876
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHH--------hcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH--------QYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
..++||||+++++|.+++. ...+++..+..++.|+++||+||| +.+ |+||||||+|||+++++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 7899999999999999983 345889999999999999999999 655 9999999999999999999
Q ss_pred EEEeecCccccCCCccc--CCcccccccCcccCccccCCCC------CCchhhHHHHHHHHHHHHcC----------CCC
Q 004416 667 KISDFGMARMFGGDELQ--GNTKRIVGTYGYMSPEYALEGV------FSVKSDVFSFGVLMLEILSS----------KKN 728 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwSlGvll~elltg----------~~p 728 (754)
||+|||+++........ .......||+.|+|||++.+.. ++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876543321 1223457999999999987763 34689999999999999999 677
Q ss_pred CCCC
Q 004416 729 TGVY 732 (754)
Q Consensus 729 ~~~~ 732 (754)
|...
T Consensus 267 ~~~~ 270 (342)
T 1b6c_B 267 YYDL 270 (342)
T ss_dssp TTTT
T ss_pred cccc
Confidence 7554
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=296.75 Aligned_cols=196 Identities=27% Similarity=0.412 Sum_probs=166.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc-----
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE----- 595 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~----- 595 (754)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .....+++.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 478999999999999999999864 5889999998653 33345778999999999999999999999887653
Q ss_pred -EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 596 -KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 596 -~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
.++||||++ ++|..++. ..+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 57776652 24889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865432 223578999999999887 678999999999999999999999997643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-33 Score=306.02 Aligned_cols=204 Identities=25% Similarity=0.418 Sum_probs=154.2
Q ss_pred CCcce-eeeeceeccEEEEeeeec---CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe--cCcEEE
Q 004416 525 ENFSI-QSKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKIL 598 (754)
Q Consensus 525 ~~y~i-~~~LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~l 598 (754)
+.|.+ .++||+|+||.||+|+.. +++.||||++..... .+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45665 458999999999999865 478899999975432 3467899999999999999999999965 568899
Q ss_pred EEEcccCCCHhhHhcCC------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE----cCCCCeEE
Q 004416 599 IYEYMVNKSLDVFLFDP------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL----DQHMNPKI 668 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl----~~~~~~kL 668 (754)
||||+++ +|..++... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 666655311 12234889999999999999999999988 9999999999999 77889999
Q ss_pred EeecCccccCCCcc-cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 669 SDFGMARMFGGDEL-QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 669 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|++||.....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999987754321 1223346899999999999874 589999999999999999999999976543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=321.57 Aligned_cols=209 Identities=26% Similarity=0.372 Sum_probs=173.9
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEe
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 592 (754)
.......++|++.+.||+|+||.||+|++.. +..||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3445566889999999999999999998642 457999998754 3344578999999999999999999999984
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
++..++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 5678999999999999999843 2345889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+++.+...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99877543322 1223467889999999998999999999999999999997 999997643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4e-33 Score=297.09 Aligned_cols=203 Identities=24% Similarity=0.382 Sum_probs=164.6
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccchh------hHHHHHHHHHHHHHc----cccceeeeEe
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKL----QHRNLVRLLG 588 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~nIv~l~~ 588 (754)
.....++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999864 5889999998654321 223456799999999 8999999999
Q ss_pred EEEecCcEEEEEEc-ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCe
Q 004416 589 CCIEQGEKILIYEY-MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNP 666 (754)
Q Consensus 589 ~~~~~~~~~lV~ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~ 666 (754)
++...+..++|+|| +.+++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+||+++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYIT---EKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 78999999884 3446899999999999999999999998 99999999999999 88999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCCCCCC-chhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFS-VKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
||+|||+++.+.... .....||+.|+|||++.+..+. .++||||||+++|||++|+.||...
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 999999998775433 2335789999999998876664 5899999999999999999999653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=298.36 Aligned_cols=200 Identities=22% Similarity=0.373 Sum_probs=168.5
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHcc-----------ccceeeeEeEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCC 590 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~~~~ 590 (754)
..++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 347899999999999999999986 46889999998653 334567889999999887 88999999998
Q ss_pred EecC----cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEc----
Q 004416 591 IEQG----EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLD---- 661 (754)
Q Consensus 591 ~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~---- 661 (754)
...+ ..++||||+ +++|..++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 8654 789999999 88998888532 234588999999999999999999997 7 99999999999994
Q ss_pred --CCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 662 --QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 662 --~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4447999999999876432 223578999999999999999999999999999999999999997654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=298.51 Aligned_cols=204 Identities=23% Similarity=0.354 Sum_probs=172.7
Q ss_pred hhccccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchh------hHHHHHHHHHHHHHcc--ccceeeeEeE
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ------GLKEFKNEMMLIAKLQ--HRNLVRLLGC 589 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~------~~~~~~~Ei~~l~~l~--H~nIv~l~~~ 589 (754)
......++|++.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445568899999999999999999985 46889999998654221 2245678999999996 5999999999
Q ss_pred EEecCcEEEEEEcccC-CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCeE
Q 004416 590 CIEQGEKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPK 667 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~k 667 (754)
+...+..++|+|++.+ ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 9999999999999976 89998884 3456889999999999999999999988 99999999999999 788999
Q ss_pred EEeecCccccCCCcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 668 ISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 668 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|+|||+++.+.... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99999998765432 223578999999999887666 67899999999999999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-31 Score=293.79 Aligned_cols=207 Identities=26% Similarity=0.345 Sum_probs=173.6
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-cc-----ceeeeEeEE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLLGCC 590 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~~~~ 590 (754)
.......++|++.+.||+|+||.||+|+.. +++.||||+++.. ....+++.+|+.+++.++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 344556689999999999999999999865 5789999999753 334567788999999885 44 499999999
Q ss_pred EecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc--CCCCeEE
Q 004416 591 IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKI 668 (754)
Q Consensus 591 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~~~kL 668 (754)
...+..++||||+++ +|.+++... ....+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||
T Consensus 126 ~~~~~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 126 MFRNHLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EETTEEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred ccCCceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 999999999999964 888887533 224588999999999999999999953 12499999999999995 4778999
Q ss_pred EeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 669 SDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 669 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876432 223678999999999999999999999999999999999999998654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=303.14 Aligned_cols=204 Identities=22% Similarity=0.321 Sum_probs=172.9
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHccc-cceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~ 600 (754)
..++|++.++||+|+||.||+|+. .+++.||||++..... .+++.+|+++++.++| +++..+..++.+....++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999986 4588999998765432 2357889999999987 55666666677788899999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE---cCCCCeEEEeecCcccc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMF 677 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl---~~~~~~kL~DFGla~~~ 677 (754)
||+ +++|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+
T Consensus 83 e~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999 9999998843 2346899999999999999999999988 9999999999999 68899999999999887
Q ss_pred CCCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 678 GGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 678 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
...... .......||+.|+|||++.+..++.++||||||++||||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 654321 122346899999999999999999999999999999999999999987553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=303.62 Aligned_cols=201 Identities=27% Similarity=0.330 Sum_probs=157.6
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+.|.+.+.||+|+||+||.+...+++.||||++... ..+.+.+|+.++.++ +||||+++++++.++...++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 456667899999999998776667999999998653 235678899999987 8999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcc----cccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC-------------CCe
Q 004416 604 VNKSLDVFLFDPTKKH----LLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH-------------MNP 666 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~-------------~~~ 666 (754)
. ++|.+++....... ...+..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999885432211 1123345789999999999999988 9999999999999754 479
Q ss_pred EEEeecCccccCCCccc--CCcccccccCcccCccccCC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 004416 667 KISDFGMARMFGGDELQ--GNTKRIVGTYGYMSPEYALE-------GVFSVKSDVFSFGVLMLEILS-SKKNTGVY 732 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DVwSlGvll~ellt-g~~p~~~~ 732 (754)
||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999987553321 12234679999999999876 668999999999999999999 99999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=313.59 Aligned_cols=201 Identities=29% Similarity=0.419 Sum_probs=174.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEe------cCcE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE------QGEK 596 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~------~~~~ 596 (754)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 78999999999999999999874 5889999998754 44456789999999999999999999998755 6678
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC---eEEEeecC
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN---PKISDFGM 673 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~---~kL~DFGl 673 (754)
++||||+++++|..++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976555556888999999999999999999988 999999999999997765 99999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 987654332 2336799999999999999999999999999999999999999854
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=287.79 Aligned_cols=201 Identities=25% Similarity=0.339 Sum_probs=171.1
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Cc-ceeeeeeccccchhhHHHHHHHHHHHHHccccc------eeeeEeEEEec
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCIEQ 593 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~-~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~~~~~~~ 593 (754)
...++|++.+.||+|+||.||+|+.. ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 34589999999999999999999864 34 68999998653 344567889999999998876 89999999999
Q ss_pred CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE-------------
Q 004416 594 GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL------------- 660 (754)
Q Consensus 594 ~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl------------- 660 (754)
+..++||||+ ++++..++... ....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred CeEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 9999999999 55565555322 2245889999999999999999999987 9999999999999
Q ss_pred ------cCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 661 ------DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 661 ------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999864332 233579999999999999999999999999999999999999997654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-32 Score=318.87 Aligned_cols=195 Identities=21% Similarity=0.330 Sum_probs=168.0
Q ss_pred cccCCcceeeeeceeccEEEEeeeec--Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCc---
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE--- 595 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~--~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~--- 595 (754)
...++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 34589999999999999999999875 5789999988654 33455678999999999999999999999988766
Q ss_pred --EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 596 --KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 596 --~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
.++||||+++++|..++.. .+++..+..++.||++||+|||+++ |+||||||+|||++++ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEeccc
Confidence 7999999999999876622 6899999999999999999999988 9999999999999986 899999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
++.+... ....||+.|+|||++.+.. +.++||||||+++|||++|.+|+...
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 9876432 3357999999999987654 88999999999999999999987653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=283.25 Aligned_cols=195 Identities=29% Similarity=0.465 Sum_probs=161.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe----------
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE---------- 592 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~---------- 592 (754)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467999999999999999999864 6889999998643 3456788999999999999999999998865
Q ss_pred ---cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 593 ---QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 593 ---~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
....++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3567999999999999999853 2345778899999999999999999988 9999999999999999999999
Q ss_pred eecCccccCCCcc------------cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHc
Q 004416 670 DFGMARMFGGDEL------------QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILS 724 (754)
Q Consensus 670 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~ellt 724 (754)
|||+++.+..... ........||+.|+|||++.+. .++.++||||||+++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999987643210 1122335789999999998764 68999999999999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=301.38 Aligned_cols=205 Identities=23% Similarity=0.348 Sum_probs=160.4
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 598 (754)
+.....+|.+.++||+|+||+|+.....+++.||||++..... ..+.+|+.+|+++ +||||+++++++.+....++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 3445567999999999999996655556789999999865432 2346799999999 79999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-----CCCeEEEeecC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGM 673 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-----~~~~kL~DFGl 673 (754)
||||+. ++|.+++.... ....+..+..++.||++||+|||+++ |+||||||+|||++. ...+||+|||+
T Consensus 96 v~E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999996 58988885432 22334456789999999999999988 999999999999953 33588999999
Q ss_pred ccccCCCcc-cCCcccccccCcccCccccC---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 674 ARMFGGDEL-QGNTKRIVGTYGYMSPEYAL---EGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
++.+..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||+...
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 987754321 12233467999999999987 4567889999999999999999 999996543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=289.20 Aligned_cols=205 Identities=26% Similarity=0.385 Sum_probs=152.5
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHH-HHHHccccceeeeEeEEEecCcEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
....++|++.+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 344588999999999999999999875 58899999987642 333445566666 667789999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCC--CCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 598 LIYEYMVNKSLDVFLFDP--TKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
+||||+++ +|..++... .....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999986 776665321 1245688999999999999999999998 7 999999999999999999999999999
Q ss_pred cccCCCcccCCcccccccCcccCcccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYA----LEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+.+..... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 174 GQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred eecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 87644321 2224789999999998 4567899999999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.52 Aligned_cols=199 Identities=22% Similarity=0.262 Sum_probs=146.4
Q ss_pred ccCCcceee-eeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEe----cCcE
Q 004416 523 ATENFSIQS-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEK 596 (754)
Q Consensus 523 ~~~~y~i~~-~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~ 596 (754)
..++|.+.+ .||+|+||.||+|+.. +++.||||++.... ....+....++.++||||+++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 447899855 6999999999999876 58899999986532 122223334566799999999999876 4458
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeecC
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGM 673 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFGl 673 (754)
++||||+++++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999998543 2346899999999999999999999988 999999999999986 45599999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 98764322 233578999999999988889999999999999999999999996544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=287.62 Aligned_cols=203 Identities=23% Similarity=0.395 Sum_probs=152.9
Q ss_pred ccccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch--hhHHHHHHHHHHHHHccccceeeeEeEEEecCcEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
....++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.++..+++.++||||+++++++.+.+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 445578999999999999999999875 588999999865432 22334455556778889999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
+||||+ ++.+..+.. .....+++..+..++.||++||+|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 101 lv~e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEECCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 999999 445555442 1234688999999999999999999985 7 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 175 LVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 64432 122357899999999984 556889999999999999999999999763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=291.54 Aligned_cols=209 Identities=28% Similarity=0.428 Sum_probs=171.1
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecC
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG 594 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~ 594 (754)
........++|++.+.||+|+||.||+|+.. ..||+|+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3455566789999999999999999999874 369999986542 233456788999999999999999999999999
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999999843 2346888999999999999999999988 99999999999998 679999999998
Q ss_pred cccCCCc---ccCCcccccccCcccCccccCC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDE---LQGNTKRIVGTYGYMSPEYALE---------GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+...... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 7653221 1122233568999999999864 457889999999999999999999997643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=272.46 Aligned_cols=174 Identities=11% Similarity=0.088 Sum_probs=151.8
Q ss_pred ccCCcceeeeeceeccEEEEeeeecC-cceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
..++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34789999999999999999998754 8899999997643 3345788999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++++|.+++.. . ....++.+++.||++||+|||+++ |+||||||+|||+++++.+||+++
T Consensus 109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~------- 173 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP------- 173 (286)
T ss_dssp EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec-------
Confidence 9999999999999832 2 245568889999999999999988 999999999999999999999743
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+|++| ++.++||||||+++|||++|+.||...+
T Consensus 174 ---------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 174 ---------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp ---------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ---------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 33433 6889999999999999999999997654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-31 Score=290.17 Aligned_cols=202 Identities=17% Similarity=0.246 Sum_probs=156.3
Q ss_pred cccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc---hhhHHHHHHHHHHHHHccc-cce-------------
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQH-RNL------------- 583 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~nI------------- 583 (754)
.....|...+.||+|+||.||+|++ .+++.||||++.... ....+.+++|+.+++.++| +|.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3445688889999999999999985 468999999987432 2335788999999999977 211
Q ss_pred --eee------EeEEEe-----cCcEEEEEEcccCCCHhhHhcC----CCCcccccHHHHHHHHHHHHHHHHHHHhcCCC
Q 004416 584 --VRL------LGCCIE-----QGEKILIYEYMVNKSLDVFLFD----PTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRL 646 (754)
Q Consensus 584 --v~l------~~~~~~-----~~~~~lV~ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~ 646 (754)
+.+ ..+... ....+++|+++ +++|.+++.. ......+++..+..++.||++||+|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 111 111111 12456677765 6788887731 223556888899999999999999999988
Q ss_pred CceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCcccc----------CCCCCCchhhHHHHH
Q 004416 647 RIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA----------LEGVFSVKSDVFSFG 716 (754)
Q Consensus 647 ~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DVwSlG 716 (754)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999999875432 233577 999999998 666688999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 004416 717 VLMLEILSSKKNTGVYN 733 (754)
Q Consensus 717 vll~elltg~~p~~~~~ 733 (754)
|++|||++|+.||....
T Consensus 305 vil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHHSSCCCCTTG
T ss_pred HHHHHHHHCCCCCCCcc
Confidence 99999999999997654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=264.22 Aligned_cols=175 Identities=22% Similarity=0.309 Sum_probs=149.8
Q ss_pred CCccee-eeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHH-HHccccceeeeEeEEEe----cCcEE
Q 004416 525 ENFSIQ-SKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLI-AKLQHRNLVRLLGCCIE----QGEKI 597 (754)
Q Consensus 525 ~~y~i~-~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~~~~~~----~~~~~ 597 (754)
++|.+. +.||+|+||.||+++.. +++.||||+++.. ..+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567777 78999999999999864 5889999998642 3567888888 55599999999999987 66789
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeecCc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMA 674 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFGla 674 (754)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998542 2346899999999999999999999988 999999999999998 788999999998
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.... +..++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 6532 244677999999999999999999999654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-28 Score=279.84 Aligned_cols=186 Identities=17% Similarity=0.148 Sum_probs=131.6
Q ss_pred eeeceeccEEEEeee-ecCcceeeeeecccc----------chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEE
Q 004416 531 SKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~-~~~~~~vAVK~l~~~----------~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~l 598 (754)
..++.|++|.+..++ ..-|+.+|+|++... .....++|.+|+++|+++ +|+||++++++++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 356788888887765 335899999998643 123456799999999999 79999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||++|++|.+.|.. ...++.. +|+.||+.||+|+|+++ ||||||||+|||+++++.+||+|||+|+.+.
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999943 3445543 58999999999999998 9999999999999999999999999998765
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKN 728 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p 728 (754)
.+.. .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4332 2344789999999999875 456789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=254.57 Aligned_cols=185 Identities=17% Similarity=0.180 Sum_probs=146.6
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeeccccc--------hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..++||+|+||.||+++. .++.+++|+..... ....+++.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 57788888754321 112456899999999999999997777777888889999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++++|.+++.. +..++.|++++|+|||+++ |+||||||+|||+++ .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4589999999999999988 999999999999999 9999999999987553
Q ss_pred cccC-----CcccccccCcccCccccCC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 681 ELQG-----NTKRIVGTYGYMSPEYALE--GVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 681 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
.... ......||+.|||||++.. ..|+...|+|+..+-..+.+.++.++.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3211 1235789999999999876 567778899999999999888877763
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=177.43 Aligned_cols=105 Identities=19% Similarity=0.377 Sum_probs=93.1
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
.|+|.+||.|.+|++|.| |.|.|.|...++ |.++. ..++||+|||+.|. ...+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCC-CccEEEEEeCCccEEEECCC
Confidence 478999999999999998 789999998877 77765 57999999999994 44689999999999999999
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
+.+||+|++.+...++.|+|+||||||||+. .||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 9999999988766678899999999999974 39998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-22 Score=210.56 Aligned_cols=151 Identities=19% Similarity=0.116 Sum_probs=120.4
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccch------------------hhHHHHHHHHHHHHHccc
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQH 580 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H 580 (754)
........|.+.+.||+|+||.||+|+..+++.||||+++.... .....+.+|+.+|++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 44445566778899999999999999987789999999864321 134678999999999994
Q ss_pred cceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEE
Q 004416 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILL 660 (754)
Q Consensus 581 ~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl 660 (754)
+++.+++. .+..++||||+++++|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||+
T Consensus 164 ---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 164 ---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp ---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred ---CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 55555443 356699999999999987 411 123469999999999999988 9999999999999
Q ss_pred cCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccC
Q 004416 661 DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702 (754)
Q Consensus 661 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 702 (754)
+ ++.+||+|||+|+. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9 99999999999964 23568899874
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-21 Score=173.94 Aligned_cols=108 Identities=19% Similarity=0.339 Sum_probs=95.8
Q ss_pred ccccccCCCcccCCCCEEE--cCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEE
Q 004416 39 LAADTLTPTTLIRDGETLV--SPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVL 116 (754)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l 116 (754)
++.++|.+||+|.+|++|+ |++|.|+|+|+.+|+ + +||++ +++||+||++.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 4679999999999999999 999999999999776 2 57875 899999999977 4568999999999999
Q ss_pred ecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 117 LNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 117 ~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
+|.++.++|+|.+........++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 99999999999987655567889999999999972 59998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-21 Score=171.66 Aligned_cols=110 Identities=25% Similarity=0.423 Sum_probs=96.7
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
.|+|.+||.|.+|++|+ ++|.|.|+|+..|+ + ++|+ .+++||.||++.| +..+.+.|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 48899999999999999 99999999998776 3 6676 5899999999887 34689999999999999999
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCc
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPT 169 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~Pt 169 (754)
+.++|+|.+......+.++|+|+|||||++. .+||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999988665677889999999999863 5999999984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=166.97 Aligned_cols=110 Identities=20% Similarity=0.328 Sum_probs=94.9
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
.|+|.+||+|.+|++|+ +|.|+|+|+.+++ +. +|+ ..++||+||++.| +.++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 58999999999999998 8999999988775 22 355 5899999999988 35689999999999999999
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcc
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTD 170 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtD 170 (754)
+.++|+|++........++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999987555567889999999999952 69999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.5e-20 Score=165.12 Aligned_cols=110 Identities=25% Similarity=0.466 Sum_probs=94.5
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
+|+|.+||.|.+|++| ++|.|+|+|+.+|+ + ++|+. +++||+||++.+ +.++.|.|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 58999999999876 3 35664 799999999864 456899999999999999 8
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCC
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYP 168 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 168 (754)
+.++|+|.+......+.++|+++|||||++. .+.++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-----~~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECC-----CCceEEECCCcc
Confidence 8899999987665667889999999999985 346899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-20 Score=161.20 Aligned_cols=104 Identities=27% Similarity=0.444 Sum_probs=89.8
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
.+||.|||.|.+|+.|+ +|.|.|+|+.+|+ +.+ |+. .++||++|++.+ +..+.|.|+.||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 37899999999999997 7999999998876 333 553 699999999886 45689999999999999999
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
+.++|+|++.+....++|+|+||||||||++ ++|||
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 9999999987655567899999999999974 49998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=154.00 Aligned_cols=105 Identities=20% Similarity=0.323 Sum_probs=88.4
Q ss_pred ccccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEec
Q 004416 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLN 118 (754)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 118 (754)
++.|+|.|||.|.+|+.|+|. .|.|.|...|+ |.+ |+. ++||++|++.. +..+.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 588999999999999999985 58888877665 555 543 58999999863 446899999999999999
Q ss_pred CCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 119 QSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 119 ~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
.++.++|+|++......++|+|+||||||||++ .+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 999999999987554557899999999999974 49987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=178.71 Aligned_cols=138 Identities=15% Similarity=0.172 Sum_probs=107.3
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcce--eeeeeccccch------------------------hhHHHHHHHHHHHHH
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSG------------------------QGLKEFKNEMMLIAK 577 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~--vAVK~l~~~~~------------------------~~~~~~~~Ei~~l~~ 577 (754)
.-|.+.+.||+|+||.||+|+. .+|+. ||||+++.... .....+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999987 67888 99998654311 112367899999999
Q ss_pred ccccce--eeeEeEEEecCcEEEEEEcccC-C----CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHH-hcCCCCce
Q 004416 578 LQHRNL--VRLLGCCIEQGEKILIYEYMVN-K----SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH-QYSRLRII 649 (754)
Q Consensus 578 l~H~nI--v~l~~~~~~~~~~~lV~ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ii 649 (754)
++|+++ +..+.. ...+|||||+.+ | +|...... .++..+..++.|++++|.||| +.+ |+
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 998864 344432 367899999953 4 56555421 224456789999999999999 877 99
Q ss_pred eCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 650 HRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 650 H~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
||||||+|||+++ .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999765
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.75 E-value=6e-18 Score=150.52 Aligned_cols=108 Identities=16% Similarity=0.277 Sum_probs=91.4
Q ss_pred ccccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEec
Q 004416 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLN 118 (754)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 118 (754)
.+.|+|.+||.|.+|+.|.+ |.|.|.|...|+ |.++.. -..++||.+|+..+ +..+.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 36799999999999999985 889999988776 666432 14689999999876 346899999999999999
Q ss_pred CCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 119 QSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 119 ~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
.++.++|+|++......+.|+|+||||||||+. .+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~~--------~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP--------AVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEecC--------CEecC
Confidence 999999999987655567899999999999973 49997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.5e-17 Score=145.42 Aligned_cols=103 Identities=21% Similarity=0.351 Sum_probs=86.9
Q ss_pred ccccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEec
Q 004416 39 LAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLN 118 (754)
Q Consensus 39 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~ 118 (754)
+|.|||.|||.|.+|+.| .+|.|.|.|...|+ |-+ |. .+|.+|+..+ +..+.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~-----~~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YN-----GNWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ET-----TTEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-Ee-----CeEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 47999999988776 333 32 1799999875 447899999999999999
Q ss_pred CCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 119 QSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 119 ~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
.++.++|+|++.+....+.|+|+||||||||+. .+|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~~--------~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP--------SVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEECS--------EEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEec--------CEECC
Confidence 999999999987654567899999999999974 49997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.4e-17 Score=142.85 Aligned_cols=96 Identities=24% Similarity=0.409 Sum_probs=79.9
Q ss_pred CCcCCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccc
Q 004416 98 PIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMK 177 (754)
Q Consensus 98 p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~k 177 (754)
|+.+...+|.|+.||||+|++. ++++|++++.+...++.|+|+++|||||++ + +.++||||+
T Consensus 15 ~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-----~~~~W~S~~----------- 76 (112)
T 1xd5_A 15 SLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-----SRAIWASNT----------- 76 (112)
T ss_dssp EEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-----TEEEEECCC-----------
T ss_pred EEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-----CEEEEECCc-----------
Confidence 4445578899999999999987 789999998765556788999999999998 3 368999993
Q ss_pred cccccccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEec-CCceeeccCCCCC
Q 004416 178 LGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYN-GSAKYTCTGPWNG 233 (754)
Q Consensus 178 l~~~~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~-~~~~yw~sg~w~g 233 (754)
+|++|.|+++++++|. +++|. +..+||++++|+|
T Consensus 77 --------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 --------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp --------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred --------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4567899999999998 45565 5679999999987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-16 Score=141.83 Aligned_cols=90 Identities=27% Similarity=0.348 Sum_probs=75.6
Q ss_pred CCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccccccc
Q 004416 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGW 180 (754)
Q Consensus 101 ~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~ 180 (754)
+...+|.|+.||||||++ .+++||++++.+...++.++|+|+|||||++.+ +.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~--------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK--------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC---------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC---------------
Confidence 446889999999999998 579999999876555678999999999999863 57899998
Q ss_pred ccccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCCC
Q 004416 181 DLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPW 231 (754)
Q Consensus 181 ~~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~w 231 (754)
+++++|.|+++++.+|. ++++++ +||+++++
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35667999999999998 456665 89999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1e-16 Score=172.29 Aligned_cols=147 Identities=14% Similarity=0.126 Sum_probs=105.2
Q ss_pred hhccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccch--------------hhHH--------HHHHHHHHHH
Q 004416 519 SVTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLK--------EFKNEMMLIA 576 (754)
Q Consensus 519 ~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~--------------~~~~--------~~~~Ei~~l~ 576 (754)
.+.....-|++.+.||+|++|.||+|...+|+.||||+++.... .... ...+|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33334445899999999999999999988899999998753210 0001 1245667777
Q ss_pred HccccceeeeEeEEEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCC
Q 004416 577 KLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (754)
Q Consensus 577 ~l~H~nIv~l~~~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~ 656 (754)
++.+.++....-+.. ...+|||||+++.+|..... ......++.||+.+|.+||..+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 776555422211111 23479999999988765431 1123568899999999999988 999999999
Q ss_pred CEEEcCCCC----------eEEEeecCccccCC
Q 004416 657 NILLDQHMN----------PKISDFGMARMFGG 679 (754)
Q Consensus 657 NILl~~~~~----------~kL~DFGla~~~~~ 679 (754)
|||+++++. +.|+||+.+.....
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 999988763 89999999876543
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=135.59 Aligned_cols=87 Identities=25% Similarity=0.310 Sum_probs=73.7
Q ss_pred CceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccccccccc
Q 004416 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (754)
Q Consensus 103 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 182 (754)
...|.|+.||||||++. +++||++++.....++.++|+|+|||||++. .+.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~-----~~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-----ENVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-----TCCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC-----CCcEEEcCC-----------------
Confidence 46799999999999987 8999999987655567899999999999986 357899998
Q ss_pred ccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 183 ~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
++|++|.|+++++++|. ++++. .+||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 45678999999999998 45565 38999886
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-15 Score=133.62 Aligned_cols=103 Identities=17% Similarity=0.252 Sum_probs=83.9
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
+|+|.|||.|.+|+.|. +|.|.|.|...|+ |.+ |. ... ||.+|+..+ +..+.|.|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~--~~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YN--EAG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-EC--SSC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-EC--CCC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 58999999999999994 6889999988776 444 43 234 999999876 34689999999999999998
Q ss_pred CC-eEEEecccC--CccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 121 NG-TIWSSNVSR--EVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 121 ~~-~~wst~~~~--~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
+. ++|+|++.. ....+.++|++|||||||+. .+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~~--------~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP--------AIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEECS--------EEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEecc--------CEEcc
Confidence 76 599999642 23457889999999999973 48997
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.5e-15 Score=133.21 Aligned_cols=91 Identities=29% Similarity=0.402 Sum_probs=76.2
Q ss_pred CceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccccccccc
Q 004416 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (754)
Q Consensus 103 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 182 (754)
...|.|+.||||+|++ .++++|++++.....++.++|+++|||||++.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCC---------------
Confidence 5779999999999998 578999999876555678899999999999863 4689999997
Q ss_pred ccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCCCCCc
Q 004416 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPWNGV 234 (754)
Q Consensus 183 ~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~w~g~ 234 (754)
|++|.|++.++.+|. +++++. +||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999998 456654 89999999754
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.41 E-value=5.3e-13 Score=118.44 Aligned_cols=95 Identities=21% Similarity=0.268 Sum_probs=73.5
Q ss_pred CCCCcCCCceEEEeccCcEEEecC-CCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccc
Q 004416 96 NSPIVDKNGVLTVSNRGNLVLLNQ-SNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQ 174 (754)
Q Consensus 96 ~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLp 174 (754)
+.|+.+...+|.|+.||||||++. .+.++|++++.+...++.++|+++|||||++.+ +.++|||=.
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-----~~~iW~S~t-------- 84 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-----LNTVFVSNT-------- 84 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECSC--------
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-----CCEEEECCC--------
Confidence 345555678899999999999998 489999999876555678899999999999863 467999721
Q ss_pred ccccccccccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 175 GMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 175 g~kl~~~~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
....|.|.+.++.+|...++ . .+.|.+|+
T Consensus 85 -----------------------~~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 85 -----------------------VGQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -----------------------CCSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -----------------------cCCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 01135588999999987654 3 68898875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.5e-12 Score=112.70 Aligned_cols=94 Identities=17% Similarity=0.214 Sum_probs=71.8
Q ss_pred CCcCCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccc
Q 004416 98 PIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMK 177 (754)
Q Consensus 98 p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~k 177 (754)
++.+....|.|+.||||||++.++ +|++++.+....+.++|+++|||||++.+ .+.++|||.-+
T Consensus 16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~----~~~~vW~S~t~---------- 79 (111)
T 3mez_A 16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN----SNTPVWVYPRS---------- 79 (111)
T ss_dssp EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS----CSSCSEEESSS----------
T ss_pred EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC----CCEEEEEeccc----------
Confidence 334456789999999999999877 99999876555678899999999999874 22359998521
Q ss_pred cccccccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 178 LGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 178 l~~~~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
.....|.|.+.++.+|...++ . .++|.++.
T Consensus 80 -------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 -------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp -------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred -------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 111347899999999997654 3 68898764
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=4.2e-12 Score=130.97 Aligned_cols=113 Identities=22% Similarity=0.380 Sum_probs=87.3
Q ss_pred ccccccCCCcc----cCCCCEEEcCCCeEEEeEeCCC--CCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccC
Q 004416 39 LAADTLTPTTL----IRDGETLVSPSQRFELGFFSPG--KSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRG 112 (754)
Q Consensus 39 ~~~~~l~~~~~----l~~~~~l~s~~g~f~lgf~~~~--~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g 112 (754)
-..||+.||+. |..|+.|.|+ ..++.|+|... .....+ ++ ++ ..+++|.+++..+ +. +.|.++.||
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--Ly-~~-~~~~yW~Sgt~~~--~~-~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--AY-GP-NGAATWNAGTQGK--GA-VRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--EE-CT-TSSEEEECCCTTT--TC-CEEEECTTS
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--EE-eC-CCeEEEECCCCCC--cc-EEEEEcCCC
Confidence 46799999999 8899999764 45555555432 222333 33 22 3689999999886 33 789999999
Q ss_pred cEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCC
Q 004416 113 NLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (754)
Q Consensus 113 ~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 167 (754)
+|+++|.++.++|++++.+. ....|+|++|||||||+. +++||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 99999998899999998754 357889999999999973 469999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-11 Score=125.70 Aligned_cols=143 Identities=17% Similarity=0.101 Sum_probs=112.5
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
+.|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. |..+.++++++...+..++||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 56888889999999999999753 6889999986532222346889999999995 677889999998888999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS--------------------------------------- 644 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------- 644 (754)
++.+|...+.. ......++.++++++..||+..
T Consensus 93 ~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 93 DGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred CCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 99998775311 1123467889999999999811
Q ss_pred -----------------CCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 645 -----------------RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 645 -----------------~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765567999998753
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.23 E-value=2.1e-11 Score=107.47 Aligned_cols=87 Identities=23% Similarity=0.299 Sum_probs=67.1
Q ss_pred CCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccccccc
Q 004416 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWD 181 (754)
Q Consensus 102 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~ 181 (754)
....|.|+.||||||++. .++|++++.+....+.++|+++|||||++.+ +.++|||-.+
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-----~~~iW~S~t~-------------- 82 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-----FKTIWSSRSS-------------- 82 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-----CCEEEECCCC--------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-----CCEEEEcCCc--------------
Confidence 357899999999999987 5999999876555678899999999999863 4689998321
Q ss_pred cccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 182 LRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 182 ~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
...|.|.+.++.+|...++ . .+.|.+|.
T Consensus 83 -----------------~~~~~~~~~L~~dGNlvly--~--~~~W~t~~ 110 (110)
T 3r0e_B 83 -----------------SKQGEYVLILQDDGFGVIY--G--PAIFETSS 110 (110)
T ss_dssp -----------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -----------------CCCCCEEEEEcCCccEEEe--c--CCEecCCC
Confidence 0234588999999987654 4 47888763
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=106.84 Aligned_cols=91 Identities=25% Similarity=0.376 Sum_probs=70.0
Q ss_pred CCCcCCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccc
Q 004416 97 SPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGM 176 (754)
Q Consensus 97 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~ 176 (754)
.|+.+....|.|+.||||||+++ +|+|++.+...+..++|+++|||||++.+ +.++|+|- |
T Consensus 16 ~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-----~~~vWss~-----t----- 76 (109)
T 3r0e_A 16 GHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-----GSTVWKSG-----A----- 76 (109)
T ss_dssp CEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-----SCEEEECC-----C-----
T ss_pred CEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-----CCEEEcCC-----C-----
Confidence 34445578899999999999985 79999886655678899999999999863 46788751 1
Q ss_pred ccccccccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCCC
Q 004416 177 KLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPW 231 (754)
Q Consensus 177 kl~~~~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~w 231 (754)
....+.|.+.++.+|...++ . .+.|.+++|
T Consensus 77 ---------------------~~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 77 ---------------------QSVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp ---------------------CCSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred ---------------------cCCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 11235688999999986654 3 689999887
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.6e-11 Score=105.27 Aligned_cols=88 Identities=22% Similarity=0.291 Sum_probs=67.7
Q ss_pred CCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccccccc
Q 004416 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWD 181 (754)
Q Consensus 102 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~ 181 (754)
....|.|+.||||||++. +.++|++++.+...++.++|+++|||||++.+ +.++|||...
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-----~~~~W~S~t~-------------- 78 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-----NNPIWASNTG-------------- 78 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-----SCEEEECCCC--------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-----CCEEEECCCC--------------
Confidence 357799999999999988 68999999876555678899999999999863 4689997321
Q ss_pred cccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 182 LRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 182 ~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
...+.|.+.++.+|...++ .. +.|.+|.
T Consensus 79 -----------------~~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 79 -----------------GENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp -----------------CSSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred -----------------CCCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 1225688999999987654 32 6787664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=1.7e-10 Score=118.25 Aligned_cols=138 Identities=17% Similarity=0.159 Sum_probs=101.8
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~ey 602 (754)
..+.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455554444456669999998777888999987543 2245788999999997555 55688888777789999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS-------------------------------------- 644 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------- 644 (754)
+++.++. ... .+ ...++.++++.+..||...
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998874 211 11 1256777888888888643
Q ss_pred -----------------CCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 645 -----------------RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 645 -----------------~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876667999999854
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.96 E-value=2.1e-09 Score=93.72 Aligned_cols=78 Identities=26% Similarity=0.341 Sum_probs=59.9
Q ss_pred CceEEEeccCcEEEecCCCCeEEEecccCCc-cCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccccccc
Q 004416 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWD 181 (754)
Q Consensus 103 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~ 181 (754)
.-+|.|+.||||||++. +++||++++.... ..+.+.|+++|||||+|.+ ++++|+|
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-----~~~vWss----------------- 76 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-----GRSLWAS----------------- 76 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-----CCEEEEC-----------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCC-----cEEEEEe-----------------
Confidence 35689999999999985 5899999987543 3567899999999999874 4678886
Q ss_pred cccCCcceEEeecCCCCCCCcceEEeeecCCCCeEE
Q 004416 182 LRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVC 217 (754)
Q Consensus 182 ~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~ 217 (754)
.+....+.+.+.++.+|...++
T Consensus 77 --------------~t~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 77 --------------HSTRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp --------------CCCCCSSCEEEEECTTSCEEEE
T ss_pred --------------cCCCCCCCEEEEEeCCCeEEEE
Confidence 1122346688999999987643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.2e-09 Score=112.91 Aligned_cols=142 Identities=15% Similarity=0.235 Sum_probs=106.0
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeecc--ccc-hhhHHHHHHHHHHHHHcc--ccceeeeEeEEEec---CcEEEEE
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQ---GEKILIY 600 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~ 600 (754)
..+.|+.|.++.||+.+.. +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4578999999999999875 4678888875 322 122356788999999997 45578888887765 3489999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS------------------------------------ 644 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------ 644 (754)
||+++..+.... ...++...+..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998764321 123567788889999999999999731
Q ss_pred -------------------CCCceeCCCCCCCEEEcCCCC--eEEEeecCccc
Q 004416 645 -------------------RLRIIHRDLKASNILLDQHMN--PKISDFGMARM 676 (754)
Q Consensus 645 -------------------~~~iiH~DIkp~NILl~~~~~--~kL~DFGla~~ 676 (754)
...++|+|++|.|||+++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997754 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=2.9e-09 Score=112.09 Aligned_cols=186 Identities=18% Similarity=0.201 Sum_probs=120.7
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccc--eeeeEeEEEecC---cEEEEEEccc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN--LVRLLGCCIEQG---EKILIYEYMV 604 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~ey~~ 604 (754)
+.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +.. +.+.+....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 468999999999874 56889986432 34567899999999984 433 344544433222 3478999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS---------------------------------------- 644 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------- 644 (754)
+..+..... ..++..++..++.++++.+..||...
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988764321 23566677788888888888888611
Q ss_pred ---------------CCCceeCCCCCCCEEEcC--CCCeEEEeecCccccCCCcccCCcc------------cccccCcc
Q 004416 645 ---------------RLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGDELQGNTK------------RIVGTYGY 695 (754)
Q Consensus 645 ---------------~~~iiH~DIkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~------------~~~gt~~y 695 (754)
...++|+|++|.||++++ ...+.|+||+.+..-.+...-.... .+....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 134799999999999998 4567899999987532211000000 00000011
Q ss_pred cC-ccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 696 MS-PEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 696 ~a-PE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
.. |+.... .....+.|+++.++|.+.+|+.++
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 221110 112368999999999999998775
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=5.6e-07 Score=90.75 Aligned_cols=105 Identities=21% Similarity=0.331 Sum_probs=76.2
Q ss_pred cccccCCCc-------ccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccC
Q 004416 40 AADTLTPTT-------LIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRG 112 (754)
Q Consensus 40 ~~~~l~~~~-------~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g 112 (754)
..|+|.+|| .|..++.+. +|.|.|.|.+.|+ +-+|. ...++|.++.... ...+.++|+.+|
T Consensus 124 g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~---~~~~~W~s~~~~~--~~~~~~~L~~~G 191 (236)
T 1dlp_A 124 GNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAGK--GTGCRAVLQPNG 191 (236)
T ss_dssp CCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCSS--CSSCEEEEETTT
T ss_pred cceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEc---CCEeEEeCCCcCC--CCceEEEECCCC
Confidence 457788888 555555444 6889999876552 44543 2368898887543 235789999999
Q ss_pred cEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccc
Q 004416 113 NLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 113 ~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
+|++++.++.++|.+.+........++|.++|||+++.. .+|+|
T Consensus 192 nl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~~--------~~W~s 235 (236)
T 1dlp_A 192 RMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 235 (236)
T ss_dssp EEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred cEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeCC--------CCccC
Confidence 999999888899998876444456789999999999953 48886
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=6.3e-06 Score=86.55 Aligned_cols=136 Identities=22% Similarity=0.209 Sum_probs=94.6
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccc---ceeeeEeEEE-ecCcEEEEEEcccC
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCI-EQGEKILIYEYMVN 605 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~ey~~~ 605 (754)
.+.++.|....||+. +..+++|+.. .......+.+|+.+|+.+.+. .+.+.+.+.. ..+..++|||++++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888988999987 5778898853 233456789999999999753 3566666664 34467899999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY------------------------------------------ 643 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------------------------------------------ 643 (754)
..+...... .++......++.++++.|..||..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 887653211 123444445555555555555532
Q ss_pred ---------------CCCCceeCCCCCCCEEEcC---CCCe-EEEeecCccc
Q 004416 644 ---------------SRLRIIHRDLKASNILLDQ---HMNP-KISDFGMARM 676 (754)
Q Consensus 644 ---------------~~~~iiH~DIkp~NILl~~---~~~~-kL~DFGla~~ 676 (754)
....++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234699999999999997 4554 8999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=6e-06 Score=84.80 Aligned_cols=135 Identities=19% Similarity=0.152 Sum_probs=94.8
Q ss_pred eeceeccE-EEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 532 KLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 532 ~LG~G~fg-~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44455554 68987654 4567899986432 3456788999999884 44577889999888999999999999887
Q ss_pred hhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 004416 609 DVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS-------------------------------------------- 644 (754)
Q Consensus 609 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------------- 644 (754)
...... .......+..++++.|..||...
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654411 11122345555666666666321
Q ss_pred -----------CCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 645 -----------RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 645 -----------~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12369999999999999877777999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=4.4e-06 Score=89.67 Aligned_cols=81 Identities=9% Similarity=0.027 Sum_probs=56.7
Q ss_pred eeeee-ceeccEEEEeeeec-------Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccc---cceeeeEeEEEec-
Q 004416 529 IQSKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQH---RNLVRLLGCCIEQ- 593 (754)
Q Consensus 529 i~~~L-G~G~fg~Vy~~~~~-------~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H---~nIv~l~~~~~~~- 593 (754)
..+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34678 88889999998764 26788899865432 1012456789999998853 3567788776554
Q ss_pred --CcEEEEEEcccCCCHh
Q 004416 594 --GEKILIYEYMVNKSLD 609 (754)
Q Consensus 594 --~~~~lV~ey~~~gsL~ 609 (754)
+..++||||+++..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=3.3e-05 Score=81.99 Aligned_cols=142 Identities=15% Similarity=0.163 Sum_probs=81.9
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccc--ceeeeEe------EEEecCcEEEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLG------CCIEQGEKILIYE 601 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~------~~~~~~~~~lV~e 601 (754)
.+.|+.|....||+....++ .+++|+.... ..++..|+.+++.+... .+.+++. +....+..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 35676677889999987554 5889988652 23344566666666422 2334443 1234567899999
Q ss_pred cccCCCHh-----h---------HhcC----CC-C------cccccHHH-------------------------------
Q 004416 602 YMVNKSLD-----V---------FLFD----PT-K------KHLLGWQL------------------------------- 625 (754)
Q Consensus 602 y~~~gsL~-----~---------~l~~----~~-~------~~~l~~~~------------------------------- 625 (754)
|+++..+. . .++. .. . .....|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 0 0110 00 0 00111211
Q ss_pred HHHHHHHHHHHHHHHHh----------cCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 626 RVRIIDGIAQGLLYLHQ----------YSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 626 ~~~i~~qia~~L~yLH~----------~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
...+..++.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01112224445666663 1235699999999999998888999999998854
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=8.7e-05 Score=80.75 Aligned_cols=75 Identities=9% Similarity=0.148 Sum_probs=50.5
Q ss_pred eeeeceeccEEEEeeeec-Ccceeeeeeccccch-------hhHHHHHHHHHHHHHccc--cc-eeeeEeEEEecCcEEE
Q 004416 530 QSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------QGLKEFKNEMMLIAKLQH--RN-LVRLLGCCIEQGEKIL 598 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-Iv~l~~~~~~~~~~~l 598 (754)
.+.||.|..+.||+++.. +++.++||....... ...+++..|.++++.+.+ +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 467899997643211 123456789999988853 33 4455543 4556789
Q ss_pred EEEcccCC
Q 004416 599 IYEYMVNK 606 (754)
Q Consensus 599 V~ey~~~g 606 (754)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00011 Score=76.11 Aligned_cols=80 Identities=16% Similarity=0.228 Sum_probs=60.0
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccc---ceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~~~~~~~~~~~lV~e 601 (754)
....-.+.+|.|..+.||+.+..+|+.|++|+...........|..|+..|+.+... .+.+.++. +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 345567899999999999999999999999987655444445788999999998532 34555543 23478999
Q ss_pred cccCCCH
Q 004416 602 YMVNKSL 608 (754)
Q Consensus 602 y~~~gsL 608 (754)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00022 Score=74.76 Aligned_cols=139 Identities=19% Similarity=0.104 Sum_probs=92.4
Q ss_pred eeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccc---cceeeeEeEEEecCcEEEEEEcccC
Q 004416 529 IQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
-.+.|+.|....+|+... ++..+++|+.... ....+..|+..|+.+.. ..+.+.+.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346899999999999976 4678889986532 35678899999998853 5688888888877889999999998
Q ss_pred CCHhh-----------HhcCCCC-c------------------ccccHHHHH---HHHH----------------HHH-H
Q 004416 606 KSLDV-----------FLFDPTK-K------------------HLLGWQLRV---RIID----------------GIA-Q 635 (754)
Q Consensus 606 gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------qia-~ 635 (754)
..+.. .++.... . -.-+|.... ++.. ++. .
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76421 1121111 0 011343321 1111 111 1
Q ss_pred HHHHHHh-cCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 636 GLLYLHQ-YSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 636 ~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
....|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1223321 2346799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00076 Score=73.90 Aligned_cols=80 Identities=9% Similarity=0.014 Sum_probs=47.7
Q ss_pred CCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCC---CCCchhhHHHHHHHHHH
Q 004416 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG---VFSVKSDVFSFGVLMLE 721 (754)
Q Consensus 645 ~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwSlGvll~e 721 (754)
...++|+|++|.|||+++++ ++|+||+.+..-.+ ......--..-...|.+|+..... .-..+.++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p-~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPM-GFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECH-HHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCch-HHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 35699999999999999876 99999998865221 100000000001245666544311 11234566677888888
Q ss_pred HHcCC
Q 004416 722 ILSSK 726 (754)
Q Consensus 722 lltg~ 726 (754)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0014 Score=68.22 Aligned_cols=71 Identities=8% Similarity=0.153 Sum_probs=46.2
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccccee-eeEeEEEecCcEEEEEEcc-cCCC
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYEYM-VNKS 607 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ey~-~~gs 607 (754)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+...++. ++++. ..+.-++|+||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 678888875432211 1225688888888644443 55543 344567899999 6544
Q ss_pred H
Q 004416 608 L 608 (754)
Q Consensus 608 L 608 (754)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0013 Score=68.90 Aligned_cols=144 Identities=15% Similarity=0.124 Sum_probs=81.7
Q ss_pred eeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEeE------EEecCcEEEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CIEQGEKILIYE 601 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~------~~~~~~~~lV~e 601 (754)
.+.|+.|....+|+....++ .+++|+..... ..+.+..|+.++..+...+ +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 46778888899999987555 68899876521 1234567888888875333 2333321 123456789999
Q ss_pred cccCCCHhh--------------Hhc----CCCCc-----ccccHHHHHH------------HHHHHHHHHHHHHhc---
Q 004416 602 YMVNKSLDV--------------FLF----DPTKK-----HLLGWQLRVR------------IIDGIAQGLLYLHQY--- 643 (754)
Q Consensus 602 y~~~gsL~~--------------~l~----~~~~~-----~~l~~~~~~~------------i~~qia~~L~yLH~~--- 643 (754)
|+++..+.. .++ ..... ....|..... +...+.+.++.++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998865321 011 00000 0111222110 011244455566532
Q ss_pred -CCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 644 -SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 644 -~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 124589999999999999876568999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0015 Score=71.69 Aligned_cols=73 Identities=22% Similarity=0.292 Sum_probs=49.9
Q ss_pred eeeeceeccEEEEeeeecC--------cceeeeeeccccchhhHHHHHHHHHHHHHccccce-eeeEeEEEecCcEEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIY 600 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~--------~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 600 (754)
.+.|+.|-...+|++...+ ++.+++|+..... ..+.+.+|..+++.+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 4678888899999998653 4678899874321 12455679999998865554 55666543 2 3899
Q ss_pred EcccCCCH
Q 004416 601 EYMVNKSL 608 (754)
Q Consensus 601 ey~~~gsL 608 (754)
||+++..+
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0047 Score=64.80 Aligned_cols=142 Identities=14% Similarity=0.162 Sum_probs=82.9
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc--eeeeEeE-----EEecCcEEEEEEcc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC-----CIEQGEKILIYEYM 603 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~~~-----~~~~~~~~lV~ey~ 603 (754)
+.|+ |....||+....+|+.+++|+..... ...+.+..|..++..+.... +++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999887677789999986331 13456677888888885333 3444432 12345668899999
Q ss_pred cCCCHh-----hH---------hc----CC--CCcccccHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 004416 604 VNKSLD-----VF---------LF----DP--TKKHLLGWQLR----VRI---------------IDGIAQGLLYLHQY- 643 (754)
Q Consensus 604 ~~gsL~-----~~---------l~----~~--~~~~~l~~~~~----~~i---------------~~qia~~L~yLH~~- 643 (754)
++..+. .. ++ .. ......++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 00 11 00 01111222111 001 11112223333321
Q ss_pred ---CCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 644 ---SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 644 ---~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.005 Score=64.89 Aligned_cols=141 Identities=14% Similarity=0.124 Sum_probs=71.8
Q ss_pred eeeceeccEE-EEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccc--ceeeeEeEEEecCcEEEEEEcccCCC
Q 004416 531 SKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCCIEQGEKILIYEYMVNKS 607 (754)
Q Consensus 531 ~~LG~G~fg~-Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~~~~lV~ey~~~gs 607 (754)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+... .+.+++.+.. ..-+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4565555444 5666553366777776543221 2345677777777533 3556666532 22378999997765
Q ss_pred HhhHhc---------------------CCCC--cccccHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 004416 608 LDVFLF---------------------DPTK--KHLLGWQLRV-------R-------------IIDGIAQGLLYLHQ-- 642 (754)
Q Consensus 608 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~qia~~L~yLH~-- 642 (754)
+...+. .... ....+..... . ....+.+.++.+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543221 1000 0011111000 0 00111222222211
Q ss_pred -cCCCCceeCCCCCCCEEEcCC----CCeEEEeecCccc
Q 004416 643 -YSRLRIIHRDLKASNILLDQH----MNPKISDFGMARM 676 (754)
Q Consensus 643 -~~~~~iiH~DIkp~NILl~~~----~~~kL~DFGla~~ 676 (754)
.....++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123469999999999999875 6789999998865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0043 Score=66.50 Aligned_cols=74 Identities=14% Similarity=0.161 Sum_probs=45.3
Q ss_pred eeeeceeccEEEEeeeecCc---------ceeeeeeccccchhhHHHHHHHHHHHHHccccce-eeeEeEEEecCcEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLNG---------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILI 599 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~---------~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV 599 (754)
.+.|+.|....+|+....++ +.+++|+....... ......|..+++.+...++ .++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 35778888889999876542 67888887543221 1123678888888864454 4666543 2 3689
Q ss_pred EEcccCCCH
Q 004416 600 YEYMVNKSL 608 (754)
Q Consensus 600 ~ey~~~gsL 608 (754)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0087 Score=66.01 Aligned_cols=74 Identities=12% Similarity=0.103 Sum_probs=48.3
Q ss_pred eeeeceeccEEEEeeeecC-cceeeeeeccccchhhHHHHHHHHHHHHHccccce-eeeEeEEEecCcEEEEEEcccCCC
Q 004416 530 QSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYEYMVNKS 607 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ey~~~gs 607 (754)
.+.|+.|-...+|+....+ +..+++|+.......... -.+|..++..+...++ .++++.+ .+ .+|+||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 3678888889999998754 477889887443222111 1579999999975555 4666665 22 35999998754
Q ss_pred H
Q 004416 608 L 608 (754)
Q Consensus 608 L 608 (754)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0078 Score=64.63 Aligned_cols=141 Identities=20% Similarity=0.216 Sum_probs=82.1
Q ss_pred eeeceeccEEEEeeeec--------CcceeeeeeccccchhhHHHHHHHHHHHHHccccce-eeeEeEEEecCcEEEEEE
Q 004416 531 SKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~--------~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~e 601 (754)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.+...++ .++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777777888988764 2467889886332 2234556789999998854343 456655432 29999
Q ss_pred cccCCCHhhH-----------------hcCCC--Ccccc--cHHHHHHHHHHHHH-------------------HHHHHH
Q 004416 602 YMVNKSLDVF-----------------LFDPT--KKHLL--GWQLRVRIIDGIAQ-------------------GLLYLH 641 (754)
Q Consensus 602 y~~~gsL~~~-----------------l~~~~--~~~~l--~~~~~~~i~~qia~-------------------~L~yLH 641 (754)
|+++..+..- |+... ..+.. -+.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9988655311 11110 11111 23444445443321 233332
Q ss_pred ----hc-CCCCceeCCCCCCCEEEcCC----CCeEEEeecCccc
Q 004416 642 ----QY-SRLRIIHRDLKASNILLDQH----MNPKISDFGMARM 676 (754)
Q Consensus 642 ----~~-~~~~iiH~DIkp~NILl~~~----~~~kL~DFGla~~ 676 (754)
.. ....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23458999999999999876 7899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.018 Score=60.78 Aligned_cols=68 Identities=12% Similarity=0.090 Sum_probs=43.8
Q ss_pred ceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccc---eeeeEeE------EEecCcEEEEEEccc
Q 004416 534 GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN---LVRLLGC------CIEQGEKILIYEYMV 604 (754)
Q Consensus 534 G~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~n---Iv~l~~~------~~~~~~~~lV~ey~~ 604 (754)
|.|....||+....++ .+++|+...... ..|+..+..+.... +++.+.. ....+..++||+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3344678999987666 899998755331 35666776664222 4444432 233567789999999
Q ss_pred CCCH
Q 004416 605 NKSL 608 (754)
Q Consensus 605 ~gsL 608 (754)
+..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8755
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.77 E-value=0.1 Score=56.73 Aligned_cols=74 Identities=14% Similarity=0.174 Sum_probs=48.5
Q ss_pred eeeeceeccEEEEeeeecC--------cceeeeeeccccchhhHHHHHHHHHHHHHccccce-eeeEeEEEecCcEEEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCIEQGEKILIY 600 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~--------~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 600 (754)
.+.|..|-...+|+....+ ++.+++|+......... .-.+|..+++.+...++ .++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3677778888899987653 57788988654332222 22578888888864444 4455432 2 37899
Q ss_pred EcccCCCH
Q 004416 601 EYMVNKSL 608 (754)
Q Consensus 601 ey~~~gsL 608 (754)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998654
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=92.94 E-value=8.3 Score=38.62 Aligned_cols=66 Identities=15% Similarity=0.297 Sum_probs=41.7
Q ss_pred CCeeEEeccCCCC--C----cCCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecC
Q 004416 86 PDTVVWVANRNSP--I----VDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDN 151 (754)
Q Consensus 86 ~~~~vW~an~~~p--~----~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~ 151 (754)
..+++|...+..+ + ..+.+.+-++.++.+..+|++|..+|............+..+.+||+++-+.
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 5688898877542 1 1123444445556667778889999998864222223456778888887654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=91.43 E-value=0.68 Score=44.93 Aligned_cols=114 Identities=12% Similarity=0.060 Sum_probs=70.4
Q ss_pred CHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCc
Q 004416 607 SLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686 (754)
Q Consensus 607 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 686 (754)
+|.++|. ..+.++++++++-++.|.+.+|.-+-... . -..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 6777773 35678999999999999999887762211 1 11233456899999999998764 1110
Q ss_pred ccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCccchhhhHH
Q 004416 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHVS 744 (754)
Q Consensus 687 ~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 744 (754)
.....+.|||... ...+.+.=|||||++||.-+- |+...+++..+-..+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD----ygL~e~eE~eLS~~LE 147 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD----YGLKENEERELSPPLE 147 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT----TTCCTTEEECCCHHHH
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh----cCCCcccchhhCHHHH
Confidence 1122466888653 455788999999999999865 4444445555544433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.95 E-value=0.29 Score=52.75 Aligned_cols=29 Identities=28% Similarity=0.442 Sum_probs=24.9
Q ss_pred ceeCCCCCCCEEE------cCCCCeEEEeecCccc
Q 004416 648 IIHRDLKASNILL------DQHMNPKISDFGMARM 676 (754)
Q Consensus 648 iiH~DIkp~NILl------~~~~~~kL~DFGla~~ 676 (754)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=86.32 E-value=3.9 Score=41.17 Aligned_cols=66 Identities=21% Similarity=0.172 Sum_probs=40.6
Q ss_pred CCeeEEeccCCC-CC---cCCCc-eEEEecc-CcEEEecCC-CCeEEEecccCCc-----cCceEEEecCCCEEEecC
Q 004416 86 PDTVVWVANRNS-PI---VDKNG-VLTVSNR-GNLVLLNQS-NGTIWSSNVSREV-----KNPVAQLLDNGNLVIRDN 151 (754)
Q Consensus 86 ~~~~vW~an~~~-p~---~~~~~-~l~~~~~-g~l~l~~~~-~~~~wst~~~~~~-----~~~~a~l~d~GNlvl~~~ 151 (754)
...++|...+.. |. ....+ .+....+ +.++..|++ |.++|........ ...-+.++.+||+++.+.
T Consensus 154 ~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~~ 231 (276)
T 3no2_A 154 NGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICNW 231 (276)
T ss_dssp TSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEEE
T ss_pred CCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEec
Confidence 368899888753 31 11223 3333333 347777887 9999998743211 123357789999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 754 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-54 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-22 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 1e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 4e-14 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-09 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-62
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQH 580
++F S+LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+V G GE + E+M SLD L K + Q+ ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+ +I+HRD+K SNIL++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
+SV+SD++S G+ ++E+ +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 1e-61
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 9/206 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ ++G G FG VYKG+ V + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+G + ++ ++ SL L K + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA-- 122
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL-- 702
IIHRDLK++NI L + + KI DFG+A + +++ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 703 -EGVFSVKSDVFSFGVLMLEILSSKK 727
+ +S +SDV++FG+++ E+++ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-59
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C+EQ L++E+M + L +L ++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+IHRDL A N L+ ++ K+SDFGM R D+ ++ + SPE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 705 VFSVKSDVFSFGVLMLEILSSKK 727
+S KSDV+SFGVLM E+ S K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 7e-59
Identities = 69/203 (33%), Positives = 105/203 (51%), Gaps = 7/203 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
RL + +I EYM N SL FL P+ L + + IA+G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
IHRDL+A+NIL+ ++ KI+DFG+AR+ +E + +PE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 705 VFSVKSDVFSFGVLMLEILSSKK 727
F++KSDV+SFG+L+ EI++ +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-57
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 7/203 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L G C +Q +I EYM N L +L + +H Q + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+ +HRDL A N L++ K+SDFG++R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 705 VFSVKSDVFSFGVLMLEILSSKK 727
FS KSD+++FGVLM EI S K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 585 RLLGCCIEQGEKI-LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+LLG +E+ + ++ EYM SL +L + +LG ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+HRDL A N+L+ + K+SDFG+ + E + +PE E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 704 GVFSVKSDVFSFGVLMLEILSSKK 727
FS KSDV+SFG+L+ EI S +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-56
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 7/203 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 585 RLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS 644
+L + ++ EYM SL FL T K+L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 645 RLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEG 704
+HRDL+A+NIL+ +++ K++DFG+AR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 705 VFSVKSDVFSFGVLMLEILSSKK 727
F++KSDV+SFG+L+ E+ + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR 212
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-56
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 582
+ + I +LG+G FG VYK + A K + +S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+LL + ++ E+ ++D + + + L + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+IIHRDLKA NIL + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 703 -----EGVFSVKSDVFSFGVLMLEILSSK 726
+ + K+DV+S G+ ++E+ +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (486), Expect = 1e-55
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 579
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H N ++ GC + + L+ EY + + D+ K L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH +IHRD+KA NILL + K+ DFG A + VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 700 YAL---EGVFSVKSDVFSFGVLMLEILSSK 726
L EG + K DV+S G+ +E+ K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-55
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 582
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+ G E + L EY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
+ I HRD+K N+LLD+ N KISDFG+A +F + + ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 703 EGVF-SVKSDVFSFGVLMLEILSSK 726
F + DV+S G+++ +L+ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-55
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 10/206 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
E++ + +G G +G K R +G+ + K L + + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 582 NLVRLLGCCIEQGEKIL--IYEYMVNKSLDVFLFDPTKKH-LLGWQLRVRIIDGIAQGLL 638
N+VR I++ L + EY L + TK+ L + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 639 YLHQYSR--LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
H+ S ++HRDLK +N+ LD N K+ DFG+AR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEI 722
SPE ++ KSD++S G L+ E+
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYEL 207
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-54
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 516 SFASVTAATENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMML 574
S SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 575 IAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIA 634
+ + ++ N+V L + E ++ EY+ S L D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 635 QGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYG 694
Q L +LH ++IHRD+K+ NILL + K++DFG + Q +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+M+PE + K D++S G++ +E++ +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 2e-54
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 22/230 (9%)
Query: 515 FSFASVTAATENFS---------IQSKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 560
F+F A F+ I+ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 561 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL 620
+ + ++F +E ++ + H N++ L G + ++I E+M N SLD FL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 621 LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 681 ELQGNTKRIVG---TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+G + +PE F+ SDV+S+G++M E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (474), Expect = 3e-54
Identities = 61/204 (29%), Positives = 108/204 (52%), Gaps = 7/204 (3%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ +++ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V+LLG C + +I E+M +L +L + ++ + + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE 703
+ IHRDL A N L+ ++ K++DFG++R+ GD + + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 704 GVFSVKSDVFSFGVLMLEILSSKK 727
FS+KSDV++FGVL+ EI +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 7e-54
Identities = 55/236 (23%), Positives = 104/236 (44%), Gaps = 23/236 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+Q +G+G FG V++G+ G+EVAVK S++ + + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 585 RLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
+ + L+ +Y + SL +L ++ + + +++ A GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 641 HQ-----YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF--GGDELQGNTKRIVGTY 693
H + I HRDLK+ NIL+ ++ I+D G+A D + VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 694 GYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLGHV 743
YM+PE + + ++D+++ G++ EI G++ V
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 5e-53
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 14/206 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQH 580
E+F I LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++RL G + LI EY ++ L +K Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
+ K D++S GVL E L K
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 6e-53
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 12/211 (5%)
Query: 523 ATENFSIQS-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
+N I +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L + +VRL+G C + +L+ E L FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR-IVGTYGYM 696
YL + +HRDL A N+LL KISDFG+++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+PE FS +SDV+S+GV M E LS +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 7e-53
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNL 583
++G G F VYKG EVA L ++ + + FK E ++ LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 584 VRLLGCCIEQGEK----ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
VR + +L+ E M + +L +L + ++ ++ I +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 640 LHQYSRLRIIHRDLKASNILL-DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
LH + IIHRDLK NI + + KI D G+A + K ++GT +M+P
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 182
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSKK 727
E E + DV++FG+ MLE+ +S+
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 2e-52
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 31/231 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-KEFKNEMMLIAK 577
N +GEG FG V++ R VAVK L ++ + +F+ E L+A+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL----------------- 620
+ N+V+LLG C L++EYM L+ FL + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 621 ----LGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
L ++ I +A G+ YL + + +HRDL N L+ ++M KI+DFG++R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+ +M PE ++ +SDV+++GV++ EI S
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 31/231 (13%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKK------------------ 618
L H N+V LLG C G LI+EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 619 --HLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676
++L ++ + +A+G+ +L +HRDL A N+L+ KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
D +M+PE EG++++KSDV+S+G+L+ EI S
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 3e-51
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LKEFKNEMMLIAKL 578
+ +++ K LG G FG V KG + VAVK L N++ E E ++ +L
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 65
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ +VR++G C E +L+ E L+ +L + + + + ++ ++ G+
Sbjct: 66 DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMK 121
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTK-RIVGTYGYMS 697
YL + +HRDL A N+LL KISDFG+++ DE + + +
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
PE FS KSDV+SFGVLM E S +
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 8e-51
Identities = 61/246 (24%), Positives = 93/246 (37%), Gaps = 26/246 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 577
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 578 L-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL---------------L 621
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ + +A+G+ +L IHRDL A NILL KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDSFNLLG 741
+M+PE V++ +SDV+S+G+ + E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 742 HVSDKL 747
+ +
Sbjct: 260 MIKEGF 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLKEFKNEMMLIAKL 578
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
+ ++ RLLG C+ LI + M L + K +G Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
YL R++HRDL A N+L+ + KI+DFG+A++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSKK 727
E L +++ +SDV+S+GV + E+++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
V+L + + Y N L ++ A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYT---AEIVSAL 121
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
IIHRDLK NILL++ M+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
E SD+++ G ++ ++++
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 532 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 586
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 587 LGCCIE-QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
LG C+ +G +++ YM + L F+ + T + + + + +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLAS 148
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVGTYGYMSPEYALE 703
+ +HRDL A N +LD+ K++DFG+AR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 704 GVFSVKSDVFSFGVLMLEILSSKK 727
F+ KSDV+SFGVL+ E+++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (444), Expect = 2e-49
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 11/205 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+++ I +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
V L + E ++IYE+M L + D + + + V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
+H DLK NI+ + K+ DFG+ + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSK 726
+D++S GVL +LS
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-49
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK 577
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
L HRNL+RL G + ++ E SL L LLG R +A+G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGT--LSRYAVQVAEGM 124
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG-NTKRIVGTYGYM 696
YL R IHRDL A N+LL KI DFG+ R ++ + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 697 SPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+PE FS SD + FGV + E+ + +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-49
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-Q 579
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFL-------------FDPTKKHLLGWQLR 626
H N++ LLG C +G L EY + +L FL + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 627 VRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT 686
+ +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFG++R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 687 KRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+M+ E V++ SDV+S+GVL+ EI+S
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 12/210 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LKEFKNEMMLIAKL 578
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 579 QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
H N++RL G + ++I EYM N +LD FL + K V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 639 YLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMS 697
YL + +HRDL A NIL++ ++ K+SDFG++R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
PE F+ SDV+SFG++M E+++ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-48
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 579
E + +GEG FG V++G ++ VA+K N + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H ++V+L+G E +I E L F +K+ L + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
L R +HRD+ A N+L+ + K+ DFG++R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSKK 727
F+ SDV+ FGV M EIL
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (435), Expect = 4e-48
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 11/205 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
+ + I +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ L ++ E +LI E++ L + + + + + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I+H D+K NI+ + KI DFG+A DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSK 726
+D+++ GVL +LS
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 7/207 (3%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
++ S +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N++ + + + Y+V + L+ K L + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNT-KRIVGTYGYMSPEY 700
++HRDLK SN+LL+ + KI DFG+AR+ D V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 701 ALEGVFSVKS-DVFSFGVLMLEILSSK 726
L KS D++S G ++ E+LS++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-45
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 17/217 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 577
E ++ +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------LGWQLRVRII 630
++VRLLG + ++I E M L +L +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 631 DGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIV 690
IA G+ YL+ + +HRDL A N ++ + KI DFGM R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 691 GTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
+MSPE +GVF+ SDV+SFGV++ EI + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-45
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 26/226 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 575
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 576 AKL-QHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHL-------------L 621
+ +H+N++ LLG C + G +I EY +L +L L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 622 GWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681
+ V +A+G+ YL + IHRDL A N+L+ + KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK 727
T +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (409), Expect = 5e-45
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
++F I LG G FG V+ R NG+ A+K L + + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++R+ G + + +I +Y+ L L + + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
II+RDLK NILLD++ + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSKK 727
++ D +SFG+L+ E+L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (404), Expect = 9e-45
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQ 579
++ + + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 580 HRNLVRLLGCCIEQGEKI----LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
H +V + + ++ EY+ +L + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG-GDELQGNTKRIVGTYG 694
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y+SPE A +SDV+S G ++ E+L+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 576
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 577 KLQHRNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLF-------------DPTKKHLLG 622
H N+V LLG C + G +++ E+ +L +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 623 WQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682
+ + +A+G+ +L + IHRDL A NILL + KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS 724
+M+PE + V++++SDV+SFGVL+ EI S
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 1e-44
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNE---MMLIAK 577
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+V + + I + M L L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
++H +++RDLK +NILLD+H + +ISD G+A F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 698 PEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
PE +GV + +D FS G ++ ++L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-44
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 12/205 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
E + I LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ L E ++I+E++ + + T L + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 644 SRLRIIHRDLKASNILLDQHMNP--KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
I H D++ NI+ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSK 726
V S +D++S G L+ +LS
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-43
Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 579
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 580 HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
H L + + + EY+ L + H I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
LH I++RDLK NILLD+ + KI+DFGM + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 700 YALEGVFSVKSDVFSFGVLMLEILSSK 726
L ++ D +SFGVL+ E+L +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 1e-42
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 581
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V L G LI + + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 642 QYSRLRIIHRDLKASNILL---DQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSP 698
I+HRDLK N+L D+ ISDFG+++M + GT GY++P
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178
Query: 699 EYALEGVFSVKSDVFSFGVLMLEILSSK 726
E + +S D +S GV+ +L
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 3e-42
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL---------KEFKNEMML 574
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 575 IAKLQ-HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
+ K+ H N+++L L+++ M L +L T+K L + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTY 693
+ + LH +L I+HRDLK NILLD MN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 694 GYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSK 726
Y++PE + + + D++S GV+M +L+
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 523 ATENFSIQSKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQG--LKEFKNE---MMLI 575
A + + +++GEG +G V+K R L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 576 AKLQHRNLVRLLGCCIEQGEKILIYEYMVNKSLD---VFLFDPTKKHLLGWQLRVRIIDG 632
+H N+VRL C +V + +D D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGT 692
+ +GL +LH R++HRDLK NIL+ K++DFG+AR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 693 YGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
Y +PE L+ ++ D++S G + E+ K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 11/206 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
ENF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+V+LL + + L++E++ D + + L + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE-Y 700
+ R++HRDLK N+L++ K++DFG+AR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
+S D++S G + E+++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (376), Expect = 8e-41
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 582
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 583 LVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ 642
+V+L + +L++E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 643 YSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYAL 702
R++HRDLK N+L+++ KI+DFG+AR FG + + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 703 -EGVFSVKSDVFSFGVLMLEILSSK 726
+S D++S G + E+++
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 532 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQHRNLVR 585
LGEG F VYK R N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
LL + L++++M +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 646 LRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALE-G 704
I+HRDLK +N+LLD++ K++DFG+A+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 705 VFSVKSDVFSFGVLMLEILSSK 726
++ V D+++ G ++ E+L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (375), Expect = 1e-40
Identities = 41/213 (19%), Positives = 87/213 (40%), Gaps = 18/213 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 583
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 584 VRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY 643
+ + ++G ++ ++ SL+ L + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 644 SRLRIIHRDLKASNILLDQHMNP-----KISDFGMARMFGGDELQGN-----TKRIVGTY 693
+++RD+K N L+ + + + DFGM + + + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
YMS L S + D+ + G + + L
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-40
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 584
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 585 RLLGCCIEQGEK------ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLL 638
RL GEK L+ +Y+ V K L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 639 YLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTYGYMS 697
Y+H I HRD+K N+LLD K+ DFG A+ E + + + Y +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 698 PEYALEGV-FSVKSDVFSFGVLMLEILSSK 726
PE ++ DV+S G ++ E+L +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 2e-40
Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 16/209 (7%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+ + K+G G FG +Y G + G+EVA+K ++ + E + +Q +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 586 LLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSR 645
+ C +G+ ++ ++ SL+ ++K + + + D + + Y+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---S 121
Query: 646 LRIIHRDLKASNIL---LDQHMNPKISDFGMARMFGGDELQGN-----TKRIVGTYGYMS 697
IHRD+K N L + I DFG+A+ + + K + GT Y S
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 698 PEYALEGVFSVKSDVFSFGVLMLEILSSK 726
L S + D+ S G +++
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 20/213 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLKEFKNEMMLIAK 577
+ + +LG G F V K R G + A K + S++ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+QH N++ L + + ILI E + L +K L + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP----KISDFGMARMFGGDELQGNTKRIVGTY 693
++ L+I H DLK NI+L P KI DFG+A K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 694 GYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+++PE +++D++S GV+ +LS
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-39
Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 20/211 (9%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE------FKNEMMLIAKLQ 579
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 580 --HRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
++RLL +LI E T++ L +L + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVGTYGYM 696
+ H ++HRD+K NIL+D + K+ DFG + GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 697 SPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
PE+ + V+S G+L+ +++
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
+ +K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 582 NLVRLLGCCIEQGEKI--------LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGI 633
N+V L+ C + L++++ + + K R++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 634 AQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKR--IVG 691
GL Y+H+ +I+HRD+KA+N+L+ + K++DFG+AR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 692 TYGYMSPEYAL-EGVFSVKSDVFSFGVLMLEILSSK 726
T Y PE L E + D++ G +M E+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-38
Identities = 47/206 (22%), Positives = 83/206 (40%), Gaps = 12/206 (5%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
L L + EY L L + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFY--GAEIVSAL 118
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
+++RD+K N++LD+ + KI+DFG+ + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
+ + D + GV+M E++ +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 1e-37
Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 581
+ + K+GEG +G V+K + + VA+K RL + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 582 NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLH 641
N+VRL + L++E+ F G + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 642 QYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYA 701
++HRDLK N+L++++ K+++FG+AR F G ++ + +V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 702 LEGVFSVKSDVFSFGVLMLEILSSKK 727
++S D++S G + E+ ++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 1e-36
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 580
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 581 RNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
LV+L + ++ EY+ + L + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H L +I+RDLK N+L+DQ +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 701 ALEGVFSVKSDVFSFGVLMLEILSSK 726
L ++ D ++ GVL+ E+ +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 4e-36
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 581
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 582 NLVRLLGCCIEQGEKILIYE-YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
N++ LL + Y+V + L K LG ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 641 HQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEY 700
H IIHRDLK N+ +++ KI DFG+AR + V T Y +PE
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189
Query: 701 ALEGV-FSVKSDVFSFGVLMLEILSSK 726
L + ++ D++S G +M E+++ K
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-36
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 525 ENFSIQSK-LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHR 581
+++ + S+ LG G G V + ++ A+K L + + + E+ L + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 582 NLVRLLGCC----IEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
++VR++ + +++ E + L + D + + I+ I + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAI 124
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNP---KISDFGMARMFGGDELQGNTKRIVGTYG 694
YLH + I HRD+K N+L K++DFG A+ T
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPY 178
Query: 695 YMSPEYALEGVFSVKSDVFSFGVLMLEI 722
Y++PE + D++S GV+M +
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYIL 206
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-34
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLKEFKNEMMLIA 576
ENF + LG G +G V+ R + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 577 KLQHR-NLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
++ LV L + + LI +Y+ L L + Q+ + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
+L L +L II+RD+K NILLD + + ++DFG+++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 696 MSPEYALEGV--FSVKSDVFSFGVLMLEILSSK 726
M+P+ G D +S GVLM E+L+
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (318), Expect = 1e-32
Identities = 42/208 (20%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN 582
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 583 LVRLLGCCIEQGEK--ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYL 640
++ L + + L++E++ N L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 641 HQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
H + I+HRD+K N+++D +H ++ D+G+A + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 700 YALE-GVFSVKSDVFSFGVLMLEILSSK 726
++ ++ D++S G ++ ++ K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 7e-32
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 13/208 (6%)
Query: 524 TENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 580
E + S +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 581 RNLVRLLGCCIEQGEKILI-YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLY 639
N++ LL Y+V + L + K L +I I +GL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 640 LHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPE 699
+H IIHRDLK SN+ +++ KI DFG+AR V T Y +PE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPE 188
Query: 700 YALEGV-FSVKSDVFSFGVLMLEILSSK 726
L + ++ D++S G +M E+L+ +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 8e-32
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 525 ENFSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 581
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 582 NLVRLLGCCIEQG------EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQ 635
N++ LL Q + L+ E M V + + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLC 130
Query: 636 GLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGY 695
G+ +LH IIHRDLK SNI++ KI DFG+AR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 696 MSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
+PE L + D++S G +M E++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 8e-29
Identities = 40/215 (18%), Positives = 84/215 (39%), Gaps = 18/215 (8%)
Query: 527 FSIQSKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 585
+ + KLG G F V+ + ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 586 LLGCCIEQGEKILIY-------------EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDG 632
K+L + + V + L + + +I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 633 IAQGLLYLHQYSRLRIIHRDLKASNILLDQH-MNPKISDFGMARMFGGDELQGNTKRIVG 691
+ GL Y+H+ R IIH D+K N+L++ + +A + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 692 TYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK 726
T Y SPE L + +D++S L+ E+++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 1e-25
Identities = 31/158 (19%), Positives = 63/158 (39%), Gaps = 20/158 (12%)
Query: 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLK--------EFKNEMMLIAK 577
+I +GEG V+ E VK ++ + S + +K F + A+
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 578 LQHRNLVRLLGCCIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGL 637
+ R L +L G + + +Y + N ++ + L D + + + + ++D I + +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 638 LYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675
+ I+H DL N+L+ I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 91.2 bits (226), Expect = 1e-22
Identities = 24/118 (20%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 50 IRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVS 109
+ +GE L Q ++ + ++ + ++ T VW +N K +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGIL-GKKGCKAVLQ 58
Query: 110 NRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167
+ GN V+ + ++W+S+ R N V L ++GN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 71.2 bits (174), Expect = 1e-15
Identities = 27/126 (21%), Positives = 44/126 (34%), Gaps = 20/126 (15%)
Query: 42 DTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVD 101
+ L + GE L F + ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 102 KNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYL 161
++ L++ GNLV+ N SN IW+SN + N V L + N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 162 WQSFDY 167
W + +
Sbjct: 102 WATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.8 bits (168), Expect = 1e-14
Identities = 18/97 (18%), Positives = 34/97 (35%), Gaps = 9/97 (9%)
Query: 80 IWYQQIP-DTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVA 138
I Y D + + L++ NLVL ++ + +WS+N + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 139 QLLDNGNLVIRDNSGSNSTESYLWQSFD--YPTDTML 173
L NG + + N +W S + +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 52.6 bits (126), Expect = 6e-09
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 5/110 (4%)
Query: 43 TLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDK 102
L T + + +Q +L + + + ++ + D VW N+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR---DDRVWS--TNTAGKGT 66
Query: 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNS 152
+ G + +L N +W+S SR V L + NL I +
Sbjct: 67 GCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 68.3 bits (166), Expect = 1e-14
Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIV 100
+D L + G +L + + + Y + VW + N
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCNL------VLYD--NNRAVWASGTNGKAS 50
Query: 101 DKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESY 160
VL + N GNLV+ + + IW+SN +R+ N L + N+VI DNS +
Sbjct: 51 GC--VLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 161 LWQSFDYPTD 170
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 67.3 bits (164), Expect = 4e-14
Identities = 21/138 (15%), Positives = 43/138 (31%), Gaps = 22/138 (15%)
Query: 30 IFYWVIKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTV 89
I + L T + ++ + + + + Y +
Sbjct: 3 IIFSKQPDDNHPQILHAT----ESLEILFGTHVYRFIMQTDCNL------VLYD--NNNP 50
Query: 90 VWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIR 149
+W N + G LV++ N T+W S V+ + + V L + N+VI
Sbjct: 51 IWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIY 108
Query: 150 DNSGSNSTESYLWQSFDY 167
++ LW +
Sbjct: 109 GDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.2 bits (130), Expect = 1e-09
Identities = 29/130 (22%), Positives = 43/130 (33%), Gaps = 22/130 (16%)
Query: 35 IKFSLAADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVAN 94
I F L+ + P TL ++L S F S + ++ D VW +N
Sbjct: 3 ILFGLSHEGSHPQTLHAA-QSLELSS--FRFTMQSDCN-----LVLFD---SDVRVWASN 51
Query: 95 RNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGS 154
+ + G LV+L N WSS + N V L + + I
Sbjct: 52 TAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPG-- 106
Query: 155 NSTESYLWQS 164
LW S
Sbjct: 107 ------LWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 754 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.87 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.87 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.85 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.7 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.66 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.53 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.35 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.18 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.12 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.04 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.76 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.7 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.68 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.47 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 85.25 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.22 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.18 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.58 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 80.5 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.41 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=376.99 Aligned_cols=204 Identities=28% Similarity=0.399 Sum_probs=178.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.++||+|+||+||+|+++ +++.||||++.... .+..+++.+|+++|++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 67999999999999999999875 58899999986543 33456789999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999883 4457899999999999999999999988 99999999999999999999999999998755443
Q ss_pred cCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 334455789999999999988876 5679999999999999999999976543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=375.99 Aligned_cols=221 Identities=24% Similarity=0.386 Sum_probs=191.2
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 367999999999999999999864 5899999999766555677899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++|+|..++. +..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+.....
T Consensus 99 ~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998773 346899999999999999999999988 99999999999999999999999999998754432
Q ss_pred cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------------CccchhhhHHHHHhhh
Q 004416 683 QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT------------DSFNLLGHVSDKLYSL 750 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~------------~~~~~~~~~~~~l~~~ 750 (754)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .......++++.++++
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence 23346899999999999999999999999999999999999999976442 1223345556667776
Q ss_pred hhc
Q 004416 751 LFD 753 (754)
Q Consensus 751 l~~ 753 (754)
|.+
T Consensus 250 i~~ 252 (293)
T d1yhwa1 250 LNR 252 (293)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=370.35 Aligned_cols=219 Identities=29% Similarity=0.389 Sum_probs=188.1
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||+||+|+.+ +++.||||++... .....+++.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 5889999998643 2334677899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999883 4456899999999999999999999988 999999999999999999999999999876433
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~l 751 (754)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||...+. ....++..+++.++++|
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 235 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 235 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHH
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 2 3346899999999999999999999999999999999999999976542 22223344566666666
Q ss_pred hc
Q 004416 752 FD 753 (754)
Q Consensus 752 ~~ 753 (754)
.+
T Consensus 236 ~~ 237 (263)
T d2j4za1 236 SR 237 (263)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=376.26 Aligned_cols=224 Identities=27% Similarity=0.376 Sum_probs=190.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999874 5889999998653 2345678999999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998873 4557899999999999999999999988 999999999999999999999999999987654
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~l 751 (754)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....++..+++.++++|
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 444444457899999999999999999999999999999999999999976542 23345566777777777
Q ss_pred hcC
Q 004416 752 FDL 754 (754)
Q Consensus 752 ~~l 754 (754)
.+|
T Consensus 242 ~~~ 244 (288)
T d1uu3a_ 242 EKL 244 (288)
T ss_dssp HTT
T ss_pred HHH
Confidence 664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=370.86 Aligned_cols=223 Identities=25% Similarity=0.403 Sum_probs=188.5
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.+.|++.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357999999999999999999875 5889999999876666778899999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+++|+|..++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 91 CAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 999999988742 2356899999999999999999999988 9999999999999999999999999997653321
Q ss_pred cCCcccccccCcccCccccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC------------ccchhhhHHH
Q 004416 683 QGNTKRIVGTYGYMSPEYAL-----EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD------------SFNLLGHVSD 745 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~------------~~~~~~~~~~ 745 (754)
.......||+.|+|||++. +..++.++|||||||++|||+||+.||...+.. .......+++
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 243 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence 1223468999999999984 456889999999999999999999999765421 2223345566
Q ss_pred HHhhhhhc
Q 004416 746 KLYSLLFD 753 (754)
Q Consensus 746 ~l~~~l~~ 753 (754)
.++++|.+
T Consensus 244 ~~~~li~~ 251 (288)
T d2jfla1 244 NFKDFLKK 251 (288)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 66666654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-44 Score=368.45 Aligned_cols=228 Identities=26% Similarity=0.411 Sum_probs=176.9
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe--cCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE--QGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~--~~~~~l 598 (754)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+ ....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999865 5889999998654 33446778999999999999999999999865 456899
Q ss_pred EEEcccCCCHhhHhcCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCC--CCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 599 IYEYMVNKSLDVFLFDP-TKKHLLGWQLRVRIIDGIAQGLLYLHQYSR--LRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~--~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
||||+++|+|.+++... .....+++..++.++.||++||+|||+++. .+|+||||||+|||+++++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988432 234568999999999999999999998652 359999999999999999999999999999
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC----------ccchhhhHHH
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD----------SFNLLGHVSD 745 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~----------~~~~~~~~~~ 745 (754)
.+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||...+.. ...++..+++
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~ 240 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 8754332 233468999999999999999999999999999999999999999765421 1123344556
Q ss_pred HHhhhhhc
Q 004416 746 KLYSLLFD 753 (754)
Q Consensus 746 ~l~~~l~~ 753 (754)
.+.++|.+
T Consensus 241 ~l~~li~~ 248 (269)
T d2java1 241 ELNEIITR 248 (269)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 66666544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=366.76 Aligned_cols=205 Identities=30% Similarity=0.483 Sum_probs=171.2
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
+...++|++.++||+|+||+||+|+++ ..||||+++.. .....++|++|+.+|++++|||||++++++. .+..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 445678999999999999999999864 35999998654 4456788999999999999999999999874 457899
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++|+|.+++.. .+..+++..+.+++.||++||+|||+++ ||||||||+||||++++.+||+|||+|+...
T Consensus 81 v~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999853 3345899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCcccCCcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
............||+.|||||++.+ ..++.++|||||||+||||+||+.||....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 5443334455789999999999864 358999999999999999999999997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-43 Score=372.02 Aligned_cols=221 Identities=24% Similarity=0.309 Sum_probs=191.4
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++++.||+|+||.||+|+.+ +++.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 67999999999999999999864 6899999998754 2335678899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999883 4566889999999999999999999998 999999999999999999999999999876443
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~l 751 (754)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+. ....++..+++.++|+|
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 32 23347899999999999999999999999999999999999999977652 22334555667777776
Q ss_pred hc
Q 004416 752 FD 753 (754)
Q Consensus 752 ~~ 753 (754)
.+
T Consensus 237 ~~ 238 (337)
T d1o6la_ 237 AG 238 (337)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=360.87 Aligned_cols=203 Identities=34% Similarity=0.521 Sum_probs=175.9
Q ss_pred hccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
.+...++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|+++|++++|||||++++++. ++..++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEE
Confidence 344567899999999999999999999888899999997543 34578999999999999999999999875 4567999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++|+|.+++... ....+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+..
T Consensus 86 ~Ey~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999877432 3345899999999999999999999987 99999999999999999999999999998765
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~ 729 (754)
..... .....||+.|||||++.+..++.++|||||||++|||+||+.|+
T Consensus 162 ~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~ 210 (272)
T d1qpca_ 162 NEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210 (272)
T ss_dssp SCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred Ccccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence 44322 23357899999999999999999999999999999999966554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=374.73 Aligned_cols=203 Identities=28% Similarity=0.376 Sum_probs=179.2
Q ss_pred cccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
...++|++.++||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+|++++|||||++++++.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999864 5889999998754 334457889999999999999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-CCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-SRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
|||+++|+|..++. +...+++..+..++.||++||.|||++ + |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 83 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999984 345689999999999999999999974 6 9999999999999999999999999998764
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred CC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32 22346899999999999999999999999999999999999999976543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-42 Score=369.96 Aligned_cols=221 Identities=24% Similarity=0.371 Sum_probs=190.3
Q ss_pred CCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 58999999999999999999864 58999999998776666788999999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC--CCCeEEEeecCccccCCCc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ--HMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~--~~~~kL~DFGla~~~~~~~ 681 (754)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998843 3446899999999999999999999988 999999999999964 5789999999999875443
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------------ccchhhhHHHHHh
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-------------SFNLLGHVSDKLY 748 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~-------------~~~~~~~~~~~l~ 748 (754)
......||+.|||||++.+..++.++|||||||++|||++|+.||...+.. .......+++.++
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 233468999999999999999999999999999999999999999765421 1112244566677
Q ss_pred hhhhc
Q 004416 749 SLLFD 753 (754)
Q Consensus 749 ~~l~~ 753 (754)
++|.+
T Consensus 258 ~li~~ 262 (350)
T d1koaa2 258 DFIRK 262 (350)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-42 Score=367.66 Aligned_cols=218 Identities=28% Similarity=0.405 Sum_probs=187.5
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999874 5899999998653 2344678899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988883 4556788888999999999999999988 999999999999999999999999999876432
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~l 751 (754)
....+||+.|||||++.+..++.++|||||||+||||++|+.||...+. ....++..+++.++++|
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 232 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 2346899999999999999999999999999999999999999976542 22234444556666665
Q ss_pred hc
Q 004416 752 FD 753 (754)
Q Consensus 752 ~~ 753 (754)
.+
T Consensus 233 ~~ 234 (316)
T d1fota_ 233 SR 234 (316)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-43 Score=364.81 Aligned_cols=208 Identities=29% Similarity=0.480 Sum_probs=181.1
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCc
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGE 595 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~ 595 (754)
+.+++...++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||++++++.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3445666789999999999999999999875 47899999987543 346789999999999999999999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+++|+|..++... ....+++..+.+++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccccee
Confidence 99999999999999988542 3456899999999999999999999987 9999999999999999999999999999
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus 164 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 164 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp TCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 77554322 2223468899999999999999999999999999999999777653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-43 Score=367.75 Aligned_cols=202 Identities=26% Similarity=0.352 Sum_probs=162.5
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
..+.|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577999999999999999999875 58899999987543 233456889999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc---CCCCeEEEeecCcccc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD---QHMNPKISDFGMARMF 677 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~---~~~~~kL~DFGla~~~ 677 (754)
||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999984 3456899999999999999999999988 99999999999994 5789999999999876
Q ss_pred CCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... .....+||+.|||||++.+..++.++|||||||+||||++|+.||....
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 5433 2234689999999999999999999999999999999999999997643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=355.20 Aligned_cols=197 Identities=30% Similarity=0.461 Sum_probs=169.3
Q ss_pred cceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe----cCcEEEE
Q 004416 527 FSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE----QGEKILI 599 (754)
Q Consensus 527 y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~----~~~~~lV 599 (754)
|++.++||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++|++++|||||++++++.. +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 366778999999999999875 5789999998654 34456789999999999999999999999875 2457999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc-CCCCeEEEeecCccccC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD-QHMNPKISDFGMARMFG 678 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~-~~~~~kL~DFGla~~~~ 678 (754)
|||+++|+|.+++. +...+++..+..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999983 4456899999999999999999999875 4599999999999996 57899999999998643
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.. .....+||+.|||||++.+ .++.++|||||||++|||++|+.||...
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 32 2334689999999998865 6999999999999999999999999654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=356.35 Aligned_cols=201 Identities=32% Similarity=0.510 Sum_probs=167.3
Q ss_pred cCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
.++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 36799999999999999999999888899999997543 34578999999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++|+|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999998853 3456889999999999999999999987 999999999999999999999999999877554322
Q ss_pred CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 004416 684 GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS-KKNTGV 731 (754)
Q Consensus 684 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg-~~p~~~ 731 (754)
. .....||+.|+|||++.+..++.++|||||||++|||+|+ ++|+..
T Consensus 158 ~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 158 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred e-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 2 2335789999999999999999999999999999999995 555544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.2e-42 Score=366.99 Aligned_cols=222 Identities=23% Similarity=0.316 Sum_probs=190.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYM 603 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~ 603 (754)
++|++.+.||+|+||.||+|+.. +++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 67999999999999999999864 68999999997766566678899999999999999999999999999999999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEc--CCCCeEEEeecCccccCCCc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLD--QHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~--~~~~~kL~DFGla~~~~~~~ 681 (754)
++|+|.+.+. .....+++.+++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999988763 23446899999999999999999999988 99999999999998 67899999999999876543
Q ss_pred ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------------ccchhhhHHHHHh
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-------------SFNLLGHVSDKLY 748 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~-------------~~~~~~~~~~~l~ 748 (754)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .......+++.+.
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 233468999999999999999999999999999999999999999764421 1123345666777
Q ss_pred hhhhcC
Q 004416 749 SLLFDL 754 (754)
Q Consensus 749 ~~l~~l 754 (754)
++|.+|
T Consensus 261 ~li~~~ 266 (352)
T d1koba_ 261 DFIKNL 266 (352)
T ss_dssp HHHHTT
T ss_pred HHHHHH
Confidence 777654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=366.55 Aligned_cols=230 Identities=29% Similarity=0.450 Sum_probs=186.2
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC------cceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEEe
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE 592 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~------~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~ 592 (754)
+...++|++.++||+|+||+||+|+... ...||||++... .....+.+.+|+.+|.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3455789999999999999999998643 236999988654 333456789999999998 89999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCC--------------------cccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCC
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTK--------------------KHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRD 652 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~D 652 (754)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 9999999999999999999864321 245889999999999999999999987 99999
Q ss_pred CCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 004416 653 LKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGV 731 (754)
Q Consensus 653 Ikp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~ 731 (754)
|||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655443333334678999999999999999999999999999999998 8999976
Q ss_pred CCCCc-----------cchhhhHHHHHhhhhhc
Q 004416 732 YNTDS-----------FNLLGHVSDKLYSLLFD 753 (754)
Q Consensus 732 ~~~~~-----------~~~~~~~~~~l~~~l~~ 753 (754)
.+... ...+.++++.+++++.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~ 302 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS 302 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 54321 12334455666666543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-42 Score=355.73 Aligned_cols=206 Identities=30% Similarity=0.450 Sum_probs=176.5
Q ss_pred cccCCcceeee-eceeccEEEEeeeec---Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSK-LGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~-LG~G~fg~Vy~~~~~---~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
...++|.+.+. ||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||++++++. .+..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~ 83 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL 83 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeE
Confidence 34567888884 999999999999764 3457999999754 3445678999999999999999999999985 4578
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++|+|.+++.. .+..+++..+.+++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999998742 3456899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCcc-cCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDEL-QGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+..... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 765432 222334578999999999999999999999999999999998 899997654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=355.28 Aligned_cols=222 Identities=26% Similarity=0.363 Sum_probs=188.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc------hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
.++|++.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999874 58899999986432 22367899999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC----CeEEEeec
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM----NPKISDFG 672 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~----~~kL~DFG 672 (754)
++||||+++|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999983 3456899999999999999999999988 99999999999998776 49999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC-------------ccch
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD-------------SFNL 739 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~-------------~~~~ 739 (754)
+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ....
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 998875433 223467899999999999999999999999999999999999999765421 1123
Q ss_pred hhhHHHHHhhhhhcC
Q 004416 740 LGHVSDKLYSLLFDL 754 (754)
Q Consensus 740 ~~~~~~~l~~~l~~l 754 (754)
..++++.++++|.+|
T Consensus 240 ~~~~s~~~~~li~~~ 254 (293)
T d1jksa_ 240 FSNTSALAKDFIRRL 254 (293)
T ss_dssp HTTSCHHHHHHHHTT
T ss_pred cCCCCHHHHHHHHHH
Confidence 345566777777654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=351.30 Aligned_cols=202 Identities=32% Similarity=0.490 Sum_probs=180.1
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEccc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMV 604 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~ 604 (754)
++|++.++||+|+||+||+|++++++.||||+++... ...++|++|++++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6788999999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccC
Q 004416 605 NKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQG 684 (754)
Q Consensus 605 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 684 (754)
+|+|..++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999988743 3456788999999999999999999987 999999999999999999999999999877654432
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+...
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~ 206 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 206 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence 2233578999999999999999999999999999999998 799998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-42 Score=360.35 Aligned_cols=197 Identities=33% Similarity=0.520 Sum_probs=173.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
+.|+++++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 46999999999999999999864 58899999986542 334567899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987663 3456899999999999999999999988 99999999999999999999999999986533
Q ss_pred cccCCcccccccCcccCccccCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALE---GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 223689999999999864 468999999999999999999999996543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-42 Score=366.26 Aligned_cols=218 Identities=25% Similarity=0.327 Sum_probs=187.2
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
++|+++++||+|+||.||+|+++ +|+.||||++... .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999875 5899999998643 2344677899999999999999999999999999999999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+.+|+|..++. ....+++..+..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999998883 4456899999999999999999999988 999999999999999999999999999987532
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhhh
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSLL 751 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~l 751 (754)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...+. .....+..+++.+.++|
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHH
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 2346899999999999999999999999999999999999999976542 12223344455555555
Q ss_pred hc
Q 004416 752 FD 753 (754)
Q Consensus 752 ~~ 753 (754)
.+
T Consensus 270 ~~ 271 (350)
T d1rdqe_ 270 RN 271 (350)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-41 Score=356.34 Aligned_cols=205 Identities=30% Similarity=0.471 Sum_probs=166.2
Q ss_pred cCCcceeeeeceeccEEEEeeeecC-c---ceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~-~---~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
.++|++.++||+|+||+||+|+++. + ..||||++... .....++|.+|+++|++++|||||++++++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4678999999999999999998753 3 25899988654 44456789999999999999999999999999999999
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
||||+++|+|..++.. ....+++.++.+++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998853 3446899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCcccC---CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 679 GDELQG---NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
...... ......||+.|||||.+.+..++.++|||||||+||||+| |+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 543221 1222467899999999999999999999999999999998 899997543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=353.85 Aligned_cols=196 Identities=31% Similarity=0.433 Sum_probs=166.6
Q ss_pred eeeceeccEEEEeeeecC---cceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEcccC
Q 004416 531 SKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEYMVN 605 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~---~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey~~~ 605 (754)
++||+|+||+||+|.+++ ++.||||+++.. .....++|.+|+++|++++|||||++++++. .+..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 579999999999997643 568999998654 3334578999999999999999999999985 4567899999999
Q ss_pred CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc-cC
Q 004416 606 KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL-QG 684 (754)
Q Consensus 606 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~ 684 (754)
|+|.+++. ....+++..+.+++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999884 4456899999999999999999999987 99999999999999999999999999998754432 22
Q ss_pred CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 685 NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 685 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
......||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 2333578999999999999999999999999999999998 899997643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=356.04 Aligned_cols=221 Identities=26% Similarity=0.369 Sum_probs=186.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc---chhhHHHHHHHHHHHH-HccccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~nIv~l~~~~~~~~~~~lV 599 (754)
++|++.++||+|+||+||+|+.+ +++.||||++++. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999875 5889999999653 2334556677777765 68999999999999999999999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCC
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGG 679 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~ 679 (754)
|||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 4456889999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---------CccchhhhHHHHHhhh
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT---------DSFNLLGHVSDKLYSL 750 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~---------~~~~~~~~~~~~l~~~ 750 (754)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....++..+++.++++
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 332 23346899999999999999999999999999999999999999976442 2223344556667776
Q ss_pred hhc
Q 004416 751 LFD 753 (754)
Q Consensus 751 l~~ 753 (754)
|.+
T Consensus 234 i~~ 236 (320)
T d1xjda_ 234 LVK 236 (320)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=351.84 Aligned_cols=204 Identities=31% Similarity=0.504 Sum_probs=170.4
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIY 600 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 600 (754)
+...++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.+|++++|||||++++++. .+..++||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEE
Confidence 34457899999999999999999999888899999996543 34578999999999999999999999985 55689999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|..++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++++||+|||+|+.+...
T Consensus 91 Ey~~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 91 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EecCCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999887432 2345899999999999999999999987 999999999999999999999999999877544
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
.... .....||+.|+|||++....++.++||||||+++|||++|+.|+..
T Consensus 167 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 167 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred Ccee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 3222 2335789999999999999999999999999999999997766543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-41 Score=361.35 Aligned_cols=219 Identities=29% Similarity=0.390 Sum_probs=180.8
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccc---hhhHHHHHHH---HHHHHHccccceeeeEeEEEecCcEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNE---MMLIAKLQHRNLVRLLGCCIEQGEKI 597 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~~~~E---i~~l~~l~H~nIv~l~~~~~~~~~~~ 597 (754)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+| +.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999875 58999999986432 1223334444 56666678999999999999999999
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcccc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMF 677 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~ 677 (754)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999983 4456789999999999999999999988 999999999999999999999999999977
Q ss_pred CCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc------------cchhhhHH
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS------------FNLLGHVS 744 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~~~~------------~~~~~~~~ 744 (754)
.... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||....... ..+...++
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 233 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSC
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCC
Confidence 5433 234689999999999875 568999999999999999999999997654321 12233456
Q ss_pred HHHhhhhhc
Q 004416 745 DKLYSLLFD 753 (754)
Q Consensus 745 ~~l~~~l~~ 753 (754)
+.++++|.+
T Consensus 234 ~~~~~li~~ 242 (364)
T d1omwa3 234 PELRSLLEG 242 (364)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 666666654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.7e-41 Score=347.50 Aligned_cols=205 Identities=26% Similarity=0.377 Sum_probs=170.7
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecC----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG---- 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~---- 594 (754)
..++|++.+.||+|+||.||+|+. .+++.||||+++.. .....+++.+|+.++++++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 347899999999999999999986 46899999998654 2344567999999999999999999999988754
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+++++|..++. ....+++.++..++.||++||+|||+++ |+||||||+|||++.++..+|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 3789999999999998873 4456899999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCc-ccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDE-LQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 7664332 2223344689999999999999999999999999999999999999997654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-40 Score=341.95 Aligned_cols=221 Identities=26% Similarity=0.337 Sum_probs=185.7
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch---------hhHHHHHHHHHHHHHcc-ccceeeeEeEEEe
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIE 592 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~---------~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~ 592 (754)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 378999999999999999999864 688999999865421 12346889999999997 9999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
++..++||||+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999994 4456899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccC------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCCc----------
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYAL------EGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTDS---------- 736 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~~---------- 736 (754)
+++.+.... ......||+.|+|||++. ...++.++||||+||+||||++|+.||...+...
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 999876533 223368999999999885 3457889999999999999999999997765211
Q ss_pred ---cchhhhHHHHHhhhhhc
Q 004416 737 ---FNLLGHVSDKLYSLLFD 753 (754)
Q Consensus 737 ---~~~~~~~~~~l~~~l~~ 753 (754)
.....++++.++++|.+
T Consensus 233 ~~~~~~~~~~s~~~~~li~~ 252 (277)
T d1phka_ 233 QFGSPEWDDYSDTVKDLVSR 252 (277)
T ss_dssp CCCTTTGGGSCHHHHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHH
Confidence 11223566667777654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-41 Score=352.59 Aligned_cols=214 Identities=29% Similarity=0.448 Sum_probs=182.6
Q ss_pred hhhhccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeE
Q 004416 517 FASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (754)
Q Consensus 517 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 589 (754)
+.+++.+.++|++.+.||+|+||+||+|+.+ +++.||||+++... .+..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4456777889999999999999999999853 35789999997653 3346789999999999999999999999
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCC---------------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPT---------------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRI 648 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 648 (754)
+......++||||+++|+|.++++... ....+++..++.|+.||+.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999885321 2234889999999999999999999987 9
Q ss_pred eeCCCCCCCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCC-C
Q 004416 649 IHRDLKASNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK-K 727 (754)
Q Consensus 649 iH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~-~ 727 (754)
|||||||+|||++.++.+||+|||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998776554444444567899999999999999999999999999999999996 5
Q ss_pred CCCCCC
Q 004416 728 NTGVYN 733 (754)
Q Consensus 728 p~~~~~ 733 (754)
||...+
T Consensus 242 p~~~~~ 247 (301)
T d1lufa_ 242 PYYGMA 247 (301)
T ss_dssp TTTTSC
T ss_pred CCCCCC
Confidence 676544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=346.86 Aligned_cols=203 Identities=32% Similarity=0.483 Sum_probs=166.7
Q ss_pred ccCCcceeeeeceeccEEEEeeeecCc-----ceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~~~-----~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
..+.|++.++||+|+||.||+|+++.. ..||||+++.. .....++|.+|+.++++++|||||++++++.+....
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 346789999999999999999987542 36999998654 334456799999999999999999999999999999
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+.++++..++.. ....+++..+.+++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999887743 3356889999999999999999999987 99999999999999999999999999988
Q ss_pred cCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 004416 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTG 730 (754)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~ 730 (754)
+...... .......||+.|||||++.+..++.++|||||||++|||++|+.|+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 7543221 12233568999999999999999999999999999999999766653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=348.39 Aligned_cols=222 Identities=22% Similarity=0.310 Sum_probs=187.3
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... ....+.+|+++|++++||||+++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999875 588999999976543 345688999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCC--CCeEEEeecCccccCCC
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQH--MNPKISDFGMARMFGGD 680 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~--~~~kL~DFGla~~~~~~ 680 (754)
+++++|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998842 2346899999999999999999999988 9999999999999854 57999999999876543
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCC---------ccc----hhhhHHHHH
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNTD---------SFN----LLGHVSDKL 747 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~~---------~~~----~~~~~~~~l 747 (754)
. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...+.. ... ...++++.+
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 3 233467899999999999999999999999999999999999999775521 111 112456667
Q ss_pred hhhhhcC
Q 004416 748 YSLLFDL 754 (754)
Q Consensus 748 ~~~l~~l 754 (754)
+++|.+|
T Consensus 235 ~~li~~~ 241 (321)
T d1tkia_ 235 MDFVDRL 241 (321)
T ss_dssp HHHHHTT
T ss_pred HHHHHHH
Confidence 7777654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-40 Score=351.55 Aligned_cols=203 Identities=31% Similarity=0.504 Sum_probs=169.6
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccc----eeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~----~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~l 598 (754)
++|++.++||+|+||+||+|++. +++ .||||+++.. .....++|.+|++++++++|||||++++++.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 56999999999999999999864 343 5888988653 34557889999999999999999999999976 46788
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccC
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFG 678 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~ 678 (754)
++||+.+++|..++.. ....+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999887743 3456889999999999999999999987 9999999999999999999999999999876
Q ss_pred CCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 679 GDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
............||+.|+|||++.++.++.++|||||||+||||+| |++||...+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 5544444444678999999999999999999999999999999999 788887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=344.89 Aligned_cols=205 Identities=27% Similarity=0.377 Sum_probs=164.9
Q ss_pred cccCCcceeeeeceeccEEEEeeeecC----cceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
...++|++.+.||+|+||.||+|++.. +..||||+++.. .....+.|.+|+.+|++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 445789999999999999999998643 346899988654 3444677999999999999999999999985 5678
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||+++|+|..++.. ....+++..++.++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999987642 3456899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+...... ......||+.|+|||++.+..++.++|||||||++|||+| |++||...+
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 6543322 2233578999999999999999999999999999999998 889987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=347.29 Aligned_cols=213 Identities=29% Similarity=0.436 Sum_probs=170.6
Q ss_pred hhhccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeE
Q 004416 518 ASVTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGC 589 (754)
Q Consensus 518 ~~~~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~ 589 (754)
...+...++|++.++||+|+||.||+|++. +++.||||+++.. .....+++.+|..++.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344556688999999999999999999753 2468999999754 334456788888888887 68999999999
Q ss_pred EEecC-cEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCC
Q 004416 590 CIEQG-EKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKA 655 (754)
Q Consensus 590 ~~~~~-~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp 655 (754)
+.+.+ ..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87654 6899999999999999985332 2345889999999999999999999987 99999999
Q ss_pred CCEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCC
Q 004416 656 SNILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK-KNTGVYN 733 (754)
Q Consensus 656 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~-~p~~~~~ 733 (754)
+||||++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999998776554444445578999999999999999999999999999999999975 5776543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=347.50 Aligned_cols=197 Identities=22% Similarity=0.291 Sum_probs=169.7
Q ss_pred CCcceee-eeceeccEEEEeeee-cCcceeeeeeccccchhhHHHHHHHHHHHHHc-cccceeeeEeEEEe----cCcEE
Q 004416 525 ENFSIQS-KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIE----QGEKI 597 (754)
Q Consensus 525 ~~y~i~~-~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~----~~~~~ 597 (754)
++|.+.+ .||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +||||+++++++.. +...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6798875 599999999999986 45889999998643 4567899987665 89999999999875 35689
Q ss_pred EEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeecCc
Q 004416 598 LIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMA 674 (754)
Q Consensus 598 lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFGla 674 (754)
+||||+++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||+++ .+.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999998532 2356999999999999999999999988 999999999999986 457999999999
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
+...... ......||+.|||||++.+..++.++|||||||+||||+||+.||...+
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 8775533 2234689999999999999999999999999999999999999996543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=343.92 Aligned_cols=196 Identities=29% Similarity=0.384 Sum_probs=166.2
Q ss_pred eeeeeceeccEEEEeeeec-Ccceeeeeeccccchh-----hHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 529 IQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 529 i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
.+++||+|+||+||+|+.+ +++.||||+++..... ..+.+.+|+.+|++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999875 5889999998654221 124688999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+.++++..+. .....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998777665 34556888899999999999999999988 99999999999999999999999999987654432
Q ss_pred cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
.....+||+.|+|||++... .++.++|||||||++|||++|++||...
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 22335799999999998654 5799999999999999999999999653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=341.12 Aligned_cols=210 Identities=30% Similarity=0.460 Sum_probs=177.3
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecC--------cceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 590 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~--------~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~ 590 (754)
....++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3456789999999999999999997532 3479999997653 34567889999999998 899999999999
Q ss_pred EecCcEEEEEEcccCCCHhhHhcCCC-------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCC
Q 004416 591 IEQGEKILIYEYMVNKSLDVFLFDPT-------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASN 657 (754)
Q Consensus 591 ~~~~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~N 657 (754)
.+++..++||||+++|+|.+++.... ....+++..+++++.||++||+|||+.+ ||||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 99999999999999999999985432 2345899999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 658 ILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 658 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
||++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||++ |++||...+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 9999999999999999998766554444555789999999999999999999999999999999998 688887544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=341.46 Aligned_cols=220 Identities=23% Similarity=0.340 Sum_probs=179.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeeccccch------hhHHHHHHHHHHHHHcc--ccceeeeEeEEEecC
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCIEQG 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~~~~~~~~ 594 (754)
.++|++.++||+|+||+||+|+.. +++.||||++..... ....++.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999864 689999999864321 12234678999999996 899999999999999
Q ss_pred cEEEEEEcccC-CCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-CCCeEEEeec
Q 004416 595 EKILIYEYMVN-KSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-HMNPKISDFG 672 (754)
Q Consensus 595 ~~~lV~ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-~~~~kL~DFG 672 (754)
..++||||+.+ +++..++ .....+++.++..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~---~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHH---HHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 5676666 24456899999999999999999999988 999999999999985 4789999999
Q ss_pred CccccCCCcccCCcccccccCcccCccccCCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCC---CCccchhhhHHHHHh
Q 004416 673 MARMFGGDELQGNTKRIVGTYGYMSPEYALEGVF-SVKSDVFSFGVLMLEILSSKKNTGVYN---TDSFNLLGHVSDKLY 748 (754)
Q Consensus 673 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlGvll~elltg~~p~~~~~---~~~~~~~~~~~~~l~ 748 (754)
+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+ .....+...+++.++
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHH
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHH
Confidence 998754332 234689999999999987765 567899999999999999999997643 222334445566666
Q ss_pred hhhhc
Q 004416 749 SLLFD 753 (754)
Q Consensus 749 ~~l~~ 753 (754)
++|.+
T Consensus 233 ~li~~ 237 (273)
T d1xwsa_ 233 HLIRW 237 (273)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=340.28 Aligned_cols=201 Identities=29% Similarity=0.433 Sum_probs=171.0
Q ss_pred CCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|+++++||+|+||+||+|+. .+++.||||+++... ....+++.+|+++|++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999986 468999999986542 2335688999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
|+.++.+..... .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997765544332 23456899999999999999999999988 9999999999999999999999999998775433
Q ss_pred ccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. ......||+.|+|||.+.... ++.++||||+||++|||++|+.||...
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 2 233358999999999877766 478999999999999999999999654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-40 Score=338.55 Aligned_cols=204 Identities=28% Similarity=0.382 Sum_probs=165.1
Q ss_pred cCCcceeeeeceeccEEEEeeeecC----cceeeeeecccc---chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEK 596 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~~----~~~vAVK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~ 596 (754)
.++|++.+.||+|+||.||+|++.. ...||||+++.. .....++|.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4679999999999999999997532 237899998654 33456789999999999999999999999965 567
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
++||||++++++.+.+.. ....+++..+++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999887743 3456899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCccc-CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 677 FGGDELQ-GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
+...... .......||..|+|||++.+..++.++||||||+++|||+| |+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 7554322 22333567889999999999999999999999999999998 899997543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-40 Score=336.51 Aligned_cols=200 Identities=31% Similarity=0.495 Sum_probs=166.1
Q ss_pred cccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEec-CcEEEEE
Q 004416 522 AATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIY 600 (754)
Q Consensus 522 ~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ 600 (754)
...++|++.++||+|+||.||+|++ .+..||||+++... ..++|.+|++++++++||||+++++++.+. +..++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 3446789999999999999999998 47789999996543 457899999999999999999999998654 5689999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGD 680 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~ 680 (754)
||+++|+|.+++... ....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred eccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999998432 2335899999999999999999999987 999999999999999999999999999865432
Q ss_pred cccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 004416 681 ELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILS-SKKNTGVYN 733 (754)
Q Consensus 681 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~ellt-g~~p~~~~~ 733 (754)
.....+|+.|+|||++.+..++.++||||||+++|||+| |+.||...+
T Consensus 157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~ 205 (262)
T d1byga_ 157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC
Confidence 233568899999999999999999999999999999998 677776644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=336.19 Aligned_cols=211 Identities=29% Similarity=0.397 Sum_probs=179.6
Q ss_pred hccccCCcceeeeeceeccEEEEeeee------cCcceeeeeeccccc-hhhHHHHHHHHHHHHHc-cccceeeeEeEEE
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCI 591 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~ 591 (754)
.+...++|++.++||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 345568999999999999999999975 245689999997643 34556789999999999 6999999999999
Q ss_pred ecCcEEEEEEcccCCCHhhHhcCCC---------------CcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCC
Q 004416 592 EQGEKILIYEYMVNKSLDVFLFDPT---------------KKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKAS 656 (754)
Q Consensus 592 ~~~~~~lV~ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~ 656 (754)
++...++||||+++|+|..++.... ....+++..+.+++.||++||+|||+++ |+||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence 9999999999999999999985322 2346889999999999999999999988 999999999
Q ss_pred CEEEcCCCCeEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCC
Q 004416 657 NILLDQHMNPKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSS-KKNTGVYN 733 (754)
Q Consensus 657 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg-~~p~~~~~ 733 (754)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+|+ ++|+...+
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987654433333446889999999999999999999999999999999995 45554443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-39 Score=338.18 Aligned_cols=211 Identities=29% Similarity=0.443 Sum_probs=180.6
Q ss_pred hccccCCcceeeeeceeccEEEEeeeec------Ccceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEe
Q 004416 520 VTAATENFSIQSKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE 592 (754)
Q Consensus 520 ~~~~~~~y~i~~~LG~G~fg~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~ 592 (754)
++...++|++.+.||+|+||.||+|++. ++..||||+++.. .......|.+|++++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 4455689999999999999999999763 3578999999754 33445678999999999999999999999999
Q ss_pred cCcEEEEEEcccCCCHhhHhcCC-------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCC
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDP-------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMN 665 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~ 665 (754)
....++||||+++|+|..++... .....+++..+.+++.|+++||.|||+++ |+||||||+|||++++++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence 99999999999999999887432 12234688999999999999999999987 999999999999999999
Q ss_pred eEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCC
Q 004416 666 PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSK-KNTGVYN 733 (754)
Q Consensus 666 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~-~p~~~~~ 733 (754)
+||+|||+|+.+.............||+.|+|||.+.+..++.++||||||+++|||+||+ +||...+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 9999999998775544433444467899999999999999999999999999999999985 6776543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=332.60 Aligned_cols=198 Identities=30% Similarity=0.487 Sum_probs=169.2
Q ss_pred eeeeceeccEEEEeeeecCc----ceeeeeecccc-chhhHHHHHHHHHHHHHccccceeeeEeEEEec-CcEEEEEEcc
Q 004416 530 QSKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-GEKILIYEYM 603 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~~----~~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-~~~~lV~ey~ 603 (754)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 25899998743 455668899999999999999999999998765 5789999999
Q ss_pred cCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCccc
Q 004416 604 VNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDELQ 683 (754)
Q Consensus 604 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 683 (754)
++++|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998853 3445678889999999999999999987 999999999999999999999999999987554322
Q ss_pred C--CcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 684 G--NTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 684 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 1 223357899999999999999999999999999999999988887543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-38 Score=331.26 Aligned_cols=200 Identities=24% Similarity=0.379 Sum_probs=172.8
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccc--hhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEEc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYEY 602 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~ey 602 (754)
++|++.++||+|+||+||+|+.++++.||||+++... ....+++.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999986542 33357889999999999999999999999999999999999
Q ss_pred ccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCcc
Q 004416 603 MVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDEL 682 (754)
Q Consensus 603 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~~ 682 (754)
+.++.+..+. ...+.+++..+..++.||++||+|||+.+ ||||||||+|||++.++.+||+|||.|........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988777766 34567999999999999999999999987 99999999999999999999999999988754432
Q ss_pred cCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 683 QGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 683 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 22335789999999998764 5689999999999999999999999643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-39 Score=337.80 Aligned_cols=202 Identities=33% Similarity=0.481 Sum_probs=170.4
Q ss_pred CCcceeeeeceeccEEEEeeeecC-cc--eeeeeecccc-chhhHHHHHHHHHHHHHc-cccceeeeEeEEEecCcEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~-~~--~vAVK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~~~~~~~~~~~lV 599 (754)
++|++.++||+|+||.||+|++++ +. .||||+++.. .....++|.+|+++|.++ +||||+++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 688999999999999999998754 33 5788887544 334566899999999999 799999999999999999999
Q ss_pred EEcccCCCHhhHhcCC-------------CCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCe
Q 004416 600 YEYMVNKSLDVFLFDP-------------TKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNP 666 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~ 666 (754)
|||+++|+|.++++.. .....+++..+.+++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467899999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCC-CCCCC
Q 004416 667 KISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKK-NTGVY 732 (754)
Q Consensus 667 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~-p~~~~ 732 (754)
||+|||+|+...... ......||+.|+|||.+.+..++.++|||||||++|||++|.. ||...
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~ 230 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 230 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence 999999998654322 2233578999999999999999999999999999999999764 67553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=334.65 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=168.1
Q ss_pred cCCcceeeeeceeccEEEEeeeec-C-cceeeeeeccccc--hhhHHHHHHHHHHHHHc---cccceeeeEeEEEec---
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCIEQ--- 593 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~-~~~vAVK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~~~~~~~--- 593 (754)
.++|+++++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999863 3 5679999986532 22233456788777766 799999999998642
Q ss_pred --CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEee
Q 004416 594 --GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDF 671 (754)
Q Consensus 594 --~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DF 671 (754)
...+++|||++++.+..... .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 46799999999887765442 34456889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 672 GMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 672 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 9998654322 234468999999999999999999999999999999999999999754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-38 Score=334.15 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=165.6
Q ss_pred CCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC----cEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 600 (754)
++|.+.+.||+|+||.||+|++ +|+.||||+++..... ....+.|+..+.+++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5688899999999999999987 6889999998654322 222345566667789999999999998764 579999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhc-----CCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQY-----SRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
||+++|+|..++. ...+++..+.+++.|++.||+|||+. ...+|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999994 34588999999999999999999974 12459999999999999999999999999998
Q ss_pred ccCCCcc--cCCcccccccCcccCccccCCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDEL--QGNTKRIVGTYGYMSPEYALEGV------FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+..... ........||+.|+|||++.+.. ++.++|||||||+||||+||..|++...
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 8754322 22334568999999999987643 5678999999999999999998875533
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=331.85 Aligned_cols=204 Identities=25% Similarity=0.382 Sum_probs=169.4
Q ss_pred ccCCcceeeeeceeccEEEEeeee-cCcceeeeeeccccc-hhhHHHHHHHHHHHHHccccceeeeEeEEEecC----cE
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----EK 596 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----~~ 596 (754)
.+++|+++++||+|+||+||+|+. .+++.||||++.... ....+++.+|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999986 468999999987543 344678899999999999999999999987653 33
Q ss_pred EEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 597 ILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 597 ~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
+++++|+.+++|.+++. ...+++..+..++.||++||+|||+++ ||||||||+|||+++++.+||+|||+|+.
T Consensus 86 ~~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566777999999983 346899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-CCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 677 FGGDELQ-GNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 677 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
....... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 6543322 22344679999999999854 567889999999999999999999996543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=330.60 Aligned_cols=202 Identities=28% Similarity=0.403 Sum_probs=173.0
Q ss_pred CCcceeeeeceeccEEEEeeeec----Ccceeeeeecccc----chhhHHHHHHHHHHHHHccc-cceeeeEeEEEecCc
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGE 595 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~----~~~~vAVK~l~~~----~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~ 595 (754)
++|++.++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999742 4789999998643 22335678899999999977 899999999999999
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.++||||+.+++|..++. ....+.+..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999883 4445678889999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcccCCcccccccCcccCccccCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEG--VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||...+
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 77543322 23346899999999998764 46789999999999999999999997655
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-36 Score=319.27 Aligned_cols=203 Identities=21% Similarity=0.294 Sum_probs=173.3
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccc-cceeeeEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~~~~~~~~~~~lV~e 601 (754)
.++|++.++||+|+||+||+|++. +++.||||+++.... .+.+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 478999999999999999999865 588999998865432 2456789999999975 899999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC-----CCCeEEEeecCccc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ-----HMNPKISDFGMARM 676 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~-----~~~~kL~DFGla~~ 676 (754)
|+ +++|..++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6788887743 3346889999999999999999999988 999999999999974 56799999999998
Q ss_pred cCCCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 004416 677 FGGDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYNT 734 (754)
Q Consensus 677 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~~ 734 (754)
+...... .......||+.|||||++.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 7543211 123446899999999999999999999999999999999999999976553
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-37 Score=330.48 Aligned_cols=197 Identities=27% Similarity=0.404 Sum_probs=164.8
Q ss_pred ccCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecC-----
Q 004416 523 ATENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG----- 594 (754)
Q Consensus 523 ~~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~----- 594 (754)
..++|+++++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3478999999999999999999864 5899999999753 3344678899999999999999999999997654
Q ss_pred -cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecC
Q 004416 595 -EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGM 673 (754)
Q Consensus 595 -~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGl 673 (754)
..++||||+ +.+|..+. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 569999999 55676665 3456899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 674 ARMFGGDELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 674 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
|+...... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 98764332 336799999999998764 5689999999999999999999999664
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=319.22 Aligned_cols=197 Identities=25% Similarity=0.386 Sum_probs=172.7
Q ss_pred CCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEecCcEEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQGEKILIYE 601 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~~~~lV~e 601 (754)
++|+++++||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999864 5888999998644 33456789999999999999999999999999999999999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCccccCCCc
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMARMFGGDE 681 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~~~~~~ 681 (754)
++.++++..++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888773 4456788999999999999999999987 9999999999999999999999999998875433
Q ss_pred ccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCC
Q 004416 682 LQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNT 729 (754)
Q Consensus 682 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~ 729 (754)
.. .....+++.|+|||.+.... ++.++||||+||++|||++|+.||
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence 22 22246788899999987665 689999999999999999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=322.77 Aligned_cols=202 Identities=26% Similarity=0.420 Sum_probs=168.8
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEe--------
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIE-------- 592 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~-------- 592 (754)
.++|++.++||+|+||+||+|+.. +++.||||++... .....+++.+|+++|++++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 378999999999999999999864 6899999998644 23345678899999999999999999998865
Q ss_pred cCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeec
Q 004416 593 QGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFG 672 (754)
Q Consensus 593 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFG 672 (754)
....++||||++++.+.... .....+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34579999999988776655 34456888999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCccc--CCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 004416 673 MARMFGGDELQ--GNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGV 731 (754)
Q Consensus 673 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~ 731 (754)
+++.+...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 99877643321 223335799999999998765 689999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-37 Score=328.02 Aligned_cols=198 Identities=26% Similarity=0.386 Sum_probs=165.8
Q ss_pred CcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceeeeEeEEEecC------cEEE
Q 004416 526 NFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQG------EKIL 598 (754)
Q Consensus 526 ~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~~------~~~l 598 (754)
+|+..++||+|+||+||+|+.. +++.||||++..... ...+|+++|++++||||+++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6889999999999999999975 588999999865432 2347999999999999999999986532 4689
Q ss_pred EEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCcccc
Q 004416 599 IYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMF 677 (754)
Q Consensus 599 V~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~ 677 (754)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755554433345567899999999999999999999987 99999999999999775 8999999999877
Q ss_pred CCCcccCCcccccccCcccCccccCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 678 GGDELQGNTKRIVGTYGYMSPEYALE-GVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 678 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 54332 233689999999998775 568999999999999999999999997544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-36 Score=315.43 Aligned_cols=202 Identities=22% Similarity=0.307 Sum_probs=166.2
Q ss_pred cCCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHccccceee-eEeEEEecCcEEEEEE
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCIEQGEKILIYE 601 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~-l~~~~~~~~~~~lV~e 601 (754)
.++|++.+.||+|+||.||+|++. +++.||||++..... .+++..|++++++++|+|++. +..+..+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999864 588999998765432 245788999999998776555 4555567788899999
Q ss_pred cccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcC---CCCeEEEeecCccccC
Q 004416 602 YMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQ---HMNPKISDFGMARMFG 678 (754)
Q Consensus 602 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~---~~~~kL~DFGla~~~~ 678 (754)
|+.+ ++...+. .....+++..+..++.|+++||+|||+++ |+||||||+|||++. +..+||+|||+|+.+.
T Consensus 84 ~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcCC-chhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9954 5555442 23456899999999999999999999988 999999999999864 5579999999999875
Q ss_pred CCccc-----CCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 679 GDELQ-----GNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 679 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 43321 12344689999999999999999999999999999999999999997655
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-35 Score=316.00 Aligned_cols=194 Identities=21% Similarity=0.373 Sum_probs=168.0
Q ss_pred CCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEec--CcEEEEE
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQ--GEKILIY 600 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~ 600 (754)
++|+++++||+|+||+||+|+.. +++.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999874 58899999986543 467889999999995 99999999998854 4689999
Q ss_pred EcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCC-CeEEEeecCccccCC
Q 004416 601 EYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHM-NPKISDFGMARMFGG 679 (754)
Q Consensus 601 ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~-~~kL~DFGla~~~~~ 679 (754)
||+.+++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 35889999999999999999999998 99999999999998655 589999999987754
Q ss_pred CcccCCcccccccCcccCccccCCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 680 DELQGNTKRIVGTYGYMSPEYALEG-VFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 680 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 43 22346789999999998765 47999999999999999999999997654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-35 Score=318.07 Aligned_cols=197 Identities=28% Similarity=0.335 Sum_probs=160.4
Q ss_pred cCCcceeeeeceeccEEEEeeeec-Ccceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec------C
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ------G 594 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~------~ 594 (754)
.++|+++++||+|+||+||+|++. +++.||||+++.. .....+++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 378999999999999999999875 5899999998654 334456789999999999999999999998643 5
Q ss_pred cEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCc
Q 004416 595 EKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMA 674 (754)
Q Consensus 595 ~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla 674 (754)
..++||||+.++.+.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 789999999776555432 34788999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 004416 675 RMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVY 732 (754)
Q Consensus 675 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~ 732 (754)
+...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 8764432 233467899999999999999999999999999999999999999654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-35 Score=316.05 Aligned_cols=198 Identities=29% Similarity=0.396 Sum_probs=166.7
Q ss_pred cCCcceeeeeceeccEEEEeeee-cCcceeeeeecccc--chhhHHHHHHHHHHHHHccccceeeeEeEEEec-----Cc
Q 004416 524 TENFSIQSKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCIEQ-----GE 595 (754)
Q Consensus 524 ~~~y~i~~~LG~G~fg~Vy~~~~-~~~~~vAVK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~~~~~~~-----~~ 595 (754)
.++|++.++||+|+||+||+|+. .+++.||||+++.. .....+++.+|+.+|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999986 46899999999754 233456788999999999999999999998643 34
Q ss_pred EEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEEeecCcc
Q 004416 596 KILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKISDFGMAR 675 (754)
Q Consensus 596 ~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~ 675 (754)
.+++++|+.+++|.+++. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 567788889999999883 345899999999999999999999988 9999999999999999999999999997
Q ss_pred ccCCCcccCCcccccccCcccCccccCCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 676 MFGGDELQGNTKRIVGTYGYMSPEYALEGV-FSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 676 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
.... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...+
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 6532 223367899999999877654 5889999999999999999999997543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=6.4e-31 Score=283.75 Aligned_cols=200 Identities=22% Similarity=0.317 Sum_probs=160.7
Q ss_pred CCcceeeeeceeccEEEEeeeec-CcceeeeeeccccchhhHHHHHHHHHHHHHcc-----------ccceeeeEeEEEe
Q 004416 525 ENFSIQSKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCIE 592 (754)
Q Consensus 525 ~~y~i~~~LG~G~fg~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~~~~~~ 592 (754)
++|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 46999999999999999999864 68999999997543 23467788999998886 4789999988765
Q ss_pred c--CcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCCCCceeCCCCCCCEEEcCCCC----
Q 004416 593 Q--GEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQ-YSRLRIIHRDLKASNILLDQHMN---- 665 (754)
Q Consensus 593 ~--~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~iiH~DIkp~NILl~~~~~---- 665 (754)
. ...++++++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4566777776655443333233455667889999999999999999998 55 999999999999986654
Q ss_pred --eEEEeecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 004416 666 --PKISDFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVLMLEILSSKKNTGVYN 733 (754)
Q Consensus 666 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvll~elltg~~p~~~~~ 733 (754)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...+
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 999999999865322 234679999999999999999999999999999999999999997654
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.87 E-value=2.6e-22 Score=174.84 Aligned_cols=107 Identities=25% Similarity=0.366 Sum_probs=95.5
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
.|+|.+||.|.+|+.|. +|.|.|+|+.+|+ |.|+. ..++||.||++.| +..+.|.|+.||+|+|++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 47899999999999995 6999999999888 77765 6789999999987 55788999999999999999
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCC
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 167 (754)
|.+||+|++.+....++|+|+||||||||+. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999988776777889999999999975 28999987
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.87 E-value=3.4e-22 Score=175.84 Aligned_cols=112 Identities=25% Similarity=0.423 Sum_probs=97.2
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
+|+|.|||.|.+|++|+| |.|.|+|+.+|+ |.++. ..++||.||++.| ...+.|.|+.||+|+|+|+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence 489999999999999985 889999999887 66765 6799999999987 3467899999999999996
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcc
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTD 170 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtD 170 (754)
+.++|++++........|+|+|+||||||+.+ +.++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-----CcEEecCCCccCC
Confidence 56788888776666778999999999999873 5689999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.8e-22 Score=196.53 Aligned_cols=168 Identities=20% Similarity=0.182 Sum_probs=119.7
Q ss_pred ceeeeeceeccEEEEeeeecCcceeeeeeccccch------------------hhHHHHHHHHHHHHHccccceeeeEeE
Q 004416 528 SIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLLGC 589 (754)
Q Consensus 528 ~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~~~ 589 (754)
.+.++||+|+||+||+|+..+|++||||+++.... ........|...+.++.|+++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 56789999999999999988899999998653210 112335678889999999999988765
Q ss_pred EEecCcEEEEEEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcCCCCceeCCCCCCCEEEcCCCCeEEE
Q 004416 590 CIEQGEKILIYEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYSRLRIIHRDLKASNILLDQHMNPKIS 669 (754)
Q Consensus 590 ~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iiH~DIkp~NILl~~~~~~kL~ 669 (754)
. ..+++|||+++..+.. ++.....+++.|++++++|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 2 3479999998865433 223345678999999999999988 9999999999999976 58999
Q ss_pred eecCccccCCCcccCCcccccccCcccCccccCCCCCCchhhHHHHHHH
Q 004416 670 DFGMARMFGGDELQGNTKRIVGTYGYMSPEYALEGVFSVKSDVFSFGVL 718 (754)
Q Consensus 670 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlGvl 718 (754)
|||+|+....+.........+ .. -.|.+ .+.|..++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~~l~rd~---~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERDV---RN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHHH---HH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHHH---HH-HHHHH-cCCCCCcccHHHHHHH
Confidence 999998764332110000000 00 01111 3567788999996443
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.85 E-value=1.3e-21 Score=170.47 Aligned_cols=108 Identities=22% Similarity=0.366 Sum_probs=93.5
Q ss_pred ccccCCCcccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCC
Q 004416 41 ADTLTPTTLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQS 120 (754)
Q Consensus 41 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~ 120 (754)
.|+|.|||.|.+|+.|.+ |.|.|+|...++ |.++. ..++||+||++.|. ...+.|.|+.||+|||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence 478999999999999975 889999998777 65554 57899999999994 45788999999999999999
Q ss_pred CCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCC
Q 004416 121 NGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDY 167 (754)
Q Consensus 121 ~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 167 (754)
|.+||+|+++.....+.|+|+||||||||+. .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 9999999987666677889999999999964 39999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.70 E-value=1.3e-17 Score=147.20 Aligned_cols=102 Identities=21% Similarity=0.280 Sum_probs=87.1
Q ss_pred EEEEecC-CCeeEEeccCCCCCcCCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCc
Q 004416 79 GIWYQQI-PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNST 157 (754)
Q Consensus 79 giw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~ 157 (754)
-|||.++ ..+++|++|+++|+.....+|.|+.||||||++. +.++|++++.+.+....|.|+++|||||++. .
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~-----~ 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN-----Q 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET-----T
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC-----C
Confidence 4788877 7799999999999988888999999999999986 6789999988777778899999999999987 4
Q ss_pred ccccccccCCCccccccccccccccccCCcceEEeecCCCCCCCcceEEeeecCCCCeEE
Q 004416 158 ESYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVC 217 (754)
Q Consensus 158 ~~~~WqSFd~PtDtlLpg~kl~~~~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~ 217 (754)
+++|||||. +.++|.|.+.++++|...+|
T Consensus 85 ~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred CCEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 578999963 34678899999999997654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=2.7e-16 Score=138.11 Aligned_cols=101 Identities=19% Similarity=0.365 Sum_probs=83.5
Q ss_pred cccCCCCEE--EcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCCCCeEE
Q 004416 48 TLIRDGETL--VSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIW 125 (754)
Q Consensus 48 ~~l~~~~~l--~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w 125 (754)
|.|.++|.| .+..|.|.|.|...|+ |.++ + ..++||.||+..| +..+.|.|+.||+|+|+|++|.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCCcEEE
Confidence 444444444 6679999999999888 6553 3 5789999999876 4468999999999999999999999
Q ss_pred EecccCCccCceEEEecCCCEEEecCCCCCCcccccccccC
Q 004416 126 SSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFD 166 (754)
Q Consensus 126 st~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd 166 (754)
++++.+....++++|+||||||||+. .+|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 99988776777889999999999964 4999954
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=5.7e-16 Score=135.06 Aligned_cols=109 Identities=22% Similarity=0.256 Sum_probs=88.7
Q ss_pred EEEecC-CCeeEEeccCCCCCcCCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcc
Q 004416 80 IWYQQI-PDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTE 158 (754)
Q Consensus 80 iw~~~~-~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~ 158 (754)
|||.-. +.+..|..+.+.++.+...+|.|+.||||||++ .+.++|++++.+. ....+.|+++|||||++. .+
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~-----~~ 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTA-----QN 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCT-----TT
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEcc-----CC
Confidence 566544 667789999999998888899999999999998 4689999998754 456789999999999987 45
Q ss_pred cccccccCCCccccccccccccccccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 159 SYLWQSFDYPTDTMLQGMKLGWDLRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 159 ~~~WqSFd~PtDtlLpg~kl~~~~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
.+||||+ ++.++|.|.+.++++|...+ | ..++|.+|.
T Consensus 76 ~~vWsS~-------------------------------t~~~~g~y~l~Lq~DGNlvl--Y--~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSG-------------------------------TKGSIGNYVLVLQPDRTVTI--Y--GPGLWDSGT 112 (115)
T ss_dssp CCSCCCC-------------------------------CCCCSSCCEEEECSSSCEEE--E--CSEEEECSC
T ss_pred CEEEEcC-------------------------------CCCCCCCEEEEECCCCcEEE--e--CCCeecCCC
Confidence 7899975 23468999999999999654 4 347898874
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.53 E-value=4.9e-15 Score=129.02 Aligned_cols=97 Identities=23% Similarity=0.341 Sum_probs=80.5
Q ss_pred cccCCCCEEEcCCCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCCCCeEEEe
Q 004416 48 TLIRDGETLVSPSQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSS 127 (754)
Q Consensus 48 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst 127 (754)
|.|.+++.| .+|.|.|.|..+|+ |.++. ..++||.+|+..+ ..+.+.|+.||||||+|.++.+||++
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEc
Confidence 556666666 45779999999888 76754 5788999998653 46889999999999999999999999
Q ss_pred cccCCccCceEEEecCCCEEEecCCCCCCccccccccc
Q 004416 128 NVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSF 165 (754)
Q Consensus 128 ~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSF 165 (754)
.+......++++|++|||||||+. .+|+|-
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssg 111 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSG 111 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEECS--------EEEECS
T ss_pred CCCCCCCCEEEEECCCCcEEEeCC--------CeecCC
Confidence 998777778899999999999964 489984
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=1.1e-12 Score=115.13 Aligned_cols=87 Identities=22% Similarity=0.351 Sum_probs=69.9
Q ss_pred CCeEEEeEeCCCCCCCeEEEEEEecCCCeeEEeccCCCCCcCCCceEEEeccCcEEEecCCCCeEEEecccCCccCceEE
Q 004416 60 SQRFELGFFSPGKSQNRYVGIWYQQIPDTVVWVANRNSPIVDKNGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQ 139 (754)
Q Consensus 60 ~g~f~lgf~~~~~~~~~y~giw~~~~~~~~vW~an~~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~ 139 (754)
.|.|.|.|...|+ |.++- ...+||.++... .+..+.+.|+.+|||||+|.++.++|+|++......+.++
T Consensus 34 ~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l~ 103 (120)
T d1dlpa2 34 LSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFV 103 (120)
T ss_dssp CSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEE
T ss_pred cCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEEE
Confidence 3557777777665 55543 567899998754 3556889999999999999999999999998776778889
Q ss_pred EecCCCEEEecCCCCCCcccccccc
Q 004416 140 LLDNGNLVIRDNSGSNSTESYLWQS 164 (754)
Q Consensus 140 l~d~GNlvl~~~~~~~~~~~~~WqS 164 (754)
|++|||||||+. .+|.|
T Consensus 104 Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 104 LQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp ECSSSCEEEECC--------CCCBC
T ss_pred ECCCCcEEEeCC--------CcccC
Confidence 999999999964 38976
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.18 E-value=4.4e-11 Score=102.85 Aligned_cols=86 Identities=23% Similarity=0.360 Sum_probs=66.6
Q ss_pred ceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccccccccc
Q 004416 104 GVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLR 183 (754)
Q Consensus 104 ~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~~ 183 (754)
-+|.|+.||||||++. +.+||++++.+.+..+.+.|+++|||||++.+ +.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-----g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-----NKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEEEEeccceEEEECCC-----ccceEEc-------------------
Confidence 4588999999999974 58999999887766778899999999999874 5778876
Q ss_pred cCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 184 TGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 184 tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
......+.|.+.++.+|...++ . .+.|.++.
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~t 106 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATGT 106 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCCC
Confidence 1222456788999999987654 2 34676653
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.12 E-value=9e-11 Score=102.34 Aligned_cols=85 Identities=24% Similarity=0.284 Sum_probs=67.1
Q ss_pred eEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccccccccccc
Q 004416 105 VLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDLRT 184 (754)
Q Consensus 105 ~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~~t 184 (754)
.|.|+.||||||+++ +.++|++++.+......+.|+++|||||++.+ +.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-----g~~vWsS~------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCC-----CcEEEECC-------------------
Confidence 588999999999976 56899999887766778899999999999874 46788751
Q ss_pred CCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCC
Q 004416 185 GLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGP 230 (754)
Q Consensus 185 g~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~ 230 (754)
+.-+.|.|.+.++.+|...++ . .+.|.++.
T Consensus 88 ------------t~~~~~~~~l~Lq~DGNlvlY--g--~~~W~S~T 117 (119)
T d1b2pa_ 88 ------------VAGKAGHYVLVLQPDRNVVIY--G--DALWATQT 117 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSCEEEE--E--SEEEECCC
T ss_pred ------------CcCCCCceEEEEcCCCCEEEE--C--CCEeccCC
Confidence 222457789999999997654 2 46888764
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.04 E-value=7.2e-10 Score=95.16 Aligned_cols=88 Identities=26% Similarity=0.363 Sum_probs=66.0
Q ss_pred CceEEEeccCcEEEecCCCCeEEEecccCCc-cCceEEEecCCCEEEecCCCCCCcccccccccCCCccccccccccccc
Q 004416 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREV-KNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWD 181 (754)
Q Consensus 103 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~ 181 (754)
.-.|.|+.||||||+. .+.+||++++.... ....+.|+++|||||++.+ +.++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-----g~~vW~s----------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-----GRSLWAS----------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-----SCEEEEC-----------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-----CcEEEEE-----------------
Confidence 3568899999999986 56899999987543 3566899999999999874 5678886
Q ss_pred cccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecCCceeeccCCC
Q 004416 182 LRTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNGSAKYTCTGPW 231 (754)
Q Consensus 182 ~~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~~~~yw~sg~w 231 (754)
.+..+.|.|.+.++.+|...+ +. .+.|.++.+
T Consensus 77 --------------~t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~ 108 (109)
T d1kj1a_ 77 --------------HSVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred --------------eeECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence 122235678899999999764 43 357877653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.76 E-value=1.6e-08 Score=87.30 Aligned_cols=88 Identities=25% Similarity=0.418 Sum_probs=66.1
Q ss_pred CceEEEeccCcEEEecCCCCeEEEecccCCccCceEEEecCCCEEEecCCCCCCcccccccccCCCcccccccccccccc
Q 004416 103 NGVLTVSNRGNLVLLNQSNGTIWSSNVSREVKNPVAQLLDNGNLVIRDNSGSNSTESYLWQSFDYPTDTMLQGMKLGWDL 182 (754)
Q Consensus 103 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~~WqSFd~PtDtlLpg~kl~~~~ 182 (754)
.-.|.|+.||||||++ .+.+||++++.+...+..+.|+.+|||||++.+ +.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE------------------
Confidence 4579999999999987 568999999877666677899999999999852 345543
Q ss_pred ccCCcceEEeecCCCCCCCcceEEeeecCCCCeEEEecC-CceeeccCC
Q 004416 183 RTGLERYQTSWKSADDPSPGNFTHRLDIHVLPQVCVYNG-SAKYTCTGP 230 (754)
Q Consensus 183 ~tg~~~~l~Sw~s~~dps~G~fs~~~~~~g~~~~~~~~~-~~~yw~sg~ 230 (754)
...-..|.+.+.++.+|...+ ++. ..+.|.++.
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvl--y~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVI--YDNSNNAIWATHT 108 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEE--ECTTSCEEEECCC
T ss_pred -------------eeccCCCceEEEEcCCCCEEE--ECCCCcEEecCCC
Confidence 222345678999999998754 443 356888754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=7.3e-07 Score=88.75 Aligned_cols=147 Identities=16% Similarity=0.105 Sum_probs=99.9
Q ss_pred ccccCCcceeeeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcc-ccceeeeEeEEEecCcEEEE
Q 004416 521 TAATENFSIQSKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCIEQGEKILI 599 (754)
Q Consensus 521 ~~~~~~y~i~~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~~~~~~~~~~~lV 599 (754)
...-+.|+..+..+-+....||+... +++.+++|+...........+.+|...+..+. +-.+.+++.+...++..++|
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 33346777766655555578998865 56677888876554444456778988888874 44467888888888889999
Q ss_pred EEcccCCCHhhHhcCCCCcccccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 004416 600 YEYMVNKSLDVFLFDPTKKHLLGWQLRVRIIDGIAQGLLYLHQYS----------------------------------- 644 (754)
Q Consensus 600 ~ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------- 644 (754)
|+++++..+........ ....++.++++.+..||+..
T Consensus 89 ~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999988755432111 11223444555555555311
Q ss_pred ---------------------CCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 645 ---------------------RLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 645 ---------------------~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
...++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11269999999999999876677999998853
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=2.7e-05 Score=76.51 Aligned_cols=75 Identities=16% Similarity=0.122 Sum_probs=54.5
Q ss_pred eeceecc-EEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccc--ceeeeEeEEEecCcEEEEEEcccCCCH
Q 004416 532 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR--NLVRLLGCCIEQGEKILIYEYMVNKSL 608 (754)
Q Consensus 532 ~LG~G~f-g~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~--nIv~l~~~~~~~~~~~lV~ey~~~gsL 608 (754)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+... .+.+++.+..+++..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 679999887788888997654432 3467788888877543 356778887888889999999988665
Q ss_pred h
Q 004416 609 D 609 (754)
Q Consensus 609 ~ 609 (754)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.26 E-value=0.00029 Score=73.91 Aligned_cols=76 Identities=11% Similarity=0.137 Sum_probs=49.1
Q ss_pred eeeeceeccEEEEeeeecC-cceeeeeecccc-------chhhHHHHHHHHHHHHHcc-c--cceeeeEeEEEecCcEEE
Q 004416 530 QSKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ-H--RNLVRLLGCCIEQGEKIL 598 (754)
Q Consensus 530 ~~~LG~G~fg~Vy~~~~~~-~~~vAVK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~~~~~~~~~~~l 598 (754)
.+.||.|....||++...+ ++.++||.-... -+....+...|++.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3578999999999998654 668888854321 1112344567888887763 2 345566544 5566789
Q ss_pred EEEcccCCC
Q 004416 599 IYEYMVNKS 607 (754)
Q Consensus 599 V~ey~~~gs 607 (754)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.45 E-value=0.0063 Score=61.44 Aligned_cols=136 Identities=15% Similarity=0.149 Sum_probs=79.5
Q ss_pred cEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccccee--eeE-----eEEEecCcEEEEEEcccCCCHhh
Q 004416 538 FGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV--RLL-----GCCIEQGEKILIYEYMVNKSLDV 610 (754)
Q Consensus 538 fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv--~l~-----~~~~~~~~~~lV~ey~~~gsL~~ 610 (754)
.-.||+++..+|+.+++|+..... ...+++..|...+..+...++. ..+ .....++..+.+++++++..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 357999999899999999876432 2356778899999888643321 111 12234567788999997644311
Q ss_pred -----H------h-------c--CCCCcccccHH-------------------HHHHHHHHHHHHHHHHHh----cCCCC
Q 004416 611 -----F------L-------F--DPTKKHLLGWQ-------------------LRVRIIDGIAQGLLYLHQ----YSRLR 647 (754)
Q Consensus 611 -----~------l-------~--~~~~~~~l~~~-------------------~~~~i~~qia~~L~yLH~----~~~~~ 647 (754)
+ + . ........+.. ....+...+.+.++.+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 0 0 00111111111 111122223333333332 22345
Q ss_pred ceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 648 IIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 648 iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 56899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.70 E-value=0.012 Score=60.96 Aligned_cols=72 Identities=19% Similarity=0.238 Sum_probs=48.0
Q ss_pred eeeceeccEEEEeeeecCc--------ceeeeeeccccchhhHHHHHHHHHHHHHcccccee-eeEeEEEecCcEEEEEE
Q 004416 531 SKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCIEQGEKILIYE 601 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~--------~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~~~~~~~~~~~lV~e 601 (754)
+.|+.|-.-.+|++...++ +.|.+++.. ... ......+|..+++.+.-.++. ++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 6788888899999976532 345666554 222 233456899999988655554 6666653 268999
Q ss_pred cccCCCH
Q 004416 602 YMVNKSL 608 (754)
Q Consensus 602 y~~~gsL 608 (754)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.68 E-value=0.045 Score=54.38 Aligned_cols=143 Identities=14% Similarity=0.049 Sum_probs=72.9
Q ss_pred eeeceeccEEEEeeeecCcceeeeeeccccchhhHHHHHHHHHHHHHcccccee--eeEe------EEEecCcEEEEEEc
Q 004416 531 SKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV--RLLG------CCIEQGEKILIYEY 602 (754)
Q Consensus 531 ~~LG~G~fg~Vy~~~~~~~~~vAVK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv--~l~~------~~~~~~~~~lV~ey 602 (754)
+.|..|---+.|+.+..++ .+++|+..... ..+++..|+++|..+.+.++. ..+. ..........++.+
T Consensus 24 ~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~ 100 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 100 (316)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred ecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeee
Confidence 4566677788899987554 58999885432 224456677788877543321 1110 11234456667777
Q ss_pred ccCCCHhhH-----------h---c------CCCCcccccH------------------HHHHHHHHHHHHHHHHHHh-c
Q 004416 603 MVNKSLDVF-----------L---F------DPTKKHLLGW------------------QLRVRIIDGIAQGLLYLHQ-Y 643 (754)
Q Consensus 603 ~~~gsL~~~-----------l---~------~~~~~~~l~~------------------~~~~~i~~qia~~L~yLH~-~ 643 (754)
+.+...... + + .......... ......+..+...+.-.+. .
T Consensus 101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (316)
T d2ppqa1 101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 180 (316)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence 765433110 0 0 0000000000 0011111122222222221 1
Q ss_pred CCCCceeCCCCCCCEEEcCCCCeEEEeecCccc
Q 004416 644 SRLRIIHRDLKASNILLDQHMNPKISDFGMARM 676 (754)
Q Consensus 644 ~~~~iiH~DIkp~NILl~~~~~~kL~DFGla~~ 676 (754)
-+.++||+|+.++||+++.+...-|+||+.+..
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccccCCcchhhhhcccccceeEeccccccc
Confidence 223589999999999999887778999998853
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.47 E-value=0.12 Score=34.40 Aligned_cols=32 Identities=22% Similarity=0.531 Sum_probs=24.6
Q ss_pred CCCCc--cCCcCCCCcccCC-CCCcccccCCCccC
Q 004416 301 DPFCH--YGDCGPNSICSVD-QTSHCECLEGFKFK 332 (754)
Q Consensus 301 ~~~C~--~g~CG~~g~C~~~-~~~~C~C~~Gf~~~ 332 (754)
.|+|. ...|..+|.|... ..-.|.|++||+-.
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 36687 5679999999854 34589999999743
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.25 E-value=0.22 Score=32.33 Aligned_cols=32 Identities=31% Similarity=0.674 Sum_probs=25.2
Q ss_pred CCCccCCcCCCCcccCC-CCCcccccCCCccCC
Q 004416 302 PFCHYGDCGPNSICSVD-QTSHCECLEGFKFKS 333 (754)
Q Consensus 302 ~~C~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 333 (754)
|+|....|...|.|... ..-.|.|++||+-..
T Consensus 1 D~C~~~PC~ngg~C~~~~~~y~C~C~~G~~G~~ 33 (39)
T d1xkba1 1 DQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKN 33 (39)
T ss_dssp CTTTTCCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred CcCCCCCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence 56887789999999864 456899999997543
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.22 E-value=0.16 Score=33.04 Aligned_cols=31 Identities=19% Similarity=0.518 Sum_probs=24.9
Q ss_pred CCCccCCcCCCCcccCC-CCCcccccCCCccC
Q 004416 302 PFCHYGDCGPNSICSVD-QTSHCECLEGFKFK 332 (754)
Q Consensus 302 ~~C~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~ 332 (754)
|.|...-|...|.|... ..-.|.|++||.-.
T Consensus 2 d~C~~~PC~n~g~C~~~~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 2 NECVSNPCQNDATCLDQIGEFQCICMPGYEGV 33 (39)
T ss_dssp CTTTTCCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred cCCcCCCCCCCCEEECCCCCEEEeCCCCCccC
Confidence 67887779999999854 45589999999754
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.18 E-value=0.17 Score=33.90 Aligned_cols=38 Identities=24% Similarity=0.508 Sum_probs=26.3
Q ss_pred CCCCc--cCCcCCCCcccCC-CCCcccccCCCccCCCCCCcc
Q 004416 301 DPFCH--YGDCGPNSICSVD-QTSHCECLEGFKFKSQQNQTC 339 (754)
Q Consensus 301 ~~~C~--~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~~~~~GC 339 (754)
.|+|. ...|. ++.|... .+-.|.|++||+...+..+.|
T Consensus 3 idEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~~~~~g~~C 43 (44)
T d1lmja1 3 IDECRISPDLCG-RGQCVNTPGDFECKCDEGYESGFMMMKNC 43 (44)
T ss_dssp CCTTTTCSSTTT-TSCEEEETTEEEECCCSSEEECTTTSSSE
T ss_pred ccccCCCCCCCC-CCEeEcCCCCeEEeCCCCCccCCCCCCcC
Confidence 36787 56675 7899754 445899999998754433445
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.58 E-value=0.23 Score=30.80 Aligned_cols=31 Identities=32% Similarity=0.647 Sum_probs=23.0
Q ss_pred CCCc-cCCcCCCCcccCC-CCCcccccCCCccCC
Q 004416 302 PFCH-YGDCGPNSICSVD-QTSHCECLEGFKFKS 333 (754)
Q Consensus 302 ~~C~-~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 333 (754)
|+|. -..|| ||.|+.- ..-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 5677 66787 6888743 344799999999865
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.50 E-value=0.28 Score=31.82 Aligned_cols=32 Identities=28% Similarity=0.533 Sum_probs=25.8
Q ss_pred CCCCccCCcCCCCcccCC-CCCcccccCCCccC
Q 004416 301 DPFCHYGDCGPNSICSVD-QTSHCECLEGFKFK 332 (754)
Q Consensus 301 ~~~C~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~ 332 (754)
.|+|....|-..|.|... ..-+|.|++||+-+
T Consensus 3 ~d~C~~~PC~ngg~C~~~~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 3 GDQCESNPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CCTTTTCCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred cccCCCCCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence 478987789999999753 45689999999754
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.41 E-value=0.65 Score=30.73 Aligned_cols=32 Identities=22% Similarity=0.421 Sum_probs=23.8
Q ss_pred CCCCccCCcCCCCcccCC-CCCcccccCCCccC
Q 004416 301 DPFCHYGDCGPNSICSVD-QTSHCECLEGFKFK 332 (754)
Q Consensus 301 ~~~C~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~ 332 (754)
.|+|..+.|+.++.|... .+-.|.|++||...
T Consensus 5 idEC~~~~~~~~~~C~Nt~Gsy~C~C~~Gy~~~ 37 (43)
T d1emoa1 5 MDECKEPDVCKHGQCINTDGSYRCECPFGYILA 37 (43)
T ss_dssp CCSSSSTTSCSSSCCCCCSSCCCCCCCTTEEES
T ss_pred eeccCCcCCCCCCEeECCCCCeEeECCCCcccC
Confidence 477884456678999864 34589999999863
|